Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ZNF595	FLJ31740	ENSG00000272602	"Zinc finger protein 595"		4	53285-88211	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"placenta: 35.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.1;K-562: 64.4;SH-SY5Y: 44.1"															NA	NA						"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.63e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.46e-2)"	5.4	5.0	3.5	3.8	5.3	4.5	5.8	15.9	5.7	6.7	3.6	3.7	3.0	2.3	6.0	3.5	2.5	4.4	2.8	2.5	3.9		3.1	3.5	4.0	5.3	4.5	4.2	10.1	4.2	3.5	10.3	35.9	7.0	4.6	3.5	3.1	2.9	2.5	5.1	3.9	1.8	6.4	5.5	5.1	2.7	4.7	4.7	9.5	7.4	1.9	5.7	4.2	3.2	12.5	11.6	11.0	2.4	16.7	6.7	3.4	1.0	3.6	2.4	2.2	14.1	17.5	18.8	1.3	1.2	1.4	1.9	1.7	1.5	28.1	2.2	1.0	2.4	0.8	13.6	1.2	2.1	2.2	1.9	0.1	0.0	0.0	0.9	0.0	7.4	1.9	1.6	1.4	1.5	1.6	1.1	12.9	64.4	0.3	1.1	8.0	0.0	7.8	4.2	0.0	1.6	0.0	0.5	0.0	2.0	1.1	2.0	44.1	1.6	1.9	0.7	10.1	13.7	4.5	7.9	1.5	10.9	0.8	1.6	0.1	13.6	3.3	0.0	0.0	4.8	3.4	2.1	11.0	6.7	2.4	3.1	12.5	3.6	4.3	3.1	12.4	5.0	5.0	3.7	16.7	2.2	11.6	2.7	3.4											6.0	9.4	10.5	8.7	4.0	8.2	4.9	7.6	2.7	19.4	3.5	2.0	8.7	13.3	6.6	3.9	8.2	1.6	0.0	3.8	7.3	4.8	4.8	7.0	3.4	3.3	3.2	0.0	9.2	3.5	4.9	10.3	2.6	5.0	1.0	2.7	9.8	3.3	2.9	8.5	4.2	6.2	0.0	4.7	12.2	12.7	4.0	7.1	8.6	3.3	5.2
ZNF718	FLJ90036	ENSG00000250312	"Zinc finger protein 718"		4	124480-202303	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 17.0"															NA	Yes						"unprognostic (1.96e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.39e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-1)"	3.1	6.0	5.9	5.7	7.7	4.7	4.6	16.0	7.5	6.9	4.7	7.7	4.5	3.0	6.5	4.3	2.8	5.9	3.6	2.9	6.5		4.8	2.7	3.5	6.5	9.7	5.8	7.2	4.6	8.8	17.8	5.4	7.2	5.9	4.4	7.8	3.1	4.2	1.4	5.3	3.3	5.0	9.1	5.0	3.4	3.9	10.5	11.0	9.1	1.7	6.2	5.4	3.0	4.3	4.4	9.6	3.2	9.0	4.2	2.1	0.0	0.9	5.1	0.1	3.2	5.9	1.2	6.3	0.9	4.1	3.4	5.3	7.1	7.6	3.8	2.2	7.2	1.9	4.0	2.9	5.5	0.0	1.5	0.0	1.3	0.0	3.9	0.0	0.2	3.1	2.6	4.1	0.5	3.6	2.7	2.2	3.5	0.0	7.0	3.9	0.7	4.8	6.3	0.0	2.4	17.0	2.0	4.3	3.3	1.9	6.8	1.6	3.2	1.1	3.8	4.2	11.7	1.9	1.9	3.0	3.8	3.8	4.6	0.0	0.0	12.1	0.0	0.0	3.7	4.7	2.5	9.6	4.2	3.2	4.1	3.9	3.6	2.6	4.3	4.3	4.2	4.0	3.1	9.0	1.9	4.4	2.7	2.1											3.0	2.2	0.5	1.7	1.8	8.3	1.6	0.0	4.0	7.9	0.0	2.0	1.6	0.0	2.8	0.3	2.9	0.5	0.0	1.2	1.2	1.5	1.5	5.7	0.4	1.2	7.9	1.2	8.0	2.1	0.4	3.4	2.5	3.3	1.0	0.7	2.4	1.2	0.0	4.2	1.8	4.6	0.0	2.8	1.7	2.3	0.6	1.1	2.9	0.6	0.6
ZNF732	FLJ59067	ENSG00000186777	"Zinc finger protein 732"	B4DXR9	4	270675-305321	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 19.5"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 8.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NTERA-2: 12.3"															NA	NA						"unprognostic (7.83e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.99e-4)"	"unprognostic (7.60e-3)"	"unprognostic (8.13e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.44e-3)"	"unprognostic (3.60e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.40e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-1)"	0.7	0.6	1.1	3.8	5.9	0.6	1.9	4.6	1.8	1.3	1.0	0.1	0.8	0.4	1.6	0.2	2.3	1.1	0.6	0.9	1.1	1.1	0.5	0.3	0.6	2.3	0.8	0.3	2.3	0.7	0.7	2.2	2.3	1.5	1.3	0.3	0.2	0.8	0.3	0.2	3.3	0.4	1.0	0.9	1.0	0.4	19.5	0.4	0.3	1.6	2.4	2.8	2.0	1.2	0.5	0.1	0.1	0.0	0.9	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	2.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.3	0.0	2.4	0.0	0.0	0.0	1.0	1.5	0.0	2.8	0.0	0.0	0.0	3.0	2.7	0.0	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.9	0.0	0.1	0.1	0.0	1.1	5.9	4.6	1.8	1.1	1.1	0.8	0.3	1.5	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	8.3	0.3	0.0	0.0	0.0	0.0
ZNF141	"D4S90, pHZ-44"	ENSG00000131127	"Zinc finger protein 141"	Q15928	4	337814-384864	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.76e-4)"	11.9	20.4	9.6	15.1	13.7	4.6	12.1	27.2	12.2	17.2	9.9	6.2	11.0	8.7	11.8	14.7	8.1	9.7	6.7	7.8	10.0	9.1	9.4	8.9	11.0	18.8	14.9	7.4	24.6	8.7	12.9	23.6	10.3	10.8	11.4	10.5	7.8	9.5	9.3	5.7	10.2	9.2	12.0	20.8	14.1	9.7	10.1	15.2	26.8	15.8	6.4	17.2	15.2	15.0	6.4	3.3	4.5	3.3	3.5	7.3	2.1	0.2	2.4	9.7	3.5	3.0	5.1	2.7	2.8	2.3	5.2	7.5	8.2	5.4	0.4	2.2	2.6	5.6	3.7	0.0	3.0	7.5	0.0	2.4	0.0	3.2	0.2	2.6	0.1	9.4	5.7	2.6	5.1	1.8	2.5	1.1	2.0	0.1	0.1	4.0	2.5	9.2	9.9	12.7	1.3	5.0	0.0	0.0	1.2	3.0	4.8	10.6	4.8	4.3	1.7	3.1	6.6	5.1	10.7	0.9	0.4	3.9	2.3	2.9	0.1	0.1	0.1	0.0	0.0	1.9	0.0	2.0	4.5	5.1	2.9	6.1	4.6	4.1	4.2	3.3	6.4	7.3	5.0	2.5	3.5	3.3	2.3	3.4	2.1	9.6	13.7	27.2	12.2	10.0	9.1	14.9	7.4	10.8	15.2	6.0	4.8	5.0	3.1	3.3	21.5	4.8	5.1	6.7	5.7	14.0	13.7	2.8	5.0	3.0	7.8	7.7	2.6	0.0	2.5	2.6	4.9	2.4	5.7	1.7	2.0	31.8	5.8	3.1	0.6	4.7	10.3	5.0	3.3	5.4	1.9	10.9	2.0	0.0	5.6	1.1	18.7	25.8	15.5	8.1	5.7	3.6	3.4	8.2	3.9	1.7
ZNF721	KIAA1982	ENSG00000182903	"Zinc finger protein 721"	Q8TF20	4	425815-499156	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA065313			Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA065313: AB_2685464"	"unprognostic (2.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (2.76e-4)"	16.1	15.3	20.9	17.2	24.5	20.8	24.7	42.3	25.6	17.7	13.9	15.9	15.4	13.4	17.2	19.3	15.4	20.4	13.5	12.1	19.4	15.3	16.1	16.3	16.4	26.9	24.6	22.8	21.5	19.2	21.1	39.2	13.1	20.7	16.5	16.4	13.9	16.1	15.0	14.5	23.5	16.0	17.5	22.1	18.3	16.2	17.7	23.9	20.3	22.5	12.7	27.8	19.0	16.7	15.1	9.5	11.3	7.8	11.5	20.8	6.5	8.8	5.8	11.2	13.9	8.4	11.2	7.0	8.2	7.2	9.1	8.2	8.5	9.1	15.2	8.8	7.8	13.1	5.8	11.6	10.0	12.1	5.4	13.6	26.4	6.0	5.8	8.0	11.0	1.7	10.2	8.8	10.3	14.9	14.0	8.9	21.7	15.4	11.0	12.5	8.7	18.1	18.0	17.5	5.9	12.3	14.8	16.3	8.4	9.4	12.4	16.7	10.6	10.7	6.1	9.9	9.9	11.5	11.9	11.4	8.3	2.9	6.3	14.1	12.6	11.8	36.9	6.2	3.1	7.4	7.0	7.8	11.3	12.0	7.6	11.9	15.1	13.1	11.5	7.6	15.1	20.8	16.0	11.1	11.5	6.7	9.5	14.6	6.5	20.9	24.5	42.3	25.6	19.4	15.3	24.6	22.8	20.7	23.9	23.8	26.4	17.4	22.0	18.7	36.4	13.2	30.6	26.8	25.0	17.4	29.5	14.3	13.3	11.7	26.5	26.3	9.5	0.0	13.0	8.4	12.5	22.0	25.4	16.3	9.5	22.3	12.2	31.3	19.9	8.8	18.1	17.6	11.8	8.2	15.7	27.0	11.4	8.6	11.3	10.2	32.8	19.4	10.3	34.4	27.7	20.3	14.5	39.2	15.3	26.8
PIGG	"FLJ20265, GPI7, LAS21"	ENSG00000174227	"Phosphatidylinositol glycan anchor biosynthesis class G"	Q5H8A4	4	499210-540196	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015997	Uncertain					NA	NA					"HPA015997: AB_2164679"	"unprognostic (3.87e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.61e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.97e-2)"	16.2	22.0	12.8	19.8	19.7	11.3	17.1	21.3	23.2	13.3	15.6	23.2	21.5	18.8	23.2	28.7	16.7	15.6	17.4	11.5	13.6	12.5	15.5	13.0	15.5	16.5	20.3	16.0	22.1	18.6	31.1	22.9	16.7	17.2	16.9	16.5	19.5	20.9	19.1	10.7	26.6	17.5	19.3	21.8	17.7	17.5	19.9	17.6	16.2	21.9	9.6	15.1	19.5	15.0	4.2	9.2	16.4	7.5	8.1	9.0	4.5	10.7	12.0	10.9	9.2	20.0	14.4	17.2	14.3	17.2	15.4	18.2	12.2	25.6	4.4	10.4	18.0	28.0	14.4	10.3	14.0	14.1	4.2	11.1	11.2	14.6	9.5	14.0	15.4	16.9	16.1	23.4	14.1	7.8	16.6	11.6	8.9	12.3	10.3	13.6	6.6	8.6	13.3	17.4	11.7	16.4	9.5	6.7	6.7	14.5	14.9	10.9	13.9	10.4	10.8	9.9	10.8	17.4	13.9	17.8	15.9	7.4	7.8	22.1	8.3	10.8	7.1	13.5	11.4	19.5	16.4	5.9	4.7	7.2	7.5	8.3	4.2	5.7	6.9	9.2	3.6	6.2	5.0	4.3	8.1	5.3	8.0	9.0	4.5	12.8	19.7	21.3	23.2	13.6	12.5	20.3	16.0	17.2	17.6	14.9	9.3	5.1	8.9	7.9	10.4	6.5	2.5	14.7	18.2	8.7	3.9	14.4	0.0	14.3	1.6	10.3	12.4	0.0	15.6	12.3	8.1	11.6	12.7	8.3	8.2	7.9	10.4	6.7	11.6	0.4	12.7	10.7	8.5	13.6	7.5	15.1	14.5	10.1	12.0	5.7	10.3	19.4	6.2	9.7	9.3	5.5	19.3	10.0	8.6	12.2
AC116565.1		ENSG00000273238			4	573880-576300	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	5	"brain: 12.7;skin 1: 7.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"glioma: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.1;NB-4: 2.6;NTERA-2: 4.8;SCLC-21H: 10.5;U-2 OS: 2.6;U-251 MG: 3.2"	"Low region specificity"	"Detected in all"													NA	NA										"unprognostic (4.13e-3)"						"unprognostic (6.97e-3)"				"unprognostic (2.65e-2)"			0.0	1.8	1.3	0.0	3.1	0.0	0.1	0.0	12.7	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1		0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	2.6	4.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625584-670782	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 64.2"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 453.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.6	1.9	12.1	4.6	19.1	6.7	3.8	2.3	13.2	2.3	1.3	30.2	1.5	0.8	2.5	3.9	1.4	9.6	3.2	5.2	18.1	10.2	4.6	0.7	4.2	12.0	29.6	9.8	2.6	1.4	9.1	3.2	2.6	14.5	2.5	1.0	64.2	3.5	2.9	0.7	1.8	2.2	2.1	20.2	8.7	2.5	3.6	22.4	4.3	11.4	0.2	8.3	4.1	1.1	16.5	14.1	11.2	5.8	10.2	13.1	7.1	0.0	0.2	0.8	0.4	0.2	0.3	0.2	0.0	0.0	0.5	1.4	0.0	0.1	0.2	8.0	0.2	0.7	0.1	1.7	0.4	0.0	0.1	0.0	0.6	0.2	0.0	4.1	0.1	0.3	0.5	0.1	2.4	0.0	0.5	0.7	11.8	0.1	0.6	0.0	0.2	20.5	0.2	6.5	0.4	0.2	11.1	0.2	0.4	1.4	0.9	14.0	8.2	0.0	0.3	0.1	3.3	0.4	0.0	0.2	0.1	0.8	0.1	0.3	5.4	15.2	0.2	0.2	0.2	0.1	11.2	4.2	0.6	11.5	5.8	10.5	10.0	7.7	7.9	6.6	16.5	12.2	13.1	1.1	10.2	5.6	14.1	11.4	7.1	12.1	19.1	2.3	10.0	18.1	10.2	29.6	9.8	14.5	22.4	3.0	5.3	4.5	1.2	0.3	18.2	3.7	0.0	16.0	5.7	0.0	78.5	0.1	1.7	5.1	0.4	1.8	0.0	0.0	0.6	0.2	0.8	0.9	3.5	0.0	9.2	11.1	1.7	2.5	3.9	0.0	1.4	3.4	3.3	7.2	0.2	20.9	0.7	0.0	1.4	6.7	453.5	0.0	0.2	3.9	2.7	0.3	0.2	7.0	0.1	0.6
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674338	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.8"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 840.9;Distal tubular cells: 1465.6;Proximal tubular cells: 1359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		NA	NA		220000	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	41.2	48.1	69.3	30.8	69.0	34.4	34.2	27.7	67.6	29.3	66.6	28.2	44.4	60.0	20.5	34.1	40.1	23.1	31.6	95.8	62.0	49.2	47.5	68.9	25.8	25.2	68.6	48.7	26.2	57.9	24.5	26.6	19.6	62.2	23.9	43.9	17.8	40.7	37.2	221.8	22.3	55.6	45.8	67.2	23.3	40.7	14.1	47.7	10.9	22.1	98.7	28.1	18.9	31.1	166.1	148.1	142.2	135.7	107.4	127.6	158.4	49.9	47.3	68.2	55.5	57.4	53.4	38.0	48.7	39.0	37.0	32.9	45.4	49.5	25.9	46.9	51.5	60.1	32.0	54.9	76.8	20.3	22.9	101.4	76.2	87.7	113.3	59.7	97.0	33.6	66.2	45.1	42.4	43.0	57.8	45.2	51.7	63.0	28.4	41.9	72.0	83.6	127.1	80.1	88.1	123.8	51.0	49.8	56.4	70.7	87.2	66.2	52.0	35.4	47.7	54.0	44.7	54.5	66.9	52.4	33.3	31.6	29.3	67.9	66.4	109.5	81.9	48.9	66.9	36.4	103.7	135.7	142.2	98.5	112.1	101.0	166.1	121.1	109.2	135.4	123.2	110.3	110.3	122.3	107.4	97.7	148.1	127.6	158.4	69.3	69.0	27.7	67.6	62.0	49.2	68.6	48.7	62.2	47.7	142.9	207.3	0.0	0.0	0.0	0.0	0.0	0.0	337.3	224.1	840.9	0.0	343.2	1465.6	413.4	0.0	0.0	0.0	0.0	598.1	265.5	0.0	0.0	112.8	0.0	580.0	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	485.1	0.0	0.0	478.0	0.0	0.0	1359.9	0.0	0.0	0.0	0.0	0.0	0.0	229.9	0.0	0.0	0.0
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 61.5"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 71.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.0;ASC TERT1: 23.4"					"Low region specificity"	"Detected in many"			"HPA037381, HPA039262"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: AB_2676418"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	9.9	11.4	14.5	10.1	12.7	8.5	12.6	13.4	14.6	6.1	10.9	14.7	14.6	18.0	7.1	19.5	10.6	7.1	8.0	4.9	13.9	11.4	9.7	11.3	7.8	19.5	10.8	10.0	7.5	15.4	13.2	7.7	5.3	10.5	9.8	11.8	10.0	61.5	10.7	18.6	16.2	15.4	10.1	9.3	8.8	7.3	15.5	3.9	7.5	7.5	24.2	9.9	6.5	6.9	11.0	12.6	8.2	9.5	15.4	6.5	4.5	2.2	3.7	13.6	7.2	34.0	23.4	6.5	5.5	7.4	5.6	5.2	4.5	9.6	2.6	2.6	8.9	4.0	3.3	2.1	3.7	1.6	4.8	2.7	3.9	5.1	4.1	11.9	5.9	3.6	17.6	3.6	4.4	4.7	8.2	3.4	5.6	4.0	3.5	6.9	4.2	3.1	4.1	2.8	4.7	5.7	2.8	2.9	1.5	9.2	10.6	6.2	3.5	1.8	4.6	3.7	4.6	7.4	5.4	5.6	4.8	0.9	4.1	3.1	13.6	2.6	1.6	5.3	5.3	2.4	8.2	7.4	1.1	3.1	4.7	3.9	7.9	5.1	1.8	6.6	11.0	6.5	6.3	5.0	15.4	9.5	12.6	2.3	4.5	14.5	12.7	13.4	14.6	13.9	11.4	10.8	10.0	10.5	3.9	0.0	11.0	9.5	6.0	10.6	5.7	1.2	7.6	6.7	2.3	7.0	19.6	5.7	10.0	8.8	16.6	4.5	31.5	0.0	4.0	4.3	6.6	7.4	12.8	14.9	18.5	11.1	5.2	9.2	16.2	71.2	6.6	7.5	6.8	20.8	8.8	16.6	6.2	10.5	3.5	30.0	78.4	6.5	5.0	14.4	3.1	11.7	4.6	6.1	13.3	8.9
SLC49A3	"FLJ22269, LP2561, MFSD7"	ENSG00000169026	"Solute carrier family 49 member 3"	Q6UXD7	4	681829-689441	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Collecting duct cells: 14.0;Ductal cells: 14.4;Extravillous trophoblasts: 28.5;Hofbauer cells: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;SK-BR-3: 7.4;T-47d: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043593	Uncertain					NA	NA					"HPA043593: AB_10959611"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.11e-1)"	13.8	3.3	4.8	5.4	3.1	3.8	13.9	4.6	4.5	4.7	6.5	1.7	4.1	7.4	4.2	10.0	7.5	3.5	5.0	8.9	1.8	1.5	7.7	8.8	17.6	9.2	2.4	2.4	2.8	8.7	11.1	2.4	4.1	3.6	5.3	2.8	7.4	10.6	2.8	2.9	9.6	7.2	4.2	3.0	9.7	9.8	23.6	2.2	2.2	9.2	4.6	2.8	4.9	5.2	0.0	0.6	4.2	1.8	1.2	0.3	0.9	0.1	0.1	2.4	1.7	1.7	3.9	7.5	0.8	0.0	0.8	0.5	0.4	5.1	0.1	0.2	3.9	0.4	0.2	0.0	0.0	0.2	0.5	0.4	1.4	0.6	0.2	0.7	0.0	1.1	2.4	0.0	3.2	0.0	0.0	1.1	0.2	0.3	0.5	0.0	0.1	0.1	0.5	0.2	0.4	0.3	0.0	0.3	0.5	0.0	0.3	0.8	0.6	0.0	7.4	0.4	0.4	23.1	1.4	0.3	0.7	0.2	0.3	0.2	2.5	1.3	0.1	0.3	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.2	1.2	0.7	0.0	0.3	0.9	4.8	3.1	4.6	4.5	1.8	1.5	2.4	2.4	3.6	2.2	3.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	14.0	0.0	0.6	1.7	14.4	0.0	0.0	0.0	0.0	0.3	28.5	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	5.4	0.0	0.0	5.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
PCGF3	"DONG1, FLJ36550, MGC40413, RNF3, RNF3A"	ENSG00000185619	"Polycomb group ring finger 3"	Q3KNV8	4	705748-770640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061879	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061879: AB_2684631"	"unprognostic (1.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.25e-4)"	17.3	29.0	18.2	22.0	18.8	28.0	18.9	31.4	21.8	17.7	15.2	12.4	21.4	24.3	20.9	19.1	17.9	17.5	18.1	14.0	16.5	11.2	14.6	15.3	17.8	18.2	17.2	17.5	28.6	15.3	6.5	20.0	21.3	15.3	20.5	11.9	15.1	20.4	15.8	15.5	55.8	22.5	15.2	11.8	26.4	20.8	18.0	16.9	20.8	21.3	19.2	17.6	15.3	20.0	7.3	7.2	6.9	11.6	6.9	5.4	3.5	11.4	10.4	19.2	21.9	8.8	9.1	23.7	15.6	8.6	12.9	13.1	11.4	12.7	8.3	10.5	15.0	13.1	8.0	8.9	12.7	9.8	10.8	9.6	11.8	12.2	20.0	10.8	8.0	15.8	11.4	17.0	11.2	5.1	8.5	16.4	15.2	16.2	6.8	12.5	12.8	21.5	28.5	12.7	7.8	18.9	21.4	12.2	5.2	7.6	18.9	27.5	20.7	8.1	8.7	8.3	13.0	17.0	11.5	19.6	12.6	10.2	10.4	20.0	16.5	13.9	12.9	9.9	12.9	23.2	5.5	11.6	4.7	5.4	7.5	4.8	6.7	3.4	3.4	5.1	7.3	4.3	3.0	6.9	6.9	3.5	7.2	5.0	3.5	18.2	18.8	31.4	21.8	16.5	11.2	17.2	17.5	15.3	16.9	11.9	30.3	15.9	14.9	22.6	11.8	16.7	22.9	9.4	18.2	8.7	11.8	11.7	3.3	18.4	44.6	21.8	17.2	0.0	17.2	22.3	17.3	17.4	16.1	12.1	10.7	6.4	18.5	25.8	11.0	39.8	15.3	17.1	21.9	10.0	21.7	9.2	26.4	14.4	14.5	8.8	7.9	6.5	16.9	20.1	24.3	25.1	19.8	13.8	18.7	25.2
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826198	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 98.8"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 30.5;Horizontal cells: 17.5;Intestinal endocrine cells: 20.6;Rod photoreceptor cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	7.8	6.5	13.1	2.9	40.7	1.5	2.4	26.3	98.8	2.2	2.5	3.9	0.0	2.8	4.2	1.5	1.6	2.3	1.9	3.0	16.9	7.6	2.4	2.4	2.8	2.4	16.3	18.3	2.4	3.0	3.4	1.7	1.8	52.8	4.4	1.7	3.8	4.4	2.5	4.5	3.0	2.8	2.0	5.4	5.6	3.2	4.9	4.2	0.0	1.8	0.0	1.6	1.7	1.7	0.2	2.3	0.1	0.0	0.0	0.8	0.0	2.7	0.2	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	8.2	0.9	2.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.1	0.0	1.2	1.1	0.0	1.3	2.2	1.3	0.0	0.0	0.8	0.0	0.2	43.0	6.0	0.2	2.8	0.0	0.1	4.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	13.1	40.7	26.3	98.8	16.9	7.6	16.3	18.3	52.8	4.2	0.0	0.0	0.0	3.4	0.9	30.5	3.0	0.0	0.0	3.4	0.0	3.9	0.0	1.7	0.4	1.2	10.8	0.5	0.0	0.7	2.6	0.7	2.0	0.0	3.8	0.2	17.5	20.6	8.0	0.3	1.9	1.7	0.0	1.7	0.0	1.7	13.7	0.7	2.9	0.0	0.8	15.0	0.0	1.4	4.7	8.2	1.0	0.8	1.0	1.5	1.1
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	16.5	18.9	16.8	42.2	22.7	29.9	16.7	32.4	27.7	18.0	32.5	19.7	18.6	48.2	22.4	18.6	23.7	20.5	26.8	11.4	16.2	13.9	25.0	22.1	22.2	22.4	17.6	19.4	21.1	33.0	19.5	18.9	16.6	17.9	20.3	15.2	16.9	70.8	20.6	26.2	25.6	41.1	15.2	14.3	30.9	39.2	28.6	18.5	23.6	19.7	19.2	22.3	18.9	18.9	4.7	7.1	10.8	19.3	4.0	8.5	6.9	15.9	12.8	7.8	13.3	7.9	6.8	20.2	15.1	9.1	10.4	8.7	16.2	22.8	13.6	10.3	9.1	18.8	13.9	8.1	12.5	4.9	13.8	14.2	15.7	12.9	12.1	14.8	16.0	24.8	9.8	10.8	10.5	5.1	6.6	11.4	16.2	16.9	17.3	7.0	15.4	27.0	41.3	14.0	17.0	23.5	22.4	9.1	12.1	8.4	13.0	13.5	14.7	8.8	11.2	10.5	6.9	18.0	13.8	18.6	14.5	8.5	14.7	20.1	28.0	18.7	15.1	16.4	19.6	13.3	2.6	9.0	10.8	8.5	8.9	7.4	4.7	5.6	5.7	6.0	4.0	3.2	4.7	6.7	4.0	19.3	7.1	5.0	6.9	16.8	22.7	32.4	27.7	16.2	13.9	17.6	19.4	17.9	18.5	23.8	28.6	15.3	12.6	15.0	27.8	9.5	15.3	16.0	22.7	24.4	60.9	16.1	8.3	16.1	102.1	20.4	83.6	0.0	24.3	13.5	15.3	23.7	17.4	25.9	31.3	11.1	28.3	21.5	37.8	102.9	23.3	25.0	15.1	16.2	53.5	15.6	29.1	45.8	17.7	26.4	25.2	19.4	15.3	30.2	26.3	19.4	26.0	27.3	45.3	36.3
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.2	22.9	20.5	13.5	24.0	17.8	12.2	29.0	27.6	17.4	10.8	23.5	16.8	13.6	13.4	14.9	13.4	12.9	16.0	13.3	18.4	19.8	11.7	24.2	14.1	21.9	16.9	25.4	9.3	26.3	18.7	26.4	11.8	20.4	15.0	6.2	17.1	26.8	16.8	14.5	25.8	12.4	10.4	17.2	18.7	14.8	11.8	17.9	13.0	19.7	9.2	12.0	16.2	9.6	13.8	29.3	16.9	23.4	9.5	13.6	11.8	3.3	6.1	3.5	4.8	17.0	8.9	8.2	8.2	6.0	5.0	7.5	2.8	13.4	2.5	5.1	8.6	8.8	5.5	3.2	6.5	2.2	6.2	7.5	5.2	9.0	2.8	9.8	2.7	9.7	12.6	7.9	4.5	3.0	3.6	3.1	5.4	5.2	20.9	4.4	10.9	6.9	11.2	2.2	3.9	17.2	4.8	2.1	7.2	4.8	3.2	9.6	8.5	5.7	3.6	5.4	1.8	16.0	7.5	4.1	9.3	2.1	10.7	6.3	14.2	3.7	4.9	9.0	6.0	7.5	16.9	19.8	15.5	13.6	23.4	9.1	12.5	11.7	10.1	17.2	13.8	8.4	11.9	16.4	9.5	21.6	29.3	11.0	11.8	20.5	24.0	29.0	27.6	18.4	19.8	16.9	25.4	20.4	17.9	11.9	9.9	12.9	8.5	5.6	24.5	8.7	5.1	4.0	5.7	14.0	3.9	21.7	1.7	7.4	4.4	8.2	12.4	0.0	10.0	9.3	12.7	8.2	6.9	23.8	13.5	44.5	15.5	8.6	15.3	3.2	11.5	11.0	18.6	4.6	8.1	43.7	8.0	14.4	15.2	6.7	25.4	12.9	9.5	22.3	10.2	6.8	15.8	13.1	7.0	5.4
DGKQ	"DAGK, DAGK4, DAGK7"	ENSG00000145214	"Diacylglycerol kinase theta"	P52824	4	958887-986895	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 28.3;Paneth cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026797, CAB033835"	Uncertain					NA	NA					"CAB033835: AB_2091307, HPA026797: AB_10600902"	"unprognostic (7.39e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-3)"	6.4	9.3	15.9	10.7	13.8	10.4	6.9	21.6	17.4	5.4	14.7	7.9	6.9	27.0	6.3	3.8	7.9	5.3	10.3	4.5	15.0	12.1	8.4	8.9	6.9	12.3	9.7	12.3	5.1	9.8	5.5	8.2	4.4	10.2	7.0	8.4	6.7	12.1	5.8	3.7	13.0	28.0	5.9	5.2	12.7	8.6	6.8	7.7	9.1	6.7	3.8	8.7	6.6	7.0	1.3	1.9	4.0	1.4	5.3	5.0	1.8	4.2	6.8	3.0	10.0	3.6	3.0	11.1	8.0	4.6	4.6	4.6	4.9	8.4	5.6	6.8	5.1	9.4	4.8	1.7	5.6	1.1	4.4	5.3	8.7	6.3	8.5	6.3	3.7	11.7	5.7	9.6	3.8	1.8	3.9	5.6	11.8	6.5	0.7	3.5	6.3	7.7	21.7	5.3	11.7	11.6	12.5	0.9	0.6	5.0	5.9	1.9	5.1	2.8	3.2	8.4	2.4	7.5	9.1	8.1	8.0	3.8	9.0	5.3	15.5	6.6	4.3	6.9	8.1	7.2	4.0	1.4	2.9	5.0	1.1	2.3	1.1	1.8	4.1	0.9	1.3	1.9	3.4	0.9	5.3	1.1	1.9	1.1	1.8	15.9	13.8	21.6	17.4	15.0	12.1	9.7	12.3	10.2	7.7	3.0	1.9	0.5	1.2	2.5	2.9	2.0	7.6	2.7	1.2	3.5	3.9	0.4	0.0	2.6	0.3	2.8	28.3	0.0	4.2	1.6	2.2	2.1	0.0	4.7	2.2	3.2	7.5	1.8	2.6	0.7	3.7	2.6	3.3	3.6	15.3	2.5	4.1	31.7	2.5	0.9	0.8	0.0	1.6	1.1	5.9	3.3	0.6	7.0	11.1	3.0
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.3	0.0	1.8	0.2	0.4	4.2	1.9	0.1	0.0	0.0	4.5	2.6	0.7	2.3	0.0	1.8	1.3	0.1	0.0	0.0	2.6	0.9	3.4	3.1	13.3	0.2	2.1	9.1	0.6	0.2	0.1	0.0	1.0	0.3	2.9	3.5	0.0	0.4	2.9	1.3	3.6	1.0	1.7	7.2	7.3	0.0	0.3	0.7	5.1	0.2	1.4	0.5	0.2	1.2	0.4	9.2	1.4	2.1	4.8	1.0	4.8	1.3	7.0	3.2	1.2	1.7	4.4	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1	0.0	0.6	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	1.3	0.0	0.3	3.3	0.2	0.1	1.1	9.0	0.6	0.0	0.0	1.3	0.3	0.0	0.9	0.0	1.7	0.0	0.6	0.2	0.6	0.2	0.4	8.5	0.1	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.6	0.1
IDUA	MPS1	ENSG00000127415	"Iduronidase, alpha-L-"	P35475	4	986997-1004506	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		130000	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	11.0	15.0	14.7	12.0	15.3	10.8	12.9	36.5	15.7	12.4	9.2	10.9	16.9	17.1	13.0	13.4	7.7	12.1	15.9	8.9	13.4	6.5	13.4	10.7	12.8	11.2	11.6	10.0	14.6	22.6	13.0	15.2	4.0	12.8	14.5	6.0	14.1	20.2	15.8	6.2	16.8	11.8	7.3	9.0	15.3	21.3	4.7	12.6	7.6	14.0	3.4	10.0	10.4	11.2	0.8	4.1	0.0	3.8	3.1	4.5	1.1	3.1	5.8	0.0	2.4	13.4	4.8	8.8	8.4	7.4	2.9	1.7	2.0	9.9	1.3	9.5	5.7	2.9	1.9	0.3	1.1	0.6	8.4	0.4	5.0	6.0	0.7	5.6	4.0	13.5	9.2	4.2	2.3	0.0	4.2	2.0	3.2	2.5	0.1	2.8	3.4	2.8	4.2	1.9	9.7	5.5	7.6	0.0	1.4	4.7	6.2	0.1	3.8	0.9	0.0	4.8	1.3	6.8	3.4	8.8	15.7	1.7	8.8	2.3	32.6	3.7	1.6	7.6	5.5	3.8	0.0	3.5	0.0	3.3	2.7	4.5	0.6	2.7	2.6	4.1	0.8	3.4	2.0	0.0	3.1	3.8	2.5	1.3	1.1	14.7	15.3	36.5	15.7	13.4	6.5	11.6	10.0	12.8	12.6	6.0	5.3	0.5	8.6	3.2	1.9	2.4	0.0	0.0	1.2	7.0	3.9	0.4	0.0	1.6	0.7	3.7	4.2	0.0	2.1	1.4	5.1	7.4	2.3	2.4	5.8	0.0	10.3	6.2	4.6	0.2	18.1	3.5	5.0	0.0	3.6	1.9	1.6	6.0	9.9	1.3	2.2	0.0	3.9	1.4	1.5	1.6	0.3	5.0	3.5	5.8
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026897	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 51.1"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 29.6;Muller glia cells: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.5;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	21.8	22.9	16.0	6.1	20.5	5.8	21.5	13.8	20.6	8.1	6.6	9.1	5.3	6.6	6.6	5.0	4.7	19.7	9.8	12.2	16.6	3.6	11.5	25.1	6.4	4.0	8.8	8.4	14.0	51.1	12.6	9.0	3.1	17.0	7.6	4.8	12.7	29.3	3.1	9.6	3.7	6.0	4.1	14.0	5.3	15.0	3.2	11.1	1.0	33.8	3.9	3.6	6.2	11.5	0.4	0.3	1.2	3.6	0.1	1.2	0.4	8.5	11.6	4.2	12.8	4.5	4.7	1.1	15.2	2.3	4.9	3.2	8.4	17.7	0.9	19.8	23.2	22.0	2.2	8.1	5.1	4.5	3.2	7.9	0.1	15.2	22.1	9.2	4.9	2.1	9.9	4.4	8.4	3.6	18.3	4.6	3.4	9.3	3.3	2.9	11.1	5.7	13.5	5.3	14.4	31.6	9.4	6.2	6.0	8.5	1.3	0.4	0.8	14.1	0.3	5.6	5.3	8.4	4.3	9.9	26.2	10.7	13.2	36.8	3.6	4.8	1.3	6.9	5.7	8.4	1.2	0.1	0.0	0.7	3.5	0.1	0.4	1.2	0.2	0.3	0.1	0.2	0.5	0.0	0.1	3.6	0.3	0.1	0.4	16.0	20.5	13.8	20.6	16.6	3.6	8.8	8.4	17.0	11.1	3.0	5.5	0.5	2.9	5.8	4.7	7.5	7.6	9.4	4.5	7.0	0.0	1.2	0.0	8.0	0.2	2.2	3.2	0.0	8.9	16.2	4.6	8.6	1.1	29.6	2.6	0.0	1.7	4.9	2.1	1.0	4.0	2.9	6.8	1.0	8.1	87.5	15.6	3.5	3.2	6.2	5.1	0.0	4.2	0.2	2.2	4.1	1.3	2.5	3.2	5.1
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113562	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.1"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 53.0;Spermatocytes: 40.2;Spermatogonia: 38.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"A-431: 8.5;HeLa: 26.0;JURKAT: 13.1;SiHa: 15.6"									HPA057527	Uncertain					NA	NA					"HPA057527: AB_2683457"	"unprognostic (2.75e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	2.9	1.9	3.1	1.7	8.4	4.5	3.9	11.4	4.7	4.6	2.4	4.3	2.0	1.2	2.7	4.3	2.4	4.0	2.1	1.3	2.4	1.6	4.7	0.6	2.9	2.7	3.4	1.1	8.8	13.0	0.8	18.1	1.0	5.3	3.3	1.8	3.6	4.2	1.4	1.9	4.4	1.8	2.2	4.1	1.9	2.6	12.1	2.1	0.5	8.2	1.0	1.9	1.4	3.0	2.1	1.2	0.1	0.7	0.4	3.8	0.9	8.5	0.5	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	3.8	0.1	0.0	2.2	0.0	2.1	0.0	0.0	0.0	13.1	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.9	0.0	15.6	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	2.2	0.7	1.8	0.6	3.8	1.0	1.2	2.1	3.8	1.2	0.0	0.4	0.0	0.4	1.1	0.9	3.1	8.4	11.4	4.7	2.4	1.6	3.4	1.1	5.3	2.1	3.0	5.8	0.0	5.2	2.5	2.3	0.5	0.0	2.7	10.3	0.0	2.0	0.0	53.0	2.7	3.4	0.5	0.1	0.0	0.8	0.1	5.8	3.6	4.6	0.0	0.5	0.0	4.7	0.0	0.0	5.1	7.8	1.6	0.0	1.0	2.3	4.5	1.0	1.4	0.7	6.0	5.7	0.0	2.0	40.2	38.5	2.8	0.2	0.5	0.7	3.8
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 238.3;Fibroblasts: 91.2;T-cells: 101.5"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 54.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 54.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.2;HSkMC: 97.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1600000	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	18.5	10.2	0.9	11.7	4.2	7.2	27.9	10.7	3.4	63.7	18.0	1.0	6.4	8.5	46.7	25.7	13.9	11.6	26.6	14.4	1.8	0.0	19.3	35.7	13.9	1.6	0.5	1.5	24.2	4.8	0.1	3.2	44.9	1.9	39.4	3.2	3.4	6.3	7.6	8.9	9.1	14.2	23.1	0.6	6.7	9.6	10.6	0.9	1.1	3.5	21.0	3.0	20.1	22.8	0.2	8.7	2.1	0.4	10.0	54.2	22.7	0.0	0.1	0.0	0.0	1.8	13.2	0.5	1.1	0.7	0.1	0.2	0.0	0.0	0.3	1.9	4.5	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	55.2	0.0	0.3	97.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.9	2.5	0.6	1.7	0.1	0.1	0.6	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.1	4.0	0.0	0.2	0.4	0.1	0.0	1.3	0.0	0.8	0.1	0.1	54.2	0.2	1.1	0.1	7.6	22.3	0.1	0.2	3.4	22.0	2.1	10.0	0.4	8.7	0.0	22.7	0.9	4.2	10.7	3.4	1.8	0.0	0.5	1.5	1.9	0.9	0.0	6.4	5.2	1.9	32.6	1.7	4.2	12.7	13.4	2.3	1.8	0.0	3.1	1.7	3.0	0.2	4.5	10.7	0.0	1.2	238.3	91.2	11.8	5.8	32.1	11.2	0.0	13.3	20.3	2.4	0.0	27.6	6.6	25.3	8.2	8.5	0.9	1.4	3.5	8.9	15.1	0.2	6.5	7.1	0.2	0.4	18.7	32.5	101.5	5.8	11.2
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211448-1249953	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	32.3	35.8	42.4	39.8	44.4	31.3	54.6	70.7	56.1	27.6	29.4	29.2	29.0	44.9	35.8	30.8	31.9	38.2	37.6	41.2	41.5	45.7	29.3	36.0	28.5	48.4	38.0	41.2	35.4	62.2	28.4	48.1	27.2	30.2	32.6	21.6	28.2	44.9	27.9	74.2	33.9	43.6	29.7	29.3	47.0	33.5	16.7	27.2	44.9	29.4	30.5	30.2	32.2	38.6	15.6	25.0	11.6	16.2	16.1	24.5	10.3	22.8	33.9	26.2	32.1	18.4	13.3	22.5	18.1	16.9	22.5	23.0	29.0	55.6	28.1	21.0	21.0	34.9	18.4	15.8	23.8	6.8	21.3	19.1	25.4	38.3	37.0	30.7	22.8	36.3	22.9	18.3	19.1	11.1	21.9	16.8	32.1	28.8	48.3	12.4	37.8	73.3	71.9	31.0	18.7	32.8	51.9	15.8	36.6	14.4	29.2	49.3	30.9	17.3	18.7	23.9	16.5	40.9	35.2	21.4	37.7	21.3	21.6	38.7	35.2	33.5	32.5	29.8	35.6	29.5	8.6	11.9	11.6	24.5	16.2	18.4	15.3	17.2	20.8	14.7	15.6	13.5	19.5	9.3	16.1	15.8	25.0	14.6	10.3	42.4	44.4	70.7	56.1	41.5	45.7	38.0	41.2	30.2	27.2	38.7	35.8	50.6	18.9	30.3	28.2	46.2	45.9	24.1	19.4	34.9	3.9	21.5	10.0	27.3	2.7	34.3	46.6	46.7	35.0	26.5	27.8	33.2	23.1	79.0	37.1	38.1	44.3	48.5	64.1	3.6	41.7	35.1	43.9	24.4	42.4	41.9	38.2	31.6	33.6	29.3	15.7	6.5	27.0	6.0	15.1	33.1	16.6	39.6	51.0	23.8
MAEA	"EMP, GID9"	ENSG00000090316	"Macrophage erythroblast attacher"	Q7L5Y9	4	1289851-1340147	"Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	23.6	35.4	25.5	26.3	28.4	19.5	20.9	34.0	35.8	24.4	33.3	21.7	26.8	39.9	27.3	23.8	34.7	26.0	29.2	36.6	23.7	33.1	33.2	27.9	19.1	26.1	23.3	32.0	33.4	32.0	21.9	30.3	27.6	34.0	23.6	17.2	22.3	36.7	28.0	27.3	29.0	38.2	20.9	17.7	31.0	30.3	23.3	26.7	26.5	26.1	28.5	26.5	26.3	25.4	19.7	18.9	48.2	28.0	17.0	35.8	21.9	22.7	27.0	19.2	19.0	12.8	12.8	25.0	23.3	12.2	18.8	17.3	28.0	29.3	20.7	18.2	16.7	34.9	16.9	18.4	28.5	7.8	16.6	20.5	19.5	29.8	26.7	15.3	21.9	21.0	15.9	15.6	15.2	9.6	13.1	15.2	20.0	27.1	16.6	16.5	24.1	32.5	33.6	25.3	24.7	29.1	31.7	15.4	18.7	20.1	27.5	34.5	24.1	20.8	15.7	15.8	11.2	29.0	19.1	21.3	35.1	15.1	16.0	38.5	20.9	32.0	22.8	24.5	20.2	19.3	23.9	20.2	27.2	25.5	20.7	35.8	19.7	20.5	24.1	18.9	16.5	18.3	18.8	48.2	17.0	28.0	13.3	23.1	21.9	25.5	28.4	34.0	35.8	23.7	33.1	23.3	32.0	34.0	26.7	17.9	23.5	19.1	12.9	16.7	25.9	30.8	12.7	14.7	21.6	15.7	19.6	42.4	39.7	39.2	5.8	20.4	33.8	0.0	26.5	43.0	21.1	18.9	10.4	15.3	34.2	20.6	19.5	18.4	22.3	8.2	32.8	16.9	27.0	55.9	30.8	20.6	33.1	32.0	35.0	28.1	18.6	12.9	16.5	25.9	41.2	17.3	79.6	27.4	32.9	18.6
UVSSA	KIAA1530	ENSG00000163945	"UV stimulated scaffold protein A"	"Q2YD98, Q8N1N5"	4	1347266-1395992	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050824, HPA053496"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050824: AB_2681251, HPA053496: AB_2682170"	"unprognostic (6.40e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.85e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.76e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (6.87e-4)"	6.5	7.1	5.7	8.0	10.8	11.8	8.1	7.2	7.1	6.1	7.6	10.6	10.9	9.7	10.0	11.4	6.8	10.7	5.5	4.8	8.0	3.4	5.8	6.3	9.4	7.6	7.8	4.3	9.5	13.4	6.7	19.0	9.4	7.0	6.7	5.6	9.6	11.1	6.7	8.7	19.6	8.7	7.2	8.4	9.9	8.9	22.2	7.6	7.1	11.5	3.1	7.3	9.3	7.0	1.5	2.4	3.6	2.1	8.2	1.6	1.5	4.3	6.8	6.3	6.6	9.8	9.7	5.9	3.9	3.0	3.1	2.5	4.6	7.3	2.6	7.5	3.3	7.5	4.6	3.6	4.6	2.6	4.5	2.2	6.4	8.7	7.0	2.6	3.9	8.5	2.9	8.8	3.3	3.8	3.7	5.1	6.1	6.5	8.9	3.8	3.1	6.3	9.1	6.7	2.6	6.1	5.7	3.1	3.8	2.7	5.9	4.8	6.3	2.7	3.5	4.7	5.9	9.1	2.2	10.8	11.9	3.0	4.5	6.4	15.8	9.0	5.8	9.0	4.9	7.3	0.2	1.8	1.7	1.6	1.1	1.0	1.2	1.3	1.5	2.4	1.5	1.3	0.9	3.6	8.2	2.1	1.4	0.6	1.5	5.7	10.8	7.2	7.1	8.0	3.4	7.8	4.3	7.0	7.6	6.0	25.8	3.7	4.3	4.8	13.8	3.1	7.6	21.4	9.1	15.7	39.3	2.6	3.3	6.5	3.9	5.3	8.8	0.0	7.4	2.5	4.8	4.7	8.1	9.0	5.7	28.6	5.8	6.2	5.9	5.1	4.9	8.5	5.0	6.4	8.0	12.9	7.5	5.7	3.5	3.6	28.3	0.0	4.7	22.1	8.3	5.4	3.1	5.9	5.5	3.1
NKX1-1	"HSPX153, SAX2"	ENSG00000235608	"NK1 homeobox 1"	Q15270	4	1402932-1406331	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"pituitary gland: 1.0;testis: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 0.2"	HPA029367	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM53A	DNTNP	ENSG00000174137	"Family with sequence similarity 53 member A"	Q6NSI3	4	1617915-1684302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.6;Early spermatids: 11.4;Spermatocytes: 14.4;Spermatogonia: 11.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.9"	"Low region specificity"	"Detected in all"							"HPA036452, HPA058138"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA036452: AB_10671841, HPA058138: AB_2683619"	"unprognostic (8.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.33e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.15e-3)"	1.3	0.8	0.8	0.6	0.7	0.9	1.2	1.6	1.1	0.9	1.0			0.0	1.6	6.0	0.8	2.1	1.5	0.5	1.1	0.7	0.7	1.2	0.7	0.9	1.5		1.5	4.0	1.3	6.8	0.1		1.1	0.2		1.7	0.8	1.5	3.3	0.4	1.0	2.7	0.8	0.9	12.7			5.7		0.2	0.9	0.6	2.4	4.9	0.6	3.8	0.9	4.4	1.0	1.2	0.8	2.0	4.0	1.4	3.5	0.8	6.6	3.6	6.4	4.3	1.6	2.9	3.2	3.3	1.8	2.5	0.2	0.0	1.3	1.7	0.8	0.9	0.8	0.3	0.7	5.6	0.0	1.2	2.7	3.8	3.2	6.4	1.3	1.0	6.8	2.4	0.9	2.8	0.8	1.9	2.0	2.5	0.6	9.1	0.9	0.5	0.1	1.7	1.9	9.9	4.2	2.5	0.5	4.7	1.5	3.1	2.1	1.6	0.3	0.4	1.2	0.8	0.4	1.6	0.8	0.1	1.2	7.8	0.0	1.1	0.6	0.5	3.8	1.2	2.4	0.7	0.8	2.5	1.6	4.4	0.2	0.0	0.9	1.5	4.9	1.0	1.0											0.0	0.0	0.0	0.4	1.1	0.8	3.6	2.5	0.0	0.0	1.8	0.0	0.0	1.7	0.3	11.4	0.5	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.8	0.2	0.0	0.0	1.3	0.0	1.3	0.6	0.3	0.0	1.0	0.0	0.3	0.4	0.0	0.4	0.3	0.4	0.0	0.9	14.4	11.8	0.4	0.0	0.0	0.4	0.1
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692800-1712555	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Spermatocytes: 268.0;Spermatogonia: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	19.8	18.1	26.9	30.4	28.0	60.7	27.5	23.8	30.0	19.3	19.3	14.2	20.7	16.3	20.4	21.9	25.0	19.0	15.8	17.9	25.1	26.5	23.7	21.2	18.7	43.9	19.9	24.0	23.1	17.8	13.0	19.5	27.7	16.0	20.0	21.3	17.9	24.7	21.2	15.1	24.7	17.0	20.5	17.1	26.1	18.2	50.6	12.4	52.4	24.9	17.7	42.8	23.7	26.6	24.4	24.1	45.3	29.8	19.8	36.1	30.4	29.4	12.1	17.5	18.4	15.5	17.7	18.2	25.9	22.2	31.5	31.9	25.0	34.4	38.9	15.5	21.4	37.2	18.1	35.1	23.5	37.0	15.9	19.0	48.8	15.1	25.1	19.2	45.1	23.8	12.2	18.9	23.9	15.9	18.3	17.9	26.1	34.9	38.5	38.5	10.6	69.4	41.1	21.8	31.1	21.6	52.3	28.6	24.6	30.3	22.4	19.9	15.3	22.0	14.3	15.3	24.7	23.7	29.8	15.1	26.5	15.2	27.9	40.3	22.4	40.7	93.0	24.8	38.7	26.0	9.3	29.8	21.8	23.6	22.3	21.4	24.4	30.8	33.2	24.1	18.0	26.5	25.1	45.3	19.8	19.8	19.1	36.1	30.4	26.9	28.0	23.8	30.0	25.1	26.5	19.9	24.0	16.0	12.4	14.9	16.8	53.9	86.5	93.4	17.7	7.1	25.5	8.1	7.9	34.9	23.6	121.4	91.2	43.6	64.1	31.8	21.2	23.3	27.3	39.1	59.3	64.3	23.1	26.1	70.1	23.8	34.4	29.4	34.0	32.9	40.9	44.4	62.4	61.3	27.5	27.6	30.6	23.0	41.4	37.4	11.4	12.9	49.1	268.0	323.2	92.5	37.4	59.9	37.5	71.2
TMEM129	D4S2561E	ENSG00000168936	"Transmembrane protein 129"	A0AVI4	4	1715952-1721358	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.22e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (9.64e-8)"	"unprognostic (1.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.36e-3)"	18.2	19.8	17.6	11.3	21.7	6.0	11.0	19.3	25.6	16.4	17.9	22.1	21.5	23.7	16.1	14.6	18.7	18.0	16.5	29.0	18.3	16.2	22.4	26.3	14.5	12.8	20.1	14.0	17.3	32.6	25.9	24.9	15.8	16.9	17.5	9.6	20.4	34.0	22.8	20.9	15.7	17.6	12.7	14.9	14.6	16.0	15.0	20.0	11.5	32.4	11.0	12.3	14.6	10.5	2.1	7.7	0.7	3.3	2.0	3.6	2.1	9.1	10.5	8.9	13.2	16.4	9.6	10.3	7.4	12.0	7.7	8.3	7.8	22.7	12.0	8.9	7.9	13.8	9.2	4.6	9.4	1.3	8.2	13.5	6.5	7.6	9.9	13.4	9.2	11.9	15.9	20.3	4.2	3.9	18.0	11.9	11.4	7.4	8.9	7.3	7.1	12.6	15.0	13.8	10.0	13.1	8.2	4.7	14.7	19.2	10.2	20.7	12.7	6.3	11.3	9.7	3.3	23.1	4.3	8.1	9.0	6.9	7.9	7.1	22.4	6.7	5.7	10.4	12.7	9.6	0.3	3.3	0.1	3.6	2.2	3.1	1.6	3.2	2.6	3.4	2.1	2.2	1.5	0.7	2.0	2.4	7.7	1.5	2.1	17.6	21.7	19.3	25.6	18.3	16.2	20.1	14.0	16.9	20.0	20.8	9.4	8.0	14.9	4.5	24.9	10.6	12.7	5.3	2.3	22.7	5.9	17.6	21.6	18.2	0.9	9.2	19.8	0.0	17.0	6.2	14.6	13.1	10.3	17.1	15.5	23.8	12.6	16.5	9.4	2.1	28.1	8.5	10.1	4.6	25.1	37.3	12.1	10.5	33.9	16.1	18.7	12.9	17.6	3.7	5.8	8.3	4.6	11.4	26.7	9.1
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes			"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.4	21.2	32.5	18.6	1.7	3.6	18.3	28.9	15.5	33.2	22.0	23.5	30.8	32.5	12.3	15.7	38.6	17.2	34.3	21.0	33.8	14.3	18.6	27.5	17.6	21.6	1.6	37.2	23.4	1.5	1.4	20.9	12.1	7.3	25.2	26.8	24.8	25.7	31.4	20.8	49.0	53.3	35.1	21.8	27.9	34.8	23.0	13.0	18.8	38.6	25.3	15.9	17.4	11.0	8.1	25.5	21.6	21.6	14.7	19.4	23.2	17.5	43.5	18.0	23.9	52.1	11.2	36.0	27.4	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9	0.0	7.9	16.0	0.5	1.9	1.0	2.2	0.0	0.0	4.5	8.7	7.9	3.3	0.0	2.1	43.8	2.5	2.0	23.3	0.6	16.5	2.6	1.0	4.7	4.3	35.7	4.8	1.2	4.9	20.5	49.1	2.6	21.9	0.0	12.6	3.1	1.4	1.9	3.5	2.5	1.8	3.2	6.5	1.0	69.6	47.8	1.3	3.3	15.3	5.7	1.3
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 131.7"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 92.2;Cholangiocytes: 94.3;Suprabasal keratinocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.3;HaCaT: 15.1;Hep G2: 32.5;NTERA-2: 15.8;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		670000	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22.0	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2.0	5.0	2.0	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23.0	1.2	3.0	5.6	15.1	3.7	3.8	1.7	3.8	9.0	1.7	131.7	7.4	1.3	9.0	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0.0	0.0	1.5	9.2	2.6	0.0	0.1	9.4	1.1	0.1	0.4	0.2	19.3	0.4	0.0	7.7	0.3	0.4	15.1	2.6	0.1	0.1	0.1	9.7	6.0	1.5	32.5	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.9	6.5	0.0	0.0	9.6	0.4	0.2	15.8	8.8	0.0	0.5	0.5	0.1	1.3	19.3	2.7	0.7	0.8	1.6	0.0	11.1	9.0	1.1	0.4	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.6	0.1	0.0	24.7	30.3	10.2	22.0	21.6	11.7	17.6	21.5	15.1	10.6	0.0	23.8	2.4	3.6	92.2	0.0	2.0	94.3	0.0	21.6	14.0	0.0	0.4	0.0	4.8	5.4	0.9	20.6	0.0	0.6	9.2	7.0	3.3	0.0	27.0	0.5	0.0	4.1	14.7	1.2	0.4	0.6	1.2	11.8	1.0	20.7	0.2	0.4	17.3	0.4	7.5	0.6	0.0	2.8	0.4	17.9	77.5	0.7	0.0	13.0	11.8
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856247	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	16.9	15.3	11.9	11.2	13.1	9.9	16.8	17.3	19.9	6.7	23.7	10.0	7.5	20.3	8.5	6.9	22.0	8.1	15.0	18.9	10.2	10.2	16.2	20.4	9.4	10.7	10.6	10.5	9.5	19.7	13.0	8.7	7.6	10.7	8.2	16.3	9.2	9.7	7.2	17.2	18.5	19.4	8.0	7.7	10.6	15.6	12.6	9.0	50.7	10.9	19.9	16.6	8.0	9.7	5.0	14.7	3.8	5.6	6.7	7.1	2.1	12.0	20.6	6.4	19.8	9.9	6.9	11.5	12.0	5.9	12.1	9.5	19.0	13.5	20.0	8.6	12.5	18.9	12.3	16.3	16.9	7.4	13.2	17.0	20.4	16.7	13.6	12.8	20.7	16.8	11.3	12.2	13.8	12.2	5.6	10.4	12.3	26.8	12.6	8.3	13.3	29.9	23.7	16.8	13.2	23.7	17.2	9.0	11.7	9.4	16.9	16.4	14.4	13.7	17.3	7.1	5.8	16.3	10.8	15.6	13.9	8.3	11.7	19.9	11.0	16.8	15.9	12.3	18.1	11.1	3.8	4.5	2.1	7.1	5.6	7.0	5.0	6.0	6.1	4.7	4.6	4.0	5.9	0.7	6.7	5.3	14.7	4.6	2.1	11.9	13.1	17.3	19.9	10.2	10.2	10.6	10.5	10.7	9.0	14.9	7.8	27.6	25.3	35.5	17.1	18.2	7.6	1.4	9.1	26.2	31.4	14.6	26.6	22.9	25.3	14.3	78.7	23.3	27.0	18.4	16.4	20.8	10.3	24.1	19.6	14.3	15.0	16.5	15.3	31.9	18.7	15.0	18.6	10.0	27.0	11.6	31.9	43.2	15.6	38.2	26.2	12.9	19.8	34.8	40.1	44.7	12.7	20.2	29.9	41.9
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871424-1982207	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 17.3;Ciliated cells: 13.4;Club cells: 14.8;Collecting duct cells: 12.2;Hofbauer cells: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	8.7	7.6	17.6	11.5	16.2	35.1	8.5	20.6	18.2	7.0	14.8	12.4	6.3	14.0	9.5	7.4	12.7	6.8	6.9	11.9	15.1	10.9	8.4	7.5	11.1	18.8	14.7	16.1	7.0	11.7	10.7	11.8	9.8	14.6	8.7	17.7	9.4	10.2	7.4	11.8	12.1	14.6	10.5	15.3	13.5	11.0	26.3	13.4	46.7	13.8	5.5	17.7	8.6	9.4	4.9	3.9	4.1	1.8	2.7	4.3	0.6	27.7	14.0	42.3	18.5	4.6	6.8	12.3	22.4	19.9	27.5	30.8	12.4	33.0	29.9	7.7	18.5	36.0	12.1	27.3	18.5	47.3	14.3	11.3	35.6	19.4	7.3	5.8	21.8	18.7	2.6	4.7	24.1	23.2	15.2	21.6	30.2	19.3	31.4	22.5	10.9	58.1	22.9	17.8	14.1	16.2	33.2	27.6	10.3	11.3	13.2	26.3	21.0	18.4	6.9	8.4	19.2	16.3	14.6	16.7	27.5	20.5	17.4	45.1	14.7	15.5	27.1	16.5	21.6	25.5	2.1	1.7	1.7	2.9	1.8	3.2	1.8	3.2	3.2	1.5	4.9	2.8	2.3	4.1	2.7	1.4	3.9	4.3	0.6	17.6	16.2	20.6	18.2	15.1	10.9	14.7	16.1	14.6	13.4	11.9	17.3	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	12.2	0.0	10.0	3.3	10.2	0.0	0.0	0.0	0.0	6.1	7.3	0.0	0.0	2.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	10.0	0.0	0.0	10.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982714-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	14.8	13.7	18.3	17.2	19.0	20.0	16.5	36.4	23.2	17.0	15.1	22.5	15.7	21.6	19.5	15.1	26.1	21.0	11.4	10.8	16.8	12.2	14.7	10.9	11.4	15.8	14.1	12.0	26.9	27.0	12.5	19.1	16.8	13.6	15.7	8.3	16.2	28.6	28.4	17.4	23.4	21.2	13.3	11.9	18.4	20.6	26.5	18.3	18.0	16.8	10.9	21.6	18.1	19.5	20.5	14.9	12.0	14.0	13.1	18.5	10.3	10.8	10.0	8.7	16.0	3.6	3.8	17.4	5.8	4.1	7.0	5.6	16.6	18.7	19.2	8.4	3.7	8.8	10.3	8.8	7.3	3.4	9.8	13.7	12.6	7.4	15.6	5.3	13.0	12.9	3.2	6.5	4.7	5.0	5.2	5.3	10.9	23.8	9.2	3.0	12.6	25.2	37.5	25.3	9.3	15.2	23.0	7.6	12.0	5.0	9.1	23.9	14.9	6.7	8.0	9.9	5.7	15.4	9.9	6.0	7.1	8.1	8.2	12.8	19.7	20.3	21.3	8.2	13.7	8.8	6.0	12.3	12.0	14.2	14.0	17.1	14.6	16.3	12.6	11.9	20.5	14.2	11.0	4.7	13.1	11.2	14.9	18.5	10.3	18.3	19.0	36.4	23.2	16.8	12.2	14.1	12.0	13.6	18.3	11.9	14.1	15.2	15.5	29.0	18.7	4.6	10.2	16.0	18.2	12.2	37.3	23.7	8.3	17.3	20.5	9.3	14.7	0.0	12.1	24.1	15.8	15.0	9.2	6.7	14.0	35.0	15.5	10.4	10.3	6.0	14.4	10.4	13.5	19.8	16.5	20.3	13.5	17.8	12.4	6.5	19.5	0.0	10.3	28.3	36.5	33.4	23.8	13.8	18.7	23.7
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.4;brain: 37.2"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 378.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 38.6;NB-4: 27.7;PC-3: 83.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA		32000	Cytosol		"HPA052447: AB_2681837"	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	11.4	7.8	25.5	9.7	22.2	5.6	4.8	7.7	37.2	3.4	19.7	18.2	3.2	6.5	4.1	3.0	1.2	3.2	3.1	3.8	26.4	26.2	5.2	2.5	4.7	8.7	24.8	15.6	2.9	16.8	5.6	19.8	5.3	14.9	3.9	3.1	4.3	5.1	4.3	3.3	3.7	16.6	2.4	30.7	9.6	9.8	13.9	15.7	1.2	2.2	0.7	2.4	2.6	2.6	29.8	49.4	67.5	78.4	4.5	31.0	28.4	7.8	6.5	1.3	6.1	0.6	0.9	8.7	7.5	1.5	1.4	1.3	4.4	4.7	1.0	7.3	0.2	2.5	2.2	0.1	0.8	0.4	4.7	38.6	2.5	3.5	2.5	1.3	5.1	17.3	0.7	1.4	0.3	0.0	0.4	1.4	4.3	8.1	0.0	0.9	4.8	5.7	27.7	3.9	0.4	83.8	13.2	2.0	2.5	1.2	2.9	10.5	14.8	3.7	0.1	10.1	0.1	2.0	2.4	6.4	3.6	7.8	2.7	8.4	5.9	5.1	0.0	3.6	3.1	5.0	11.5	78.4	67.5	21.5	50.6	22.0	29.8	27.8	23.9	44.2	22.6	16.0	16.7	59.0	4.5	44.0	49.4	31.0	28.4	25.5	22.2	7.7	37.2	26.4	26.2	24.8	15.6	14.9	15.7	0.0	3.4	61.1	5.3	19.5	14.6	6.1	17.8	6.7	3.4	190.1	0.0	7.5	59.7	304.2	76.9	29.1	185.6	23.3	194.2	111.5	25.9	12.6	109.2	8.9	199.3	17.5	225.6	114.2	260.9	247.7	17.8	117.6	310.4	64.9	97.5	43.9	199.3	378.7	26.5	6.8	11.5	12.9	12.8	61.7	167.2	8.8	11.0	64.3	73.8	9.2
NAT8L	"FLJ37478, Hcml3"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059512-2069089	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 45.9;brain: 45.9;testis: 11.8"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 76.3;Muller glia cells: 25.6"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	45.9	2.0	23.5	1.3	28.3	1.2	7.9	16.4	45.9	1.2	1.5	7.4	0.3	1.3	1.6	2.8	1.3	2.4	1.3	2.1	20.8	12.9	8.2	1.2	1.2	1.4	16.4	12.6	1.4	3.9	1.2	5.6	1.3	12.8	2.4	1.3	1.2	3.8	3.2	7.3	2.4	1.5	1.4	6.5	1.5	1.6	11.8	8.2	0.0	1.6	0.0	1.2	1.2	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	6.6	3.6	7.3	0.7	0.0	4.2	0.1	0.0	0.2	0.0	2.9	0.2	0.0	1.3	0.0	1.1	0.1	8.2	0.0	0.1	0.0	9.6	0.1	1.4	4.7	1.2	10.1	5.0	0.0	0.1	0.0	0.0	1.4	0.0	2.5	7.8	0.0	0.3	4.4	0.1	14.7	10.3	0.0	3.0	0.5	1.7	0.2	0.1	0.3	19.0	6.3	4.8	0.0	15.1	0.6	0.5	5.9	0.0	0.0	2.5	0.1	3.9	0.0	0.0	0.1	0.0	4.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	23.5	28.3	16.4	32.7	20.8	12.9	16.4	12.6	12.8	8.2	0.0	0.0	0.0	0.0	0.2	7.1	2.0	0.0	0.0	0.0	1.8	5.9	0.0	0.0	4.2	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.7	76.3	1.7	0.0	0.0	3.1	0.0	0.1	10.1	0.0	0.0	25.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 9.2;Spermatocytes: 17.6;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035939: AB_2674875, HPA035940: AB_2674876"	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	13.6	3.9	6.1	2.5	5.7	1.8	5.2	11.1	5.5	2.8	2.9	3.5	2.9	2.7	4.0	5.8	2.6	3.6	3.3	2.8	4.4	2.9	3.6	3.4	3.0	2.7	4.3	4.0	2.8	3.1	2.4	7.6	2.3	3.8	4.6	1.8	1.7	4.7	3.5	2.7	2.7	2.4	3.3	5.6	3.5	2.9	12.3	5.2	8.5	2.4	0.9	2.6	2.5	2.6	0.2	0.1	2.4	0.0	0.0	0.9	0.1	0.3	2.7	0.5	2.0	5.7	2.2	0.0	2.0	1.0	1.1	1.6	0.1	0.2	1.2	0.6	1.7	1.0	0.4	2.2	0.8	1.6	0.3	2.9	0.1	2.0	0.0	0.7	0.2	2.6	3.1	0.8	1.7	1.4	2.6	0.6	0.5	0.2	2.3	3.1	0.3	0.2	0.2	0.2	0.1	0.6	0.0	3.8	0.9	0.8	0.5	2.5	0.0	0.2	0.0	0.2	1.0	0.1	0.7	0.3	0.1	1.9	1.1	0.6	0.6	0.7	0.0	0.6	1.9	1.1	0.0	0.0	2.4	0.2	0.0	0.9	0.2	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.1	6.1	5.7	11.1	5.5	4.4	2.9	4.3	4.0	3.8	5.2	0.0	0.0	0.0	1.0	0.8	3.2	1.6	2.5	1.4	2.3	0.0	0.0	0.2	3.3	0.4	6.8	0.8	0.0	0.0	0.9	0.2	1.7	1.1	0.0	0.6	0.5	3.2	4.6	4.9	1.0	9.2	4.0	1.4	0.0	0.0	0.0	2.6	0.4	0.0	3.5	0.5	3.6	0.0	1.3	17.6	10.0	1.4	0.0	0.7	0.2	1.3
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2227464-2242164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040649, HPA048190"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Microtubules, Mitochondria"	"Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	11.7	10.8	15.5	10.9	14.7	44.4	11.5	26.3	14.3	8.6	9.5	10.0	8.6	9.6	11.0	9.1	10.3	8.8	6.9	6.3	11.8	5.9	7.8	8.8	11.1	15.0	11.7	11.0	10.8	13.6	7.3	18.9	10.3	10.5	10.7	8.8	6.0	10.8	8.5	9.0	10.4	11.2	9.6	14.5	15.2	10.5	12.5	13.7	20.7	9.8	4.3	13.0	9.3	9.6	11.0	8.6	14.9	7.8	12.2	15.6	7.6	9.8	5.0	14.5	14.2	6.9	9.6	14.2	15.7	6.9	14.3	13.2	8.7	12.7	18.5	6.7	6.0	17.8	9.1	11.6	7.9	18.3	7.0	7.7	11.0	11.7	7.1	5.5	11.5	12.5	5.5	10.6	12.9	6.5	7.5	11.6	8.8	21.0	22.4	14.4	5.1	16.7	20.0	12.3	9.0	12.0	13.3	12.9	11.1	7.2	7.0	17.9	9.9	9.7	7.1	9.0	12.3	15.4	7.6	8.1	17.8	9.6	10.8	16.6	11.3	11.3	17.2	9.5	17.3	13.4	10.1	5.5	14.9	10.9	7.4	14.4	7.7	11.5	12.2	5.0	11.0	13.4	12.1	6.4	12.2	7.8	8.6	15.6	7.6	15.5	14.7	26.3	14.3	11.8	5.9	11.7	11.0	10.5	13.7	3.0	4.5	4.2	4.8	11.2	11.1	4.6	10.2	4.0	12.5	3.5	11.8	6.4	1.7	6.3	9.9	6.7	3.0	0.0	4.9	9.5	7.8	4.5	12.7	3.0	6.2	23.8	6.9	6.2	4.1	4.9	9.2	8.7	11.8	8.2	5.3	6.9	4.4	0.0	8.1	2.6	11.6	0.0	6.7	20.1	15.1	6.8	4.2	20.2	5.2	2.6
MXD4	"bHLHc12, MAD4, MST149, MSTP149"	ENSG00000123933	"MAX dimerization protein 4"	Q14582	4	2247432-2262294	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053363			Supported	Cytosol		NA	NA			Cytosol		"HPA053363: AB_2682128"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.54e-2)"	"prognostic favorable (2.21e-5)"	"unprognostic (1.64e-1)"	"unprognostic (5.94e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.39e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.12e-2)"	31.9	21.6	20.1	11.8	17.1	23.3	26.2	63.2	23.3	16.5	17.6	15.1	29.8	17.4	19.7	19.7	13.6	24.4	19.2	19.8	16.0	13.1	23.3	12.1	20.0	19.9	13.5	12.4	12.6	18.7	11.4	32.7	24.5	14.4	17.6	7.3	18.3	32.7	26.3	19.3	24.3	16.8	13.8	11.4	29.8	15.1	11.8	11.3	34.8	17.6	8.0	16.1	16.2	21.3	3.5	10.6	8.1	4.3	2.7	5.6	1.9	1.0	3.6	5.7	6.8	20.2	15.0	1.3	7.2	7.4	5.4	5.5	0.8	3.1	3.0	16.2	10.8	2.8	4.9	1.6	5.7	1.4	2.7	17.4	0.5	12.2	10.0	14.9	2.3	6.5	23.4	10.2	1.7	2.7	11.9	12.8	4.5	4.1	5.1	5.0	6.9	5.3	13.4	2.3	4.1	16.1	3.6	1.9	6.3	6.3	5.6	9.3	17.4	6.7	3.3	5.1	7.4	15.6	14.9	30.0	6.0	2.4	4.4	1.6	7.8	5.5	1.1	8.2	2.1	1.7	8.1	4.2	4.8	5.3	4.3	4.3	3.4	4.7	5.0	3.6	3.5	2.4	2.5	1.7	2.7	4.1	10.6	5.6	1.9	20.1	17.1	63.2	23.3	16.0	13.1	13.5	12.4	14.4	11.3	17.9	14.5	26.4	14.2	16.9	79.3	15.7	15.3	5.3	14.8	57.6	82.5	34.2	13.3	14.4	8.0	36.0	42.9	23.3	15.5	42.1	33.4	28.8	24.2	29.8	42.0	62.0	32.2	108.1	54.1	22.1	30.8	25.9	21.9	4.6	47.2	66.8	16.1	28.8	53.0	18.4	95.5	25.8	30.2	4.9	21.1	23.1	27.3	29.9	29.8	10.8
ZFYVE28	KIAA1643	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418663	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 63.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 28.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	4.5	8.6	7.7	5.1	15.8	3.1	3.7	63.6	15.1	3.7	7.4	4.6	1.8	10.4	4.1	3.1	3.4	4.3	5.9	2.4	7.1	5.5	5.7	4.2	4.4	6.1	7.9	8.0	3.4	7.3	7.9	7.5	1.8	9.9	2.9	5.1	5.8	9.5	5.4	4.3	5.7	11.9	2.8	9.4	7.0	7.5	7.9	6.7	1.2	5.3	3.1	4.0	4.5	3.2	3.1	0.7	0.9	0.4	0.3	4.4	1.3	0.8	1.0	0.2	3.7	2.2	0.7	0.1	1.8	3.1	1.0	0.3	0.1	6.7	0.0	1.9	3.2	2.6	3.8	1.2	0.3	0.6	9.7	1.3	0.2	4.3	0.3	4.4	0.7	11.2	3.0	0.6	1.1	0.1	7.0	3.1	1.0	1.8	8.2	0.9	2.2	0.1	12.1	0.1	2.0	8.2	0.0	0.0	3.9	1.5	0.5	5.8	0.4	1.8	0.1	1.0	0.1	2.5	0.3	0.5	1.8	0.0	5.5	0.1	12.8	9.3	0.2	5.4	2.3	1.8	0.9	0.4	0.1	4.4	0.0	1.9	0.9	2.3	3.2	0.7	3.1	3.2	3.2	0.1	0.3	0.3	0.2	4.0	1.3	7.7	15.8	63.6	15.1	7.1	5.5	7.9	8.0	9.9	6.7	0.0	1.7	0.0	3.2	5.3	10.7	3.3	5.1	1.4	3.4	10.4	17.7	0.3	6.6	2.7	28.4	4.5	16.9	0.0	2.0	0.2	1.9	1.5	9.2	4.9	1.8	7.9	2.4	5.5	1.9	5.8	1.4	7.1	6.8	4.6	5.9	1.4	2.1	9.0	2.1	3.1	16.3	0.0	2.8	2.1	9.0	4.3	0.2	21.0	5.2	4.1
CFAP99		ENSG00000206113	"Cilia and flagella associated protein 99"	D6REC4	4	2418974-2462942	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;fallopian tube: 8.8;testis: 37.2"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 5.3;Club cells: 3.4;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Early spermatids: 6.3;Late spermatids: 9.5;Rod photoreceptor cells: 5.5;Spermatocytes: 7.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.4;SCLC-21H: 1.6;T-47d: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.54e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.93e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.49e-1)"	0.0	1.7	0.8	0.1	5.5	0.0	0.1	0.0	0.6	0.4	0.1	3.5	0.0	0.1	0.5	4.5	0.0	8.8	0.2	0.0	2.4		0.6	0.3	2.9	0.0	0.0	0.0	0.8	0.8	0.0	2.9	0.0	9.9	0.1	0.1	1.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	37.2	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.2	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.6	3.4	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.4	0.0	0.2	0.6	1.3	1.3	0.8	0.2	0.1	0.0	0.6	1.1	0.0	1.6	0.7	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.8	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	3.4	3.5	3.9	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	5.5	0.0	0.0	7.2	0.7	0.0	0.0	0.0	0.0	0.1
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	28.6	29.1	25.4	32.2	39.4	36.4	28.6	35.9	50.3	28.2	25.1	34.8	28.4	27.0	32.2	28.0	30.3	27.8	27.1	24.6	22.7	22.8	32.3	25.6	27.4	41.9	23.5	23.4	32.1	31.0	31.2	30.0	29.4	36.7	28.5	26.7	29.2	36.1	28.5	26.0	28.5	29.3	31.8	23.1	41.9	28.9	36.8	23.7	50.4	29.3	19.1	51.5	27.7	26.3	36.9	35.3	41.8	39.9	39.7	43.7	45.8	20.1	19.1	20.0	13.9	17.5	18.2	22.4	24.6	27.7	26.2	23.8	21.6	19.0	25.5	14.7	24.8	34.7	13.2	21.2	19.3	25.0	12.0	12.8	30.9	19.7	20.7	26.2	21.7	27.1	21.1	23.4	24.3	20.3	18.4	24.2	21.7	16.3	35.3	26.7	13.8	34.7	30.3	30.8	16.9	24.0	25.4	19.1	13.2	17.8	25.7	18.6	17.6	17.3	13.4	17.2	22.5	21.3	16.4	20.1	22.9	11.2	21.5	37.7	45.7	60.8	28.3	22.3	23.7	23.7	14.6	29.6	41.8	43.7	39.3	43.7	36.9	37.5	43.0	35.3	27.2	36.2	36.3	32.9	39.7	39.9	23.6	39.9	45.8	25.4	39.4	35.9	50.3	22.7	22.8	23.5	23.4	36.7	23.7	20.8	20.3	25.1	14.7	24.5	12.4	15.7	17.8	13.4	21.6	21.0	15.7	18.0	18.3	19.5	11.0	20.2	14.8	0.0	20.4	27.8	17.2	19.5	13.9	17.8	17.4	12.7	11.6	15.4	34.2	17.3	15.8	20.0	6.8	27.9	14.2	9.2	25.2	14.0	19.4	17.7	16.5	25.8	21.7	26.7	47.3	28.1	18.2	33.1	15.6	29.1
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536631-2732565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	17.1	14.1	17.8	25.5	17.7	22.4	19.7	33.0	23.2	17.4	14.5	18.2	21.3	15.3	23.5	16.0	12.1	16.4	17.2	11.9	16.7	14.3	12.4	13.7	20.2	17.3	18.0	11.8	23.7	17.4	20.4	21.5	15.3	16.1	16.4	11.9	18.8	16.4	19.3	18.1	16.6	15.8	16.0	13.9	17.0	14.7	29.1	17.2	26.3	15.4	13.7	16.0	14.6	30.7	2.5	3.9	5.7	6.3	3.2	2.9	1.0	7.1	9.0	16.7	9.5	10.2	10.5	9.1	11.0	9.4	10.8	9.1	9.1	11.7	14.0	6.8	11.9	13.3	6.2	11.6	7.8	8.9	8.7	7.6	21.0	11.1	9.4	12.4	12.6	14.8	11.5	8.3	10.6	10.8	9.8	10.6	8.4	14.7	15.5	8.8	7.5	20.5	20.5	13.7	7.1	10.2	20.3	8.8	6.9	7.2	9.4	14.7	12.6	9.3	6.5	9.5	9.4	12.0	13.0	14.3	16.5	9.8	8.9	14.2	15.7	11.5	13.6	9.3	10.6	11.7	5.7	2.2	1.8	2.2	1.5	1.5	1.5	1.9	2.9	1.4	2.5	1.9	2.7	4.2	3.2	6.3	3.9	1.4	1.0	17.8	17.7	33.0	23.2	16.7	14.3	18.0	11.8	16.1	17.2	11.9	15.6	2.7	6.0	8.4	24.2	13.1	0.0	4.0	21.6	1.8	45.2	5.9	1.7	7.9	6.7	12.6	11.6	0.0	6.5	5.7	10.8	9.1	8.1	4.9	7.5	14.3	13.8	10.4	8.2	11.0	15.8	11.3	13.5	8.2	9.0	15.4	8.7	9.0	13.8	2.2	24.7	6.5	10.0	29.8	28.5	8.7	4.7	6.4	8.9	6.4
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756376	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	16.7	10.3	7.8	14.5	14.0	18.9	32.5	3.4	12.4	9.8	26.4	7.3	7.1	16.4	11.9	10.1	14.5	9.6	13.7	26.6	7.4	6.5	23.4	16.6	16.0	17.9	11.2	4.7	12.3	24.2	3.5	11.4	15.3	12.4	13.6	10.1	9.7	10.7	13.5	21.9	10.5	37.2	23.9	12.2	17.8	15.3	11.7	11.1	8.1	14.2	12.3	18.2	15.1	33.7	9.8	7.3	20.9	11.8	4.4	11.2	4.7	12.2	16.7	5.3	8.0	17.0	11.7	23.0	13.4	12.0	12.5	12.2	19.1	19.9	11.2	15.2	14.6	28.1	8.1	9.5	15.4	7.4	8.7	11.9	13.4	9.9	21.1	21.2	10.9	17.0	15.1	14.0	13.8	12.5	9.7	17.8	10.3	13.6	15.9	8.6	25.4	14.3	27.0	13.9	18.3	28.6	9.5	8.1	5.8	13.4	13.8	8.0	9.0	10.4	10.9	14.7	9.6	12.0	16.1	20.6	9.7	10.7	15.1	20.5	16.5	11.2	8.1	17.7	19.8	10.4	6.4	7.2	20.9	6.7	11.2	7.2	7.8	10.2	11.2	7.3	9.8	8.4	7.0	7.1	4.4	11.8	3.4	10.2	4.7	7.8	14.0	3.4	12.4	7.4	6.5	11.2	4.7	12.4	11.1	6.0	9.8	20.6	45.8	54.5	2.1	12.0	5.1	6.7	11.4	14.0	2.0	44.9	11.6	51.5	2.1	31.7	65.3	0.0	52.5	89.5	32.8	52.4	12.7	14.9	31.4	0.0	18.4	28.8	18.9	5.4	19.8	35.5	25.3	104.6	33.4	10.0	53.3	52.6	16.6	33.2	6.5	19.4	37.0	15.8	60.0	69.1	80.0	34.8	32.9	71.1
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793023-2841098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 83.9;Suprabasal keratinocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036790	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	17.5	7.0	9.7	20.4	14.5	30.2	13.1	6.1	10.1	9.0	11.6	9.8	7.5	8.9	7.9	18.7	10.8	8.7	9.5	9.9	9.3	8.8	26.3	18.3	20.2	18.5	12.0	3.5	8.8	10.1	3.6	7.6	20.8	15.4	8.4	7.4	11.6	9.3	7.8	11.0	31.2	14.2	8.9	14.5	46.8	10.8	5.0	12.2	5.2	8.0	6.9	17.4	11.6	10.9	4.4	8.6	16.7	21.9	3.8	7.0	5.4	5.3	3.2	3.7	5.2	3.1	7.9	3.5	8.5	7.0	6.6	5.9	2.3	16.7	8.4	9.7	7.1	5.5	2.5	0.2	5.6	4.0	4.3	3.4	19.7	6.6	2.7	10.3	8.1	13.9	14.9	5.3	3.7	3.3	7.2	14.4	7.5	1.1	19.5	7.8	4.3	1.2	9.7	6.0	11.5	6.3	0.4	3.4	3.6	11.2	8.4	11.3	8.4	6.2	5.9	4.2	3.5	9.0	13.5	18.3	6.4	4.9	2.3	6.3	8.2	3.8	1.7	7.5	21.9	6.8	1.8	10.5	6.7	7.0	18.6	4.4	1.4	1.9	4.6	8.6	4.4	1.0	2.7	16.7	3.8	21.9	3.5	3.5	5.4	9.7	14.5	6.1	10.1	9.3	8.8	12.0	3.5	15.4	12.2	3.0	4.3	12.4	8.1	33.9	0.8	6.1	7.6	2.7	9.1	38.4	0.0	0.9	3.3	6.3	7.4	27.2	19.0	0.0	19.1	1.2	11.3	12.4	9.2	40.4	43.6	0.0	9.8	39.9	83.9	5.8	12.7	47.9	18.6	7.2	13.3	30.8	21.0	23.4	9.6	30.1	5.1	38.8	17.5	1.6	3.4	72.9	3.5	17.3	12.1	17.0
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 557.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	44.0	31.7	43.1	27.9	52.1	26.7	35.6	46.3	66.6	37.5	43.3	47.2	27.3	30.8	47.9	29.2	35.1	43.0	33.1	41.1	39.5	34.1	36.8	23.4	38.0	27.9	40.5	46.7	65.3	25.0	31.3	28.4	31.2	44.7	43.1	30.7	36.3	26.2	54.9	69.5	25.5	33.6	58.1	33.8	34.9	32.6	25.2	37.0	25.5	27.9	19.6	28.5	45.3	34.9	21.3	16.2	21.5	6.5	16.4	12.9	9.1	18.5	15.6	37.1	19.1	55.0	41.2	13.9	31.5	37.9	32.9	27.9	22.9	23.6	9.7	16.6	54.0	38.6	11.9	27.7	26.5	27.6	12.4	12.7	27.5	13.5	22.0	26.9	16.3	19.6	40.6	24.9	28.9	11.6	34.3	40.9	18.5	28.5	23.6	37.5	10.9	50.2	22.8	20.8	17.1	22.2	22.3	20.6	11.4	24.1	41.3	22.2	28.9	22.8	9.3	19.5	29.4	21.8	15.5	49.4	27.0	13.9	22.1	26.0	19.0	15.4	12.4	26.0	20.3	26.0	11.0	4.8	21.5	12.9	4.5	11.8	16.1	7.2	10.8	7.5	21.3	6.8	8.1	6.7	16.4	6.5	16.2	9.2	9.1	43.1	52.1	46.3	66.6	39.5	34.1	40.5	46.7	44.7	37.0	65.5	42.1	48.2	25.8	23.9	91.0	71.2	40.8	34.8	51.2	57.6	379.0	29.9	13.3	33.6	44.3	61.8	38.1	0.0	39.8	26.5	52.3	36.5	35.9	41.0	35.3	104.9	55.5	59.5	43.4	29.2	71.9	38.1	33.7	57.7	42.6	228.9	44.9	31.6	114.5	36.3	557.2	97.0	52.0	40.7	36.8	32.0	30.6	55.8	35.2	27.7
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934859	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	21.6	9.1	10.3	15.2	10.7	62.9	34.4	20.2	13.0	17.1	18.1	8.9	17.5	13.8	16.0	17.1	18.0	16.3	23.5	13.5	9.6	10.1	15.7	6.0	16.8	17.6	9.1	10.1	20.6	20.9	4.2	13.3	13.5	8.4	22.0	5.2	7.1	27.1	14.5	10.3	10.0	19.0	10.9	7.7	16.3	18.7	11.1	7.4	8.3	29.9	15.0	14.9	15.2	16.7	18.4	22.2	42.5	33.1	16.1	33.2	15.0	12.9	12.3	3.5	9.0	6.0	4.3	9.8	12.0	5.9	5.9	6.8	6.5	31.4	2.3	6.4	7.5	10.9	12.2	3.2	17.3	1.6	14.6	11.1	4.9	10.5	6.7	10.1	15.5	7.2	6.5	10.2	6.6	4.2	9.1	6.7	5.2	6.8	4.8	4.4	14.0	4.4	71.8	11.7	10.2	14.8	5.4	1.7	10.8	8.7	8.0	9.3	11.1	2.8	8.4	12.5	3.8	22.1	29.5	9.8	4.7	8.3	5.9	9.5	3.2	1.4	3.5	13.7	39.7	7.5	21.0	21.4	42.5	29.9	26.4	25.3	18.4	19.3	33.2	22.2	14.8	9.9	17.3	16.8	16.1	33.1	17.4	12.6	15.0	10.3	10.7	20.2	13.0	9.6	10.1	9.1	10.1	8.4	7.4	35.7	29.0	29.6	60.0	27.8	6.7	4.6	28.1	29.4	21.6	43.6	7.9	55.4	3.3	85.0	10.1	33.1	37.5	0.0	39.9	70.0	33.4	67.6	32.3	2.9	65.2	14.3	27.1	38.6	37.6	12.2	33.6	46.5	40.5	72.1	34.1	9.8	74.5	42.1	21.2	17.3	9.4	90.5	37.6	14.3	16.0	23.5	70.0	69.2	41.7	89.7
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.3	13.9	8.3	17.1	11.2	12.7	14.5	15.1	10.8	15.8	13.0	18.1	17.3	46.3	10.7	12.2	11.5	11.3	22.8	19.6	17.0	8.8	21.8	36.8	13.2	16.4	14.8	39.9	16.1	12.8	17.7	17.8	16.3	7.8	13.2	14.3	33.3	16.5	11.8	11.7	42.1	30.1	21.6	15.1	22.8	27.3	12.6	15.4	7.9	26.4	17.2	10.1	12.5	9.3	11.8	7.9	17.8	15.8	16.4	13.2	7.7	16.1	27.7	12.4	19.9	40.0	13.8	29.6	13.7	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4	17.9	22.5	10.4	13.9	23.0	9.0	18.2	15.3	17.4	35.2	1.8	13.7	12.7	10.0	12.9	1.7	14.3	3.6	0.0	20.6	13.2	7.6	9.5	19.7	23.1	9.9	19.1	8.6	9.2	3.2	2.1	11.5	11.3	0.0	15.4	9.7	6.0	16.8	8.6	9.2	10.1	7.1	12.9	13.3	9.2	20.6	28.4	9.6	12.5	13.4	14.8
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	"G protein-coupled receptor kinase 4"	P32298	4	2963608-3040747	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.2"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 115.8;Early spermatids: 282.7;Late spermatids: 377.5;Spermatocytes: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028737, HPA057023"	Approved		Approved	Lysosomes		NA	NA			Lysosomes		"HPA028737: AB_2672757, HPA057023: AB_2683313"	"unprognostic (1.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"	3.4	3.6	5.4	1.6	5.1	1.7	4.8	12.5	5.9	3.0	2.1	4.2	1.0	1.5	2.7	3.1	2.4	2.0	3.0	5.6	5.2	4.8	2.8	2.3	2.4	1.6	5.3	5.3	3.4	7.9	3.9	6.2	2.2	5.9	2.4	2.0	3.1	4.0	2.9	5.0	2.9	1.7	2.8	5.4	1.9	2.5	41.2	3.7	1.6	4.1	1.6	1.7	2.5	3.3	1.2	2.5	4.5	2.0	1.6	1.7	1.0	2.5	0.9	3.0	8.7	7.4	7.1	1.9	4.9	2.1	2.8	2.4	2.4	0.8	5.6	2.1	7.7	5.4	0.8	4.0	4.0	2.5	3.8	4.0	6.1	3.5	2.8	4.4	2.4	2.2	4.8	6.3	4.9	2.3	3.1	5.2	6.0	5.7	7.4	6.5	2.8	5.2	5.2	2.4	3.5	6.9	6.6	3.9	2.2	2.6	3.1	17.6	5.4	2.9	1.3	4.4	2.2	6.7	3.8	6.0	7.6	2.0	5.1	4.3	7.6	4.3	4.3	3.7	5.4	2.5	4.5	1.1	2.1	1.1	2.0	1.4	1.1	0.7	0.7	0.3	1.2	1.7	1.6	4.0	1.6	0.7	2.5	0.4	1.0	5.4	5.1	12.5	5.9	5.2	4.8	5.3	5.3	5.9	3.7	3.0	9.0	0.0	2.5	10.0	48.5	9.0	7.6	1.4	7.9	3.5	115.8	1.8	11.6	2.4	282.7	3.8	1.0	0.0	3.3	3.5	9.9	1.5	5.7	2.5	3.0	17.5	9.9	3.1	2.2	377.5	12.0	3.2	6.8	2.8	1.7	10.3	1.8	0.0	7.8	3.6	48.9	6.5	4.4	110.9	13.6	9.9	2.5	4.4	1.2	2.3
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3074681-3243960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 170.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	12.9	13.8	19.4	16.6	18.3	14.1	12.3	24.7	32.3	10.0	13.6	11.6	11.0	10.5	11.5	15.9	16.3	11.6	9.4	8.9	19.7	12.1	11.3	13.1	21.5	18.1	11.8	19.5	13.0	27.0	29.5	13.0	12.0	12.8	10.5	11.4	13.3	10.2	11.4	19.1	25.4	12.8	12.0	10.4	17.4	12.0	14.9	10.4	17.4	13.3	7.3	15.6	11.7	9.6	2.9	3.5	2.8	4.5	2.9	4.3	1.9	12.4	8.7	12.2	7.2	22.4	12.8	12.4	5.8	7.2	8.8	8.3	11.5	8.1	19.1	6.2	14.0	16.1	7.1	14.4	10.6	8.9	5.0	10.6	18.2	12.4	12.2	5.3	12.2	26.7	8.9	6.5	17.2	8.1	6.0	10.2	8.6	11.9	6.9	7.7	12.0	13.0	11.5	14.9	6.3	14.1	11.7	11.7	3.7	9.4	12.9	13.4	9.5	10.4	3.9	10.2	9.7	10.8	7.6	14.1	12.3	7.7	8.4	13.0	5.3	6.2	15.2	9.2	11.3	8.8	0.0	2.6	2.8	3.5	3.4	2.4	2.9	2.7	4.3	3.5	2.4	2.0	2.4	0.4	2.9	4.5	2.6	3.5	1.9	19.4	18.3	24.7	32.3	19.7	12.1	11.8	19.5	12.8	10.4	23.8	15.0	13.9	7.0	12.2	42.6	10.1	20.4	5.3	13.6	14.0	170.8	10.3	5.0	10.2	9.0	10.8	18.4	0.0	14.9	9.2	10.8	13.1	11.5	13.5	23.3	42.9	17.7	23.9	23.5	7.5	15.0	14.5	8.5	13.6	11.4	19.1	18.0	20.1	11.0	9.8	45.2	12.9	7.1	10.4	19.4	17.6	7.0	10.2	16.2	9.9
MSANTD1	"C4orf44, LOC345222"	ENSG00000188981	"Myb/SANT DNA binding domain containing 1"	Q6ZTZ1	4	3244369-3271738	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 9.7;testis: 6.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 34.1;Late spermatids: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.0"	"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.24e-1)"	0.7	0.8	3.3	1.0	9.4	1.0	0.7	2.0	9.7	0.5	0.7	1.3	0.0	0.8	0.7	1.6	0.5	0.6	0.5	0.5	6.9	4.7	1.0	0.5	1.3	0.8	0.8	5.8	0.8	1.5	0.5	1.4	0.7	1.4	1.0	0.5	0.3	1.5	0.8	2.4	0.8	0.8	0.6	0.4	1.3	1.1	6.3	1.0	0.0	1.2	0.0	0.7	0.3	0.4	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.3	0.5	1.7	0.4	0.1	0.7	0.3	0.2	0.1	0.4	0.9	0.8	0.7	0.6	0.3	1.8	0.4	0.3	0.1	0.3	0.5	0.4	0.8	1.2	1.2	0.0	0.1	2.2	0.7	0.5	0.3	0.5	0.3	0.3	1.0	0.4	1.0	0.0	0.7	0.6	2.0	1.4	0.5	1.5	0.4	0.1	0.5	0.2	0.8	2.3	0.5	0.3	0.1	0.5	1.2	0.6	0.3	0.5	0.7	1.4	0.9	0.9	1.6	1.3	0.4	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	9.4	2.0	9.7	6.9	4.7	0.8	5.8	1.4	1.0	0.0	0.0	0.0	0.1	0.9	1.4	1.1	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	34.1	0.0	0.0	0.0	6.2	0.2	0.2	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.4	0.0	1.9	0.0	0.0	3.8	1.2	0.3	0.0	0.0	0.0	0.0
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	4.7	4.4	20.7	4.1	22.0	2.3	4.4	10.2	37.2	5.4	2.9	10.2	1.5	5.3	6.4	5.6	13.5	7.5	4.4	4.7	13.4	5.6	4.4	6.7	6.5	3.4	12.3	16.3	8.9	3.1	3.1	6.1	4.1	9.4	6.8	2.2	3.1	6.5	5.7	6.8	20.6	4.6	3.0	18.9	4.1	3.2	5.5	9.9	4.3	3.8	3.4	3.6	5.5	7.9	1.0	1.5	1.6	3.9	0.4	1.3	0.7	4.0	5.1	10.3	7.4	3.5	2.7	4.3	4.3	3.5	4.5	3.3	4.1	2.4	1.0	2.7	3.8	6.6	3.9	2.0	13.9	1.5	0.1	1.6	0.4	2.9	10.0	3.1	0.3	5.7	2.3	9.5	2.3	3.2	4.1	9.9	3.6	4.7	0.2	4.1	3.4	0.7	10.8	4.9	2.3	4.9	10.2	4.0	3.3	2.3	12.0	11.7	12.0	2.7	1.9	9.1	2.6	4.7	6.9	7.4	8.8	5.8	1.8	4.6	5.1	4.0	2.3	5.1	6.0	6.2	1.0	1.2	0.3	0.9	3.9	0.3	0.2	0.8	0.5	1.5	1.0	1.3	0.5	1.6	0.4	3.7	0.8	0.6	0.7	20.7	22.0	10.2	37.2	13.4	5.6	12.3	16.3	9.4	9.9	6.0	8.3	0.5	118.6	75.0	19.0	7.5	15.3	29.4	20.5	5.2	27.5	5.3	3.3	9.0	3.8	21.1	5.1	0.0	9.2	1.0	10.0	34.2	13.9	22.7	19.8	9.5	14.3	25.8	6.1	4.2	13.8	19.0	16.9	5.4	9.9	38.9	11.1	0.0	7.4	18.1	18.7	0.0	8.8	20.2	14.9	96.1	5.6	4.5	8.0	169.4
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441887-3449495	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"liver: 128.0"	"Group enriched"	"Detected in some"	14	"Early spermatids: 70.8;Hepatocytes: 52.3;Late spermatids: 115.2"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	11000000000			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.0	1.3	0.7	0.4	0.1	0.0	0.0	0.6	1.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.5	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.3	0.0	3.2	0.0	2.5	3.5	115.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.3	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	0.1	1.0	0.0	3.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	27.8	0.0	1.1	0.2	1.2	0.1	0.0	5.4	0.2	1.8	2.4	0.5	0.1	2.3	0.0	0.0	0.0	6.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4	0.0	1.0	0.0	3.2	0.0	0.2	11.9	0.0	1.4	4.5	5.2	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	3.8	0.0	0.3	1.8	0.0	0.0	0.1	0.0	5.8	0.0	0.0	4.8	0.9	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.4	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3506376-3532559	"Disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 500.6;Syncytiotrophoblasts: 580.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	9.4	11.3	13.7	8.7	34.4	17.4	8.5	11.4	22.1	10.1	9.3	9.1	15.5	10.6	11.1	16.7	7.2	10.5	11.2	28.1	11.6	13.1	17.7	16.5	10.8	9.9	10.6	14.5	13.2	28.8	20.0	18.1	35.2	9.9	11.2	7.6	11.5	23.0	18.9	12.5	10.9	10.3	8.4	7.2	10.9	10.7	10.9	12.0	4.8	11.6	6.9	6.5	8.6	8.0	6.2	8.8	37.7	15.9	7.3	7.1	15.1	4.3	9.1	6.6	9.6	9.3	4.9	14.2	7.1	8.1	6.4	5.2	17.9	8.7	2.3	7.5	6.8	8.8	7.0	4.2	7.6	3.8	1.8	9.9	3.2	9.1	11.8	5.8	5.3	15.3	6.2	5.9	5.1	2.8	6.1	7.9	4.5	5.8	8.9	5.6	7.0	3.4	20.3	5.5	6.5	9.5	4.6	5.1	8.5	7.0	9.9	6.0	5.3	8.7	3.6	9.2	4.4	7.8	9.8	6.4	6.2	5.8	4.8	9.2	5.0	3.3	3.2	7.4	15.7	8.4	11.2	15.9	37.7	6.5	12.5	5.6	6.2	6.0	6.1	8.8	5.9	6.7	6.1	13.3	7.3	11.4	6.6	7.1	15.1	13.7	34.4	11.4	22.1	11.6	13.1	10.6	14.5	9.9	12.0	101.3	71.8	70.1	148.3	60.2	64.5	138.2	94.3	111.1	83.0	184.9	43.2	500.6	43.1	137.9	29.8	84.7	141.2	0.0	93.8	144.8	164.2	115.9	79.6	88.4	225.9	36.5	79.3	47.9	91.5	43.0	116.8	129.5	140.0	128.0	72.2	127.1	91.5	101.7	142.5	235.8	70.5	77.6	128.1	198.2	166.9	53.6	580.0	69.2	81.2	127.8
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.1"	"Cell type enhanced"	"Detected in some"	13	"Collecting duct cells: 12.2;Muller glia cells: 5.2;Smooth muscle cells: 4.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 11.1;MCF7: 18.4;NTERA-2: 6.5;OE19: 7.3;SCLC-21H: 7.1;SH-SY5Y: 8.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 41.4"	HPA057688	Uncertain					NA	NA					"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	6.5	2.4	2.1	1.0	9.8	0.4	9.2	0.5	2.6	35.1	1.5	0.6	12.8	1.0	20.3	18.0	2.1	6.4	5.5	3.0	1.2	1.0	9.2	1.3	2.0	1.2	0.7	1.6	7.6	4.1	0.5	4.2	27.6	1.1	7.3	0.6	3.6	0.8	24.6	2.6	2.1	0.9	3.0	0.7	7.5	0.7	6.2	2.0	0.2	0.8	1.9	0.5	2.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.1	0.5	0.0	0.2	0.4	0.0	0.0	0.0	2.0	1.2	0.0	2.1	0.3	0.7	0.0	0.2	0.0	0.0	0.0	5.7	0.0	0.0	11.1	0.6	0.0	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.7	18.4	0.0	0.0	6.5	7.3	0.0	0.0	6.0	0.0	0.0	0.3	7.1	8.5	2.5	0.0	0.1	1.7	6.1	0.1	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	9.8	0.5	1.4	1.2	1.0	0.7	1.6	1.1	2.0	0.0	0.0	0.0	0.1	0.0	1.4	0.9	2.5	0.0	0.0	12.2	0.0	0.8	3.3	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.3	3.2	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.2	0.2	0.0	3.5	1.8	0.0	0.0	4.1	0.0	0.7	0.0	1.4	0.0	0.0	0.1
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188803-4226889	"Predicted membrane proteins, Transporters"	"Biomineralization, Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;skin 1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035599	Uncertain					NA	NA					"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0			0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.8			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM128	MGC13159	ENSG00000132406	"Transmembrane protein 128"	Q5BJH2	4	4235542-4248212	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044809	Uncertain					NA	NA					"HPA044809: AB_10963539"	"unprognostic (4.97e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	14.4	19.8	20.7	11.7	22.6	4.8	23.0	16.7	27.6	18.4	15.4	28.0	18.3	13.8	18.9	33.8	14.2	20.6	12.3	17.7	22.1	26.0	23.2	12.9	22.4	26.7	25.6	19.2	26.3	32.7	21.4	14.9	18.0	22.4	19.0	17.3	19.5	15.2	18.9	18.3	15.0	12.8	13.9	36.7	14.2	15.8	27.7	15.8	12.9	25.9	13.5	15.1	12.5	13.9	20.9	33.0	22.4	26.9	23.0	34.8	19.1	7.3	5.8	21.5	16.3	17.5	14.7	15.4	16.0	18.1	17.3	16.4	6.5	29.4	4.3	8.4	14.2	16.3	6.4	10.2	10.9	16.4	11.7	6.4	8.0	4.2	9.0	24.7	19.3	14.8	20.4	19.1	6.6	13.5	15.5	10.1	14.6	11.4	8.8	19.8	8.0	15.7	26.0	17.7	10.8	11.4	6.2	8.7	9.1	25.7	11.7	12.1	19.6	6.6	6.3	18.6	14.8	21.6	19.2	9.9	16.3	6.9	15.2	16.5	24.5	20.1	14.6	17.0	13.6	19.7	12.7	20.7	22.4	21.1	26.9	26.1	20.9	25.6	20.7	20.6	19.3	34.8	29.2	9.5	23.0	22.8	33.0	19.1	19.1	20.7	22.6	16.7	27.6	22.1	26.0	25.6	19.2	22.4	15.8	11.9	20.7	13.7	14.0	15.9	9.5	7.3	17.8	24.1	15.9	29.6	2.0	39.5	24.9	23.1	16.6	21.5	19.1	23.3	20.6	34.3	31.9	18.6	15.1	14.9	27.4	12.7	16.6	23.9	23.5	5.8	37.7	19.4	37.1	24.4	20.8	22.9	17.3	30.3	35.3	30.5	10.7	45.3	14.4	77.0	31.3	22.0	36.6	18.7	18.5	16.7
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290169	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	11.1	5.7	6.8	11.9	10.1	10.9	8.2	7.3	8.0	6.6	6.9	4.3	4.1	5.7	6.9	5.5	11.2	7.1	5.4	10.1	7.0	4.6	5.0	9.9	7.7	13.8	10.9	4.5	11.1	6.3	4.4	15.6	7.1	8.4	7.8	6.8	3.7	5.4	6.4	15.1	5.9	6.2	9.1	7.9	18.2	5.8	60.2	12.0	10.0	6.3	11.9	10.9	10.1	10.4	7.3	7.1	8.9	12.9	10.7	32.8	10.3	13.3	7.0	6.3	9.2	5.5	6.3	10.8	12.2	4.2	12.7	8.8	22.0	17.6	35.9	8.8	5.2	20.5	8.5	23.5	12.7	16.7	6.4	17.3	36.0	6.7	24.6	9.4	41.5	9.8	4.9	8.1	14.6	24.9	3.3	10.9	20.5	48.1	12.0	8.8	13.5	14.1	53.5	31.3	14.2	23.0	21.7	11.5	17.3	5.7	9.3	15.0	6.4	6.6	7.3	12.4	8.4	7.5	12.4	10.2	12.7	10.1	16.5	38.4	8.5	12.8	57.4	8.6	35.1	10.2	8.9	9.7	8.5	28.6	9.6	32.8	7.3	18.9	30.8	7.1	5.7	8.9	19.0	2.8	10.7	12.9	5.3	8.8	10.3	6.8	10.1	7.3	8.0	7.0	4.6	10.9	4.5	8.4	12.0	14.9	30.0	19.7	34.4	106.7	9.4	21.6	12.7	26.8	36.4	1.8	7.9	43.0	8.3	15.1	74.2	29.5	2.8	0.0	17.0	43.6	29.4	25.4	20.8	10.6	32.5	14.3	10.3	8.6	30.8	61.9	31.7	32.1	20.3	19.0	16.0	9.6	22.6	13.9	25.1	5.1	28.7	38.8	35.0	435.9	39.2	101.3	16.9	130.7	24.0	62.3
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.88e-5)"	7.3	5.4	5.0	6.0	9.0	11.8	6.8	9.2	8.7	7.2	6.2	9.9	3.4	4.5	9.5	7.0	5.6	6.3	5.3	6.2	6.1	5.1	4.7	5.9	6.5	7.5	6.8	5.3	10.6	7.7	6.0	13.3	5.6	8.9	7.9	4.4	7.1	10.0	6.5	10.1	4.8	6.3	6.5	6.1	9.2	6.0	10.3	6.7	6.7	8.1	5.0	8.5	7.8	5.8	2.9	1.9	12.1	2.7	3.2	6.4	1.8	2.0	3.4	4.3	7.2	5.8	6.1	5.1	2.6	5.1	5.7	4.4	3.0	4.0	7.4	2.7	2.8	7.0	3.6	7.5	4.3	5.9	2.4	2.9	8.6	2.3	4.2	4.9	5.2	3.2	3.9	3.6	5.2	3.4	3.2	5.7	8.0	4.4	4.0	5.3	3.4	10.2	10.2	7.3	3.0	4.6	6.1	5.6	4.6	2.2	3.7	5.2	5.0	5.7	2.2	5.7	6.0	3.1	5.1	5.5	5.1	2.3	3.4	5.5	4.9	4.8	6.3	3.7	4.4	5.0	3.7	2.6	12.1	6.4	2.7	5.0	2.2	3.6	6.0	1.9	2.9	4.1	4.7	6.2	3.2	2.2	0.4	3.2	1.8	5.0	9.0	9.2	8.7	6.1	5.1	6.8	5.3	8.9	6.7	0.0	1.4	2.7	1.6	2.3	2.4	1.6	0.0	1.4	2.3	1.8	3.9	1.6	0.0	1.8	1.5	2.2	0.9	0.0	2.2	1.2	2.0	1.5	1.1	1.5	1.6	1.6	1.2	3.7	2.6	0.0	1.4	2.1	3.3	3.6	1.7	1.7	1.0	2.9	2.1	0.8	7.8	0.0	1.1	9.5	5.3	2.3	1.3	2.9	1.3	1.0
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8;pituitary gland: 49.1;skin 1: 70.0"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 151.1;Cytotrophoblasts: 92.7;Melanocytes: 276.7;Suprabasal keratinocytes: 155.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 25.5"	"Lineage enriched"	"Detected in single"	58	"T-cells: 25.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 23.4;SCLC-21H: 47.7;SH-SY5Y: 23.2;SK-MEL-30: 22.3;TIME: 56.4;U-698: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	1.4	16.1	8.9	2.8	44.8	1.0	4.2	32.2	32.0	4.7	5.1	3.1	0.4	4.4	5.3	2.6	17.2	12.7	1.3	3.8	6.0	31.9	1.3	0.7	1.4	2.3	15.8	19.2	29.5	1.6	0.5	49.1	20.9	38.8	14.4	4.8	7.6	4.5	12.5	1.0	70.0	3.8	4.7	6.2	1.8	5.3	9.8	4.4	3.7	0.8	4.3	2.6	10.2	8.3	0.0	0.0	0.4	0.0	0.3	25.5	6.9	0.0	0.0	0.2	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	2.9	0.1	0.9	0.6	23.4	1.5	0.1	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.3	0.0	0.6	0.0	4.0	6.2	0.0	0.0	0.3	0.0	1.8	0.1	2.8	0.0	0.1	0.0	0.0	0.1	0.0	1.3	47.7	23.2	0.1	0.0	22.3	2.0	0.2	0.0	56.4	0.0	3.7	0.0	0.0	0.0	0.1	20.3	0.0	0.0	0.1	0.0	0.0	0.0	19.2	0.0	25.5	0.0	18.0	15.6	0.0	0.0	4.7	12.0	0.4	0.3	0.0	0.0	1.7	6.9	8.9	44.8	32.2	32.0	6.0	31.9	15.8	19.2	38.8	4.4	8.9	0.0	0.0	71.8	77.0	151.1	0.0	0.0	1.4	5.7	0.0	3.9	92.7	0.0	0.0	30.8	0.5	0.0	0.0	0.0	13.3	7.6	12.1	1.1	0.0	7.4	7.9	2.4	1.8	0.0	35.3	2.8	1.7	276.7	0.0	0.0	6.4	0.2	0.0	5.3	3.7	17.4	0.0	2.1	2.3	12.8	155.8	64.2	11.5	0.0	80.5
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 98.6"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.84e-4)"	"prognostic favorable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.69e-4)"	14.0	17.6	12.4	16.0	18.4	9.2	11.0	11.2	15.9	98.6	19.7	19.5	12.2	15.0	46.5	11.9	11.5	38.9	16.1	11.0	11.3	14.2	24.2	14.0	9.8	10.4	14.5	12.3	12.4	18.5	12.2	24.1	17.5	17.3	12.3	11.9	12.7	12.2	14.7	19.0	11.0	19.6	13.5	14.8	14.2	15.0	28.5	10.3	18.1	10.1	9.8	15.0	11.8	12.3	11.2	25.5	7.1	13.0	10.8	13.4	9.3	14.3	9.3	11.1	11.3	9.6	14.0	14.9	16.5	15.2	15.8	13.2	19.6	20.9	19.1	39.8	15.3	14.4	7.8	19.6	9.7	15.6	8.0	9.8	12.0	12.3	23.7	14.3	20.8	10.1	13.1	8.5	13.4	9.8	8.9	13.3	15.4	11.5	17.0	11.2	7.6	18.8	14.8	14.7	11.9	19.4	17.0	8.3	15.2	16.3	8.7	14.1	12.5	12.4	8.3	14.4	10.0	12.2	10.1	15.1	9.6	10.5	8.7	17.7	12.2	18.5	22.0	11.7	16.0	11.9	4.8	10.6	7.1	10.9	10.4	13.4	11.2	10.1	9.9	16.0	9.3	8.5	9.8	2.1	10.8	13.0	25.5	9.1	9.3	12.4	18.4	11.2	15.9	11.3	14.2	14.5	12.3	17.3	10.3	29.8	7.0	10.4	7.5	7.0	20.2	18.3	10.2	34.8	25.0	19.2	19.6	25.1	59.7	27.4	58.7	11.9	28.7	0.0	24.4	16.2	18.5	12.5	8.1	8.3	24.9	9.5	4.7	6.7	14.5	62.0	13.0	16.9	13.5	30.7	19.0	22.5	28.8	24.6	13.8	18.3	16.1	6.5	11.3	58.5	33.4	8.4	26.5	10.7	17.5	10.5
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859666-4863936	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 47.2"	"Cell type enhanced"	"Detected in some"	11	"Endothelial cells: 14.6;Fibroblasts: 22.2;Melanocytes: 15.1;Smooth muscle cells: 26.1"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 29.5;EFO-21: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	9.0	3.8	4.6	1.5	2.9	1.0	11.4	1.4	8.6	47.2	1.4	6.0	1.0	1.4	17.9	1.2	1.5	4.5	2.2	2.5	8.7	2.2	1.4	1.3	2.1	1.4	4.2	1.6	2.5	2.0	1.2	11.5	5.1	14.0	3.9	0.9	1.7	3.7	4.9	18.3	2.5	1.2	4.3	3.6	3.3	1.3	1.4	3.8	0.0	4.7	2.6	1.2	5.9	18.8	0.5	0.4	1.9	0.8	0.7	0.6	0.2	1.5	0.9	0.3	1.8	5.2	3.3	5.6	3.8	1.8	2.2	1.1	29.5	9.6	0.1	13.7	2.7	10.9	0.0	6.6	0.0	0.8	1.2	7.7	0.0	5.1	10.5	0.4	0.1	0.9	0.6	0.5	1.7	0.5	0.7	0.5	2.5	4.7	0.2	1.1	0.7	0.8	1.5	0.1	0.4	7.0	3.9	4.1	0.3	0.1	0.9	0.3	0.1	3.4	0.1	2.3	0.5	0.6	1.3	1.2	2.6	5.8	8.3	6.0	0.6	0.5	3.4	1.7	1.9	2.5	1.9	0.4	0.5	0.3	0.5	0.4	0.5	0.3	0.4	0.3	0.4	0.6	0.4	1.4	0.7	0.8	0.4	0.5	0.2	4.6	2.9	1.4	8.6	8.7	2.2	4.2	1.6	14.0	3.8	0.0	0.0	0.0	1.9	6.4	0.7	4.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.2	0.4	14.6	0.7	0.0	0.8	0.1	22.2	3.2	0.0	0.0	0.4	0.0	0.0	6.7	0.6	0.0	1.1	0.9	15.1	0.0	0.1	0.3	0.4	0.0	0.4	0.4	0.8	0.0	26.1	0.7	1.5	4.1	0.2	0.0	1.5	1.5
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell type enhanced"	"Detected in some"	12	"Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Cell line enhanced"	"Detected in some"		"HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	34.2	0.0	0.0	1.7	0.0	0.0	0.0	83.4	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	5.2	0.0	0.0	0.0	11.7	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	20.2	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4	0.0	0.3	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	8.3	0.0	0.0	0.0	0.1	15.8	0.5	9.2	0.0	12.7	0.0	0.0	1.3	0.0	0.0	0.0	5.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.5	0.0	0.0	0.6
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6;lymphoid tissue: 33.6"	"Cell type enhanced"	"Detected in some"	25	"Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.3;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.3;dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	5.2	0.8	6.0	2.1	4.8	2.3	7.3	1.0	5.8	6.0	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3.0	2.9	1.9	2.1	3.6	1.6	7.0	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.2	0.4	0.0	4.0	0.5	2.7	0.1	0.0	0.0	0.0	0.9	8.2	11.9	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.1	11.7	0.6	0.0	0.0	1.4	0.0	0.0	0.8	1.7	0.0	0.0	10.3	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	3.5	0.3	0.0	0.0	3.0	0.0	1.2	18.7	0.0	0.4	0.0	0.0	0.0	0.0	47.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.0	4.8	1.0	5.8	4.5	7.6	5.3	2.2	4.2	2.9	0.0	0.6	0.0	0.1	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.8	83.1	1.6	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	31.4	1.4	0.9	5.0	0.0	0.0	0.0	0.3	0.0	1.1	13.3	0.0	0.0	0.3	0.9	3.0	0.9	0.0	0.0	0.0	0.0
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 5.5;Fibroblasts: 5.3;Leydig cells: 10.6;Peritubular cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.0;BJ hTERT+: 8.9;HHSteC: 12.4;hTERT-HME1: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	6.9	1.2	1.2	7.6	1.6	0.3	15.7	1.6	1.0	13.2	5.2	1.1	3.4	1.3	14.1	8.5	5.1	6.3	8.2	4.7	1.9	0.7	8.0	1.4	4.1	3.7	1.6	0.5	14.4	5.0	8.1	2.5	2.6	1.3	8.6	1.3	7.7	5.0	4.2	2.8	5.6	2.9	14.2	1.7	3.6	3.5	4.5	0.6	1.1	12.4	3.7	7.9	7.2	24.6	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.0	2.5	0.0	6.1	8.0	9.0	0.0	3.7	8.9	3.3	5.6	0.0	0.0	4.6	0.0	2.9	1.9	2.6	0.0	1.5	3.2	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	5.6	4.2	4.3	9.9	0.0	3.5	0.0	0.0	0.2	4.8	0.0	0.0	0.0	3.6	0.0	0.0	7.6	7.6	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	1.5	0.0	0.5	6.0	0.0	0.0	2.2	0.0	3.8	4.1	1.1	2.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.8	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.2	1.6	1.6	1.0	1.9	0.7	1.6	0.5	1.3	0.6	0.0	0.3	0.0	3.9	1.9	0.0	0.9	2.5	0.0	1.2	0.0	0.0	5.5	0.0	1.3	1.4	1.0	0.0	0.0	0.4	0.2	5.3	2.2	2.3	0.0	0.5	0.0	0.0	1.8	0.0	0.4	10.6	0.0	0.0	0.0	0.0	1.7	0.8	0.0	7.4	0.6	0.0	0.0	1.9	1.6	2.0	0.6	1.1	0.0	0.0	1.2
EVC	DWF-1	ENSG00000072840	"EvC ciliary complex subunit 1"	P57679	4	5711197-5814305	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 8.0;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.4;hTERT-HME1: 26.4;hTERT-RPE1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008703, HPA016046"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008703: AB_1078765, HPA016046: AB_1848299"	"unprognostic (1.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (5.60e-9)"	"unprognostic (3.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (9.47e-5)"	5.0	2.9	2.5	4.6	2.7	0.0	4.1	1.9	2.3	13.2	4.3	1.8	8.4	0.6	17.2	10.1	6.0	8.1	16.0	3.8	2.2	2.2	26.5	3.7	6.4	1.0	2.3	1.4	20.2	9.2	14.9	2.3	1.8	2.9	10.2	1.6	12.0	9.1	5.7	2.4	4.2	2.8	15.8	2.4	2.1	3.6	5.3	1.0	1.0	6.9	3.9	3.8	7.5	9.0	0.1	0.3	1.2	0.1	0.1	0.5	0.0	3.0	3.9	2.2	5.7	14.3	20.7	0.8	6.9	26.4	8.0	10.4	0.0	0.0	0.0	2.2	10.9	13.4	3.7	2.3	5.7	6.6	5.1	1.5	0.0	2.2	1.0	10.6	0.0	0.6	10.2	8.4	10.7	26.4	22.9	5.5	0.0	0.0	0.0	18.5	0.0	0.0	0.0	2.4	0.0	3.6	4.7	6.0	0.0	2.8	0.5	1.2	3.7	0.0	0.0	2.8	2.2	1.4	0.2	9.6	6.8	1.3	4.8	6.0	4.2	3.4	0.3	19.6	0.0	6.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.3	0.5	0.0	2.5	2.7	1.9	2.3	2.2	2.2	2.3	1.4	2.9	1.0	3.0	2.9	0.0	1.6	3.1	0.0	1.6	2.5	1.4	1.2	3.5	0.0	0.0	1.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	8.0	0.7	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	5.0	0.0	0.0	2.1	0.2	0.0	0.7	1.1	0.0	0.0	1.7	0.0	0.0	2.5	0.1	0.0	0.0	1.1
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 117.0;Horizontal cells: 198.6;Muller glia cells: 68.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 20.8;HAP1: 29.8;NTERA-2: 21.6;REH: 56.6;RH-30: 33.4;SCLC-21H: 43.3;SH-SY5Y: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.8	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	7.0	0.5	29.8	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.6	0.0	0.6	56.6	33.4	5.0	0.0	0.0	43.3	27.4	0.0	0.1	0.3	14.6	0.2	0.0	1.7	1.0	7.2	0.6	0.6	3.8	0.5	0.0	2.5	0.2	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5	0.0	1.4	0.0	0.0	0.3	117.0	0.8	0.0	0.0	0.0	0.0	17.7	0.1	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.1	3.1	0.4	0.0	0.0	0.4	198.6	2.4	0.0	0.0	3.8	0.6	0.0	1.7	0.0	0.0	68.8	0.7	0.0	0.4	0.0	20.1	6.5	2.5	0.6	9.8	0.1	0.2	0.0	0.0	0.0
C4orf50	FLJ46481	ENSG00000181215	"Chromosome 4 open reading frame 50"	Q6ZRC1	4	5897373-6018507	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	12	"brain: 6.0"	"Cell type enhanced"	"Detected in some"	15	"Horizontal cells: 1.6;Late spermatids: 1.1;Muller glia cells: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 5.0"															NA	NA						"unprognostic (7.02e-3)"	"unprognostic (6.55e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.35e-2)"	"unprognostic (9.94e-5)"	"unprognostic (4.31e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.88e-6)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.68e-2)"	0.0	0.5	1.0	0.2	6.0	0.2	0.0	0.0	4.1	0.1	0.1			0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.7	0.0	0.1	0.1	0.1	0.5		0.1	0.0	0.0	0.1	0.0		0.5	0.1		0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.3			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JAKMIP1	"FLJ31564, Gababrbp, JAMIP1, MARLIN1"	ENSG00000152969	"Janus kinase and microtubule interacting protein 1"	Q96N16	4	6026199-6200591	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.5;brain: 37.4"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 57.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"gdT-cell: 14.9;MAIT T-cell: 6.5;memory CD4 T-cell: 6.7;memory CD8 T-cell: 13.0;naive CD8 T-cell: 6.2;T-reg: 19.5"	"Lineage enriched"	"Detected in single"	37	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.8;JURKAT: 9.1;MOLT-4: 27.3;SCLC-21H: 12.3;U-266/70: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044570	Uncertain					NA	NA					"HPA044570: AB_2678995"	"unprognostic (4.79e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.86e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.25e-4)"	"unprognostic (7.14e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-8)"	"unprognostic (1.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.96e-3)"	1.3	8.5	15.7	2.3	35.0	2.6	1.0	2.5	37.4	1.0	1.5	2.7	0.0	1.2	1.1	1.0	1.1	1.0	1.7	1.0	15.6	14.7	1.0	1.1	1.9	4.7	10.8	13.3	1.6	1.6	1.0	3.8	1.0	7.2	7.4	1.3	0.1	2.0	1.1	1.0	1.0	1.7	1.3	4.3	2.9	1.7	5.9	7.6	0.0	1.4	0.0	1.8	2.3	0.1	0.1	0.0	0.0	0.0	0.5	19.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.2	27.3	0.0	2.2	0.0	1.7	1.4	0.0	0.7	0.0	0.0	12.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	6.5	0.1	6.7	13.0	0.0	0.1	0.5	6.2	0.0	0.5	0.0	0.0	19.5	2.5	15.7	35.0	2.5	21.2	15.6	14.7	10.8	13.3	7.2	7.6	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	3.2	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	57.2	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.9	3.7	0.1	0.0	8.7	0.0	0.0
AC092442.1		ENSG00000284684			4	6064977-6070162	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	16	"blood: 1.5"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.5;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"hypothalamus: 0.7"											NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 122.1;Extravillous trophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA					"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	28.5	13.3	17.9	7.0	52.5	1.5	16.5	9.4	24.2	22.3	15.5	13.2	21.9	12.0	31.2	15.1	12.1	28.9	24.0	27.8	19.4	12.2	7.1	7.6	30.2	7.4	13.5	16.5	51.0	12.4	8.8	20.7	25.4	13.6	22.6	4.5	16.6	12.1	39.0	10.3	10.0	11.1	28.1	14.2	16.9	12.5	18.3	14.9	1.3	23.4	4.4	3.2	24.2	12.2	4.4	0.6	0.0	1.6	2.5	6.9	2.4	5.2	10.8	3.6	13.0	15.0	3.9	39.4	9.3	12.3	6.4	5.6	9.2	14.4	2.4	13.7	10.1	29.3	2.4	2.6	5.2	2.6	2.1	5.4	0.0	4.8	28.5	13.4	0.0	0.3	13.3	7.3	5.5	5.2	5.3	9.8	0.9	0.1	9.6	3.8	9.7	0.4	0.1	5.1	7.6	15.2	1.2	3.6	2.7	2.5	22.8	2.3	6.1	5.4	6.7	5.1	4.3	11.7	0.1	8.0	7.4	9.5	7.2	5.6	10.6	3.5	0.0	9.3	0.0	7.4	0.0	1.0	0.0	4.9	1.6	6.9	4.4	2.6	3.5	0.3	2.3	2.3	2.8	0.0	2.5	1.6	0.6	1.3	2.4	17.9	52.5	9.4	24.2	19.4	12.2	13.5	16.5	13.6	14.9	122.1	18.0	0.0	1.5	2.2	3.8	37.8	2.5	9.4	5.7	24.4	0.0	18.0	0.0	4.7	9.3	18.4	2.0	0.0	3.8	107.4	6.7	3.8	1.1	11.0	15.1	3.2	32.1	27.0	1.6	16.6	37.2	2.2	11.8	1.0	2.8	37.2	9.3	1.4	54.5	3.7	3.8	12.9	10.8	10.2	15.3	3.0	33.2	0.5	2.8	2.0
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 52.2;Late spermatids: 144.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 14.2;A549: 21.0;CAPAN-2: 14.0;GAMG: 34.1;MCF7: 17.3;PC-3: 19.9;SCLC-21H: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	1.5	6.6	28.2	1.6	33.9	1.1	2.4	17.0	78.4	11.8	1.5	13.8	0.5	1.7	25.3	7.0	25.2	10.5	1.4	1.9	25.8	19.5	1.2	1.1	1.1	1.3	25.6	19.3	1.3	1.7	1.1	5.9	1.1	19.1	5.5	1.4	0.4	1.4	14.4	1.7	28.8	2.0	11.8	32.0	1.3	1.9	4.7	13.5	0.0	1.1	3.9	3.6	1.5	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	21.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	9.2	0.0	34.1	6.6	10.3	0.3	0.0	0.0	1.2	0.0	1.4	1.6	0.3	0.0	0.0	3.0	5.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.8	17.3	0.0	0.0	1.0	0.3	19.9	0.0	0.0	0.6	0.0	0.0	19.3	3.6	0.6	0.0	0.0	0.6	8.9	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	33.9	17.0	40.2	25.8	19.5	25.6	19.3	19.1	13.5	0.0	0.0	0.0	0.5	13.1	10.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	0.1	0.0	0.0	0.2	0.0	0.2	1.2	0.0	0.0	0.1	3.2	0.0	0.0	0.0	144.3	6.4	0.0	0.0	0.0	0.0	4.1	1.3	0.0	4.2	0.0	2.4	0.0	1.4	1.0	0.9	19.3	0.0	0.0	0.0	0.1
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575175-6623362	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		11000000				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	21.3	15.4	12.4	15.6	23.2	15.7	16.7	5.1	26.8	17.3	14.3	16.2	12.1	15.9	20.0	21.5	13.9	18.1	24.7	23.2	11.6	14.2	15.8	32.4	20.1	19.4	13.7	11.4	30.4	26.0	10.8	19.2	17.0	14.3	20.6	9.8	22.2	18.6	15.2	7.8	13.5	15.9	14.5	11.6	19.7	20.9	8.7	13.4	16.6	27.3	10.4	18.4	20.7	20.7	5.0	8.4	13.4	15.7	6.0	12.0	9.1	8.1	7.4	1.6	10.1	22.3	15.5	9.6	16.8	19.6	8.2	11.3	4.3	15.5	4.1	8.1	18.1	19.3	8.3	0.5	5.3	4.5	4.8	4.2	5.4	5.4	4.8	9.8	10.2	25.4	20.4	5.3	6.5	1.8	14.9	9.5	5.3	2.3	10.6	10.6	5.0	5.0	6.5	1.8	10.3	5.7	5.0	7.0	4.8	4.3	8.2	2.5	2.7	11.2	6.7	4.3	5.2	13.4	13.8	17.3	15.0	4.6	18.6	10.5	4.4	3.8	2.2	17.5	12.0	12.8	13.1	8.5	13.4	12.0	13.0	9.3	4.4	7.4	10.9	8.4	5.0	6.9	8.7	10.7	6.0	15.7	3.2	10.1	9.1	12.4	23.2	5.1	26.8	11.6	14.2	13.7	11.4	14.3	13.4	14.9	20.5	11.5	3.9	4.4	9.1	14.7	22.9	10.7	13.6	10.4	5.9	9.9	1.7	8.9	0.4	7.3	11.9	0.0	9.3	7.5	10.1	7.8	10.4	36.3	17.8	9.5	7.5	12.3	27.8	0.0	18.1	10.4	3.3	3.6	8.7	12.1	9.5	7.0	23.0	3.7	6.8	12.9	7.3	0.9	0.7	3.3	7.1	10.9	6.6	3.7
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	52.8	77.4	88.5	32.3	81.7	24.6	51.2	64.5	87.7	53.9	43.6	57.8	42.4	39.3	57.5	59.3	41.5	54.0	36.6	67.1	77.3	83.7	60.7	65.9	40.2	31.3	87.2	95.9	69.0	39.9	64.2	65.6	52.0	59.7	54.5	37.0	38.4	43.0	60.5	82.3	33.0	39.2	59.1	91.6	45.9	37.7	51.0	69.1	19.1	54.2	57.2	34.4	45.5	58.4	34.3	62.7	71.1	65.3	46.4	49.6	58.2	52.6	58.6	49.9	57.4	61.4	55.7	39.4	69.6	64.5	64.6	64.7	57.7	57.3	33.0	54.1	64.3	73.4	30.2	67.2	72.7	78.4	13.4	48.7	49.2	68.4	62.4	57.6	36.7	24.8	57.6	66.8	59.3	60.4	61.5	71.6	29.3	64.5	21.7	63.6	66.4	27.6	86.6	62.1	46.0	75.3	36.1	90.4	27.9	78.0	40.0	78.7	61.6	45.1	32.6	64.5	45.6	90.8	45.0	63.8	56.9	38.2	42.2	91.3	32.2	39.7	54.9	58.9	78.6	55.0	60.1	65.3	55.3	47.4	52.8	47.8	33.0	47.4	47.4	62.7	34.3	49.3	48.1	71.1	46.4	49.6	50.5	49.6	58.2	88.5	81.7	64.5	87.0	77.3	83.7	87.2	95.9	59.7	69.1	148.9	130.0	79.5	227.3	167.4	108.6	201.1	155.4	147.2	116.0	83.7	15.7	451.0	185.6	196.0	36.0	186.5	82.1	70.0	177.2	244.5	165.5	214.4	148.7	169.8	172.2	104.9	170.8	146.1	121.9	44.4	290.8	105.8	119.8	143.3	103.2	214.1	184.1	109.1	286.4	178.7	82.2	213.4	216.5	343.0	235.0	151.9	269.5	109.0	123.5	202.6
AC093323.1		ENSG00000170846	"Putative MORF4 family-associated protein 1-like protein UPP "	B2RBV5	4	6663396-6676755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 10.1;Club cells: 7.9;Cytotrophoblasts: 17.0;Distal tubular cells: 11.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.08e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.33e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-3)"	2.1	4.5	5.9	3.1	10.8	4.0	5.7	4.0	10.0	4.9	4.4	4.8	2.8	1.8	5.2	5.5	3.3	3.3	5.1	3.1	5.1		4.1	4.0	3.6	5.5	3.7	7.6	6.0	4.6	6.0	5.1	3.3	5.5	5.3	6.1	4.9	4.4	3.6	5.5	10.0	3.1	6.6	3.1	5.5	5.9	3.5	5.5	3.4	3.7	3.3	5.9	4.9	2.9	0.2	0.4	0.0	0.3	0.9	1.4	0.1	3.1	4.0	6.1	6.2	3.0	3.8	5.8	4.9	2.1	3.9	3.2	4.6	4.6	3.0	2.5	2.3	4.0	4.1	4.7	3.4	6.7	1.3	6.7	13.1	5.5	3.5	1.0	13.8	8.3	1.7	3.2	3.8	3.5	5.5	2.5	5.9	9.5	1.1	3.3	6.2	9.3	12.8	6.3	4.8	6.3	4.5	4.0	1.4	1.3	2.2	13.8	4.8	4.1	2.5	2.1	2.3	13.2	4.3	3.4	2.9	0.0	2.1	6.6	2.1	4.5	1.0	0.8	15.4	4.5	0.0	0.0	0.0	0.9	0.1	1.0	0.0	1.4	0.3	0.0	0.2	0.4	1.0	0.0	0.9	0.3	0.4	0.6	0.1											6.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.9	5.2	0.0	17.0	11.6	1.7	0.0	0.0	0.0	0.0	2.8	5.1	0.0	0.0	1.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	2.8	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693069-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6"	"Group enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 2319.4;Urothelial cells: 3591.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"					"Group enriched"	"Detected in some"	41	"basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9"	"Lineage enriched"	"Detected in many"	68	"granulocytes: 89.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.5;Hep G2: 30.0;hTCEpi: 33.4;OE19: 130.4;RT4: 61.3;SK-BR-3: 34.3"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1200000	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.0	1.1	0.0	42.8	0.0	0.0	0.0	0.3	5.2			0.1	0.0	0.0	23.3	0.3	1.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0		0.0	0.0	0.0	0.0	16.4		4.8	5.4		1.1	0.0	0.0	3.9	0.5	0.1	0.0	4.4	70.0	0.0			0.0		2.5	47.6	5.1	0.0	0.0	89.9	1.3	0.0	0.0	0.4	3.8	2.4	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	4.7	0.0	0.0	0.0	1.8	0.0	0.0	2.7	30.0	0.0	1.7	0.1	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	3.5	0.0	130.4	4.3	0.0	0.0	0.0	0.0	61.3	0.0	0.0	5.6	34.3	0.0	1.2	0.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	47.8	1.3	24.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.0	0.0	0.4											8.9	66.8	2.9	152.0	1.0	0.0	0.8	43.3	224.9	151.2	1.8	0.0	512.0	0.0	0.2	11.8	0.5	133.5	0.0	27.6	604.2	12.6	292.8	30.1	1.1	61.5	0.0	16.0	1.8	14.1	5.6	0.0	3.6	8.5	2.8	160.2	0.0	481.5	254.0	0.0	0.1	0.0	0.0	2.1	0.0	0.2	5.5	2319.4	2.2	48.0	3591.7
MRFAP1L1	MGC9651	ENSG00000178988	"Morf4 family associated protein 1 like 1"	Q96HT8	4	6707701-6709880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (5.77e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.40e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.80e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (5.26e-5)"	17.6	26.3	39.9	18.0	44.9	9.8	33.0	42.5	40.8	29.8	19.7	27.5	17.0	15.1	28.5	32.2	21.4	26.1	20.4	30.7	36.1	38.5	26.5	33.4	21.7	28.9	35.5	36.9	33.2	17.5	22.1	34.7	24.2	32.6	31.4	20.6	19.4	28.2	26.6	24.3	19.1	16.9	23.0	34.5	25.0	23.4	11.9	40.5	16.4	25.6	25.2	27.2	26.8	20.5	22.2	14.4	55.7	12.9	30.7	40.1	26.9	21.7	13.6	31.1	24.7	31.8	27.2	19.6	20.2	33.2	25.2	23.8	14.7	29.2	25.7	20.5	24.5	33.6	15.7	24.6	29.4	27.6	17.6	17.2	35.0	24.1	34.4	19.9	23.9	20.2	28.2	34.9	22.4	22.7	23.5	23.7	17.9	35.0	21.0	24.5	27.0	33.7	48.1	31.9	21.8	32.7	21.5	37.6	21.6	33.9	18.8	35.8	27.9	16.5	16.9	32.4	19.3	31.3	24.9	21.0	21.2	18.0	15.7	27.6	31.9	47.1	19.6	20.8	37.5	20.0	55.7	11.4	41.3	38.9	11.0	38.4	22.2	36.9	40.1	14.4	21.1	37.4	37.9	24.0	30.7	12.9	13.6	35.0	26.9	39.9	44.9	42.5	40.8	36.1	38.5	35.5	36.9	32.6	40.5	29.8	40.9	22.2	20.9	30.2	24.7	45.9	38.2	72.3	50.0	17.4	15.7	35.1	19.9	18.8	2.3	26.4	8.8	23.3	16.2	27.8	27.1	25.2	32.5	32.7	19.0	50.9	17.9	22.7	29.7	2.7	28.4	19.1	25.3	14.4	16.2	45.0	19.0	14.0	26.5	23.4	18.4	25.8	20.6	28.7	33.0	32.6	24.8	44.6	14.9	22.1
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716055-6717671	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	14.6	15.5	9.2	11.8	11.5	13.6	11.4	10.7	14.4	15.4	15.2	9.5	10.1	14.6	13.8	14.3	14.1	12.3	15.7	9.6	9.3	7.7	13.6	13.8	8.7	16.9	8.6	9.4	19.1	18.4	8.4	9.8	23.2	9.8	13.7	9.4	13.3	10.8	11.2	16.6	10.7	15.8	8.2	7.4	17.7	13.3	14.0	8.9	20.9	16.8	10.1	15.5	12.3	10.9	6.1	3.8	13.7	4.8	2.5	9.6	1.8	10.1	7.0	10.6	10.8	8.3	10.7	21.3	8.3	9.1	7.7	6.8	6.2	11.0	9.7	8.9	7.3	10.9	7.0	5.9	9.5	6.0	7.7	9.7	14.8	6.7	15.3	10.2	7.1	13.9	10.1	9.5	6.1	5.3	7.6	7.1	8.5	19.3	8.9	8.0	10.1	11.6	24.9	13.8	7.5	13.9	12.1	11.7	8.6	10.6	9.0	9.1	12.3	6.9	4.9	14.7	8.5	15.6	13.9	7.9	7.2	6.3	8.3	10.3	13.2	12.8	12.9	8.0	13.2	11.3	2.5	3.1	13.7	5.1	4.8	5.2	6.1	6.2	5.5	3.8	4.9	9.6	5.3	1.8	2.5	3.1	3.7	5.1	1.8	9.2	11.5	10.7	14.4	9.3	7.7	8.6	9.4	9.8	8.9	6.0	5.1	27.0	27.5	20.9	29.5	4.2	20.4	2.7	5.7	22.7	5.9	58.7	21.6	5.7	1.1	19.4	21.8	0.0	6.1	79.4	30.2	31.7	3.5	20.5	30.4	28.6	10.9	31.9	17.1	1.4	30.0	14.2	28.7	3.6	24.1	29.5	8.6	35.1	21.2	38.7	22.8	6.5	20.2	10.9	16.4	21.8	53.0	42.0	23.3	27.1
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541"	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	12.5	12.7	18.7	8.1	22.2	14.0	13.8	22.8	25.5	13.3	13.8	20.5	12.4	8.5	15.8	13.4	21.1	15.9	12.7	32.2	19.8	18.8	19.5	15.0	12.0	7.0	20.7	17.5	13.9	10.6	25.4	22.2	25.8	25.4	15.5	12.7	11.5	10.6	15.7	32.4	7.7	18.8	13.5	19.8	12.3	11.0	13.5	17.9	10.0	15.5	13.3	8.5	12.1	13.2	1.6	2.4	13.1	2.5	2.1	3.8	0.9	9.0	8.7	18.3	11.4	13.3	14.4	9.7	11.8	12.3	8.3	7.0	5.5	7.6	5.9	4.0	13.2	12.8	4.7	9.3	5.2	10.8	3.3	3.8	17.6	7.5	7.2	7.0	7.6	23.3	9.6	12.3	9.2	5.1	10.7	8.5	6.0	13.3	5.2	10.5	4.4	14.5	7.7	9.7	6.8	9.7	10.4	18.8	2.7	14.0	8.6	14.0	9.0	8.7	7.8	8.1	13.2	9.9	14.0	10.8	7.6	9.1	6.8	10.0	9.0	9.0	4.8	9.4	8.2	20.6	1.9	2.4	6.3	2.8	1.6	3.8	1.6	2.1	3.1	1.6	1.6	2.0	2.0	13.1	2.1	2.5	2.4	1.9	0.9	18.7	22.2	22.8	25.5	19.8	18.8	20.7	17.5	25.4	17.9	29.8	31.7	8.3	22.9	11.3	72.9	121.5	7.6	66.9	34.2	12.2	35.3	11.7	34.9	20.0	36.5	15.7	31.1	46.7	10.2	5.9	11.8	25.5	11.6	36.0	9.6	93.8	24.1	16.0	24.8	44.7	23.0	17.7	6.8	16.2	16.6	51.2	15.7	24.6	31.1	21.7	41.3	25.8	13.1	27.2	17.9	9.7	18.8	12.8	13.7	24.3
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 64.3"	"Low region specificity"	"Detected in all"							"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	20.0	31.2	31.9	24.4	33.8	10.6	22.0	18.1	32.8	16.0	20.2	22.5	17.0	17.3	16.2	21.9	24.3	18.8	15.0	22.9	28.6	27.5	32.1	21.6	20.7	48.4	28.8	20.5	23.3	19.3	23.6	20.7	18.0	29.0	19.6	20.7	26.1	23.2	16.7	35.1	37.3	20.0	17.8	37.3	26.2	35.8	22.4	29.3	24.0	14.9	17.9	19.9	16.7	15.4	5.3	7.5	26.4	8.2	5.5	8.9	6.0	10.5	11.5	13.0	14.5	10.8	9.1	7.9	8.5	9.3	8.0	6.8	11.9	22.1	17.0	5.0	10.1	20.3	7.7	21.8	19.5	9.8	4.7	7.1	28.5	7.6	12.4	7.5	12.8	64.3	7.0	27.7	7.5	12.4	10.2	7.5	16.2	26.9	6.1	9.6	6.9	19.7	13.0	17.6	12.7	13.0	24.8	17.1	18.4	11.9	7.5	19.9	14.2	7.0	7.7	26.1	10.6	10.6	12.3	7.4	8.8	6.7	7.7	12.5	11.8	27.4	17.5	8.3	16.6	8.4	1.7	8.2	3.5	5.9	5.3	8.9	5.2	6.4	6.3	6.9	5.3	4.9	4.5	26.4	5.5	2.4	7.5	7.5	6.0	31.9	33.8	18.1	28.0	28.6	27.5	28.8	20.5	29.0	29.3	6.0	15.3	5.2	6.6	8.0	8.4	3.4	10.2	5.3	11.4	14.0	13.7	10.5	16.6	9.8	45.7	4.7	10.4	0.0	8.7	6.1	5.1	11.2	7.0	21.7	20.9	23.8	6.3	7.4	37.2	22.1	6.6	13.2	18.6	6.4	15.6	10.6	9.0	14.0	8.1	19.2	6.3	0.0	5.2	15.8	18.9	10.5	13.7	15.0	16.6	9.1
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7042939	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 52.9"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 53.5;Early spermatids: 56.9;Late spermatids: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047546	Enhanced					NA	NA					"HPA047546: AB_2680082"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	1.4	1.7	0.5	3.9	1.1	1.2	1.1	2.6	0.8	0.6	2.4	0.6	0.9	0.9	3.3	0.8	10.5	1.0	0.5	2.4	2.7	1.2	0.5	1.7	0.7	1.5	2.4	3.0	1.3	1.1	3.0	0.5	4.0	0.9	0.6	0.8	0.9	1.2	0.6	1.6	0.6	0.7	1.2	0.8	1.0	52.9	1.5	0.0	1.5	0.5	0.6	0.6	1.0	0.6	1.6	0.5	3.8	0.4	1.6	0.6	1.6	4.6	2.4	2.0	3.2	2.2	0.5	4.6	2.8	5.2	3.1	1.6	4.1	1.0	1.3	2.6	6.9	2.1	0.9	2.1	1.6	0.1	0.7	1.0	2.1	1.1	1.6	1.3	2.6	2.0	2.2	3.1	0.4	0.6	2.1	3.2	0.7	0.4	3.3	3.9	2.7	1.6	1.0	1.5	2.8	1.1	1.6	0.3	9.1	1.6	6.7	1.5	3.7	1.7	0.8	2.4	1.7	2.4	2.3	4.3	1.2	2.7	3.5	0.0	0.1	0.9	3.4	0.1	1.4	0.0	1.6	0.0	0.3	3.8	0.7	0.6	0.4	0.0	1.6	0.0	0.3	1.6	0.5	0.4	2.9	0.0	0.0	0.6	1.7	3.9	1.1	2.6	2.4	2.7	1.5	2.4	4.0	1.5	0.0	3.7	0.0	0.7	0.6	2.5	0.8	0.0	53.5	10.3	3.5	11.8	0.6	1.7	2.0	56.9	1.4	0.5	0.0	1.0	0.5	0.7	1.1	0.0	0.8	1.1	0.0	5.2	2.5	1.8	64.6	2.8	2.6	1.7	1.8	1.1	6.7	1.4	2.9	3.9	4.3	18.2	0.0	0.4	13.7	4.0	0.9	0.5	0.0	0.8	0.7
TADA2B	MGC21874	ENSG00000173011	"Transcriptional adaptor 2B"	Q86TJ2	4	7041899-7057952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 38.1;Rod photoreceptor cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035770	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035770: AB_10603993"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.17e-11)"	"unprognostic (5.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (1.59e-4)"	8.7	15.0	10.9	12.9	15.3	24.0	13.9	12.5	16.0	10.5	10.6	7.5	12.4	10.2	11.5	8.8	11.4	11.0	11.0	15.6	10.9	7.0	12.9	13.6	8.9	12.4	8.3	9.8	15.8	26.2	10.8	9.0	12.6	9.9	10.2	8.0	17.0	20.5	10.8	42.8	10.6	11.3	10.4	6.6	12.4	11.9	13.0	8.9	9.8	12.8	12.7	10.4	10.6	12.8	3.7	2.1	10.3	3.0	2.1	4.4	1.8	8.6	13.2	9.2	10.9	10.3	11.8	8.9	12.8	13.1	16.5	10.2	12.9	13.0	11.5	7.6	14.1	21.9	7.1	12.7	6.7	10.7	6.8	9.7	11.7	8.2	9.7	12.6	13.4	19.2	8.5	14.4	11.0	12.8	11.4	7.6	10.8	13.0	18.7	12.3	8.2	16.1	11.5	11.0	11.6	20.5	10.6	19.0	6.0	15.2	12.2	15.2	10.9	11.0	9.9	13.0	7.8	14.9	20.2	11.8	10.5	8.1	12.7	17.3	17.0	14.2	15.1	8.6	7.3	10.6	1.1	2.2	10.3	4.4	2.6	3.2	3.7	2.9	4.4	1.9	2.7	3.9	2.9	7.1	2.1	3.0	2.1	3.0	1.8	10.9	15.3	12.5	16.0	10.9	7.0	8.3	9.8	9.9	8.9	8.9	15.9	2.2	2.7	4.0	27.8	10.5	5.1	6.7	12.5	7.0	29.5	3.2	5.0	3.9	2.1	3.8	6.6	0.0	8.0	2.5	6.1	4.8	9.2	14.7	4.9	38.1	6.9	2.5	7.9	3.4	15.5	6.0	6.8	3.6	8.7	8.3	6.6	7.0	12.0	6.9	35.0	0.0	2.8	5.9	4.2	5.1	3.7	6.9	5.8	4.7
GRPEL1	"FLJ25609, GrpE, hMGE"	ENSG00000109519	"GrpE like 1, mitochondrial"	Q9HAV7	4	7058906-7068197	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036647	Supported		Supported	Mitochondria		NA	NA		1900000	Mitochondria		"HPA036647: AB_10672359"	"unprognostic (6.13e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (9.61e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.30e-2)"	14.7	35.8	11.5	7.3	10.8	20.7	11.4	10.6	15.2	7.9	9.9	9.3	8.5	8.9	7.8	8.8	11.4	8.7	7.6	22.8	10.9	11.6	22.6	46.8	8.1	9.0	12.5	10.9	10.9	12.9	9.6	7.7	11.0	14.8	8.3	9.9	7.2	9.1	8.5	38.0	10.2	10.4	8.4	11.4	17.2	10.7	14.2	11.7	8.1	9.4	15.8	10.7	11.2	8.3	17.6	22.9	24.8	16.8	15.8	21.5	15.8	9.9	9.4	5.4	10.6	10.5	8.9	6.7	13.2	10.5	14.9	11.0	16.5	13.1	21.6	8.9	10.0	23.2	10.2	21.4	15.1	17.6	5.1	13.4	23.0	8.5	17.8	12.3	23.2	11.7	8.8	20.0	13.2	16.0	7.6	13.0	14.6	13.5	9.1	17.5	10.1	18.3	28.8	8.1	18.1	31.4	12.3	20.3	9.0	14.9	10.5	15.3	7.4	10.3	10.3	11.1	5.7	9.2	13.6	11.2	10.0	6.2	14.2	22.8	9.8	14.0	14.5	13.6	15.1	7.9	6.3	16.0	24.8	15.3	16.8	21.5	17.6	16.7	17.3	22.9	12.8	21.4	16.4	5.5	15.8	13.4	13.9	16.3	15.8	11.5	10.8	10.6	15.2	10.9	11.6	12.5	10.9	14.8	11.7	23.8	27.2	41.9	79.6	118.5	28.6	86.2	40.8	37.5	30.7	36.6	9.8	62.7	112.7	73.0	41.6	39.6	43.9	0.0	41.4	65.1	35.6	36.7	55.6	100.8	54.6	27.0	17.7	21.5	28.9	58.0	25.9	42.5	60.8	70.3	20.9	23.6	69.6	25.2	27.3	143.8	22.5	0.0	77.8	36.3	49.8	109.4	72.0	46.5	36.2	76.0
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1"	"Cell type enhanced"	"Detected in many"	19	"Bipolar cells: 66.5;Muller glia cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061916			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA061916: AB_2684636"	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	4.9	2.6	12.0	6.4	16.6	3.3	1.8	4.8	22.4	13.8	4.0	32.1	3.2	3.1	6.0	8.2	4.7	3.5	7.1	3.2	10.7	6.9	7.4	5.2	8.3	2.0	9.9	11.2	7.4	1.7	0.8	2.7	0.9	11.2	7.5	2.6	7.5	2.6	5.3	2.4	1.9	4.2	11.5	11.2	1.3	1.9	3.4	11.3	0.8	6.2	2.2	2.7	5.2	3.7	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.9	1.1	0.2	0.1	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.5	0.0	6.6	4.2	1.1	16.6	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.2	0.1	0.0	12.5	0.2	3.7	5.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.7	0.0	1.3	7.4	0.2	0.0	0.7	0.6	12.0	0.0	0.0	0.7	0.0	7.0	0.0	4.3	1.3	0.0	0.1	0.0	0.0	0.0	1.4	7.3	0.2	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	12.0	16.6	4.8	17.7	10.7	6.9	9.9	11.2	11.2	11.3	3.0	13.7	0.0	0.2	0.1	66.5	2.0	0.0	2.7	7.9	5.2	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.2	0.2	1.6	0.0	0.0	0.3	10.2	11.8	0.3	1.7	0.0	0.0	31.9	0.7	0.0	7.4	0.7	2.4	0.0	0.5	0.1	0.1	0.4	0.0	0.0	0.0	0.4
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell type enriched"	"Detected in single"	14	"Suprabasal keratinocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 151.9;Extravillous trophoblasts: 100.0;Late spermatids: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.0;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"TIME: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA			"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	14.0	3.9	9.5	11.6	10.2	1.0	15.8	10.3	12.2	11.0	17.8	4.4	6.5	6.7	18.7	6.6	13.1	9.0	14.7	11.0	7.1	5.8	5.2	1.8	8.7	5.3	4.7	6.9	12.1	6.6	31.9	13.0	14.4	5.6	10.3	11.7	12.4	9.6	12.7	5.7	5.8	8.8	32.1	8.3	4.6	8.4	21.7	3.2	3.3	8.6	5.6	6.1	16.2	13.1	0.0	0.0	6.0	0.9	0.0	2.9	1.5	10.1	7.6	5.4	4.3	5.3	9.6	7.2	15.2	22.6	14.7	13.6	2.4	2.4	0.0	5.1	24.7	24.4	4.9	2.8	6.1	9.7	0.2	1.9	0.0	11.0	1.4	14.8	0.0	0.1	5.9	4.6	18.3	12.0	24.4	17.6	1.5	0.2	2.2	7.6	3.3	0.1	0.0	2.3	4.3	14.7	0.0	4.0	0.5	1.6	1.3	10.7	17.9	5.2	3.6	4.1	7.5	1.3	0.1	41.6	18.0	4.0	23.3	7.4	0.0	0.0	0.0	6.4	0.0	20.5	0.0	0.9	6.0	1.1	0.2	1.4	0.0	1.6	1.5	0.0	0.0	2.9	1.3	2.3	0.0	0.1	0.0	1.3	1.5	9.5	10.2	10.3	10.8	7.1	5.8	4.7	6.9	5.6	3.2	6.0	1.3	0.0	7.2	2.6	1.0	4.9	17.8	5.3	9.1	10.4	3.9	4.5	0.0	16.4	151.9	13.7	8.0	0.0	6.7	100.0	15.5	12.1	0.0	0.0	6.9	0.0	13.9	16.5	0.3	257.9	10.3	0.0	1.7	1.0	19.4	9.1	19.5	5.8	11.7	2.6	0.4	6.5	10.3	11.4	8.8	3.8	7.3	3.2	12.4	8.9
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0;skeletal muscle: 71.8"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 11.1;Intestinal endocrine cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 13.2;SiHa: 5.8;U-2197: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	4.0	3.8	8.2	1.9	19.1	0.8	2.1	4.0	26.0	1.4	2.1	2.3	0.0	1.1	1.2	1.3	10.5	1.4	1.7	5.7	3.4	5.1	2.5	1.2	1.8	1.4	2.8	7.6	1.1	3.3	2.4	6.1	1.2	9.9	1.8	2.1	1.3	2.6	1.2	71.8	3.8	1.8	2.1	1.8	14.8	1.8	1.5	4.0	0.0	2.4	1.9	2.3	1.5	1.7	0.7	0.5	0.0	0.2	0.0	3.0	0.2	1.0	0.0	0.2	1.5	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.3	2.9	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.6	1.9	0.1	0.0	1.2	2.7	0.9	0.1	1.0	0.6	0.2	0.0	13.2	1.0	5.8	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.4	20.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.1	3.0	0.0	2.5	0.0	0.5	0.7	1.2	0.9	0.0	0.0	0.2	0.0	1.2	0.2	8.2	19.1	4.0	26.0	3.4	5.1	2.8	7.6	9.9	4.0	0.0	1.4	0.0	0.1	2.3	5.1	3.6	0.0	2.7	0.0	3.5	0.0	0.0	0.0	3.0	1.7	2.7	7.5	0.0	3.8	0.5	0.4	0.3	2.3	0.4	0.1	11.1	10.3	1.3	0.3	4.2	0.0	0.0	0.0	0.0	3.0	2.7	3.4	4.5	3.5	0.3	2.9	6.5	4.2	0.0	1.5	5.5	0.0	0.0	5.2	0.1
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 36.2;Kupffer cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.3;MOLT-4: 26.5;SK-MEL-30: 15.2;U-2197: 11.5"	"Low region specificity"	"Detected in many"							"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	16.8	4.2	3.7	12.7	7.6	7.5	8.5	0.9	4.0	5.7	3.2	8.6	3.3	1.9	3.2	7.9	9.7	3.9	10.0	4.5	6.6	3.5	19.9	11.2	10.1	14.2	7.4	1.0	2.8	8.6	1.1	3.3	5.8	7.2	5.9	2.4	6.4	5.9	6.0	2.0	3.3	5.6	4.1	9.6	17.0	9.6	1.7	5.8	24.4	5.6	3.8	14.5	9.9	6.3	6.5	14.5	1.0	8.6	0.4	2.0	2.6	2.2	3.5	0.1	0.0	0.0	0.4	2.6	0.2	0.2	0.3	0.5	1.8	1.3	3.1	3.0	0.0	0.5	1.3	0.0	6.6	0.0	8.1	0.1	0.0	2.8	2.9	2.6	0.0	0.4	0.1	8.2	0.1	6.7	0.2	15.3	2.0	0.4	4.3	0.3	2.5	26.5	2.1	0.1	1.3	2.9	1.7	0.9	0.9	0.3	0.4	0.2	1.4	1.0	0.3	15.2	1.0	0.0	0.5	6.2	0.0	1.8	11.5	0.2	0.1	0.6	2.7	0.1	1.2	2.0	0.0	7.5	1.0	0.7	6.9	0.7	4.2	1.5	0.9	6.2	6.5	0.7	0.6	0.2	0.4	8.6	14.5	2.0	2.6	3.7	7.6	0.9	4.0	6.6	3.5	7.4	1.0	7.2	5.8	0.0	8.0	7.4	10.1	0.7	0.8	2.8	7.6	1.4	3.4	24.4	0.0	1.8	6.6	3.2	0.5	6.9	0.2	0.0	4.8	2.7	1.7	4.0	17.3	7.3	19.3	22.3	1.2	36.2	27.9	1.0	0.6	18.1	0.0	5.4	0.9	18.4	7.4	2.9	0.7	12.5	0.6	0.0	2.1	0.0	0.0	0.5	2.5	6.9	1.2	15.7
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269765-8307111	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.9"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 14.0;Fibroblasts: 45.9;Leydig cells: 40.3;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	9	"basal ganglia: 8.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-2197: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	23.7	1.8	0.6	7.3	8.2	5.3	35.6	0.7	0.9	12.3	9.4	0.8	5.4	3.7	19.6	26.6	14.4	7.9	19.8	57.9	0.7	0.3	1.7	1.6	15.4	4.3	0.8	0.9	30.7	2.8	0.0	5.1	9.6	0.9	15.4	2.0	8.6	6.6	3.0	12.9	9.0	6.7	50.1	0.8	1.8	6.8	7.2	0.6	1.3	9.3	11.6	3.0	28.7	12.7	0.0	0.4	1.3	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	2.1	3.9	0.1	0.8	0.0	1.0	0.2	0.0	0.0	0.0	4.8	2.1	0.5	0.0	0.4	0.0	0.3	0.0	0.8	0.4	5.0	0.0	2.2	0.0	0.2	0.4	0.0	1.4	0.0	0.6	3.4	0.0	0.1	0.0	3.5	0.0	0.0	12.2	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.1	9.1	0.1	0.0	10.6	0.0	0.4	2.7	0.5	1.7	64.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.6	8.2	0.7	0.9	0.7	0.3	0.8	0.9	0.9	0.6	0.0	0.0	0.0	0.3	4.6	0.0	14.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.6	3.1	0.0	0.0	0.0	3.7	45.9	0.1	0.0	0.0	1.1	0.0	0.0	4.3	0.0	0.5	40.3	0.9	0.0	0.0	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.0	5.1	0.2	0.9	4.5	1.1	0.0	0.0	0.1
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Syncytiotrophoblasts: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Approved	Peroxisomes		NA	NA			Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	9.6	12.0	9.9	7.4	10.9	5.0	15.5	11.7	12.8	12.2	9.9	11.5	11.2	10.8	10.7	12.3	32.0	9.2	7.4	20.6	9.0	6.7	8.3	18.0	8.9	7.4	10.3	8.4	9.8	15.4	10.0	14.8	28.9	10.2	13.4	8.0	12.0	19.1	11.2	8.2	14.8	10.5	18.6	7.2	7.6	12.7	5.0	11.6	9.0	11.5	7.4	14.2	14.8	16.0	4.6	16.8	2.6	12.0	7.3	8.0	6.9	6.3	6.9	7.8	10.3	8.4	14.3	12.7	8.0	11.1	13.8	12.0	3.4	8.5	8.5	8.7	16.4	18.6	3.9	3.3	10.4	10.7	2.9	3.3	3.7	5.8	10.5	13.9	7.4	7.0	14.3	9.0	12.3	4.8	9.9	16.2	9.5	4.9	7.8	11.8	5.8	7.9	11.0	4.3	8.1	12.0	8.4	12.8	10.1	8.4	8.9	3.8	8.7	10.3	5.3	5.3	6.7	5.3	10.7	15.6	13.6	4.4	5.5	8.4	5.9	3.9	3.8	17.3	9.4	8.6	0.0	10.6	2.6	5.2	12.0	5.4	4.6	6.1	6.6	14.0	4.5	5.6	5.8	2.5	7.3	10.6	16.8	8.0	6.9	9.9	10.9	11.7	12.8	9.0	6.7	10.3	8.4	10.2	11.6	6.0	5.1	6.4	6.8	3.9	8.6	8.5	7.6	4.0	4.5	10.4	31.4	19.8	3.3	13.9	2.2	3.9	11.8	0.0	11.9	8.2	5.8	7.8	0.0	9.9	8.9	1.6	1.7	5.5	3.2	2.1	6.4	4.2	5.0	8.2	4.9	4.1	15.1	9.9	10.6	5.1	15.8	0.0	6.2	1.2	1.9	5.1	62.4	5.0	6.7	10.0
TRMT44	"C4orf23, FLJ35725, METTL19, TRM44"	ENSG00000155275	"TRNA methyltransferase 44 homolog"	Q8IYL2	4	8436140-8493531	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045461	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045461: AB_10961276"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.34e-3)"	11.5	7.6	13.3	7.3	17.5	13.1	15.4	20.3	16.2	10.1	9.2	14.1	10.1	7.1	16.3	10.7	13.6	12.3	8.6	9.8	12.1	6.3	7.1	8.9	8.8	9.8	12.2	14.7	17.1	9.7	11.3	10.9	10.2	8.7	10.8	7.2	9.4	12.4	8.7	11.5	17.2	7.6	9.7	6.7	8.1	11.3	15.8	13.8	7.8	9.9	9.0	10.7	10.8	11.4	2.1	2.1	0.4	2.1	0.8	3.0	0.5	5.6	6.0	7.4	8.8	8.0	7.8	16.2	6.8	4.8	8.9	8.0	7.3	8.1	7.7	3.3	2.7	7.2	4.3	10.8	6.6	7.9	3.9	5.3	7.2	9.3	5.7	6.9	12.4	6.0	4.7	9.1	6.8	7.5	7.6	9.5	5.3	11.0	8.4	5.6	3.7	10.3	9.1	8.5	7.2	9.0	7.7	8.0	4.9	7.7	6.9	8.1	5.6	4.4	4.0	5.9	8.8	3.6	4.8	5.6	5.5	3.0	5.1	10.4	9.8	6.1	7.1	6.1	11.7	5.3	0.4	1.2	0.1	2.3	1.2	1.6	0.8	2.1	2.5	2.1	2.1	3.0	0.9	0.2	0.8	2.1	1.7	0.2	0.5	13.3	17.5	20.3	16.2	12.1	6.3	12.2	14.7	8.7	13.8	8.9	5.3	2.2	3.7	6.1	7.8	2.6	12.7	5.3	2.3	7.0	23.6	8.6	5.0	4.2	3.0	3.9	2.3	0.0	3.9	5.3	5.1	3.9	4.7	2.9	4.0	3.2	1.7	3.1	4.6	1.4	5.5	2.9	1.7	4.6	2.3	3.2	3.6	2.5	3.5	2.2	10.9	0.0	1.8	6.2	6.1	5.1	13.6	3.2	2.8	7.0
GPR78		ENSG00000155269	"G protein-coupled receptor 78"	Q96P69	4	8558725-8619761	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"placenta: 53.3"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 4.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	202	"BEWO: 21.7"									HPA013209	Uncertain					NA	NA					"HPA013209: AB_10601657"	"unprognostic (6.41e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.70e-2)"		"unprognostic (3.82e-4)"	"unprognostic (6.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.88e-15)"	"unprognostic (5.55e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.90e-3)"	"unprognostic (8.15e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.0	0.7	2.2	0.2	29.5	17.0	22.9	6.4	2.6	0.7	0.3	0.0	1.6	9.3	0.1	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.2	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	0.1	9.3	0.0	25.1	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	3.8	0.1	0.0	0.0	0.9	1.2	18.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HMX1	"H6, NKX5-3"	ENSG00000215612	"H6 family homeobox 1"	Q9NP08	4	8846076-8871817	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cataract, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 17.4"	"Group enriched"	"Detected in some"	16	"Horizontal cells: 252.6;Muller glia cells: 197.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.1;EFO-21: 7.1;HEK 293: 13.1;SH-SY5Y: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.11e-2)"				"unprognostic (1.63e-2)"	"unprognostic (2.97e-1)"				"unprognostic (6.35e-2)"		"unprognostic (7.94e-2)"		"unprognostic (9.36e-2)"	"unprognostic (1.97e-1)"			0.5	1.0	3.9	0.4	3.6	0.3	0.3	0.8	5.0	0.3	0.3	1.1	0.0	0.8	0.3	0.3	0.3	0.3	0.3	0.3	3.1	3.5	0.3	0.3	0.3	0.3	3.6	0.1	0.3	0.3	0.3	0.4	0.3	2.7	0.3	0.4	17.4	0.5	0.3	0.5	0.6	0.3	0.3	1.8	0.3	0.4	3.5	1.6	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	1.7	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.6	0.8	2.8	3.1	3.5	3.6	0.1	2.7	1.6	0.0	0.0	0.0	0.0	0.0	14.5	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	252.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.6	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0
FAM90A26	FAM90A26P	ENSG00000229924	"Family with sequence similarity 90 member A26"		4	9170409-9176730	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 1.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (1.80e-2)"				"unprognostic (3.76e-1)"			"unprognostic (1.56e-1)"		"unprognostic (1.37e-2)"			"unprognostic (2.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.41e-1)"		0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.2	1.6	0.0	0.0			0.0	0.1	0.1	0.0	0.3	0.4	0.3	0.1	0.1	0.0	0.1	0.2	0.0	0.0		0.7	0.3	0.0	0.2	0.0		0.2	0.0		0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L10		ENSG00000231396	"Ubiquitin specific peptidase 17-like family member 10"	C9JJH3	4	9210657-9212608	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17-like family member 11"	C9JVI0	4	9215405-9217356	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.0;fallopian tube: 1.2;thyroid gland: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;JURKAT: 1.4;NTERA-2: 1.6"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0			0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			1.3		0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L12		ENSG00000227551	"Ubiquitin specific peptidase 17-like family member 12"	C9JPN9	4	9220152-9221744	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L13		ENSG00000232399	"Ubiquitin specific peptidase 17-like family member 13"	C9JLJ4	4	9224896-9226847	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.2"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.3		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L15		ENSG00000223569	"Ubiquitin specific peptidase 17-like family member 15"	C9J2P7	4	9234385-9236334	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;epididymis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.2"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	1.0	0.1	0.0			0.0	0.2	1.0	0.0	0.3	0.0	0.1	0.3	0.4	0.0	0.4	0.2	0.0	0.2		0.0	0.0	0.4	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0			0.1		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L17		ENSG00000249104	"Ubiquitin specific peptidase 17-like family member 17"	D6RBQ6	4	9243879-9245830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;NTERA-2: 1.4"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.4	0.0			0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			1.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L18		ENSG00000250844	"Ubiquitin specific peptidase 17-like family member 18"	D6R9N7	4	9248630-9250581	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.2"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.5	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L19		ENSG00000248920	"Ubiquitin specific peptidase 17-like family member 19"	D6RCP7	4	9253378-9255329	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L20		ENSG00000250745	"Ubiquitin specific peptidase 17-like family member 20"	D6RJB6	4	9258124-9260075	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;hTERT-HME1: 1.1"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L21		ENSG00000249811	"Ubiquitin specific peptidase 17-like family member 21"	D6R901	4	9262872-9264823	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L22		ENSG00000248933	"Ubiquitin specific peptidase 17-like family member 22"	D6RA61	4	9267619-9269570	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"									HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4			0.5		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L23		ENSG00000250913	"Ubiquitin specific peptidase 17-like family member 23"	D6RBM5	4	9272364-9272914	"Enzymes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"gallbladder: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HMC-1: 1.4"															NA	NA																							0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L24		ENSG00000232264	"Ubiquitin specific peptidase 17-like family member 24"	Q0WX57	4	9325165-9327116	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L25		ENSG00000230430	"Ubiquitin specific peptidase 17-like family member 25"	Q0WX57	4	9329911-9331862	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L26		ENSG00000229579	"Ubiquitin specific peptidase 17-like family member 26"	Q0WX57	4	9334658-9336609	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L5		ENSG00000227140	"Ubiquitin specific peptidase 17-like family member 5"	A8MUK1	4	9339403-9340995	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L27		ENSG00000235780	"Ubiquitin specific peptidase 17-like family member 27"	Q0WX57	4	9344148-9345740	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L28		ENSG00000231051	"Ubiquitin specific peptidase 17-like family member 28"	Q0WX57	4	9348893-9350485	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L29		ENSG00000231637	"Ubiquitin specific peptidase 17-like family member 29"	Q0WX57	4	9353638-9355230	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L30		ENSG00000228856	"Ubiquitin specific peptidase 17-like family member 30"	Q0WX57	4	9363129-9364721	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA					"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB131A	"DEFB-31, DEFB131"	ENSG00000186146	"Defensin beta 131A"	P59861	4	9444534-9450514	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"ductus deferens: 31.3;epididymis: 65.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	18	"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"TIME: 6.8"														"Secreted in other tissues"	NA	NA																					"unprognostic (2.11e-1)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	9.0	0.0	31.3	5.5	0.1	65.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	10.9	0.1	0.1	10.3	0.0	0.1	0.1	0.2	0.3	0.0	0.0	8.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 43.4"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 16.4;Proximal tubular cells: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 20.6;myeloid DC: 16.7"	"Group enriched"	"Detected in many"	31	"dendritic cells: 16.7;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 29.6;Hep G2: 14.2;hTCEpi: 12.5;THP-1: 12.5;U-937: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA					"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	5.6	2.8	1.0	1.3	2.0	1.2	3.2	0.6	1.2	2.6	10.4	2.3	5.7	7.8	1.7	12.0	5.8	2.6	1.7	2.7	1.0	0.9	43.4	17.7	4.7	2.8	1.9	0.7	1.5	1.3	1.5	1.8	8.8	2.1	4.6	1.1	4.1	10.8	15.6	1.1	2.4	12.0	1.4	4.1	3.0	1.2	1.3	2.3	3.0	2.9	3.4	3.9	7.1	3.9	0.2	16.7	0.6	20.6	0.1	0.2	4.9	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.2	1.5	0.0	2.2	0.4	0.0	4.5	0.0	29.6	0.0	4.8	0.1	0.0	0.0	14.2	1.0	0.1	4.0	2.2	12.5	0.0	3.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.2	1.4	0.0	0.2	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	20.6	0.4	0.1	4.1	0.2	0.2	0.2	0.0	16.7	0.1	0.1	0.0	0.6	0.1	0.4	6.6	0.1	4.9	1.0	2.0	0.6	1.2	1.0	0.9	1.9	0.7	2.1	2.3	0.0	0.0	1.4	11.1	0.8	0.0	2.1	0.0	4.0	3.4	3.5	2.0	16.4	3.3	0.4	3.9	1.4	2.9	0.0	0.9	1.3	1.1	1.0	1.1	4.9	9.3	0.0	0.0	2.5	6.5	2.8	0.0	10.2	0.0	1.0	0.8	0.8	0.4	0.0	0.4	47.2	0.4	0.0	1.0	0.7	1.2	0.5	7.1	0.5	1.0	8.8
DRD5	"DRD1B, DRD1L2"	ENSG00000169676	"Dopamine receptor D5"	P21918	4	9781680-9784009	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Dystonia, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 8.4;lymphoid tissue: 3.5;stomach 1: 10.9"	"Cell type enhanced"	"Detected in single"	41	"Horizontal cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.6;THP-1: 2.0;U-2 OS: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048930	Supported					NA	NA					"HPA048930: AB_2680562"		"unprognostic (2.03e-2)"			"unprognostic (2.63e-1)"	"unprognostic (9.73e-2)"		"unprognostic (4.27e-2)"		"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-4)"	"unprognostic (5.09e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.36e-3)"	0.2	0.2	2.8	3.5	4.1	0.1	0.2	0.0	8.4	0.1	0.9	0.0	0.0	0.9	0.1	0.1	0.3	0.3	0.1	0.1	3.2	3.2	0.2	0.1	0.4	0.2	1.9	0.8	0.1	0.2	0.1	1.0	0.1	7.4	0.6	0.2	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.6	0.1	10.9	1.3	1.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.0	2.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.1	0.0	8.4	3.2	3.2	1.9	0.8	7.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 926.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		280000000	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	40.2	23.7	19.0	49.4	18.1	33.5	35.0	8.1	22.6	53.5	53.3	25.8	38.4	39.2	80.9	54.2	59.6	54.9	57.6	49.5	19.6	20.5	55.4	41.3	41.7	57.4	22.1	17.1	51.5	22.2	19.5	18.6	40.4	26.8	47.1	38.3	37.6	38.5	49.1	32.1	31.6	54.5	88.0	19.5	46.9	41.1	38.0	16.0	74.5	49.9	36.4	50.2	69.6	41.5	22.9	40.2	54.2	61.2	32.5	55.6	64.1	30.5	30.7	27.5	23.1	20.9	34.7	43.4	77.3	71.4	69.9	55.0	36.7	38.7	21.3	25.2	92.2	76.0	20.0	29.9	56.5	74.8	33.2	10.2	60.7	31.4	26.0	48.9	19.2	70.4	33.3	29.0	70.9	35.5	53.5	75.1	38.0	18.1	35.4	67.7	17.5	84.8	27.1	32.6	24.6	30.8	40.0	25.2	18.0	43.6	48.8	9.3	10.2	33.0	18.3	31.8	37.7	15.3	20.9	112.9	53.9	22.6	44.6	67.6	22.4	35.8	27.9	57.0	29.3	66.8	37.1	29.0	54.2	48.3	51.7	37.4	22.9	40.6	48.2	37.8	16.9	41.7	44.4	54.1	32.5	61.2	40.2	55.6	64.1	19.0	18.1	8.1	22.6	19.6	20.5	22.1	17.1	26.8	16.0	32.8	48.2	70.0	155.9	129.0	22.1	55.6	73.9	62.9	60.3	99.5	39.3	147.9	72.9	294.0	462.5	69.7	206.5	0.0	185.6	249.1	66.7	101.7	80.8	62.3	224.0	31.8	104.6	84.7	141.3	926.6	43.4	122.8	75.9	402.2	113.7	74.5	238.9	137.2	86.7	88.0	24.9	97.0	170.5	94.8	67.2	119.7	193.7	125.0	117.8	177.3
ZNF518B	KIAA1729	ENSG00000178163	"Zinc finger protein 518B"	Q9C0D4	4	10439874-10457410	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031215, HPA031216"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031215: AB_10600200, HPA031216: AB_10601449"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.89e-3)"	11.2	9.6	9.4	10.5	12.2	6.1	12.9	16.0	13.2	11.4	10.3	6.0	9.6	6.4	10.4	11.4	7.7	8.3	7.8	11.0	9.3	9.9	6.2	4.2	7.5	12.6	7.5	7.6	15.8	5.7	10.5	12.7	13.1	8.3	12.7	5.4	9.3	12.1	13.5	12.1	6.5	11.4	10.0	6.4	11.1	7.9	15.1	4.7	19.5	14.1	7.3	14.8	10.7	11.5	9.5	4.5	11.8	5.3	6.8	4.8	2.3	4.9	3.4	13.2	3.8	1.7	2.6	0.0	5.8	1.4	3.6	4.3	0.0	0.0	0.0	5.9	8.4	10.2	0.1	3.0	6.4	8.0	0.0	5.5	16.0	0.0	0.0	7.7	0.0	7.1	7.5	3.8	5.7	0.0	7.4	12.2	12.0	17.2	0.0	2.9	0.0	10.8	0.4	12.8	2.5	7.7	9.3	5.6	1.8	0.1	7.0	9.9	2.9	2.7	0.0	1.8	11.0	2.1	4.3	9.2	0.0	12.1	0.0	5.4	6.8	5.0	9.4	0.7	0.9	0.7	2.8	2.5	11.8	2.9	2.6	3.8	9.5	4.6	3.3	4.5	5.2	4.8	4.4	6.5	6.8	5.3	1.5	3.4	2.3	9.4	12.2	16.0	13.2	9.3	9.9	7.5	7.6	8.3	4.7	3.0	4.6	4.2	17.0	14.2	9.2	23.8	5.1	5.3	10.3	0.0	9.8	7.9	3.3	2.4	10.3	12.6	4.2	0.0	3.3	7.4	6.7	17.5	16.1	1.6	7.7	11.1	1.2	9.2	8.2	15.2	15.0	5.0	1.7	4.6	2.7	8.3	1.9	2.9	20.1	1.0	10.6	0.0	6.2	12.3	8.3	12.4	7.7	5.7	3.0	15.8
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 10.9;lymphoid tissue: 10.8"	"Cell type enhanced"	"Detected in some"	9	"Distal tubular cells: 11.6;granulocytes: 11.5"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 9.2;U-937: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.4	0.5	0.3	5.7	0.3	0.5	0.7	0.4	0.3	1.9	1.8	0.1	0.1	0.7	0.8	1.7	2.0	0.4	1.4	0.3	0.3	0.3	10.9	1.2	3.2	5.0	0.3	0.1	0.5	0.7	0.0	3.2	1.5	0.5	0.5	0.4	1.6	2.5	0.1	0.3	1.2	2.3	1.7	0.3	6.3	1.6	1.1	0.1	8.4	0.5	1.5	10.8	0.4	0.4	3.4	5.5	1.6	0.4	4.3	3.6	0.5	0.1	0.6	0.5	0.3	0.8	0.2	0.6	0.4	0.0	0.1	0.2	0.0	0.4	0.3	0.1	0.4	0.1	0.4	0.0	0.0	0.1	9.2	0.4	0.4	0.5	0.1	0.1	0.3	0.3	0.4	0.1	0.0	0.3	0.2	0.1	0.2	0.1	0.7	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.2	0.1	1.1	0.1	0.6	0.8	0.1	0.3	0.5	0.3	0.3	0.3	0.0	1.0	0.2	0.3	0.6	0.3	0.5	0.1	0.4	0.5	4.8	0.2	1.0	0.4	0.6	0.7	0.3	0.3	3.4	1.2	0.4	5.5	2.9	0.5	0.5	1.6	4.3	0.2	1.4	3.6	0.5	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.1	0.5	0.1	3.0	4.8	0.8	0.8	0.7	1.1	0.6	0.0	0.0	1.2	0.0	2.0	0.3	11.6	0.0	4.9	0.3	0.0	0.0	0.0	1.6	0.4	0.4	11.5	0.2	0.2	0.0	0.0	0.6	0.3	3.1	0.3	1.3	1.7	0.0	0.0	0.2	0.2	0.0	2.1	0.0	0.8	0.0	0.4	1.1	0.5	0.4	0.1	2.5	0.0	0.6
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429765	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;gallbladder: 31.9;ovary: 30.3"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 64.3;Club cells: 83.0;granulocytes: 93.6;Peritubular cells: 84.8;Urothelial cells: 90.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"cerebellum: 27.4;cerebral cortex: 9.0"	"Group enriched"	"Detected in some"	39	"memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3"	"Group enriched"	"Detected in many"	99	"B-cells: 15.8;dendritic cells: 22.3"	"Cell line enhanced"	"Detected in some"		"A-431: 4.5;CAPAN-2: 14.4;HaCaT: 4.3;RPTEC TERT1: 12.6;RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (8.67e-4)"	2.3	2.9	1.6	2.8	2.2	2.8	2.0	27.4	9.0	3.3	2.7	1.1	3.6	3.5	4.3	5.0	10.2	4.3	31.9	2.2	1.7	1.8	10.4	0.9	3.4	2.1	1.9	1.5	30.3	1.1	0.7	8.9	1.0	2.4	3.2	1.7	1.7	3.7	2.4	0.7	0.8	2.9	1.7	2.2	3.0	7.0	3.0	0.3	3.8	1.8	7.0	7.4	7.3	2.4	15.8	22.3	0.1	0.1	0.0	0.1	0.6	4.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.4	0.0	0.4	0.0	0.0	4.3	0.0	2.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.9	1.2	1.0	0.0	0.0	12.6	10.3	3.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.6	1.6	2.2	27.4	9.0	1.7	1.8	1.9	1.5	2.4	0.3	3.0	8.0	2.2	9.8	8.0	1.5	2.4	15.3	64.3	83.0	19.2	3.9	0.5	0.0	17.1	0.8	23.4	3.0	0.0	1.8	31.9	5.0	4.1	93.6	0.0	37.3	1.6	2.4	9.2	2.7	0.8	8.1	9.0	1.7	7.2	5.6	39.8	32.0	2.6	84.8	3.7	2.2	0.0	6.4	6.0	5.5	7.0	1.1	0.9	3.7	90.2
RAB28		ENSG00000157869	"RAB28, member RAS oncogene family"	P51157	4	13361354-13484365	"Disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044575	Approved					NA	NA					"HPA044575: AB_10959460"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.31e-3)"	"prognostic favorable (1.61e-4)"	12.5	14.8	23.5	8.9	26.3	12.8	15.8	34.5	24.0	12.9	13.5	15.3	11.8	7.8	17.5	15.1	9.2	17.4	12.0	22.5	18.6	20.5	12.6	8.9	13.1	12.5	21.4	10.6	18.1	8.8	23.5	29.0	14.7	22.7	12.9	14.2	13.2	8.8	13.1	5.8	15.0	8.7	13.5	20.6	12.2	10.6	27.2	21.1	14.8	15.2	7.2	12.3	9.8	12.4	19.9	17.2	25.3	17.2	19.5	22.4	11.0	9.6	4.9	16.7	8.5	8.8	16.6	8.7	8.5	10.3	10.0	13.5	5.0	10.1	11.5	5.7	8.6	21.2	5.0	14.2	7.9	18.4	6.7	7.1	8.2	8.6	4.6	8.6	9.0	5.0	7.5	10.8	9.1	8.7	12.3	10.8	14.9	15.9	44.1	13.8	3.9	19.3	22.7	23.1	7.3	9.0	12.5	10.4	9.4	8.7	5.3	13.2	8.0	7.6	5.6	12.1	13.6	6.1	10.4	7.3	13.0	5.8	10.9	13.3	10.9	7.4	15.0	11.8	17.0	17.4	17.2	17.2	25.3	17.8	15.7	18.3	19.9	16.7	17.4	17.2	17.4	22.4	18.3	15.6	19.5	14.3	13.5	17.0	11.0	23.5	26.3	34.5	24.0	18.6	20.5	21.4	10.6	22.7	21.1	6.0	5.4	18.2	23.3	24.4	30.1	17.6	0.0	28.1	10.3	7.0	31.4	20.3	16.6	11.9	12.8	17.2	6.6	0.0	12.5	18.3	23.7	16.5	4.7	6.8	14.9	30.2	9.9	10.4	14.5	17.5	17.3	14.9	28.7	14.4	12.6	26.3	9.5	10.5	22.6	14.7	42.4	19.4	22.3	101.1	67.1	26.2	23.3	20.2	13.4	16.2
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13545050	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 18.3;lymphoid tissue: 6.5"	"Cell type enriched"	"Detected in single"	31	"Cardiomyocytes: 3.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.7	0.0	0.1	6.5	0.1	0.0	0.1	0.1	0.1	1.1	18.3	0.1	0.1	1.6	0.9	0.1	2.3	0.2	0.4	1.8	0.1	0.0	0.4	0.1	0.1	2.0	0.1	0.1	2.9	0.2	0.0	0.9	0.1	0.1	0.6	2.4	0.1	1.5	0.6	0.1	0.1	2.0	3.2	0.1	5.3	2.8	0.9	0.1	0.1	0.3	0.9	0.1	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	1.9	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	1.0	0.0	4.6	0.0	0.0	0.0	2.6	0.6	1.7	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	1.9	0.0	0.7	1.7	0.0	0.7	0.0	0.4	12.7	7.2	0.0	0.5	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	2.3	1.0	7.6	0.0	0.5	3.0	0.1	0.5	2.2	0.0	0.0	0.4	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BOD1L1	"BOD1L, FAM44A, FLJ33215, KIAA1327"	ENSG00000038219	"Biorientation of chromosomes in cell division 1 like 1"	Q8NFC6	4	13568738-13627723	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036943, HPA037362, HPA041290"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.48e-6)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.60e-2)"	17.5	12.6	18.9	23.8	24.3	40.2	18.3	30.4	34.9	21.5	16.8	10.4	18.2	12.1	20.5	19.8	15.2	16.9	14.1	13.6	18.4	12.4	14.2	12.6	22.8	22.0	20.1	21.7	26.8	16.0	28.6	16.0	18.3	21.1	15.4	14.5	7.1	17.1	27.3	13.2	19.5	20.9	18.2	21.1	26.9	16.1	18.0	21.6	23.4	16.4	11.7	22.3	16.5	16.2	2.2	2.5	12.2	1.4	0.7	1.6	0.5	10.2	13.8	13.8	9.9	16.8	17.8	10.6	11.9	12.6	9.9	11.2	10.3	11.2	13.8	5.4	13.0	18.5	7.0	11.2	11.8	19.2	9.5	6.5	19.4	17.4	12.6	10.4	29.1	16.1	14.2	13.5	20.5	15.9	13.7	10.2	9.8	13.6	16.6	12.4	6.1	15.0	19.5	17.7	6.6	12.0	11.5	20.5	5.5	18.5	10.4	8.2	15.1	13.1	4.6	10.6	15.5	5.4	11.3	23.1	15.4	8.1	9.5	15.6	19.7	11.5	17.5	15.2	13.8	12.2	2.5	1.4	2.8	1.6	1.4	1.3	1.7	1.0	1.1	0.9	2.2	1.5	1.1	12.2	0.7	0.9	2.5	0.9	0.5	18.9	24.3	30.4	34.9	18.4	12.4	20.1	21.7	21.1	21.6	77.4	85.8	51.3	16.8	23.4	156.0	80.3	53.5	52.2	75.1	34.9	84.4	13.6	3.3	26.0	15.3	42.2	24.0	23.3	21.8	14.9	25.9	20.4	60.2	30.4	18.6	152.6	33.4	33.7	36.5	13.5	46.6	34.3	23.6	21.6	26.0	103.2	26.0	21.0	54.5	4.5	187.0	45.3	24.0	75.4	15.2	25.2	15.6	37.3	21.0	22.8
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002674-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 76.2;Suprabasal keratinocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol		Yes	No			Cytosol		"HPA072513: AB_2686529"	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	10.0	7.5	18.5	6.0	21.5	23.0	13.6	11.5	21.0	8.8	11.5	28.7	13.2	9.6	8.2	9.4	13.6	7.1	10.7	7.8	17.4	16.2	13.5	18.9	9.5	6.4	27.2	17.4	7.9	5.4	23.8	6.4	7.4	16.4	10.2	10.7	20.7	8.9	21.9	7.1	23.0	9.5	10.8	21.7	6.6	10.8	37.4	27.6	3.6	6.1	7.8	7.2	8.3	12.6	0.4	0.7	2.4	0.4	1.3	1.6	0.3	1.3	8.3	0.8	0.3	6.2	11.4	1.4	4.6	3.1	2.9	2.1	0.2	1.6	0.8	0.9	4.2	5.4	1.5	1.8	1.0	1.8	2.3	0.6	0.2	6.4	1.4	2.9	0.3	1.1	5.6	5.5	7.0	6.8	3.6	2.6	0.1	0.1	6.0	11.8	0.6	0.1	1.8	0.8	2.4	1.2	0.1	0.6	0.3	25.2	1.1	0.7	4.6	1.5	1.0	4.7	3.9	0.6	5.3	5.1	10.4	0.9	6.5	2.5	3.9	0.5	0.4	8.5	4.7	3.8	0.0	0.4	1.7	0.5	0.4	1.6	0.1	0.8	0.5	0.7	0.4	0.9	0.3	2.4	1.3	0.2	0.3	0.2	0.3	18.5	21.5	11.5	21.0	17.4	16.2	27.2	17.4	16.4	27.6	29.8	13.9	5.8	9.4	76.2	7.6	18.3	15.3	1.4	6.8	29.6	25.5	1.1	1.7	3.5	47.6	11.4	23.2	0.0	4.2	1.2	11.0	8.7	10.4	21.2	9.1	14.3	9.8	12.9	15.4	15.5	5.8	12.2	50.6	2.8	10.9	6.1	5.9	11.9	7.8	10.3	19.0	0.0	13.4	14.7	3.1	113.2	1.1	6.4	6.6	14.4
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 15.1;Fibroblasts: 10.3;Leydig cells: 21.0;Peritubular cells: 29.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.2;ASC TERT1: 6.4;HSkMC: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	238000000		Vesicles		"CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596"	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	6.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1	0.0	0.0	0.0	0.0	3.2	15.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	10.3	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	21.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	29.7	1.0	0.9	6.5	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1
CC2D2A	"JBTS9, KIAA1345, MKS6"	ENSG00000048342	"Coiled-coil and C2 domain containing 2A"	Q9P2K1	4	15469865-15601557	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	23	"Ciliated cells: 153.9;Cone photoreceptor cells: 536.0;Rod photoreceptor cells: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.4;RPTEC TERT1: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044124	Approved					NA	NA					"HPA044124: AB_10969197"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.01e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.42e-9)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.18e-2)"	6.5	7.4	9.1	7.2	10.3	2.8	6.3	4.9	8.0	13.2	12.6	7.2	12.1	4.5	13.7	15.4	13.3	33.6	13.5	7.9	9.0	9.2	19.5	2.3	8.5	2.6	9.8	7.3	6.5	7.5	10.9	19.9	7.4	12.3	12.7	5.2	20.5	3.0	11.6	1.9	2.5	4.1	25.9	10.0	3.0	7.4	6.2	5.7	0.0	6.4	7.4	1.2	18.1	6.4	0.4	6.7	4.0	3.7	1.7	1.6	1.0	1.4	5.2	6.9	1.8	9.2	20.4	1.2	1.4	6.3	4.3	5.8	2.2	6.6	0.4	2.5	2.9	9.1	0.6	3.5	4.3	4.8	0.0	1.5	1.2	1.9	1.8	2.8	0.5	0.1	10.5	6.5	7.7	2.1	9.8	2.5	0.1	1.5	0.2	7.9	1.0	0.3	0.4	11.8	0.2	7.3	1.1	0.6	0.6	14.9	1.5	1.6	3.3	0.1	1.1	7.4	6.3	1.2	0.8	1.0	6.9	2.2	4.8	3.7	0.1	0.2	0.2	12.3	0.1	2.3	1.0	3.7	0.2	1.1	2.7	1.1	0.1	0.6	0.1	6.7	0.4	0.6	0.7	4.0	1.7	1.3	0.4	1.6	1.0	9.1	10.3	4.9	7.6	9.0	9.2	9.8	7.3	12.3	5.7	11.9	10.5	0.0	4.7	1.9	12.9	21.8	12.7	153.9	38.7	24.4	536.0	9.2	28.2	4.8	9.5	5.2	1.0	0.0	0.8	2.8	8.1	4.1	0.0	1.3	4.0	7.9	5.8	8.6	4.6	5.2	8.6	3.8	11.8	0.0	0.3	15.7	1.6	0.0	15.6	34.8	131.9	6.5	11.3	1.6	0.1	1.1	1.3	0.0	2.6	3.3
FBXL5	"FBL4, FBL5, FLR1"	ENSG00000118564	"F-box and leucine rich repeat protein 5"	Q9UKA1	4	15604539-15681679	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 187.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 76.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 20.6;granulocytes: 76.0;monocytes: 40.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.53e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.70e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.18e-2)"	45.3	38.1	32.3	24.8	40.2	59.5	47.8	36.2	38.2	36.9	31.9	30.9	30.4	19.4	30.9	42.3	28.8	31.1	33.4	40.2	30.6	29.0	81.3	48.6	30.8	35.4	38.4	30.7	28.9	29.8	34.1	44.9	23.5	45.4	35.1	23.8	30.3	25.1	39.1	50.9	24.5	25.8	40.0	51.8	33.7	29.5	41.3	33.0	38.7	46.6	19.8	20.0	33.7	25.7	6.1	20.6	76.0	40.8	7.7	9.4	32.2	8.5	6.9	16.0	9.3	25.5	25.2	5.1	11.4	14.2	12.6	17.8	5.3	13.1	6.7	5.6	13.7	22.3	3.3	8.4	13.5	19.1	6.6	4.2	6.4	5.5	6.3	24.9	7.9	6.2	23.0	18.2	11.8	18.1	28.8	33.1	6.0	5.4	5.5	37.3	3.9	15.2	12.1	8.6	7.1	6.1	11.0	16.7	5.7	19.3	12.1	7.9	7.4	10.9	3.8	12.1	23.2	6.1	13.3	8.5	14.6	4.0	9.9	14.3	7.9	8.0	6.1	12.8	14.0	17.7	31.2	40.8	21.0	9.4	21.3	9.0	6.1	8.8	9.0	20.6	5.5	9.3	9.4	76.0	7.7	17.9	3.1	7.5	32.2	32.3	40.2	36.2	38.2	30.6	29.0	38.4	30.7	45.4	33.0	41.7	53.1	15.7	35.4	24.3	50.9	72.3	40.8	66.9	47.8	34.9	5.9	45.4	66.3	24.8	61.5	34.6	26.5	0.0	20.5	30.5	34.3	30.3	38.2	60.4	43.7	38.1	24.9	38.1	115.5	42.4	36.8	60.5	28.7	27.9	18.5	33.6	15.6	24.6	54.8	187.3	40.4	58.2	41.2	150.6	62.4	22.8	22.1	30.5	23.3	28.0
FAM200B	C4orf53	ENSG00000237765	"Family with sequence similarity 200 member B"	P0CF97	4	15681662-15705565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 344.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA017855	Uncertain					NA	NA					"HPA017855: AB_1847703"	"unprognostic (7.38e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.82e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (4.39e-4)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.35e-5)"	12.2	14.9	16.1	10.1	21.0	6.8	15.9	27.0	18.2	14.5	10.5	10.2	13.4	18.0	14.1	21.2	11.8	10.3	11.7	10.4	15.1	14.8	21.4	14.4	9.9	11.7	20.1	12.2	19.2	10.6	11.4	27.7	13.5	15.7	13.7	14.0	12.2	12.0	15.3	7.3	12.3	13.9	16.2	17.3	13.0	9.9	11.5	20.4	17.3	21.4	7.7	9.0	13.6	13.0	0.9	2.5	6.5	4.5	1.3	5.8	2.1	3.5	2.9	12.3	7.1	4.9	3.4	3.7	4.4	2.7	5.4	5.9	4.9	3.3	5.4	2.4	3.5	10.8	3.5	8.5	5.2	10.8	0.7	4.5	4.2	8.4	6.2	4.0	2.6	2.0	3.5	4.2	4.6	2.4	7.0	3.3	2.9	5.2	2.5	12.9	2.3	3.5	4.1	7.2	2.0	4.5	3.6	15.2	0.7	5.4	3.8	16.8	9.5	3.1	0.9	5.8	7.3	2.2	3.8	2.9	8.3	5.7	6.5	7.2	1.5	3.1	2.0	5.3	4.4	21.0	1.8	4.5	6.5	2.6	3.0	2.8	0.7	3.0	1.9	2.5	0.9	5.8	4.3	1.0	1.3	2.1	0.5	2.2	2.1	16.1	21.0	27.0	17.9	15.1	14.8	20.1	12.2	15.7	20.4	26.8	43.4	26.0	55.4	47.9	52.7	84.3	76.5	50.9	37.5	73.3	11.8	62.6	344.8	44.8	183.4	47.0	46.7	70.0	51.7	50.8	60.9	54.0	12.7	78.8	60.3	50.9	63.4	36.2	80.5	191.6	86.9	51.3	59.1	28.9	67.9	53.2	40.9	63.1	65.7	137.3	19.5	45.3	58.5	87.4	28.2	44.7	28.9	49.8	73.4	49.3
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15702950-15738313	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5;bone marrow: 54.9;intestine: 61.3"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 39.0;Kupffer cells: 36.4;Macrophages: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 52.7;neutrophil: 59.5"	"Group enriched"	"Detected in many"	105	"dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 37.1;TIME: 20.4;U-937: 24.2;WM-115: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		170000000			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	14.3	2.0	1.1	5.6	2.0	54.9	6.6	0.8	1.5	7.2	33.8	1.5	2.1	20.4	6.4	7.0	4.6	5.6	10.3	14.5	1.8	0.8	6.6	3.7	9.4	9.6	1.3	1.9	5.5	1.0	0.4	1.3	8.0	1.3	7.5	4.0	5.4	2.8	2.2	3.4	3.5	61.3	7.9	1.5	13.6	2.4	2.4	1.2	2.8	3.5	2.9	1.8	7.5	16.1	0.4	16.6	59.5	52.7	0.1	0.3	19.6	0.2	5.5	0.5	0.4	13.5	3.2	0.7	10.5	1.0	9.6	10.8	0.1	5.7	0.3	0.9	5.3	0.2	0.1	1.5	0.2	8.2	0.3	0.2	2.5	0.3	0.2	3.4	3.3	7.3	2.7	0.7	6.1	0.5	0.4	1.5	2.3	0.3	0.2	5.6	0.1	1.0	1.9	1.2	0.4	1.1	0.3	0.7	0.2	0.3	0.3	0.7	2.1	0.2	0.3	7.0	0.5	0.2	37.1	20.4	0.3	0.5	3.7	0.4	0.2	0.0	0.3	1.3	24.2	22.1	7.6	52.7	3.9	0.2	19.8	0.3	0.4	0.1	0.1	16.6	0.2	0.2	0.1	59.5	0.1	13.6	5.5	0.2	19.6	1.1	2.0	0.8	1.5	1.8	0.8	1.3	1.9	1.3	1.2	3.0	3.0	0.0	0.8	4.0	0.2	0.8	5.1	2.7	1.2	1.8	0.0	14.0	1.7	4.1	2.7	2.1	3.2	0.0	2.3	18.7	18.6	0.5	16.1	1.8	39.0	0.0	1.2	3.7	36.4	0.7	2.8	29.9	13.5	0.0	7.0	0.3	0.8	7.0	2.1	6.7	0.0	6.5	10.8	2.3	1.2	2.6	5.9	0.0	16.6	2.7
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	50.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	14.2	0.0	0.0	12.8	3.1	0.0	0.0	0.0	10.3	0.0	8.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	11.0	0.1	9.6	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5	3.0	10.8	23.4	0.4	0.0	0.0	0.8	0.0	49.5	18.2	0.0	9.8	0.2	0.0	0.0	1.6	0.1	0.0	46.7	0.0	0.0	0.5	10.7	39.1	1.3	4.6	0.0	0.0	3.1	31.1	0.0	0.0	10.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	2.2	1.4	0.0	0.5	30.5	0.7	0.1
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935569-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 927.5;Suprabasal keratinocytes: 687.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 79.0;HBEC3-KT: 136.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"	NA	NA					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.2	0.0	0.2	0.6	0.2	0.0	4.1	0.2	0.2	27.1	5.1	0.2	0.2	0.4	1.1	0.2	106.6	0.1	0.3	0.2	0.2	0.0	0.3	0.2	1.9	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.7	0.2	0.3	4.6	0.4	14.1	0.2	0.2	14.6	1.3	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.3	133.1	56.8	1.8	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	1.5	0.0	0.0	79.0	0.0	136.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.7	0.0	0.0	0.0	13.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	5.9	0.0	92.0	927.5	0.0	0.0	0.0	37.5	51.2	0.0	0.0	0.1	0.0	10.2	0.0	0.0	32.6	0.0	6.6	0.0	6.1	13.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	70.9	1.0	12.3	0.0	81.1	20.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	687.3	1.9	0.0	8.4	179.5
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960243-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.8"	"Group enriched"	"Detected in many"	8	"Melanocytes: 43.9;T-cells: 86.3"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Region enriched"	"Detected in many"	6	"midbrain: 16.0"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.8"	"Lineage enriched"	"Detected in many"	10	"T-cells: 79.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 11.2;T-47d: 5.5;WM-115: 2.2"														"Secreted to blood"	NA	NA	346000000	6900000				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	21.0	1.4	0.3	0.4	1.0	33.4	19.4	0.0	0.9	1.1	7.1	0.2	0.9	0.2	0.6	6.0	3.4	0.7	0.8	16.1	0.4	0.2	0.5	0.8	6.7	1.9	16.0	1.0	0.9	0.2	0.1	0.2	0.8	2.8	3.1	0.8	30.7	5.7	0.9	6.7	14.4	1.8	5.3	5.0	10.4	1.2	11.3	0.0	5.8	0.7	3.8	1.9	1.5	3.7	0.1	0.2	1.2	0.2	8.3	79.8	39.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.2	0.3	5.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	2.2	0.4	0.1	0.3	79.8	0.1	0.7	0.1	19.7	47.0	0.1	0.0	7.6	47.5	1.2	8.3	0.2	0.2	0.1	39.3	0.3	1.0	0.0	0.9	0.4	0.2	16.0	1.0	2.8	0.0	0.0	7.7	0.9	0.0	8.5	0.0	1.4	0.0	0.0	2.3	5.2	7.9	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	3.5	0.2	0.0	0.0	0.0	4.9	0.3	1.7	0.0	2.2	43.9	0.0	0.0	1.0	0.2	0.0	0.4	0.8	0.3	0.0	0.8	0.3	0.1	6.8	0.8	86.3	0.0	0.0
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 52.4;salivary gland: 71.0"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 547.8;Rod photoreceptor cells: 281.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.9;CACO-2: 25.6;CAPAN-2: 10.9;EFO-21: 25.1;NTERA-2: 37.2;RPTEC TERT1: 34.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA004922, CAB011525, HPA031053"	Enhanced					NA	NA					"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.5	0.5	2.5	11.5	2.2	1.3	11.2	1.0	2.2	20.1	13.8	2.3	1.6	5.2	4.7	3.1	1.8	1.9	12.6	2.7	3.1	2.1	30.2	1.6	3.6	0.1	2.3	0.6	1.6	10.7	0.0	1.8	12.7	2.1	1.6	7.4	52.4	71.0	2.9	0.7	1.1	13.5	1.7	1.8	0.6	10.9	5.0	0.9	0.3	1.7	3.8	10.2	3.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	10.9	0.3	25.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	37.2	0.0	0.0	1.0	0.0	0.0	34.5	0.1	4.3	1.5	0.0	0.8	1.0	1.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.5	2.2	1.0	2.2	3.1	2.1	2.3	0.6	2.1	0.9	3.0	3.7	0.0	0.1	0.0	10.1	7.9	30.6	93.7	22.7	78.5	547.8	0.4	0.0	51.2	32.2	2.5	26.6	0.0	14.0	0.1	0.0	0.9	0.0	0.0	0.1	9.5	42.7	0.6	0.0	34.0	2.8	0.7	0.0	1.0	9.2	47.2	32.3	24.9	6.0	1.4	281.4	0.0	0.3	1.2	0.7	0.0	0.1	0.0	18.0	0.9
TAPT1	FLJ90013	ENSG00000169762	"Transmembrane anterior posterior transformation 1"	Q6NXT6	4	16160505-16227410	"Disease related genes, Predicted membrane proteins"	"Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis"	"Developmental protein, Receptor"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 108.0;Late spermatids: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042567, HPA048658"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA042567: AB_2678055, HPA048658: AB_2680482"	"unprognostic (2.34e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (9.75e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.30e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (7.07e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (9.00e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.25e-3)"	"prognostic favorable (4.18e-4)"	10.2	19.2	18.6	7.4	18.0	26.2	13.1	15.0	17.3	10.2	10.1	20.2	8.2	8.3	15.1	12.2	8.2	10.7	10.8	14.4	17.5	13.5	15.8	35.9	14.7	11.0	20.1	10.8	10.8	9.8	14.4	14.5	17.2	13.5	10.2	10.7	11.3	9.4	11.0	38.0	9.8	12.8	12.0	18.5	11.2	9.2	13.1	19.1	15.3	17.8	7.8	9.9	10.1	16.8	6.5	1.8	2.6	0.7	0.9	2.4	0.7	3.0	2.2	3.8	4.4	5.7	4.4	1.6	5.0	3.7	4.7	5.2	3.0	5.3	19.4	5.4	3.1	6.9	2.5	3.2	2.5	6.0	1.8	4.0	3.8	3.2	3.2	5.5	7.6	4.0	2.7	4.9	4.6	3.4	5.8	2.3	12.1	5.8	9.1	4.5	2.1	11.2	6.2	2.5	5.7	5.3	27.4	5.3	3.5	7.6	3.1	6.3	5.1	4.6	3.9	5.7	2.7	7.2	7.5	4.4	3.9	2.6	2.6	6.3	8.9	7.3	14.8	8.0	19.0	4.5	2.6	0.7	0.2	0.6	0.6	0.2	2.1	1.8	1.0	1.1	6.5	2.4	1.7	1.6	0.9	0.7	1.8	1.3	0.7	18.6	18.0	15.0	16.2	17.5	13.5	20.1	10.8	13.5	19.1	29.8	50.5	7.1	5.3	8.0	20.4	13.4	12.7	17.4	10.3	7.0	108.0	3.6	3.3	6.4	69.0	8.4	8.4	0.0	7.0	2.3	6.6	5.8	2.3	37.6	3.6	66.7	13.8	6.2	7.5	117.7	9.2	11.5	15.1	2.8	10.1	28.6	7.9	8.6	14.2	7.9	54.9	6.5	7.2	23.1	5.5	6.9	5.8	5.9	7.3	5.6
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	21	"Endothelial cells: 120.7;Ito cells: 249.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7"	"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.1"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	27.9	9.5	14.5	4.6	30.3	0.4	26.8	1.1	45.3	27.1	6.8	2.7	8.0	4.0	54.9	14.4	9.5	15.6	18.3	18.5	16.6	4.8	14.9	15.0	31.3	6.9	5.5	21.7	11.9	4.6	15.2	5.6	33.7	3.4	10.4	5.4	15.4	6.1	8.6	7.5	5.4	6.8	32.8	4.2	32.9	6.7	6.4	3.4	0.7	17.8	7.5	3.0	14.7	13.3	0.2	0.0	0.3	0.0	5.1	0.0	0.6	0.0	0.0	9.7	0.0	5.6	9.3	0.0	5.3	4.1	0.6	1.5	0.0	0.0	0.0	0.0	9.8	0.0	0.0	18.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.2	0.0	6.7	0.0	1.4	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	8.9	13.7	0.0	0.7	0.0	4.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.6	14.5	30.3	1.1	45.3	16.6	4.8	5.5	21.7	3.4	3.4	0.0	8.5	1.9	0.2	7.7	21.5	9.2	5.1	1.4	0.0	0.0	0.0	0.2	0.0	1.7	1.1	120.7	0.0	0.0	0.2	0.2	22.0	0.3	5.7	1.3	0.3	0.0	0.0	249.8	20.4	1.5	35.4	2.3	8.5	0.0	0.0	9.8	0.3	0.0	47.4	0.0	1.7	6.5	13.4	0.0	0.6	5.9	0.1	5.4	0.0	0.1
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.1;liver: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 298.8;Muller glia cells: 301.8;Proximal tubular cells: 369.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		1800000	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	22.5	25.9	67.8	3.4	111.9	4.4	7.4	16.0	54.1	5.7	7.5	56.3	2.6	9.1	5.5	12.5	5.2	6.4	6.3	15.0	80.7	58.2	36.1	64.8	8.0	3.7	114.1	36.7	6.7	10.3	13.7	6.2	4.1	82.5	10.3	5.9	2.6	12.4	7.5	34.2	4.6	8.1	6.4	93.6	4.8	9.1	4.1	94.7	0.7	7.7	2.8	4.4	4.5	2.6	7.5	42.5	1.0	21.9	9.9	15.0	12.3	11.6	22.8	9.0	12.5	21.9	11.1	15.9	16.6	7.0	15.5	13.6	18.2	15.4	4.3	10.7	9.2	17.3	6.6	12.8	18.8	9.7	13.1	2.6	11.8	11.8	43.0	13.2	15.3	1.1	13.7	11.9	9.7	13.4	8.3	7.8	11.0	12.6	9.9	16.6	6.0	22.8	24.6	15.3	11.0	15.4	9.5	6.9	17.2	16.0	6.4	17.1	21.8	11.0	1.8	47.2	10.3	5.0	5.9	13.5	9.0	16.1	8.9	13.2	15.4	24.0	30.2	18.0	13.5	14.9	0.0	14.4	1.0	12.3	21.9	11.1	7.5	13.3	12.8	18.0	6.2	15.0	12.9	0.4	9.9	16.3	42.5	6.9	12.3	67.8	111.9	16.0	54.1	80.7	58.2	114.1	36.7	82.5	94.7	26.8	26.9	18.2	16.6	17.7	34.9	59.2	38.2	4.0	14.8	36.6	7.9	65.3	92.9	37.2	0.8	17.8	14.2	0.0	20.5	28.8	26.3	26.4	25.3	298.8	69.8	77.9	167.4	25.8	34.9	3.3	21.0	26.9	145.1	20.8	22.6	301.8	17.0	7.0	35.7	369.1	26.6	25.8	26.4	3.3	60.7	14.1	15.3	16.7	36.6	11.1
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 1.2;salivary gland: 1.1;testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042407	Uncertain					NA	NA					"HPA042407: AB_10806237"																		0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.6	0.3	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.1	0.4	0.0	0.4		0.0	0.0	0.0	0.2	0.0		0.1	0.0		1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 227.4;monocytes: 251.5;Proximal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.9	9.6	9.2	8.7	18.3	22.3	0.1	17.3	19.5	62.9	76.5	17.5	20.9	43.2	11.5	13.3	37.5	6.8	34.5	12.2	24.0	16.4	9.9	23.9	10.6	22.8	21.3	21.5	15.4	22.7	7.8	20.6	10.9	7.2	21.8	11.4	23.1	30.9	14.8	11.8	19.1	29.5	19.2	20.6	18.4	29.7	8.8	21.8	16.4	12.9	13.6	11.2	15.8	9.8	33.8	13.3	8.3	8.3	14.1	16.0	10.8	16.8	30.0	28.4	43.4	37.3	21.6	35.9	15.4	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7	26.8	44.7	44.2	21.0	19.6	8.0	43.2	10.2	46.8	26.1	26.2	2.0	31.2	99.5	46.8	71.4	104.1	38.5	0.0	96.6	44.5	25.9	23.1	63.4	92.3	227.4	6.4	15.6	68.2	96.6	22.8	21.3	135.7	40.5	251.5	30.0	93.7	42.5	30.2	32.9	217.2	12.6	32.3	24.7	46.4	13.2	19.9	46.6	30.5	39.9	21.7
MED28	"DKFZP434N185, EG1, magicin"	ENSG00000118579	"Mediator complex subunit 28"	Q9H204	4	17614631-17634105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035900, HPA035901"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035900: AB_10673223, HPA035901: AB_2674853"	"unprognostic (1.14e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.07e-3)"	12.8	12.4	16.5	15.3	18.2	22.7	20.1	23.6	19.4	18.9	15.8	20.2	17.4	13.1	25.1	22.0	15.0	19.7	11.9	11.3	16.4	15.7	13.0	10.9	16.7	21.4	18.7	17.4	30.2	16.5	14.1	20.4	18.3	15.1	18.5	15.6	17.0	16.5	17.1	27.8	22.0	16.5	16.4	16.1	20.0	15.0	16.7	17.9	27.3	18.9	14.9	23.2	16.4	17.7	9.5	10.1	14.9	10.7	8.4	11.2	10.7	3.3	2.1	17.1	8.6	7.6	6.0	7.0	4.8	5.6	6.4	5.8	5.8	8.0	9.0	3.3	4.3	5.6	3.3	10.3	5.1	6.5	3.5	5.1	15.8	6.9	8.7	5.3	11.0	8.0	5.7	7.1	3.9	3.4	6.7	5.5	13.1	13.9	8.3	5.6	3.2	16.2	19.1	11.8	6.5	3.5	12.6	6.3	4.1	6.1	4.9	12.3	6.2	4.1	3.6	4.0	10.5	6.8	11.4	6.7	4.2	3.0	3.0	4.4	6.3	2.8	11.7	3.8	10.7	4.4	6.7	10.7	9.8	7.6	8.0	7.5	9.0	8.4	7.0	10.1	9.5	11.2	8.6	14.9	8.4	6.5	7.0	6.5	10.7	16.5	18.2	23.6	19.4	16.4	15.7	18.7	17.4	15.1	17.9	17.9	25.9	61.1	99.1	81.9	38.0	16.5	33.1	24.1	37.5	21.0	15.7	101.0	71.3	52.8	8.7	68.0	25.0	23.3	46.6	148.4	70.1	83.1	58.8	24.9	81.0	31.8	42.5	41.1	73.2	17.0	52.3	65.7	57.3	101.0	38.4	49.8	50.1	40.3	44.2	44.5	33.7	32.3	50.1	82.8	93.7	81.8	112.6	68.2	42.3	82.7
FAM184B	KIAA1276	ENSG00000047662	"Family with sequence similarity 184 member B"	Q9ULE4	4	17629306-17781512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.1;skeletal muscle: 11.1"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 30.0;Erythroid cells: 23.3;Horizontal cells: 30.2;Muller glia cells: 22.9;Rod photoreceptor cells: 27.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 6.9;T-47d: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044119, HPA048458"	Enhanced					NA	NA					"HPA044119: AB_2678817, HPA048458: AB_2680401"	"unprognostic (1.20e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.13e-4)"	"unprognostic (2.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-4)"	1.5	0.6	3.2	0.5	5.0	0.8	0.6	2.0	5.1	0.3	1.1	2.5	0.0	0.3	0.4	0.8	0.4	0.3	0.4	0.3	3.6	2.7	1.2	0.3	0.4	0.5	3.3	1.2	0.5	0.3	0.8	0.4	0.3	3.7	0.5	0.8	0.1	0.9	0.3	11.1	1.1	0.4	0.3	2.0	0.5	0.5	0.6	2.9	0.0	0.4	0.4	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.4	0.8	0.0	0.1	0.2	0.7	0.0	0.2	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.5	0.1	0.2	1.0	0.1	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.8	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	6.9	0.2	0.0	0.0	1.0	0.2	1.8	0.2	0.3	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.1	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.3	0.9	0.2	0.0	0.1	0.0	0.0	0.0	3.2	5.0	2.0	3.1	3.6	2.7	3.3	1.2	3.7	2.9	0.0	1.3	5.2	5.5	3.9	30.0	0.6	5.1	0.0	1.2	0.0	13.7	3.9	0.0	0.0	0.7	1.4	0.3	23.3	0.9	2.9	3.1	3.5	13.8	1.7	1.1	30.2	4.1	0.6	2.7	0.9	10.6	3.1	3.3	0.0	0.1	22.9	0.8	0.0	7.1	0.5	27.9	0.0	1.9	6.9	8.7	8.4	4.5	2.5	0.2	4.7
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.40e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favorable (7.67e-4)"	13.0	13.1	12.7	12.1	20.5	23.3	19.8	19.4	19.7	18.5	13.1	22.5	9.9	12.0	26.9	16.5	11.5	16.1	11.3	11.8	13.9	15.7	11.3	6.8	12.6	16.7	14.4	16.2	29.6	16.0	17.8	25.8	14.8	19.0	16.9	14.8	17.1	15.2	13.0	16.2	22.4	14.0	17.2	16.0	13.3	13.6	19.2	16.3	30.6	15.7	7.0	18.3	16.3	14.6	4.8	3.0	9.7	2.8	3.6	6.3	2.2	12.2	2.6	14.3	15.0	4.1	7.2	7.9	8.0	9.5	9.6	11.4	7.5	10.0	13.9	6.4	7.4	7.8	6.2	8.4	8.5	14.3	4.7	7.7	19.4	8.8	12.2	9.9	17.0	7.9	9.4	7.0	12.2	12.1	6.5	6.6	13.7	20.8	23.1	5.5	4.6	18.7	16.4	11.8	3.6	7.7	19.8	16.4	8.9	4.1	9.7	21.4	17.2	8.5	2.3	9.2	7.6	8.4	4.7	8.3	11.2	8.8	12.3	10.1	10.3	4.1	17.3	9.2	11.9	7.5	9.7	2.4	3.4	4.5	2.8	5.9	3.7	5.0	4.9	1.5	4.8	6.3	5.9	1.8	3.6	1.9	3.0	3.4	2.2	12.7	20.5	19.4	19.7	13.9	15.7	14.4	16.2	19.0	16.3	17.9	19.0	9.0	15.5	22.6	11.8	14.8	15.3	21.4	17.0	8.7	5.9	14.1	11.6	8.6	14.8	12.1	7.1	23.3	6.7	7.7	16.1	12.3	16.2	5.7	6.4	14.3	16.8	11.6	9.7	9.1	19.5	9.6	10.1	5.4	16.5	23.4	8.7	5.8	20.8	5.0	13.6	12.9	13.2	24.2	17.2	18.4	10.3	15.2	13.0	14.3
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810902-17844862	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 65.4"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 23.3;Extravillous trophoblasts: 22.2;Spermatocytes: 40.4;Spermatogonia: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039613	Uncertain					NA	Yes					"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	1.4	1.1	0.3	18.0	0.4	12.5	2.5	0.7	0.5	1.4	2.9	0.3	0.2	3.7	0.8	1.2	7.1	0.3	0.7	1.6	0.4	0.7	0.9	1.1	1.8	8.3	2.0	0.3	0.6	0.5	0.0	0.4	3.7	0.5	0.7	2.4	0.3	1.6	0.9	0.6	3.4	3.3	0.7	1.0	6.4	1.9	11.8	0.3	65.4	0.5	6.7	8.6	1.6	2.0	0.5	0.5	0.0	0.4	0.3	2.9	1.7	16.4	10.6	24.3	15.9	1.5	3.0	8.9	21.4	8.4	21.1	21.7	13.4	10.1	24.7	4.3	5.9	18.3	7.5	20.6	8.2	29.1	11.2	10.1	19.6	14.5	10.9	0.1	13.8	7.7	0.5	0.5	15.6	7.2	3.3	10.5	10.8	19.1	28.2	20.9	4.9	15.8	13.4	12.5	9.6	10.5	15.6	22.0	10.3	6.4	5.1	19.2	11.4	19.2	4.1	6.1	10.9	9.7	7.8	8.6	20.3	9.2	11.4	29.1	8.8	8.3	21.0	8.4	14.4	13.4	0.0	0.0	0.0	0.5	0.2	0.0	0.5	1.0	0.6	0.5	0.2	0.1	0.7	0.0	0.3	0.4	0.0	2.9	1.7	0.3	0.4	0.7	0.5	0.4	0.7	2.0	0.3	0.5	0.3	0.0	1.4	1.5	0.2	2.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	2.0	0.0	0.0	12.5	0.0	0.2	23.3	0.0	22.2	0.6	0.3	1.1	0.0	7.7	0.0	1.7	3.1	2.2	8.4	0.6	2.2	1.7	1.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	40.4	29.7	1.0	1.8	1.5	2.3	0.1
LCORL	"FLJ30696, MLR1"	ENSG00000178177	"Ligand dependent nuclear receptor corepressor like"	Q8N3X6	4	17841199-18021876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028794, HPA028795, HPA060033"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192"	"unprognostic (1.06e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (3.22e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.90e-4)"	"unprognostic (3.46e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	8.3	7.8	11.3	5.7	11.9	5.1	6.6	21.9	10.4	7.0	9.2	6.9	4.7	14.2	6.3	5.1	7.3	4.6	7.1	3.9	10.3	9.8	9.6	7.2	7.5	8.0	14.8	6.5	7.6	6.4	8.4	11.3	8.7	8.9	5.9	8.8	5.0	7.0	5.3	7.9	8.6	22.3	5.8	16.2	12.6	9.1	12.2	15.3	17.1	8.1	2.7	5.7	6.5	5.4	4.4	3.8	8.2	4.6	2.4	3.2	1.5	4.8	3.2	13.0	4.0	6.9	10.8	3.3	6.0	5.9	5.2	6.8	1.6	6.5	9.4	3.2	4.0	8.0	2.2	6.2	2.5	7.3	2.6	3.9	7.5	5.7	3.9	4.4	6.0	6.1	5.9	3.0	3.5	7.3	7.6	7.0	6.1	4.5	15.0	7.0	1.3	5.8	12.3	4.5	4.3	4.7	5.8	8.0	5.2	8.4	2.6	9.7	9.3	4.3	2.2	4.2	5.1	3.9	5.8	4.7	8.2	4.1	5.1	9.4	12.2	4.6	7.9	6.7	8.1	6.5	8.2	4.5	4.9	2.9	4.6	2.4	4.4	2.0	1.8	3.8	3.0	2.3	2.7	2.2	2.4	3.6	2.6	3.2	1.5	11.3	11.9	21.9	10.4	10.3	9.8	14.8	6.5	8.9	15.3	11.9	10.4	17.9	3.8	21.2	18.3	8.1	40.8	17.4	6.8	7.0	39.3	7.3	8.3	9.7	26.0	20.2	18.1	0.0	9.7	7.4	8.7	8.5	18.5	11.9	13.9	19.1	34.0	9.2	11.7	15.2	13.6	22.6	3.3	8.2	17.8	9.8	10.0	14.1	7.1	14.0	20.9	19.4	6.1	40.8	15.6	16.7	8.2	6.9	14.9	4.2
SLIT2	"SLIL3, Slit-2"	ENSG00000145147	"Slit guidance ligand 2"	O94813	4	20253260-20620561	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 46.7;Fibroblasts: 64.7;Leydig cells: 24.5;Peritubular cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 28.5;BJ hTERT+: 57.2;BJ hTERT+ SV40 Large T+: 27.8;fHDF/TERT166: 32.3;HBF TERT88: 32.2;HEK 293: 25.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007590, HPA019511, HPA023088"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227"	"unprognostic (1.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (4.93e-3)"	"unprognostic (6.80e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.16e-4)"	4.7	18.1	2.8	3.8	9.8	0.0	6.3	0.6	11.5	18.3	7.1	1.2	5.0	1.5	16.7	6.5	6.9	9.1	6.3	5.2	4.5	6.7	8.6	1.0	22.8	1.2	2.4	6.2	6.1	1.7	0.5	6.5	16.8	4.2	9.1	3.6	3.5	4.5	11.6	1.5	2.4	3.0	17.1	1.5	23.1	6.5	3.3	1.0	0.6	6.3	0.7	1.2	8.6	11.0	0.0	0.0	0.3	1.4	0.0	0.0	0.1	0.0	0.0	15.5	0.0	11.0	10.2	0.5	28.5	57.2	27.8	10.5	0.1	0.0	0.0	0.9	32.3	0.0	0.3	4.2	2.1	32.2	0.0	25.5	0.0	0.1	0.0	2.2	0.2	0.0	2.4	0.0	18.0	5.4	0.6	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.5	0.0	2.0	16.4	0.1	0.0	0.2	0.0	1.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.5	10.4	1.4	10.0	15.5	0.0	0.0	0.0	0.2	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.1	2.8	9.8	0.6	11.5	4.5	6.7	2.4	6.2	4.2	1.0	0.0	13.6	0.0	1.8	7.1	46.7	3.7	0.0	13.4	2.3	0.0	0.0	1.0	1.7	1.5	0.4	1.8	0.0	0.0	0.4	0.9	64.7	1.6	2.3	0.0	1.7	0.0	1.2	6.2	1.0	1.1	24.5	0.7	8.5	0.0	0.0	0.7	0.2	0.0	25.1	11.4	1.1	6.5	8.2	0.1	1.0	5.8	1.7	0.0	0.0	1.8
PACRGL	"C4orf28, MGC29898"	ENSG00000163138	"Parkin coregulated like"	Q8N7B6	4	20696282-20752907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 166.5;Late spermatids: 63.0;Spermatocytes: 76.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054666			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA054666: AB_2682564"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.90e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (4.85e-4)"	7.9	8.7	12.2	10.7	15.6	3.2	16.5	7.8	19.0	9.1	8.9	9.3	14.6	6.6	13.9	15.1	9.6	14.2	10.0	9.5	14.1	12.4	8.7	4.7	7.7	7.3	12.1	12.9	14.0	6.7	9.7	13.7	7.4	10.5	11.2	9.4	8.4	7.7	11.4	10.1	14.3	7.7	13.1	15.1	6.8	7.7	37.3	10.7	4.5	15.8	10.0	6.3	11.1	8.9	4.3	7.0	1.4	4.7	4.1	6.1	2.9	9.0	7.0	12.4	9.4	16.8	15.6	6.0	11.6	9.2	10.7	13.0	6.3	19.3	9.6	7.8	6.6	17.0	4.3	6.9	8.7	18.4	3.0	6.1	6.0	10.6	10.1	8.9	12.4	6.5	10.8	13.0	13.4	12.5	9.9	10.8	8.7	10.4	5.6	9.1	6.5	12.4	11.5	15.7	7.4	10.0	6.6	13.5	5.9	10.7	5.9	20.5	13.5	8.5	4.4	8.7	6.6	8.0	7.0	8.4	10.5	9.7	14.5	16.0	5.7	1.6	8.9	15.3	8.3	18.0	0.0	3.1	1.4	2.7	4.7	6.1	4.3	3.0	2.7	5.3	4.0	4.7	3.0	1.2	4.1	3.7	7.0	3.5	2.9	12.2	15.6	7.8	19.0	14.1	12.4	12.1	12.9	10.5	10.7	8.9	5.4	0.5	9.6	12.0	5.5	5.2	7.6	32.1	9.1	7.0	3.9	4.9	6.6	6.9	166.5	6.7	5.1	0.0	7.9	5.7	9.6	8.5	2.3	2.9	3.7	4.8	8.6	5.5	4.3	63.0	12.0	4.9	5.0	2.8	5.2	8.4	6.7	8.2	11.7	4.2	10.4	12.9	5.5	76.4	32.5	9.3	4.9	2.2	7.6	6.8
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728616-21948799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 32.3;Distal tubular cells: 53.0;Muller glia cells: 43.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 10.1;SCLC-21H: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	1.1	3.6	15.8	2.2	28.3	1.0	0.9	22.4	38.9	15.0	4.2	1.8	0.0	2.4	9.6	1.1	5.6	3.9	2.6	1.8	11.9	16.2	7.8	0.7	1.1	1.1	11.6	19.3	1.9	1.0	0.5	5.1	1.8	16.9	1.0	5.2	3.5	1.4	0.8	1.3	2.3	5.5	7.8	3.9	1.1	1.3	1.3	3.5	0.0	8.9	0.0	0.5	2.7	1.1	0.3	0.7	0.0	0.7	0.8	0.7	0.3	1.7	1.5	2.2	2.2	0.0	0.0	1.1	1.3	0.0	0.0	0.0	1.9	1.7	3.4	1.4	0.5	1.7	0.9	0.0	0.1	0.0	0.4	2.3	1.2	2.5	1.2	0.0	3.2	0.5	0.0	0.8	0.0	1.4	2.9	0.6	1.3	2.0	1.1	0.0	0.6	2.8	1.9	2.8	1.3	1.4	0.8	4.2	1.3	10.1	1.0	7.9	4.7	1.4	1.7	2.2	2.7	0.9	1.2	2.2	1.1	1.5	2.4	3.2	1.0	0.1	1.2	3.7	2.7	1.7	0.0	0.3	0.0	0.2	0.7	0.7	0.2	0.1	0.2	0.7	0.3	0.5	0.5	0.0	0.8	0.5	0.3	0.2	0.3	15.8	28.3	22.4	33.0	11.9	16.2	11.6	19.3	16.9	3.5	0.0	0.0	0.0	0.0	0.0	32.3	0.4	0.0	0.0	0.0	14.0	0.0	0.0	53.0	0.0	6.9	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.2	0.0	0.0	3.3	1.0	0.0	43.9	0.0	7.0	0.0	4.7	11.8	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.3	0.0
ADGRA3	"FLJ38547, GPR125, PGR21"	ENSG00000152990	"Adhesion G protein-coupled receptor A3"	Q8IWK6	4	22345071-22516054	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008904	Uncertain				"Intracellular and membrane"	NA	NA		160000			"HPA008904: AB_1849258"	"unprognostic (3.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-3)"	5.3	6.9	15.5	3.0	14.7	1.2	7.6	5.7	11.6	8.2	11.8	12.8	5.9	5.0	10.9	7.1	3.8	15.6	5.4	7.4	17.8	8.6	7.5	51.8	3.5	2.4	13.1	8.5	6.6	14.6	9.7	5.5	6.4	14.2	8.9	12.3	6.7	5.7	10.6	11.8	3.1	4.8	10.0	12.8	1.8	6.4	4.5	11.8	3.2	17.9	4.1	1.8	4.6	3.6	0.0	0.3	0.0	0.0	2.9	0.6	0.0	8.3	6.3	16.3	13.6	13.3	6.0	14.6	10.3	11.3	7.0	3.8	7.1	16.8	1.3	5.3	4.9	9.7	9.3	10.2	14.7	10.0	0.0	7.2	0.7	4.9	15.8	4.4	7.3	0.0	5.6	18.4	4.5	7.9	13.3	10.4	5.3	7.6	0.2	11.5	3.7	6.4	0.2	18.0	7.9	6.5	30.3	33.5	2.1	8.4	8.7	12.2	14.1	4.3	0.3	7.2	11.8	4.4	6.4	0.2	10.5	7.5	4.7	9.6	1.2	0.0	0.0	5.8	5.2	8.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.9	0.0	0.3	0.0	0.0	15.5	14.7	5.7	11.6	17.8	8.6	13.1	8.5	14.2	11.8	3.0	2.6	0.0	12.1	0.0	13.6	11.5	20.4	4.0	9.1	15.7	19.6	16.6	0.0	14.9	5.8	1.0	4.3	23.3	10.0	7.2	6.6	10.4	0.0	93.3	3.0	0.0	11.7	6.2	4.7	5.5	8.9	0.6	0.0	0.0	26.0	4.8	16.8	7.0	9.2	5.7	12.3	0.0	3.2	1.2	7.7	0.0	6.1	0.7	19.7	8.8
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.5;liver: 49.7;skeletal muscle: 55.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 81.8;Cholangiocytes: 66.2;Early spermatids: 52.7;Hepatocytes: 48.9;Late spermatids: 51.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"A-431: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.07e-3)"	5.7	2.4	3.1	2.4	4.2	0.3	1.3	4.7	5.5	2.6	9.4	4.2	1.8	5.7	0.9	4.8	3.0	1.2	2.2	24.6	3.3	3.1	49.5	49.7	2.5	0.4	3.1	1.8	1.3	2.8	14.6	7.6	0.3	7.8	2.6	6.6	14.0	30.4	3.0	55.6	5.5	14.2	1.6	3.2	0.8	3.1	3.4	3.4	0.3	17.4	18.2	1.5	1.7	1.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	43.9	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	2.1	5.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.3	0.0	6.3	0.0	2.1	0.1	1.4	0.0	1.8	2.2	0.2	0.7	0.0	0.4	0.4	0.0	0.8	3.9	0.0	0.0	0.8	0.7	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	4.2	4.7	5.5	3.3	3.1	3.1	1.8	7.8	3.4	17.9	1.6	1.7	5.5	0.8	3.8	81.8	66.2	8.1	6.8	34.9	37.3	0.0	44.7	6.6	52.7	0.3	26.8	0.0	0.0	0.0	0.2	1.4	1.1	48.9	0.0	0.0	25.6	1.8	2.4	51.4	0.9	0.0	6.8	0.0	13.0	5.8	0.9	7.0	2.1	22.6	0.7	0.0	5.1	0.7	0.2	1.0	0.0	1.0	10.8	0.4
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584550	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		30000	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	34.3	29.6	23.2	32.1	27.5	42.5	33.0	38.0	27.6	31.1	31.9	29.5	24.1	22.8	37.5	23.4	40.8	30.6	22.9	32.6	22.8	18.8	30.0	29.5	31.2	34.7	29.4	17.7	36.5	35.9	42.5	32.8	39.2	27.4	28.2	37.7	22.4	34.1	24.9	36.5	36.0	30.7	30.7	22.8	32.4	32.4	21.0	27.9	58.3	33.5	31.6	43.0	35.4	35.7	20.3	26.7	31.4	24.1	24.5	28.8	17.7	30.1	29.6	49.1	24.3	24.2	23.6	29.3	35.2	31.0	37.2	37.0	30.0	36.7	55.5	21.7	28.8	43.4	25.3	63.1	42.4	58.0	20.3	29.9	48.1	32.4	24.2	14.2	49.5	33.2	19.7	25.5	36.2	24.5	23.9	31.0	26.2	45.0	22.4	42.1	22.8	64.9	33.2	53.4	30.2	26.9	42.8	57.6	25.9	44.3	43.5	42.2	26.4	27.3	26.3	24.7	36.8	28.8	25.7	28.3	31.6	20.8	23.8	41.0	17.0	28.6	66.4	21.1	40.5	37.5	31.4	20.2	18.8	21.1	20.6	28.8	19.9	23.6	24.5	26.7	20.3	24.9	23.7	9.7	24.5	24.1	17.8	25.8	17.7	23.2	27.5	38.0	27.6	22.8	18.8	29.4	17.7	27.4	27.9	71.5	53.1	27.6	56.7	87.6	28.3	26.0	28.1	49.5	71.7	26.2	21.6	64.7	31.5	51.9	23.9	49.1	52.6	0.0	36.1	61.0	55.6	53.7	55.4	42.4	39.4	25.4	58.2	47.3	49.9	11.8	36.5	48.1	45.5	36.1	59.4	22.6	47.7	37.4	37.8	26.9	28.3	25.8	58.7	54.9	45.5	87.4	73.8	35.5	57.5	79.7
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 392.7;Peritubular cells: 343.7;Smooth muscle cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.9;BJ: 11.0;PC-3: 16.0;RPTEC TERT1: 67.3;T-47d: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	830000000			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	90.0	9.9	3.7	13.8	5.0	0.8	31.9	1.6	8.3	46.4	24.7	14.7	8.0	10.4	34.4	21.1	52.1	39.5	55.1	61.9	6.4	1.9	40.4	3.9	40.1	6.7	3.4	6.2	36.1	41.0	1.6	4.6	30.4	24.3	40.0	8.1	45.0	13.7	15.5	16.1	19.9	13.7	53.6	5.4	8.4	25.4	25.9	2.1	4.4	68.0	25.2	17.7	61.1	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	5.2	0.6	11.0	4.8	0.6	0.4	0.1	0.0	0.0	3.5	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	4.6	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.3	0.0	16.0	0.0	0.0	0.1	67.3	0.2	0.0	0.0	0.0	0.3	0.0	0.6	10.0	0.0	0.0	2.6	0.3	0.4	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.0	1.6	8.3	6.4	1.9	3.4	6.2	24.3	2.1	11.9	17.8	0.8	63.7	80.6	0.3	15.1	79.0	0.0	13.6	85.5	0.0	93.1	13.3	64.9	10.0	6.8	5.1	0.0	1.5	13.0	180.5	65.7	0.0	0.0	14.9	0.0	33.3	15.4	0.0	24.2	392.7	4.3	75.9	0.0	50.3	19.4	5.0	86.3	343.7	114.0	1.0	194.1	404.7	27.7	3.7	61.5	158.9	2.2	57.8	8.9
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA044158: AB_2678840, HPA047913: AB_2680207"	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	11.7	8.3	20.1	8.2	14.7	2.8	16.7	14.8	20.6	13.2	10.8	6.9	11.1	5.3	12.9	9.2	7.9	13.9	9.9	10.9	15.9	11.5	7.5	10.3	10.0	4.4	11.5	12.7	15.9	31.7	12.8	11.2	11.6	11.3	14.3	8.6	7.5	29.8	10.1	8.6	6.9	6.4	14.5	9.9	5.8	13.8	5.4	9.4	0.9	11.9	4.6	4.3	9.6	18.3	0.0	0.8	0.8	4.5	0.2	0.0	1.2	4.1	1.6	3.3	0.5	5.2	9.6	1.0	6.0	9.1	4.8	5.6	0.0	4.6	0.0	2.9	11.4	5.4	0.7	1.0	0.7	3.1	0.0	0.0	0.0	0.3	0.3	4.4	0.0	0.0	6.6	4.3	2.7	0.0	13.5	3.8	0.0	0.0	0.8	2.9	4.4	0.0	0.1	3.8	0.4	4.6	0.0	0.0	0.2	8.6	3.0	4.6	0.0	2.5	3.8	12.3	3.7	6.4	9.2	9.3	7.0	0.8	5.2	5.1	0.1	0.0	0.0	21.5	0.9	4.8	0.0	4.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.2	1.5	0.7	0.0	1.2	20.1	14.7	14.8	20.0	15.9	11.5	11.5	12.7	11.3	9.4	0.0	7.4	0.0	6.2	5.6	11.5	5.3	5.1	4.0	3.4	7.0	9.8	4.5	0.0	5.6	0.9	13.5	1.1	0.0	8.8	1.5	5.8	10.2	0.0	6.0	9.7	4.8	1.7	6.2	11.1	1.3	10.0	3.0	8.5	0.0	10.9	9.4	7.5	3.5	11.0	2.2	11.5	6.5	11.3	1.4	1.9	2.8	8.9	0.5	4.3	5.6
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030879	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 113.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Uncertain	Centrosome	"Secreted to blood"	NA	NA			Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	2.5	1.6	2.8	6.7	3.3	0.8	2.3	7.9	7.8	3.7	4.0	0.0	1.0	1.1	8.9	4.9	4.1	11.4	4.2	3.7	2.4	3.9	3.0	0.9	1.4	2.0	7.2	0.4	9.1	2.6	113.9	0.5	2.6	18.7	1.0	1.6	6.0	0.9	1.4	0.9	0.9	2.6	7.1	2.9	1.2	2.4	2.0	0.9	0.6	1.8	0.6	4.6	1.8	1.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.2	0.0	4.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.7	0.0	0.8	0.0	0.9	10.4	0.4	0.0	14.7	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.2	1.6	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.3	7.9	7.8	2.4	3.9	7.2	0.4	18.7	0.9	0.0	0.0	0.0	0.1	0.1	0.4	2.6	0.0	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.8	1.6	0.0	1.3	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0
SEPSECS	"SLA, SLA/LP"	ENSG00000109618	"Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase"	Q9HD40	4	25120014-25160442	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.2"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070409			Approved	Vesicles		NA	NA			Vesicles		"HPA070409: AB_2686265"	"unprognostic (1.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.37e-3)"	"unprognostic (5.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.82e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-3)"	7.0	6.1	3.8	8.5	6.4	11.8	7.4	5.4	6.0	5.3	13.5	7.8	8.9	11.8	6.7	9.6	5.3	6.5	8.9	5.6	4.8	3.6	10.5	34.2	9.4	9.7	7.2	4.9	8.5	11.3	7.3	5.1	4.4	5.4	4.7	7.8	5.2	6.2	9.2	5.5	10.9	15.3	3.7	7.0	7.5	7.4	8.9	6.8	12.3	7.7	4.8	8.0	6.8	5.5	5.7	5.9	3.2	4.0	3.4	5.5	2.2	2.9	1.6	6.2	3.3	5.7	7.9	5.4	3.0	4.1	3.4	3.4	1.3	7.2	5.4	3.0	3.4	3.8	3.6	4.8	3.6	3.8	2.7	1.6	6.6	5.6	2.6	6.4	5.8	8.7	7.4	5.7	2.5	5.6	5.2	3.6	12.2	10.4	5.5	2.7	1.7	9.3	16.3	2.9	2.4	6.1	4.8	7.4	4.8	4.7	3.1	4.7	4.4	2.7	2.2	5.2	4.6	4.2	5.6	3.7	5.2	2.7	1.6	2.9	8.6	9.6	6.0	3.2	9.6	3.1	2.4	4.0	2.2	3.6	3.4	3.5	3.4	4.5	4.9	3.4	5.7	4.6	5.5	3.2	3.4	2.4	5.9	2.6	2.2	3.8	6.4	5.4	6.0	4.8	3.6	7.2	4.9	5.4	6.8	0.0	7.4	4.1	1.5	2.2	2.6	3.9	25.5	9.4	3.4	15.7	0.0	4.7	6.6	4.2	17.7	6.3	8.5	0.0	4.1	3.2	4.0	2.3	3.5	35.0	5.4	4.8	5.8	6.7	6.9	13.0	3.1	5.8	3.3	6.4	6.4	3.1	4.6	7.0	6.0	17.4	2.2	0.0	1.8	13.4	18.5	2.9	4.9	4.9	7.3	1.1
AC104662.2		ENSG00000281028			4	25160663-25277306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	14	"Ciliated cells: 1.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004099	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA004099: AB_1855353"					"unprognostic (3.59e-2)"													1.7	2.3	6.7	5.5	11.1	6.7	3.7	9.7	9.3	2.0	4.1	4.3	5.0	7.8	1.7	2.5	5.4	3.5	1.6	1.5	7.3		2.8	10.1	4.0	4.4	10.0	2.4	1.5	1.8	2.9	14.9	2.8	7.1	1.1	5.4	2.1	4.5	2.5	1.8	0.0	6.0	2.6	11.3	2.5	3.6	9.2	10.6	6.1	5.3	1.6	5.3	3.1	4.8	2.1	2.0	7.5	1.9	1.4	4.3	0.9	5.3	3.7	4.4	2.4	3.2	6.1	4.1	8.9	9.1	11.4	12.2	4.0	7.5	13.5	2.1	11.4	10.7	2.9	9.3	3.8	6.9	5.8	2.6	6.3	9.1	3.8	0.6	12.4	3.6	3.1	0.7	4.5	4.6	2.2	3.9	6.0	4.2	15.7	3.5	6.1	10.8	0.9	3.6	6.7	2.4	6.3	12.0	5.9	2.7	9.8	5.0	1.0	3.6	1.3	2.6	4.4	2.9	1.7	7.4	6.3	1.8	2.9	5.2	10.6	12.0	19.1	5.4	6.5	4.6	7.5	1.9	6.2	2.4	1.8	1.6	2.1	2.4	2.3	1.4	1.9	1.8	2.1	3.2	1.4	1.3	2.0	4.3	0.9											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25233975-25279092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 49.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA004099	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	9.2	7.1	3.4	13.6	2.9	3.9	8.0	3.2	2.3	8.7	48.4	4.1	11.3	19.4	7.4	8.0	13.5	4.9	9.5	4.2	3.1	2.7	12.9	38.6	14.3	9.4	3.5	2.3	6.9	10.5	4.2	5.7	7.7	2.9	6.4	9.8	3.3	22.6	12.0	4.4	8.6	49.3	6.9	4.5	13.8	11.3	8.0	2.7	18.6	16.2	12.9	14.1	7.8	10.3	1.4	1.8	1.5	1.0	0.4	4.1	0.4	11.5	2.1	4.9	5.2	6.6	12.3	11.9	17.4	16.4	15.2	19.5	3.7	12.4	29.9	4.0	13.1	10.6	4.8	11.1	8.7	15.1	9.1	3.9	9.5	5.2	9.2	6.3	19.2	7.5	8.2	7.9	5.7	6.0	4.6	10.3	8.5	6.3	25.1	14.8	4.4	18.5	17.2	8.5	13.8	4.7	11.2	19.2	17.4	13.4	8.2	10.2	2.2	8.8	7.0	3.6	5.5	9.9	11.1	10.5	10.8	2.8	6.6	11.2	28.8	13.8	22.8	12.7	16.3	11.0	1.5	0.4	0.0	1.3	1.0	0.9	1.4	1.5	1.2	0.3	1.0	1.4	1.3	0.2	0.4	0.9	1.8	4.1	0.4	3.4	2.9	3.2	2.3	3.1	2.7	3.5	2.3	2.9	2.7	6.0	14.4	14.1	11.2	13.4	1.9	0.0	7.6	2.7	12.5	8.7	0.0	18.1	5.0	5.1	0.6	6.4	14.2	23.3	6.2	10.1	8.3	11.3	0.0	36.0	9.1	1.6	8.1	6.7	12.4	0.9	4.0	7.0	5.0	12.6	12.8	1.1	5.0	8.6	4.2	15.6	3.0	0.0	7.2	8.0	12.7	13.7	11.3	5.0	12.7	11.9
ZCCHC4	"FLJ23024, HSPC052, ZGRF4"	ENSG00000168228	"Zinc finger CCHC-type containing 4"	Q9H5U6	4	25312785-25370383	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035575, HPA035576"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles, Golgi apparatus"		"HPA035575: AB_2674682, HPA035576: AB_10671516"	"unprognostic (5.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.07e-2)"	11.5	10.3	9.7	14.6	12.8	8.1	12.4	13.1	12.4	11.3	9.5	12.8	12.5	8.9	14.6	10.4	9.1	11.7	8.0	10.6	9.0	6.5	9.3	8.8	8.7	11.5	13.7	7.0	15.4	9.4	12.7	11.6	10.7	9.8	10.9	10.0	11.6	10.0	10.3	16.6	10.4	10.4	13.5	10.0	12.4	9.1	11.2	10.9	15.0	11.3	7.6	11.1	11.0	12.7	6.5	4.4	2.4	3.8	6.5	7.5	3.9	3.9	2.4	8.1	3.6	6.4	8.1	7.2	10.0	10.7	11.8	13.7	3.8	10.4	6.5	2.8	6.1	11.7	3.1	7.8	7.3	16.5	1.5	4.2	6.0	5.4	6.4	8.1	9.7	4.4	6.3	8.2	11.2	8.8	7.0	5.6	10.1	10.7	3.3	9.9	2.9	10.0	12.9	11.1	6.4	5.3	6.8	12.4	3.9	6.3	4.1	7.6	5.2	4.3	3.6	6.4	8.3	5.3	5.9	4.4	9.9	4.1	6.4	13.3	6.5	8.1	9.5	10.7	9.5	9.5	2.4	3.2	1.0	5.3	3.8	7.5	6.0	6.8	6.4	4.4	6.5	6.7	7.3	1.8	6.5	3.6	3.5	6.5	3.9	9.7	12.8	13.1	12.4	9.0	6.5	13.7	7.0	9.8	10.9	0.0	4.3	1.4	3.6	3.3	3.9	4.5	0.0	10.7	6.8	0.0	2.0	5.0	3.3	3.2	1.1	4.1	2.6	0.0	2.0	4.0	3.2	1.9	1.1	2.4	4.6	3.2	2.4	3.1	5.2	0.0	3.7	4.4	3.3	2.8	4.1	4.8	2.7	3.7	4.9	3.7	4.5	0.0	5.2	6.0	7.7	3.0	3.1	5.7	3.8	2.0
ANAPC4	APC4	ENSG00000053900	"Anaphase promoting complex subunit 4"	Q9UJX5	4	25377213-25418498	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032519, HPA038395, HPA038396"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356"	"unprognostic (1.36e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (5.73e-7)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.18e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (1.12e-6)"	12.2	15.4	14.5	15.7	14.9	14.7	14.5	16.4	16.4	22.7	13.0	14.8	25.4	10.5	29.2	21.4	13.0	32.3	11.0	10.7	12.6	10.6	12.6	13.0	13.0	16.6	15.8	10.4	18.8	15.3	15.3	22.4	13.7	13.5	15.4	15.5	14.7	13.3	36.5	12.3	13.0	14.4	23.4	16.2	18.2	13.0	9.6	14.2	19.6	13.4	7.3	15.9	18.3	13.4	8.5	6.4	13.8	11.3	9.4	13.8	6.0	12.4	7.3	12.9	13.5	13.7	15.3	18.6	14.9	11.2	14.1	13.7	11.7	20.0	20.5	8.0	12.7	18.1	10.1	13.7	12.6	16.4	7.2	10.6	19.9	13.1	10.9	9.2	15.4	16.3	11.8	9.5	12.5	7.6	10.1	12.2	18.2	28.6	6.2	17.9	9.7	19.8	25.2	18.0	11.0	9.2	14.3	21.8	15.2	11.9	13.6	14.6	8.7	11.1	6.7	9.2	13.9	9.9	16.7	12.4	12.2	7.7	9.3	17.1	8.3	14.4	19.6	13.1	22.1	11.4	1.8	7.4	13.8	10.1	8.7	13.8	8.5	9.1	11.8	6.4	7.0	8.3	10.3	3.0	9.4	11.3	4.1	11.0	6.0	14.5	14.9	16.4	16.4	12.6	10.6	15.8	10.4	13.5	14.2	8.9	12.6	4.2	15.2	11.4	12.1	11.5	12.7	65.6	18.2	7.0	9.8	46.1	5.0	8.6	3.3	9.0	7.4	0.0	10.5	10.3	11.6	5.8	24.3	6.4	15.4	20.6	12.1	14.1	14.5	2.5	9.5	11.0	16.9	11.8	7.7	11.6	7.3	3.5	14.2	4.5	12.9	19.4	9.9	11.4	14.0	8.2	19.9	17.5	11.3	6.5
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	81	"BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0	443.7	1050.6	0.0	0.1	0.0	0.0	0.6	40.8	125.8	178.6	19.2	0.0	1.6	5.0	57.7	3.5	0.0	0.0	0.0	7.1	0.0	0.0	3.5	26.7	0.0	0.2	0.0	0.0	0.0	0.0	14.0	1.1	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747427-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 48.0"	"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 45.9"	"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9"	"Group enriched"	"Detected in many"	4	"B-cells: 20.8;dendritic cells: 17.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 65.9;OE19: 49.9;U-698: 43.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 191.0"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	5.4	3.3	4.0	36.3	5.6	2.3	3.8	45.9	6.4	13.7	19.3	1.5	1.5	19.3	2.2	18.1	6.2	3.6	22.0	2.4	3.3	2.8	6.9	3.6	14.3	27.7	2.1	1.7	3.1	48.0	10.9	2.9	13.7	3.0	4.2	16.7	12.9	23.1	1.0	1.3	1.7	30.3	3.4	2.1	33.5	24.6	2.2	1.1	2.8	12.5	3.8	46.7	14.8	2.2	20.8	17.9	0.4	0.1	3.7	4.3	1.4	4.8	5.3	3.9	1.3	0.6	0.8	0.6	2.4	6.6	1.8	6.0	3.3	22.7	65.9	11.7	16.6	15.9	3.1	2.9	10.5	2.5	3.5	1.7	0.7	8.8	4.5	17.1	9.0	0.4	1.3	8.5	6.6	2.6	7.5	24.8	1.3	4.3	0.0	1.3	3.7	0.0	0.6	11.4	49.9	4.7	0.3	21.7	9.1	14.5	16.4	9.8	1.9	16.1	0.2	1.6	5.7	0.8	11.2	10.8	0.1	7.9	0.1	6.9	0.4	0.1	43.0	30.0	3.8	4.5	0.4	0.1	0.0	2.8	0.0	3.4	20.8	3.5	3.1	0.7	20.8	1.5	2.4	0.3	3.7	0.1	17.9	4.3	1.4	4.0	5.6	45.9	6.4	3.3	2.8	2.1	1.7	3.0	1.1	11.9	29.0	65.6	3.0	0.8	2.1	1.2	63.7	8.1	55.7	3.5	0.0	23.3	0.0	64.6	46.5	8.4	31.3	23.3	28.5	1.3	1.5	12.0	2.3	1.7	4.6	0.0	11.1	13.5	16.0	58.1	1.4	6.4	8.5	15.4	74.5	32.9	37.4	24.6	0.4	9.7	29.0	0.0	1.4	0.6	2.4	1.4	13.7	26.1	35.6	4.2
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	14.9	20.5	21.8	15.6	26.7	7.1	25.0	11.4	28.0	12.9	16.4	8.3	12.8	24.1	13.7	46.4	11.9	15.1	22.5	33.7	17.9	16.2	27.1	22.7	18.5	26.0	19.2	14.3	19.5	50.0	8.7	10.0	9.5	22.8	13.6	16.1	11.3	20.4	15.7	51.3	6.9	23.8	24.0	22.6	12.7	18.8	17.7	13.5	9.3	21.3	15.3	14.5	14.5	15.9	27.1	21.4	13.3	20.3	18.1	31.1	18.2	12.9	10.9	14.6	14.1	16.2	35.4	19.6	12.7	15.4	10.9	14.0	9.6	23.1	21.4	22.1	14.0	22.7	3.8	17.0	16.2	15.3	12.1	13.5	12.3	7.9	18.3	27.6	14.6	8.2	25.0	32.6	13.9	21.2	21.4	8.4	14.5	19.7	7.0	13.4	8.3	15.8	24.9	27.6	17.3	16.3	13.1	19.1	13.7	24.3	9.5	18.9	17.6	8.1	5.7	27.9	16.8	11.8	20.9	13.9	11.9	14.1	13.3	16.1	13.8	11.3	22.4	18.0	15.6	15.0	13.3	18.2	8.4	15.7	20.3	20.5	27.1	22.7	19.7	20.5	26.8	31.1	24.7	9.2	18.1	15.2	21.4	23.2	18.2	21.8	26.7	11.4	28.0	17.9	16.2	19.2	14.3	22.8	13.5	8.9	35.3	39.7	30.7	19.5	7.0	54.2	58.6	29.4	35.2	34.9	7.9	53.4	111.0	55.9	8.3	17.8	60.0	0.0	54.3	51.6	39.2	34.0	10.4	52.1	61.7	1.6	18.6	19.0	49.0	18.9	34.8	47.0	42.2	36.1	53.7	55.6	48.1	35.1	45.3	134.2	16.1	71.1	36.2	42.9	40.5	16.9	36.6	25.9	63.5	25.3
RBPJ	"CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH"	ENSG00000168214	"Recombination signal binding protein for immunoglobulin kappa J region"	Q06330	4	26163455-26435131	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000251, HPA060647"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000251: , HPA060647: AB_2684337"	"unprognostic (2.68e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.15e-3)"	37.7	16.2	23.9	25.7	37.0	35.9	26.3	28.0	34.1	27.5	30.4	37.2	19.4	16.3	37.0	20.9	24.0	22.7	21.7	18.5	27.3	22.4	18.3	13.3	29.6	19.9	33.4	23.5	30.6	21.8	25.3	21.2	44.3	28.3	24.8	23.1	14.1	20.4	20.1	21.5	26.1	21.6	32.3	36.5	22.1	21.0	24.3	38.9	21.9	21.3	15.8	20.6	35.7	36.1	11.8	43.7	70.6	29.8	23.1	21.0	18.0	19.1	6.0	18.4	11.5	27.9	37.9	13.6	16.5	13.9	15.4	18.3	5.0	10.8	16.0	11.2	10.8	12.1	3.5	16.4	8.6	30.3	9.2	8.9	12.6	8.2	8.7	13.4	23.3	11.2	17.9	8.1	30.4	11.1	20.8	8.1	10.6	12.9	6.3	28.4	6.5	15.7	22.9	48.7	5.8	8.7	14.9	35.1	7.4	8.2	7.3	26.7	11.1	7.4	6.3	7.2	17.9	6.5	16.2	9.8	15.6	8.3	25.0	15.6	12.2	14.0	17.3	36.6	26.0	13.6	6.4	29.8	35.8	10.5	24.1	13.5	11.8	16.4	11.4	43.7	11.2	14.2	12.1	70.6	23.1	21.7	10.0	21.0	18.0	23.9	37.0	28.0	34.1	27.3	22.4	33.4	23.5	28.3	38.9	44.7	63.4	40.1	72.5	135.8	91.7	36.3	58.6	66.9	85.3	43.6	121.7	84.8	63.0	58.7	33.2	75.2	26.5	23.3	57.8	61.5	101.0	92.3	55.4	49.9	286.2	81.0	75.2	51.0	181.5	46.8	125.4	205.8	75.9	86.6	45.2	97.1	64.6	38.6	79.2	44.7	103.8	84.1	99.8	114.2	139.3	95.5	70.1	63.8	45.2	45.7
CCKAR		ENSG00000163394	"Cholecystokinin A receptor"	P32238	4	26481400-26490462	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"gallbladder: 47.5;stomach 1: 14.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.3;RH-30: 1.3;U-2 OS: 1.3"	"Region enhanced"	"Detected in some"		"hypothalamus: 8.3"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.48e-2)"				"unprognostic (3.70e-2)"	"unprognostic (7.13e-2)"					"unprognostic (3.08e-2)"	"unprognostic (3.36e-1)"		"unprognostic (3.79e-1)"				0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.0	1.3	0.3	0.0	1.3	0.0	47.5	0.1	0.1	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	0.0	14.0	0.2	0.1	0.2	0.0	1.0	7.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.1	1.3	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26755351	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.51e-1)"	6.1	13.9	8.6	5.4	10.2	2.8	6.8	11.5	11.2	11.8	8.8	8.7	7.7	3.1	22.4	11.0	4.8	11.9	11.8	10.7	6.6	9.0	24.9	4.6	6.6	3.5	9.3	7.7	13.9	7.7	21.9	23.4	6.1	14.8	8.7	5.1	8.4	5.8	10.4	5.7	4.2	3.8	13.5	8.6	4.4	6.9	10.0	7.1	33.3	12.1	2.9	4.2	8.3	7.0	4.1	2.4	2.3	0.9	6.6	8.7	1.8	1.4	1.3	4.6	2.8	6.8	10.5	1.4	5.9	4.6	2.7	3.0	2.1	3.4	3.2	5.3	8.3	8.8	0.6	2.5	3.3	2.6	1.0	1.3	0.7	3.7	0.7	3.6	1.6	0.7	5.1	2.5	5.4	3.1	11.2	3.7	4.2	2.5	0.0	40.9	0.0	3.4	1.9	2.1	1.7	4.9	2.5	4.7	0.3	10.5	1.3	4.6	1.9	2.8	0.6	2.8	3.7	1.2	0.7	3.3	3.5	1.0	2.6	1.4	0.8	1.7	1.4	12.2	0.9	3.6	1.6	0.9	2.3	8.1	0.9	8.7	3.2	6.2	8.3	1.4	4.1	4.9	5.1	0.1	6.6	0.8	2.4	3.0	1.8	8.6	10.2	11.5	11.2	6.6	9.0	9.3	7.7	14.8	7.1	3.0	2.6	4.7	4.8	3.2	7.5	5.3	2.5	18.7	0.0	19.2	13.7	3.6	5.0	4.8	4.8	5.7	0.4	0.0	2.8	1.7	6.2	2.5	9.2	1.8	1.6	4.8	9.1	6.7	1.6	1.9	8.3	2.3	10.1	1.0	1.9	8.2	2.1	0.0	8.5	11.3	19.4	0.0	4.7	22.0	5.7	4.0	1.6	17.5	1.3	1.6
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857678-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 73.1;U-698: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported					NA	NA					"CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453"	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	13.5	11.0	15.2	23.3	19.9	15.1	16.0	12.0	16.8	12.3	11.9	12.6	10.2	18.0	13.4	20.3	7.6	12.7	22.3	9.6	14.9	8.8	16.9	12.2	17.9	25.1	12.5	13.1	20.7	14.3	10.2	17.3	9.4	18.8	14.7	14.4	25.2	14.8	7.1	8.2	16.0	19.7	9.8	10.2	24.0	14.8	8.7	12.6	19.2	14.6	6.5	23.5	15.9	10.3	7.9	7.3	11.0	7.5	2.7	6.8	1.8	4.5	6.0	5.6	9.0	5.2	3.7	5.8	8.5	3.1	5.9	5.8	4.4	12.6	18.6	4.7	3.5	6.1	4.2	4.1	11.1	5.8	4.4	7.1	5.4	9.1	3.9	4.1	9.9	4.7	4.3	5.0	6.8	3.2	6.0	5.8	6.5	4.7	3.7	11.0	4.9	7.7	9.7	6.1	8.3	8.2	73.1	10.7	4.2	4.1	9.9	11.3	3.9	6.8	4.8	2.5	3.9	2.5	7.2	6.3	7.9	4.2	5.2	6.8	8.9	8.4	34.1	7.9	9.7	11.1	11.0	2.5	1.7	6.0	2.0	3.8	6.0	6.5	5.0	1.7	7.9	6.8	5.9	4.0	2.7	7.5	7.3	3.3	1.8	15.2	19.9	12.0	16.8	14.9	8.8	12.5	13.1	18.8	12.6	11.9	24.0	31.8	12.6	14.5	33.9	8.1	28.1	100.4	19.4	31.4	76.6	9.6	11.6	8.4	8.0	32.1	14.4	0.0	17.7	7.3	8.6	10.8	35.8	9.6	6.8	28.6	43.9	33.7	17.0	5.0	14.1	22.7	8.5	7.2	25.9	22.7	10.0	10.1	6.7	3.3	56.8	19.4	7.8	15.6	24.2	13.6	4.1	34.6	11.5	10.5
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 66.6;Basal keratinocytes: 75.6;Cardiomyocytes: 73.6;Collecting duct cells: 61.1;Urothelial cells: 51.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.7;RH-30: 47.0;RT4: 24.8"	"Low region specificity"	"Detected in all"							"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	2.0	3.2	11.9	4.9	11.5	0.4	3.0	1.2	25.3	23.2	18.4	1.7	34.3	3.1	15.3	22.9	13.0	8.9	7.4	16.7	13.4	11.9	2.2	1.2	2.8	1.4	8.0	11.0	4.5	1.1	0.5	0.8	0.5	11.7	9.9	7.3	6.2	1.6	32.2	0.9	10.1	5.3	23.7	5.3	15.3	14.2	1.2	4.4	0.0	3.9	1.3	1.4	20.1	7.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	5.6	7.8	11.7	11.5	0.0	1.4	0.0	0.7	0.3	0.7	10.2	0.0	0.0	0.0	0.0	5.8	0.5	14.7	1.3	0.0	16.7	0.0	10.6	0.0	12.1	0.2	0.0	6.8	3.4	0.3	4.2	6.9	2.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	3.5	1.5	0.0	47.0	0.0	0.3	24.8	0.3	0.1	0.1	0.4	0.5	3.3	0.7	2.6	0.0	9.5	2.4	2.6	0.0	0.0	0.0	0.0	7.4	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.5	1.2	24.9	13.4	11.9	8.0	11.0	11.7	4.4	0.0	0.0	0.0	66.6	75.6	29.7	73.6	0.0	13.4	3.4	61.1	0.0	0.1	0.0	0.1	12.1	4.8	0.0	0.0	0.6	0.1	7.7	12.5	1.1	0.0	0.3	9.5	0.0	12.9	0.6	7.9	0.3	0.8	20.3	0.0	0.0	1.3	15.4	0.0	26.9	0.0	2.9	0.0	12.2	1.1	2.4	33.8	0.1	0.0	0.0	51.1
ARAP2	"CENTD1, PARX"	ENSG00000047365	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2"	Q8WZ64	4	35948221-36244509	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 142.9;Early spermatids: 113.2;Late spermatids: 89.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.0;hTCEpi: 11.3;MOLT-4: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035925	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"HPA035925: AB_10672075"	"unprognostic (2.97e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	5.2	2.5	16.3	9.1	27.5	32.5	5.2	4.8	20.8	4.2	5.1	18.3	0.3	8.5	3.5	4.1	12.7	3.5	9.2	2.5	16.0	9.5	3.9	8.8	12.7	13.7	24.4	12.1	1.9	6.8	8.2	5.1	3.5	18.4	2.9	5.8	0.7	5.8	3.3	1.4	16.1	8.2	4.4	15.3	10.4	5.8	5.9	32.0	26.4	22.4	4.0	10.2	6.2	7.2	2.4	1.7	0.6	5.8	8.6	5.7	0.7	7.3	0.6	0.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.6	12.0	3.5	2.9	0.3	0.0	2.8	1.1	5.8	0.0	0.0	6.6	0.1	2.4	0.2	1.5	4.6	0.0	0.4	11.3	0.0	2.5	4.4	0.0	9.7	0.2	0.6	0.0	3.1	10.7	3.8	0.8	5.1	2.3	5.5	0.0	4.0	8.3	7.5	6.5	0.0	0.4	1.8	2.4	0.4	5.0	1.4	0.0	2.0	6.7	0.0	1.0	0.0	0.0	6.8	0.8	5.3	1.7	0.0	0.8	0.0	5.7	2.7	5.3	2.4	3.2	3.9	0.4	1.4	1.1	2.9	0.6	8.6	5.8	1.7	1.5	0.7	16.3	27.5	4.8	20.8	16.0	9.5	24.4	12.1	18.4	32.0	142.9	21.8	22.6	24.0	34.8	0.3	1.7	10.2	20.1	43.3	7.0	0.0	0.1	6.6	7.2	113.2	13.5	14.6	0.0	8.6	0.2	4.5	28.3	9.2	3.8	7.3	0.0	2.9	3.1	32.3	89.9	2.6	17.8	5.0	16.2	9.2	5.4	15.9	17.5	0.7	4.1	1.0	0.0	1.4	3.2	1.9	59.0	0.7	42.4	6.4	46.4
DTHD1	FLJ16686	ENSG00000197057	"Death domain containing 1"	Q6ZMT9	4	36281622-36345756	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.6;fallopian tube: 20.6;lung: 18.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 286.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 6.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (9.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.45e-5)"	"unprognostic (5.12e-3)"	"unprognostic (9.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.05e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.12e-3)"	0.7	0.5	1.9	5.8	14.8	0.9	0.4	0.3	0.3	2.1	1.1	2.8	1.4	0.7	1.1	11.9	0.7	20.6	3.5	0.4	3.1	2.9	0.4	0.7	18.5	5.4	0.4	0.0	8.1	0.3	0.2	0.8	0.2	16.6	0.5	0.7	0.1	0.6	0.3	0.2	0.2	1.3	0.4	0.7	8.0	0.8	2.2	4.5	0.0	0.6	1.2	4.0	3.1	0.5	0.0	0.0	0.1	0.0	1.1	6.8	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.1	6.8	0.0	1.2	0.0	0.6	2.1	0.0	0.0	0.0	2.6	0.0	1.1	0.0	0.0	0.0	0.7	1.9	14.8	0.3	0.2	3.1	2.9	0.4	0.0	16.6	4.5	3.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	286.4	40.9	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.6	16.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	20.1	0.0	0.0
NWD2	KIAA1239	ENSG00000174145	"NACHT and WD repeat domain containing 2"	Q9ULI1	4	37244220-37449465	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.8;breast: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AF22: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046911	Uncertain					NA	NA					"HPA046911: AB_2679861"	"unprognostic (1.14e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.53e-1)"		"unprognostic (5.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.26e-2)"	4.9	0.3	2.1	0.3	2.9	0.2	20.0	1.0	11.8	0.3	1.6	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	2.3	3.2	0.2	0.5	0.2	0.3	0.7	2.0	0.2	0.7	0.3	0.3	0.3	2.0	0.2	0.8	0.0	0.4	0.2	0.2	0.7	0.4	0.4	0.3	0.2	0.3	0.6	0.0	0.4	2.7	0.0	0.3	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.9	1.0	8.9	2.3	3.2	0.7	2.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453941-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 37.7;placenta: 38.3"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 45.7;Exocrine glandular cells: 45.6;Pancreatic endocrine cells: 48.4;Paneth cells: 37.4;Syncytiotrophoblasts: 39.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 11.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.4"	"Group enriched"	"Detected in some"	5	"OE19: 25.1;RT4: 32.3;SK-BR-3: 13.0;T-47d: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"		No	No			"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	2.0	0.5	2.6	1.5	2.7	1.6	2.2	2.8	5.4	6.5	14.6	2.5	2.3	10.3	4.2	1.9	2.1	1.7	7.4	0.7	4.4	1.7	11.9	26.2	2.8	0.0	3.1	2.5	0.6	37.7	5.8	6.1	38.3	6.2	1.9	14.0	1.9	22.2	9.8	0.6	1.7	11.0	2.3	3.8	0.6	12.4	1.5	2.2	0.0	1.3	1.0	3.3	5.9	2.9	0.9	2.2	11.4	2.1	1.2	1.2	0.3	0.0	0.0	1.3	0.1	0.0	0.0	1.7	0.3	0.0	0.0	0.0	5.2	2.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.2	25.1	0.7	0.0	3.2	0.0	5.1	32.3	0.4	0.1	0.2	13.0	0.4	1.7	46.3	0.2	0.2	0.1	1.9	0.0	0.6	0.0	0.0	0.2	0.0	2.6	2.2	0.9	2.1	2.5	0.8	0.3	0.5	0.3	0.5	0.5	0.3	0.9	0.8	1.2	11.4	1.2	0.2	2.2	0.9	0.3	2.6	2.7	2.8	5.4	4.4	1.7	3.1	2.5	6.2	2.2	0.0	13.0	1.3	4.9	0.2	0.2	0.2	22.9	6.7	0.0	10.4	0.0	5.1	10.0	18.9	1.0	0.1	45.7	0.0	45.6	4.6	0.2	5.3	0.0	11.5	0.6	0.0	9.2	0.0	0.0	1.3	0.0	0.0	3.3	1.0	28.4	4.3	48.4	37.4	0.0	7.9	1.0	0.0	0.1	0.1	0.0	0.0	39.7	0.0	28.5	13.7
RELL1		ENSG00000181826	"RELT like 1"	Q8IUW5	4	37590800-37686376	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.2;TIME: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013377	Approved		Supported	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane, Microtubules"		"HPA013377: AB_1844403"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.71e-2)"	21.1	3.0	5.5	6.2	9.7	28.8	19.3	6.4	6.5	8.4	10.4	6.5	2.8	7.2	8.3	7.8	9.8	7.3	9.7	12.1	5.1	5.0	4.9	5.5	10.4	14.6	9.1	2.1	8.9	4.0	2.6	3.2	20.7	17.9	6.2	7.5	8.1	5.3	5.0	10.1	11.5	8.6	11.1	28.2	10.9	14.7	4.1	5.3	6.0	18.1	9.6	6.6	15.6	13.3	0.1	3.2	16.1	4.0	0.9	1.7	1.3	2.9	3.8	9.2	6.5	6.4	5.3	7.3	5.2	5.4	4.6	5.8	11.6	3.6	0.6	4.0	4.8	6.7	2.8	3.0	5.5	7.2	0.0	1.5	1.2	3.2	9.9	3.8	4.3	3.0	7.2	4.5	5.6	5.6	1.8	18.3	2.3	2.2	3.0	3.4	2.4	4.5	2.3	1.8	3.1	1.1	1.6	33.2	1.5	4.5	4.3	2.0	5.7	4.8	3.6	4.6	1.9	12.3	1.5	21.8	9.3	5.4	7.0	5.8	1.5	1.6	4.9	8.4	6.8	7.0	0.0	4.0	2.5	1.3	0.8	1.2	0.1	1.2	1.1	1.6	0.0	1.1	1.7	16.1	0.9	0.5	3.2	1.1	1.3	5.5	9.7	6.4	6.5	5.1	5.0	9.1	2.1	17.9	5.3	8.9	1.9	2.4	1.2	3.0	0.4	1.7	10.2	4.0	5.7	0.0	0.0	1.0	0.0	2.6	5.2	6.4	5.1	0.0	7.3	3.0	2.1	2.3	2.3	0.8	2.3	3.2	1.2	8.0	2.8	4.0	3.4	3.1	1.7	2.8	1.1	4.9	9.3	1.9	5.6	0.0	1.5	12.9	2.8	1.2	0.1	4.1	4.3	5.7	0.6	3.8
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826633-37862937	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1900000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15.0	7.6	41.3	7.0	11.0	8.3	7.1	4.0	11.1	13.3	7.5	13.2	4.4	5.7	10.0	9.0	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11.0	5.0	2.4	17.7	8.6	12.2	6.9	13.4	9.0	9.0	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7.0	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12.0	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17.0	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10.0	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8.0	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4.0	5.0	16.3	13.2	8.0	3.4	7.0	7.2	7.7	5.9	9.8	5.7	7.1	4.0	4.4	5.7	10.4	3.9	0.0	8.0	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0.0	26.6	5.0	13.0	0.8	25.5	7.9	0.0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5.0	52.3	9.0	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891087-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	13.6	3.7	9.3	19.8	8.3	19.0	9.8	9.5	8.4	36.0	48.9	7.1	24.5	10.2	63.4	16.5	14.9	22.9	30.6	24.0	7.5	6.0	29.0	8.8	13.3	16.6	7.0	7.6	16.1	9.4	55.9	8.0	32.4	7.4	18.0	9.8	18.2	8.3	28.1	41.9	5.6	15.1	31.6	7.4	21.2	18.1	15.6	5.4	30.4	26.1	23.1	13.3	27.2	26.8	6.0	4.8	14.0	16.7	6.2	4.3	2.2	5.7	6.6	12.1	13.0	4.3	12.2	10.4	15.8	26.5	14.9	15.3	3.8	18.9	29.7	3.9	10.5	18.9	0.3	9.1	11.4	23.1	2.3	5.2	11.4	4.6	7.9	7.0	21.1	13.1	14.7	2.3	9.2	6.4	12.5	22.9	20.9	13.9	5.1	15.5	4.4	29.3	19.9	6.8	0.9	6.0	26.1	19.7	8.6	12.3	10.7	10.6	9.5	5.8	5.4	6.6	28.6	5.3	16.4	15.6	19.8	22.5	4.9	22.8	12.6	15.5	78.1	8.6	19.4	17.4	1.9	5.0	14.0	2.6	15.6	4.3	4.8	2.6	2.2	4.8	6.0	2.4	3.0	13.9	6.2	16.7	4.2	2.1	2.2	9.3	8.3	9.5	8.4	7.5	6.0	7.0	7.6	7.4	5.4	11.9	7.0	34.9	12.1	7.0	10.8	58.5	20.4	2.7	6.8	26.2	0.0	18.0	64.6	13.4	22.1	27.3	14.6	23.3	34.7	22.8	13.9	30.2	2.3	16.1	28.6	9.5	42.5	20.9	50.5	34.2	21.6	33.1	10.1	36.1	9.0	9.3	33.5	11.9	18.7	55.2	0.9	38.8	93.2	10.3	20.6	7.5	24.4	26.2	9.9	26.3
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960435-37961125	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 4.1;Early spermatids: 3.1;Spermatocytes: 1.9;Suprabasal keratinocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4;T-reg: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;MOLT-4: 3.1;U-698: 2.1"									"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	1.0	0.4	0.9	5.2	1.2	5.0	0.5	2.2	2.4	1.1	3.9	0.2	0.0	0.0	1.6	2.2	3.3	1.8	1.5	2.5	1.0	0.4	0.7	0.5	0.9	1.0	0.7	0.4	1.2	1.0	1.4	0.4	1.8	0.3	0.8	0.7	0.0	0.2	1.4	1.9	0.6	3.1	2.0	0.9	2.3	1.0	5.3	0.0	15.8	1.3	7.5	7.3	1.8	0.7	0.4	0.0	1.4	0.4	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.7	0.5	0.9	0.0	0.5	0.3	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	1.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	1.0	0.1	0.9	1.2	2.2	2.4	1.0	0.4	0.7	0.4	0.3	0.0	0.0	0.0	1.4	0.5	4.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.7	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.2	2.5	0.0	0.0	0.0	0.3
KLF3	BKLF	ENSG00000109787	"Kruppel like factor 3"	P57682	4	38664196-38701042	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 244.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049512, HPA065054"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049512: AB_2680799, HPA065054: AB_2685415"	"unprognostic (4.20e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.10e-3)"	23.0	14.3	11.1	14.7	14.4	41.7	25.6	8.9	13.7	20.2	31.2	21.7	10.4	21.0	20.0	14.1	51.9	14.6	39.3	12.0	11.9	8.1	13.2	25.2	21.4	16.6	16.2	8.2	36.1	18.6	21.6	11.4	20.4	13.8	19.0	27.6	12.4	24.0	17.6	12.5	43.1	40.3	18.7	16.7	22.3	25.6	7.9	18.2	6.5	16.4	25.7	34.9	26.1	28.3	4.0	3.1	14.3	10.9	2.7	9.4	2.1	9.5	6.6	25.0	5.0	11.5	17.2	7.9	5.3	15.5	3.6	4.5	6.2	17.7	0.0	7.5	11.5	10.4	10.5	7.1	9.3	5.8	0.1	5.2	9.1	9.7	13.0	11.8	2.2	0.0	15.5	25.8	5.2	9.7	6.8	13.8	3.6	25.9	4.5	5.7	2.2	2.4	4.0	5.8	19.8	4.8	3.2	12.1	10.4	12.8	23.1	7.2	9.3	5.8	4.6	11.1	10.5	2.8	3.2	21.8	12.0	6.8	20.3	5.7	6.3	2.0	0.0	4.9	6.9	5.1	8.8	4.0	14.3	6.3	6.9	4.3	3.7	7.0	5.6	3.1	4.0	9.4	5.6	12.8	2.7	10.9	0.7	7.2	2.1	11.1	14.4	8.9	13.7	11.9	8.1	16.2	8.2	13.8	18.2	20.8	25.6	15.7	113.6	107.8	41.2	15.3	63.7	21.4	23.9	29.6	29.5	23.5	10.0	75.6	0.6	80.0	132.1	140.2	75.2	17.8	67.1	127.0	19.6	48.4	47.0	33.4	83.1	51.0	71.6	1.9	48.1	51.1	47.2	34.3	132.6	51.1	83.4	132.3	45.3	18.4	36.2	25.8	29.9	0.7	0.9	194.5	22.9	35.8	87.7	244.9
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Cell type enriched"	"Detected in some"	18	"B-cells: 39.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"	"Group enriched"	"Detected in some"	55	"Daudi: 38.2;REH: 12.8;U-698: 13.7"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4	0.0	1.4	39.2	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.0	1.2	0.6	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.3;lymphoid tissue: 40.4"	"Cell type enhanced"	"Detected in many"	14	"Hofbauer cells: 14.0;Kupffer cells: 33.2;Macrophages: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.3"	"Group enriched"	"Detected in all"	6	"granulocytes: 43.3;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 9.6;HUVEC TERT2: 11.0;RPMI-8226: 11.9;U-698: 17.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (7.82e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.25e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.97e-2)"	10.9	4.6	7.1	17.9	11.4	21.0	5.4	2.0	6.0	3.4	3.7	5.9	0.5	4.2	5.8	3.9	3.2	5.3	6.5	4.0	6.5	3.4	4.6	5.8	9.8	26.4	12.9	2.6	7.4	7.7	1.0	4.2	6.6	10.6	3.9	4.6	2.2	11.0	2.5	1.7	3.1	6.7	6.5	19.4	40.4	4.2	1.6	10.9	10.1	2.4	1.7	13.1	6.3	2.8	2.3	4.5	43.3	13.1	1.8	1.1	2.4	0.2	1.7	0.1	0.0	0.2	1.3	0.0	0.0	0.4	0.1	1.0	0.2	4.7	9.6	1.0	0.0	4.7	0.3	0.1	1.2	0.2	1.1	0.5	1.2	0.4	0.0	0.0	1.8	0.5	0.4	0.2	0.4	0.0	0.4	11.0	0.2	1.3	2.9	1.4	0.0	0.4	3.9	0.0	0.0	0.0	6.5	0.1	11.9	1.1	0.0	0.0	1.4	0.0	0.1	0.4	0.1	0.1	2.3	2.8	1.0	0.4	0.1	0.6	1.1	0.1	17.8	2.5	6.6	0.3	0.0	6.8	2.6	1.0	10.4	0.8	2.3	1.1	0.8	4.5	2.0	1.1	0.6	43.3	1.8	13.1	1.5	0.4	2.4	7.1	11.4	2.0	6.0	6.5	3.4	12.9	2.6	10.6	10.9	0.0	1.0	6.4	0.5	0.2	0.2	0.0	0.0	8.1	2.3	1.8	0.0	0.1	1.7	3.9	0.0	2.1	0.2	0.0	3.8	0.2	0.7	1.0	3.5	2.5	14.0	0.0	0.0	0.0	33.2	0.0	0.0	18.2	0.0	2.8	0.3	1.7	1.9	0.0	2.5	1.2	0.2	0.0	0.0	0.1	0.1	0.5	0.1	4.4	1.5	0.9
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell type enhanced"	"Detected in some"	12	"B-cells: 5.0;Hofbauer cells: 5.9;Kupffer cells: 11.8;Macrophages: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.5;GAMG: 12.9;RPMI-8226: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.4	5.7	0.2	0.1	0.3	6.7	0.0	1.6	6.9	0.7	2.3	0.0	12.5	6.9	2.7	0.3	12.9	0.6	0.1	1.2	1.1	0.0	0.5	3.2	6.9	0.2	0.4	3.5	5.2	2.8	1.3	2.8	1.5	0.2	1.4	1.1	3.5	2.2	3.1	0.0	0.0	6.1	0.2	0.0	0.9	3.4	3.1	9.8	0.4	0.1	0.0	0.1	0.2	0.0	0.9	0.3	0.3	1.8	1.9	2.2	7.5	0.9	2.4	0.1	0.0	5.8	5.1	4.1	1.6	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8	0.0	0.0	5.0	1.1	0.6	0.7	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.8	0.8	2.3	0.0	5.9	0.0	0.0	0.6	11.8	0.0	0.6	9.5	0.0	1.8	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.4	0.2	0.0	0.6	0.2	0.0	0.0	0.9
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 102.6;Peritubular cells: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.5;ASC TERT1: 44.4;BJ hTERT+: 50.7;fHDF/TERT166: 56.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175"	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	15.8	27.3	4.4	11.8	7.3	0.3	17.9	2.5	5.1	23.3	18.9	8.0	17.1	9.0	34.1	23.5	19.9	11.4	24.1	14.1	7.0	4.2	9.6	31.8	14.5	6.1	5.8	5.0	21.7	33.4	8.8	18.7	19.1	6.5	22.0	14.0	13.0	59.9	12.6	9.3	10.1	15.8	36.7	6.2	6.3	13.9	10.8	5.8	1.5	11.5	16.7	15.1	29.1	17.8	0.7	4.3	3.8	6.3	0.1	0.2	1.3	8.7	6.3	3.8	4.5	42.5	44.4	1.2	34.6	50.7	14.7	22.5	1.6	6.8	0.0	4.8	56.0	25.1	2.4	0.0	11.0	17.0	0.0	0.9	0.6	6.7	8.1	15.2	0.0	1.2	26.2	3.5	21.3	4.9	33.4	21.0	0.0	0.6	0.0	21.4	2.2	0.0	0.4	0.8	3.7	3.2	0.1	19.1	0.6	4.9	1.7	0.1	1.9	6.9	0.1	7.1	9.4	4.3	0.7	32.0	16.0	7.5	20.0	8.0	0.1	0.0	0.0	26.2	0.6	13.0	0.8	5.1	0.1	0.2	6.3	0.1	0.7	0.2	0.1	4.3	0.3	0.2	0.2	3.8	0.1	2.2	0.5	0.1	1.3	4.4	7.3	2.5	5.1	7.0	4.2	5.8	5.0	6.5	5.8	14.9	10.4	0.0	39.8	10.9	0.1	14.4	10.2	40.2	23.9	7.0	0.0	1.5	8.3	41.1	0.9	28.7	35.9	0.0	54.0	35.9	79.4	79.1	1.1	66.9	14.7	0.0	15.1	30.1	6.7	2.2	102.6	9.9	20.3	5.4	70.8	10.6	41.7	35.1	109.3	8.4	1.0	19.4	25.7	0.5	1.1	8.9	2.9	2.5	27.3	53.6
TMEM156	FLJ23235	ENSG00000121895	"Transmembrane protein 156"	Q8N614	4	38966744-39032922	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 30.6;brain: 12.7;intestine: 8.3;lymphoid tissue: 23.7"	"Cell type enhanced"	"Detected in some"	23	"B-cells: 75.1;Cholangiocytes: 20.4;T-cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 30.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 16.3;GAMG: 12.7;HBEC3-KT: 34.9;hTERT-HME1: 27.5;NB-4: 14.2;PC-3: 15.6;U-698: 18.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (4.09e-4)"	"unprognostic (7.36e-3)"	"unprognostic (3.31e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.17e-2)"	"unprognostic (8.73e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.92e-4)"	"unprognostic (9.06e-2)"	0.9	1.7	5.8	11.8	6.6	1.7	1.1	0.7	4.1	0.6	1.7	6.1	0.0	1.7	0.6	0.3	2.0	1.0	1.9	0.6	4.1	2.6	1.4	2.6	1.6	20.2	6.2	0.8	0.5	0.8	0.3	0.7	0.2	5.3	0.9	2.0	0.0	2.0	0.6	0.6	0.5	8.3	0.5	12.7	17.3	2.3	0.6	4.2	7.4	1.0	0.3	23.7	4.5	0.8	30.6	5.0	18.8	0.3	4.8	9.0	3.6	1.0	9.8	0.1	0.1	0.0	0.3	0.1	0.0	2.7	0.0	0.0	0.1	0.1	16.3	0.1	0.0	12.7	0.1	0.1	34.9	0.1	0.2	0.0	0.9	3.3	0.2	5.8	6.7	0.1	0.0	1.8	0.7	27.5	2.1	3.0	2.7	2.3	0.1	1.2	0.1	1.2	14.2	0.0	0.4	15.6	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	7.4	1.2	0.2	0.0	0.3	0.0	0.0	18.6	2.2	6.3	0.0	5.4	0.3	18.8	5.2	0.1	6.1	30.6	9.0	5.2	3.3	21.9	3.5	4.6	0.8	4.8	0.1	5.0	6.0	3.6	5.8	6.6	0.7	4.1	4.1	2.6	6.2	0.8	5.3	4.2	0.0	2.6	75.1	0.5	0.5	0.6	0.3	20.4	1.4	1.2	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.4	1.1	0.7	0.0	0.2	1.6	1.6	0.0	2.5	12.0	1.4	0.0	2.7	10.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.5	0.2	28.7	0.0	0.7
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved					NA	NA					"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	24.6	15.0	31.9	21.2	27.6	5.1	33.1	10.4	20.9	11.9	29.5	20.7	15.6	8.1	12.7	9.2	21.3	6.7	15.1	10.1	31.5	25.2	16.4	35.2	14.0	19.6	33.4	11.9	12.5	7.3	7.3	6.4	33.1	18.1	24.4	10.9	6.5	8.1	44.5	6.1	4.6	9.8	32.3	34.2	14.3	10.9	6.9	20.7	6.9	14.0	4.6	23.9	25.7	14.3	7.4	4.1	5.6	5.2	1.8	2.6	1.3	12.5	17.8	9.5	6.9	5.4	14.0	13.8	10.1	74.2	8.5	8.3	14.6	9.2	19.4	12.3	10.3	45.2	0.7	11.6	25.6	10.9	1.9	2.3	8.2	16.8	10.4	46.8	2.4	2.8	17.7	14.4	12.9	32.4	31.5	16.9	3.1	6.2	3.9	20.0	5.3	2.5	4.3	2.9	3.2	17.4	4.6	12.5	0.4	7.3	5.2	0.6	6.9	5.7	1.8	4.9	12.0	4.4	5.1	21.4	22.8	15.6	5.9	12.0	4.5	4.0	17.9	18.5	6.4	5.2	5.6	3.9	0.8	1.4	5.2	2.1	7.4	2.6	1.5	4.1	5.9	2.1	1.0	4.3	1.8	2.3	1.5	0.5	1.3	31.9	27.6	10.4	15.8	31.5	25.2	33.4	11.9	18.1	20.7	14.9	1.4	25.3	7.3	3.3	6.5	3.9	15.3	24.1	29.6	10.4	3.9	0.5	14.9	33.8	2.4	26.3	0.0	0.0	18.5	50.9	10.0	14.8	2.3	27.6	12.6	66.7	1.2	20.3	18.6	5.4	7.5	19.4	16.9	22.6	0.0	9.2	18.6	0.0	13.1	17.9	3.2	0.0	16.5	8.4	4.4	3.0	4.8	7.5	0.0	6.7
WDR19	"DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182404-39285810	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 41.1"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 41.5;Spermatocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;ASC TERT1: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	8.5	7.6	8.1	4.8	12.9	3.4	9.2	21.0	14.5	13.2	7.8	5.7	7.8	1.9	15.5	11.2	5.4	20.9	8.6	5.1	11.7	4.1	8.6	7.0	8.6	4.4	6.0	11.0	19.0	6.6	10.1	41.1	6.3	14.6	8.1	4.3	6.9	7.6	8.2	3.1	6.0	5.7	9.5	9.7	4.3	8.0	12.7	7.3	6.8	17.1	3.8	5.0	9.9	8.9	3.9	1.1	1.5	2.0	2.3	2.4	0.8	3.2	2.3	5.5	6.6	25.4	28.5	2.5	4.3	9.7	4.5	6.0	1.4	3.7	5.3	2.1	4.1	9.7	1.9	5.4	2.8	5.0	0.3	3.9	1.0	4.4	2.7	7.9	5.2	1.4	17.3	6.1	6.0	3.8	12.5	5.4	5.4	4.7	5.3	5.4	1.1	3.5	3.6	1.8	1.9	2.6	4.3	5.6	2.4	3.7	1.3	6.1	5.6	4.2	1.4	2.8	6.9	2.8	1.9	3.9	4.4	3.0	9.7	4.2	3.9	3.6	3.7	6.6	1.5	2.0	0.7	1.2	0.9	1.7	2.0	1.3	3.4	2.1	2.4	1.1	3.9	2.1	2.1	1.5	2.3	1.7	0.7	1.4	0.8	8.1	12.9	21.0	14.5	11.7	4.1	6.0	11.0	14.6	7.3	11.9	5.7	3.2	4.9	4.2	7.6	3.8	2.5	41.5	12.5	17.4	9.8	1.0	0.0	4.5	3.0	4.5	0.0	0.0	3.1	2.0	5.6	3.1	2.3	10.6	2.7	23.8	2.4	4.3	1.9	2.6	15.3	2.9	1.7	1.0	2.2	7.3	2.9	0.0	17.7	3.4	22.5	0.0	3.8	30.3	10.2	4.1	1.1	1.0	1.0	1.8
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	18.7	24.0	20.2	22.5	24.9	26.8	21.2	19.9	22.7	23.8	17.8	17.1	20.3	12.5	20.7	19.0	19.4	15.8	11.9	15.4	17.9	14.6	23.4	24.9	17.2	26.3	29.0	22.7	26.2	34.1	41.3	30.7	17.6	23.5	20.1	14.5	10.5	17.4	18.9	13.5	17.8	16.0	21.0	32.7	21.6	17.1	12.4	28.9	33.6	22.3	14.6	27.3	25.3	17.4	15.3	13.0	6.4	8.1	10.8	13.5	4.7	15.8	7.2	20.5	16.7	9.9	12.6	10.5	18.4	16.8	18.9	22.5	13.9	16.2	39.2	12.5	12.3	20.3	7.7	18.8	16.0	30.5	7.0	12.8	17.5	13.8	12.7	12.0	24.5	11.7	9.6	12.9	19.1	21.4	15.1	14.6	19.6	17.3	8.3	14.3	6.4	35.9	15.8	12.5	9.9	9.2	28.6	37.4	12.3	8.2	11.1	14.4	14.0	10.8	4.3	13.9	13.4	11.3	13.8	11.1	15.6	19.3	14.4	23.3	11.9	16.1	37.3	12.8	25.7	15.5	6.4	8.1	3.2	13.2	6.2	9.6	12.4	11.4	11.2	6.2	15.3	13.5	11.9	3.7	10.8	7.4	13.0	9.9	4.7	20.2	24.9	19.9	22.7	17.9	14.6	29.0	22.7	23.5	28.9	59.6	101.9	40.2	33.4	18.3	67.9	62.9	30.6	45.5	48.9	54.1	56.9	32.4	61.3	47.2	30.3	54.6	23.3	23.3	57.3	45.5	31.2	43.3	24.4	70.3	26.9	81.0	28.8	55.9	42.4	22.0	75.9	33.8	15.1	37.9	46.9	81.0	46.5	31.6	86.3	63.9	74.7	58.2	24.5	40.8	69.2	18.6	26.9	55.4	43.2	40.9
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406853-39451536	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adipose tissue: 17.3;liver: 49.2;pancreas: 21.4"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 12.1;Hepatocytes: 28.7;Intestinal endocrine cells: 16.7;Spermatocytes: 11.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"ASC diff: 6.5;Hep G2: 23.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021136	Uncertain					NA	NA		290000			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	17.3	0.0	0.2	1.9	1.0	0.2	3.9	0.4	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.5	0.3	0.1	1.3	0.5	1.0	0.2	0.1	49.2	1.4	0.5	0.1	0.0	0.2	21.4	0.2	0.2	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.4	0.5	0.6	0.3	0.0	0.0	1.5	2.5	0.2	0.0	0.1	0.4	0.0	0.3	0.2	0.5	2.5	2.3	0.7	0.4	0.4	0.2	0.0	0.2	0.0	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	23.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.7	0.2	0.3	0.4	0.2	0.4	0.2	0.2	0.1	0.5	0.2	0.4	2.3	0.4	0.5	2.5	0.1	0.2	0.2	1.0	0.4	0.2	1.0	0.2	0.1	0.0	0.4	0.2	3.0	12.1	0.0	0.9	0.5	2.1	0.9	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.9	5.9	0.3	1.4	0.0	3.7	1.1	0.4	1.0	0.0	28.7	0.2	1.6	16.7	0.0	0.3	1.1	1.4	0.2	1.7	0.0	6.7	0.3	1.4	3.5	0.7	0.8	1.6	0.0	0.0	11.1	0.7	0.6	1.1	0.0	0.6	0.7
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452521-39458949	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		24000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	52.6	35.2	42.2	73.9	44.4	179.1	202.3	35.7	51.6	63.0	59.8	34.5	42.2	69.8	50.4	226.8	49.9	48.1	69.7	58.2	42.3	27.6	47.4	73.2	35.8	48.7	34.7	51.7	158.5	126.2	37.4	44.7	38.7	42.5	47.8	59.1	31.7	93.7	71.4	66.3	62.9	38.8	49.5	34.0	45.2	46.5	56.9	25.9	36.0	63.2	70.1	59.0	46.0	56.6	118.3	72.5	26.2	41.4	63.0	145.0	148.9	3.2	2.8	122.9	2.8	6.6	9.0	4.8	57.9	87.4	72.3	54.8	8.1	65.7	143.5	6.6	58.2	57.3	65.4	5.5	6.3	79.1	52.3	115.6	4.5	24.2	7.8	8.6	9.3	38.0	11.9	181.8	4.4	83.1	107.6	5.5	5.8	109.7	67.0	5.0	4.3	77.9	9.9	109.8	79.6	3.9	71.9	123.2	4.9	89.9	3.8	4.6	49.0	2.0	47.5	7.4	118.9	104.9	6.8	4.1	3.1	4.6	84.1	8.0	103.0	144.6	124.7	83.4	87.3	3.3	26.2	41.4	12.3	52.1	40.1	101.2	118.3	102.2	71.4	57.2	103.8	145.0	111.7	6.9	63.0	31.2	72.5	77.0	148.9	42.2	44.4	35.7	51.6	42.3	27.6	34.7	51.7	42.5	25.9	616.4	695.5	3946.9	4635.1	3670.9	362.7	367.2	1765.6	426.9	687.0	673.4	151.2	2652.9	2316.1	1697.3	1288.9	2348.7	1394.0	817.7	3813.6	4743.2	2040.6	3407.8	885.2	1749.4	2435.4	187.5	1780.1	1927.4	2668.8	1161.7	4462.6	2606.9	1756.2	2952.2	2900.0	510.1	3233.5	2563.6	2250.5	2828.8	405.3	1487.5	2143.4	695.4	462.3	4086.9	2843.5	2427.5	4009.2	4396.5
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39458587-39485109	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 82.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	9.8	12.9	9.9	7.0	12.7	10.2	11.3	10.2	13.3	7.0	10.7	12.9	8.1	10.4	9.1	10.7	11.6	11.9	7.4	14.0	10.6	10.6	15.7	15.5	5.7	9.0	12.3	10.5	19.2	12.4	10.0	11.5	6.8	15.7	8.2	12.4	9.0	7.8	7.0	42.7	8.8	9.9	13.6	12.4	8.9	9.9	20.1	13.2	8.7	8.8	13.5	8.3	10.0	7.9	9.6	5.8	3.7	7.1	6.9	16.7	4.3	4.0	3.1	4.0	3.8	8.4	8.2	3.4	4.6	2.6	4.3	2.9	5.0	5.5	14.6	5.3	1.7	10.9	3.6	11.3	6.3	5.8	1.6	2.8	6.1	1.6	5.0	7.7	13.2	4.0	7.9	10.5	5.1	16.2	9.6	4.9	9.1	14.4	3.6	5.2	2.5	7.4	17.0	5.3	10.6	10.1	6.5	10.8	8.8	5.1	2.1	4.4	3.8	2.7	3.6	14.9	5.8	4.0	6.1	1.8	3.5	7.7	4.5	10.7	7.1	10.8	10.2	5.4	15.4	3.0	2.0	6.2	3.7	6.1	7.1	12.6	9.6	8.3	8.0	5.8	8.5	16.7	11.5	3.3	6.9	5.1	5.4	5.2	4.3	9.9	12.7	10.2	13.3	10.6	10.6	12.3	10.5	15.7	13.2	8.9	9.3	13.4	11.9	8.7	24.0	16.5	10.2	20.1	13.6	17.4	9.8	21.5	18.3	10.7	82.3	7.1	13.1	0.0	5.5	12.9	8.0	5.2	17.3	17.0	15.4	9.5	17.4	5.5	11.7	80.7	9.5	10.9	1.7	17.2	12.1	15.2	9.0	10.5	11.7	23.2	23.3	0.0	9.5	47.0	20.9	8.2	8.0	12.9	18.1	8.4
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 125.8"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 293.1;Hepatocytes: 215.1;Pancreatic endocrine cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 85.7;Hep G2: 99.2;U-2197: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		42000	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	25.9	11.3	4.4	24.7	3.2	0.2	12.7	4.0	3.1	13.0	29.3	3.8	10.2	13.7	11.5	9.7	22.9	9.9	12.9	10.1	3.6	3.5	28.2	125.8	13.5	4.7	4.0	2.2	20.6	24.9	5.1	4.7	26.8	5.3	13.2	23.3	7.5	8.2	7.3	7.5	5.5	24.2	17.7	3.7	3.3	14.1	5.0	3.8	1.7	16.7	12.7	7.1	30.2	24.1	12.0	12.3	17.1	12.0	21.8	22.4	10.2	4.9	85.7	9.4	12.3	30.9	34.4	7.9	16.3	19.4	16.1	14.8	12.0	18.5	3.1	10.2	22.6	14.8	5.1	9.8	4.6	16.9	4.0	1.7	3.5	11.1	99.2	12.2	4.3	3.5	11.5	2.5	27.6	8.7	13.0	10.3	2.5	4.6	2.6	11.1	14.6	4.2	4.7	7.6	32.4	6.3	7.2	14.6	3.1	8.9	19.7	4.8	7.1	10.0	5.9	6.8	7.2	3.3	3.6	12.0	16.6	7.7	61.6	7.8	6.0	4.3	3.1	14.0	3.6	8.6	17.1	12.0	10.9	14.3	10.6	22.4	10.9	11.4	14.8	10.7	12.0	9.8	12.0	2.3	21.8	6.1	12.3	7.3	10.2	4.4	3.2	4.0	3.0	3.6	3.5	4.0	2.2	5.3	3.8	23.8	22.2	19.5	56.0	103.1	7.7	7.3	22.9	72.3	30.7	19.2	13.7	18.5	59.7	44.3	0.9	20.2	111.9	0.0	293.1	59.3	101.2	100.0	35.7	215.1	16.1	9.5	108.6	23.4	18.5	0.9	30.8	17.2	28.7	26.2	69.3	5.2	205.5	85.2	27.3	54.9	8.6	32.3	92.4	2.4	4.0	35.0	24.3	11.5	88.0	69.0
SMIM14	"C4orf34, FLJ13289"	ENSG00000163683	"Small integral membrane protein 14"	Q96QK8	4	39546330-39639090	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 520.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 19.4;Daudi: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051299	Uncertain					NA	NA					"HPA051299: AB_2681429"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.48e-2)"	"prognostic favorable (3.00e-6)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-3)"	13.6	34.5	13.0	10.0	12.2	2.4	18.1	13.2	14.5	20.9	19.8	16.1	28.2	7.6	10.0	22.1	12.9	13.4	12.0	7.4	13.3	14.8	14.9	59.9	11.9	18.5	15.5	10.1	13.7	35.5	12.9	23.8	8.2	18.4	18.3	19.3	12.4	26.8	27.9	4.2	8.6	11.4	10.4	17.0	12.8	23.4	9.2	12.3	4.3	16.4	6.6	23.2	11.6	11.6	32.4	30.3	13.2	17.4	12.1	6.8	11.7	2.9	5.2	2.6	2.6	17.9	19.4	4.5	3.9	5.5	1.9	2.7	1.8	11.6	75.6	3.9	4.8	3.1	1.2	0.6	0.9	1.7	1.2	0.5	0.0	2.1	2.7	5.5	0.4	0.6	7.0	3.5	2.0	1.3	7.3	2.8	2.2	0.6	2.4	3.2	9.3	0.6	1.3	1.3	14.6	3.5	2.8	0.1	0.6	4.0	2.8	1.8	2.3	4.8	6.9	1.6	1.1	5.6	0.9	10.3	4.7	0.9	5.8	0.7	7.5	1.4	0.3	7.6	0.7	1.7	13.2	17.4	7.9	6.1	14.6	6.8	30.9	4.5	5.6	18.4	32.4	3.3	5.0	12.4	12.1	13.8	30.3	2.4	11.7	13.0	12.2	13.2	14.5	13.3	14.8	15.5	10.1	18.4	12.3	53.6	102.0	236.2	66.6	43.8	80.2	14.9	63.7	133.8	83.0	99.5	33.4	33.5	71.3	76.7	228.5	48.4	147.6	0.0	127.3	41.6	65.2	244.8	45.0	520.6	40.9	87.4	101.8	47.3	76.7	22.9	104.7	68.2	43.9	121.8	388.9	95.4	175.2	123.8	117.0	86.4	45.1	58.2	45.0	74.8	24.4	52.2	87.1	32.0	89.7	87.6
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		150000	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	24.2	24.9	13.4	12.7	8.4	7.9	22.8	33.4	7.1	9.0	9.4	37.6	25.0	30.3	29.4	9.4	22.1	10.2	25.8	14.6	14.4	20.3	18.5	39.2	25.2	32.5	10.6	42.1	22.2	7.4	16.5	12.6	13.6	9.4	11.7	13.3	39.8	10.9	9.2	23.5	29.3	23.4	17.8	14.0	19.0	17.3	40.3	11.3	12.5	33.8	27.9	12.3	25.0	9.5	14.9	15.5	12.2	14.1	32.0	14.0	29.7	16.6	30.7	15.4	45.0	33.3	7.3	27.0	16.4	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9	53.6	50.8	35.6	49.5	109.2	60.1	57.3	45.9	71.0	67.1	47.1	27.5	74.8	56.3	76.3	97.5	58.3	92.6	70.0	77.7	144.5	61.6	76.6	33.5	101.0	71.4	98.5	57.3	61.4	71.5	150.7	60.4	73.4	54.0	103.6	63.5	70.2	109.4	73.0	53.0	81.7	38.2	38.8	67.9	71.4	46.9	120.6	123.3	48.4	65.5	98.3
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	24.9	18.7	15.8	34.7	17.3	22.6	44.9	25.9	19.2	20.5	23.8	12.7	22.9	17.5	20.7	19.8	28.3	17.2	17.4	18.3	17.0	16.6	21.1	29.6	26.8	35.1	16.5	13.1	26.3	23.7	34.0	18.7	30.3	15.5	19.9	22.0	12.2	23.2	21.4	22.3	21.6	21.9	18.7	19.3	26.9	18.1	12.1	15.4	61.3	26.0	18.6	29.9	21.3	41.7	5.2	4.6	3.7	3.4	6.3	6.7	2.2	19.6	14.7	18.9	19.9	18.3	18.4	15.1	15.9	15.2	18.9	18.9	14.2	22.3	38.4	17.6	18.8	30.1	10.8	32.2	18.6	27.3	12.8	12.2	26.3	18.5	14.9	18.3	32.1	22.6	12.1	21.1	20.0	29.7	16.8	24.0	23.0	31.1	16.4	19.3	13.8	40.0	28.2	10.7	18.6	9.9	37.4	33.7	14.0	18.1	20.0	26.2	15.5	22.0	15.2	14.1	14.8	15.4	28.5	22.5	21.4	22.3	15.5	26.9	13.9	24.2	41.3	15.3	33.0	16.8	3.7	2.5	3.7	5.2	3.4	6.7	4.5	5.1	5.7	3.8	5.2	6.2	4.7	1.0	6.3	2.2	4.6	4.2	2.2	15.8	17.3	25.9	19.2	17.0	16.6	16.5	13.1	15.5	15.4	80.4	55.3	32.7	32.4	50.4	33.3	34.7	12.7	17.4	53.4	21.0	56.9	26.4	6.6	19.2	7.4	38.6	26.7	0.0	22.5	31.3	29.0	40.9	27.8	51.6	26.8	12.7	29.3	43.0	40.7	5.0	30.5	41.3	43.9	22.6	36.1	14.1	31.8	24.6	31.1	22.3	25.8	32.3	25.8	28.7	44.7	59.6	32.4	34.1	34.7	50.3
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056826-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.6"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	3.5	3.1	3.4	7.4	5.1	7.0	5.8	6.1	3.2	5.5	4.3	1.2	7.1	4.7	7.0	6.6	5.2	4.8	3.8	3.5	2.5	3.6	3.2	11.3	7.5	9.2	1.9	1.6	7.0	13.1	2.5	14.3	11.9	2.8	4.9	4.5	4.3	10.7	11.0	2.9	5.4	5.3	3.2	3.1	4.3	3.8	3.5	2.1	35.6	7.2	3.5	7.8	5.6	5.2	2.4	8.1	5.7	1.2	10.6	4.5	1.2	1.5	1.6	9.4	1.5	0.6	3.1	7.7	1.8	1.9	1.0	2.2	3.0	3.1	8.3	3.5	1.7	1.7	1.2	6.0	1.9	2.5	2.6	1.9	3.7	1.4	1.4	1.6	10.0	8.9	3.5	2.7	1.7	3.7	0.3	2.7	7.9	8.2	3.6	2.0	1.5	20.2	4.3	4.7	1.2	1.3	11.8	11.1	1.9	0.8	3.7	3.8	6.7	1.6	1.3	1.5	6.3	1.1	2.7	3.7	1.1	5.9	0.7	1.3	5.9	6.0	5.7	1.2	3.6	2.3	5.7	1.1	0.5	2.3	1.2	2.4	1.7	3.0	1.7	1.7	2.4	4.5	2.5	0.3	10.6	1.0	8.1	1.3	1.2	3.4	5.1	6.1	3.2	2.5	3.6	1.9	1.6	2.8	2.1	20.8	19.5	2.9	12.0	10.6	30.6	12.3	12.7	6.7	18.2	21.0	25.5	34.4	0.0	5.4	2.6	6.6	6.0	23.3	10.7	11.4	12.3	12.2	4.7	15.5	10.4	68.3	18.6	4.9	16.3	2.7	9.2	17.8	6.8	9.0	15.0	11.8	9.7	8.6	3.5	3.1	20.2	12.9	5.7	13.6	27.0	11.4	22.5	13.8	8.0	8.4
RHOH	"ARHH, RhoH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.8;lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	5	"B-cells: 118.6;granulocytes: 136.5;Melanocytes: 54.0;T-cells: 125.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 34.9;HMC-1: 26.8;JURKAT: 35.1;MOLT-4: 48.5;U-266/70: 18.8;U-266/84: 15.1;U-698: 32.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"	1.8	0.6	0.6	33.8	1.1	21.7	5.2	0.4	0.4	1.3	2.4	0.5	0.4	1.6	2.0	0.9	2.5	1.5	4.1	1.1	0.6	0.7	1.6	1.7	4.8	43.2	0.8	0.2	0.7	0.8	0.0	0.9	0.3	0.8	2.1	2.0	1.0	7.8	0.6	0.5	1.2	15.1	0.7	1.2	33.1	2.7	0.7	0.6	94.7	1.6	1.9	41.0	5.1	1.5	41.2	4.7	32.2	0.2	12.3	54.8	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.2	0.0	0.0	0.0	5.7	26.8	0.4	0.0	0.0	0.0	0.0	0.0	35.1	0.4	0.3	0.0	0.0	48.5	3.6	0.6	0.0	0.1	5.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.1	0.1	0.0	0.1	0.0	0.0	18.8	15.1	32.2	0.0	1.2	0.0	32.2	0.2	29.6	21.6	0.1	19.4	30.5	34.6	29.1	0.3	41.2	54.8	43.3	1.6	12.3	0.2	4.7	47.0	21.1	0.6	1.1	0.4	0.4	0.6	0.7	0.8	0.2	0.8	0.6	3.0	16.4	118.6	1.4	6.4	0.0	0.8	2.5	1.4	4.5	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	23.3	0.0	0.1	4.1	1.1	136.5	0.0	2.2	0.0	0.0	1.8	4.6	0.0	0.0	12.1	54.0	10.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	6.0	0.2	125.8	0.0	1.8
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335329-40355217	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 3.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 19.2"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.2	4.6	0.7	2.6	0.0	0.0	0.0	2.7	0.0	0.0	2.7	0.0	0.0	3.3	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.5	0.0	0.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.4	0.2	0.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 42.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"A549: 16.8;BEWO: 50.3;CAPAN-2: 22.1;SK-BR-3: 16.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	8.2	33.6	1.9	8.2	2.4	2.6	10.9	0.8	1.2	5.4	22.9	3.3	28.7	24.1	2.6	15.4	27.3	5.3	12.7	4.0	2.4	1.1	37.0	16.1	14.5	11.3	3.0	0.3	4.6	19.2	8.0	2.9	27.2	6.6	13.2	17.3	9.2	60.8	36.0	0.9	6.0	42.8	2.2	4.1	15.0	22.2	7.1	2.2	1.6	31.5	13.7	20.6	7.8	9.7	2.0	11.3	42.4	14.2	0.1	0.1	4.8	11.6	16.8	0.0	0.5	0.0	0.0	50.3	0.3	0.3	0.1	0.1	9.8	22.1	0.0	8.8	0.3	0.9	4.6	0.3	3.3	0.1	0.0	2.8	0.0	1.2	2.7	0.2	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	0.0	0.6	2.5	0.0	6.6	0.0	0.3	5.1	16.3	0.9	0.0	0.0	13.0	15.5	14.8	0.5	0.1	6.6	16.8	0.1	3.8	7.4	3.1	0.0	0.1	0.6	0.1	0.3	8.9	13.2	1.4	1.5	1.4	0.0	0.1	14.2	0.1	0.0	10.9	0.1	2.0	0.0	0.0	11.3	1.2	0.1	0.0	42.4	0.1	8.1	4.6	0.0	4.8	1.9	2.4	0.8	1.2	2.4	1.1	3.0	0.3	6.6	2.2	74.5	109.6	29.8	66.4	52.3	0.0	2.0	63.7	107.1	92.1	106.4	0.0	84.5	54.7	73.9	0.9	3.4	253.2	0.0	99.6	71.8	8.3	174.3	6.9	117.3	81.1	1.6	116.9	35.0	113.3	1.5	2.3	85.9	35.4	57.7	177.9	0.4	94.8	165.8	1.1	114.0	0.0	0.0	3.1	1.9	11.4	65.9	219.6	0.0	144.7	244.6
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749897-40809985	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.5"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 48.2;Early spermatids: 34.5;Late spermatids: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;SuSa: 5.1;T-47d: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.7	1.2	0.9	2.8	2.0	0.7	5.1	0.2	1.0	3.2	7.0	2.4	7.3	2.3	5.9	9.7	4.5	9.1	5.4	5.5	1.0	1.9	6.6	0.7	8.1	4.2	1.0	0.5	4.6	14.1	7.7	7.5	2.8	2.6	5.7	3.2	4.3	15.2	10.3	0.1	1.9	6.7	2.6	1.8	3.6	3.8	39.5	0.2	2.4	11.9	1.5	5.3	3.7	1.5	1.1	0.0	6.1	0.1	0.0	0.0	0.0	3.9	0.4	1.9	0.0	0.0	0.0	2.9	0.0	0.3	0.2	0.2	1.5	8.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	4.1	0.1	0.0	2.3	0.0	0.5	0.1	0.1	0.0	4.2	1.1	1.0	2.3	0.6	2.7	0.0	5.1	6.3	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.2	1.0	1.0	1.9	1.0	0.5	2.6	0.2	8.9	5.6	0.0	3.3	1.0	0.0	3.7	0.0	48.2	15.9	8.7	0.0	7.5	8.3	4.4	34.5	0.3	2.1	0.0	4.7	2.8	0.5	4.2	0.0	0.0	3.0	0.0	7.9	0.6	0.3	53.6	1.4	0.7	0.0	1.8	5.8	2.0	5.3	0.0	0.0	5.2	0.0	0.0	0.3	22.8	12.4	0.9	3.8	0.5	7.5	4.3
APBB2	"FE65L, FE65L1, MGC35575"	ENSG00000163697	"Amyloid beta precursor protein binding family B member 2"	Q92870	4	40810027-41216714	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Horizontal cells: 58.8;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 9.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 41.7;TIME: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023542	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA023542: AB_1844909"	"unprognostic (4.43e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (5.91e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.19e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.61e-1)"	35.1	9.1	18.4	5.1	25.5	7.2	20.9	7.6	30.1	13.9	10.8	42.9	8.3	7.9	14.2	5.9	9.0	11.6	15.8	18.8	19.4	15.1	17.0	13.9	17.5	6.7	34.3	16.8	31.5	10.1	9.8	10.2	16.3	29.8	8.4	8.2	13.7	7.6	10.3	22.4	10.6	6.0	14.4	30.7	13.2	10.1	8.8	35.1	2.3	32.9	5.3	5.4	11.8	15.4	9.4	0.3	0.6	0.4	0.2	0.1	0.4	5.3	2.7	6.2	8.6	21.3	16.4	13.7	10.4	13.6	4.2	7.4	9.5	11.4	9.9	5.9	4.6	12.7	1.6	11.0	14.4	7.7	0.3	2.2	0.1	6.7	6.3	20.7	5.5	0.3	24.4	7.8	12.5	13.0	18.0	41.7	5.7	0.3	0.2	27.0	4.7	1.8	1.0	5.1	2.8	5.2	14.8	17.9	11.5	6.2	2.5	8.3	4.8	3.3	2.0	2.1	7.6	5.0	0.6	55.2	6.0	17.4	4.1	18.0	2.5	5.1	12.0	6.6	9.1	7.1	0.6	0.4	0.2	0.1	0.1	0.1	0.7	0.1	0.1	0.3	9.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.4	18.4	25.5	7.6	24.6	19.4	15.1	34.3	16.8	29.8	35.1	74.5	12.6	0.8	3.6	9.5	6.2	13.6	15.3	4.0	7.9	8.7	5.9	12.6	6.6	3.6	13.9	32.4	4.6	0.0	5.6	2.1	18.8	2.1	1.1	12.1	2.7	58.8	2.9	45.4	5.6	15.2	33.1	3.1	6.8	0.0	3.8	11.2	5.4	4.9	35.0	4.8	7.2	58.2	24.7	3.6	9.8	10.5	5.0	0.5	6.4	2.7
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 109.9;Distal tubular cells: 218.8;Horizontal cells: 138.2;Spermatogonia: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 99.0;SCLC-21H: 98.8;U-251 MG: 90.4;U-266/84: 87.2;U-87 MG: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	56.1	11.6	0.0	1.5	1.9	0.0	58.7	30.3	20.8	21.0	11.3	0.0	0.0	99.0	29.9	31.4	0.1	21.4	0.0	8.5	0.1	8.7	0.0	0.3	0.0	44.9	0.0	0.0	10.8	0.2	16.7	0.0	34.7	0.1	0.0	0.0	0.2	11.0	0.0	0.0	0.9	33.6	0.0	63.4	0.0	24.8	0.0	31.4	0.0	98.8	62.0	0.3	0.2	0.2	13.9	0.0	0.5	0.3	1.3	0.4	0.0	90.4	46.4	87.2	0.2	96.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3	0.0	1.9	0.8	0.8	1.4	19.7	2.5	0.0	12.0	5.7	109.9	7.9	2.5	218.8	3.6	2.0	2.1	0.0	0.0	0.7	0.8	15.8	2.8	2.3	0.4	4.7	138.2	4.1	11.1	0.3	4.4	34.2	1.7	3.3	1.0	0.0	22.6	4.0	0.0	16.3	7.9	39.1	0.0	7.3	6.6	90.2	1.4	1.3	0.0	0.0	0.6
LIMCH1	"DKFZP686A01247, LIMCH1A, LMO7B"	ENSG00000064042	"LIM and calponin homology domains 1"	Q9UPQ0	4	41359607-41700044	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 87.1"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 604.5;Cardiomyocytes: 206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 4.4"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 27.6;HeLa: 47.6;hTERT-RPE1: 38.2;RT4: 45.4;SiHa: 25.8;WM-115: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004184, HPA063840"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA004184: AB_1078673, HPA063840: AB_2685133"	"prognostic unfavorable (5.55e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.82e-7)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.24e-3)"	19.4	18.7	24.9	3.1	27.6	0.9	11.7	13.8	24.6	6.7	4.3	30.2	8.4	3.0	4.0	6.5	8.8	9.3	11.2	45.0	29.1	21.3	15.0	6.4	58.2	1.9	34.4	18.2	19.1	5.8	59.6	8.6	15.8	23.3	28.7	4.5	13.6	32.5	13.6	87.1	6.6	4.2	7.2	43.3	49.1	5.4	5.1	25.2	0.2	20.6	23.5	2.4	12.4	9.4	0.0	4.4	0.0	0.4	0.0	0.0	0.1	0.6	6.7	10.4	0.6	0.0	0.0	1.0	8.5	4.3	8.6	4.3	1.0	2.6	0.0	27.6	22.6	0.2	4.7	5.8	3.9	9.7	0.0	0.8	0.0	47.6	0.0	8.8	0.0	0.0	0.1	11.5	0.0	2.7	38.2	0.8	0.0	0.0	0.0	2.4	3.7	0.0	0.0	0.7	1.4	0.7	0.0	12.7	0.1	7.2	45.4	9.8	19.9	25.8	10.3	0.1	8.7	0.7	0.0	0.0	0.1	10.2	2.3	6.5	0.0	0.0	0.0	0.6	0.0	36.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.9	27.6	13.8	21.6	29.1	21.3	34.4	18.2	23.3	25.2	604.5	166.2	0.0	43.2	34.7	24.7	206.0	17.8	105.7	147.9	90.7	35.3	12.1	18.3	32.7	54.1	58.8	4.2	0.0	12.0	30.0	23.8	134.4	4.7	9.3	10.2	0.0	9.2	108.6	17.8	20.9	1.7	5.5	13.5	33.3	5.1	100.0	7.4	8.6	7.1	9.3	73.0	0.0	6.2	5.1	12.0	26.7	38.6	5.4	5.1	49.4
PHOX2B	"NBPhox, Phox2b, PMX2B"	ENSG00000109132	"Paired like homeobox 2b"	Q99453	4	41744082-41748970	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.5;brain: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	99	"pons and medulla: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"SH-SY5Y: 53.6"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	14.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	24.8	0.2	1.4	0.8	0.0	0.0	0.0	0.0	3.2	0.5	0.4	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM33	FLJ10525	ENSG00000109133	"Transmembrane protein 33"	P57088	4	41935120-41960572	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075863	Approved					NA	NA					"HPA075863: "	"unprognostic (7.14e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.70e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.36e-2)"	15.8	24.7	14.7	18.1	17.3	12.6	20.4	11.1	22.3	12.6	17.8	16.7	14.5	20.0	12.6	25.4	30.6	12.0	16.6	14.6	15.2	16.0	24.0	59.4	18.6	20.4	16.0	15.0	14.7	18.1	23.9	31.8	22.3	17.4	17.3	20.6	15.9	22.0	17.9	14.0	16.3	22.2	10.8	21.7	19.2	18.4	11.2	14.0	23.6	22.7	16.4	18.4	17.7	16.5	8.8	15.0	27.0	20.8	9.8	12.3	9.8	13.0	15.1	14.0	19.2	17.9	12.2	16.5	17.8	19.6	15.4	17.7	18.6	44.8	23.0	27.7	14.9	31.7	20.9	45.6	23.8	20.8	5.9	9.3	28.4	19.5	16.7	21.7	38.2	25.1	12.7	25.8	19.4	28.6	10.0	12.2	14.2	30.1	9.2	20.9	11.3	33.9	25.7	24.8	20.7	18.1	15.4	21.4	18.3	21.5	19.1	15.3	21.9	14.6	14.4	23.3	13.9	15.7	13.8	18.9	18.2	24.3	18.1	32.1	16.5	26.3	27.8	19.5	31.6	26.3	19.3	20.8	13.4	10.4	19.5	12.3	8.8	10.7	9.7	15.0	7.4	9.6	10.5	27.0	9.8	19.9	11.7	12.1	9.8	14.7	17.3	11.1	22.3	15.2	16.0	16.0	15.0	17.4	14.0	56.6	26.4	27.6	25.8	65.1	19.0	15.9	28.1	16.0	28.4	52.4	15.7	48.9	19.9	39.5	2.0	22.6	49.6	0.0	33.1	41.7	36.6	65.9	38.1	73.1	53.1	27.0	33.7	22.7	58.5	2.2	18.7	54.6	54.0	24.4	38.2	37.6	42.8	41.9	21.9	34.8	18.4	25.8	22.6	27.0	30.0	58.5	111.3	23.5	32.1	57.0
DCAF4L1	WDR21B	ENSG00000182308	"DDB1 and CUL4 associated factor 4 like 1"	Q3SXM0	4	41981696-41986467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 37.5"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 81.2;Spermatogonia: 91.3"	"Cancer enriched"	"Detected in single"	49	"testis cancer: 8.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"REH: 3.6"									CAB073535	Enhanced					NA	NA					"CAB073535: "	"unprognostic (6.24e-2)"	"unprognostic (7.52e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.64e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.36e-4)"	0.1	0.1	0.1	0.2	0.2	0.1	1.1	0.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.9	0.3	0.1	0.1	0.1	0.5	0.0	37.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.3	1.4	0.3	0.0	0.4	0.0	0.1	0.2	0.3	2.4	0.1	0.1	1.5	0.4	0.1	0.3	0.2	0.3	0.8	0.6	0.3	0.1	0.3	0.8	2.0	0.2	0.6	0.2	0.8	2.1	2.0	0.4	0.2	2.3	1.3	0.1	2.2	0.6	0.3	0.0	0.0	0.7	1.0	0.0	0.2	0.1	0.8	2.9	0.3	0.4	0.6	3.6	0.4	0.6	0.2	0.4	0.7	0.7	0.2	0.1	0.3	0.4	0.2	0.2	0.4	0.3	2.1	0.6	2.1	0.9	2.8	0.3	0.3	2.0	1.0	0.9	0.3	0.1	0.3	0.2	0.0	0.3	0.4	0.2	0.1	0.6	0.0	0.4	1.4	0.0	0.3	0.3	0.0	0.0	0.1	0.2	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.3	1.3	0.9	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.6	0.7	0.0	0.0	0.5	0.2	0.4	1.2	0.0	0.8	0.3	0.0	0.0	0.0	2.6	5.4	1.1	0.1	3.3	1.0	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.0	0.0	81.2	91.3	0.6	0.5	0.0	0.4	0.1
SLC30A9	"C4orf1, GAC63, HUEL, ZNT9"	ENSG00000014824	"Solute carrier family 30 member 9"	Q6PML9	4	41990472-42090457	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transcription, Transcription regulation, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004014	Approved					NA	NA					"HPA004014: AB_1080005"	"unprognostic (4.26e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (2.86e-14)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.39e-2)"	11.0	20.4	23.6	11.2	28.8	7.0	18.1	24.2	32.4	16.5	17.0	12.8	15.3	16.1	13.8	21.8	12.5	13.3	11.5	33.4	22.7	24.4	38.2	17.9	11.6	9.0	22.7	23.7	15.1	16.6	30.4	32.6	12.2	27.7	18.3	18.4	11.5	15.0	16.4	17.1	12.6	15.5	11.5	19.2	11.9	16.1	8.8	15.4	12.0	22.5	15.8	10.0	11.8	11.6	4.0	7.1	6.2	6.5	5.9	5.5	3.9	8.5	4.3	14.2	16.1	11.0	15.4	8.1	11.9	14.4	10.5	12.5	4.4	11.2	8.8	8.7	13.6	13.5	4.4	11.9	9.8	15.0	3.0	7.2	10.1	7.6	7.3	19.5	13.8	7.3	12.2	10.1	8.9	11.7	16.9	11.3	9.0	13.5	4.2	18.2	4.1	7.9	13.2	10.9	13.3	6.0	4.0	12.9	7.2	21.2	7.2	15.9	17.9	8.4	9.4	10.5	10.6	12.0	10.5	12.1	12.3	7.2	12.3	13.7	8.3	6.3	8.4	16.8	11.8	10.7	6.2	5.3	3.0	3.6	6.5	4.2	4.0	4.2	4.6	7.1	3.8	5.5	4.3	2.6	5.9	5.0	5.1	4.7	3.9	23.6	28.8	24.2	32.4	22.7	24.4	22.7	23.7	27.7	15.4	44.7	38.5	16.7	19.2	13.5	33.9	83.2	25.5	49.5	34.2	36.6	23.6	37.0	87.9	31.8	3.9	18.8	23.6	0.0	31.7	28.0	22.1	27.9	33.5	23.6	21.4	47.7	32.1	22.7	21.0	6.9	19.2	20.3	23.6	28.9	35.3	24.3	29.0	10.5	21.2	80.0	36.5	6.5	23.1	11.7	14.9	19.8	41.3	14.9	36.5	19.2
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110938-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 26.7"	"Group enriched"	"Detected in some"	7	"Muller glia cells: 10.2;Spermatogonia: 35.8"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"memory B-cell: 1.1;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 23.9;HEK 293: 5.8;HEL: 14.6;MOLT-4: 8.9;SuSa: 11.8;U-698: 9.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.4	0.3	3.9	5.0	1.0	1.6	0.3	0.2	2.6	0.2	0.6	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.4	0.3	2.8	1.9	0.3	0.5	1.0	3.7	2.8	1.1	0.6	0.3	0.1	3.8	0.8	1.8	6.4	0.7	0.2	0.8	0.2	0.2	0.2	2.8	0.4	0.4	4.8	0.5	26.7	0.3	4.8	0.3	0.0	3.0	0.7	2.3	3.3	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	23.9	0.0	0.0	0.0	5.8	14.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	4.9	0.0	0.0	0.0	0.0	8.9	0.0	4.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.9	1.0	0.2	2.6	2.8	1.9	2.8	1.1	1.8	0.3	0.0	0.0	0.9	0.1	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.2	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	35.8	0.0	0.0	0.0	0.0	0.0
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397839-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 30.0"	"Group enriched"	"Detected in some"	9	"Distal tubular cells: 36.5;Ito cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"memory B-cell: 2.1;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Group enriched"	"Detected in some"	7	"AN3-CA: 70.7;PC-3: 41.0"	"Region enriched"	"Detected in single"	24	"olfactory region: 63.3"	"Low region specificity"	"Detected in some"			HPA054754			Approved	"Lipid droplets,Cytosol"		NA	NA			Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.5	2.1	1.0	2.3	3.5	0.1	1.8	0.7	1.3	0.9	5.0	0.1	2.9	2.9	0.3	6.2	8.6	0.4	4.2	12.9	0.9	1.5	30.0	1.0	4.7	15.4	8.3	0.7	1.4	0.3	0.1	0.5	0.2	3.3	2.6	4.1	0.3	1.2	1.5	3.4	0.4	8.4	10.7	1.0	0.6	3.5	2.0	2.2	0.0	4.6	2.6	1.1	6.8	4.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	41.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.5	0.7	1.3	0.9	1.5	8.3	0.7	3.3	2.2	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	3.5	0.0	0.0	36.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	23.9	0.8	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA		20000	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.3	17.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	28.1	8.0	0.1	0.0	1.4	4.0	0.0	0.0	4.4	2.8	9.9	1.0	0.4	0.0	2.4	0.2	0.3	0.0	0.0	0.0	0.3	0.1	6.3	0.0	3.2	0.0	1.2	3.5	0.8	1.3	1.1	0.3	9.7	0.0	3.1	6.1	0.3	3.1	9.3	0.2	5.9	0.0	0.7	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.7	0.4	3.4	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9	26.8	61.4	5.1	1.7	1.3	17.7	12.8	0.0	0.0	9.1	5.2	76.6	0.0	3.3	0.0	3.0	9.3	46.1	0.0	2.2	0.1	2.2	16.2	8.1	1.1	1.5	58.8	81.2	17.8	7.5	2.3	3.1	3.8	3.3	1.8	23.3	1.0	0.8	7.0	1.8	1.4	41.3	0.0	0.3	1.1	4.1	1.3	0.0	21.8	23.1	2.4
GRXCR1	"DFNB25, PPP1R88"	ENSG00000215203	"Glutaredoxin and cysteine rich domain containing 1"	A8MXD5	4	42893267-43030658	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"seminal vesicle: 11.0"	"Cell type enriched"	"Detected in single"	9	"Early spermatids: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040824	Uncertain					NA	NA					"HPA040824: AB_10794863"																		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
KCTD8		ENSG00000183783	"Potassium channel tetramerization domain containing 8"	Q6ZWB6	4	44173909-44448807	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.5"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 7.6;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 16.2"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;NTERA-2: 2.9;PC-3: 1.8;SCLC-21H: 10.9;U-2 OS: 3.3"	"Low region specificity"	"Detected in all"							HPA031562	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA031562: AB_10602609"	"unprognostic (1.49e-2)"	"unprognostic (7.70e-3)"		"unprognostic (1.53e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.77e-2)"		"unprognostic (1.48e-1)"		"unprognostic (7.85e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.44e-1)"	2.0	1.4	5.4	0.9	12.2	0.7	0.9	19.5	18.9	2.2	1.0	8.5	3.5	0.8	4.2	1.3	0.8	1.1	1.5	1.1	4.8	5.2	2.8	0.7	1.0	0.7	8.9	4.0	4.3	2.4	0.7	0.2	0.7	6.8	1.5	1.1	2.3	1.7	3.1	2.6	0.8	0.9	2.3	8.0	0.7	2.6	3.8	8.3	0.0	8.6	0.4	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	12.2	19.5	8.5	4.8	5.2	8.9	4.0	6.8	8.3	0.0	0.0	0.0	0.6	0.0	2.7	0.2	7.6	0.0	0.0	3.5	3.9	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	1.0	16.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
YIPF7	"FinGER9, FLJ39576"	ENSG00000177752	"Yip1 domain family member 7"	Q8N8F6	4	44622065-44678556	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 45.3;tongue: 14.8"	"Cell type enhanced"	"Detected in single"	32	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;fHDF/TERT166: 1.3;GAMG: 1.8;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6"	"Region enriched"	"Detected in single"	6	"cerebellum: 0.7"	"Region enriched"	"Detected in single"	29	"cerebellum: 14.8"	HPA030642	Uncertain					NA	NA					"HPA030642: AB_10601027"	"unprognostic (9.41e-4)"	"unprognostic (2.27e-1)"		"unprognostic (2.90e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.34e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.98e-2)"	1.5	0.0	0.3	0.0	0.5	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.6	0.1	45.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	14.8	0.7	0.0	0.0	2.3	3.3	0.3	1.0	0.3	0.9	0.3	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.8	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.3	0.3	0.0	0.7	0.0	0.6	0.3	0.0	0.3	0.5	1.1	0.0	0.0	0.0	1.6	0.0	1.0	0.0	0.5	0.7	0.4	2.3	0.9	0.7	0.6	0.6	0.3	0.4	0.3	0.3	0.2	3.3	0.1	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678427-44700926	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	10.0	11.3	12.7	7.5	16.6	11.4	10.8	9.7	17.7	7.6	11.5	9.4	8.7	9.4	10.2	9.1	13.2	8.9	7.9	12.3	12.6	9.9	15.1	16.0	6.6	10.8	10.4	11.6	10.6	9.3	11.5	11.3	7.8	13.0	10.6	12.4	7.4	10.4	8.0	31.1	11.5	12.5	7.6	11.8	9.7	15.4	11.7	11.1	13.9	11.2	13.1	9.3	11.7	9.2	4.8	4.7	4.6	6.1	5.2	7.0	3.9	7.7	3.9	7.4	9.4	3.1	6.4	16.3	10.6	5.6	11.1	8.6	7.0	5.6	16.9	8.5	5.2	10.1	6.2	12.7	12.3	12.7	5.7	8.1	20.2	3.4	4.8	10.0	21.9	8.7	6.4	5.6	8.2	7.2	5.2	7.9	10.1	20.3	3.3	8.9	3.8	12.2	4.6	4.8	5.6	9.3	8.8	15.3	7.1	3.3	3.0	10.2	7.6	6.8	2.9	7.5	6.0	4.5	6.4	7.9	7.6	8.8	10.1	12.7	12.2	11.1	12.4	8.3	13.1	6.4	1.1	4.6	4.6	4.7	6.1	6.1	4.8	4.7	4.2	4.3	4.4	4.5	4.6	0.1	5.2	4.0	4.7	7.0	3.9	12.7	16.6	9.7	17.7	12.6	9.9	10.4	11.6	13.0	11.1	6.0	7.4	12.1	7.4	3.5	9.7	19.3	2.5	22.7	10.3	7.0	2.0	11.2	11.6	7.9	1.4	6.8	9.1	23.3	8.8	14.4	7.3	8.4	1.1	13.4	10.4	11.1	10.9	10.4	11.7	1.5	5.2	6.6	6.8	6.4	12.4	8.6	11.9	5.8	6.7	8.4	10.2	0.0	8.2	9.2	9.6	6.1	11.2	8.9	11.9	9.1
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726595	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		710000	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	12.3	13.7	14.8	11.2	21.5	7.3	14.9	47.5	24.5	15.2	12.3	7.3	8.7	8.0	17.5	15.3	11.2	13.3	10.8	17.8	14.5	13.9	14.3	4.3	10.0	11.7	13.7	17.6	24.2	8.1	13.0	29.9	6.6	16.5	15.7	8.5	11.5	9.8	16.2	10.9	10.2	8.7	16.6	12.7	11.4	9.9	11.1	11.3	10.0	18.9	8.4	10.2	13.5	11.0	11.6	3.3	5.8	4.1	8.4	11.4	4.4	9.0	6.3	6.8	5.7	10.7	14.9	2.2	16.1	17.5	10.4	9.7	3.2	11.2	7.9	9.4	13.8	17.9	3.1	6.3	15.0	11.7	10.5	7.1	11.2	10.3	5.6	11.9	11.7	10.5	17.4	10.6	10.6	8.0	13.4	15.4	10.3	6.7	10.4	19.5	0.4	14.0	6.6	3.2	5.9	11.8	9.3	14.5	4.4	10.3	5.4	11.7	9.5	7.0	4.1	15.2	3.5	8.8	7.0	15.8	14.2	13.3	22.9	18.3	13.6	21.4	11.3	23.3	8.4	12.6	5.8	2.3	4.5	9.7	3.3	11.3	11.6	9.1	9.0	3.3	10.4	11.4	10.9	1.1	8.4	4.1	2.6	9.6	4.4	14.8	21.5	47.5	24.5	14.5	13.9	13.7	17.6	16.5	11.3	8.9	2.9	11.8	7.4	11.1	14.3	11.7	0.0	4.0	6.8	14.0	7.9	0.9	13.3	10.5	24.9	11.4	1.7	23.3	13.1	1.0	15.9	4.1	15.1	1.6	4.3	12.7	6.4	11.1	1.9	2.4	15.0	3.5	8.5	3.6	4.2	18.1	10.0	3.5	22.3	11.6	16.3	12.9	14.4	16.2	27.2	9.4	0.5	16.0	4.2	4.1
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor gamma1 subunit"	Q8N1C3	4	46035769-46124081	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 35.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 5.9;Muller glia cells: 15.1;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		1.5	1.5	20.3	1.2	25.9	1.2	1.3	26.4	35.7	1.3	1.3	12.2	0.0	1.4	1.4	1.3	1.3	1.7	1.3	1.2	26.0	14.6	1.4	1.4	1.2	1.3	10.2	14.0	3.9	1.2	1.3	1.6	1.2	17.9	1.2	1.3	0.0	1.2	1.3	1.2	1.2	1.4	1.4	17.8	1.4	1.3	1.8	17.8	0.0	1.5	0.0	1.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.3	1.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	25.9	26.4	18.5	26.0	14.6	10.2	14.0	17.9	17.8	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	1.8	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor alpha2 subunit"	P47869	4	46248427-46475230	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Uncertain	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	2.2	1.3	38.5	1.4	34.4	1.2	1.9	10.4	52.6	1.7	4.5	4.9	0.0	2.0	1.4	11.7	1.7	1.0	1.6	1.0	38.9	7.7	8.8	1.4	1.0	1.4	3.7	31.0	1.9	1.0	0.9	0.6	1.5	10.5	1.0	3.5	0.0	1.2	1.9	1.0	1.3	7.7	1.3	6.9	2.3	1.6	1.5	7.1	0.0	1.1	0.0	1.4	1.2	0.8	0.2	0.3	1.0	0.1	0.1	0.1	0.0	0.5	0.5	0.1	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.1	0.6	0.2	0.5	0.0	0.1	0.8	0.0	0.0	0.2	0.5	0.5	0.1	0.7	0.3	0.8	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.8	0.2	0.0	0.4	0.0	0.3	0.9	1.8	0.1	0.0	0.6	0.4	0.1	0.6	0.2	0.0	0.1	0.3	0.0	0.6	0.4	0.4	0.1	0.5	9.6	0.5	0.1	0.8	1.2	0.2	4.5	0.4	5.1	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.1	0.3	0.0	0.0	38.5	34.4	10.4	31.4	38.9	7.7	3.7	31.0	10.5	7.1	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	38.4	3.9	0.0	3.3	0.0	6.4	0.2	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	30.6	0.0	0.0	6.9	0.6	0.0	1.7	0.0	1.9	0.3	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0
COX7B2		ENSG00000170516	"Cytochrome c oxidase subunit 7B2"	Q8TF08	4	46734827-46909235	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"testis: 43.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 328.3;Late spermatids: 134.7;Spermatocytes: 292.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enriched"	"Detected in some"	15	"Karpas-707: 28.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA												"unprognostic (2.82e-1)"								"unprognostic (2.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	3.4	0.2	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.1	0.0	0.4	0.1	0.0	3.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.7	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	292.2	34.5	0.0	0.0	0.0	0.0	0.0
GABRA4		ENSG00000109158	"Gamma-aminobutyric acid type A receptor alpha4 subunit"	P48169	4	46918900-46994407	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 16.1"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 11.0;Muller glia cells: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	177	"REH: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA								"unprognostic (2.78e-2)"		"unprognostic (6.57e-3)"	"unprognostic (2.46e-1)"			"unprognostic (2.23e-1)"		"unprognostic (3.17e-1)"			"unprognostic (1.11e-1)"	"unprognostic (6.91e-2)"			0.0	0.1	2.7	0.1	8.9	0.0	0.0	0.3	16.1	0.1	0.1			0.6	0.0	0.0	0.2	0.0	0.1	4.0	1.9	1.4	0.1	0.0	0.0	0.0	1.0		0.0	0.0	0.0	0.2	0.3		0.0	0.1		0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.5	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GABRB1		ENSG00000163288	"Gamma-aminobutyric acid type A receptor beta1 subunit"	P18505	4	46993723-47426444	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.5;pituitary gland: 14.7"	"Cell type enriched"	"Detected in some"	25	"Muller glia cells: 39.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.4;REH: 4.2;SCLC-21H: 1.1;U-87 MG: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.11e-2)"		"unprognostic (7.56e-3)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"			"unprognostic (1.11e-1)"		"unprognostic (4.98e-3)"		"unprognostic (8.16e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.34e-1)"		1.0	1.3	19.9	1.0	34.5	0.9	1.0	14.7	27.9	1.0	1.2	2.7	0.0	1.6	1.2	1.0	1.0	1.2	1.2	6.0	16.3	4.2	1.8	1.1	1.1	0.9	2.8	18.5	1.1	0.9	0.9	14.7	1.3	5.6	1.0	1.2	0.0	0.9	0.9	0.9	0.9	1.3	1.0	3.4	1.0	1.0	1.1	6.7	0.0	1.3	0.0	0.9	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	34.5	14.7	16.6	16.3	4.2	2.8	18.5	5.6	6.7	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.0
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450796-47463719	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	11.4	14.0	14.7	13.9	21.3	13.1	10.9	9.5	18.8	9.7	12.5	5.7	7.7	13.1	9.7	17.3	21.1	8.3	10.0	19.1	14.1	14.0	32.5	16.1	15.1	21.4	13.9	15.0	8.4	10.4	15.5	20.5	20.0	11.3	9.2	13.4	6.5	9.8	9.2	7.7	12.5	17.1	12.8	11.6	14.5	10.0	16.9	10.9	15.2	15.7	19.7	17.5	15.5	12.7	21.1	32.7	39.8	36.4	23.9	22.9	27.9	12.5	6.9	6.1	3.1	13.0	18.6	8.5	18.9	12.6	12.4	16.9	11.6	14.8	20.1	15.9	17.8	28.1	6.7	19.6	15.4	22.5	11.8	8.8	11.5	7.8	9.0	17.8	28.1	14.9	16.0	20.8	11.8	13.2	11.6	15.7	13.3	8.5	8.2	30.2	7.0	16.7	22.9	4.2	8.5	9.1	8.4	14.0	4.3	35.6	10.3	12.1	6.1	7.8	6.4	15.0	11.2	11.8	18.7	12.9	17.8	17.1	15.8	22.5	8.7	10.4	16.1	19.3	37.0	12.8	39.8	26.2	29.5	21.3	34.9	22.9	21.1	19.6	21.1	32.7	18.8	18.5	21.0	12.9	23.9	36.4	15.3	22.0	27.9	14.7	21.3	9.5	18.8	14.1	14.0	13.9	15.0	11.3	10.9	20.8	13.9	28.1	10.6	20.0	18.5	38.3	10.2	52.2	19.4	27.9	3.9	74.5	91.2	38.2	28.4	22.9	18.0	0.0	40.4	94.8	31.8	6.4	32.3	10.2	81.6	6.4	20.2	20.9	60.2	8.5	50.3	51.3	11.8	59.5	20.0	25.7	23.9	21.5	38.2	147.8	18.8	19.4	34.0	66.9	52.6	26.2	88.4	57.3	24.6	7.3
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 57.5;Syncytiotrophoblasts: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.4"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.4	1.0	2.3	1.6	6.7	7.3	0.4	10.4	12.6	5.0	9.0	5.4	9.0	4.6	3.9	16.8	8.5	2.7	24.4	8.7	7.7	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.5	16.5	8.4	2.3	0.0	2.5	13.6	0.5	2.4	0.7	0.8	0.0	1.3	2.8	5.3	0.0	9.1	1.8	1.5	2.9	4.8	1.2	3.1	5.4	2.2	1.2	12.7	12.4	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	3.9	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3	8.9	6.9	15.0	7.9	17.1	10.9	3.6	0.0	2.7	2.3	15.7	29.5	27.1	1.7	4.3	1.6	14.0	1.6	0.0	4.1	7.4	11.8	5.8	2.3	4.9	11.7	12.7	9.2	17.8	16.1	0.6	57.5	9.1	6.8	7.2	4.3	28.8	2.7	2.5	23.7	9.1	8.9	25.8	9.8	0.4	2.7	23.6	147.8	11.5	3.7	6.5
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 50.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 32.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.5	32.6	0.0	1.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0	0.0	6.9	0.0	0.2	3.4	0.8	50.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.8	4.4	0.0	5.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.1	0.0	4.2	3.0	4.6	2.4	0.0	0.0	0.0	0.2
NFXL1	HOZFP	ENSG00000170448	"Nuclear transcription factor, X-box binding like 1"	Q6ZNB6	4	47847233-47914667	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 100.7;Spermatocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059132	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059132: AB_2683917"	"unprognostic (5.37e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.26e-3)"	"unprognostic (8.48e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.72e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.01e-2)"	8.3	5.8	7.8	7.2	8.7	6.5	10.8	19.1	9.4	10.1	7.4	6.2	12.2	7.8	13.3	19.2	9.7	9.6	6.9	5.5	6.7	5.5	7.4	9.5	7.4	6.5	7.0	9.6	10.9	12.8	11.9	19.6	8.7	7.6	9.0	8.6	5.3	12.4	10.2	7.1	9.3	7.4	8.8	8.8	7.5	8.2	21.3	7.0	5.9	17.2	4.4	7.7	9.2	10.9	2.5	1.9	5.6	2.3	1.5	3.5	1.7	5.5	3.5	3.9	8.1	7.5	12.4	13.4	3.8	5.4	6.2	7.8	5.9	12.7	4.4	7.3	2.5	12.1	5.7	10.1	7.6	7.4	3.4	3.9	4.7	6.5	10.8	9.7	11.5	9.5	8.1	10.2	4.3	25.6	7.4	5.4	9.3	8.4	5.5	6.4	5.3	9.0	5.4	9.5	7.6	5.5	8.1	7.6	7.3	7.9	10.6	12.5	6.0	2.8	8.0	5.5	7.9	5.5	3.4	4.4	8.2	5.1	3.8	8.4	8.9	5.4	8.9	4.7	6.5	7.1	0.0	1.7	1.7	2.3	2.3	2.8	2.2	3.2	2.5	1.6	2.5	3.5	3.4	5.6	1.5	1.1	1.9	2.0	1.7	7.8	8.7	19.1	9.4	6.7	5.5	7.0	9.6	7.6	7.0	6.0	8.3	1.5	4.0	4.7	19.0	100.7	15.3	8.1	13.6	7.0	9.8	5.0	10.0	7.2	28.3	7.3	5.8	0.0	6.0	9.5	8.0	6.1	2.3	7.2	4.3	7.9	10.9	4.3	3.5	12.4	11.8	6.2	1.7	4.6	7.4	9.1	6.3	3.5	9.6	3.1	16.0	0.0	3.6	72.2	24.3	3.8	5.6	4.9	6.9	5.1
NIPAL1	"DKFZp686A06115, NPAL1"	ENSG00000163293	"NIPA like domain containing 1"	Q6NVV3	4	47914142-48040173	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.8"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 40.1;Paneth cells: 31.6;Urothelial cells: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 11.0;CAPAN-2: 9.9;HaCaT: 13.1;HBEC3-KT: 9.4;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA036765	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036765: AB_10672366"	"unprognostic (3.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.03e-7)"	"unprognostic (2.55e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	0.5	0.4	0.4	5.4	1.4	0.0	2.2	0.8	0.7	3.6	9.1	0.1	0.0	3.3	0.4	6.3	18.5	1.1	1.8	0.6	0.7	0.7	4.6	10.7	0.5	0.0	0.4	0.2	0.8	6.6	2.9	5.5	30.8	0.7	3.0	8.9	1.2	5.3	0.6	0.7	17.1	12.6	1.0	0.6	0.4	4.3	0.8	0.3	0.2	2.0	9.8	11.2	4.2	5.3	1.0	1.4	1.4	0.8	0.6	0.9	0.0	11.0	0.2	0.0	0.0	0.0	0.0	1.8	2.1	2.0	1.6	2.8	6.6	9.9	0.0	1.5	0.0	2.9	13.1	1.9	9.4	4.1	0.1	2.4	0.0	0.1	0.4	0.0	0.1	0.1	0.1	3.5	0.1	2.3	2.7	0.5	0.7	0.1	0.0	2.3	4.2	0.1	0.1	1.7	7.6	2.9	0.0	0.0	0.0	5.6	15.1	1.0	0.3	1.0	3.7	1.6	0.9	2.4	0.0	4.2	0.1	3.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	4.2	0.9	0.8	0.5	0.8	0.4	0.6	0.4	0.5	0.3	0.1	1.0	0.7	0.9	1.4	0.6	0.5	1.4	0.3	0.0	0.4	1.4	0.8	0.7	0.7	0.7	0.4	0.2	0.7	0.3	8.9	6.7	0.0	22.7	12.8	0.1	2.6	0.0	2.7	14.8	40.1	0.0	1.6	0.0	8.8	0.5	0.3	27.6	0.0	5.8	1.0	1.3	24.9	0.0	10.4	0.3	0.0	11.1	0.6	0.0	0.0	0.0	0.2	1.7	1.0	27.4	0.5	10.3	31.6	0.0	1.0	3.8	0.0	2.1	1.0	1.5	28.9	3.0	0.7	29.9	36.3
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel alpha 1"	P29973	4	47935977-48016672	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.7"	"Cell type enriched"	"Detected in many"	9	"Rod photoreceptor cells: 880.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	4.9	1.1	0.6	2.7	1.0	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1.0	0.6	0.6	4.9	23.7	0.5	0.0	1.3	0.0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	13.4	0.1	0.7	0.0	3.6	2.1	0.3	0.4	0.1	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.3	0.1	0.6	0.0	0.1	1.6	0.0	1.1	0.9	0.7	0.2	1.3	0.1	0.2	0.6	2.0	3.1	0.1	0.0	0.1	0.6	10.7	0.3	0.1	0.2	0.6	0.2	0.3	1.2	0.0	0.6	0.3	4.2	0.1	0.1	0.9	1.0	0.1	0.1	0.1	2.4	0.2	0.4	0.0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1.0	0.3	0.5	0.6	0.6	1.3	0.0	0.4	0.2	0.0	0.0	0.0	1.4	0.1	78.5	0.4	2.5	0.0	0.0	59.3	86.4	0.0	0.0	7.8	0.4	0.1	8.4	0.0	5.9	0.0	0.2	4.0	0.0	30.0	1.3	42.9	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	3.2	100.9	1.6	10.5	0.0	0.3	880.8	0.0	3.1	0.3	1.3	2.4	0.2	0.0	2.9	15.6
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134256	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4"	"Cell type enriched"	"Detected in some"	9	"T-cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 43.5"	"Group enriched"	"Detected in many"	26	"NK-cells: 43.5;T-cells: 17.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles		NA	NA			Vesicles		"HPA062482: AB_2684778"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	1.8	1.5	0.3	15.3	0.4	3.9	1.5	0.2	0.6	0.8	2.1	0.3	0.2	1.3	1.3	11.6	2.4	2.6	1.7	0.7	0.2	0.4	2.1	2.8	4.0	49.1	0.5	0.5	0.5	1.0	0.4	1.3	28.4	0.6	0.9	1.0	1.0	6.1	0.2	0.5	1.7	7.9	0.4	0.4	17.8	1.0	1.7	0.2	14.0	1.9	0.2	19.3	2.4	1.4	0.0	0.1	1.1	0.0	43.5	17.5	10.6	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.8	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.4	0.2	0.1	2.4	0.0	0.0	0.0	0.3	11.3	0.0	0.0	0.1	0.0	0.8	0.1	0.4	0.2	0.0	0.7	0.0	0.0	2.1	0.0	0.6	0.8	0.3	0.0	0.0	1.4	1.3	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.1	5.5	6.8	0.4	0.0	0.4	25.4	1.1	0.0	0.3	13.2	0.0	17.4	0.0	6.8	6.4	0.0	0.0	17.5	11.9	0.8	43.5	0.0	0.1	5.1	10.6	0.3	0.4	0.2	0.6	0.2	0.4	0.5	0.5	0.6	0.2	0.0	2.6	0.8	0.5	0.3	0.0	0.2	2.5	0.0	0.0	0.0	3.9	0.2	1.7	1.3	4.3	0.1	0.0	0.0	0.0	0.1	0.5	0.4	1.1	1.0	1.2	0.0	0.0	4.3	5.1	1.3	0.3	0.5	1.7	0.0	0.0	2.3	0.2	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.2	1.0	0.5	43.1	0.2	0.6
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 12.7;granulocytes: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 13.3;eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in many"		"HEL: 10.6;HMC-1: 16.7;U-266/70: 16.7;U-266/84: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2.0	3.4	4.8	0.5	8.4	2.8	3.0	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4.0	5.7	6.4	7.0	1.5	0.3	2.9	2.9	2.6	6.4	2.0	3.2	2.0	2.5	3.0	6.8	4.7	2.1	8.1	6.5	3.0	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.4	1.8	1.1	2.3	0.0	1.8	1.5	1.7	0.0	0.0	0.5	0.9	0.0	1.5	0.1	0.7	10.6	0.8	0.1	0.0	1.7	16.7	0.0	0.2	1.4	0.0	1.1	0.0	0.5	5.8	0.4	3.3	0.8	1.0	3.8	0.3	1.1	0.7	2.4	2.2	0.0	2.8	0.7	0.0	0.2	0.5	0.3	0.4	0.9	0.6	3.4	0.0	0.0	0.0	2.3	0.0	16.7	11.9	2.1	0.0	2.4	0.1	13.3	0.5	11.0	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0.0	0.3	0.8	1.1	0.6	2.0	0.9	0.9	1.5	0.3	3.2	0.6	6.0	5.0	0.8	1.5	2.3	0.5	1.6	12.7	0.0	4.5	0.0	0.0	1.3	0.0	1.3	3.9	0.6	2.2	0.0	0.9	0.1	0.9	1.1	18.5	3.2	4.0	0.0	2.9	0.0	4.5	1.7	0.0	2.8	1.7	0.0	1.4	5.0	0.9	0.0	0.4	1.8	2.4	6.5	0.7	0.7	1.1	2.6	0.7	2.5	2.0	1.3
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.5	4.9	9.0	8.8	13.9	17.2	6.3	19.4	24.8	17.4	18.1	4.9	10.6	7.6	12.0	22.2	31.3	8.3	36.7	18.2	30.7	6.2	3.7	13.3	7.3	5.6	15.0	12.1	13.6	14.6	27.0	20.1	23.5	13.1	10.2	6.8	8.4	8.5	17.4	6.4	13.9	10.0	3.8	9.9	7.1	7.9	17.5	4.8	15.2	13.9	6.0	7.6	7.9	5.9	8.3	8.6	7.4	8.7	12.9	19.1	18.1	12.0	19.7	11.6	12.0	6.5	15.0	13.8	13.7	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8	50.6	34.2	23.6	40.6	74.9	14.4	68.6	15.3	75.0	27.3	26.2	13.7	24.2	18.3	26.4	122.5	23.3	27.7	0.0	30.2	23.9	23.6	48.5	21.8	28.9	19.9	33.4	24.2	22.1	17.5	234.7	25.3	24.3	18.6	29.7	30.2	19.7	25.2	28.8	34.6	20.7	38.1	32.3	32.3	69.6	47.8	79.9	63.2	29.8	19.0	50.2
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489196	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.3;brain: 19.0"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 1.4"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.6;HEL: 4.6;K-562: 10.6;SH-SY5Y: 28.2;THP-1: 4.6"					"Group enriched"	"Detected in many"	5	"basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5"	HPA028835	Uncertain	Supported				NA	NA					"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.4	12.3	1.4	2.7	7.3	3.4	0.5	0.5	6.4	2.9	1.6	0.7	0.0	0.8	0.4	0.2	0.4	0.4	0.6	0.6	1.2	6.3	0.3	0.2	1.1	0.3	19.0	0.8	0.3	0.3	0.4	7.5	0.4	15.3	0.4	1.5	4.0	4.9	0.9	0.9	0.4	1.3	0.6	1.1	0.4	0.8	1.2	0.7	0.0	1.5	0.0	0.3	0.4	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	2.1	0.0	10.6	0.0	0.1	0.0	2.3	4.6	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.7	28.2	0.5	0.0	0.1	0.6	0.0	4.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.3	0.5	6.3	1.2	6.3	19.0	0.8	15.3	0.7	0.0	2.7	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0
ZAR1	Z3CXXC6	ENSG00000182223	"Zygote arrest 1"	Q86SH2	4	48490252-48494389	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 2.0;brain: 2.7;salivary gland: 1.3;testis: 4.2"	"Group enriched"	"Detected in some"	13	"Early spermatids: 3.4;Late spermatids: 6.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.3;HeLa: 1.5;K-562: 1.2;SCLC-21H: 2.4;SH-SY5Y: 3.2"					"Low region specificity"	"Detected in some"									NA	NA							"unprognostic (9.71e-2)"	"unprognostic (2.58e-1)"		"unprognostic (4.59e-3)"	"unprognostic (2.47e-2)"		"unprognostic (6.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-1)"				"unprognostic (1.08e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.32e-5)"	"unprognostic (4.51e-1)"	0.0	0.0	0.0	0.0	0.8	2.0	0.0	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.7		0.4	0.0	0.0	0.5	0.0		0.0	0.0		1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.2			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.2	0.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497361-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Mucus-secreting cells: 166.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 12.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	9.6	7.5	13.4	13.1	27.4	12.4	8.3	10.1	20.2	7.3	30.5	23.4	7.1	8.6	8.5	3.7	6.3	6.5	7.1	7.7	13.8	8.6	7.6	4.8	9.0	10.6	30.2	7.9	7.1	5.8	28.4	12.5	9.0	17.6	5.9	30.8	5.5	6.1	6.2	9.1	8.8	13.4	8.1	25.8	8.8	9.1	5.2	30.1	11.8	6.9	3.9	10.9	8.8	6.0	2.1	2.2	12.6	2.0	3.3	2.8	0.9	10.3	6.3	14.9	9.5	6.2	8.8	8.1	9.4	9.7	10.1	12.0	4.9	8.3	13.0	8.0	10.2	18.4	6.6	9.7	16.1	21.4	7.4	3.3	24.3	6.4	2.3	4.2	16.7	9.7	6.7	6.2	13.8	14.4	9.2	14.5	11.9	7.5	5.2	12.6	5.3	17.0	5.9	2.5	4.7	5.8	13.6	18.9	2.6	9.2	11.3	13.2	5.9	9.8	2.6	5.3	7.6	3.9	10.9	21.6	10.9	14.6	5.8	19.0	7.1	9.2	11.8	9.1	11.1	10.8	12.6	1.2	2.3	2.8	2.0	2.2	2.1	2.5	2.2	1.1	1.8	2.8	2.7	3.7	3.3	1.2	2.2	1.8	0.9	13.4	27.4	10.1	20.2	13.8	8.6	30.2	7.9	17.6	30.1	35.7	34.5	32.0	20.8	42.0	41.5	31.3	17.8	5.3	21.6	15.7	127.6	19.2	3.3	11.5	8.8	48.5	86.6	23.3	10.2	16.6	20.2	32.9	45.1	11.1	16.4	44.5	76.3	41.7	29.4	2.6	15.8	27.0	25.3	21.6	166.5	39.2	21.6	80.1	17.3	6.5	111.4	19.4	27.8	9.0	6.9	43.2	9.0	24.5	66.0	48.0
OCIAD1	"Asrij, FLJ20455, OCIA, TPA018"	ENSG00000109180	"OCIA domain containing 1"	Q9NX40	4	48805212-48861817	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044803	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044803: AB_10961287"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.82e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.10e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.34e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	28.8	43.6	59.9	24.7	73.5	21.8	35.9	55.3	82.2	37.4	37.6	36.1	35.4	33.5	34.1	49.3	28.1	41.6	29.9	47.9	62.7	61.9	57.8	79.0	27.7	32.0	51.4	60.7	40.4	34.6	52.4	53.5	29.0	53.6	34.8	39.6	29.1	34.8	36.4	53.5	23.9	30.1	33.4	51.0	23.7	31.0	23.7	35.1	29.1	55.1	37.2	31.0	31.6	24.0	33.2	35.9	30.7	33.6	41.9	43.2	30.0	25.3	18.6	38.3	26.2	38.0	45.9	29.6	41.5	64.9	42.7	50.1	18.1	72.1	29.4	41.5	36.4	50.3	22.2	36.3	38.4	51.9	24.4	24.3	45.8	18.9	14.7	56.3	47.1	49.6	48.9	56.2	33.5	41.4	50.5	43.7	28.7	50.9	16.5	49.6	17.3	40.4	47.1	31.5	31.6	17.5	28.2	37.2	31.1	82.7	25.6	22.5	41.4	20.4	16.2	45.9	31.9	32.7	41.3	33.0	28.3	32.7	19.4	51.7	42.8	59.3	46.3	34.5	37.8	34.5	17.6	26.0	30.7	30.5	28.5	41.6	33.2	34.7	36.2	32.5	29.3	43.2	37.2	21.2	41.9	33.6	35.9	29.0	30.0	59.9	73.5	55.3	82.2	62.7	61.9	51.4	60.7	53.6	35.1	148.9	102.8	64.1	94.0	70.7	125.5	130.0	91.7	135.1	126.3	115.1	62.8	145.3	116.0	119.6	27.3	96.7	127.3	23.3	111.9	141.2	103.1	99.3	136.5	146.0	135.1	84.2	124.9	116.0	90.1	28.7	122.6	103.2	82.7	75.7	122.7	180.6	107.9	109.4	130.8	136.7	91.1	122.9	84.8	156.2	74.3	66.4	137.8	88.7	125.2	76.6
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Pancreatic endocrine cells: 896.7;Proximal tubular cells: 1166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.2;U-251 MG: 66.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	4.0	10.7	24.5	15.7	18.3	4.7	8.1	3.7	14.0	7.2	23.0	1.9	14.0	41.6	8.9	19.5	12.4	7.7	22.3	7.2	19.9	11.7	51.6	43.6	6.6	10.7	9.7	9.9	3.7	13.2	9.4	18.7	2.9	8.8	8.8	17.3	6.6	18.3	12.9	1.8	9.0	37.5	5.2	4.1	5.2	27.9	4.1	5.7	24.9	14.9	5.8	13.3	9.3	8.5	29.7	22.9	32.7	0.6	27.1	60.8	26.1	34.4	18.4	0.2	0.0	0.0	0.0	0.5	9.0	4.1	4.8	4.6	0.0	42.8	6.0	40.1	5.1	43.2	11.1	5.1	56.2	5.0	14.0	3.8	0.0	13.5	0.0	4.5	16.9	0.0	2.6	25.7	0.0	11.0	14.2	20.1	24.2	0.0	3.0	5.1	13.0	28.3	11.4	17.7	39.1	24.9	6.4	0.0	9.9	49.9	22.7	39.8	12.1	12.9	4.4	0.9	0.1	4.5	4.2	33.4	0.0	37.2	0.2	66.8	8.5	9.7	19.0	28.7	0.0	0.0	32.7	0.6	12.4	20.4	0.2	27.0	29.7	38.4	29.2	3.4	27.0	50.2	33.6	2.1	27.1	0.2	22.9	60.8	26.1	24.5	18.3	3.7	14.0	19.9	11.7	9.7	9.9	8.8	5.7	26.8	63.5	79.5	119.3	96.9	7.4	32.5	201.2	73.6	62.6	167.5	27.5	30.6	184.1	416.6	0.8	82.3	395.2	46.7	497.9	9.4	14.8	156.3	35.8	172.0	35.7	1.6	294.2	16.5	3.7	1.2	4.6	15.3	62.4	17.2	244.9	20.9	896.7	160.4	20.1	1166.8	52.0	0.0	20.8	0.9	2.2	114.8	12.8	114.6	155.7	207.5
CWH43	"CWH43-C, FLJ21511"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986247-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 22.9"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 22.7;Collecting duct cells: 7.0;Glandular cells: 8.2;Paneth cells: 11.5;Suprabasal keratinocytes: 8.0;Undifferentiated cells: 8.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;NB-4: 1.4;SH-SY5Y: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain					NA	NA					"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.1	0.0	0.1	9.3	0.1	0.0	1.0	0.1	0.2	5.1	9.7	0.2	11.1	0.0	2.0	2.2	19.8	8.6	0.4	0.1	0.1	0.1	7.6	1.1	0.8	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	26.1	9.1	0.4	2.7	22.9	0.1	16.9	0.1	1.9	0.1	0.1	5.2	0.7	0.1	0.3	10.6	12.6	3.6	3.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.3	0.0	22.7	2.3	7.0	0.0	0.0	1.7	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	11.5	0.0	3.4	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	8.9	0.3
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	16.9	22.9	15.9	9.9	26.1	3.5	13.5	15.4	24.8	15.9	14.3	12.8	15.5	7.6	17.8	17.3	13.4	13.6	14.2	14.9	29.8	22.3	19.4	36.5	10.4	10.7	17.7	22.0	20.8	9.8	9.9	19.8	9.3	24.6	16.6	12.0	9.4	15.9	22.9	14.3	10.2	9.8	31.4	24.0	11.4	14.6	20.4	13.4	3.9	16.8	8.6	8.2	20.3	13.7	4.6	2.9	10.2	4.2	4.4	10.7	5.3	5.7	10.3	13.9	20.1	14.3	14.3	5.3	17.9	13.3	10.2	9.2	6.6	6.2	4.3	11.6	20.1	13.5	5.8	17.7	11.2	14.1	2.7	5.2	7.6	8.0	15.9	30.2	10.5	10.3	14.8	13.2	11.7	10.2	13.6	10.2	4.1	8.4	3.2	17.6	8.4	12.9	7.4	8.2	11.6	8.5	6.2	7.2	2.4	13.3	6.8	8.2	8.9	7.7	9.6	14.8	8.2	9.8	6.7	16.6	13.6	11.1	10.9	14.2	5.8	8.3	4.0	9.5	10.1	7.7	5.5	4.2	10.2	7.2	3.7	10.7	4.6	8.1	8.0	2.9	3.3	7.8	8.5	1.7	4.4	2.6	1.9	3.7	5.3	15.9	26.1	15.4	24.8	29.8	22.3	17.7	22.0	24.6	13.4	6.0	13.1	10.4	16.2	33.1	22.1	33.1	20.4	16.0	12.5	15.7	15.7	4.6	11.6	9.4	58.2	21.5	8.7	0.0	10.5	7.4	21.0	13.4	12.7	32.7	7.2	28.6	6.4	18.4	6.3	89.6	13.8	10.8	30.4	3.6	6.9	14.1	10.8	10.5	24.4	19.5	15.9	0.0	18.6	22.8	27.9	29.1	2.9	10.1	8.1	13.7
LRRC66		ENSG00000188993	"Leucine rich repeat containing 66"	Q68CR7	4	51993702-52017620	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 50.2"	"Cell type enhanced"	"Detected in some"	23	"Enterocytes: 11.9;Mucus-secreting cells: 4.0;Paneth cells: 2.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.0;CAPAN-2: 5.1;OE19: 6.5"					"Low region specificity"	"Detected in all"			"HPA014549, HPA027839"	Uncertain					NA	NA					"HPA014549: AB_1853062, HPA027839: AB_10602705"	"unprognostic (1.10e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.06e-1)"	0.5	0.1	0.8	2.6	1.0	0.0	0.5	1.4	0.9	0.5	11.3	0.5	0.5	19.6	0.5	0.5	0.5	0.5	1.6	0.6	0.8	0.8	0.9	0.5	0.5	0.5	0.8	0.5	0.5	0.5	0.5	3.1	0.5	0.5	0.5	5.2	0.5	0.5	0.5	6.7	0.0	50.2	0.5	0.6	0.5	4.6	0.7	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.2	0.4	0.6	1.7	4.0	0.1	0.6	1.0	0.3	0.7	0.2	5.1	0.0	0.1	0.9	0.1	0.0	0.3	0.2	0.3	1.6	0.6	0.0	0.2	0.0	0.2	0.1	0.1	1.6	0.8	0.8	0.2	1.3	0.4	0.3	0.0	0.0	2.0	0.0	0.1	0.0	0.0	6.5	0.9	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.4	1.1	0.0	0.7	0.5	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.4	0.9	0.8	0.8	0.8	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	11.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	4.0	0.0	0.3	2.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0
SGCB	"A3b, LGMD2E, SGC"	ENSG00000163069	"Sarcoglycan beta"	Q16585	4	52020706-52038482	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011422, HPA058656"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA011422: AB_1856795, HPA058656: AB_2683790"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.53e-6)"	"unprognostic (3.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (7.61e-4)"	17.7	13.2	17.6	5.4	19.0	0.5	8.8	18.6	20.7	14.9	18.3	17.5	3.7	7.7	17.1	7.0	13.2	11.5	11.6	32.4	16.5	14.5	20.5	6.4	9.0	3.4	20.4	12.9	12.6	4.0	29.9	17.5	13.9	17.9	15.4	9.9	7.9	7.8	17.0	54.1	4.4	8.7	21.8	24.7	6.3	9.0	9.2	20.3	0.9	7.9	10.4	2.8	13.5	11.8	4.3	1.7	0.9	2.0	0.5	6.6	2.0	3.4	4.2	8.9	3.3	34.4	26.0	3.2	19.7	25.3	11.1	11.7	1.1	4.7	0.9	3.8	25.8	17.2	1.7	6.6	7.2	11.9	5.7	2.5	0.0	4.0	2.1	14.1	2.0	1.1	28.5	5.1	9.6	5.6	29.1	14.5	3.4	0.0	0.0	23.6	1.3	4.5	0.0	3.2	1.4	6.5	0.0	4.7	0.0	9.3	1.2	5.2	9.1	12.5	0.6	4.3	10.4	1.6	1.2	14.7	16.5	5.5	7.7	17.4	4.8	6.1	1.7	12.1	0.7	18.8	0.4	2.0	0.1	3.9	0.8	3.7	4.3	4.6	4.1	0.9	3.6	3.3	4.1	0.9	0.5	0.6	1.7	6.6	2.0	17.6	19.0	18.6	17.5	16.5	14.5	20.4	12.9	17.9	20.3	29.8	12.5	7.0	23.0	11.8	22.7	71.9	20.4	18.7	12.5	12.2	5.9	4.3	1.7	23.7	46.3	25.1	15.9	0.0	46.3	44.3	51.2	9.7	2.3	14.3	2.6	27.0	15.6	35.0	2.2	132.8	35.9	5.1	25.3	1.8	2.6	22.7	35.3	3.5	85.9	54.8	13.4	45.3	63.4	9.8	15.8	9.3	5.3	7.5	11.3	12.3
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051331-52097292	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 41.7;testis: 65.7"	"Group enriched"	"Detected in many"	10	"Early spermatids: 536.7;Late spermatids: 1836.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Cell type enriched"	"Detected in single"	23	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 20.1;BEWO: 15.1;BJ hTERT+: 9.7;HSkMC: 18.5;hTCEpi: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	4.2	2.6	1.2	3.3	0.0	3.7	0.1	1.1	6.8	2.3	3.6	5.3	1.2	2.5	9.9	4.9	41.7	11.5	1.5	3.1	2.8	3.7	4.4	12.0	0.3	0.6	0.6	7.6	1.6	4.2	6.1	1.8	12.5	3.5	3.5	1.4	13.2	6.0	1.1	4.3	2.8	1.8	0.8	0.5	2.9	65.7	0.8	1.3	1.6	4.1	3.1	2.3	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	0.0	8.0	20.1	15.1	5.6	9.7	0.3	0.4	0.0	0.9	0.0	0.0	7.4	0.1	0.1	0.0	4.3	0.2	0.0	0.6	0.0	0.0	4.7	7.1	0.0	0.0	18.5	17.8	0.6	2.8	3.2	4.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	1.2	0.6	0.0	0.0	6.3	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.3	0.1	1.1	3.1	2.8	0.6	0.6	12.5	0.8	8.9	4.0	0.0	6.6	4.6	0.0	2.4	7.6	115.1	18.2	0.0	0.0	1.4	1.7	0.9	536.7	0.4	1.1	0.0	2.4	1.1	2.3	5.1	2.3	1.7	0.3	0.0	1.7	2.5	1.2	1836.3	10.0	1.2	0.0	0.0	1.6	0.0	1.2	2.9	10.3	5.4	0.0	0.0	1.8	11.7	6.8	6.6	0.7	0.0	3.8	6.4
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590972-52659335	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 123.5;Early spermatids: 151.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.7	9.5	26.0	3.5	20.9	2.8	7.0	23.7	29.4	8.9	4.2	12.8	5.2	4.8	7.2	6.2	12.4	7.8	5.8	28.9	21.9	19.0	10.8	3.1	4.4	3.7	19.1	13.9	12.3	5.6	12.2	5.3	10.6	12.7	7.7	4.6	5.3	8.0	7.8	13.7	8.0	4.5	5.5	18.9	3.5	6.3	12.2	15.0	1.0	10.0	4.3	5.8	7.3	5.7	1.4	4.4	2.0	1.4	1.2	3.9	1.0	5.4	3.8	12.5	9.2	13.6	17.1	13.8	8.9	7.2	6.6	5.6	7.7	4.2	3.6	10.5	8.8	9.3	3.2	21.7	10.3	12.1	3.1	7.6	5.6	3.7	8.6	13.6	7.3	6.5	14.5	9.7	6.8	6.4	12.9	9.8	5.1	5.5	5.1	13.9	4.9	3.1	3.9	9.2	6.0	4.7	8.0	9.1	0.7	14.2	10.0	7.5	9.0	4.3	14.9	8.5	12.5	5.4	5.5	9.0	6.5	14.2	7.6	13.3	5.2	2.4	2.9	10.0	4.5	8.0	2.0	1.4	0.3	2.3	1.2	1.7	1.4	3.9	2.0	2.8	1.2	0.9	0.8	0.3	1.2	0.9	4.4	1.2	1.0	26.0	20.9	23.7	24.3	21.9	19.0	19.1	13.9	12.7	15.0	6.0	4.5	1.9	9.8	4.7	123.5	42.3	12.7	24.1	11.4	14.0	3.9	10.5	18.3	10.3	151.7	8.4	3.8	0.0	10.5	10.9	10.3	17.3	0.0	5.7	5.0	33.4	4.1	7.4	7.6	24.3	26.7	4.4	8.5	14.4	5.6	21.3	9.7	7.6	33.9	12.6	7.9	6.5	8.3	3.0	11.5	7.2	6.4	4.4	6.0	15.9
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		5000000	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.5	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	28.2	6.0	0.0	0.6	0.1	0.4	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	20.3	0.0	3.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	1.9	1.8	0.8	0.0	0.0	0.0	15.1	0.4	1.2	0.3	1.9	0.8	0.0	3.0	2.5	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3	0.0	0.0	0.0	1.1	0.5	0.0	2.4	0.0	0.0	0.0	7.0	0.0	66.3	0.0	2.3	3.2	0.1	0.0	0.0	0.7	80.6	1.3	1.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.3	0.2	0.4	0.1	14.5	0.0	0.4	1.1
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862290-52866835	"Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 38.0"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 31.4;Cytotrophoblasts: 80.5;Extravillous trophoblasts: 60.5;Peritubular cells: 64.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.9;CACO-2: 7.7;NTERA-2: 10.5;RPTEC TERT1: 6.6;SH-SY5Y: 26.8;SuSa: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	1.1	1.6	9.2	0.6	3.8	0.2	0.7	9.8	11.5	2.2	0.4	0.1	12.5	0.1	5.3	2.7	0.3	2.9	2.4	12.4	2.7	1.9	8.5	0.5	0.7	0.7	0.7	5.5	38.0	0.8	19.9	0.4	8.8	0.4	2.2	0.3	1.3	0.8	20.2	0.3	2.0	0.5	1.9	0.5	15.2	2.5	3.9	0.0	0.0	0.6	0.0	1.0	1.2	2.8	0.2	0.9	0.0	0.1	2.2	1.3	0.2	0.2	0.0	3.9	0.0	3.5	1.6	9.9	0.1	0.0	0.2	0.0	7.7	0.0	0.0	0.3	0.0	0.1	0.0	0.5	2.3	0.0	0.0	0.9	0.3	0.0	0.0	0.7	0.0	0.3	1.7	4.1	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.8	0.7	0.0	10.5	0.8	0.1	0.0	4.5	0.0	6.6	1.0	2.2	26.8	0.1	1.7	0.8	6.9	0.9	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.9	0.0	2.2	0.0	0.9	0.0	0.2	9.2	3.8	9.8	11.5	2.7	1.9	0.7	5.5	0.4	0.0	6.0	0.0	0.0	1.2	0.8	3.5	4.1	0.0	0.0	2.3	31.4	0.0	80.5	0.0	1.1	0.3	0.7	0.5	0.0	0.5	60.5	7.3	0.5	0.0	0.0	6.9	0.0	0.0	1.3	0.0	1.5	22.5	0.0	0.0	1.0	0.5	2.0	0.6	3.5	64.3	0.0	1.1	0.0	3.8	2.1	8.1	0.4	19.3	0.0	0.5	0.2
SCFD2	"FLJ39514, STXBP1L1"	ENSG00000184178	"Sec1 family domain containing 2"	Q8WU76	4	52872982-53366075	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036526, HPA036527"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036526: AB_10673499, HPA036527: AB_2675175"	"unprognostic (1.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.81e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.51e-2)"	13.7	19.4	11.0	15.8	15.1	12.5	13.7	7.8	17.6	12.9	11.7	16.2	6.5	10.5	14.2	9.0	16.7	9.9	10.0	11.9	11.5	13.2	13.6	17.2	10.4	12.7	15.7	9.3	13.2	18.3	11.4	15.3	11.2	16.4	8.7	11.8	10.5	13.0	10.4	13.8	13.5	10.7	14.2	13.2	12.7	10.6	5.1	12.4	16.2	10.1	10.2	19.3	10.4	12.1	6.5	15.9	1.4	9.7	13.9	9.5	9.1	6.6	6.2	3.6	8.3	11.9	12.1	4.4	15.5	11.7	5.4	4.6	4.4	8.6	12.7	12.0	29.5	5.7	4.2	11.5	13.5	10.4	3.9	6.7	7.1	6.6	5.3	5.6	8.4	13.1	8.3	8.2	10.4	4.1	5.2	9.1	3.4	12.0	7.4	9.2	7.7	12.4	5.4	2.1	19.1	7.8	7.7	3.3	13.4	6.0	4.5	10.3	5.8	3.5	13.1	6.9	4.3	5.1	4.1	8.4	11.8	7.5	13.3	11.3	8.7	4.7	15.0	8.0	10.5	33.5	0.0	5.6	1.4	7.8	9.7	7.8	6.5	6.4	8.8	15.9	5.7	9.5	8.6	1.2	13.9	9.3	10.3	5.5	9.1	11.0	15.1	7.8	16.9	11.5	13.2	15.7	9.3	16.4	12.4	0.0	1.9	7.5	4.6	3.3	3.3	2.8	15.3	5.3	0.0	3.5	5.9	6.7	1.7	3.5	1.8	3.0	2.2	0.0	4.5	6.2	5.1	2.5	12.7	5.3	4.7	4.8	1.2	3.1	2.7	1.7	6.1	3.9	5.0	0.0	3.0	3.8	2.2	2.9	5.3	5.4	3.2	0.0	3.1	4.3	3.2	4.6	3.5	4.4	4.0	1.8
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377643-53460861	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037475: AB_10696933, HPA058202: AB_2683636"	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	25.7	24.4	20.2	27.6	25.8	35.8	24.0	23.0	25.1	24.5	18.0	19.4	16.1	16.0	27.4	17.7	23.4	22.4	16.2	19.7	17.1	16.6	19.7	19.0	20.3	24.5	20.1	26.0	32.2	16.9	26.6	26.6	28.2	20.9	21.7	21.0	16.2	21.5	18.0	33.9	24.5	20.0	23.5	19.4	24.5	20.4	40.2	22.4	42.4	22.7	17.8	29.2	26.6	22.6	26.5	32.7	36.5	24.0	33.7	32.4	21.3	18.3	12.1	22.2	13.3	16.8	17.1	28.4	23.3	29.3	19.0	14.7	17.6	17.1	33.7	18.1	24.8	17.8	11.6	24.1	17.3	24.7	11.7	13.1	26.6	10.0	16.2	26.7	39.5	22.8	19.6	15.8	24.0	24.6	18.4	14.0	20.4	30.6	15.8	14.9	13.5	35.6	18.2	14.6	23.5	11.9	32.0	10.1	14.8	15.4	16.6	17.3	18.7	16.3	18.8	26.7	21.8	10.7	14.7	14.7	19.5	17.0	18.1	27.9	19.8	11.5	42.6	16.9	24.8	34.7	25.8	16.9	36.5	25.7	17.8	29.2	26.5	25.8	25.1	22.6	24.2	28.9	25.4	20.7	33.7	24.0	32.7	32.4	21.3	20.2	25.8	23.0	25.1	17.1	16.6	20.1	26.0	20.9	22.4	23.8	20.1	45.5	37.4	34.5	40.5	13.1	17.8	45.5	27.3	26.2	17.7	52.0	31.5	34.1	7.4	26.3	21.3	0.0	30.6	43.6	38.6	25.4	47.4	18.7	28.6	73.1	35.2	33.2	19.4	8.8	61.9	27.7	30.4	46.9	24.6	45.2	30.3	31.7	50.2	19.6	28.8	38.8	24.7	112.4	78.8	29.7	72.2	41.5	25.5	30.3
AC058822.1		ENSG00000282278			4	53377839-54295272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"brain: 19.1"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.4;fHDF/TERT166: 12.7;HDLM-2: 3.4;NTERA-2: 2.9;U-2197: 2.9"									HPA058202			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058202: AB_2683636"																		4.3	2.6	3.6	9.5	5.0	2.7	3.4	4.3	19.1	4.7	4.6	3.4	2.6	2.6	5.5	2.6	3.2	2.6	2.6	4.5	2.6		3.0	3.3	5.4	3.9	3.6	5.1	7.8	6.6	2.6	5.3	5.3	3.8	4.0	2.8	2.6	3.0	3.1	3.2	2.6	7.1	6.5	3.3	4.7	4.1	4.7	4.2	9.3	4.3	3.0	4.2	4.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	2.0	0.0	0.2	5.4	0.0	0.1	1.0	0.0	0.0	0.0	12.7	0.0	0.0	1.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	1.5	0.0	2.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.5	0.5	1.8	0.9	3.3	6.9	8.7	1.4	0.7	0.0	0.0	2.5	7.9	1.9	1.1	3.9	0.5	1.5	0.0	0.2	0.0	0.5	4.4	2.8	1.6	1.5	1.4	2.6	0.8	5.1	0.2	0.4	0.0	2.1	2.7	0.9	1.6	0.9	6.2	4.4	2.2	1.7	4.5	13.4	0.9	1.4	0.7	0.8	6.0	8.3	2.2	2.4	0.7	9.2	1.0	9.8	4.9	1.3	7.6	9.9	2.9	3.2	1.7	3.7	0.5	1.3	9.1	2.2	1.7	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0	0.0	3.8	0.8	15.3	7.2	5.9	1.3	7.6	17.4	7.9	7.0	5.9	25.0	16.6	10.0	114.3	7.1	13.2	0.0	10.3	17.0	4.1	9.4	2.3	4.4	2.2	39.7	13.3	2.5	0.3	33.7	4.0	0.6	5.0	0.0	12.2	2.0	9.9	21.0	8.1	2.6	5.0	0.0	1.7	0.9	1.5	10.5	12.5	0.0	12.3	13.6
CHIC2	BTL	ENSG00000109220	"Cysteine rich hydrophobic domain 2"	Q9UKJ5	4	54009789-54064690	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Basal keratinocytes: 309.8;Suprabasal keratinocytes: 326.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA026784, HPA076603"	Uncertain		Enhanced	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317"	"unprognostic (4.56e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.47e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.40e-2)"	17.0	17.5	9.5	14.6	9.7	23.7	17.1	17.9	12.0	12.8	14.2	7.1	11.9	13.0	16.8	14.9	25.3	11.0	22.1	14.3	7.3	7.9	12.3	20.2	17.7	13.5	6.6	10.0	13.2	9.9	5.5	16.7	18.5	9.9	12.3	9.6	15.9	15.3	9.9	10.9	24.7	20.6	10.8	8.1	18.5	12.9	50.1	8.3	32.3	11.8	11.6	20.5	12.9	16.3	8.4	10.9	63.8	15.9	13.6	15.6	13.6	11.6	2.1	6.5	5.7	10.8	8.3	6.3	16.2	17.2	9.7	9.7	8.3	10.4	9.9	14.5	10.4	8.8	3.5	8.7	11.8	10.5	5.4	4.4	5.4	2.0	6.3	32.4	8.7	11.2	11.2	9.7	14.6	22.4	19.6	14.2	10.8	5.8	7.5	19.3	3.2	10.2	14.1	4.3	5.4	8.0	6.7	3.5	3.8	11.1	3.9	9.4	8.9	3.8	5.7	11.8	9.7	3.0	13.1	24.1	12.5	9.7	17.8	10.4	8.9	4.2	8.1	9.2	8.8	8.9	56.0	15.9	32.2	12.6	12.4	12.1	8.4	12.8	14.2	10.9	8.2	11.8	12.7	63.8	13.6	12.5	9.1	15.6	13.6	9.5	9.7	17.9	12.0	7.3	7.9	6.6	10.0	9.9	8.3	6.0	8.2	16.1	80.5	309.8	7.1	4.0	12.7	29.4	7.9	7.0	7.9	24.6	14.9	37.6	40.4	37.2	22.7	23.3	24.6	33.5	50.4	75.8	36.8	21.5	22.8	12.7	24.8	38.6	38.9	11.4	15.8	40.6	64.1	23.4	21.3	8.2	45.8	24.6	23.0	22.8	7.0	19.4	37.6	152.1	82.4	326.7	39.9	39.9	18.0	124.8
GSX2	Gsh2	ENSG00000180613	"GS homeobox 2"	Q9BZM3	4	54099523-54102505	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Dystonia, Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.8;retina: 16.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"glioma: 2.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;hTERT-RPE1: 1.6;RPTEC TERT1: 1.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in single"									NA	NA										"unprognostic (4.48e-2)"						"unprognostic (1.05e-1)"				"unprognostic (7.01e-2)"	"unprognostic (1.89e-1)"		0.0	0.0	3.3	0.4	4.8	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	16.7	0.0	0.0	0.0	1.7	0.3	0.0	0.7	0.2	0.1	2.2	0.5	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	4.8	0.0	0.9	0.7	0.7	1.0	0.8	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Group enriched"	"Detected in many"	9	"Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	82.8	38.8	0.1	4.3	48.0	0.0	0.1	11.5	0.0	0.1	0.1	33.4	0.1	0.1	3.3	0.0	0.0	0.4	0.1	0.1	0.1	0.2	28.0	0.0	0.0	70.4	0.0	5.5	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.7	0.0	0.1	0.0	0.3	0.1	0.0	0.1	15.2	0.5	16.6	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3	0.0	0.3	0.9	0.3	15.1	0.7	4.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	2.9	1.6	3.3	0.0	0.0	5.8	1.2	171.4	0.4	0.0	0.8	2.8	0.0	0.0	38.1	0.6	3.7	416.6	1.6	21.9	8.2	0.0	18.3	12.2	0.0	384.4	0.0	0.4	0.0	13.2	1.1	3.5	13.8	1.1	0.0	0.0	0.8
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 496.5;Melanocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.7;NK-cells: 9.7"	"Group enriched"	"Detected in some"	13	"HEL: 48.8;HMC-1: 102.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		48000000	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12.0	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36.0	4.4	9.4	1.1	13.8	3.8	3.6	6.0	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4.0	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0.0	1.8	12.7	0.9	9.7	1.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6	0.9	2.6	3.2	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.5	0.0	2.2	0.0	1.2	48.8	0.0	0.0	0.0	0.0	102.6	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.6	0.1	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.1	0.0	0.0	0.0	4.8	1.2	0.4	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	12.7	0.0	10.0	0.1	0.0	1.9	0.0	0.3	0.7	1.8	0.0	0.0	0.0	0.8	9.7	0.9	0.0	0.0	0.1	9.5	11.8	18.3	12.0	36.0	4.4	3.6	6.0	5.7	4.5	6.0	34.8	1.4	1.1	12.7	0.0	0.4	5.1	0.0	5.7	3.5	0.0	0.0	3.3	0.8	0.0	2.4	0.0	0.0	0.0	0.1	1.3	0.5	496.5	0.0	0.3	0.0	5.2	1.8	0.3	0.0	1.1	3.1	200.8	0.0	0.3	2.4	0.0	0.0	0.0	0.6	0.3	0.0	0.5	0.0	8.2	3.3	0.2	2.2	0.3	0.3
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078259-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 100.3;Ito cells: 200.7;Muller glia cells: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 32.5;TIME: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004028	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		7400000	"Plasma membrane"		"CAB004028: AB_2212507"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	19.7	6.2	1.8	4.4	3.1	0.4	20.5	1.1	2.2	11.4	6.0	1.8	11.5	2.3	28.8	10.2	5.2	9.5	6.2	12.1	2.3	1.7	7.8	10.4	13.2	14.1	3.1	2.9	6.0	8.1	8.0	6.8	34.5	3.9	9.5	1.4	27.6	7.1	10.3	5.3	3.0	3.8	7.7	2.6	4.4	4.2	5.3	1.2	0.5	20.0	5.3	3.0	4.4	12.0	0.1	0.1	0.7	0.0	0.2	0.2	0.1	0.0	0.0	1.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.2	0.2	32.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	3.1	1.1	2.2	2.3	1.7	3.1	2.9	3.9	1.2	0.0	8.2	7.5	0.4	2.3	7.4	4.8	0.0	6.7	30.7	0.0	0.0	0.1	0.0	0.5	0.8	100.3	0.0	0.0	0.0	0.1	1.9	0.4	2.3	1.3	0.4	0.0	0.0	200.7	14.5	0.6	0.0	1.0	6.8	0.0	0.0	229.2	0.3	0.0	0.4	0.0	6.0	0.0	1.4	0.2	0.2	2.4	0.1	0.0	0.0	0.4
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346109-55373096	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 42.6"	"Low region specificity"	"Detected in all"							HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	13.8	12.2	11.5	5.9	13.4	6.6	17.8	7.3	18.3	22.9	11.3	20.3	3.5	6.9	13.8	9.6	24.4	5.9	22.6	10.5	13.2	10.7	12.3	15.0	12.4	10.1	15.5	12.0	3.5	26.8	14.0	7.0	8.8	13.6	8.9	10.9	6.8	16.3	6.6	5.8	15.6	8.3	6.2	22.1	6.9	13.8	4.0	15.3	10.0	7.6	9.9	12.1	12.1	12.1	5.9	28.4	10.3	25.2	3.6	9.2	10.3	4.8	3.2	5.8	5.5	19.5	12.5	2.9	5.3	6.2	2.2	3.6	3.2	10.1	11.5	6.0	8.3	6.2	3.8	4.1	4.9	2.8	3.3	7.3	6.3	3.6	8.6	5.2	11.6	3.5	11.4	9.1	3.8	3.5	4.8	9.0	21.5	10.7	25.8	12.6	6.3	17.0	5.1	7.3	27.6	4.3	5.5	1.8	6.5	7.4	5.2	9.0	5.0	5.6	42.6	3.8	6.0	5.2	10.2	4.4	14.2	2.6	1.0	4.0	13.8	7.6	4.2	18.0	16.0	13.8	10.3	16.5	4.9	7.9	25.1	9.2	5.9	6.0	7.4	14.1	5.2	5.3	7.1	0.8	3.6	25.2	28.4	5.8	10.3	11.5	13.4	7.3	18.3	13.2	10.7	15.5	12.0	13.6	15.3	8.9	15.7	3.0	9.5	12.0	4.6	4.6	45.9	12.0	12.5	5.2	3.9	22.7	3.3	67.0	2.0	14.3	8.4	0.0	92.9	88.2	17.0	22.1	13.9	17.1	62.0	9.5	11.5	17.8	20.9	0.0	1.7	27.9	23.6	24.4	19.3	18.6	133.4	5.8	5.3	12.2	3.8	12.9	9.5	2.1	18.8	26.0	6.3	4.9	20.9	49.7
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 421.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	28.5	37.6	19.4	25.6	49.0	6.0	27.3	11.3	26.1	31.1	20.0	54.4	17.6	19.8	22.4	20.7	33.0	19.1	29.4	23.9	29.1	20.0	26.7	11.9	30.4	22.3	65.8	16.2	14.0	23.6	22.9	14.9	37.6	33.1	24.9	21.6	15.7	25.5	20.8	9.9	16.2	16.0	25.0	50.5	22.6	23.8	8.4	49.4	14.4	24.3	16.5	25.5	34.0	23.2	11.3	22.8	17.6	24.8	11.3	11.8	17.8	18.8	7.9	12.5	13.2	39.0	28.9	13.3	36.1	55.8	26.1	28.7	8.8	28.3	19.7	26.3	22.2	15.0	14.0	13.1	14.8	26.6	11.1	12.1	16.8	14.1	16.9	24.3	23.1	20.0	29.6	19.3	14.9	10.0	22.1	29.7	6.6	28.3	12.6	30.6	13.8	18.2	19.4	13.6	25.0	18.6	13.2	9.4	10.6	39.2	18.1	12.9	17.3	18.1	68.9	21.5	12.9	10.8	16.7	25.5	22.3	13.3	9.8	26.1	11.8	9.5	12.1	26.5	19.7	17.8	12.7	24.8	15.5	9.9	20.9	11.3	11.3	9.6	11.8	22.8	7.8	8.2	9.8	17.6	11.3	20.5	17.5	10.8	17.8	19.4	49.0	11.3	26.1	29.1	20.0	65.8	16.2	33.1	49.4	50.6	44.9	77.0	225.4	217.7	52.2	28.4	71.4	24.1	36.4	75.0	76.6	95.8	14.9	148.1	29.0	90.3	40.6	46.7	143.8	136.2	133.6	205.0	20.7	16.1	94.9	27.0	48.4	110.5	75.9	17.9	54.4	126.9	84.4	71.3	52.4	71.5	188.4	45.6	59.8	43.2	75.4	97.0	160.3	38.1	23.7	234.9	67.4	84.1	48.5	421.9
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55547138	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	9.3	9.2	7.8	5.8	11.7	1.7	8.4	16.2	14.3	12.5	9.5	5.2	9.2	7.1	10.5	8.4	13.9	8.1	6.7	10.5	7.9	7.9	12.4	9.1	8.2	9.4	7.0	9.8	11.7	8.6	18.7	21.9	8.5	8.4	9.7	8.4	5.6	8.2	9.2	16.1	9.4	12.6	13.8	8.3	9.1	9.6	18.5	5.0	4.0	14.7	5.9	5.2	8.4	17.1	2.5	3.6	0.6	3.0	2.9	4.7	1.4	13.6	5.9	5.4	8.4	8.1	8.2	2.7	14.1	11.6	9.9	9.1	3.7	10.9	3.7	7.3	16.4	7.4	11.4	6.9	10.9	16.7	4.5	2.5	2.9	6.3	4.6	7.2	4.7	3.4	4.8	10.9	13.6	13.4	7.4	9.2	3.1	6.7	7.5	14.8	7.5	2.6	2.7	3.9	11.2	6.9	1.7	6.2	2.4	7.6	7.4	5.3	4.7	10.2	12.6	6.4	4.7	4.2	2.6	12.7	13.4	14.4	4.4	18.9	6.8	4.9	2.3	11.9	4.2	10.6	0.0	3.0	0.6	2.8	3.0	4.7	1.4	3.2	2.5	3.6	2.5	1.9	2.4	0.6	2.9	2.7	2.1	3.1	1.4	7.8	11.7	16.2	14.3	7.9	7.9	7.0	9.8	8.4	5.0	38.7	23.0	9.8	18.1	27.6	61.3	50.4	12.7	12.0	13.6	14.0	41.2	9.5	1.7	11.5	25.0	28.9	20.3	0.0	14.4	5.7	30.8	25.1	3.5	25.9	10.1	31.8	38.2	28.8	12.7	12.1	22.2	14.3	10.1	8.2	19.3	29.6	19.8	15.3	33.9	17.0	39.4	12.9	30.8	56.9	73.3	32.9	4.3	10.2	14.9	46.9
PDCL2	GCPHLP	ENSG00000163440	"Phosducin like 2"	Q8N4E4	4	55556525-55592212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 43.0"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1101.1;Late spermatids: 498.3"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.8;ovarian cancer: 2.0;testis cancer: 3.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;Daudi: 3.6;HaCaT: 6.2;HAP1: 1.1;PC-3: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048260	Enhanced					NA	NA					"HPA048260: AB_2680333"		"unprognostic (5.93e-3)"		"unprognostic (1.19e-7)"		"unprognostic (1.04e-1)"				"unprognostic (3.01e-3)"				"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.41e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.2	0.0	0.0	6.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1101.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	498.3	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	12.9	0.0	42.2	43.2	0.3	0.1	0.0	0.0	0.0
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.9;skin 1: 28.3;tongue: 28.4"	"Cell type enhanced"	"Detected in some"	24	"Basal keratinocytes: 14.4;Erythroid cells: 23.3;Suprabasal keratinocytes: 64.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	10	"MAIT T-cell: 7.2;memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	51	"T-cells: 7.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 81.3;K-562: 63.9;Karpas-707: 29.3"	"Region enhanced"	"Detected in single"		"pons and medulla: 4.7"	"Low region specificity"	"Detected in many"			HPA025926	Uncertain				"Secreted in other tissues"	NA	NA					"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.2	2.0	1.1	5.9	1.3	0.1	3.4	5.4	1.1	0.2	2.5	0.6	0.5	0.0	42.9	0.2	0.3	0.3	0.2	0.9	0.1	0.0	1.0	0.4	0.4	0.5	0.0	0.0	0.0	2.8	2.1	0.3	0.1	0.6	0.0	6.6	1.5	0.1	28.3	1.7	0.2	1.2	0.1	3.1	1.3	0.0	0.7	17.2	28.4	8.5	0.1	12.2	0.1	0.0	0.0	0.0	0.0	7.2	0.1	8.5	0.0	4.7	1.2	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	13.1	18.9	1.8	0.0	1.8	81.3	9.8	0.7	0.5	1.1	5.3	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	2.2	0.0	1.3	63.9	29.3	0.0	2.0	0.2	0.0	2.5	1.5	2.4	0.0	0.0	0.1	0.4	0.0	4.2	10.7	6.5	0.1	0.0	0.9	4.5	0.0	0.5	0.0	6.1	0.0	11.4	8.5	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	2.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.1	3.4	0.2	0.9	0.4	0.5	0.3	0.0	0.0	2.9	1.5	0.6	14.4	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.2	0.2	0.0	23.3	0.2	0.1	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.5	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	1.5	7.6	64.4	0.1	0.0	1.7	8.0
EXOC1L		ENSG00000250821	"Exocyst complex component 1 like"		4	55819819-55837487	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.7;blood: 5.2;testis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	52	"NK-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"NK-cells: 5.2"	"Group enriched"	"Detected in some"	6	"HEK 293: 5.8;HSkMC: 2.3"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.0"	"Not detected"	"Not detected"									NA	NA																							1.7	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0	0.4	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.7	1.3			0.0		0.1	0.0		0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	5.8	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853616-55905034	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	21.2	19.7	20.7	21.0	24.0	12.9	25.3	22.8	40.7	18.4	20.2	18.2	14.6	18.9	20.8	24.6	32.7	18.3	17.9	19.8	26.9	23.6	18.7	11.4	26.2	29.2	24.7	22.8	18.2	14.9	29.7	20.0	23.4	30.7	16.8	22.4	12.9	20.3	19.2	14.6	31.6	20.5	18.4	29.1	23.7	17.5	18.5	21.5	19.1	19.0	15.8	21.9	18.8	21.4	7.3	11.7	16.4	18.1	10.1	9.2	6.3	11.5	6.7	12.1	13.9	20.9	26.2	8.1	16.3	16.5	13.4	14.1	4.6	20.2	11.2	11.5	17.5	16.2	13.9	9.8	13.0	19.3	5.9	6.8	10.3	8.4	5.4	19.7	11.2	14.7	21.1	17.8	13.9	15.4	17.4	21.8	8.7	14.8	11.0	29.0	7.3	8.1	11.4	7.6	16.6	12.8	9.5	9.0	9.0	14.9	12.7	9.0	16.0	9.8	16.1	13.5	10.8	10.2	12.1	26.2	16.6	13.6	14.2	14.0	13.3	6.6	9.9	21.6	12.5	15.7	15.2	12.1	10.4	5.8	15.7	7.5	7.3	8.2	8.2	11.7	6.7	7.4	5.4	16.4	10.1	18.1	5.3	9.2	6.3	20.7	24.0	22.8	40.7	26.9	23.6	24.7	22.8	30.7	21.5	38.7	29.4	13.7	12.5	30.9	45.5	26.4	20.4	44.2	26.1	21.0	29.5	53.7	16.6	18.4	31.3	32.2	30.4	0.0	17.4	27.7	28.1	16.9	34.8	9.7	35.9	27.0	21.4	41.7	40.5	10.6	19.8	36.1	38.8	19.8	26.7	45.2	26.5	28.1	22.3	14.0	30.3	32.3	21.4	27.7	34.1	34.9	42.8	18.8	25.1	19.6
CEP135	"CEP4, FLJ13621, KIAA0635"	ENSG00000174799	"Centrosomal protein 135"	Q66GS9	4	55948871-56033363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.1"	"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 56.2;monocytes: 85.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073950			Uncertain	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA073950: "	"unprognostic (2.75e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.89e-3)"	"unprognostic (9.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-9)"	"unprognostic (7.55e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (6.11e-5)"	5.5	3.0	2.9	13.8	6.0	12.8	5.2	5.1	5.3	8.5	4.6	3.1	7.5	4.3	12.8	4.5	4.7	7.4	4.5	3.4	5.3	3.4	5.7	2.9	7.0	13.0	5.8	3.9	9.6	4.5	4.1	6.9	8.1	4.5	4.4	4.6	2.5	3.7	5.9	2.3	5.4	6.2	7.1	5.5	11.1	3.6	9.3	4.6	27.1	5.0	4.5	10.1	4.8	5.6	9.2	8.7	11.9	4.4	7.1	7.5	2.0	6.9	3.8	10.7	10.0	2.2	4.3	4.6	6.9	4.9	6.4	7.5	4.3	7.3	18.9	5.3	3.1	5.1	3.3	11.1	4.3	12.1	5.1	7.1	6.6	5.7	3.8	2.4	11.9	10.4	3.3	3.4	8.0	5.8	2.9	5.3	9.7	12.1	9.1	6.5	4.2	16.6	7.4	6.7	3.5	4.2	12.1	5.1	3.9	4.6	5.2	7.7	8.1	6.2	4.2	5.1	6.7	5.7	7.7	5.2	8.7	14.2	10.3	12.1	5.0	3.5	12.9	4.4	9.4	10.6	11.9	3.4	4.2	4.7	4.1	4.3	4.6	6.0	4.5	2.1	9.2	7.5	4.8	7.0	7.1	4.4	8.7	3.7	2.0	2.9	6.0	5.1	5.3	5.3	3.4	5.8	3.9	4.5	4.6	6.0	14.3	15.9	7.2	8.0	12.6	7.3	2.5	22.7	14.8	7.0	9.8	15.3	3.3	7.8	56.2	15.3	3.9	23.3	4.7	11.7	5.9	4.3	13.9	1.8	9.0	25.4	5.2	12.3	9.2	11.4	5.5	17.8	5.0	85.6	4.3	4.7	11.0	5.7	7.8	9.0	21.0	6.5	6.6	53.2	43.8	5.8	8.0	16.0	5.2	5.5
KIAA1211		ENSG00000109265	KIAA1211	Q6ZU35	4	56049073-56328625	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.9;testis: 27.0"	"Group enriched"	"Detected in some"	15	"Early spermatids: 102.6;Late spermatids: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 16.0;SH-SY5Y: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	1.0	2.1	4.5	4.2	3.7	3.0	0.8	4.2	6.8	2.3	12.6	3.3	3.2	11.8	3.7	3.9	1.0	2.7	14.4	1.6	5.7	7.0	1.6	1.0	1.4	1.8	5.3	3.0	2.2	1.6	7.6	1.9	2.3	13.4	1.6	7.2	4.7	0.9	5.5	0.7	0.9	39.9	4.0	4.8	2.1	2.4	27.0	1.5	0.2	0.8	0.0	1.6	1.5	2.2	1.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	1.7	6.7	0.5	0.2	0.0	2.4	0.0	0.2	0.3	0.7	1.9	0.2	5.9	0.1	0.0	5.4	0.0	5.6	0.1	0.2	0.5	3.3	3.2	3.0	0.3	0.9	2.7	0.5	0.3	0.1	0.0	0.1	2.2	3.1	5.3	0.0	5.8	0.0	0.8	4.0	0.2	3.6	5.0	4.3	3.9	3.7	0.1	0.0	1.5	16.0	34.2	0.6	0.2	4.1	5.9	1.4	0.3	1.2	0.1	1.7	0.4	1.5	5.8	3.9	0.0	1.7	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	3.7	4.2	6.8	5.7	7.0	5.3	3.0	13.4	1.5	0.0	0.0	0.0	0.0	0.1	2.3	2.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	102.6	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.4	4.7	0.6	0.0	87.5	0.6	0.0	0.0	0.0	0.7	2.7	1.8	0.9	0.4	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.1	0.0	1.1	0.0
AASDH	"ACSF4, LYS2, NRPS998"	ENSG00000157426	"Aminoadipate-semialdehyde dehydrogenase"	Q4L235	4	56338287-56387508	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036472, HPA036473"	Approved					NA	NA					"HPA036472: AB_2675142, HPA036473: AB_10673656"	"unprognostic (1.95e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.85e-3)"	9.4	13.5	12.0	7.4	15.4	6.8	14.5	28.9	15.6	10.7	8.0	10.2	12.5	7.5	11.7	14.6	10.3	12.3	7.5	7.9	12.8	7.5	11.5	10.7	8.0	9.8	12.9	13.3	15.3	8.1	16.8	28.9	8.4	14.5	11.4	10.1	11.0	11.3	9.9	9.4	12.4	8.6	9.9	12.4	9.4	8.9	8.2	16.0	12.0	12.4	6.9	11.0	11.1	11.0	5.2	3.9	2.5	4.2	4.4	7.7	2.4	5.0	3.4	9.0	6.9	13.8	16.0	5.6	6.4	7.8	6.7	5.8	3.9	10.6	11.0	6.0	7.0	5.0	3.3	6.5	6.5	7.5	4.4	6.5	5.2	6.0	5.0	12.3	9.4	3.9	9.2	10.8	7.1	10.6	9.6	10.2	7.2	11.8	5.7	7.6	5.0	11.0	7.9	5.1	9.3	5.1	8.3	4.5	5.1	9.6	4.3	6.1	5.9	7.3	11.8	7.3	9.0	9.3	6.1	6.9	4.4	6.1	4.7	4.6	4.6	3.5	7.2	7.1	8.6	4.8	0.0	3.6	2.5	5.1	4.2	6.9	4.3	5.2	4.4	3.9	5.2	7.7	5.6	0.7	4.4	2.7	3.3	4.9	2.4	12.0	15.4	28.9	15.6	12.8	7.5	12.9	13.3	14.5	16.0	6.0	11.5	17.9	12.2	9.0	36.1	9.5	12.7	8.1	14.8	17.4	25.5	33.7	21.6	8.3	9.3	11.3	8.0	23.3	6.7	16.2	13.2	11.6	19.7	17.4	13.4	33.4	11.6	18.4	19.3	3.0	15.5	14.6	10.1	10.0	13.8	29.8	5.9	16.5	17.0	17.7	52.0	6.5	8.3	26.5	22.6	13.7	20.0	13.1	14.2	6.3
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No			"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	5.6	10.1	10.8	9.5	11.7	7.3	11.1	11.7	13.7	7.3	6.0	6.9	7.6	6.1	7.4	5.6	8.1	7.1	5.3	4.4	8.9	9.7	9.7	10.3	3.9	12.0	9.7	12.1	12.5	10.8	5.6	6.8	10.3	9.5	6.2	7.7	3.8	9.2	7.6	7.0	6.7	5.1	5.6	9.7	6.3	5.5	13.0	8.9	15.2	9.4	6.4	12.0	7.0	6.6	8.2	3.7	3.3	3.9	11.2	9.5	4.3	8.7	7.3	15.1	7.3	4.9	6.4	12.3	9.8	4.3	8.1	8.7	14.6	10.7	30.8	13.3	4.6	7.5	6.5	29.0	9.8	16.3	8.0	12.9	12.4	9.2	16.1	7.5	24.4	7.8	5.5	7.7	11.5	13.0	5.0	8.5	12.7	31.2	17.1	9.1	7.9	30.1	18.6	20.0	19.9	8.8	25.5	9.9	21.6	13.6	6.2	25.5	12.4	7.8	14.3	8.8	14.8	9.6	5.2	5.9	8.5	14.7	8.5	17.2	12.8	12.8	32.0	9.5	15.6	7.9	3.3	2.0	1.0	4.6	3.1	6.9	8.2	6.3	6.2	2.8	6.3	9.5	8.6	0.5	11.2	3.9	3.7	4.7	4.3	10.8	11.7	11.7	13.7	8.9	9.7	9.7	12.1	9.5	8.9	0.0	5.6	6.7	8.0	27.5	8.3	3.6	5.1	8.1	11.4	3.5	2.0	24.8	8.3	3.7	2.1	7.1	0.5	0.0	2.3	21.1	10.4	5.9	6.9	6.6	6.9	36.5	4.1	8.0	1.8	2.0	7.2	3.4	8.5	1.0	3.7	4.9	2.7	0.0	5.3	9.5	4.5	0.0	10.4	7.7	28.6	27.9	6.4	9.6	8.9	5.3
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464579	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		340000	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	15.5	27.1	21.6	20.4	17.4	21.4	29.3	15.8	20.6	17.5	22.5	18.5	18.4	17.2	19.6	12.6	29.0	19.6	11.4	13.4	16.7	22.6	26.5	63.7	11.3	25.6	26.4	19.2	23.3	27.7	26.2	17.9	24.3	29.8	17.5	30.5	13.1	15.7	16.8	23.8	20.0	16.1	19.4	23.5	19.8	12.8	18.3	15.9	44.9	17.8	26.8	33.1	18.7	18.9	13.7	12.8	3.2	6.4	10.9	14.4	6.7	34.3	25.8	53.3	33.0	11.4	25.9	45.9	29.8	21.6	42.8	42.2	40.9	40.9	79.6	34.7	19.9	23.3	21.3	84.1	43.3	73.4	15.9	29.6	43.2	39.5	45.3	21.9	76.8	19.3	21.9	31.4	45.4	34.3	23.7	35.0	45.7	74.5	29.7	36.8	22.9	88.1	38.5	61.1	66.2	32.3	71.6	22.8	52.3	40.5	24.1	57.3	34.3	29.3	41.0	18.0	45.5	27.1	24.6	18.8	33.9	44.4	33.3	60.8	21.0	18.0	83.7	35.7	56.3	37.3	3.2	3.7	0.3	4.1	6.4	11.8	13.7	11.5	7.3	11.4	8.9	14.4	12.1	0.9	10.9	4.8	12.8	8.3	6.7	21.6	17.4	15.8	20.6	16.7	22.6	26.4	19.2	29.8	15.9	20.8	19.3	31.8	57.8	50.4	26.0	20.9	56.0	21.4	31.8	31.4	5.9	117.2	31.5	30.5	45.8	21.6	14.2	46.7	22.8	137.4	35.6	28.6	20.7	68.6	45.7	27.0	23.8	11.6	15.8	6.6	27.6	17.1	16.9	22.6	34.9	13.2	23.3	7.0	21.9	41.1	22.9	0.0	17.9	39.4	47.7	44.2	45.7	16.0	65.0	44.1
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467336-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA					"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	28.7	26.4	18.5	23.1	27.0	37.3	29.8	24.1	33.5	27.0	22.7	17.3	31.3	17.1	30.2	22.7	32.1	24.3	20.2	21.6	17.2	20.9	26.6	52.5	24.9	33.4	20.5	23.6	32.7	43.8	26.7	32.5	40.9	32.1	21.8	25.3	13.0	49.6	30.1	34.4	33.3	23.2	27.1	22.6	34.4	24.1	15.9	18.8	41.8	32.9	34.8	31.9	28.7	25.4	25.7	37.4	16.8	32.4	25.9	31.5	23.9	26.9	20.8	26.4	25.4	16.8	24.2	25.5	40.1	32.1	33.7	27.1	23.0	30.8	41.9	27.6	33.4	17.8	15.6	32.5	34.0	40.1	11.0	18.9	36.5	24.6	21.4	30.8	70.1	30.4	22.8	45.8	35.9	64.0	29.4	30.0	32.3	52.9	40.5	32.1	20.9	41.3	18.2	22.8	33.8	21.9	37.1	21.3	31.5	23.2	25.7	16.4	27.3	25.4	49.9	22.1	22.2	19.8	25.5	36.2	28.1	37.8	28.6	41.4	29.1	13.8	46.0	30.2	37.4	33.9	14.6	30.0	16.8	24.8	32.4	31.5	25.7	25.1	24.5	37.4	22.8	25.0	24.5	3.8	25.9	24.5	28.1	26.8	23.9	18.5	27.0	24.1	33.5	17.2	20.9	20.5	23.6	32.1	18.8	68.5	57.4	61.0	74.3	86.4	58.8	42.5	45.9	68.3	83.0	26.2	17.7	105.5	56.3	84.6	70.7	79.2	35.5	46.7	113.8	163.4	78.3	66.7	98.3	74.0	91.1	54.0	51.0	54.6	79.0	91.4	60.4	87.7	55.6	90.2	73.1	54.0	101.1	35.1	62.6	51.0	31.7	38.8	73.4	41.2	101.8	88.2	139.2	67.1	82.7	104.0
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56525481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;testis: 12.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 81.2;Late spermatids: 192.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2"					"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA072942: AB_2686561"	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	1.3	1.1	4.4	0.8	4.9	3.4	2.0	1.5	7.1	1.3	1.3	0.6	2.4	1.0	2.0	1.1	1.1	1.2	2.4	0.8	3.9	3.2	0.5	0.5	0.6	1.0	1.3	2.9	3.0	0.4	0.4	1.6	0.3	8.7	2.2	1.0	1.9	0.9	3.8	0.4	4.1	1.0	3.7	2.5	0.8	1.0	12.6	0.6	0.1	1.1	1.2	0.7	1.5	2.5	2.1	2.2	1.6	0.4	1.4	1.4	0.1	0.0	0.5	0.6	0.5	1.2	2.9	0.1	0.9	0.5	2.1	2.1	0.5	0.7	0.7	0.0	1.5	0.1	0.2	0.4	0.2	1.2	0.1	0.1	0.3	0.0	0.1	2.8	0.3	0.7	4.4	0.7	1.9	0.4	0.4	2.1	0.2	0.2	0.9	2.0	0.0	0.3	0.1	2.2	0.1	1.3	8.7	0.0	0.1	0.1	0.3	9.2	0.1	0.3	0.4	0.2	0.2	0.2	0.1	0.4	0.3	0.4	0.0	0.1	0.4	0.4	0.4	0.1	0.0	0.3	0.8	0.4	0.4	0.7	0.4	0.4	1.0	1.2	1.0	0.3	2.1	1.4	0.6	1.6	1.4	0.4	2.2	1.0	0.1	4.4	4.9	1.5	7.1	3.9	3.2	1.3	2.9	8.7	0.6	0.0	1.4	0.0	0.8	5.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	81.2	0.2	0.0	0.0	0.2	0.1	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.3	192.4	1.4	0.0	5.0	0.0	0.3	1.0	0.6	0.0	1.1	0.3	0.0	0.0	0.2	12.2	0.9	1.4	0.0	0.0	0.4	0.3
THEGL		ENSG00000249693	"Theg spermatid protein like"	P0DJG4	4	56530609-56603507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9;vagina: 10.7"	"Group enriched"	"Detected in some"	58	"Early spermatids: 18.2;Late spermatids: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.8;HSkMC: 3.7;hTEC/SVTERT24-B: 2.3;K-562: 3.0;SH-SY5Y: 2.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA066627, HPA068093"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA066627: , HPA068093: AB_2685951"	"unprognostic (4.33e-2)"	"unprognostic (2.88e-3)"		"unprognostic (7.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.69e-2)"		"unprognostic (3.26e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.41e-2)"	0.1	0.2	0.6	0.1	0.5	0.8	1.9	0.1	1.1	1.7	0.7	0.6	1.0	0.1	0.4	1.3	0.2	0.4	0.8	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.0	0.3	0.0	0.8	0.7	0.1	0.2	0.2	0.5	0.1	1.2	0.2	1.8	0.2	0.1	0.3	8.9	0.4	0.0	0.1	0.0	0.1	3.0	10.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.3	3.7	0.0	2.3	0.0	0.5	0.4	0.0	3.0	0.0	0.9	0.0	0.8	0.0	0.2	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.1	0.3	0.8	0.1	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.1	1.1	0.2	0.4	0.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.8;skin 1: 154.6"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 696.8;Alveolar cells type 2: 414.3;Basal keratinocytes: 368.4;Suprabasal keratinocytes: 329.7;Syncytiotrophoblasts: 269.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 68.6;NK-cell: 90.9"	"Group enriched"	"Detected in many"	14	"NK-cells: 90.9;T-cells: 68.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.4;HUVEC TERT2: 29.7;RT4: 22.1;TIME: 33.6;U-266/70: 11.7"									"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	1.7	5.0	24.1	5.2	13.0	2.0	23.1	4.0	28.2	26.4	3.1	3.6	3.0	3.4	2.5	106.2	90.3	2.3	6.7	5.7	20.0	8.2	2.3	0.7	112.4	3.4	12.1	12.9	1.4	1.1	2.3	1.2	128.8	15.0	4.5	1.6	1.0	19.0	12.9	3.4	154.6	3.4	20.9	11.2	2.3	3.2	9.6	1.9	1.8	65.9	93.2	66.3	6.8	37.8	5.6	0.4	1.5	0.5	90.9	68.6	38.2	0.0	0.0	0.0	0.0	2.3	7.3	2.6	0.0	0.0	0.6	0.4	0.0	0.0	5.4	0.3	0.1	1.0	1.0	0.6	0.0	0.8	13.4	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.2	5.4	1.6	0.0	1.5	29.7	0.0	0.0	0.2	1.4	0.2	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.1	0.0	22.1	0.4	0.2	0.0	0.0	0.0	2.1	0.0	0.0	33.6	0.0	0.1	0.2	0.0	11.7	0.0	0.0	1.4	0.0	0.0	0.6	0.1	0.2	68.6	0.4	37.4	5.6	17.1	30.1	0.3	4.3	3.1	21.0	1.5	90.9	0.5	0.4	1.0	38.2	24.1	13.0	4.0	28.2	20.0	8.2	12.1	12.9	15.0	1.9	696.8	414.3	13.2	36.1	368.4	1.6	11.3	0.0	20.1	221.8	1.8	0.0	1.7	1.7	0.0	27.8	9.0	0.5	0.0	0.2	4.7	21.3	17.3	9.3	0.8	3.5	0.0	8.1	5.5	16.3	34.5	2.8	8.0	33.7	62.3	1.9	104.0	2.3	0.0	2.8	0.2	4.3	32.3	77.3	2.6	10.4	329.7	269.1	177.7	0.3	25.7
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor, Kazal type 2"	P20155	4	56809860-56821742	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 376.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 772.8;Late spermatids: 1064.2;Spermatocytes: 1687.5"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 43.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 43.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 44.5"									"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA					"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.2	0.1	0.2	0.5	0.2	0.7	0.3	0.1	0.3	0.4	0.4	0.0	85.2	0.0	0.2	376.2	0.1	0.2	0.0	2.2	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.0	1.4	0.0	1.1	1.1	0.1	0.0	0.6	49.9	0.5	0.2	0.5	0.0	0.2	0.6	0.2	85.5	0.0	0.3	0.2	0.0	0.2	1.3	1.3	3.9	0.4	1.3	0.0	43.3	7.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	1.3	8.6	0.2	0.0	0.0	0.0	0.0	2.0	0.0	2.8	0.1	1.5	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	44.5	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	0.2	2.3	1.7	1.8	0.4	3.9	3.9	7.3	0.3	43.3	0.0	0.2	0.1	2.0	0.2	0.2	0.1	0.3	0.3	0.3	0.2	0.0	1.1	0.0	0.0	0.0	4.5	12.1	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	772.8	0.1	0.2	0.0	0.0	0.2	0.5	9.5	1.1	0.0	0.1	0.0	1.7	0.0	0.0	1064.2	35.1	0.2	11.8	0.0	5.3	1.4	0.0	9.3	23.0	0.0	0.0	12.9	1.0	1687.5	136.3	0.3	0.0	7.5	1.7	2.2
REST	"NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966678	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	14.4	11.4	6.0	15.6	8.9	21.5	39.7	2.1	6.3	13.7	11.0	5.6	13.0	6.5	14.2	13.7	14.5	11.2	13.8	22.1	6.1	4.5	13.9	12.0	18.2	35.6	8.2	3.0	13.9	15.9	22.4	4.5	14.4	11.8	17.3	7.6	7.2	14.0	27.6	13.8	11.6	12.0	16.3	15.2	18.7	10.4	15.3	8.2	43.4	13.4	8.3	14.0	15.6	19.5	16.7	10.7	9.0	8.4	16.7	15.3	4.2	7.1	9.0	12.6	12.4	9.5	11.9	15.9	10.6	9.5	11.3	10.3	9.0	11.0	16.9	17.0	11.5	7.5	6.5	9.2	11.2	17.9	8.9	5.5	15.4	7.2	7.9	11.5	19.5	9.3	11.8	10.0	10.9	11.2	14.2	14.0	12.6	9.9	18.2	13.1	11.3	22.4	13.3	10.6	8.0	5.9	19.9	10.8	5.3	12.8	12.8	0.2	5.7	12.8	12.5	9.5	18.1	13.3	12.7	19.7	14.5	12.9	8.1	9.5	7.3	5.4	10.3	9.3	11.1	7.4	9.0	3.6	7.7	10.6	5.3	8.9	12.0	10.5	10.4	8.1	16.7	15.3	9.3	3.7	16.7	8.4	10.7	10.3	4.2	6.0	8.9	2.1	6.3	6.1	4.5	8.2	3.0	11.8	8.2	65.5	53.4	33.5	45.2	50.7	0.7	41.7	45.9	45.5	45.5	27.9	76.6	44.5	19.9	50.7	6.8	41.7	19.2	23.3	33.6	47.5	36.3	41.5	50.7	27.6	29.0	0.0	3.5	39.9	29.8	7.6	36.5	34.3	20.3	92.8	21.2	48.8	37.7	26.8	34.6	18.5	36.6	32.3	40.1	56.1	40.7	40.0	55.5	57.1	21.8	42.5
NOA1	"C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3"	ENSG00000084092	"Nitric oxide associated 1"	Q8NC60	4	56963370-56978823	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 22.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035838, HPA035839"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA035838: AB_10669531, HPA035839: AB_10669658"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (8.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.27e-2)"	4.5	4.7	2.6	3.0	3.2	5.4	5.3	4.3	2.8	4.3	5.3			7.0	5.9	3.8	6.1	6.0	2.9	3.5	2.5	2.1	3.6	2.8	3.3	5.1	2.1		5.6	13.9	3.6	2.1	2.3		3.8	4.9		5.9	3.7	10.5	6.8	4.9	3.2	2.6	3.8	6.0	1.7			4.0		5.8	6.7	4.5	20.2	16.5	7.0	14.1	20.3	22.3	14.3	7.5	7.0	5.2	9.2	9.6	17.2	14.3	6.0	10.8	6.9	7.0	12.0	14.2	27.1	10.4	5.0	5.7	8.1	9.8	10.6	6.6	5.0	12.7	6.8	6.2	13.0	7.5	12.3	7.4	15.9	12.9	6.4	11.2	14.7	11.5	11.9	11.4	9.8	9.3	10.9	17.6	16.5	6.8	14.5	10.8	12.3	5.6	10.2	9.9	11.3	12.0	10.2	6.1	25.0	8.9	6.9	11.2	8.8	7.5	5.6	13.4	6.7	11.1	12.6	5.2	14.1	5.7	7.9	7.1	6.2	14.1	7.0	12.2	13.0	18.3	20.2	18.2	15.2	16.5	17.0	22.3	18.4	4.8	20.3	11.2	13.3	21.1	14.3											3.0	4.3	15.3	14.0	22.6	6.3	12.0	12.7	18.7	10.3	7.0	3.9	27.0	16.6	15.6	19.3	11.3	11.0	0.0	19.7	29.3	15.0	12.7	8.1	4.3	16.0	1.6	16.8	6.7	17.8	9.1	15.0	14.6	11.8	19.0	19.9	8.0	18.7	21.0	21.9	11.2	8.0	12.9	16.5	7.5	10.5	21.7	23.3	19.1	38.8	19.5
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031168	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	24.5	34.3	31.1	34.6	31.0	21.4	24.8	43.8	33.3	25.9	26.0	18.8	24.9	22.5	35.1	21.4	27.4	28.3	21.2	32.9	29.3	21.7	26.2	21.4	21.2	32.4	28.0	30.2	26.4	28.1	40.7	37.3	25.4	28.3	24.8	26.5	18.4	30.5	28.2	61.8	24.4	27.3	27.6	26.4	27.1	28.8	26.6	26.8	33.4	27.0	34.7	35.1	31.5	22.4	19.8	15.2	27.8	13.9	18.0	23.8	12.7	25.3	21.1	38.2	32.3	31.6	28.5	20.5	33.7	34.3	33.8	31.7	26.9	25.5	39.5	32.0	31.2	24.3	18.0	45.9	25.6	48.4	18.7	20.6	29.7	23.6	23.4	36.6	51.0	34.3	30.7	25.8	38.6	23.5	28.1	40.2	31.8	44.0	33.7	38.9	18.5	48.0	19.7	31.4	32.8	24.8	35.1	25.2	21.7	23.1	28.9	31.9	35.7	21.0	39.9	29.0	32.0	21.4	28.4	29.3	24.6	33.1	25.7	44.2	27.2	25.9	57.5	28.1	27.5	30.4	27.8	12.2	16.8	20.7	12.4	22.0	19.8	20.3	21.4	15.2	14.4	19.9	23.8	11.3	18.0	13.9	12.9	20.9	12.7	31.1	31.0	43.8	33.3	29.3	21.7	28.0	30.2	28.3	26.8	26.8	41.7	44.7	39.5	36.7	45.8	30.9	38.2	57.6	45.5	34.9	41.2	41.3	16.6	52.1	4.5	31.4	29.1	0.0	47.4	25.1	30.5	50.4	55.6	27.2	25.9	42.9	28.7	35.6	42.2	5.4	53.2	38.7	42.2	44.1	31.2	30.4	47.4	30.2	35.7	26.9	48.2	71.1	26.2	79.4	64.2	34.9	34.3	61.0	31.7	71.1
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 10593.1;Peritubular cells: 11028.0;Sertoli cells: 8052.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 72.1;BJ hTERT+: 67.4;hTERT-RPE1: 157.3;RPTEC TERT1: 72.4;TIME: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	240000000	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	95.8	46.5	15.1	38.7	23.7	8.5	65.3	5.6	19.2	73.0	47.8	33.1	79.6	22.7	95.2	164.5	50.5	66.3	241.7	121.0	20.4	14.2	187.5	35.5	55.4	109.0	23.9	24.1	53.0	45.6	12.3	29.5	30.4	91.2	78.1	19.0	126.9	22.2	151.6	30.5	21.1	27.0	119.9	21.9	91.7	32.6	68.0	15.7	3.9	128.9	41.2	18.1	96.8	85.3	0.0	8.4	15.5	3.2	8.7	0.1	1.1	0.1	0.4	0.1	0.0	14.6	5.5	0.5	72.1	67.4	6.3	2.0	0.2	0.0	0.0	46.2	3.4	3.7	7.2	0.0	11.5	1.6	0.1	0.5	0.2	8.4	0.0	22.6	1.7	1.8	25.4	5.9	10.2	2.8	157.3	14.5	0.0	0.0	0.0	14.9	0.0	0.0	7.5	0.6	0.0	0.1	1.3	0.0	0.2	72.4	0.0	0.1	0.1	13.5	1.0	0.0	30.7	0.1	6.6	104.5	6.4	4.9	0.8	11.7	4.3	0.0	0.1	17.0	6.0	0.1	1.6	3.0	15.5	0.1	3.1	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.2	8.7	3.2	0.3	0.1	1.1	15.1	23.7	5.6	19.0	20.4	14.2	23.9	24.1	91.2	15.7	104.2	26.5	28.2	113.1	211.8	3.7	148.5	22.9	163.3	72.8	1980.3	21.6	4.6	437.7	2492.0	58.3	2171.1	0.0	0.0	12.7	4.7	511.0	37.3	15.1	7.2	25.9	0.0	1.2	2456.5	118.7	133.2	10593.1	113.8	895.8	35.1	0.0	9.3	120.5	0.0	11028.0	461.5	9.2	8052.1	3278.8	32.0	37.3	156.6	4.8	78.4	1.5	34.4
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;parathyroid gland: 23.1"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 33.8;Late spermatids: 24.4;Muller glia cells: 39.3"	"Cancer enriched"	"Detected in some"	8	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 30.1;EFO-21: 7.9;HEK 293: 4.6;SCLC-21H: 4.6;SuSa: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA					"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	4.9	7.6	19.7	1.6	19.0	0.4	2.7	11.3	30.5	7.3	4.8	5.0	0.4	3.3	4.9	2.6	1.6	3.3	2.3	3.2	13.1	12.3	2.4	0.9	3.4	0.8	11.8	11.9	1.8	0.7	23.1	0.9	4.9	9.8	2.0	5.0	0.4	0.8	5.6	0.8	2.6	4.4	3.9	8.5	0.8	3.9	4.8	6.1	0.0	0.9	0.6	0.6	2.2	2.9	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.7	0.0	2.8	0.4	0.1	0.1	0.0	3.3	0.1	0.0	4.6	0.2	0.0	0.0	0.0	5.7	0.0	2.3	0.0	0.1	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	19.7	19.0	11.3	23.3	13.1	12.3	11.8	11.9	9.8	6.1	0.0	0.0	0.0	0.0	0.0	3.8	3.3	0.0	0.0	0.0	0.0	3.9	0.2	8.3	0.0	33.8	0.3	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.1	1.6	0.0	1.8	0.0	24.4	0.0	0.0	0.0	0.0	0.0	39.3	0.0	0.0	1.1	0.0	2.2	6.5	0.0	0.5	2.1	0.0	1.8	0.0	0.0	0.1
TECRL	"DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL"	ENSG00000205678	"Trans-2,3-enoyl-CoA reductase like"	Q5HYJ1	4	64275257-64409468	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 131.5"	"Cell type enriched"	"Detected in single"	16229	"Cardiomyocytes: 1622.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"OE19: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA																							0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	131.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.3	0.0	0.9	0.9	0.6	1.1	0.5	0.2	0.3	1.1	0.0	0.1	0.2	1.1	0.7	0.5	0.3	0.3	0.6	0.5	0.3	0.1	0.4	0.5	0.0	0.7	1.4	1.4	0.2	1.2	0.6	0.1	0.5	0.2	0.3	1.0	0.2	0.3	0.7	1.1	0.2	0.2	0.5	0.8	0.7	2.8	0.2	0.5	0.8	0.4	2.5	0.5	0.2	0.6	0.5	0.1	0.1	1.4	0.4	0.5	0.7	1.1	0.8	0.7	0.8	1.0	0.2	0.7	0.5	0.8	0.6	0.6	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1622.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHA5	"CEK7, EHK1, Hek7, TYRO4"	ENSG00000145242	"EPH receptor A5"	P54756	4	65319563-65670495	"Enzymes, Predicted membrane proteins"	Neurogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 12.1;Late spermatids: 12.5;Muller glia cells: 6.4"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.8;PC-3: 7.1;TIME: 9.5;U-138 MG: 19.9;U-2197: 12.1;U-251 MG: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.02e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.89e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.60e-1)"		"unprognostic (6.68e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.25e-2)"		"unprognostic (5.88e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.81e-3)"	0.9	2.7	17.6	1.0	9.0	0.8	0.8	1.9	25.5	5.9	1.2	1.5	1.8	0.9	1.9	0.9	1.1	1.0	0.9	2.7	17.3	6.8	0.9	0.8	1.1	0.9	5.4	13.2	6.2	0.8	0.8	6.5	2.7	10.2	4.2	1.1	2.6	1.2	4.1	0.8	1.2	0.9	1.4	17.7	1.5	1.1	2.2	0.7	0.0	3.0	0.0	0.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.3	0.0	0.3	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.2	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	19.9	2.5	12.1	15.3	0.0	0.0	0.0	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	9.0	1.9	24.7	17.3	6.8	5.4	13.2	10.2	0.7	0.0	0.0	0.0	0.0	0.5	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	1.6	0.0	0.0	0.0	12.5	0.9	0.0	3.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.0	0.2	0.1	0.0	0.0	0.0	0.0
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468748-67545606	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Supported	"Nucleoplasm,Nuclear bodies,Midbody"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Midbody"	"HPA049740: , HPA058252: AB_2683654"	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	9.4	8.6	9.3	11.9	14.6	12.9	13.5	26.9	12.2	12.6	7.3	4.6	6.2	5.6	12.6	10.1	9.1	10.1	6.6	6.9	8.0	5.8	9.0	6.6	8.7	7.7	11.8	7.7	20.9	16.4	8.0	21.2	6.3	9.1	12.3	6.0	5.0	10.2	13.4	5.3	9.8	9.1	10.3	13.4	10.5	9.5	7.5	12.6	17.7	13.0	9.1	6.8	10.2	10.4	5.1	2.4	2.8	1.5	1.6	5.0	1.2	0.8	1.0	2.9	1.6	3.4	2.1	1.6	1.0	0.9	1.3	1.1	1.2	2.3	4.5	1.6	1.3	0.7	1.5	3.7	1.7	2.0	1.7	0.7	3.5	1.8	1.6	1.2	6.3	1.5	2.5	0.6	1.0	2.2	2.2	0.7	3.1	5.0	3.1	1.9	1.5	8.6	5.8	3.1	1.6	0.7	4.2	7.0	1.5	1.7	1.5	4.8	2.4	2.2	4.2	1.2	3.0	1.4	2.4	1.0	1.8	1.3	1.3	0.9	2.3	1.0	4.8	2.1	3.7	1.1	2.7	1.3	2.8	3.2	1.5	1.9	3.3	3.6	3.4	1.1	5.1	5.0	3.7	1.0	1.6	1.1	2.4	2.0	1.2	9.3	14.6	26.9	12.2	8.0	5.8	11.8	7.7	9.1	12.6	29.8	31.5	29.9	25.5	13.5	51.4	20.0	15.3	36.1	38.7	15.7	13.7	15.9	10.0	9.7	3.1	19.2	14.8	23.3	14.6	11.7	14.6	15.2	25.5	13.2	11.0	49.3	12.6	19.0	16.4	4.2	32.2	15.1	15.1	15.4	15.8	42.4	12.3	11.5	24.1	13.9	28.4	19.4	15.5	33.5	46.1	8.2	15.3	44.5	14.3	20.9
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in some"	23	"B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 63.5;U-698: 28.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	9.2	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0	0.0	10.1	31.9	0.0	0.2	0.0	0.0	0.0	1.4	1.2	5.2	0.0	0.0	8.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.6	0.0	0.0	0.0	0.0	5.2	0.3	0.6	15.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.9	0.0	0.0
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	15.1	8.5	14.1	11.0	7.0	8.2	9.5	31.4	12.3	14.4	16.9	8.9	20.5	19.2	11.2	12.9	14.7	9.0	14.5	15.6	21.8	22.1	4.0	12.3	15.0	8.3	6.0	21.6	9.5	5.9	5.0	18.6	11.3	9.9	12.7	9.9	29.2	11.4	17.0	5.7	22.4	4.9	8.3	10.8	10.3	13.3	28.9	7.1	11.8	17.2	6.9	8.7	17.7	12.6	5.9	12.3	8.4	5.8	18.3	13.4	15.1	10.8	13.7	8.2	6.4	19.4	23.8	6.0	12.8	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6	23.8	20.8	33.8	52.9	62.3	46.2	14.4	12.7	25.4	20.5	15.7	51.1	22.4	3.3	21.4	1.4	34.4	21.2	0.0	14.8	12.9	28.2	64.5	30.1	17.3	20.5	31.8	31.0	17.8	27.9	4.0	19.8	35.3	23.6	33.3	24.7	19.8	36.7	21.0	18.7	10.2	42.3	19.4	23.0	37.9	35.1	40.4	49.2	29.9	19.6	126.8
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67739328-67754360	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"pituitary gland: 56.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"K-562: 3.0"	"Not detected"	"Not detected"							HPA013424	Enhanced					NA	NA					"HPA013424: AB_2668840"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	0.1	3.9	0.1	0.4	0.2	0.2	0.1	0.3	1.7	0.3	0.1	0.1	0.1	0.7	0.1	0.1	1.6	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.3	0.0	56.6	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.2	0.9	0.1	0.1	0.1	0.2	0.3	0.3	0.1	0.2	1.0	0.1	0.4	0.1	0.5	1.3	0.2	0.0	0.0	0.4	0.3	0.0	0.2	1.5	1.5	1.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.5	1.7	1.3	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.7	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	3.0	0.0	0.0	0.8	0.6	0.4	1.0	0.5	0.0	0.6	1.3	0.6	0.0	0.0	0.9	2.1	0.0	0.3	0.0	0.3	0.3	0.2	1.0	0.1	0.2	0.6	0.2	1.2	0.3	0.6	1.4	0.8	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.3	0.2	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11D		ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884032	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1"	"Cell type enriched"	"Detected in single"	32	"Urothelial cells: 8.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077704	Enhanced				"Intracellular and membrane"	NA	NA					"HPA077704: "	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	67.6	20.3	0.4	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6
TMPRSS11A	ECRG1	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909385-67964140	"Enzymes, Predicted membrane proteins"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 4.6;Urothelial cells: 6.2"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;OE19: 2.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA					"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	47.6	18.7	0.3	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2
TMPRSS11F	FLJ16046	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129880	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1"	"Cell type enhanced"	"Detected in single"	19	"Cytotrophoblasts: 1.1"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 2.5;K-562: 5.5;Karpas-707: 1.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA026911	Uncertain					NA	NA					"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	13.1	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.3
TMPRSS11B		ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245720	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0"	"Group enriched"	"Detected in some"	35	"Early spermatids: 8.5;Late spermatids: 11.5"	"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (4.24e-2)"				"prognostic favorable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	11.2	0.1	0.0	0.0	0.1	0.5	0.1	138.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	13.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	44.0	57.0	0.1	23.2	0.7	0.6	2.4	0.5	0.4	0.7	0.0	0.3	1.4	0.8	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.3	0.9	0.4	1.4	0.2	0.4	0.4	1.1	0.2	0.1	0.0	0.1	1.6	0.8	1.9	2.1	0.1	1.1	1.4	0.5	0.2	0.0	0.1	0.2	0.0	0.5	0.7	2.0	0.1	0.7	0.5	1.3	0.1	0.3	1.0	0.6	0.6	0.5	0.2	1.5	0.9	0.3	0.1	0.2	0.1	0.6	0.4	0.2	1.3	1.0	0.3	0.5	0.1	0.3	0.9	0.8	0.3	1.0	0.1	0.3	0.4	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.0	0.7	0.3	0.7	2.4	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350089	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	22.1	16.6	25.1	28.8	33.2	101.8	24.3	38.4	25.8	30.3	20.8	24.4	24.0	16.7	29.2	25.1	25.4	20.2	17.6	18.5	23.5	19.6	19.8	19.5	21.1	26.8	26.1	23.4	39.7	24.2	27.6	32.4	33.2	22.8	25.2	21.3	13.8	22.7	30.2	32.9	26.1	21.2	27.6	25.4	23.6	20.6	17.7	35.1	30.2	23.8	20.2	26.7	34.8	30.3	18.0	15.1	41.6	9.3	7.5	11.1	3.2	17.6	10.6	21.7	13.0	13.1	11.4	18.0	19.5	12.3	12.2	12.9	13.1	16.3	29.0	16.0	9.9	9.9	13.4	20.3	17.1	19.9	21.4	12.3	22.1	15.2	14.5	13.4	23.3	17.1	10.8	18.6	10.9	26.2	15.7	13.2	14.1	20.8	17.1	17.8	13.5	27.1	21.0	16.3	17.3	10.5	23.8	24.6	12.9	19.1	20.5	18.9	14.8	17.0	18.4	14.1	21.2	14.4	16.3	13.9	14.1	14.9	9.7	12.8	17.8	11.9	30.3	9.5	15.2	12.9	20.2	8.3	14.7	9.9	5.0	7.7	12.7	8.0	7.9	4.6	18.0	11.1	9.2	41.6	7.5	9.3	15.1	7.3	3.2	25.1	33.2	38.4	25.8	23.5	19.6	26.1	23.4	22.8	35.1	104.2	120.5	72.4	101.3	106.6	102.8	78.1	73.9	139.2	159.3	69.8	66.8	58.2	44.7	60.9	61.3	76.3	40.0	23.3	49.7	94.0	62.9	98.5	88.2	72.1	37.8	85.8	82.2	47.9	51.2	14.3	69.0	70.8	60.8	45.1	60.5	91.4	65.5	48.7	63.6	32.1	131.7	51.8	97.3	131.7	89.6	117.6	99.5	74.8	54.4	85.9
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447449-68497604	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6"	"Group enriched"	"Detected in some"	6	"Basal glandular cells: 12.6;Urothelial cells: 38.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.8"	"Group enriched"	"Detected in some"	6	"HaCaT: 5.0;HBEC3-KT: 1.9;OE19: 5.2;SuSa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051062	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.9	0.0	0.0	1.2	0.0	1.1	10.5	103.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.6	0.5	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	40.5	39.1	2.6	36.6	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	38.8
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	5.2	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646630-68670628	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 22.4;intestine: 50.7;liver: 65.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.2;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1"									HPA045108	Approved					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	48.0	0.1	0.1	5.4	0.1	0.1	0.2	0.0	22.4	0.1	0.1	0.0	0.1	65.4	0.1	0.1	0.1	0.1	0.1	5.3	0.0	0.1	0.1	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.0	50.7	0.1	0.1	0.1	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	1.2	1.1	0.0	0.2	0.1	0.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.4	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	168.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	1.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	134.4	0.0	0.0	0.0	1.8	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.5
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815993-68831196	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	277	"liver: 120.4"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 221.7"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"Hep G2: 16.1"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	120.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.7	0.0	0.0	0.0	1.3	4.7	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951791	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 150.5;kidney: 43.2"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.3"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 21.0"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.1	0.1	0.1	4.3	0.1	0.0	0.7	0.1	0.1	0.1	63.8	0.1	0.1	31.9	0.1	1.7	0.1	0.1	14.6	0.3	0.1	0.1	43.2	9.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.1	0.1	0.1	0.1	8.6	0.1	0.1	0.1	0.1	0.1	150.5	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	94.3	0.0	0.0	3.5	0.0	0.0	10.0	21.3	0.0	0.0	115.5	0.0	2.3	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	28.2	0.0	6.0	52.6	0.0	125.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 539.4;Proximal tubular cells: 775.7"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 21.0;RPTEC TERT1: 83.6"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	83.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	3.9	0.6	0.1	0.0	0.0	58.6	0.0	0.0	118.7	0.0	0.0	82.9	5.6	0.2	0.0	6.7	0.0	9.1	0.0	0.0	0.4	0.0	539.4	0.1	0.0	3.4	6.2	10.7	0.0	1.7	0.0	3.3	0.0	20.1	0.0	11.8	11.9	0.0	775.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	2.0
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214731	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"breast: 77.4"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 12.7"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"basophil: 6.8;eosinophil: 5.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	3.3	0.1	0.1	0.0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.0	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280499-69295050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 71.7;salivary gland: 25.6"	"Cell type enriched"	"Detected in single"	178	"Cholangiocytes: 17.8"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 2.5;eosinophil: 4.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.0"	"Group enriched"	"Detected in some"	10	"Daudi: 7.1;NB-4: 6.5"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.2	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 831.9"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 10.4"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	34.2	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	831.9	0.1	0.0	0.0	14.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 32.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6"									"HPA017261, HPA045108"	Uncertain					NA	NA					"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	Q9Y4X1	4	69589309-69639642	"Enzymes, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 2.6"	"Not detected"	"Not detected"							HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.4	0.0	0.0	0.0		0.0	0.0	0.0	3.8	0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721162-69787961	"Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 137.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 232.6;Paneth cells: 154.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 48.3;OE19: 11.1;TIME: 15.6;U-2197: 13.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	1.2	0.6	0.9	9.3	1.8	1.3	1.1	0.5	1.5	1.1	38.6	0.5	0.7	31.8	0.8	0.6	1.0	1.5	1.2	1.2	0.9	0.9	1.1	24.8	2.4	12.9	1.2	0.7	0.7	0.5	0.0	0.4	0.6	2.0	0.6	20.3	1.3	0.6	0.2	0.4	0.4	137.6	1.4	3.6	13.3	13.9	0.5	0.7	2.0	0.6	0.3	2.0	0.7	1.2	0.2	1.8	21.9	3.2	1.8	3.6	1.6	0.3	0.2	0.3	0.4	0.8	0.9	0.6	0.4	0.2	0.1	0.1	0.3	0.3	0.6	0.3	0.4	0.4	0.5	0.0	0.1	0.3	0.7	0.4	0.5	0.5	0.2	1.2	0.6	0.7	5.5	0.0	0.1	0.2	0.5	48.3	0.7	0.3	1.1	0.4	0.3	0.3	0.5	0.4	11.1	0.2	0.2	1.7	0.3	0.1	0.8	0.7	0.4	0.2	0.2	0.2	0.3	0.7	0.3	15.6	0.5	0.8	13.9	0.3	0.9	0.4	0.2	0.2	1.4	0.6	5.8	3.2	0.8	0.7	1.9	0.2	0.1	1.1	0.3	1.8	0.2	3.6	1.7	21.9	1.8	2.2	0.2	0.5	1.6	0.9	1.8	0.5	1.5	0.9	0.9	1.2	0.7	2.0	0.7	17.9	17.3	2.2	0.0	0.2	0.0	0.4	0.0	22.7	12.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	232.6	0.0	4.0	0.1	0.2	0.1	15.1	42.3	0.3	0.0	32.4	4.3	35.4	0.0	0.0	5.4	0.0	0.0	38.4	0.0	11.4	154.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.8	43.0	0.1
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 47.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4"									"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	38.0	0.0	0.0	17.2	14.3	0.0	0.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1	0.0	0.0	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.2	0.1	0.0	0.0	47.0	0.2	0.0	0.0	1.8	1.0	0.0	0.3	0.0	1.7	0.0	0.2	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.3	0.0	0.0	0.1
CSN1S1	"CASA, CSN1"	ENSG00000126545	"Casein alpha s1"	P47710	4	69931081-69946574	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 184.8"	"Cell type enriched"	"Detected in single"	11	"Cardiomyocytes: 1.6"	"Cancer enriched"	"Detected in some"	10	"breast cancer: 17.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"NK-cell: 1.6;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.2;NK-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;HL-60: 1.4;U-266/70: 1.5"									"HPA035659, HPA057031"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035659: AB_10696356, HPA057031: AB_2683315"					"unprognostic (1.52e-2)"										"unprognostic (1.01e-1)"			44.7	0.0	0.0	0.0	0.1	0.0	184.8	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.2	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.6	0.0	3.2	0.0	0.2	0.0	0.1	0.0	0.9	0.1	1.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"breast: 82.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-266/70: 1.4"					"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"	NA	NA					"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	82.6	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995930-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	162	"salivary gland: 5940.6"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 2.1"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HHSteC: 1.4"									HPA044569	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.3	1.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5940.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	36.5	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028413-70036538	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	535	"salivary gland: 3346.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.5;HL-60: 4.9"									CAB073541	Enhanced				"Secreted to digestive system"	NA	NA					"CAB073541: "																		0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	1.4	0.0	6.2	0.0	0.0	0.2	0.0	0.0	3346.6	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	3.3	0.3	0.1	0.1	1.2	0.6	2.2	1.2	0.5	1.0	0.4	1.1	1.4	0.5	0.5	0.0	0.3	0.4	0.2	0.0	0.6	0.6	0.2	1.6	1.7	0.8	0.2	2.0	0.9	0.0	0.3	0.1	4.5	0.7	0.3	0.9	0.6	0.0	4.9	3.5	0.4	0.8	0.1	0.0	0.5	0.7	0.8	0.6	3.0	0.5	0.6	1.3	2.4	1.2	0.6	1.4	3.0	0.8	0.6	0.3	0.6	2.0	1.2	1.1	0.8	0.9	1.0	2.2	1.3	0.0	1.2	1.8	1.2	0.9	2.0	2.3	0.7	1.1	1.5	2.5	2.2	0.7	0.5	0.5	1.1	0.3	1.0	0.8	0.4	0.4	1.2	1.0	0.6	2.0	0.5	1.2	0.6	0.5	0.4	0.1	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTN1	HIS1	ENSG00000126550	"Histatin 1"	P15515	4	70050402-70058845	"Predicted secreted proteins"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	1306	"salivary gland: 1826.6"	"Cell type enhanced"	"Detected in single"	33	"Club cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;hTCEpi: 1.0;SK-MEL-30: 3.6"									HPA077315	Approved				"Secreted to digestive system"	NA	NA					"HPA077315: "									"unprognostic (2.22e-1)"									0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1826.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	1.3	1.1	0.1	0.1	0.2	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 669.3"	"Group enriched"	"Detected in some"	32	"Early spermatids: 11.0;Late spermatids: 7.0"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.3"									"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.5	0.2	2.4	0.3	0.5	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.2	1.3	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.0	0.2	0.2	0.5	0.0	0.7	0.1	0.4	0.5	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.0	0.4	0.0	0.3	0.2	0.2	0.2	0.2	0.4	0.1	0.3	0.1	0.0	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.5	0.2	0.2	2.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"salivary gland: 157.7"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4;Ductal cells: 6.3;Exocrine glandular cells: 7.3;Pancreatic endocrine cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 24.2;OE19: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	2.5	0.2	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.0	0.4	0.1	0.0	157.7	2.6	0.0	0.0	0.3	1.9	0.1	0.0	2.5	0.0	0.0	0.0	5.1	10.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.4	0.0	1.1	0.0	0.0	0.0	2.5	0.0	2.3	1.8	0.0	0.3	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3
FDCSP	"C4orf7, FDC-SP"	ENSG00000181617	"Follicular dendritic cell secreted protein"	Q8NFU4	4	70226071-70235252	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 176.5;salivary gland: 452.5"	"Cell type enriched"	"Detected in single"	38	"Ductal cells: 37.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 336.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;GAMG: 10.9;HL-60: 2.0;RH-30: 3.0;U-87 MG: 8.0"									"HPA014326, CAB014890"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB014890: , HPA014326: AB_1845719"	"unprognostic (1.26e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.73e-3)"	"unprognostic (9.62e-2)"		"prognostic favorable (2.38e-4)"	"unprognostic (5.99e-3)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.79e-1)"		"unprognostic (1.96e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.83e-2)"	0.4	0.4	0.4	95.4	0.4	0.0	9.7	0.4	0.4	0.4	1.0	0.0	0.0	0.0	0.4	0.0	1.9	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.5	124.7	0.4	0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.4	0.7	0.0	452.5	0.0	0.5	0.4	3.7	0.0	0.4	12.1	0.4	0.4	0.0	0.4	0.5	35.9	176.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.2	8.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	96	"breast: 91.1;salivary gland: 31.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 3.2;Late spermatids: 1.1;Spermatocytes: 1.0"	"Group enriched"	"Detected in some"	15	"breast cancer: 35.3;lung cancer: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.4;U-266/70: 1.6"					"Not detected"	"Not detected"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.1	0.0	0.1	0.1	0.1	0.0	91.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	31.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0
CABS1	"C4orf35, CLPH, FLJ32897, NYD-SP26"	ENSG00000145309	"Calcium binding protein, spermatid associated 1"	Q96KC9	4	70334966-70337116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"testis: 75.3"	"Group enriched"	"Detected in some"	102	"Early spermatids: 1181.5;Late spermatids: 2745.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"NTERA-2: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044016, HPA055352"	Enhanced					NA	NA					"HPA044016: AB_10964494, HPA055352: AB_2682790"															"unprognostic (1.36e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1181.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2745.2	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	19.3	5.9	0.0	0.0	0.0	0.0	0.0
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360761-70367158	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"salivary gland: 186.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.3"									HPA044567	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	186.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMR3B	"P-B, PRL3, PROL3"	ENSG00000171201	"Submaxillary gland androgen regulated protein 3B"	P02814	4	70370093-70390244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2372	"salivary gland: 6520.0"	"Group enriched"	"Detected in some"	60	"Early spermatids: 8.1;Late spermatids: 3.8"	"Cancer enriched"	"Detected in some"	22	"breast cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	35	"EFO-21: 9.8"														"Secreted to digestive system"	NA	NA		4500000																			"unprognostic (3.72e-1)"		0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	6520.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397882-70410194	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"breast: 19.1;salivary gland: 59.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"GAMG: 1.0"									HPA065711	Approved				"Secreted in other tissues"	NA	NA		36000			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 1562.5"	"Cell type enriched"	"Detected in single"	60	"Melanocytes: 11.8"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.2;GAMG: 1.4"									HPA006411	Enhanced				"Secreted to digestive system"	NA	NA					"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1562.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518540-70532742	"Disease related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 24.6;salivary gland: 12.9;stomach 1: 6.7"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 1.1;Urothelial cells: 1.3"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 14.9;hTERT-RPE1: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.8	12.9	0.0	0.0	0.5	0.0	0.0	0.6	0.0	6.7	0.2	0.0	0.0	0.9	0.9	24.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.9	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	21.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70686816	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.1;heart muscle: 5.0;kidney: 7.9"	"Cell type enriched"	"Detected in some"	7	"Melanocytes: 32.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"					"Group enriched"	"Detected in some"	18	"memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"B-cells: 1.7;dendritic cells: 2.2"	"Group enriched"	"Detected in some"	4	"Daudi: 2.4;RPTEC TERT1: 1.5;U-266/70: 2.5;U-266/84: 3.4;U-698: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	10.1	0.0	0.1	1.5	5.0	0.0	0.0	7.9	0.5	0.0	0.0	0.0		0.0	2.5	0.8	0.5	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	1.3	1.2			0.0		0.0	0.0	0.0	1.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	3.4	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.5	0.0	0.0	3.5	0.0	0.0	3.3	0.7	4.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	32.1	0.0	0.0	0.0	0.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1"	"Cell type enhanced"	"Detected in some"	26	"Alveolar cells type 2: 174.1;B-cells: 379.6;Erythroid cells: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	118	"memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7"	"Group enriched"	"Detected in many"	142	"B-cells: 213.0;dendritic cells: 160.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 162.4;Karpas-707: 86.7;RPMI-8226: 172.1;U-266/70: 366.4;U-266/84: 142.2;U-698: 211.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		4200000000			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	4.4	1.6	0.9	209.3	0.9	0.4	69.6	0.9	0.9	27.2	403.3	2.1	0.7	132.7	1.7	1.5	29.2	9.8	79.4	2.4	0.9	1.0	19.9	12.7	62.8	111.7	0.9	0.6	14.0	8.6	0.0	1.4	0.7	0.8	5.7	142.5	8.2	220.1	30.1	1.1	1.7	361.5	4.0	1.0	161.3	124.6	7.0	0.7	8.0	7.1	36.8	96.7	42.1	5.9	213.0	160.7	1.3	0.3	0.2	0.9	52.6	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	162.4	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	86.7	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.2	0.1	172.1	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.5	0.2	0.2	366.4	142.2	211.2	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	0.9	213.0	0.1	0.2	0.3	91.6	0.1	0.1	1.3	0.2	0.1	160.7	0.1	52.6	0.9	0.9	0.9	0.9	0.9	1.0	0.9	0.6	0.8	0.7	20.8	174.1	379.6	2.5	0.0	0.0	0.3	10.2	6.7	14.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	864.3	0.0	0.1	0.0	0.5	73.2	1.5	0.3	0.0	7.0	91.4	24.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.9	0.2	0.0	0.2	10.2	0.0	0.3
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3, small subunit processome component"	Q9NQZ2	4	70688479-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: AB_2677488"	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	19.9	23.4	17.6	21.3	17.9	14.5	17.1	20.1	20.3	15.7	16.1	12.1	12.1	14.3	19.4	14.2	23.5	19.4	13.3	18.9	17.0	12.1	24.5	27.5	16.4	26.7	15.5	16.2	17.2	17.0	16.4	21.2	22.9	18.4	14.5	15.2	9.9	16.0	16.7	18.1	20.1	22.8	18.2	14.7	38.7	19.5	11.5	20.3	33.3	16.5	21.6	27.2	15.5	17.6	7.3	13.6	6.3	12.7	6.5	8.6	5.2	12.3	12.1	16.2	13.5	23.1	17.5	13.9	25.7	16.6	14.7	14.4	15.7	16.5	54.4	16.2	21.9	16.9	10.4	23.7	35.2	21.5	16.8	13.6	20.7	16.2	16.8	25.1	31.2	18.4	23.7	21.2	18.0	17.8	16.4	19.7	16.0	23.6	18.4	23.8	25.5	28.9	17.5	11.3	25.5	17.7	12.4	22.4	22.2	26.6	20.0	13.7	18.7	10.9	25.0	15.9	18.6	13.7	12.6	21.9	15.1	25.6	14.3	16.4	26.9	19.8	39.6	18.4	15.4	13.1	6.3	11.1	5.5	7.0	12.7	7.3	7.3	5.8	7.8	13.5	6.8	8.6	7.2	0.9	6.5	10.8	13.6	7.0	5.2	17.6	17.9	20.1	20.3	17.0	12.1	15.5	16.2	18.4	20.3	53.6	50.4	14.5	40.4	20.4	18.4	17.9	10.2	60.2	61.4	12.2	5.9	22.5	16.6	25.7	0.7	22.8	13.4	23.3	25.9	12.8	18.2	14.0	28.8	23.7	19.4	15.9	14.5	19.6	29.5	1.5	16.1	25.1	11.8	14.4	12.3	26.4	20.3	8.6	23.7	25.4	21.9	12.9	25.5	11.6	9.3	22.3	18.1	21.8	12.7	31.6
RUFY3	"KIAA0871, RIPx, Singar1, ZFYVE30"	ENSG00000018189	"RUN and FYVE domain containing 3"	Q7L099	4	70704204-70807315	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.2"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 190.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022952, HPA022970"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA022952: AB_2671005, HPA022970: AB_1856307"	"unprognostic (4.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (8.02e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.45e-3)"	"unprognostic (5.41e-1)"	10.9	24.5	39.1	11.8	53.4	6.9	12.5	36.4	66.3	12.3	8.7	24.1	6.7	8.1	20.6	16.3	15.3	9.3	12.7	8.9	64.5	34.4	15.5	13.6	14.8	13.6	37.0	51.3	25.5	9.8	8.5	61.4	12.0	54.2	13.8	11.4	12.8	10.1	11.5	15.4	29.9	9.9	15.1	80.2	16.0	12.8	25.3	32.5	7.1	31.6	5.9	11.5	9.3	12.3	3.5	6.0	0.0	3.1	2.2	2.8	1.0	3.7	2.6	31.2	7.3	15.1	17.6	12.4	12.2	4.7	4.0	4.5	4.5	9.2	15.0	5.1	10.1	8.9	3.8	4.7	5.4	6.4	8.1	6.0	3.2	3.6	4.9	8.6	3.7	1.9	12.4	8.4	5.3	6.2	18.6	8.4	16.2	8.8	15.5	8.7	4.6	23.2	3.9	7.5	6.6	3.4	5.7	9.7	6.8	7.8	3.6	29.2	14.4	4.4	7.9	7.4	12.6	5.4	1.8	7.1	13.6	9.5	4.0	2.8	17.3	7.8	16.0	14.1	2.7	2.7	0.0	3.1	0.0	2.2	3.0	2.8	3.5	1.5	2.0	6.0	3.1	1.5	1.6	0.0	2.2	2.8	4.8	1.0	1.0	39.1	53.4	36.4	66.3	64.5	34.4	37.0	51.3	54.2	32.5	32.8	68.4	13.4	19.5	17.2	119.8	18.3	10.2	34.8	45.5	22.7	249.4	12.7	6.6	12.7	57.5	30.2	8.7	0.0	17.9	5.7	21.6	29.3	20.7	21.8	9.7	131.9	14.5	34.4	31.8	95.1	43.7	29.7	40.5	83.8	8.3	45.6	18.9	3.5	47.7	12.8	190.1	25.8	29.9	13.4	29.3	25.2	6.4	8.7	8.3	16.0
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815782-70839945	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.8"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 449.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	17.9	33.4	21.3	22.3	19.9	8.8	29.0	19.1	42.5	16.8	22.7	19.7	15.0	18.1	17.2	18.2	21.7	18.9	22.9	33.3	22.9	22.6	23.9	23.6	23.7	24.6	24.8	20.2	17.3	26.9	19.6	13.7	18.3	23.6	17.7	27.1	12.0	32.1	20.9	101.8	18.7	17.2	18.1	24.1	17.3	22.5	13.6	19.1	37.0	19.7	31.1	21.7	21.1	15.4	5.7	20.0	7.6	11.6	14.3	11.7	5.6	32.3	22.1	26.0	27.0	27.6	32.3	37.4	39.3	24.9	29.7	24.4	22.5	33.3	46.8	30.1	40.4	15.4	12.4	46.0	30.7	39.8	25.4	15.1	24.6	22.7	31.1	34.1	35.9	14.2	27.1	29.6	29.9	20.9	35.9	30.5	26.1	28.1	27.2	41.2	34.6	59.1	25.3	27.7	35.4	23.4	24.4	40.5	19.9	36.6	40.5	27.2	24.5	18.5	52.8	64.8	31.8	22.9	17.7	27.8	27.8	29.3	22.9	24.7	22.7	18.0	30.1	23.0	23.4	27.0	7.6	11.6	5.2	7.6	8.8	9.5	5.7	11.2	11.7	20.0	4.9	11.2	9.5	1.6	14.3	10.5	19.3	9.3	5.6	21.3	19.9	19.1	42.5	22.9	22.6	24.8	20.2	23.6	19.1	29.8	29.3	32.1	42.4	44.4	17.5	125.4	40.8	21.4	26.1	26.2	23.6	87.9	63.0	61.2	5.7	32.2	41.3	0.0	53.0	115.0	34.8	51.4	17.3	45.7	56.0	27.0	66.2	28.8	58.2	5.3	32.2	42.5	59.1	449.1	69.7	23.1	55.3	42.1	36.7	56.1	17.4	19.4	40.1	21.9	55.1	44.2	64.5	37.9	79.0	54.6
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 70.0;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 34.3"	"Low region specificity"	"Detected in all"							"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	9.8	10.1	15.7	17.8	13.0	30.9	11.1	10.4	20.0	10.5	9.7	17.3	4.8	6.1	13.9	8.6	9.9	11.8	9.1	11.1	19.8	10.6	29.3	8.3	20.6	13.4	15.5	18.6	13.8	11.0	18.0	10.9	11.2	12.8	12.7	8.5	8.0	11.1	8.6	10.8	11.2	8.4	14.1	17.4	10.6	10.1	7.6	15.4	52.3	14.4	8.2	12.8	10.8	9.8	0.6	5.3	2.5	3.1	0.7	1.4	1.2	3.9	3.2	12.2	9.9	6.6	8.4	10.0	11.9	6.5	6.7	5.9	4.2	7.6	22.0	5.7	10.5	4.5	2.8	7.5	10.0	16.2	11.6	2.6	34.3	3.6	3.3	6.6	7.5	6.9	6.9	5.5	7.5	6.1	7.5	7.9	11.4	21.0	7.2	10.5	4.2	23.2	4.6	4.0	2.6	4.2	7.5	11.8	3.0	11.1	6.9	4.2	8.1	5.1	2.3	15.9	6.8	5.4	4.8	9.4	18.6	9.5	8.4	4.8	4.6	1.5	9.4	6.5	5.5	8.5	0.8	3.1	2.5	1.3	1.6	1.1	0.5	0.6	0.6	4.0	0.6	0.8	0.7	0.4	0.7	0.9	5.3	1.4	1.2	15.7	13.0	10.4	20.0	19.8	10.6	15.5	18.6	12.8	15.4	23.8	15.5	2.2	5.2	15.9	2.0	14.7	7.6	21.4	12.5	41.8	17.7	4.6	8.3	4.9	0.4	9.5	0.9	70.0	4.0	4.9	11.2	9.8	10.4	6.4	9.9	6.4	36.4	9.8	34.3	1.4	4.0	21.6	10.1	52.3	8.4	6.0	8.0	0.0	8.1	15.9	4.3	25.8	21.7	7.2	9.8	14.9	4.8	5.4	5.6	8.4
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 60.9;U-698: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	8.0	8.3	11.9	30.9	16.8	17.2	6.9	11.4	14.8	5.6	8.6	10.4	2.6	7.6	7.5	4.4	8.8	5.5	6.1	5.5	12.3	13.1	5.8	4.8	9.7	42.8	11.7	10.3	6.0	5.0	3.6	4.2	7.9	11.1	5.9	10.4	6.4	6.3	4.0	6.8	7.9	12.4	7.5	17.6	17.5	8.2	5.6	8.6	80.9	8.3	3.8	39.9	9.5	6.5	27.9	34.2	17.5	12.7	18.5	24.9	25.1	6.7	4.5	9.9	5.9	3.1	5.5	5.7	17.5	6.5	13.9	11.6	2.9	14.8	60.9	7.6	7.2	8.1	3.9	8.8	5.5	18.8	12.9	5.4	12.6	5.2	4.6	3.2	25.1	16.3	2.7	6.7	8.4	5.1	6.8	7.9	17.3	5.0	23.2	15.8	3.9	31.0	9.9	4.7	11.5	5.5	26.4	20.1	4.8	6.9	4.7	8.8	9.4	6.6	12.9	7.7	4.7	5.8	13.2	6.3	15.7	11.8	13.1	9.4	8.8	5.8	49.4	10.9	15.7	11.6	13.1	10.7	17.5	16.2	12.7	20.3	27.9	21.8	20.0	14.3	26.4	23.4	23.5	5.4	18.5	12.1	34.2	24.9	25.1	11.9	16.8	11.4	14.8	12.3	13.1	11.7	10.3	11.1	8.6	0.0	11.3	75.5	8.0	38.1	13.6	4.6	7.6	1.4	3.4	12.2	5.9	9.8	24.9	17.7	0.4	14.3	9.0	186.9	5.6	16.0	12.9	9.5	23.0	5.3	33.7	17.5	20.2	21.5	48.3	1.1	7.8	41.6	43.9	68.5	17.2	14.3	8.9	7.0	9.6	6.1	8.2	6.5	20.6	34.4	28.8	37.9	3.8	61.7	14.3	6.2
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71186757-71572087	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.4;pancreas: 113.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.8;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA					"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	2.4	0.9	14.3	4.3	19.9	0.7	1.1	18.1	15.2	5.8	17.2	4.5	0.1	22.4	0.8	0.7	1.1	1.0	24.9	2.9	13.1	8.1	47.4	9.4	5.8	0.6	9.7	11.2	1.0	113.8	10.0	4.1	1.6	18.1	14.6	17.1	11.1	1.5	1.1	1.3	0.7	10.4	1.3	21.6	0.9	8.3	0.7	8.0	0.0	9.5	0.0	0.6	2.6	0.9	0.0	0.1	0.0	0.0	0.5	2.8	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.1	13.9	1.9	2.3	1.8	0.0	0.1	0.0	0.1	6.3	0.6	0.0	0.2	0.0	5.7	0.0	1.8	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.9	0.0	0.6	1.2	0.0	4.7	0.2	0.1	0.2	0.0	0.0	0.0	0.9	14.9	4.2	1.0	0.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	7.9	0.7	5.7	0.6	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.8	2.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.3	14.3	19.9	18.1	12.4	13.1	8.1	9.7	11.2	18.1	8.0	3.0	32.5	1.3	4.2	0.0	0.0	20.1	107.0	14.7	31.8	24.4	0.0	0.2	13.3	81.5	6.6	1.9	173.4	0.0	21.6	0.1	1.1	63.3	1.1	31.7	0.2	0.0	8.2	1.8	0.6	1.0	0.0	1.0	1.7	1.8	66.7	3.3	19.9	56.6	0.0	149.5	1.1	6.5	2.5	0.1	0.4	0.0	0.2	6.9	42.6	7.0
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC, vitamin D binding protein"	P02774	4	71741693-71804041	"Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 552.1"	"Group enriched"	"Detected in some"	30	"Cholangiocytes: 1228.0;Hepatocytes: 2290.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 4.2;K-562: 1.8;RH-30: 6.5;SiHa: 3.2;U-2 OS: 1.8;U-698: 2.3;U-937: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	NA	NA	143000000000	69000000000			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favorable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavorable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.0	0.0	2.6	0.1	0.2	0.1	0.1	43.7	0.1	0.1	0.1	2.0	552.1	0.1	0.0	0.1	0.0	0.1	6.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.1	0.4	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.5	1.0	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.8	0.0	2.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	1228.0	0.0	0.0	0.0	0.0	0.0	5.0	18.0	0.2	0.0	0.0	46.7	14.8	0.1	0.0	0.0	0.0	2290.1	0.1	0.0	0.0	57.1	59.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	19.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;seminal vesicle: 10.1"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 5.4;Extravillous trophoblasts: 7.3;Horizontal cells: 3.2;Muller glia cells: 4.8;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"GAMG: 22.5;NTERA-2: 7.3;RPTEC TERT1: 9.5;SH-SY5Y: 11.2;U-2 OS: 11.2"	"Region enriched"	"Detected in single"	4	"olfactory region: 5.3"	"Low region specificity"	"Detected in many"			HPA026825			Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Actin filaments"	"HPA026825: AB_10603123"	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.9	0.2	5.5	0.7	2.6	0.2	1.4	0.2	3.5	0.5	0.5	0.0	0.0	0.5	0.1	2.8	0.3	0.8	0.4	0.4	0.9	2.9	0.6	0.2	0.2	0.6	0.5	4.0	0.3	1.2	0.1	1.0	4.6	1.5	3.2	0.9	1.4	0.3	10.1	0.3	0.7	0.5	0.2	0.6	0.5	0.4	1.6	0.0	15.4	1.2	0.0	0.6	2.5	0.7	0.6	0.3	2.3	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	11.2	0.0	0.0	0.0	1.6	0.0	0.0	1.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.2	1.1	0.8	0.3	0.3	0.2	0.1	5.5	2.6	0.2	3.5	0.9	2.9	0.5	4.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.4	0.1	0.0	0.0	0.2	7.3	1.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	8.1	0.0	0.0	0.0
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569386	"Cancer-related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 13.7;Leydig cells: 18.4;Rod photoreceptor cells: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.6;AN3-CA: 7.3;HEL: 12.9;K-562: 11.0;SH-SY5Y: 6.6;U-2 OS: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			"Intermediate filaments"		"HPA021368: AB_2670681, HPA021369: AB_2670682"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	5.3	2.6	3.3	4.4	5.6	2.1	7.8	0.3	4.6	4.4	2.3	1.1	1.9	0.5	9.6	14.4	1.0	7.5	1.9	2.8	1.3	0.9	4.7	2.7	3.1	2.0	0.7	2.2	7.5	1.0	12.4	1.1	8.2	2.2	2.6	1.1	3.9	1.4	3.4	0.8	1.5	0.9	4.6	1.8	1.9	1.6	5.6	1.3	0.6	4.4	0.8	1.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	7.3	0.1	0.3	0.1	0.6	2.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.6	0.0	1.8	0.0	1.6	12.9	1.0	0.0	0.2	0.0	0.0	1.7	0.1	0.6	0.1	3.1	0.0	0.0	11.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	3.8	0.0	2.5	0.0	4.3	0.0	0.5	6.6	0.0	0.5	0.2	1.4	0.1	0.1	0.1	5.4	8.1	0.0	0.6	0.0	0.0	0.0	1.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.6	0.3	4.6	1.3	0.9	0.7	2.2	2.2	1.3	0.0	4.3	0.0	1.0	0.5	0.8	0.8	0.0	0.0	2.3	1.8	13.7	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.2	1.6	0.7	1.1	0.0	0.0	0.0	0.0	2.5	0.0	1.3	18.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.2	0.2	11.9	0.0	0.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0
COX18	FLJ38991	ENSG00000163626	"COX18, cytochrome c oxidase assembly factor"	Q8N8Q8	4	73052362-73069755	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046772, HPA049489"	Approved					NA	NA					"HPA046772: AB_2679799, HPA049489: AB_2680791"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (9.01e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.22e-7)"	"unprognostic (1.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.22e-3)"	8.5	20.4	8.9	6.8	11.6	4.4	8.3	8.5	11.7	8.2	10.4	12.3	11.2	9.8	11.0	9.5	7.9	7.3	9.6	16.3	8.2	9.1	14.7	18.9	7.2	12.6	9.1	9.5	8.4	15.9	6.8	9.2	8.2	9.6	9.3	10.2	10.4	16.5	8.4	10.4	7.4	8.4	5.5	10.6	9.8	9.7	15.6	7.8	10.9	10.1	9.0	9.9	8.4	6.1	4.2	6.7	2.1	6.0	2.6	5.4	3.0	4.3	9.4	4.1	7.0	4.8	6.1	6.0	6.2	4.3	2.5	3.0	6.7	7.1	9.2	5.4	4.7	4.5	3.0	7.5	5.2	3.1	8.6	3.7	5.0	5.7	8.3	4.8	8.3	7.3	7.3	4.0	2.8	7.3	4.5	5.8	8.1	8.6	7.0	5.6	6.2	9.9	4.0	6.4	5.5	10.0	6.2	8.0	10.2	4.9	6.1	8.1	5.3	4.9	8.1	3.2	4.1	5.7	3.4	6.8	5.2	2.5	9.2	3.8	16.4	7.8	6.5	6.4	6.3	5.7	2.1	5.9	1.8	3.4	5.6	4.9	3.8	3.5	3.8	4.6	4.2	5.4	5.3	1.5	2.6	6.0	6.7	2.9	3.0	8.9	11.6	8.5	11.7	8.2	9.1	9.1	9.5	9.6	7.8	3.0	4.6	10.0	3.1	2.3	11.3	11.5	5.1	8.1	6.8	8.7	21.6	6.6	11.6	5.6	3.3	5.9	5.3	23.3	6.8	7.2	3.5	5.3	0.0	15.8	7.7	19.1	5.2	14.1	8.3	1.5	8.3	6.9	5.0	8.2	8.5	8.8	7.3	2.9	8.9	11.2	14.8	12.9	5.2	7.7	7.0	1.3	2.5	9.6	9.0	3.0
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	19.6	20.2	28.9	23.2	32.4	10.3	24.8	41.2	29.9	22.8	19.4	21.2	19.5	18.2	19.3	24.2	22.2	23.5	18.8	20.4	23.4	21.6	25.3	25.3	18.0	17.4	22.3	19.4	23.4	22.8	40.2	34.6	23.2	31.8	19.7	24.2	21.5	23.1	23.1	32.7	22.2	18.5	20.7	18.0	17.7	19.2	13.5	25.1	22.3	22.7	15.9	21.1	21.1	18.9	4.5	7.6	3.2	2.8	9.3	5.3	1.7	12.3	13.6	21.7	17.1	24.5	21.6	11.9	18.2	21.5	16.4	15.9	16.5	16.3	33.6	15.2	18.6	8.7	10.4	27.1	16.1	22.8	13.0	11.5	22.8	14.8	23.9	13.1	29.8	14.1	18.2	17.6	23.5	18.8	17.1	21.8	13.8	31.9	12.4	19.6	11.4	24.4	10.6	14.1	16.0	13.8	19.5	23.9	13.9	17.5	18.7	21.1	14.3	17.6	19.9	9.5	17.7	10.7	11.8	26.2	17.4	16.7	15.5	14.2	10.4	5.2	25.7	14.1	13.1	17.7	2.3	2.8	3.0	5.3	1.8	2.7	3.0	3.3	3.6	2.3	4.5	3.2	3.6	3.2	9.3	2.1	7.6	2.0	1.7	28.9	32.4	41.2	29.9	23.4	21.6	22.3	19.4	31.8	25.1	44.7	48.2	16.6	32.2	67.7	55.9	71.9	33.1	22.7	48.9	38.4	115.8	24.2	6.6	26.7	4.0	47.7	39.9	0.0	25.0	20.0	36.8	36.1	30.1	45.3	23.8	65.2	43.4	40.5	26.7	4.2	32.5	26.4	27.0	22.6	40.3	32.1	25.1	17.3	35.3	19.8	77.0	19.4	28.2	24.7	28.7	71.0	28.3	24.9	41.9	42.2
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 49859.9"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 315.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	315.9	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	683.8	0.0	0.0	0.0	0.1	12066.1	0.0	0.0	36.6	0.0	0.8	61.3	4.3	2.0	0.0	0.0	1612.0	237.4	2.3	0.2	0.1	0.0	49859.9	8.2	0.0	1.7	1417.3	1529.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	261.7	0.0	0.0	442.7	0.0	0.0	0.4	0.2	0.2	0.1	17.7	22.3	0.0	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 99.9;Proximal tubular cells: 38.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	190	"Hep G2: 219.7"	"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	930000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.3	0.0	2.4	0.7	0.3	0.0	0.0	99.9	2.1	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481683-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 169.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 272.5"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	5000000000			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	2.5	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	272.5	0.1	0.0	0.0	4.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 77.9"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 70.5;Intestinal endocrine cells: 115.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 6.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 6.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.3;hTERT-HME1: 9.7;RPTEC TERT1: 10.4;RT4: 30.0;U-266/70: 8.9;U-698: 26.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.5	0.3	0.3	12.9	0.3	0.0	4.8	0.3	0.3	1.8	12.1	0.4	3.7	5.8	0.4	3.7	3.7	1.3	7.7	0.3	0.3	0.5	13.4	1.2	4.2	3.0	0.3	0.1	1.8	11.3	0.0	2.2	11.2	1.1	6.4	7.8	0.4	5.1	6.3	0.4	3.1	23.2	2.1	0.5	0.6	21.5	0.9	0.1	77.9	3.3	2.0	8.2	11.0	2.5	6.4	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	5.2	32.3	0.5	0.0	0.1	1.6	0.0	2.6	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.7	0.1	0.0	0.0	0.2	10.4	30.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	6.4	0.4	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.1	1.1	0.1	11.9	3.2	3.2	34.4	8.8	0.0	1.1	25.5	37.5	40.9	7.0	0.0	42.9	14.9	16.0	0.2	0.1	49.3	0.0	70.5	17.2	0.7	17.9	1.1	3.9	3.9	0.0	115.4	0.0	0.8	0.0	0.0	0.7	1.7	1.0	48.1	14.3	57.4	59.6	0.0	32.3	0.4	0.0	1.0	0.0	0.0	1.3	39.5	0.0	16.8	36.0
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740506-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 79.4;bone marrow: 300.7;lung: 106.1"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 9866.5;Glandular cells: 5032.8;Urothelial cells: 12569.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	428	"neutrophil: 79.4"	"Lineage enriched"	"Detected in single"	794	"granulocytes: 79.4"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 291.3;GAMG: 80.6"					"Not detected"	"Not detected"			HPA057179	Supported				"Secreted to blood"	NA	NA	7260				"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	13.4	1.6	1.8	21.9	1.9	300.7	1.7	0.4	1.5	6.5	1.4	0.8	0.0	0.5	4.5	0.9	6.7	3.9	18.9	17.7	1.3	1.1	2.4	8.4	106.1	2.3	2.4	0.9	4.4	4.3	0.3	1.1	9.6	7.8	4.3	1.0	1.9	7.4	0.3	2.9	0.5	1.6	1.4	5.5	1.6	2.8	13.5	1.1	1.0	1.1	9.3	7.7	27.9	1.5	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.4	0.0	1.8	291.3	2.6	8.6	0.0	0.9	0.0	39.9	0.0	80.6	3.4	0.0	0.0	41.6	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.1	0.9	0.1	8.7	0.2	0.9	9.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.0	1.4	0.0	0.0	0.0	23.1	1.2	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.3	22.4	4.2	0.3	1.1	3.8	0.0	0.0	0.1	18.8	2.1	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	1.5	1.3	1.1	2.4	0.9	7.8	1.1	47.6	287.8	4.2	9866.5	0.0	0.2	22.2	150.3	327.9	783.7	0.0	0.0	3.4	0.0	1020.3	1.4	16.9	1.6	0.0	220.3	4.9	10.8	5032.8	48.7	2.5	332.1	0.0	18.3	23.9	507.0	0.5	0.6	391.0	0.0	2049.7	1.0	0.4	645.9	0.0	0.4	0.4	1.1	38.8	17.7	0.0	1.2	0.0	17.8	4.3	1.6	12569.9
CXCL6	"CKA-3, GCP-2, SCYB6"	ENSG00000124875	"C-X-C motif chemokine ligand 6"	P80162	4	73836497-73849064	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.6"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 280.2;Ductal cells: 403.7;Glandular cells: 173.8;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	107	"neutrophil: 10.7"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 17.2;EFO-21: 41.4;HUVEC TERT2: 27.0;RPTEC TERT1: 32.1"														"Secreted to blood"	NA	NA	108000					"unprognostic (4.35e-4)"	"unprognostic (4.47e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	3.5	0.1	0.1	5.7	0.2	0.5	0.3	0.1	0.2	7.4	3.7	0.0	1.7	3.1	0.1	0.9	1.6	1.7	16.3	2.7	0.5	0.1	4.4	4.6	8.9	0.9	0.3	0.3	0.7	9.4	0.0	0.2	0.0	1.3	3.5	0.1	0.3	2.4	4.7	0.1	0.1	5.2	0.0	0.5	59.6	0.3	1.4	0.0	1.4	0.1	0.6	2.2	13.7	3.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.5	0.0	0.9	17.2	0.1	0.2	0.0	0.0	0.0	41.4	0.0	1.3	3.4	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.1	8.7	0.0	0.1	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	32.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.1	0.3	0.3	1.3	0.0	3.0	1.3	0.0	76.4	0.3	0.0	0.2	280.2	68.3	72.8	0.0	0.0	0.0	0.0	403.7	0.0	0.0	0.0	0.0	3.2	0.0	2.3	173.8	0.0	0.0	0.2	0.0	75.3	0.0	0.8	0.0	0.0	1.1	0.0	13.6	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	356.0
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853189-73854155	"Plasma proteins, Predicted secreted proteins"		"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;lymphoid tissue: 27.8"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 10.2;Club cells: 2.3;Intestinal endocrine cells: 5.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	28	"basophil: 9.1;neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in some"		"BJ: 2.8;CAPAN-2: 3.6;EFO-21: 5.7;HHSteC: 2.2;HSkMC: 3.5;HUVEC TERT2: 1.8;RPTEC TERT1: 3.3;U-2197: 1.9"									HPA052485	Supported				"Secreted to blood"	NA	NA		1400000000			"HPA052485: AB_2681847"		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.3	0.2	0.1	0.9	0.4	2.8	0.6	0.2	0.5	0.8	0.7	0.0	0.7	4.8	0.1	1.1	0.6	0.5	0.5	8.7	0.4	0.6	2.0	1.9	2.6	0.9	0.4	0.3	7.4	0.4	0.1	0.4	2.0	1.2	1.0	0.7	0.2	1.5	4.0	0.1	0.2	3.2	0.0	0.6	27.8	0.2	0.3	0.0	0.1	0.2	1.1	0.2	5.0	1.0	0.1	0.3	11.2	0.2	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.7	0.6	0.3	2.8	0.4	0.0	0.0	0.0	3.6	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.0	3.5	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.2	0.0	0.1	0.3	0.0	12.6	0.1	0.4	0.2	0.5	0.4	0.6	0.4	0.3	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.2	0.0	2.3	1.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871242	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.8"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 990.8;Club cells: 598.3;Ductal cells: 654.4;Glandular cells: 1080.1;Intestinal endocrine cells: 612.7;Urothelial cells: 1138.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	253	"neutrophil: 25.3"	"Lineage enriched"	"Detected in single"	253	"granulocytes: 25.3"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 80.8;EFO-21: 206.4;RPTEC TERT1: 74.5"														"Secreted to blood"	NA	NA	384000					"prognostic favorable (7.83e-4)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	12.0	0.8	1.3	22.5	2.2	14.8	4.1	0.8	1.4	49.2	7.7	1.0	0.7	4.3	0.9	2.1	27.8	6.1	11.2	12.1	1.7	1.3	8.9	4.2	23.0	10.9	3.1	1.0	3.8	13.0	0.0	0.7	26.1	3.9	8.7	7.1	2.1	8.1	4.1	3.2	0.8	10.8	1.2	3.8	124.8	3.1	2.1	1.7	1.7	0.7	7.9	22.6	29.9	6.6	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	1.3	0.0	2.2	80.8	1.9	2.0	0.0	1.4	0.0	206.4	0.1	7.9	4.1	0.0	0.3	10.5	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.0	0.1	14.5	1.1	0.1	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	74.5	1.7	0.0	0.0	0.1	0.0	4.0	0.2	0.0	0.1	18.6	0.0	0.7	4.0	0.1	0.0	0.1	0.3	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	1.3	2.2	0.8	1.4	1.7	1.3	3.1	1.0	3.9	1.7	41.7	227.2	0.5	990.8	112.5	0.0	3.2	298.1	463.1	598.3	5.2	0.0	0.2	0.0	654.4	0.0	47.2	8.0	0.0	37.1	0.6	117.2	1080.1	15.1	1.3	22.0	0.0	612.7	4.3	11.7	0.0	0.0	126.7	118.1	99.2	4.2	0.0	202.8	8.2	0.0	0.8	0.0	0.0	77.8	0.2	0.1	92.0	0.3	6.9	15.1	1138.8
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell type enhanced"	"Detected in some"	18	"Intestinal endocrine cells: 12.9;Pancreatic endocrine cells: 6.2;Undifferentiated cells: 5.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"	"Cell line enriched"	"Detected in some"	10	"HEL: 30.4"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000				"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	30.4	0.0	0.0	1.5	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.8	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.0	12.9	1.8	2.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.1	0.1
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73987038-73988197	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Ductal cells: 3.4;Kupffer cells: 8.8;Pancreatic endocrine cells: 4.1"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"basophil: 30.0;neutrophil: 18.4"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 30.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.1;HEL: 12.0;RPTEC TERT1: 2.8"					"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	3500000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.4	0.6	0.4	0.6	1.7	67.0	0.6	0.2	0.4	0.5	0.2	0.1	0.0	0.1	0.3	0.5	0.5	0.8	0.9	35.7	0.3	0.3	0.5	1.9	13.3	0.1	1.6	0.0	6.0	0.4	0.1	0.5	8.7	1.3	0.6	0.2	0.4	0.5	0.1	1.0	0.3	0.2	0.2	1.3	60.0	0.3	0.5	0.0	0.0	2.2	0.9	0.1	1.7	11.0	0.3	2.6	30.0	1.8	0.2	0.5	206.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	30.0	1.8	1.1	0.2	0.6	0.3	0.1	0.1	0.0	1.0	0.3	0.5	0.1	18.4	0.2	0.5	2.6	0.2	206.7	0.4	1.7	0.2	0.4	0.3	0.3	1.6	0.0	1.3	0.0	3.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	1.3	8.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Group enriched"	"Detected in some"	8	"Ductal cells: 71.4;Pancreatic endocrine cells: 163.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 34.5;EFO-21: 29.1;HSkMC: 20.9;hTEC/SVTERT24-B: 15.0;RPTEC TERT1: 111.3"									HPA065474	Approved				"Secreted to blood"	NA	NA	1110000				"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	34.5	0.1	0.0	0.0	1.3	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	29.1	0.0	6.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.9	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2	3.0	0.0	0.0	0.8	0.8	0.0	1.3	15.3	1.4	3.4	0.0	0.0	0.0	0.0	71.4	0.2	0.7	0.0	0.0	1.2	0.0	0.5	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	9.3	0.0	2.8	0.0	0.0	163.7	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.3	0.0	0.0	0.0	0.3
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.5"	"Cell type enhanced"	"Detected in many"	12	"Macrophages: 757.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 23.2;hTEC/SVTERT24-B: 36.5;RPTEC TERT1: 21.0"														"Secreted to blood"	NA	NA	28700					"unprognostic (2.12e-3)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	18.8	0.6	1.7	16.5	1.2	10.3	4.3	0.2	1.2	19.6	3.3	1.0	0.4	0.5	0.7	2.2	1.3	1.7	9.2	7.2	1.3	0.8	1.7	3.2	28.5	1.8	2.0	1.0	4.9	3.1	0.0	0.6	1.5	3.0	2.3	7.9	0.8	4.4	0.9	2.3	0.6	2.8	1.2	2.2	5.3	10.3	1.6	0.6	2.7	0.8	2.7	1.9	11.7	0.5	0.0	0.5	0.4	1.0	0.0	0.4	2.4	0.2	1.7	0.7	0.0	0.4	0.7	0.0	2.5	23.2	0.6	1.4	0.0	2.8	0.0	2.5	0.0	8.6	0.1	0.1	0.8	5.1	0.0	0.0	1.9	0.2	0.0	2.8	0.2	0.0	0.5	0.6	36.5	3.6	0.6	0.5	0.4	0.4	0.0	1.0	0.0	0.5	0.1	0.3	3.3	0.7	0.0	0.8	0.0	21.0	0.6	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.0	0.9	5.2	0.2	2.6	6.4	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	0.5	0.0	2.4	1.7	1.2	0.2	1.2	1.3	0.8	2.0	1.0	3.0	0.6	92.3	203.1	5.1	105.8	203.0	0.0	6.1	33.1	87.0	40.9	5.2	0.0	0.5	0.0	138.2	0.4	32.1	49.7	0.0	85.9	1.0	32.9	154.6	26.5	1.1	74.4	0.0	50.8	10.4	119.3	0.9	13.0	757.6	178.8	48.7	41.4	0.0	148.4	28.8	0.4	0.0	0.0	38.8	169.7	0.7	3.1	129.9	6.8	2.5	59.8	50.3
CXCL2	"CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2"	ENSG00000081041	"C-X-C motif chemokine ligand 2"	P19875	4	74097035-74099293	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 1610.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.0;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	25	"granulocytes: 1.4;monocytes: 3.5"	"Cell line enriched"	"Detected in some"	8	"GAMG: 95.1"														"Secreted to blood"	NA	NA						"prognostic favorable (5.93e-5)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (1.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	22.8	3.8	2.4	19.9	4.3	20.7	10.9	0.8	1.7	20.4	5.7	2.3	0.9	0.9	4.4	3.8	6.2	5.8	15.2	14.2	1.7	2.0	3.2	113.1	22.4	35.0	2.8	0.5	5.8	24.9	0.6	2.3	1.4	4.3	5.1	6.4	5.1	4.8	3.6	30.9	1.3	3.8	4.1	4.6	3.7	7.5	3.1	1.6	0.0	2.1	18.5	1.8	11.7	4.1	0.0	0.0	1.4	3.5	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.2	0.9	0.0	0.9	11.3	0.4	1.3	0.0	1.7	0.0	1.5	0.0	95.1	0.0	0.0	2.4	1.8	0.0	0.0	0.7	0.9	0.0	7.9	0.3	0.0	0.9	8.3	6.0	8.1	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	1.0	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	1.5	0.4	0.1	1.7	0.8	0.0	0.0	0.0	6.9	1.8	0.0	1.4	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.5	0.0	0.0	0.1	2.4	4.3	0.8	1.7	1.7	2.0	2.8	0.5	4.3	1.6	443.7	1610.2	15.2	162.7	369.1	0.0	20.4	257.4	125.8	325.3	8.7	0.0	1.9	0.0	632.5	1.0	297.5	87.8	0.0	520.6	3.2	166.5	200.8	79.0	270.4	117.3	0.0	126.9	134.4	220.1	0.6	14.7	392.1	263.2	87.4	36.2	0.5	376.8	15.8	0.0	0.5	0.0	71.1	657.8	1.2	3.4	199.1	1.8	7.9	38.9	91.4
MTHFD2L	MGC72244	ENSG00000163738	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like"	Q9H903	4	74114174-74303099	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 105.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035434	Uncertain					NA	NA					"HPA035434: AB_10601038"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.42e-4)"	"unprognostic (3.45e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.81e-3)"	5.4	11.7	10.2	6.0	8.8	5.2	10.3	6.9	8.5	4.5	5.6	5.9	8.2	5.3	5.6	10.9	6.3	5.0	5.6	17.7	9.3	10.7	6.9	16.2	7.0	5.8	10.5	4.1	5.8	13.6	6.1	7.4	5.8	6.6	5.3	4.0	4.8	4.9	6.2	9.3	4.2	5.6	4.9	11.0	5.1	4.1	2.9	7.3	14.8	10.5	5.0	3.8	3.8	8.4	3.9	3.9	1.4	6.5	2.5	2.7	2.5	2.6	2.8	3.9	3.6	1.4	2.1	0.9	3.3	2.6	2.2	2.4	2.1	2.5	2.9	4.5	1.5	1.6	1.7	3.2	2.1	3.3	2.9	1.9	3.5	1.9	2.5	2.5	5.5	0.7	1.5	5.1	3.3	7.9	4.1	4.6	6.5	6.2	3.6	2.7	2.6	10.2	7.9	1.2	4.3	3.1	10.4	2.7	4.8	14.2	1.3	3.7	8.1	1.8	2.8	3.3	4.5	1.5	3.9	4.7	2.5	3.8	4.8	5.4	3.6	4.6	8.5	15.6	1.3	3.8	0.4	2.1	0.9	0.7	2.0	0.7	3.9	0.6	0.9	3.3	1.5	2.1	2.2	1.4	2.5	6.5	3.9	2.7	2.5	10.2	8.8	6.9	7.3	9.3	10.7	10.5	4.1	6.6	7.3	20.8	15.8	16.8	49.0	14.7	0.0	21.3	25.5	22.7	21.6	47.1	0.0	16.4	71.3	20.8	53.1	14.3	16.8	46.7	16.6	6.3	12.2	87.5	10.3	105.4	21.6	0.0	35.7	18.4	22.7	16.4	11.8	19.6	15.1	11.8	31.5	0.0	16.0	17.5	8.1	35.8	0.0	25.8	18.4	6.5	10.0	19.7	10.3	12.2	33.8	58.9
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"hTCEpi: 62.6;U-2197: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavorable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	1.2	0.0	1.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.1	0.0	62.6	1.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	28.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.2	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	2.2
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000		Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	9.1	0.0	0.0	0.9	1.5	0.0	2.0	60.3	0.6	0.3	7.1	17.1	0.0	10.1	0.0	4.6	0.5	0.0	13.1	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.6	19.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	41.1	0.0	0.0	0.0	0.0	70.5	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	6.0	11.1	1.9	4.9	4.7	0.0	15.7	2.5	4.0	29.6	0.0	0.0	0.5	0.0	0.0	3.1	2.2	44.2	0.0	0.2	0.7	6.1	2.0	6.9	0.0	28.2	0.0	3.5	0.6	56.9	0.4	0.3	122.8	6.8	29.7	24.7	0.0	0.4	17.5	0.0	0.1	0.0	0.0	2.2	0.5	0.2	8.2	0.6	1.0	27.7	6.7
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445134-74455009	"Cancer-related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 83.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 11.6;NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5"	"Region enriched"	"Detected in single"	4	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	19.5	1.1	0.4	9.2	2.1	28.9	20.3	0.3	0.4	5.7	6.7	0.2	0.2	0.7	1.7	1.6	22.3	6.0	34.8	13.6	0.5	0.4	2.5	1.7	14.4	13.3	0.4	0.0	5.8	1.0	0.0	7.8	83.5	1.3	1.9	5.0	1.4	3.9	0.9	9.9	3.4	10.0	1.5	1.0	11.3	5.3	4.6	0.0	1.6	1.2	13.4	13.6	8.7	4.6	0.4	0.8	11.6	0.0	3.3	0.4	0.1	1.7	12.2	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.3	42.8	6.8	0.0	0.9	0.0	0.0	1.9	0.0	74.1	0.7	0.0	0.0	0.0	0.3	2.0	23.0	0.2	0.0	0.7	75.5	4.4	161.4	0.1	0.0	0.0	0.1	0.0	1.6	46.5	0.0	0.0	0.0	8.8	4.9	0.0	0.0	0.0	4.2	0.3	0.0	0.0	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.0	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	8.2	0.0	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.4	0.2	0.0	0.1	3.3	0.0	0.1	0.0	0.1	0.4	2.1	0.3	0.4	0.5	0.4	0.4	0.0	1.3	0.0	184.6	339.4	82.8	759.9	994.1	0.0	30.5	71.4	92.3	310.5	48.8	0.0	1.3	0.0	52.7	45.1	3.9	632.3	0.0	8.6	1.2	28.2	73.6	633.9	2.9	31.8	0.0	39.8	10.4	189.5	5.9	0.3	134.1	32.1	1.8	188.0	0.0	301.5	221.0	1.1	0.5	0.0	19.4	4.4	52.0	45.0	299.4	0.9	149.6	119.9	1407.8
BTC		ENSG00000174808	Betacellulin	P35070	4	74744759-74794686	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.5"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 45.5;Club cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;MCF7: 5.8;RPTEC TERT1: 9.9;SK-BR-3: 6.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	314000					"unprognostic (7.36e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.76e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.05e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.35e-1)"	"prognostic favorable (6.10e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.31e-3)"	3.0	1.2	1.0	5.2	2.2	0.0	3.7	0.3	2.8	2.2	23.5	1.2	3.1	3.0	2.4	5.6	9.9	6.1	10.3	2.5	1.3	1.3	3.7	0.8	3.4	0.2	0.8	1.0	3.6	2.9	5.2	4.5	0.9	2.1	3.7	5.9	7.0	6.8	3.6	0.6	12.4	11.3	8.3	0.6	0.4	6.9	0.8	0.9	0.4	5.2	1.9	2.3	5.6	3.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.2	0.0	16.4	0.0	3.5	0.0	2.4	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.2	0.4	0.1	2.7	0.1	0.0	0.0	0.1	0.4	5.8	0.1	0.0	0.1	1.7	2.5	0.0	0.0	0.0	9.9	4.7	0.2	0.0	2.4	6.6	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.3	2.8	0.3	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	2.2	0.3	2.8	1.3	1.3	0.8	1.0	2.1	0.9	8.9	6.7	0.0	3.8	0.6	1.7	0.5	0.0	45.5	17.0	10.4	2.0	0.3	0.0	3.2	1.4	0.2	3.6	0.0	5.1	0.0	0.6	3.9	0.0	0.2	0.1	0.0	11.5	3.1	0.0	0.0	0.3	0.0	0.0	0.0	9.0	10.6	3.4	6.5	0.0	1.1	5.2	0.0	3.8	0.0	0.0	2.6	0.2	0.0	6.8	6.0
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	15	"B-cells: 10.1;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	23.1	21.5	5.7	25.0	15.2	0.3	16.4	1.3	29.4	18.7	36.0	1.2	28.5	2.8	20.3	18.0	5.8	12.2	11.5	39.8	6.9	13.0	27.5	1.1	15.1	10.2	3.3	10.3	11.9	29.2	23.2	32.1	16.1	4.8	35.0	45.8	70.2	25.6	27.6	7.4	6.2	8.3	29.3	2.4	9.7	5.5	11.2	1.2	6.3	79.8	3.7	8.0	24.9	19.7	10.1	4.6	0.1	0.5	0.0	0.0	0.7	0.5	1.0	0.9	0.0	24.5	0.1	0.1	0.0	0.1	0.0	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.0	8.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	4.1	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.9	0.4	0.2	2.6	0.1	2.3	0.0	1.4	0.0	2.2	6.0	0.1	4.9	1.5	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	1.4	1.6	0.1	2.1	26.8	2.5	6.8	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	10.1	0.0	0.0	4.6	6.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.7	5.7	15.2	1.3	29.4	6.9	13.0	3.3	10.3	4.8	1.2	14.9	63.1	13.4	17.1	2.9	7.9	143.3	30.6	1.4	11.4	0.0	0.0	0.3	3.3	0.1	6.8	3.8	80.6	23.3	43.2	0.6	15.4	43.3	1.1	0.0	1.4	0.0	19.1	3.1	0.0	20.6	33.9	7.2	8.5	1.0	90.2	0.0	26.9	120.2	70.0	27.6	1.0	45.3	52.3	1.7	3.3	1.6	0.7	1.5	46.2	8.4
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.8	12.1	15.7	9.9	20.1	15.6	17.8	20.7	16.8	10.2	12.7	9.8	8.7	9.0	11.0	7.5	8.4	12.9	7.2	17.6	14.1	16.2	17.1	12.5	10.4	12.2	15.9	15.7	16.2	10.6	14.9	13.0	10.5	17.1	12.0	14.2	7.7	12.3	11.3	29.7	5.9	9.2	12.4	16.7	12.2	10.3	13.4	15.4	14.9	20.3	8.0	12.7	9.7	12.1	4.4	7.4	18.9	8.8	4.6	7.4	4.3	6.1	3.2	9.5	8.9	10.0	8.8	5.4	4.1	9.7	8.6	10.2	8.7	7.6	10.2	7.9	5.9	8.5	3.7	24.1	7.3	13.1	8.3	7.9	13.2	6.0	11.1	8.6	17.8	7.3	8.1	9.2	9.9	9.3	10.4	17.3	13.3	12.2	10.4	20.0	9.9	16.3	7.2	15.8	16.8	5.6	8.8	22.4	8.7	13.4	10.5	14.7	8.1	6.8	16.0	17.7	10.9	9.0	8.1	6.8	5.7	5.6	5.0	6.9	11.1	7.9	14.5	6.9	12.7	8.9	18.9	8.8	8.5	4.3	5.2	7.4	4.4	5.3	5.0	7.4	2.2	3.9	5.5	3.7	4.6	4.7	3.8	5.2	4.3	15.7	20.1	20.7	16.8	14.1	16.2	15.9	15.7	17.1	15.4	17.9	6.4	18.7	28.1	36.1	36.0	49.4	12.7	6.7	7.9	22.7	19.6	28.8	58.0	26.3	26.2	18.6	15.4	0.0	19.8	19.5	23.5	31.2	4.7	21.3	16.6	22.3	13.3	23.9	33.0	39.2	20.8	22.4	27.0	14.4	23.7	22.1	21.3	24.6	23.7	44.0	19.0	32.3	22.7	60.0	42.9	27.0	28.3	34.8	27.1	23.7
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 108.2;Spermatocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	15.7	14.9	11.5	18.7	17.6	14.4	18.6	21.2	17.0	18.4	17.0	24.4	16.5	14.9	20.2	23.8	15.5	15.6	13.5	17.2	12.0	11.9	17.8	21.9	13.1	17.9	21.9	14.0	19.3	14.9	19.9	30.9	24.3	17.8	18.3	14.5	17.3	17.0	13.3	20.3	20.8	21.1	18.8	19.2	17.8	13.1	26.5	21.3	18.0	20.4	16.9	15.2	16.5	14.3	10.7	7.1	18.5	8.7	6.8	13.6	6.5	6.9	5.0	11.1	7.7	12.7	12.5	6.3	16.6	8.6	8.7	9.1	6.3	17.4	10.1	8.6	5.4	9.8	7.4	9.9	7.9	10.7	11.5	6.9	7.3	8.2	8.0	17.5	9.8	8.3	10.5	13.8	9.9	15.4	14.0	4.7	12.1	12.6	20.9	9.2	8.1	8.9	6.7	6.3	9.7	5.1	8.7	12.2	7.0	8.1	5.9	8.5	8.8	7.8	10.7	9.2	9.7	11.6	8.2	5.7	14.9	9.9	17.2	8.5	18.7	9.2	9.6	10.4	7.9	12.5	14.6	8.7	12.2	9.8	7.5	13.0	8.9	11.9	9.2	7.1	10.7	13.6	10.4	18.5	6.8	8.0	5.9	13.0	6.5	11.5	17.6	21.2	16.5	12.0	11.9	21.9	14.0	17.8	21.3	11.9	8.3	14.8	14.8	7.3	20.4	15.1	10.2	22.7	9.1	21.0	29.5	8.4	13.3	7.2	108.2	7.9	9.3	0.0	5.6	7.9	10.4	10.1	10.4	8.5	6.5	15.9	12.1	8.6	13.9	18.2	13.0	10.9	6.8	6.4	10.3	14.3	6.5	7.8	10.6	10.2	17.2	0.0	9.9	56.5	15.1	5.9	6.4	10.1	7.4	6.4
ODAPH	"AI2A4, C4orf26, FLJ23657"	ENSG00000174792	"Odontogenesis associated phosphoprotein"	Q17RF5	4	75556048-75565885	"Disease related genes, Predicted secreted proteins"			"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 10.4;placenta: 34.3"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 6.2;Syncytiotrophoblasts: 22.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"basophil: 10.4"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 10.4"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 31.1"														"Secreted in other tissues"	NA	NA						"unprognostic (1.13e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-2)"		"unprognostic (1.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.17e-7)"	"unprognostic (8.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.40e-4)"	"unprognostic (6.53e-3)"	0.3	0.1	1.5	0.4	1.9	0.6	0.2	1.2	0.9	0.3	0.2	0.2	0.2	0.1	0.3	0.4	0.4	0.1	0.3	0.2	1.9	1.5	0.3	0.4	0.3	0.5	2.4	0.2	0.4	0.2	0.0	1.3	34.3	0.7	0.2	0.5	0.2	0.2	0.3	1.6	0.9	0.3	0.2	2.7	0.4	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.1	10.4	0.2	0.2	0.3	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	31.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	1.4	0.0	1.3	0.1	0.1	0.0	0.0	1.4	0.1	0.4	5.6	0.0	0.1	0.3	0.2	0.0	10.4	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	1.5	1.9	1.2	0.9	1.9	1.5	2.4	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.7	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.8	2.4	2.0	0.5	1.2	0.1	0.9	0.1	2.3	0.8	0.0	0.5	2.3	0.2	3.8	0.0	0.2	0.0	4.4	0.0	0.1	1.5	2.1	0.4	0.8	1.9	0.1	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	8.2	0.3	3.1	2.5	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1	23.8	55.4	0.0	0.4	0.1	16.6	0.8	0.0	28.1	7.9	8.7	3.9	0.0	6.6	2.0	24.5	0.0	0.0	0.0	0.2	0.5	0.2	0.3	1.1	0.0	0.1	9.5	1.7	0.6	0.0	16.4	1.7	0.5	1.7	0.0	0.2	10.4	0.1	0.0	1.1	20.7	19.5	0.0	0.0	46.8	1.7	0.3	0.2	1.0	2.6	0.1
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75642782-75724525	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	22.7	24.7	28.2	21.9	48.4	31.6	23.9	52.2	55.6	24.3	28.6	21.5	18.7	24.5	25.1	18.7	24.5	26.9	23.3	23.0	29.3	46.3	32.3	33.7	21.3	24.8	31.3	30.0	20.4	18.8	31.0	27.6	17.7	57.9	37.7	27.3	16.3	22.0	24.2	69.7	15.3	27.8	25.9	35.2	22.9	22.0	27.4	19.6	29.9	35.4	28.1	26.6	26.9	17.9	18.8	20.4	32.5	28.2	31.9	41.4	24.7	27.6	28.8	47.0	38.7	40.6	41.5	15.6	42.6	40.8	27.3	29.1	37.2	38.8	53.2	38.2	34.0	25.1	18.7	48.4	49.7	40.0	31.6	20.0	55.2	28.7	41.9	35.8	50.6	41.2	32.8	42.6	33.1	34.4	36.7	49.3	34.0	40.5	40.6	43.5	17.8	58.8	18.2	49.2	38.9	13.3	44.6	58.0	27.8	32.3	34.0	38.6	41.4	31.3	45.1	55.3	50.3	21.7	25.6	49.9	27.8	22.6	31.1	23.7	39.6	37.7	54.6	39.8	34.7	36.0	32.5	17.0	30.7	26.8	23.1	41.4	18.8	26.1	28.8	20.4	14.6	26.3	28.4	16.6	31.9	28.2	9.9	22.1	24.7	28.2	48.4	52.2	55.6	29.3	46.3	31.3	30.0	57.9	19.6	50.6	115.9	82.1	60.0	79.0	59.4	66.9	22.9	78.9	92.1	50.6	47.1	31.6	34.9	45.0	180.8	63.3	78.6	46.7	59.3	41.8	54.5	74.8	101.8	66.8	40.5	66.7	130.0	49.7	73.0	184.9	24.5	67.6	57.3	90.2	97.3	31.7	70.8	56.1	37.4	71.9	60.6	19.4	46.4	56.0	66.1	68.0	34.6	94.8	60.7	90.4
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724593-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		43000	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	18.1	22.1	9.9	14.9	11.5	4.1	14.6	13.8	13.2	18.1	16.5	9.1	24.9	13.0	18.6	25.3	20.1	15.8	12.1	35.4	10.9	10.4	18.7	38.8	13.6	10.8	11.5	11.7	23.2	23.6	16.8	32.1	23.1	16.1	19.4	14.0	11.4	20.8	22.2	94.4	13.2	17.3	19.1	14.7	13.5	14.8	15.3	10.6	15.0	20.7	27.0	14.1	23.8	18.8	10.1	14.6	16.8	21.2	19.1	20.7	11.2	14.2	11.3	16.0	21.3	39.2	52.0	14.6	33.6	41.3	18.5	22.6	11.2	22.2	18.8	20.8	30.8	16.0	16.6	23.8	20.9	28.0	20.7	9.3	13.0	10.1	23.6	30.8	17.1	15.0	29.4	25.8	19.3	37.9	36.0	27.7	13.2	22.4	21.7	27.4	9.4	16.8	9.0	21.8	30.3	6.8	11.2	15.2	15.1	27.7	16.6	12.8	12.4	12.3	26.2	21.2	24.9	19.2	14.0	21.2	17.0	10.6	30.8	12.6	20.5	11.0	9.2	25.3	10.3	20.1	16.8	11.4	10.1	15.2	16.5	20.7	9.3	12.9	14.5	14.6	10.1	13.6	13.1	7.0	19.1	21.2	11.8	12.9	11.2	9.9	11.5	13.8	13.2	10.9	10.4	11.5	11.7	16.1	10.6	56.6	72.1	28.3	45.2	33.8	31.7	119.3	33.1	77.6	72.8	24.4	41.2	41.6	29.9	33.3	7.0	31.7	32.6	0.0	42.1	41.2	49.4	55.7	47.4	50.5	38.8	25.4	38.5	33.2	29.4	7.8	72.8	35.6	27.0	52.3	62.2	30.7	47.4	31.6	64.3	39.6	50.3	38.8	44.0	44.7	71.1	35.3	75.7	29.2	38.5	52.8
PPEF2	PPP7CB	ENSG00000156194	"Protein phosphatase with EF-hand domain 2"	O14830	4	75859864-75902571	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 75.7"	"Group enriched"	"Detected in some"	22	"Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 518.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-2)"	"unprognostic (2.92e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"			"unprognostic (1.53e-1)"		"unprognostic (9.02e-2)"	"unprognostic (3.32e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.54e-8)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.66e-3)"	0.1	0.0	0.0	0.2	0.4	0.2	0.3	3.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	75.7	0.0	0.0	0.3	0.4	0.1	0.1	0.1	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	3.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.2	518.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0
NAAA	ASAHL	ENSG00000138744	"N-acylethanolamine acid amidase"	Q02083	4	75913657-75941051	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 89.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 97.1;Kupffer cells: 106.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 31.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 89.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 89.9"	"Cell line enhanced"	"Detected in many"		"U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026135	Approved				"Intracellular and membrane"	NA	NA					"CAB026135: "	"unprognostic (5.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.21e-2)"	11.2	6.7	5.8	12.3	10.3	6.5	16.9	10.2	10.5	10.8	26.4	6.0	6.0	13.1	9.8	7.1	12.5	8.4	6.8	9.5	7.0	8.2	18.2	29.6	10.0	52.2	11.8	5.3	6.1	6.9	5.5	9.0	8.2	9.1	32.4	31.2	16.6	19.8	5.1	6.2	11.2	34.0	10.2	11.2	44.9	9.8	3.4	6.9	10.2	11.2	8.0	19.5	10.3	12.6	8.1	19.7	14.3	89.9	4.5	15.1	25.9	4.4	10.1	0.4	0.3	24.6	25.0	0.4	6.6	4.4	4.6	1.5	3.4	15.7	0.4	3.5	16.3	0.1	8.8	13.2	5.1	2.8	6.3	0.5	3.1	7.5	8.3	5.7	11.5	11.5	6.3	3.9	4.0	1.4	7.1	7.3	7.1	3.4	13.8	4.0	16.2	7.3	7.5	5.1	19.8	4.0	5.0	0.1	20.5	4.8	2.5	6.1	0.9	6.8	21.6	1.9	0.7	24.3	20.1	10.8	0.2	0.6	30.4	0.3	3.4	1.3	2.2	5.8	16.6	2.8	5.5	37.2	14.3	9.0	89.9	9.7	8.1	11.5	8.9	19.7	5.3	9.7	8.1	12.5	4.5	74.4	7.3	15.1	25.9	5.8	10.3	10.2	10.5	7.0	8.2	11.8	5.3	9.1	6.9	0.0	8.2	28.2	16.1	10.1	9.6	3.9	28.1	24.1	6.8	5.2	17.7	21.0	11.6	4.6	0.4	11.7	97.1	0.0	7.4	16.3	27.2	69.0	14.0	30.2	35.4	11.1	46.1	17.8	106.0	0.0	9.8	77.1	16.9	16.2	28.2	6.5	3.9	28.5	7.1	9.2	78.9	0.0	18.4	0.7	0.9	16.6	11.1	36.2	21.4	12.1
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	17.0	17.9	19.6	16.5	30.2	7.3	21.5	17.6	26.7	19.9	17.9	9.6	14.0	14.0	26.2	23.2	19.5	18.9	10.6	16.4	18.2	15.4	21.9	23.9	14.6	22.8	16.4	19.1	22.7	26.9	20.4	30.6	17.5	22.6	18.5	18.6	9.4	18.3	20.8	32.3	19.6	16.1	24.9	16.2	23.5	18.1	24.1	19.9	21.5	25.8	17.1	22.9	21.3	17.5	13.2	10.3	5.6	16.8	15.4	17.8	10.5	14.6	5.9	14.6	19.5	17.4	15.7	15.3	20.8	18.1	17.4	15.2	18.2	21.0	23.0	15.7	19.0	16.7	15.1	22.2	20.1	21.9	20.2	11.7	19.6	13.1	15.0	16.4	33.3	22.4	13.7	22.8	18.4	20.3	10.8	15.2	15.7	35.1	19.0	17.8	16.2	33.7	11.8	23.7	23.7	9.0	20.5	27.5	19.3	16.6	16.4	22.1	18.4	14.2	29.0	23.5	16.6	13.3	19.6	14.3	18.8	19.0	22.4	17.3	17.5	18.2	31.4	21.1	15.1	23.2	5.6	9.9	2.7	14.2	12.7	17.7	12.1	17.4	16.1	10.3	13.2	17.8	14.9	1.6	15.4	16.8	9.0	14.7	10.5	19.6	30.2	17.6	26.7	18.2	15.4	16.4	19.1	22.6	19.9	17.9	26.7	35.6	21.5	24.5	19.7	10.6	15.3	33.5	50.0	21.0	5.9	26.9	29.9	34.3	86.0	21.1	13.9	0.0	21.5	26.1	23.2	22.2	48.5	20.5	32.6	12.7	21.9	16.0	23.5	81.4	23.6	29.5	23.6	39.7	22.8	22.4	28.9	22.9	31.1	37.2	19.7	19.4	24.5	58.5	94.3	29.0	20.9	32.0	26.0	19.7
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell type enhanced"	"Detected in some"	15	"Hofbauer cells: 6.6;Kupffer cells: 11.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	902000					"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	6.6	0.0	0.0	0.0	11.9	1.4	0.6	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.7	0.3	0.1	0.0	0.0	0.1
ART3		ENSG00000156219	"ADP-ribosyltransferase 3"	Q13508	4	76011184-76112802	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 65.9;Spermatocytes: 192.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 29.1"	"Cell type enriched"	"Detected in single"	5	"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.9"	"Group enriched"	"Detected in some"	8	"NB-4: 6.2;NTERA-2: 16.9;SK-MEL-30: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		45000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	3.5	0.6	4.9	0.9	1.9	0.4	0.7	29.1	9.0	1.0	1.3	6.0	0.0	0.6	0.5	1.1	2.5	0.5	0.5	55.1	3.0	0.9	0.5	0.5	0.6	0.5	3.9	2.0	0.5	3.8	0.4	1.1	0.5	2.7	1.0	1.4	0.4	1.3	1.0	85.2	0.5	0.8	0.6	3.0	1.5	0.9	42.6	7.2	0.0	0.5	27.2	0.5	0.6	0.7	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.2	16.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.9	1.9	29.1	9.0	3.0	0.9	3.9	2.0	2.7	7.2	0.0	0.0	0.0	0.4	0.5	0.4	65.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.4	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.0	1.7	0.0	1.7	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.0	3.1	192.9	19.4	0.3	0.0	0.0	0.0	0.4
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	253000					"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.2	3.4	3.4	0.3	0.1	3.0	0.3	0.0	7.9	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	6.3	0.1	3.6	0.0	0.0	0.0	0.7	2.0	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9	0.0	2.1	0.5	9.7	0.8	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.8	10.1	1.1	0.0	18.2	0.0	0.0	0.0	5.6	3.5	0.3	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 20.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Basal glandular cells: 2.5;Cholangiocytes: 2.5;Exocrine glandular cells: 3.0;Kupffer cells: 4.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+: 8.3;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;GAMG: 2.3"					"Not detected"	"Not detected"			CAB009921	Uncertain				"Secreted to blood"	NA	NA	187000				"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.31e-7)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	3.6	0.3	3.8	10.5	3.1	0.0	3.4	1.3	2.0	3.3	1.4	0.6	0.1	0.6	1.3	2.0	2.3	1.4	2.0	3.3	2.2	2.8	2.5	2.1	13.7	10.0	3.1	1.5	1.3	8.9	0.0	0.7	3.5	2.8	8.5	4.5	0.3	2.9	1.1	6.4	0.6	1.0	1.4	9.8	7.0	5.6	0.6	1.5	4.3	20.1	3.6	1.4	3.2	0.7	0.0	0.9	0.0	2.1	0.0	0.1	0.6	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.3	8.3	8.8	0.0	0.2	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	3.8	3.1	1.3	2.0	2.2	2.8	3.1	1.5	2.8	1.5	3.0	0.0	0.0	2.5	0.1	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	3.0	0.0	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.6	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148515	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	23.7	14.5	13.5	18.2	15.2	28.4	25.7	26.0	17.2	23.1	20.0	14.6	17.9	15.3	22.9	18.2	21.4	22.5	15.1	17.0	12.2	10.8	16.4	20.3	17.8	22.8	20.5	13.1	25.3	19.3	13.3	16.8	22.8	14.9	19.8	19.7	12.2	20.0	24.1	17.8	21.2	18.4	24.7	14.7	23.6	19.2	19.6	20.0	36.1	19.8	18.1	22.1	24.1	21.8	10.0	11.4	7.7	10.0	21.6	16.5	7.5	17.1	6.8	21.8	15.7	18.6	17.8	19.2	17.4	25.1	25.8	26.6	16.0	24.6	26.0	14.7	17.3	14.0	11.6	23.4	19.4	32.4	17.1	13.7	15.7	8.5	15.2	17.6	30.4	19.0	16.2	14.0	20.4	21.7	11.4	22.1	17.1	26.9	16.4	18.6	15.0	32.0	14.3	34.9	20.9	6.1	25.1	34.4	9.9	15.3	16.5	13.2	11.0	16.1	19.1	14.0	17.8	8.1	18.7	14.7	20.8	18.6	24.7	21.1	10.7	3.9	24.8	14.8	17.9	18.2	6.5	7.5	7.7	12.2	9.0	16.5	9.0	12.9	11.7	11.4	10.0	13.8	13.0	3.5	21.6	10.0	8.4	12.5	7.5	13.5	15.2	26.0	17.2	12.2	10.8	20.5	13.1	14.9	20.0	20.8	11.8	23.1	37.0	31.3	13.7	9.9	7.6	18.7	12.5	10.4	19.6	36.3	24.9	18.9	7.9	20.4	11.5	0.0	24.2	38.9	30.9	23.1	23.1	11.9	19.3	7.9	13.8	18.4	18.3	5.6	25.3	17.0	16.9	30.7	18.4	11.8	15.9	21.0	24.4	17.2	19.1	32.3	26.8	38.4	40.1	25.5	32.7	27.7	21.7	29.4
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158733-76234536	"Disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 18.3;granulocytes: 6.2;monocytes: 15.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 88.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavorable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	33.6	20.6	30.7	13.0	32.9	4.1	34.1	22.9	42.8	40.1	34.9	63.7	21.4	22.7	26.8	37.0	20.3	24.9	34.5	29.7	35.7	30.3	29.0	51.6	43.8	21.7	43.9	31.6	37.0	32.3	47.5	14.5	41.0	44.1	44.2	32.7	23.1	40.3	34.1	54.3	16.5	27.6	24.4	70.5	26.7	36.1	16.1	40.7	6.2	39.2	16.5	10.8	31.7	40.3	2.6	18.3	6.2	15.3	0.7	3.0	3.6	5.7	4.6	7.2	13.9	88.2	43.1	6.1	19.3	44.4	16.9	31.4	8.2	15.9	0.0	15.3	41.3	16.3	4.9	5.1	12.0	17.9	24.8	5.8	0.5	4.2	3.9	21.6	3.0	2.0	31.9	12.1	17.9	10.3	39.3	30.2	1.5	2.7	29.2	26.0	8.8	0.2	0.6	1.7	17.1	4.5	3.6	14.7	4.9	11.9	3.8	17.1	17.7	16.5	11.5	16.7	9.4	5.2	3.0	19.9	17.1	8.6	14.1	6.0	27.1	17.0	0.0	19.9	3.9	25.2	6.2	8.8	2.1	1.8	15.3	1.9	2.6	1.5	1.1	5.2	2.0	1.8	3.0	1.5	0.7	14.7	18.3	1.8	3.6	30.7	32.9	22.9	41.1	35.7	30.3	43.9	31.6	44.1	40.7	163.8	38.3	16.4	69.4	21.3	92.5	50.2	96.8	45.5	37.5	94.2	56.9	29.5	6.6	100.8	5.0	72.9	82.1	0.0	63.0	42.1	60.9	149.5	3.5	90.6	138.6	57.2	98.3	91.4	117.9	2.9	42.0	58.7	64.1	26.2	73.9	73.8	79.5	66.0	62.6	27.2	69.7	90.5	54.8	3.4	13.2	29.5	49.7	10.5	48.8	82.4
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283780	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Ciliated cells: 75.0;Early spermatids: 25.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 3.1;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	5	"B-cells: 3.1;dendritic cells: 2.3"	"Cell line enriched"	"Detected in many"	5	"OE19: 24.0"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	5.5	6.8	12.5	0.8	8.5	1.2	8.9	2.4	14.8	3.7	3.2	9.2	4.4	4.3	2.4	15.5	1.6	23.5	5.1	3.2	10.1	13.7	9.1	11.2	4.8	0.9	10.7	15.5	1.2	9.7	9.9	10.3	10.0	12.1	5.2	3.8	2.7	5.4	4.0	9.5	2.0	4.2	3.0	13.3	1.8	6.0	9.2	6.2	0.0	13.2	1.5	0.9	2.6	1.1	3.1	2.3	0.1	0.4	0.1	0.5	0.1	0.4	2.0	1.8	0.5	1.4	0.2	0.4	0.2	1.3	0.3	0.4	2.3	1.7	0.1	0.5	0.7	4.1	0.6	0.8	0.4	0.7	1.8	0.1	0.1	1.1	3.3	0.8	0.4	0.3	0.8	0.5	0.5	0.5	0.7	0.2	0.2	0.2	1.1	0.6	2.8	0.1	0.2	0.4	24.0	0.9	0.3	0.5	0.3	2.5	1.6	3.1	2.2	0.8	1.0	0.3	0.5	1.0	0.2	0.5	0.4	0.4	1.1	0.3	4.4	1.0	0.1	1.3	0.2	0.6	0.0	0.4	0.1	0.2	0.0	0.5	0.2	0.2	0.1	0.2	3.1	0.4	0.1	0.1	0.1	0.4	2.3	0.0	0.1	12.5	8.5	2.4	14.8	10.1	13.7	10.7	15.5	12.1	6.2	8.9	1.6	0.5	2.2	0.6	11.4	6.2	5.1	75.0	7.9	0.0	11.8	2.2	8.3	5.8	25.0	1.5	5.4	0.0	6.9	0.9	1.5	4.2	0.0	3.0	0.7	1.6	7.5	2.5	0.0	3.1	0.6	0.0	1.7	0.0	4.9	4.3	5.1	2.9	0.4	7.8	6.9	0.0	1.2	10.9	3.9	0.3	2.9	0.0	2.7	1.6
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 38.2;skeletal muscle: 41.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.7;Ciliated cells: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.1;Karpas-707: 23.8"									HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	17.4	2.3	7.8	1.6	8.0	4.0	7.6	1.9	13.9	2.5	8.2	8.6	4.1	2.1	3.0	7.3	3.5	5.0	4.2	16.5	9.4	3.9	4.2	38.2	7.5	0.6	5.4	14.6	2.6	4.6	2.8	9.2	9.4	11.4	6.3	9.0	2.5	5.0	5.0	41.3	1.6	10.7	6.5	9.6	1.6	3.7	6.1	5.8	0.0	8.1	1.3	0.9	4.9	2.5	0.2	1.0	2.2	1.5	3.4	1.6	0.4	2.0	2.4	1.0	2.1	17.1	5.8	2.2	3.4	7.1	2.9	3.0	4.0	2.2	0.0	2.1	8.1	7.9	1.1	3.5	1.4	2.7	2.6	0.5	0.8	4.8	5.7	1.8	1.7	2.4	2.5	9.0	2.8	3.6	11.1	0.3	0.0	0.2	23.8	7.0	3.7	0.0	1.8	1.0	13.2	1.6	0.0	0.5	1.5	3.3	6.0	1.0	4.2	1.5	4.7	0.1	2.2	0.9	1.0	0.9	1.5	0.7	3.8	2.9	5.7	2.6	0.0	4.2	1.8	1.3	0.0	0.5	2.2	1.1	1.5	0.6	0.2	1.1	1.2	0.9	0.1	0.9	1.3	1.3	3.4	0.1	1.0	1.6	0.4	7.8	8.0	1.9	13.9	9.4	3.9	5.4	14.6	11.4	5.8	6.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 12.0;Ductal cells: 5.3;Enterocytes: 4.9;Exocrine glandular cells: 3.5;Pancreatic endocrine cells: 3.5;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.0;Karpas-707: 31.5;U-266/70: 20.4"	"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.8	1.8	0.2	2.4	5.3	1.4	3.3	4.2	2.5	1.6	1.9	1.8	4.5	0.0	3.4	2.7	3.7	2.4	0.7	0.9	0.6	15.0	1.0	0.2	2.3	2.2	0.7	2.1	2.8	0.8	2.7	1.3	0.7	4.1	0.0	0.0	0.1	31.5	2.8	2.5	0.2	1.8	0.4	2.7	2.0	0.0	0.9	2.6	0.9	1.9	0.8	4.4	3.3	4.2	0.0	0.4	1.1	0.7	0.7	3.2	2.0	7.5	2.3	20.4	3.7	0.0	4.4	1.4	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4											0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	4.9	0.0	3.5	1.1	0.3	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	3.5	3.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.5	0.6
CCDC158	FLJ25770	ENSG00000163749	"Coiled-coil domain containing 158"	Q5M9N0	4	76312997-76421868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 26.3"	"Group enriched"	"Detected in some"	52	"Early spermatids: 54.8;Late spermatids: 56.3;Spermatocytes: 86.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.2;SiHa: 1.5;WM-115: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.68e-1)"	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.1			0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.2	0.2	1.2	0.0	0.0	0.2		0.0	0.2	0.0	0.4	0.0		0.3	0.0		0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	26.3			1.0		0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	1.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.1	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	56.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	86.1	1.3	0.0	0.0	0.0	0.0	0.0
SHROOM3	"APXL3, KIAA1481, SHRM, ShrmL"	ENSG00000138771	"Shroom family member 3"	Q8TF72	4	76435100-76783253	"Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 47.0"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 105.8;Paneth cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;AF22: 18.8;BJ hTERT+: 18.0;EFO-21: 19.9;OE19: 19.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047784	Enhanced					NA	NA					"HPA047784: AB_2680155"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.64e-13)"	"unprognostic (2.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	1.0	1.5	3.3	3.0	4.5	0.0	9.0	7.4	6.4	3.9	11.3	2.3	4.9	8.5	2.5	21.2	18.2	9.1	16.7	2.6	5.6	1.1	5.9	6.2	6.3	0.3	5.5	2.5	0.8	4.6	11.1	4.4	2.1	6.8	6.3	10.0	9.4	47.0	4.7	0.3	3.0	12.1	5.3	6.6	6.8	12.7	0.6	1.2	0.6	2.8	14.6	14.8	4.7	2.4	0.2	0.1	1.0	0.0	0.1	0.1	0.0	19.2	3.8	18.8	12.3	0.0	0.3	0.7	6.0	18.0	0.4	0.8	3.2	12.8	0.3	19.9	16.6	1.5	9.8	2.4	8.6	0.3	0.0	3.3	0.0	3.7	0.0	0.1	0.0	0.0	0.1	2.1	0.6	3.3	4.8	0.3	0.1	0.0	4.7	0.4	1.7	0.3	0.0	7.9	19.2	2.3	1.6	3.1	3.0	2.9	0.4	7.4	9.8	2.5	13.8	1.0	12.0	3.3	0.0	0.0	3.2	2.8	0.1	2.6	5.9	6.1	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.1	0.0	0.0	3.3	4.5	7.4	6.4	5.6	1.1	5.5	2.5	6.8	1.2	83.4	41.9	1.4	4.5	0.8	16.4	9.5	86.6	46.8	46.6	33.2	70.7	0.3	0.0	28.7	4.8	0.3	105.8	0.0	31.2	0.2	6.1	44.1	0.0	34.7	0.2	1.6	83.4	1.3	1.6	3.3	0.3	0.1	3.3	2.8	82.5	9.5	55.3	101.7	0.0	4.5	32.0	0.0	4.2	3.4	2.2	0.3	0.1	0.0	59.4	4.9
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894928-76898147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.3"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 1.4;Distal tubular cells: 1.7;Urothelial cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.8;CACO-2: 4.2;OE19: 6.7;RT4: 18.9;T-47d: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.3	0.6	1.2	2.1	1.1	0.0	0.9	0.5	7.9	1.7	6.9	0.2	7.4	5.1	0.3	0.7	9.7	0.9	4.3	0.2	1.0	1.1	6.9	16.3	1.6	0.0	0.7	2.0	0.2	7.3	5.6	0.9	0.6	1.4	2.2	5.8	0.3	11.1	2.7	0.2	2.2	12.6	0.0	0.4	0.2	4.2	0.2	0.2	0.0	3.9	2.3	4.9	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	4.2	2.6	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.5	18.9	0.1	0.0	0.0	1.4	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.5	7.9	1.0	1.1	0.7	2.0	1.4	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2
SEPT11	FLJ10849	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949703-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 227.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol		NA	NA		6500000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	39.9	6.4	25.0	12.1	36.6	3.2	28.0	24.8	49.7	21.1	22.8	9.9	7.8	10.1	16.7	12.2	10.9	11.1	21.8	14.6	17.2	13.7	25.5	16.0	18.8	10.3	11.4	27.1	10.2	10.4	7.8	5.7	39.1	14.3	12.3	19.5	7.9	8.5	13.1	17.4	6.7	16.2	19.2	10.5	11.6	11.5	4.5	13.9	2.7	10.1	5.9	10.3	15.9	16.8	2.7	12.0	18.2	3.8	21.2	6.9	3.7	12.9	5.3	51.0	45.2	30.5	24.4	14.7	75.7	58.5	17.2	24.3	9.6	9.6	0.3	15.8	91.1	8.1	5.5	16.8	11.2	26.8	16.9	5.6	25.5	7.1	6.9	26.7	13.7	10.9	30.9	5.3	24.9	9.3	13.7	25.8	5.2	10.5	7.2	50.6	7.5	18.0	0.4	17.1	10.6	2.7	21.2	58.0	1.5	9.7	14.2	17.5	13.1	14.7	8.4	12.0	34.2	7.6	5.5	28.0	57.8	17.3	28.3	13.9	4.4	3.5	0.1	22.0	1.5	11.6	6.6	1.4	18.2	5.1	1.2	3.1	2.0	5.8	6.9	4.5	2.7	2.2	5.9	0.4	21.2	3.8	12.0	3.2	3.7	25.0	36.6	24.8	49.7	17.2	13.7	11.4	27.1	14.3	13.9	14.9	13.2	17.5	0.0	20.4	51.2	11.2	15.3	36.1	21.6	82.0	23.6	74.7	33.2	0.0	3.4	49.3	65.6	46.7	0.0	227.1	109.2	0.0	81.0	42.3	44.8	58.8	35.2	60.8	13.0	3.1	99.5	34.0	28.7	0.0	49.9	32.4	0.0	56.1	112.8	45.9	25.0	135.8	45.3	1.4	8.1	13.4	50.6	27.4	62.6	0.0
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047158-77076005	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 248.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	49.0	26.6	48.1	47.1	45.8	50.3	121.1	101.3	248.9	66.3	56.8	21.6	36.9	25.6	56.7	69.0	56.2	50.7	45.2	87.7	44.8	34.1	48.2	34.5	64.7	70.1	55.8	33.5	94.9	65.4	36.5	33.1	35.4	46.7	61.4	34.9	32.7	45.5	62.9	64.3	38.5	45.8	61.6	58.1	41.3	42.4	53.0	20.3	55.4	81.2	28.2	60.0	82.7	62.6	49.2	42.9	70.5	39.8	33.6	56.2	24.3	24.6	14.8	48.4	42.2	72.8	66.6	18.5	19.1	46.7	30.2	29.2	18.2	37.6	45.6	29.3	47.8	18.9	12.9	33.0	66.7	48.2	32.3	13.0	27.3	17.3	17.3	71.5	46.8	55.2	52.0	79.9	27.8	68.4	86.9	42.3	24.1	23.3	49.7	42.9	28.4	60.8	44.3	21.2	17.3	9.2	38.2	45.7	19.2	45.0	28.2	61.4	33.6	25.3	38.9	30.8	35.4	22.1	20.0	28.6	37.0	22.1	39.3	25.9	27.6	12.5	48.2	31.3	32.4	23.9	43.1	32.9	70.5	31.7	33.4	44.9	46.6	52.4	47.2	37.3	49.2	56.2	47.4	47.0	33.6	39.8	42.9	44.8	24.3	48.1	45.8	101.3	248.9	44.8	34.1	55.8	33.5	46.7	20.3	160.8	205.6	381.1	554.3	375.7	387.2	381.6	262.4	87.0	102.4	186.7	64.8	225.4	673.1	338.9	56.4	305.8	254.0	186.9	291.0	357.2	371.0	733.0	274.5	108.3	295.2	171.6	395.9	297.7	542.3	122.9	559.2	420.6	381.3	312.8	295.3	254.5	414.7	272.5	929.9	450.1	187.1	543.3	450.1	159.5	349.2	345.0	317.4	433.7	302.4	523.8
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157151-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	18.4	8.1	11.3	13.5	15.1	25.9	26.7	53.0	17.2	15.1	12.3	8.9	9.6	8.6	16.4	10.7	45.2	8.0	10.4	6.3	9.6	5.4	23.0	3.4	12.8	21.4	7.3	10.6	12.5	7.2	8.8	7.7	20.0	7.3	26.1	11.0	12.2	18.4	10.5	7.5	12.8	9.8	13.5	7.4	14.2	7.7	8.0	7.8	25.3	17.3	7.2	22.6	20.3	18.6	4.8	2.2	16.0	2.3	1.6	4.6	0.6	10.3	1.3	23.4	12.4	15.5	19.9	15.8	8.7	25.2	6.8	12.8	1.5	15.1	20.9	14.1	8.1	6.5	7.5	6.1	28.9	13.2	14.5	4.1	1.7	6.0	3.0	8.1	3.1	21.9	16.8	14.4	3.2	7.1	22.9	10.2	12.4	1.0	12.8	12.5	4.0	14.2	6.6	2.3	5.0	1.4	8.2	22.8	1.3	43.0	28.8	6.2	19.9	10.3	16.4	6.1	14.6	12.2	4.7	9.5	9.3	9.5	6.7	1.4	9.5	7.2	14.8	6.5	4.9	4.6	11.4	1.5	16.0	0.8	2.0	1.9	2.7	1.2	0.8	1.5	4.8	0.9	0.5	6.5	1.6	2.3	2.2	4.6	0.6	11.3	15.1	53.0	17.2	9.6	5.4	7.3	10.6	7.3	7.8	11.9	10.5	50.6	33.0	33.0	67.4	4.0	5.1	4.0	4.5	52.4	21.6	23.6	72.9	23.7	0.6	35.4	27.6	0.0	17.2	86.4	68.4	86.4	38.1	1.6	26.8	23.8	16.0	31.9	38.3	0.9	25.6	27.7	54.0	67.7	29.5	17.3	37.9	17.5	25.8	40.8	46.6	64.7	34.8	5.2	10.0	23.3	13.2	22.4	13.5	38.8
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 82.5"	"Cell type enriched"	"Detected in some"	6	"monocytes: 67.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.4;RH-30: 1.2;U-266/70: 5.4"									HPA052613	Uncertain				"Secreted to blood"	NA	NA	93700				"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favorable (9.12e-4)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	0.2	0.1	0.0	15.3	0.2	0.0	1.5	0.3	0.0	0.1	1.1			0.0	0.8	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.3	4.3	0.2	65.1	0.0		0.2	0.0	0.0	0.8	0.0		3.8	1.8		0.8	0.0	0.0	0.1	15.5	0.0	0.0	82.5	3.7	0.3			0.5		57.5	6.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.3	0.0	10.4	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	2.8	1.1	8.6	10.5	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	2.8
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 51.3"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	13.6	7.8	8.6	21.5	8.2	15.3	11.0	11.1	9.2	7.8	7.3	7.0	4.6	7.5	11.4	6.3	10.2	7.1	8.3	7.5	6.0	5.7	7.7	10.8	12.7	19.2	7.6	7.3	8.8	10.8	14.6	10.0	12.3	6.7	8.4	8.9	10.3	9.9	7.4	9.1	12.2	11.5	8.4	6.9	23.4	7.9	7.3	5.6	51.3	9.1	6.2	21.1	10.7	10.3	7.5	6.1	20.2	9.3	7.4	10.0	4.4	8.8	5.7	7.2	4.8	8.5	7.4	7.1	7.0	9.3	6.3	8.6	2.2	9.9	15.3	8.9	9.8	5.0	5.7	9.3	9.7	8.5	15.3	5.2	14.3	7.9	6.4	5.4	14.2	12.6	4.8	12.6	7.1	13.0	6.0	20.0	11.1	11.9	20.5	7.3	6.0	26.2	7.2	3.3	7.0	1.8	6.5	20.4	10.9	7.2	10.0	8.9	4.3	12.1	11.1	4.9	8.8	3.5	7.3	21.7	6.1	6.8	11.5	3.8	26.3	11.2	19.0	6.6	6.2	4.5	20.2	4.7	10.2	10.0	7.0	10.0	5.3	7.5	7.8	4.5	7.5	7.3	8.5	6.7	7.4	9.3	6.1	6.0	4.4	8.6	8.2	11.1	9.2	6.0	5.7	7.6	7.3	6.7	5.6	20.8	16.0	29.6	11.9	51.4	38.1	14.5	22.9	14.7	28.4	34.9	37.3	22.8	51.4	5.9	3.4	42.7	16.9	0.0	10.5	7.4	21.1	30.3	36.9	27.0	14.9	30.2	25.2	41.7	40.3	2.8	17.3	33.5	23.6	14.4	31.3	20.1	8.9	14.0	12.0	17.0	40.7	32.3	31.7	19.1	30.9	57.7	20.4	121.5	23.0	16.3
MRPL1	BM022	ENSG00000169288	"Mitochondrial ribosomal protein L1"	Q9BYD6	4	77862520-77952790	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043656	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043656: AB_2678601"	"unprognostic (9.03e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.14e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (7.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"unprognostic (9.17e-3)"	13.6	16.5	14.8	10.9	16.0	13.5	14.0	12.3	20.3	13.6	16.2	4.4	9.6	11.8	12.5	13.6	17.2	10.5	6.9	23.5	18.5	14.7	22.4	22.4	7.6	12.4	13.5	14.0	12.0	12.0	10.5	18.9	16.1	16.6	17.3	17.9	4.3	11.1	11.5	46.6	8.2	12.0	20.3	12.1	15.4	12.3	5.4	9.5	11.9	11.7	24.7	13.4	17.2	14.3	14.9	12.0	4.7	10.1	12.6	18.3	8.9	12.2	7.7	15.2	12.7	11.7	15.4	13.2	14.1	8.8	18.2	12.5	15.6	22.2	21.7	17.6	11.3	11.7	10.4	21.9	25.3	23.8	14.5	11.5	18.4	8.3	16.4	15.5	38.0	9.0	11.9	23.9	16.1	16.4	12.0	21.8	15.5	26.6	7.3	22.8	13.1	23.9	24.7	16.9	28.6	10.2	27.3	19.0	12.4	35.4	11.8	16.5	8.4	10.9	28.3	26.0	12.8	13.7	19.2	12.8	12.1	18.2	12.1	19.9	6.5	8.2	22.6	10.2	21.6	15.4	4.7	6.5	3.9	12.7	10.1	12.5	14.9	14.0	13.9	12.0	14.3	16.8	18.3	1.1	12.6	8.5	9.8	16.6	8.9	14.8	16.0	12.3	20.3	18.5	14.7	13.5	14.0	16.6	9.5	23.8	33.1	40.2	16.9	11.3	24.1	104.6	61.1	17.4	22.7	31.4	17.7	59.7	114.4	39.4	8.2	35.1	21.4	23.3	31.6	43.1	28.8	13.4	40.5	105.0	42.2	23.8	46.0	44.8	26.3	4.9	28.7	23.1	15.1	31.5	58.4	19.3	32.8	17.5	31.5	99.5	36.0	38.8	23.7	17.6	52.2	11.2	29.2	50.3	64.2	8.9
FRAS1	"FLJ14927, FLJ22031, KIAA1500"	ENSG00000138759	"Fraser extracellular matrix complex subunit 1"	Q86XX4	4	78057570-78544269	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 17.9"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 29.8;Cholangiocytes: 22.9;Collecting duct cells: 27.9;Cytotrophoblasts: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.4;Hep G2: 14.1;RH-30: 13.5;SiHa: 14.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051601	Approved				"Intracellular and membrane"	NA	NA					"HPA051601: AB_2681547"	"unprognostic (1.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (4.69e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.09e-2)"	2.0	1.2	6.2	5.0	10.1	0.1	1.3	0.9	6.4	3.6	2.7	0.7	0.1	0.6	3.3	3.1	2.0	1.5	4.1	2.6	2.3	2.3	11.6	0.8	5.2	0.3	1.2	1.8	0.9	7.9	0.7	5.5	8.3	3.8	3.2	2.2	1.3	1.8	1.3	3.7	2.1	1.4	2.2	0.9	1.1	1.6	1.4	1.0	2.1	17.9	1.9	0.4	1.3	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.9	4.4	1.8	0.0	4.8	2.0	3.2	0.7	2.7	0.4	0.2	3.5	6.5	0.0	5.5	23.4	0.0	0.9	2.5	1.4	0.1	0.0	2.5	2.7	5.3	14.1	0.5	0.0	0.0	9.7	1.5	0.0	3.5	3.7	0.1	0.2	0.0	0.0	2.7	0.1	0.1	0.0	5.7	2.3	0.9	0.0	13.5	0.0	5.9	6.4	3.3	6.5	14.1	4.5	0.8	8.6	0.0	0.0	0.0	0.0	3.1	1.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	10.1	0.9	6.4	2.3	2.3	1.2	1.8	3.8	1.0	29.8	0.0	0.0	2.3	1.6	9.0	6.9	22.9	1.4	14.8	27.9	0.0	22.8	3.3	4.7	1.9	2.1	0.4	0.0	1.6	1.0	5.4	1.4	0.0	0.0	3.9	0.0	1.2	0.6	0.0	2.0	0.6	0.3	1.7	0.0	1.1	0.3	1.9	0.0	0.0	3.9	2.6	0.0	3.2	0.0	1.3	1.1	13.0	0.0	1.0	0.2
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 547.9;Ductal cells: 468.5;Exocrine glandular cells: 274.5;Pancreatic endocrine cells: 473.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Cell line enhanced"	"Detected in many"		"A-431: 51.5;CACO-2: 52.8;CAPAN-2: 71.5;EFO-21: 43.8;hTERT-HME1: 72.9;OE19: 61.8;RPTEC TERT1: 61.4"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		7400000	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	51.5	9.8	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	52.8	71.5	0.0	43.8	1.8	0.0	20.4	0.0	37.7	2.3	0.2	0.4	4.6	21.1	3.1	6.1	0.6	0.0	0.3	33.4	0.5	72.9	7.6	14.9	1.2	0.1	0.0	0.2	2.0	0.2	0.0	1.6	61.8	7.2	0.0	0.1	0.0	61.4	5.9	0.0	0.0	30.4	7.5	2.1	25.3	1.3	0.6	18.9	0.1	6.8	0.0	11.6	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0	547.9	38.9	0.0	51.1	22.0	0.0	6.4	58.6	36.1	144.5	36.6	0.0	172.1	14.9	468.5	0.9	32.1	19.7	0.0	274.5	87.0	24.3	117.9	4.7	0.4	16.1	0.0	5.2	20.3	0.0	0.0	2.8	1.7	5.0	36.1	30.9	0.8	473.1	58.5	0.4	1.1	0.3	0.0	9.5	1.2	0.7	5.8	52.5	0.5	28.7	32.0
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916372	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 124.9;Hofbauer cells: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 38.8;HMC-1: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	11.4	11.1	15.6	18.6	15.0	15.3	12.0	8.2	12.7	11.1	13.9	20.3	2.1	8.0	11.3	9.6	15.7	10.0	12.3	17.0	18.0	9.5	8.3	10.2	14.1	22.9	20.9	12.0	6.5	6.4	7.7	7.8	14.4	14.5	8.4	18.9	11.4	10.2	6.0	7.5	14.5	15.9	10.4	28.3	19.2	7.4	19.6	16.5	19.9	12.5	5.9	24.4	9.7	12.8	2.7	1.7	3.8	2.6	0.4	0.4	0.5	5.5	2.0	3.0	4.0	6.0	5.8	2.4	5.4	8.3	6.0	7.9	3.8	2.9	6.7	2.7	25.8	5.2	1.3	3.6	4.3	11.0	1.9	1.3	38.8	2.4	1.7	6.7	8.1	42.0	8.4	5.6	9.4	8.7	3.2	8.1	4.9	10.4	19.5	7.1	1.2	4.8	3.4	1.4	3.7	1.4	7.0	5.5	1.6	7.3	3.0	4.8	2.6	7.8	4.0	4.7	3.8	1.4	4.2	7.9	5.9	2.3	9.8	5.7	3.6	1.4	2.6	5.2	10.2	4.1	0.4	2.2	1.2	0.1	0.9	0.1	2.7	0.1	0.0	1.7	2.7	0.4	0.2	3.8	0.4	2.6	1.3	0.0	0.5	15.6	15.0	8.2	12.7	18.0	9.5	20.9	12.0	14.5	16.5	26.8	18.1	10.4	3.8	22.1	9.6	5.7	2.5	6.7	6.8	7.0	3.9	4.0	0.0	7.0	11.1	12.4	19.7	46.7	7.6	11.6	12.4	6.3	124.9	16.3	112.6	9.5	6.4	30.7	61.7	7.6	7.5	31.6	27.0	22.6	41.6	46.4	10.6	48.2	6.3	18.1	8.4	6.5	7.4	24.1	9.6	27.5	2.9	3.9	21.8	2.3
PAQR3		ENSG00000163291	"Progestin and adipoQ receptor family member 3"	Q6TCH7	4	78887127-78939438	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.9"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 70.2;Late spermatids: 101.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.5;HMC-1: 3.6;MOLT-4: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.41e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.27e-1)"	2.7	2.1	4.6	3.4	7.7	2.8	2.2	5.2	6.7	2.1	2.9	4.3	0.0	5.1	2.2	1.7	2.1	1.9	2.9	2.4	3.6	1.9	2.7	2.3	2.1	4.0	3.7	4.2	2.2	2.1	1.4	2.1	2.2	5.6	2.3	1.7	1.6	2.4	1.3	2.4	3.5	4.4	1.6	7.6	2.6	2.4	12.9	3.3	1.5	2.6	1.7	1.9	2.3	2.2	0.6	0.3	0.1	0.1	0.9	0.3	0.0	0.5	0.0	0.6	1.0	0.1	0.1	0.9	1.4	0.1	0.2	0.1	0.0	0.3	1.8	1.5	0.2	0.0	0.4	0.6	0.2	0.2	0.7	3.5	1.1	0.9	0.4	0.2	1.8	3.6	0.1	0.0	0.2	0.1	0.3	0.1	0.7	1.9	0.6	0.2	0.0	3.9	0.7	0.4	0.8	0.8	1.5	0.6	0.3	0.0	0.5	1.3	1.0	2.1	0.2	1.3	0.6	0.3	0.7	1.6	0.8	2.0	0.6	1.7	1.4	0.9	1.1	1.2	0.8	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.1	0.2	0.0	0.9	0.1	0.3	0.1	0.0	4.6	7.7	5.2	6.7	3.6	1.9	3.7	4.2	5.6	3.3	3.0	8.8	2.7	4.7	15.7	19.7	8.6	2.5	2.7	5.7	10.4	3.9	7.8	0.0	2.4	70.2	5.8	8.5	0.0	3.2	10.7	10.6	4.8	23.1	9.0	3.8	4.8	8.1	2.5	6.0	101.4	6.9	6.9	6.8	1.8	6.7	11.1	2.4	7.0	9.9	2.4	11.0	12.9	5.9	9.1	13.6	20.5	10.9	6.9	5.0	2.8
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	25.1	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	21.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	14.4	15.0	0.0	11.1	0.0	0.0	0.0
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406352-79408293	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 61.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 439.5;Late spermatids: 112.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	52	"SCLC-21H: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060687	Uncertain					NA	NA					"HPA060687: AB_2684343"															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	439.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	44.6	2.7	0.0	0.0	0.0	0.0	0.0
ANTXR2	"CMG-2, CMG2, FLJ31074"	ENSG00000163297	"Anthrax toxin receptor 2"	P58335	4	79901149-80125454	"Disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.4;HHSteC: 37.2;LHCN-M2: 43.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		6600000				"unprognostic (3.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-1)"	18.6	8.8	1.7	14.4	2.0	4.3	16.8	1.0	1.8	30.7	24.6	2.4	10.2	4.1	36.3	11.1	20.1	14.6	22.9	10.0	2.9	1.5	4.1	10.4	9.8	10.1	1.9	2.0	23.5	3.1	16.7	2.5	23.1	2.8	40.2	11.1	6.2	4.6	22.2	8.9	4.8	17.3	56.5	3.9	9.1	19.5	11.1	2.1	4.3	4.3	5.0	8.2	38.0	20.3	9.2	12.4	22.1	6.8	1.5	14.1	5.0	2.6	0.2	6.4	1.1	43.4	25.6	0.6	8.7	25.9	3.8	4.5	0.1	2.1	0.0	0.1	16.0	2.3	0.8	0.9	10.3	14.9	0.3	0.8	2.1	0.1	0.8	37.2	9.0	5.6	30.4	3.0	27.2	14.4	29.0	11.2	0.3	4.9	6.5	43.9	0.0	0.1	4.9	0.8	4.0	12.4	0.4	3.8	1.6	2.1	2.7	6.1	8.4	0.9	0.1	1.1	3.3	0.1	1.8	12.5	28.2	1.5	31.2	15.9	0.3	0.0	0.0	15.8	6.8	8.6	22.1	6.8	21.1	5.1	3.6	5.6	9.2	8.1	5.0	12.4	3.8	4.6	2.0	20.2	1.5	6.8	10.3	14.1	5.0	1.7	2.0	1.0	1.8	2.9	1.5	1.9	2.0	2.8	2.1	11.9	11.4	18.5	14.4	6.3	2.8	20.6	2.5	4.0	14.8	0.0	27.5	10.0	3.3	3.4	1.8	10.5	20.2	0.0	5.8	24.2	36.7	10.6	57.8	18.8	15.6	0.0	17.9	17.8	15.2	4.4	36.2	15.5	1.7	60.5	14.5	8.1	28.0	32.8	60.1	2.9	11.6	38.8	16.4	0.5	1.5	3.8	5.5	17.3	8.1	1.4
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;prostate: 30.9;seminal vesicle: 34.0"	"Cell type enriched"	"Detected in many"	31	"Bipolar cells: 289.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;LHCN-M2: 18.2;NB-4: 20.4;SCLC-21H: 44.1"	"Region enhanced"	"Detected in many"		"hippocampal formation: 31.4"	"Group enriched"	"Detected in all"	4	"amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7"	HPA057253			Approved	"Nuclear bodies"		No	NA			"Nuclear bodies"		"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31.0	9.3	8.2	10.9	1.8	2.1	8.2	3.0	2.8	3.7	2.7	1.9	30.9	6.0	1.4	0.9	2.0	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34.0	3.0	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9.0	0.0	1.1	0.0	3.5	9.0	8.2	2.2	0.5	2.1	0.0	0.7	2.4	0.4	0.9	0.0	0.3	0.0	0.9	3.3	0.0	2.5	9.0	1.2	1.4	0.0	0.9	0.0	0.0	3.1	0.8	0.3	0.0	1.0	5.4	3.7	0.8	0.3	0.0	0.0	1.9	3.7	1.1	2.0	0.0	4.9	1.4	12.2	0.1	1.0	0.0	1.6	18.2	0.0	1.7	20.4	0.0	0.0	7.4	0.6	0.0	0.0	0.5	0.1	44.1	6.1	0.1	0.0	0.0	0.0	0.0	1.9	3.8	3.2	0.4	2.3	0.1	0.7	0.0	0.0	7.9	1.8	0.4	0.0	0.0	0.0	1.6	0.0	2.4	0.3	2.1	2.0	0.3	2.2	1.3	0.7	2.1	0.7	0.0	0.5	0.9	0.4	17.6	10.1	3.6	31.0	30.9	6.0	12.3	18.1	7.5	9.0	0.0	0.3	3.5	3.2	0.6	289.0	1.8	0.0	6.7	9.1	1.8	2.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.2	0.1	3.0	2.3	0.0	0.0	0.5	3.2	0.0	0.0	0.0	3.3	2.8	0.7	1.7	1.0	0.0	4.1	0.4	0.0	3.2	0.0	9.2	0.0	1.7	0.4	0.5	0.1	0.1	1.0	0.0	0.6
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell type enhanced"	"Detected in some"	16	"Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	7.2	0.0	20.2	38.1	5.3	3.9	0.0	0.0	0.0	0.0	27.5	0.4	0.0	0.0	7.0	28.7	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.0	2.0	0.0	15.6	7.5	9.0	1.8	0.0	0.0	0.1	25.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.5	35.6	1.4	1.7	17.0	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell type enhanced"	"Detected in some"	25	"Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	1.9	0.0	4.0	0.7	0.1	0.1	0.0	0.0	1.1	0.0	1.4	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	1.0	1.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4	0.0	1.0	0.0	0.1	0.0	0.6	0.0	0.0	163.3	23.9	0.0	0.0	0.0	0.0	0.0	74.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	40.9	2.3	0.0	0.0	0.0	0.0	0.0
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030965-81057531	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;lung: 21.0;urinary bladder: 18.7"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 25.1;Club cells: 20.5;Enterocytes: 20.2;Paneth cells: 23.7"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 7.5"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AF22: 10.6;Daudi: 16.1;RT4: 13.5;SK-BR-3: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	2.4	0.5	1.4	3.8	0.6	0.8	4.5	0.8	0.7	0.9	15.0	0.0	0.3	3.5	0.2	0.3	4.2	1.1	2.5	0.2	0.7	1.0	0.3	0.2	21.0	0.5	0.3	0.4	3.0	1.0	0.0	0.4	0.0	0.5	3.7	7.9	2.9	6.9	0.0	0.6	0.7	11.2	1.5	0.9	0.2	2.2	0.3	0.0	0.0	0.3	1.6	2.3	18.7	10.5	3.5	0.0	0.6	0.1	1.2	0.1	0.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.5	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.5	1.2	0.0	0.0	0.0	0.2	1.4	0.6	0.8	0.7	0.7	1.0	0.3	0.4	0.5	0.0	3.0	25.1	0.0	0.6	0.1	2.2	1.1	0.0	9.4	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.6	0.2	0.2	23.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	5.5	3.0
PRKG2	"cGKII, PRKGR2"	ENSG00000138669	"Protein kinase, cGMP-dependent, type II"	Q13237	4	81087370-81215117	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.3"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 1: 32.8;Enterocytes: 13.8;Paneth cells: 8.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 4.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.0;MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.0;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.2;ASC TERT1: 4.0;HEL: 20.8;hTCEpi: 4.1;SCLC-21H: 6.4"	"Low region specificity"	"Detected in many"							"HPA007386, CAB018739"	Approved					NA	NA					"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	4.7	0.4	5.2	0.4	2.9	0.6	2.2	0.8	5.3	1.4	7.7	1.2	0.7	12.2	0.6	0.6	3.8	0.6	0.4	6.3	2.9	3.3	0.7	0.3	4.3	0.3	2.5	1.9	0.3	1.8	0.0	12.1	0.2	9.3	12.7	3.8	1.4	0.8	4.6	0.3	2.1	34.3	0.7	1.3	0.3	1.3	1.7	2.4	0.0	1.3	0.0	0.6	1.2	1.3	0.4	0.0	2.0	0.0	0.4	2.2	0.4	0.1	0.3	0.1	0.0	5.2	4.0	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.0	0.2	0.9	0.0	0.1	0.3	1.6	0.0	0.4	0.0	20.8	0.6	0.0	0.0	0.0	0.0	0.6	4.1	0.0	0.0	1.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.1	0.0	0.9	6.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.3	0.0	0.4	0.8	0.9	0.0	0.4	0.0	0.0	0.0	0.4	5.2	2.9	0.8	5.3	2.9	3.3	2.5	1.9	9.3	2.4	32.8	1.6	0.0	0.6	0.0	0.0	2.6	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.1	5.3	0.0	13.8	0.0	0.0	0.1	0.0	0.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.6	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.2
RASGEF1B	"FLJ31695, GPIG4"	ENSG00000138670	"RasGEF domain family member 1B"	Q0VAM2	4	81426393-82044244	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0"	"Group enriched"	"Detected in many"	5	"B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 12.0;Daudi: 15.4;Karpas-707: 10.4;NTERA-2: 7.1;OE19: 8.5;SCLC-21H: 6.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044574	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044574: AB_10794292"	"unprognostic (3.24e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (4.42e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-2)"	"prognostic favorable (4.21e-6)"	"unprognostic (4.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.04e-2)"	11.7	5.3	12.2	8.4	18.9	22.2	14.3	3.5	8.4	7.6	8.0	10.0	2.6	10.8	3.0	9.9	10.9	6.6	10.1	4.9	6.2	8.2	9.4	32.8	19.1	9.2	13.0	3.5	3.3	2.5	1.7	12.6	10.3	38.3	3.8	6.0	6.1	9.7	4.2	3.5	20.3	10.7	5.0	8.7	13.2	12.2	1.9	19.3	8.0	3.9	4.7	8.5	4.8	5.6	8.8	18.0	0.8	12.4	2.5	2.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	12.0	0.3	15.4	0.0	0.0	0.1	0.3	1.0	0.1	0.0	0.1	2.2	1.2	1.0	0.5	0.5	0.3	0.7	0.2	0.5	0.0	0.5	0.1	0.0	2.6	0.2	10.4	0.0	0.5	5.0	0.5	7.1	8.5	3.2	1.5	0.1	5.8	0.5	0.2	6.9	0.1	0.0	2.1	0.0	7.3	1.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	4.7	1.1	0.2	0.1	0.4	2.1	0.2	1.4	7.7	1.5	6.4	1.1	1.1	1.7	8.8	2.0	1.9	0.8	2.5	12.4	18.0	0.3	0.7	12.2	18.9	3.5	8.4	6.2	8.2	13.0	3.5	38.3	19.3	26.8	22.3	27.4	6.7	52.3	9.9	8.1	15.3	44.2	12.5	14.0	35.3	26.8	11.6	2.8	0.4	8.7	10.4	0.0	3.5	2.1	12.4	11.0	104.0	39.5	37.5	3.2	25.7	51.5	43.3	1.1	0.9	59.7	59.1	1.0	6.8	0.8	2.4	5.1	1.8	7.7	4.4	0.0	15.9	0.7	0.2	49.4	9.4	7.5	6.5	6.5
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		550000	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	45.5	40.0	35.4	58.8	46.1	88.0	49.4	49.1	40.6	55.2	49.8	37.2	40.5	45.1	56.2	39.1	55.5	47.9	48.5	40.8	28.4	27.4	36.4	40.6	43.2	72.2	26.5	37.1	64.5	48.9	51.6	38.7	51.9	32.9	44.9	45.8	41.5	52.9	48.6	51.6	49.5	49.9	53.1	27.9	61.4	46.7	30.4	30.7	136.1	41.5	53.7	80.4	58.2	49.9	17.8	21.8	18.0	11.9	12.4	17.5	5.9	60.1	23.9	103.1	32.7	13.6	17.8	48.7	47.4	36.6	54.7	47.2	42.7	53.5	123.3	34.4	32.1	29.1	29.8	81.9	35.5	86.0	22.9	42.3	88.3	32.9	57.8	27.8	117.0	45.5	21.7	15.9	44.1	44.7	28.1	49.4	60.3	97.1	42.7	46.4	23.2	142.4	81.3	85.7	45.1	22.2	105.5	104.8	51.1	45.6	36.9	52.1	56.2	46.7	40.7	23.6	50.2	30.4	46.7	41.7	42.3	57.7	32.5	60.9	45.3	35.6	143.5	32.5	60.5	48.1	18.0	10.8	10.8	13.2	11.3	14.5	17.8	15.9	16.5	12.3	14.4	17.5	14.5	13.1	12.4	11.9	21.8	17.2	5.9	35.4	46.1	49.1	40.6	28.4	27.4	26.5	37.1	32.9	30.7	95.3	129.9	97.5	173.8	232.1	125.8	176.6	81.5	117.8	162.7	106.4	58.9	238.7	59.7	146.2	21.6	142.9	61.9	93.5	181.6	291.7	117.2	144.5	88.0	106.3	135.9	101.7	140.7	111.1	121.5	16.8	115.6	129.0	86.0	133.5	128.6	156.0	133.5	42.1	96.2	65.2	99.6	109.9	139.4	99.7	128.2	200.9	227.5	109.0	142.2	181.5
HNRNPDL	"HNRPDL, JKTBP, laAUF1"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422564-82430408	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056820: AB_2683246, HPA063147: AB_2684950"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	60.5	43.9	52.0	58.8	82.9	98.2	58.8	67.6	79.7	50.1	51.9	60.4	42.9	41.8	73.7	57.8	45.3	53.5	42.4	47.7	49.0	44.7	43.0	37.4	52.9	64.4	86.9	74.2	101.7	66.0	43.5	41.0	46.2	79.0	49.8	44.5	31.6	46.4	52.3	89.7	46.0	47.8	60.6	69.4	55.7	51.1	32.8	80.8	48.3	49.0	59.2	51.3	44.9	51.5	27.7	20.3	14.4	31.1	17.6	35.6	19.9	52.6	27.9	104.1	20.6	39.1	21.4	34.2	57.1	62.1	50.9	48.5	38.3	43.7	98.3	36.4	61.8	26.3	41.1	78.4	52.7	59.8	21.6	56.8	56.9	45.2	68.6	18.4	96.7	42.4	37.7	15.3	56.9	51.0	40.3	40.3	62.8	73.7	40.8	49.3	22.0	90.3	67.9	71.4	47.8	33.0	81.1	84.1	44.9	59.3	34.5	44.3	76.6	35.5	45.9	33.5	49.0	48.0	55.0	33.8	51.4	63.5	33.6	68.1	48.0	45.9	108.2	45.0	56.6	43.2	14.4	15.7	13.2	28.5	25.7	23.3	27.7	25.5	26.0	12.6	26.8	35.6	30.6	6.7	17.6	31.1	20.3	19.4	19.9	52.0	82.9	67.6	79.7	49.0	44.7	86.9	74.2	79.0	80.8	253.1	256.3	276.8	560.8	585.3	217.8	173.8	101.9	365.4	381.1	144.8	100.1	445.7	252.0	241.5	42.1	260.0	120.7	23.3	220.9	513.8	334.8	344.9	370.4	124.1	286.8	166.8	226.5	117.9	193.0	32.1	196.8	307.6	295.3	348.1	161.4	241.5	205.1	122.8	190.6	215.4	158.8	161.7	311.0	158.6	399.4	484.4	435.7	307.9	180.7	425.7
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430562-82461091	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		140000	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	10.2	15.4	43.4	12.1	37.1	14.3	16.3	22.9	38.8	13.8	12.7	34.7	5.1	12.2	10.5	23.3	13.5	10.4	9.0	11.1	44.2	34.9	20.8	13.3	11.1	16.0	47.5	26.4	12.9	14.6	17.8	11.7	17.7	31.0	17.2	15.3	8.9	11.4	11.9	9.8	13.1	11.0	11.1	66.2	12.8	13.2	6.1	29.4	14.2	18.0	8.2	18.6	10.7	9.5	13.0	14.1	4.3	10.4	14.4	20.2	12.2	18.5	12.3	22.1	13.7	13.5	13.3	24.2	21.6	14.5	19.8	17.7	22.4	20.8	37.0	22.7	16.4	21.7	10.0	29.2	27.4	35.9	22.2	13.6	22.4	12.0	29.8	21.9	37.0	19.4	12.8	29.1	20.7	24.6	14.3	20.0	23.5	28.9	20.4	25.8	23.9	40.8	22.0	20.3	47.0	10.0	29.1	33.9	20.1	32.3	18.4	31.3	19.1	12.3	37.3	27.5	20.7	16.8	17.9	14.7	24.6	18.3	24.3	28.5	23.5	20.1	46.1	15.9	23.1	33.0	3.4	8.7	4.3	14.4	10.4	18.0	13.0	17.3	16.5	12.7	11.0	20.2	16.2	0.7	14.4	8.8	14.1	18.4	12.2	43.4	37.1	22.9	38.4	44.2	34.9	47.5	26.4	31.0	29.4	14.9	8.0	28.1	32.4	60.9	36.5	11.3	12.7	12.0	15.9	12.2	15.7	71.0	74.6	41.8	4.1	24.5	12.6	0.0	22.6	47.0	29.3	32.2	38.0	10.2	49.6	27.0	28.2	13.5	22.1	4.1	24.5	27.7	37.1	45.1	21.1	46.8	34.7	8.6	22.6	42.5	27.7	12.9	30.9	6.8	22.6	56.0	39.0	34.8	25.8	31.0
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 74.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 67.6;Syncytiotrophoblasts: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.1;MCF7: 25.1;SCLC-21H: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA					"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	7.0	30.0	10.8	3.2	12.8	1.5	12.4	0.6	16.0	8.4	4.4	8.3	12.9	4.4	3.2	74.9	2.5	4.6	3.9	7.4	12.7	7.9	9.7	7.7	3.6	8.1	7.5	10.3	18.0	2.2	1.7	10.5	5.5	7.3	7.1	2.6	12.4	10.3	4.7	3.5	3.1	4.4	4.0	5.4	7.6	3.0	4.2	6.8	2.7	7.0	1.6	6.9	3.2	3.3	5.5	1.4	5.0	0.9	1.3	0.7	0.3	0.3	0.9	7.0	9.1	0.0	0.1	0.7	1.5	3.8	1.0	1.1	0.0	0.4	0.2	0.7	0.2	2.8	0.2	4.3	0.0	1.1	0.4	2.1	0.5	0.8	0.0	0.0	0.0	1.0	4.2	0.4	0.0	0.0	0.6	2.2	4.4	0.0	0.1	0.1	25.1	0.5	0.6	3.2	0.0	0.4	0.9	0.1	0.8	0.3	3.4	17.7	2.7	0.5	0.3	2.4	3.3	0.4	0.2	0.5	0.4	0.2	0.1	0.8	0.1	0.4	0.3	0.5	0.3	1.9	5.0	0.9	1.0	0.7	0.4	0.4	3.5	0.7	0.6	0.2	5.5	0.5	0.6	3.7	1.3	0.6	1.4	0.2	0.3	10.8	12.8	0.6	16.0	12.7	7.9	7.5	10.3	7.3	6.8	0.0	0.6	0.0	3.0	2.2	0.4	7.2	5.1	12.0	9.1	14.0	2.0	67.6	0.0	5.2	2.6	16.1	0.0	0.0	2.3	0.9	4.8	7.9	5.8	20.3	5.1	1.6	1.2	19.0	1.8	2.2	13.3	0.9	1.7	13.6	0.0	16.7	1.7	0.0	9.2	1.8	1.6	0.0	2.0	0.7	3.4	1.0	98.1	0.5	0.5	0.9
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798857	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 69.1;brain: 137.3;epididymis: 44.5;ovary: 42.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 92.6;Horizontal cells: 95.3;Muller glia cells: 134.1"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 27.5;RPTEC TERT1: 36.3"					"Low region specificity"	"Detected in all"			HPA042380	Uncertain					NA	NA					"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	3.0	69.1	61.2	2.7	48.6	2.5	3.0	33.5	137.3	5.9	3.0	50.4	1.8	3.0	6.7	44.5	3.7	9.3	5.1	3.5	49.6	43.4	15.4	2.3	7.5	2.3	58.2	36.3	42.7	18.1	2.2	6.9	4.4	42.0	6.9	3.0	6.3	5.6	12.4	1.7	4.8	3.7	6.2	57.1	3.0	4.3	14.8	43.4	1.2	16.4	0.0	3.0	3.8	2.0	0.9	1.3	3.0	1.2	2.0	7.2	1.8	4.5	2.9	14.7	7.5	8.1	5.3	0.3	27.5	13.6	12.0	9.3	0.3	0.7	8.9	9.6	5.7	3.3	8.0	4.3	3.0	15.2	1.7	1.9	0.4	3.5	0.4	1.2	3.9	2.9	4.1	12.4	2.4	2.1	12.5	19.3	10.4	0.6	1.1	6.3	1.8	16.2	0.9	1.2	0.1	2.0	13.9	8.7	7.0	36.3	4.5	8.3	4.7	4.6	0.4	2.6	1.6	0.6	2.0	23.6	13.0	7.6	4.9	7.4	2.5	1.0	0.9	6.3	4.1	3.7	3.0	1.2	0.4	7.2	0.5	4.6	0.5	1.7	4.3	0.5	0.9	1.5	5.1	2.0	2.0	0.9	1.3	0.4	1.8	61.2	48.6	33.5	41.2	49.6	43.4	58.2	36.3	42.0	43.4	41.7	3.8	0.5	14.0	9.5	79.3	2.0	12.7	12.0	31.8	26.2	23.6	0.7	11.6	71.1	92.6	7.1	0.0	0.0	42.3	0.1	14.4	9.5	0.0	0.0	1.0	95.3	7.5	6.7	1.2	73.6	50.9	1.8	3.3	1.8	0.0	134.1	11.2	0.0	54.8	20.8	12.4	6.5	11.3	3.3	1.4	6.4	0.1	3.9	0.8	8.6
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	25.1	11.4	33.1	23.3	59.0	73.6	24.1	46.9	52.7	26.5	32.8	19.8	32.4	32.7	20.7	93.6	15.3	12.1	32.6	31.0	36.6	33.3	13.0	19.9	19.7	51.7	58.7	21.3	25.4	70.4	39.5	40.3	46.4	45.7	42.8	14.8	30.3	32.5	47.0	22.0	28.0	17.2	22.6	26.9	10.5	20.9	17.9	24.2	42.6	14.5	21.4	23.8	18.7	32.5	30.3	35.2	25.3	24.1	43.7	34.8	18.1	30.5	29.4	24.4	10.4	44.9	34.8	25.7	39.9	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3	98.3	74.0	44.9	45.0	53.8	48.4	69.9	50.9	80.3	120.6	45.4	51.1	47.9	23.2	54.7	22.3	50.3	62.5	23.3	61.8	70.7	94.4	74.7	70.7	86.8	41.3	39.7	36.8	58.3	42.7	13.0	128.9	48.4	49.0	43.3	90.1	43.6	63.6	38.6	118.5	55.5	61.5	51.8	81.2	28.3	33.4	64.7	68.2	34.8	46.5	74.0
THAP9	FLJ34093	ENSG00000168152	"THAP domain containing 9"	Q9H5L6	4	82900684-82919969	"Predicted intracellular proteins, Transcription factors"	"DNA integration, DNA recombination"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 33.8;Late spermatids: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037420, HPA037421"	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA037420: AB_2675467, HPA037421: AB_10673631"	"unprognostic (7.54e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.64e-3)"	"unprognostic (8.74e-4)"	3.5	4.0	6.1	4.8	11.4	4.2	7.6	5.6	7.8	4.9	3.7	5.0	6.8	3.6	5.9	8.8	3.4	4.4	3.4	5.9	7.0	5.5	7.3	7.4	4.6	3.9	11.8	4.3	7.9	6.1	8.5	10.3	5.9	7.5	6.0	4.1	3.0	6.6	10.5	20.5	4.2	3.9	3.7	8.8	3.7	3.5	14.0	13.4	6.0	9.8	5.9	3.9	4.6	5.2	3.7	2.6	0.3	4.0	1.5	3.5	1.7	1.5	2.1	8.2	4.5	2.5	3.0	5.7	1.5	2.6	1.6	1.5	3.1	2.8	8.6	2.9	2.1	3.0	2.0	6.4	2.6	2.0	3.3	2.4	3.7	3.2	4.0	2.9	3.4	3.0	3.1	4.2	0.8	4.0	2.5	2.5	7.1	3.2	5.9	2.0	2.1	8.1	4.1	6.5	3.0	1.2	7.5	3.4	5.0	2.9	1.8	6.8	4.7	3.1	4.2	5.6	7.1	2.6	3.0	1.6	2.1	2.3	1.6	1.1	3.9	1.7	8.4	2.5	2.0	3.1	0.0	2.3	0.3	1.6	4.0	2.0	3.7	1.1	1.4	2.6	3.1	3.5	2.9	0.1	1.5	2.7	1.7	0.6	1.7	6.1	11.4	5.6	7.8	7.0	5.5	11.8	4.3	7.5	13.4	3.0	2.2	0.5	2.6	0.7	2.1	5.0	0.0	1.4	2.3	1.8	5.9	2.7	0.0	1.3	33.8	1.5	1.1	0.0	2.2	1.8	1.1	2.3	1.1	0.9	1.1	0.0	2.9	1.3	0.8	43.1	1.7	1.8	0.0	1.0	1.5	4.1	0.9	0.0	0.0	2.1	4.6	6.5	1.2	4.8	5.3	1.5	2.7	0.0	1.4	1.4
LIN54	"CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1"	ENSG00000189308	"Lin-54 DREAM MuvB core complex component"	Q6MZP7	4	82909973-83012926	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 27.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056606	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA056606: AB_2683187"	"unprognostic (2.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.56e-3)"	"unprognostic (6.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (3.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-2)"	6.9	6.2	9.0	6.7	13.7	16.5	7.1	13.3	12.4	8.4	8.4	12.2	2.0	7.6	6.5	6.1	15.4	5.5	5.6	6.0	10.2	8.6	10.9	11.6	6.1	8.5	15.7	7.5	7.6	4.6	9.8	8.5	8.8	10.5	5.9	10.2	6.7	8.1	6.7	10.6	7.7	6.0	6.5	15.2	7.8	6.4	9.5	12.7	27.2	14.9	8.5	11.9	7.5	8.2	3.4	2.2	8.1	8.8	6.9	7.6	3.6	7.1	4.2	6.7	7.6	3.5	3.4	5.0	11.6	8.1	8.8	8.5	5.0	8.3	7.8	6.4	11.9	5.8	5.6	9.1	3.7	10.8	8.4	4.0	7.1	6.7	5.6	3.1	8.7	52.6	2.9	2.2	9.7	4.7	2.7	5.3	7.4	7.7	15.7	8.5	5.0	18.5	3.6	2.8	8.8	2.8	10.1	7.4	5.5	4.2	6.2	7.0	3.7	7.0	11.3	4.6	4.4	4.9	5.7	4.1	10.6	7.9	9.8	5.2	7.8	5.8	13.3	5.9	5.5	8.3	5.3	3.8	7.7	6.1	3.0	6.9	2.7	6.1	6.6	2.2	3.4	7.6	6.4	8.1	6.9	8.8	1.7	6.8	3.6	9.0	13.7	13.3	12.4	10.2	8.6	15.7	7.5	10.5	12.7	6.0	5.6	7.0	3.2	10.8	8.6	5.1	5.1	4.0	3.4	5.2	2.0	2.9	0.0	2.7	27.1	4.3	4.9	23.3	3.1	4.0	4.3	4.1	2.3	6.2	5.5	4.8	4.1	5.5	4.9	11.6	2.3	5.9	8.5	1.0	3.8	6.3	3.1	2.9	4.6	5.4	8.0	12.9	4.4	2.2	2.8	10.9	2.9	5.1	4.6	6.8
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036894, HPA042828"	Uncertain		Supported	"Nuclear speckles"		NA	NA		84000	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	16.3	24.1	22.5	12.5	35.8	21.1	19.4	20.8	33.0	20.5	15.6	13.4	11.5	13.8	19.2	18.0	20.6	16.1	13.5	34.9	22.0	28.9	23.3	18.3	13.1	16.0	24.2	25.4	20.2	14.5	22.3	32.0	21.7	35.7	18.8	15.4	11.6	14.1	19.4	55.1	16.3	12.9	20.1	15.6	17.0	14.3	27.6	14.6	24.8	23.2	23.9	18.6	20.8	14.9	20.3	22.4	34.2	27.7	25.4	28.5	24.1	17.2	10.2	22.5	20.4	20.1	25.9	12.2	22.9	29.8	26.2	23.3	14.7	18.0	29.5	20.2	48.2	14.6	13.1	27.8	23.6	35.6	18.5	19.7	17.1	16.9	14.1	16.7	28.8	48.7	19.5	16.4	19.7	16.8	19.9	34.8	18.2	21.4	16.7	31.7	14.4	34.3	21.2	12.3	27.4	14.0	24.6	17.0	16.2	21.0	16.0	23.7	13.8	15.3	24.2	14.6	15.9	18.2	15.8	22.7	18.5	19.6	13.8	16.2	17.5	10.6	32.4	17.7	18.7	18.1	34.2	18.4	26.0	22.9	24.9	28.5	20.3	25.4	26.2	22.4	18.6	24.3	26.0	4.2	25.4	27.7	14.6	23.1	24.1	22.5	35.8	20.8	33.0	22.0	28.9	24.2	25.4	35.7	14.6	11.9	15.3	29.7	33.9	38.0	40.3	70.0	25.5	34.8	31.8	19.2	29.5	70.9	76.3	33.7	85.1	30.0	14.4	0.0	29.2	51.1	38.3	20.9	33.5	19.5	43.1	25.4	30.0	18.4	27.3	20.9	28.4	27.9	32.1	36.1	19.3	59.6	24.6	22.6	40.3	51.6	32.9	32.3	41.2	64.2	40.9	30.7	79.4	29.8	24.5	33.2
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta specific 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 305.1;Ciliated cells: 487.2;Enterocytes: 398.3;Extravillous trophoblasts: 527.8;Kupffer cells: 319.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 181.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 32.2;CAPAN-2: 93.1;HL-60: 57.7;NB-4: 28.4;RPMI-8226: 41.6;THP-1: 33.5;U-937: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	2.3	1.3	1.7	47.9	5.9	62.0	1.6	0.7	4.1	6.1	44.1	0.6	0.2	14.6	1.0	0.9	34.5	3.1	7.5	2.4	1.4	1.9	1.6	12.4	23.4	51.6	2.5	0.2	1.9	1.2	0.0	1.3	32.3	3.0	2.0	31.4	1.3	9.7	1.0	0.8	0.7	66.5	3.1	5.2	74.8	21.8	0.7	2.7	18.2	1.5	1.4	53.1	3.4	2.5	41.5	181.6	7.0	47.8	77.6	32.9	36.0	32.2	0.2	0.1	0.2	0.0	0.0	5.3	0.8	0.2	2.0	2.5	0.6	93.1	5.4	0.2	9.4	3.2	3.4	0.5	0.2	7.7	0.0	0.1	0.1	6.4	2.7	0.3	57.7	0.3	0.1	0.6	0.3	0.4	0.0	0.1	2.8	0.0	0.4	5.3	0.1	10.9	28.4	0.2	2.5	0.1	1.4	1.9	41.6	0.1	0.9	4.7	0.0	0.2	5.4	0.1	1.7	0.3	33.5	0.2	0.2	6.0	0.1	0.1	0.3	0.0	14.4	0.4	26.6	0.0	2.7	11.0	7.0	32.9	47.8	24.9	41.5	15.7	18.7	10.0	38.4	19.4	22.0	2.4	77.6	25.8	181.6	1.0	36.0	1.7	5.9	0.7	4.1	1.4	1.9	2.5	0.2	3.0	2.7	181.7	50.7	305.1	1.9	0.3	0.0	0.4	2.5	487.2	61.4	0.0	0.0	7.9	0.0	0.0	0.2	1.4	398.3	0.0	3.3	527.8	0.9	0.9	25.5	1.5	20.9	1.6	83.1	171.9	319.5	0.4	0.0	79.4	6.8	1.0	179.6	1.3	57.7	270.0	0.0	0.8	0.1	6.5	0.3	0.2	0.1	0.1	11.9	261.7	36.3	8.4
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 45.2;Kupffer cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.6	25.5	4.9	8.4	7.0	8.9	9.9	1.9	6.0	7.4	12.1	5.8	8.4	7.8	8.0	10.2	13.1	5.4	7.4	17.5	4.3	4.1	8.0	14.9	9.8	9.0	6.5	3.4	8.0	5.9	6.7	12.3	7.2	5.0	6.6	12.5	5.2	12.7	8.5	21.8	13.8	8.2	5.8	6.7	14.1	4.8	6.6	6.7	2.9	10.1	23.9	9.2	6.2	7.4	3.6	11.8	6.0	17.4	3.7	2.0	6.8	11.7	6.9	6.8	12.9	5.3	5.4	4.8	7.6	12.6	14.5	17.0	4.8	17.0	7.9	5.6	13.5	11.5	9.1	11.5	12.4	18.3	8.1	7.3	7.1	9.0	6.7	5.8	14.4	34.2	8.0	7.9	7.0	12.1	4.3	14.4	4.5	4.6	9.5	13.4	12.1	3.8	9.7	5.0	13.9	9.7	6.6	5.3	10.2	21.1	5.7	4.8	3.1	8.7	11.1	3.9	3.2	7.1	7.9	10.0	6.8	7.1	5.1	10.6	2.8	2.3	4.7	13.3	16.9	9.3	1.1	16.3	2.3	1.6	14.4	1.2	3.6	1.8	1.5	11.8	3.5	1.3	2.0	6.0	3.7	17.4	6.2	2.0	6.8	4.9	7.0	1.9	6.0	4.3	4.1	6.5	3.4	5.0	6.7	0.0	3.4	11.8	9.6	6.0	5.2	17.1	5.1	2.7	6.8	8.7	0.0	20.5	26.6	5.8	0.6	3.6	9.6	0.0	9.5	25.6	5.4	9.8	0.0	11.4	45.2	1.6	4.6	12.9	48.6	0.6	3.4	26.3	6.8	1.0	15.2	12.9	4.7	14.0	4.6	8.2	4.2	0.0	4.7	4.3	14.5	11.0	10.4	10.0	23.9	8.9
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 15.9;Kupffer cells: 27.7;Macrophages: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.3;OE19: 20.5"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	7.6	0.3	0.0	1.0	1.8	0.5	0.0	0.9	4.2	1.9	8.1	0.2	5.7	0.2	1.4	2.1	13.0	7.4	9.7	1.3	3.4	0.7	0.9	2.0	5.5	0.1	1.0	1.3	4.6	0.8	2.9	1.3	9.2	0.8	10.2	1.3	0.0	23.3	0.8	1.6	0.1	0.1	0.4	20.5	1.4	0.0	0.3	0.3	5.3	0.2	5.5	0.0	10.6	5.9	0.8	1.5	0.8	1.8	11.8	0.8	2.7	0.8	0.9	0.3	3.6	0.1	6.1	6.2	1.4	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8	6.0	4.1	0.0	2.6	3.1	0.0	0.4	0.0	2.7	3.4	1.8	0.0	0.5	0.0	1.3	0.6	0.6	5.1	0.0	1.2	2.3	0.6	1.5	0.0	0.2	15.9	0.0	6.3	3.1	27.7	0.0	0.6	10.2	0.0	0.0	2.9	0.0	0.8	8.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	3.1	1.3	3.2	4.6	3.7
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455856	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	10.5	20.8	6.3	12.2	7.8	7.2	10.4	12.6	9.2	10.7	9.8	9.3	8.2	5.6	9.9	8.7	8.2	9.1	9.0	10.5	6.2	5.7	11.9	10.0	8.0	15.3	6.8	5.7	17.4	8.1	13.3	20.7	11.7	9.0	11.4	7.2	11.0	10.0	10.4	14.6	8.7	9.8	8.0	8.4	14.4	8.4	10.7	7.4	18.5	14.3	8.3	13.4	10.2	9.2	10.1	4.6	6.8	4.7	5.5	9.7	2.9	4.3	3.3	7.1	4.6	8.7	9.2	3.7	6.5	9.8	8.5	8.4	3.1	4.5	12.2	5.2	5.6	5.8	4.4	8.6	4.8	8.9	7.0	3.8	7.3	5.4	4.2	5.6	8.8	18.0	7.1	6.5	6.7	7.0	7.5	6.7	8.2	9.6	10.7	8.6	5.1	8.0	6.3	3.6	6.9	2.4	6.2	8.2	4.3	7.0	2.7	5.8	4.8	6.3	6.9	7.1	7.1	4.3	9.5	5.1	6.4	5.6	8.2	5.1	9.9	4.2	10.3	5.4	6.7	7.1	5.4	3.7	6.8	5.7	4.0	5.4	5.8	6.3	6.4	4.6	10.1	9.7	8.7	2.3	5.5	4.7	4.5	7.8	2.9	6.3	7.8	12.6	9.2	6.2	5.7	6.8	5.7	9.0	7.4	3.0	9.4	10.0	8.0	3.8	9.2	9.2	7.6	22.7	7.9	5.2	7.9	9.6	10.0	5.1	20.9	7.1	3.5	0.0	4.8	8.1	6.4	4.9	7.0	4.0	9.1	6.4	0.0	10.4	5.6	5.8	12.0	8.4	6.8	7.2	4.5	9.1	4.7	6.0	7.4	8.8	13.2	0.0	8.2	20.0	12.8	3.3	9.6	13.1	5.2	4.7
MRPS18C	"CGI-134, FLJ11146, FLJ22967, MRPS18-1"	ENSG00000163319	"Mitochondrial ribosomal protein S18C"	Q9Y3D5	4	83455932-83469735	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050404	Approved					NA	NA					"HPA050404: AB_2681115"	"unprognostic (4.53e-3)"	"unprognostic (7.58e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.25e-2)"	"unprognostic (8.26e-3)"	"prognostic favorable (2.90e-5)"	"unprognostic (1.52e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.31e-3)"	20.1	25.5	23.7	18.9	25.8	18.9	18.3	17.3	29.6	14.0	20.1	16.7	13.7	19.5	18.6	15.8	25.5	21.1	13.1	25.1	20.4	21.6	33.8	40.8	15.3	18.6	23.7	22.9	16.7	18.3	17.1	19.4	20.3	24.1	13.5	21.1	14.0	17.6	13.1	61.2	16.5	19.5	17.9	18.6	23.0	17.7	12.6	18.3	24.3	20.9	27.5	25.7	17.5	15.9	53.3	52.5	60.1	43.3	34.9	59.7	33.4	22.9	24.0	18.3	14.1	11.5	7.8	18.3	24.5	12.2	19.1	16.4	42.3	20.4	20.6	28.1	11.6	22.1	12.4	18.7	14.3	22.4	18.9	15.3	18.0	34.0	41.7	15.7	43.5	23.2	8.0	12.9	15.0	18.6	10.8	12.3	26.7	24.4	17.4	12.0	43.9	28.3	26.6	10.9	32.7	16.6	16.4	16.1	17.1	14.3	20.7	19.8	10.8	12.1	26.2	19.6	19.0	11.2	26.5	14.7	17.1	26.3	16.7	32.3	16.1	20.4	46.9	16.1	22.5	21.0	34.7	40.7	60.1	36.2	43.3	36.8	53.3	43.9	39.6	45.5	50.3	45.8	40.6	18.2	34.9	34.8	52.5	59.7	33.4	23.7	25.8	17.3	29.6	20.4	21.6	23.7	22.9	24.1	18.3	47.6	54.1	84.8	65.1	60.6	33.2	83.7	89.2	84.3	42.1	73.3	35.3	111.0	193.9	96.6	62.7	69.3	59.1	0.0	163.3	98.9	56.6	48.8	105.3	146.9	99.3	30.2	32.2	70.0	58.7	14.3	75.9	64.8	59.1	52.3	52.2	48.5	110.5	76.3	72.9	144.8	47.6	58.2	63.2	107.2	60.0	56.0	80.4	62.8	72.7	54.5
ABRAXAS1	"ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614"	ENSG00000163322	"Abraxas 1, BRCA1 A complex subunit"	Q6UWZ7	4	83459517-83523348	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 40.2;Distal tubular cells: 36.5;Proximal tubular cells: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037654	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA037654: AB_2675588"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.24e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.57e-2)"	13.2	5.7	2.4	6.4	3.7	8.6	7.4	2.0	2.7	15.4	9.7	3.8	3.7	4.4	16.9	7.1	9.3	7.3	7.0	6.4	2.4	2.6	7.8	3.4	7.4	10.0	4.0	2.0	23.2	7.2	3.3	4.6	4.4	5.4	13.2	3.3	4.2	5.3	7.9	25.0	7.1	6.3	13.6	6.4	9.6	5.3	13.3	3.7	25.7	13.1	7.2	5.1	13.3	8.4	7.0	3.5	6.5	5.0	8.5	10.6	3.8	3.8	2.6	4.9	6.2	4.3	18.5	2.7	3.1	3.7	1.5	2.0	5.2	6.5	15.1	2.5	3.2	3.1	2.1	2.5	2.0	2.5	6.2	1.7	8.9	3.0	6.2	3.5	10.3	8.3	8.0	1.8	2.0	1.7	7.1	6.1	9.0	24.4	9.6	3.3	2.5	11.3	4.0	8.0	4.3	3.7	6.2	5.5	3.9	3.0	3.2	4.7	4.0	3.9	1.8	6.8	4.0	4.8	4.3	8.4	5.5	5.7	5.4	4.1	8.5	5.6	11.3	4.8	9.0	3.8	6.5	5.0	4.2	4.5	4.2	5.5	4.0	7.0	5.0	3.5	7.0	10.6	8.4	6.4	8.5	4.1	2.8	5.7	3.8	2.4	3.7	2.0	2.1	2.4	2.6	4.0	2.0	5.4	3.7	14.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	40.2	15.9	12.2	0.0	4.2	36.5	7.8	0.0	0.0	0.0	0.0	5.7	5.9	0.0	0.0	5.8	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	7.5	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	9.8	9.7	0.0	0.1	0.5	1.2	0.2	0.7	1.4	0.2	0.2	0.7	51.6	0.0	1.1	1.8	39.2	2.2	4.6	0.9	0.1	0.6	2.2	0.0	3.1	9.5	1.4	2.8	19.0	0.6	0.0	0.3	1.1	3.8	4.8	2.7	7.9	7.8	0.2	1.0	0.7	0.7	0.2	14.5	4.2	0.1	2.2	3.7	9.8	0.6	0.2	0.0	1.9	2.0	5.4	0.5	0.4	0.5	0.2	2.3	4.2	2.3	9.3	0.4	0.6	0.0	22.6	5.6	17.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4	6.0	5.0	0.0	41.3	0.0	0.0	0.0	7.6	2.7	9.1	10.4	0.0	0.2	13.3	1.6	68.5	0.6	21.6	0.0	5.9	1.0	0.1	25.8	7.0	11.9	15.3	4.8	1.2	5.5	16.7	17.2	1.1	28.3	0.0	5.4	4.8	0.0	6.6	8.0	0.7	50.3	0.2	6.5	0.0	8.8	1.7	0.0	0.8	0.0	2.1	25.4
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491987-84498450	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 6.0;esophagus: 11.0;pancreas: 10.8"	"Cell type enhanced"	"Detected in some"	19	"Ductal cells: 7.1;Early spermatids: 2.5;Spermatocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;HAP1: 8.1;HEK 293: 7.1;HMC-1: 5.5;PC-3: 4.8;U-2197: 9.0"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in many"			"HPA036774, CAB070169"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.2	0.0	0.3	0.2	2.2	0.0	6.0	1.0	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	11.0	0.0	0.2	0.2	0.4	1.3	0.2	0.2	0.2	0.2	2.5	0.2	0.2	10.8	0.0	0.2	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	1.3	0.2	1.5	2.1	0.2	0.2	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.6	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.2	2.3	0.0	8.1	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.1	4.8	0.0	2.4	0.0	0.0	0.3	1.5	0.0	0.7	0.0	0.0	1.5	0.0	0.8	0.1	0.0	2.5	9.0	2.3	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	1.0	1.1	0.4	1.3	2.5	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	2.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.0	0.0	0.0	0.0	0.0	0.0
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84582979-84651338	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.0"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	0.9	4.6	7.4	2.5	10.4	0.4	6.7	13.3	12.9	4.3	16.7	3.3	9.3	24.8	2.0	19.1	17.4	20.5	8.8	0.5	7.4	8.4	11.9	0.6	10.6	0.8	6.4	4.7	5.5	4.5	19.3	7.1	19.7	14.1	6.1	13.6	4.2	11.2	4.3	0.2	12.9	48.0	0.8	2.4	1.0	11.5	5.1	2.3	0.9	19.3	7.9	6.1	3.5	7.4	0.0	2.1	0.0	0.0	0.0	0.4	0.0	11.4	0.2	0.6	0.1	0.0	0.0	12.0	0.0	0.1	0.3	0.2	4.8	20.5	0.0	0.9	0.0	2.4	12.1	3.7	10.2	0.1	0.8	5.7	0.0	1.8	1.1	0.0	0.3	0.8	0.1	25.6	0.0	3.7	0.4	0.0	0.7	0.0	0.0	0.0	8.1	0.1	0.0	1.7	19.7	0.8	0.0	0.0	2.4	5.7	8.7	4.8	0.1	1.3	27.8	0.0	2.3	8.5	0.2	0.0	0.0	0.6	1.2	1.5	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	10.4	13.3	12.9	7.4	8.4	6.4	4.7	14.1	2.3	14.9	36.5	0.5	24.3	25.8	16.5	1.6	17.8	105.7	27.3	38.4	9.8	49.0	3.3	23.6	5.9	2.1	44.6	0.0	20.1	9.6	1.5	29.0	0.0	0.0	10.4	20.6	21.5	1.8	2.2	3.1	0.6	5.6	0.0	1.0	45.1	28.4	30.8	31.6	0.4	14.7	28.1	0.0	1.3	2.3	3.8	47.3	47.9	0.0	47.2	32.3
WDFY3	"ALFY, KIAA0993, ZFYVE25"	ENSG00000163625	"WD repeat and FYVE domain containing 3"	Q8IZQ1	4	84669610-84966391	"Disease related genes, Predicted intracellular proteins"	Autophagy	"Developmental protein"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	23	"dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"TIME: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042734, HPA048572"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoli, Plasma membrane"	"HPA042734: AB_2678135, HPA048572: AB_2680447"	"unprognostic (7.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.64e-5)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.95e-2)"	10.1	15.2	17.2	7.5	18.7	13.1	9.0	17.9	18.6	9.6	8.3	17.6	4.8	3.6	11.5	6.9	9.4	9.3	9.0	7.3	17.3	6.5	21.3	5.8	7.9	2.4	22.8	9.5	14.7	9.0	24.0	14.6	11.8	17.0	9.2	5.9	8.6	9.8	8.1	13.7	10.9	5.6	8.7	14.8	7.5	7.8	8.0	21.4	0.4	12.1	3.2	2.6	14.2	6.6	0.0	1.1	4.3	1.5	0.0	0.0	0.3	6.5	4.5	8.1	4.5	14.5	11.4	5.1	6.3	6.7	6.6	6.0	5.0	5.4	0.0	6.5	10.4	7.0	3.3	8.7	6.9	8.4	4.5	2.7	4.1	4.9	3.0	5.5	3.2	7.8	8.3	6.3	8.6	8.7	8.0	20.9	3.4	4.1	20.0	12.0	4.7	3.1	0.7	4.2	6.3	2.2	4.6	6.5	0.9	11.4	8.6	9.6	4.5	7.7	8.6	4.3	8.1	4.4	8.0	31.7	8.7	8.7	4.8	7.9	0.0	0.0	0.0	5.9	2.8	9.5	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.3	17.2	18.7	17.9	18.6	17.3	6.5	22.8	9.5	17.0	21.4	17.9	11.7	1.5	8.3	13.1	41.7	15.5	15.3	10.7	12.5	15.7	33.4	9.5	1.7	8.5	6.7	16.9	4.6	0.0	6.2	5.5	12.3	13.0	0.0	7.6	17.1	27.0	8.7	22.1	39.6	7.7	17.0	17.4	6.8	5.4	7.0	26.8	8.9	5.8	23.0	14.9	41.9	25.8	15.6	7.4	7.8	14.1	12.1	0.5	6.6	10.0
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475114-86002670	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 62.5"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 105.7;Distal tubular cells: 192.3;Proximal tubular cells: 165.1;Syncytiotrophoblasts: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5"	"Group enriched"	"Detected in many"	4	"B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.4;ASC TERT1: 22.1;HHSteC: 21.3;HUVEC TERT2: 39.2;RPTEC TERT1: 22.0;TIME: 27.6;U-138 MG: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	21.3	1.9	5.3	16.4	7.9	10.7	17.6	1.8	9.4	5.8	6.2	8.4	2.4	4.8	9.2	7.3	7.7	3.9	7.1	16.8	6.3	7.3	62.5	6.0	9.9	23.8	11.0	3.3	4.1	21.5	6.9	8.2	13.9	9.0	6.7	4.3	8.7	9.0	5.8	7.6	6.2	8.7	13.2	19.8	33.6	15.9	2.8	6.7	2.1	17.8	6.5	24.2	13.0	5.2	23.1	6.5	2.8	8.0	0.0	0.0	1.4	0.9	1.9	1.4	0.0	36.4	22.1	1.5	6.9	9.2	1.7	2.7	0.0	0.0	0.9	2.4	15.4	2.1	0.0	0.0	2.9	3.6	0.0	0.3	1.1	0.2	0.0	21.3	0.1	0.0	16.1	0.3	3.3	1.5	7.8	39.2	0.0	2.0	0.1	14.9	0.0	0.0	0.0	0.1	0.4	3.6	0.1	7.3	3.6	22.0	0.0	0.7	0.7	0.7	1.1	2.4	1.6	0.1	0.0	27.6	19.7	0.4	1.4	0.1	0.1	0.0	1.2	3.3	0.7	6.4	0.0	8.0	0.0	0.0	1.5	0.0	23.1	0.0	0.0	1.9	18.4	0.0	0.0	2.8	0.0	1.1	6.5	0.0	1.4	5.3	7.9	1.8	9.4	6.3	7.3	11.0	3.3	9.0	6.7	53.6	24.5	105.7	2.4	7.2	3.7	22.1	43.3	25.4	10.3	43.6	5.9	36.9	192.3	7.0	17.7	4.9	0.0	0.0	10.3	22.3	17.9	2.2	1.1	6.6	10.1	104.9	2.4	5.5	24.7	6.8	15.5	12.9	18.6	0.0	2.5	40.3	7.3	2.9	11.7	165.1	6.2	6.5	14.0	5.2	4.1	5.5	194.7	0.9	3.0	1.7
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	"Mitogen-activated protein kinase 10"	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.3"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 92.3;Early spermatids: 179.3;Late spermatids: 303.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"AF22: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022625	Approved					NA	NA					"CAB022625: "	"unprognostic (2.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.22e-3)"	"prognostic favorable (5.57e-4)"	17.2	11.9	31.6	3.7	34.5	9.7	6.2	26.1	58.3	11.4	4.0	12.6	8.1	3.2	11.0	14.2	7.4	11.9	10.4	5.1	36.0	28.6	15.0	2.7	6.5	3.9	31.5	36.4	11.3	5.6	10.9	31.5	3.4	37.9	16.6	4.3	5.4	3.4	18.9	2.0	3.5	3.9	11.4	23.1	5.3	4.3	18.2	15.8	0.0	15.3	0.4	3.6	11.1	10.2	3.7	3.0	6.9	1.8	3.3	3.6	2.3	1.1	2.0	60.3	1.9	1.7	1.4	2.3	1.2	1.1	1.0	0.5	1.1	1.8	2.6	2.0	0.7	1.5	3.7	0.6	1.6	1.7	3.8	1.6	2.2	2.4	1.9	1.4	1.0	1.2	1.6	0.8	1.4	1.9	2.1	1.3	1.8	1.9	9.9	0.7	1.6	1.7	1.1	3.5	0.3	1.2	1.9	1.5	0.9	4.3	6.4	3.6	3.3	1.2	4.9	0.8	2.0	3.5	1.3	2.8	2.6	2.7	1.1	1.0	3.2	1.9	1.7	3.8	1.3	1.4	6.9	1.8	3.3	2.3	1.6	2.4	3.7	1.9	2.5	1.6	3.3	2.7	3.6	6.2	3.3	1.5	3.0	2.7	2.3	31.6	34.5	26.1	58.3	36.0	28.6	31.5	36.4	37.9	15.8	20.8	26.0	0.0	12.6	0.7	19.8	0.8	12.7	92.3	15.9	21.0	5.9	0.3	10.0	2.1	179.3	1.1	0.0	0.0	0.0	0.5	1.5	10.1	2.3	0.0	0.2	36.5	2.4	1.8	0.3	303.7	24.5	2.5	1.7	0.0	0.0	16.4	1.7	0.0	51.6	16.2	10.2	6.5	2.0	8.8	2.2	0.9	0.1	0.0	0.0	17.9
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase, non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 152.9;Basal keratinocytes: 97.1;Rod photoreceptor cells: 171.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"AF22: 45.2;RT4: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	10.3	5.9	10.8	2.7	16.9	0.7	9.9	5.7	11.6	15.9	4.1	13.0	7.6	1.2	10.8	21.2	18.7	11.4	6.5	5.3	10.4	5.7	22.1	1.6	18.0	4.3	16.9	7.9	24.1	4.3	26.6	38.3	3.0	14.2	12.0	2.4	39.0	5.9	9.4	1.0	43.0	2.3	8.7	10.3	3.5	3.6	12.2	17.6	1.9	16.9	12.4	11.8	15.7	17.6	0.0	0.5	0.1	4.9	0.1	2.3	0.1	5.1	2.6	45.2	4.4	19.1	16.7	0.0	9.5	19.4	3.6	4.6	0.0	2.6	0.0	2.1	10.5	1.3	17.0	7.8	14.3	7.0	0.1	5.8	4.3	5.6	0.0	2.3	7.5	0.0	10.7	4.6	2.6	8.7	7.6	0.0	0.0	0.0	7.4	0.0	2.3	0.6	2.7	10.3	0.0	1.9	1.5	0.0	0.0	13.8	21.5	2.6	3.8	2.8	6.3	5.2	7.6	3.7	0.2	0.0	3.5	2.7	0.0	1.2	7.7	0.0	0.0	3.7	0.0	1.5	0.0	0.2	0.0	0.2	3.0	2.3	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.1	0.1	10.8	16.9	5.7	11.6	10.4	5.7	16.9	7.9	14.2	17.6	44.7	152.9	0.0	21.0	97.1	9.8	1.7	10.2	32.1	75.1	45.4	86.4	0.2	3.3	4.3	20.2	2.2	0.0	0.0	3.0	0.1	20.2	12.1	4.7	0.0	0.2	1.6	4.6	1.8	2.2	14.8	42.3	5.7	18.6	0.0	0.5	14.1	4.3	3.5	30.8	9.2	171.6	12.9	12.5	24.4	21.6	86.9	0.2	4.4	0.2	45.5
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849263	"Predicted membrane proteins"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.3;breast: 15.2;skin 1: 17.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 62.9;Late spermatids: 160.4"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.0;BJ: 4.9;BJ hTERT+: 4.0;HaCaT: 3.7;HBEC3-KT: 1.6;U-266/84: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016662	Enhanced					NA	NA					"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	20.3	0.5	0.6	0.9	0.7	0.0	15.2	0.1	0.6	3.7	1.6	0.0	2.1	0.1	2.0	0.8	12.5	0.8	1.4	1.2	0.4	0.2	0.2	0.2	1.2	0.1	2.7	0.0	0.4	1.1	0.9	3.7	0.3	0.9	0.9	0.4	0.0	2.0	0.5	2.3	17.7	0.4	2.4	1.6	0.3	0.5	4.9	1.1	0.0	1.4	11.2	2.9	4.6	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	2.0	0.1	0.2	4.9	4.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	3.7	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.7	0.1	0.6	0.4	0.2	2.7	0.0	0.9	1.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.4	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.4	21.8	0.0	0.0	0.0	0.1
C4orf36	MGC26744	ENSG00000163633	"Chromosome 4 open reading frame 36"	Q96KX1	4	86876205-86892422	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 14.0"	"Group enriched"	"Detected in many"	11	"Early spermatids: 140.3;Late spermatids: 253.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 1.8;cerebral cortex: 1.6;hippocampal formation: 3.3;pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.8;CAPAN-2: 4.6;hTCEpi: 3.8;hTERT-HME1: 5.5"									HPA057434	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057434: AB_2683438"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.76e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.69e-5)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.75e-2)"	0.6	0.2	0.1	0.7	1.8	0.0	2.1	0.4	1.6	1.7	0.3	0.7	0.0	0.3	1.0	0.4	1.0	0.4	0.0	1.4	3.3	0.2	0.6	0.5	0.9	0.0	0.2	0.4	1.7	0.5	0.0	2.6	0.2	1.4	1.3	0.3	0.1	0.6	0.3	0.1	4.2	0.1	0.6	0.3	0.8	0.2	14.0	0.0	0.0	0.8	0.0	0.4	0.5	0.8	0.1	0.9	0.3	0.0	0.0	0.1	0.0	5.8	0.5	0.3	0.2	0.0	0.3	1.2	2.9	0.8	0.7	0.0	0.3	4.6	0.0	0.5	0.0	0.1	2.6	0.4	2.6	0.7	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	5.5	0.1	0.0	0.2	0.4	0.1	0.0	2.7	1.8	0.2	0.8	1.2	0.0	1.4	0.0	0.0	0.9	2.4	0.7	1.8	0.8	0.4	0.0	0.5	1.1	0.0	0.0	0.6	1.0	0.3	0.4	0.2	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.4	1.6	3.3	0.2	0.2	0.4	1.4	0.0	0.0	0.0	3.4	9.5	4.4	4.8	18.1	12.7	0.0	0.0	0.0	9.8	0.9	0.0	0.0	140.3	7.1	10.2	0.0	0.0	1.6	3.8	3.9	0.0	2.4	2.8	1.6	2.9	4.3	5.4	253.3	4.9	1.5	1.7	0.0	7.4	6.3	0.3	9.3	3.2	0.0	6.8	6.5	3.1	3.7	7.0	8.9	8.1	2.2	5.2	3.9
AC093827.5		ENSG00000285458	"Uncharacterized protein C4orf36 "	Q96KX1	4	86886472-86936178	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 11.9;Ciliated cells: 14.7;Club cells: 3.4;Distal tubular cells: 5.0"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.2"									HPA057434	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057434: AB_2683438"																		2.0	2.0	4.4	0.9	8.1	1.5	3.4	1.0	4.5	2.0	1.3	9.7	2.2	1.6	1.8	3.7	2.2	1.6	1.1	6.8	4.6		3.0	0.8	1.5	0.3	8.9	3.7	1.8	1.2	3.3	1.6	1.6	5.8	2.5	1.8	2.6	2.0	2.4	4.8	5.1	1.6	3.0	8.9	1.2	2.1	3.2	8.2	0.0	3.9	2.4	0.3	1.6	0.0	2.0	2.8	3.3	1.8	2.0	3.1	0.6	2.9	1.8	0.9	1.3	2.8	2.5	1.4	2.7	2.8	0.9	1.4	1.3	4.9	0.5	2.5	1.8	2.3	2.0	1.3	1.6	1.1	2.3	1.0	2.3	2.2	1.3	1.6	3.6	1.5	1.7	4.2	0.9	3.2	1.5	0.8	1.2	1.6	12.2	0.5	0.9	1.5	1.4	2.1	2.8	1.2	2.9	1.2	2.6	2.9	2.1	1.0	1.8	2.1	2.1	2.4	1.4	3.8	2.6	1.0	2.3	3.1	1.0	1.6	4.4	2.0	4.0	1.9	1.7	1.2	1.6	1.7	1.5	2.0	1.8	2.5	1.6	1.4	2.0	1.5	2.0	1.9	3.1	3.3	2.0	1.3	2.8	0.7	0.6											11.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	14.7	3.4	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 121.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.7	16.6	8.0	11.8	9.5	19.5	26.5	6.5	12.2	20.2	21.0	10.5	18.9	11.1	27.4	16.6	15.8	18.6	15.3	22.4	10.3	5.3	27.6	15.5	18.4	12.9	9.3	5.5	24.7	19.0	28.6	18.5	121.7	9.5	16.8	14.3	27.0	16.0	25.6	58.8	18.6	16.2	20.3	11.5	13.9	15.0	6.7	10.3	17.0	38.8	21.1	13.9	19.5	26.5	11.3	14.6	21.1	5.4	5.1	8.8	2.8	7.9	7.3	6.1	6.4	10.1	12.1	8.6	8.0	11.8	6.1	9.2	7.7	14.8	9.0	11.0	9.8	7.8	3.6	9.6	12.1	8.5	15.4	3.8	18.8	19.1	6.4	7.8	18.0	14.9	9.8	8.8	10.5	9.3	8.9	22.5	7.6	11.5	25.6	2.6	2.1	16.2	5.2	8.1	13.3	2.6	12.9	3.6	11.5	18.1	7.6	13.9	2.5	12.3	8.1	3.9	13.4	4.8	15.1	11.3	11.4	10.4	6.9	4.4	22.2	12.3	15.6	9.4	20.8	4.1	3.5	5.4	11.7	6.7	4.1	7.4	8.0	8.8	6.6	6.0	11.3	4.7	4.4	21.1	5.1	2.2	14.6	7.5	2.8	8.0	9.5	6.5	12.2	10.3	5.3	9.3	5.5	9.5	10.3	38.7	57.2	25.4	12.5	21.4	44.7	96.4	40.8	40.2	31.8	87.2	212.1	0.9	3.3	11.6	6.6	38.8	30.8	46.7	10.9	3.8	14.6	24.9	23.3	27.7	11.3	17.5	31.0	65.1	43.0	5.4	27.0	25.6	21.9	8.2	40.8	22.0	11.1	31.7	26.9	40.9	150.1	25.8	15.6	3.5	6.4	27.7	27.5	15.2	25.3	14.4
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 56.2"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 205.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.8	7.3	6.9	5.6	8.1	3.0	12.0	10.0	10.7	9.2	7.5	5.3	3.8	7.3	8.3	56.2	5.3	5.4	5.0	7.4	7.7	7.2	11.4	10.3	9.0	8.1	6.3	5.6	6.1	6.3	7.1	14.2	6.6	7.3	5.7	8.5	4.6	6.5	7.7	23.4	4.8	8.2	6.6	8.0	6.9	5.5	4.2	6.5	7.0	17.3	2.9	4.7	6.8	10.9	3.8	10.3	8.6	12.1	8.7	4.9	5.0	6.5	5.8	10.5	4.7	9.6	7.0	5.6	8.4	4.5	5.6	6.6	9.2	5.0	9.5	6.8	6.2	4.6	2.8	11.1	8.3	12.2	9.1	7.0	11.6	4.4	5.4	8.2	19.0	7.3	8.8	6.0	8.6	8.7	5.5	6.7	7.3	14.9	8.7	5.8	7.2	22.7	9.6	2.6	14.8	2.3	8.6	9.0	5.8	9.5	6.8	22.0	7.7	5.5	13.5	6.2	4.1	4.7	14.1	6.2	7.2	8.8	7.6	7.0	13.1	8.5	16.9	5.4	9.1	7.8	1.9	12.1	7.3	3.0	9.2	4.9	3.3	2.4	2.5	10.3	3.8	4.4	4.3	8.6	8.7	9.0	2.7	0.9	5.0	6.9	8.1	10.0	10.7	7.7	7.2	6.3	5.6	7.3	6.5	3.0	18.5	11.3	9.5	12.2	18.4	11.7	5.1	6.7	10.3	41.8	39.3	3.2	10.0	4.5	2.8	9.5	12.2	0.0	3.9	4.6	8.6	10.5	7.0	17.1	8.6	22.3	8.6	5.5	30.8	2.4	8.9	13.4	10.1	2.8	12.0	205.6	5.0	8.6	7.8	16.5	44.7	12.9	9.2	11.2	19.4	12.9	19.9	7.7	13.3	9.8
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322906	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 158.8"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 61.6;Club cells: 78.5;Hepatocytes: 112.8;Urothelial cells: 30.7"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	8.0	0.1	0.1	0.2	0.1	0.3	1.8	1.0	0.1	1.3	0.3	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.9	0.1	0.0	0.1	158.8	0.8	0.1	0.1	0.1	0.1	2.4	0.0	0.1	0.3	0.1	2.4	0.1	0.1	0.2	0.1	0.1	1.4	0.1	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.1	0.3	2.7	1.8	0.6	3.7	0.7	0.8	0.8	0.1	0.2	0.3	0.8	0.9	1.1	0.8	0.6	0.1	0.3	0.0	0.1	0.0	1.8	0.6	0.6	0.3	0.1	0.4	0.2	0.2	0.2	0.6	0.3	1.0	1.1	1.8	0.8	2.6	1.1	0.4	0.0	0.0	0.1	0.9	0.3	0.9	0.8	0.9	0.3	0.3	0.4	4.9	0.4	1.4	0.5	0.8	1.0	0.3	0.3	0.5	0.5	2.1	0.6	0.4	0.2	0.5	0.2	1.6	1.0	0.5	2.7	0.7	0.4	0.5	0.3	0.5	0.3	2.0	1.0	3.7	0.7	1.5	0.4	0.2	0.4	1.8	0.4	0.4	0.1	1.1	0.8	0.7	2.8	0.8	0.3	0.6	0.4	0.1	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	5.4	0.0	19.6	2.3	0.0	0.3	2.5	61.6	78.5	1.8	0.0	0.1	0.0	0.0	2.1	0.4	0.0	0.0	0.4	0.2	1.0	1.1	0.0	112.8	0.2	0.0	1.7	1.3	1.6	1.8	0.0	0.5	0.0	0.0	0.7	0.3	0.2	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.6	30.7
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 489.8;Paneth cells: 501.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.5"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.7	5.2	13.1	16.1	22.2	7.4	5.8	9.1	3.8	7.0	8.9	68.5	0.0	11.2	5.9	3.6	0.2	15.2	1.2	4.2	16.9	3.2	14.7	5.9	30.0	9.1	26.2	27.5	15.7	0.4	5.2	1.8	12.1	7.3	6.4	15.3	7.6	7.0	0.4	5.3	32.1	8.9	33.3	1.8	14.7	4.8	17.3	10.5	16.4	1.7	16.7	11.4	0.3	19.5	7.0	0.0	25.6	6.1	2.6	11.8	10.5	3.0	3.7	1.5	1.6	4.9	18.6	17.8	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6	291.8	133.2	72.8	64.6	24.8	1.2	4.4	310.8	75.0	111.5	41.8	2.0	27.4	21.6	38.6	0.9	71.4	489.8	0.0	51.8	45.8	75.4	36.7	98.1	303.2	118.3	17.5	90.0	101.9	213.8	0.9	96.4	169.0	64.1	36.1	155.1	34.2	52.9	501.0	55.9	148.1	3.9	71.1	54.2	2.6	13.1	18.7	12.5	110.7	226.2	80.0
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422582-87459454	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9000	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	14.2	25.6	19.5	10.0	22.7	4.0	31.1	22.5	22.3	17.9	19.6	11.8	18.0	27.0	17.3	24.5	12.8	16.2	11.4	18.0	21.8	19.4	28.1	30.9	15.8	12.2	22.9	16.5	18.4	64.1	35.4	33.1	17.5	20.0	22.5	18.3	11.3	20.2	18.7	23.8	10.2	30.0	16.0	17.0	9.9	14.1	14.1	22.6	7.6	22.7	16.0	9.7	13.6	35.9	13.9	13.8	3.7	13.9	9.3	18.3	10.6	10.6	11.6	12.9	6.5	25.6	16.2	10.4	20.7	13.5	8.0	8.0	8.1	18.5	15.7	21.2	16.7	14.6	7.4	11.9	14.5	12.8	11.7	9.1	5.1	13.5	14.3	16.1	9.4	8.5	15.5	19.3	9.5	9.0	16.5	15.9	5.1	14.4	10.6	15.0	14.1	13.1	10.2	10.4	25.1	4.7	15.4	11.5	9.2	60.2	9.9	15.7	10.7	13.3	23.6	10.5	17.5	13.5	13.6	16.3	12.9	12.5	9.4	10.1	8.1	6.3	12.8	18.5	8.9	16.3	0.9	11.7	3.7	13.4	13.8	12.4	13.9	13.4	13.2	13.8	12.0	15.9	18.3	1.3	9.3	13.9	13.0	12.3	10.6	19.5	22.7	22.5	22.3	21.8	19.4	22.9	16.5	20.0	22.6	62.5	31.4	15.2	36.7	8.9	13.8	35.3	43.3	45.5	60.3	22.7	25.5	27.4	34.9	42.5	19.0	27.0	24.4	0.0	31.7	28.2	26.6	34.7	19.7	42.0	28.9	6.4	16.1	17.8	11.6	7.6	23.6	17.1	10.1	22.6	15.4	21.8	28.5	25.8	25.1	47.3	15.3	25.8	26.7	29.8	21.7	8.3	31.5	7.2	22.2	26.3
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	20	"Endothelial cells: 1521.8;Peritubular cells: 2372.1;Sertoli cells: 4598.4"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 17.8;SuSa: 25.3;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"	NA	NA		660000000			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (3.33e-4)"	102.2	21.9	110.3	18.8	139.9	0.9	52.1	42.9	212.1	123.2	58.0	17.9	23.8	19.7	148.7	74.6	56.4	92.8	74.7	80.9	98.8	40.9	13.2	4.5	58.7	14.6	67.5	106.4	45.2	13.0	15.8	38.3	48.8	69.7	97.0	30.4	7.9	31.5	166.0	35.2	13.1	27.4	185.6	82.5	23.9	40.8	29.2	53.9	1.2	38.8	24.4	15.6	103.9	50.3	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.5	0.0	17.8	0.2	0.1	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.0	1.9	0.0	0.0	1.4	0.0	0.2	0.8	0.3	0.8	0.2	1.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.4	0.1	2.7	0.4	0.0	0.0	0.2	0.3	0.8	0.0	0.1	0.6	1.4	0.1	0.1	0.1	25.3	0.3	0.3	0.0	0.2	0.2	1.0	0.1	7.0	0.9	0.4	2.7	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.3	0.0	0.0	110.3	139.9	42.9	136.4	98.8	40.9	67.5	106.4	69.7	53.9	11.9	84.8	13.7	145.4	41.1	7.3	256.0	2.5	13.4	79.6	7.0	2.0	1.7	11.6	0.5	9.5	1521.8	0.0	0.0	0.4	4.4	128.5	36.6	7.0	7.4	8.4	3.2	0.0	459.7	4.1	21.4	610.7	30.6	54.0	0.0	0.0	177.6	0.1	0.0	2372.1	11.0	29.9	4598.4	816.1	4.7	6.6	34.9	2.1	4.9	0.0	107.5
DSPP	"DFNA39, DGI1, DMP3"	ENSG00000152591	"Dentin sialophosphoprotein"	Q9NZW4	4	87608529-87616910	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Deafness, Disease mutation"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036230	Uncertain				"Secreted in other tissues"	NA	NA					"HPA036230: AB_10672239"				"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.27e-1)"		"unprognostic (2.21e-2)"				"unprognostic (1.26e-1)"			"unprognostic (1.76e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMP1		ENSG00000152592	"Dentin matrix acidic phosphoprotein 1"	Q13316	4	87650307-87664361	"Disease related genes, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.9;testis: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.4;SuSa: 1.1;U-266/70: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037465	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA037465: AB_10672492"	"unprognostic (6.77e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.96e-3)"		"unprognostic (7.73e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-2)"		"unprognostic (8.50e-9)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-3)"	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799581-87812435	"Cancer-related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2"	"Cell type enriched"	"Detected in single"	46	"Hofbauer cells: 6.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-138 MG: 13.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.2	0.0	1.9	0.6	0.4	1.0	0.1	2.0	4.5	4.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.8	1.3	1.0	0.1	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.8	6.2	1.1	2.6	0.4	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	2.0	1.5	1.0	0.1	0.9	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MEPE		ENSG00000152595	"Matrix extracellular phosphoglycoprotein"	Q9NQ76	4	87821411-87846817	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 34.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 34.2;cerebral cortex: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.0"					"Group enriched"	"Detected in some"	4	"amygdala: 1.3;basal ganglia: 0.7"	"HPA038003, HPA038004"	Uncertain				"Secreted to extracellular matrix"	NA	NA		24000000			"HPA038003: AB_2675780, HPA038004: AB_10670537"	"unprognostic (2.88e-1)"				"unprognostic (8.15e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.41e-1)"		"unprognostic (5.64e-4)"	0.2	0.2	34.2	0.2	5.2	0.3	0.5	0.0	10.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	2.4	1.7	0.3	0.2	0.3	0.2	0.5	5.4	0.2	0.2	0.2	0.1	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	5.2	0.0	10.0	2.4	1.7	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell type enriched"	"Detected in many"	9	"Hofbauer cells: 50179.8"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	54000000	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.2	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	218.9	0.1	17.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	107.8	0.0	0.3	0.2	0.0	0.0	1.5	0.0	5.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	10.1	0.0	0.0	0.1	0.0	51.4	477.9	0.0	0.0	0.0	0.0	0.0	14.4	21.2	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	20.0	0.0	20.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9	3.0	6.6	20.0	2.2	1.3	34.3	4.3	1834.4	2.7	0.0	2071.0	25.5	256.7	850.5	3124.6	0.0	17.5	0.0	0.0	59.8	221.1	15.4	0.3	0.0	2.9	50179.8	742.1	0.0	6.7	63.8	0.4	0.9	93.6	1.7	120.8	0.0	3889.3	343.9	0.0	0.0	5328.4	135.9	0.0	4.4	0.3	0.2	0.9	558.5	1.5	0.0	12.7
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 66.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 36.9;BJ hTERT+: 56.1;fHDF/TERT166: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.9	12.3	6.3	28.6	19.1	3.6	36.9	56.1	17.3	17.3	0.5	3.4	1.0	8.1	44.4	6.6	2.4	2.2	5.5	15.2	5.5	1.9	1.7	5.6	1.1	15.9	4.2	3.5	15.8	2.5	13.5	7.3	23.7	7.8	2.0	0.2	2.9	15.0	3.7	2.9	2.0	6.4	1.4	1.8	5.6	7.3	1.5	15.4	4.6	2.5	5.5	6.8	0.3	8.7	13.0	2.6	3.2	12.0	16.4	3.6	4.6	4.9	2.4	0.7	1.2	9.7	0.6	15.0	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0	3.0	4.6	1.4	4.2	6.5	14.6	6.3	20.4	16.0	10.3	66.3	9.8	8.7	0.0	10.3	0.3	11.2	0.7	0.0	3.3	3.5	23.9	4.3	1.1	6.8	10.3	25.4	6.4	20.9	4.9	0.7	21.3	8.3	21.9	9.0	2.7	20.1	3.0	5.7	47.7	14.7	1.5	25.8	20.6	0.7	0.9	5.8	2.3	0.7	2.6	2.5
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7"									"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.6	18.8	5.6	0.0	0.2	0.0	32.9	0.7	0.6	1.0	1.6	4.1	0.2	0.0	0.2	0.1	2.4	5.5	0.1	0.5	1.4	5.3	0.8	0.2	0.1	5.6	0.0	0.2	0.0	0.1	2.3	2.2	0.1	0.5	1.7	0.4	0.4	0.0	0.6	10.9	2.6	0.0	1.9	25.5	0.0	1.2	0.0	16.5	0.0	4.0	0.0	0.2	3.9	0.4	0.5	12.7	0.1	0.0	0.0	0.7	0.7	0.2	0.0	5.2	1.9	0.0	1.4	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5	3.0	1.4	0.5	0.2	3.4	0.0	1.1	0.0	1.4	0.0	0.0	0.0	14.3	1.7	0.0	2.6	9.0	135.7	0.0	0.2	47.1	2.1	0.2	5.7	25.0	105.8	0.0	2.9	13.5	1.0	0.4	1.1	1.1	5.0	0.0	2.9	0.9	0.1	35.1	0.4	4.5	0.2	0.0	1.4	0.9	3.4	0.4	31.5	0.8	0.8	0.1
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.1"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 417.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.5;Karpas-707: 24.0;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	3.6	6.1	19.2	8.8	17.2	5.9	9.3	21.1	26.8	12.9	3.8	12.5	2.5	3.0	21.8	5.5	7.6	14.1	6.0	59.1	23.1	14.6	11.8	5.1	6.5	14.5	21.6	15.9	22.0	7.3	10.4	8.4	6.4	17.0	11.1	4.3	4.7	7.1	5.3	8.3	1.9	6.7	18.2	15.0	10.9	5.4	12.3	19.4	7.3	5.4	1.9	15.8	6.5	8.1	31.8	38.8	5.5	3.4	7.9	16.1	7.1	2.2	0.7	2.8	5.0	4.3	5.6	1.1	3.5	6.4	11.8	14.0	5.7	0.5	27.5	3.9	2.2	5.7	0.2	8.4	2.7	4.7	21.2	3.5	4.9	2.2	5.1	3.3	6.7	2.6	3.7	1.3	7.2	6.3	2.4	1.9	11.9	7.3	24.0	3.4	3.1	8.8	3.7	1.7	1.6	1.1	5.0	4.7	10.5	4.1	0.9	2.2	1.9	2.2	0.2	2.6	4.9	11.4	1.9	0.4	4.1	2.1	1.3	2.0	7.6	6.9	23.0	4.5	5.5	6.8	5.5	2.9	2.3	12.4	3.4	16.1	30.4	11.8	12.4	5.5	31.8	11.7	14.1	0.9	7.9	0.9	38.8	13.3	7.1	19.2	17.2	21.1	26.8	23.1	14.6	21.6	15.9	17.0	19.4	44.7	11.3	104.3	16.5	8.8	97.4	417.4	7.6	24.1	17.0	47.1	17.7	9.4	132.6	5.9	6.1	17.6	2.0	46.7	5.4	2.6	28.3	31.2	18.5	22.1	23.1	81.0	9.2	20.3	11.1	6.2	22.2	13.9	20.3	111.0	15.6	19.2	6.3	4.9	29.7	39.1	14.1	25.8	38.7	35.6	21.3	4.6	2.4	54.8	2.9	5.7
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443111	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 47.0;BJ hTERT+ SV40 Large T+ RasG12V: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	8.0	7.5	7.8	7.2	10.2	7.3	6.3	2.1	14.6	13.6	6.3	5.9	3.4	5.4	13.2	9.6	23.9	10.4	11.2	9.8	7.7	8.4	10.4	5.0	8.3	4.6	7.3	15.8	9.8	6.3	5.2	8.4	7.1	8.5	9.1	6.5	7.2	28.4	5.7	2.9	4.3	7.1	8.5	5.6	8.0	7.3	3.9	5.3	9.0	5.9	7.6	7.8	7.2	13.8	3.6	2.7	4.5	6.4	5.6	13.4	4.2	2.6	1.7	0.1	0.3	0.1	1.6	0.5	0.3	8.8	47.0	35.0	0.1	3.3	0.0	0.6	0.8	7.6	1.0	4.3	2.2	3.1	5.3	0.9	2.4	1.5	0.2	1.5	4.3	1.7	2.1	0.5	3.6	0.1	2.8	1.3	2.0	0.0	0.6	1.0	1.5	2.0	1.3	0.6	2.3	0.9	1.3	0.0	0.1	3.2	3.2	0.1	1.1	3.2	1.1	5.2	2.4	1.9	0.8	0.4	0.6	0.9	0.1	0.8	0.1	0.0	0.0	2.1	1.0	2.1	4.4	3.1	4.5	6.7	3.1	13.4	3.6	9.4	6.5	2.7	2.7	7.5	5.1	1.9	5.6	6.4	0.3	11.8	4.2	7.8	10.2	2.1	14.6	7.7	8.4	7.3	15.8	8.5	5.3	11.9	8.8	2.4	4.4	2.5	11.4	10.6	5.1	16.0	10.3	5.2	15.7	4.9	0.0	6.6	0.9	8.4	5.2	0.0	15.0	1.3	3.7	8.2	5.7	2.1	4.3	1.6	1.7	4.3	3.7	1.3	4.0	2.2	5.0	4.6	2.9	4.3	9.1	3.1	5.3	3.6	1.0	6.5	2.0	0.5	1.1	1.0	2.1	7.7	1.7	6.2
HERC5	CEB1	ENSG00000138646	"HECT and RLD domain containing E3 ubiquitin protein ligase 5"	Q9UII4	4	88457117-88506163	"Predicted membrane proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.9"	"Cell type enriched"	"Detected in many"	9	"Spermatogonia: 510.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 32.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.1;SK-MEL-30: 19.3"					"Low region specificity"	"Detected in all"			HPA043929	Supported					NA	NA					"HPA043929: AB_10962492"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-1)"	12.3	4.8	4.1	6.8	6.1	11.6	6.6	1.2	4.0	9.8	5.2	4.0	2.6	2.8	19.1	5.9	3.1	6.0	4.2	3.5	4.2	3.4	5.1	6.8	6.0	11.3	3.9	3.7	13.3	8.7	8.9	7.4	7.6	5.3	7.8	1.9	4.5	7.7	4.4	2.9	2.5	4.7	9.9	5.3	8.0	4.4	48.9	4.1	13.2	5.9	1.5	5.2	7.3	8.7	5.2	5.8	18.1	6.0	5.6	19.5	3.7	2.5	1.2	0.7	0.1	0.1	0.3	10.0	0.2	3.8	32.6	45.1	0.3	7.0	0.1	1.7	0.0	14.8	0.5	4.8	0.7	2.8	15.9	3.0	4.2	4.7	0.1	0.3	5.0	2.0	0.3	0.2	8.1	0.0	1.7	0.2	8.6	0.1	10.1	0.6	0.3	15.5	6.2	2.7	0.1	0.8	15.6	12.9	0.6	0.5	0.6	0.2	4.2	5.3	0.1	19.3	8.8	0.4	2.8	0.1	0.4	0.1	0.1	2.0	14.0	12.2	0.1	3.1	3.7	0.3	7.7	5.2	8.0	6.0	6.0	6.6	5.2	6.8	4.9	1.9	3.7	4.3	3.7	18.1	5.6	5.2	5.8	19.5	3.7	4.1	6.1	1.2	4.0	4.2	3.4	3.9	3.7	5.3	4.1	0.0	0.3	2.7	4.4	3.5	2.3	1.7	5.1	1.4	1.2	1.8	17.7	19.2	19.9	2.4	56.1	18.6	0.3	0.0	4.3	9.4	4.0	6.3	2.3	5.5	13.0	0.0	0.0	8.6	7.0	12.8	9.2	9.9	6.8	2.8	0.4	9.2	4.2	2.9	8.5	6.9	2.5	19.4	8.0	51.1	510.0	1.6	10.0	8.6	0.1	1.6
PYURF	PreY	ENSG00000145337	"PIGY upstream reading frame"	Q96I23	4	88520985-88523813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036455	Uncertain		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA036455: AB_10673388"	"unprognostic (8.25e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	40.4	48.3	47.3	29.2	43.9	44.2	63.2	28.2	43.4	40.6	38.4	31.2	35.2	35.8	47.4	56.4	40.9	41.0	36.4	62.5	45.4	45.1	48.7	59.1	33.5	43.1	47.6	35.3	44.9	61.8	40.7	42.6	39.0	43.2	42.7	37.7	31.6	48.6	42.9	54.0	37.1	37.5	44.7	51.4	36.9	33.8	28.5	38.4	28.3	47.7	40.5	33.0	41.7	51.4	45.3	50.8	35.0	43.3	47.3	54.1	74.3	29.4	9.9	19.9	23.6	40.3	41.5	13.5	21.8	30.7	27.4	23.2	7.7	23.5	0.1	24.6	30.8	18.6	12.7	18.0	27.4	34.6	36.0	31.3	32.7	13.2	29.3	30.6	54.0	21.1	28.6	41.5	17.6	36.1	26.0	44.7	10.2	36.7	33.2	39.5	22.3	32.8	33.1	16.7	34.5	19.1	33.5	18.6	34.3	22.5	16.7	24.1	23.6	27.6	25.3	57.4	20.6	11.7	27.2	30.4	29.2	26.9	28.4	20.0	23.6	19.1	3.6	25.6	27.5	32.0	30.9	43.3	35.0	45.0	42.0	50.2	45.3	52.0	48.5	50.8	35.5	54.1	51.6	8.6	47.3	41.0	31.9	51.8	74.3	47.3	43.9	28.2	43.4	45.4	45.1	47.6	35.3	43.2	38.4	47.6	58.8	74.6	136.8	204.7	28.0	4.5	68.8	84.3	85.3	82.0	9.8	205.8	243.7	96.5	35.0	121.7	71.5	23.3	113.5	97.9	127.4	138.8	102.8	109.9	125.1	25.4	110.1	92.7	113.8	79.3	116.5	112.4	330.7	100.0	88.2	79.4	90.7	113.1	112.8	171.4	25.3	58.2	140.4	100.3	65.3	252.6	137.1	99.2	113.0	120.5
PIGY	MGC14156	ENSG00000255072	"Phosphatidylinositol glycan anchor biosynthesis class Y"	Q3MUY2	4	88521573-88521789	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	8	"blood: 38.4;intestine: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 6.5;GAMG: 12.0;hTEC/SVTERT24-B: 8.0;hTERT-RPE1: 6.5;JURKAT: 6.0;MOLT-4: 13.6;OE19: 23.5;SuSa: 6.6"									HPA059018	Uncertain					NA	NA					"HPA059018: AB_2683884"																		1.4	2.9	0.5	1.1	1.2	1.1	1.2	1.8	1.4	2.0	10.6			1.1	2.1	1.1	1.7	1.1	1.1	1.6	0.1	0.3	1.1	1.7	1.1	1.1	1.1		1.3	1.4	1.1	1.2	1.1		1.1	1.1		1.1	1.1	3.1	1.1	1.1	1.1	2.3	1.2	1.3	1.1			1.5		1.1	1.4	1.3	24.8	38.4	21.0	26.6	24.3	33.1	35.9	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	8.0	0.0	6.5	0.0	6.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	16.3	26.0	21.0	27.3	26.6	28.5	24.8	27.9	27.5	38.4	19.8	30.1	29.1	4.5	24.3	21.6	14.2	33.1	35.9											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC098582.1		ENSG00000285385			4	88523810-88649847	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.5;RPTEC TERT1: 3.4"															NA	NA																							1.4	0.1	2.4	2.5	3.3	2.8	2.4	2.8	6.3	0.9	0.4	3.3	1.3	0.1	1.1	3.2	0.7	2.2	0.3	0.7	1.4		1.3	0.5	1.3	0.6	0.8	3.5	1.3	0.1	0.1	8.8	1.0	4.8	1.3	2.0	2.2	2.4	1.5	3.1	0.8	0.9	1.1	3.0	2.0	0.1	1.8	1.7	0.0	3.6	0.1	0.7	0.7	0.5	0.9	0.0	0.0	0.2	0.6	2.8	0.7	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.7	0.0	1.9	0.0	1.1	0.0	0.5	1.4	1.2	0.4	0.0	0.0	0.0	0.9	0.0	1.4	0.0	0.6	0.9	0.0	0.0	0.9	1.3	0.0	4.5	1.4	1.4	0.2	1.2	0.9	0.0	0.0	1.0	0.3	0.0	0.1	0.6	1.1	0.4	0.4	3.4	0.0	0.0	1.7	0.0	0.4	0.1	1.1	0.5	0.0	0.0	0.6	0.7	0.0	1.9	2.3	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.4	0.3	1.4	0.3	0.0	0.9	2.8	1.5	0.0	0.6	0.2	0.0	0.7	0.7											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592423-88708542	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.6;hTERT-HME1: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039170	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favorable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	12.7	13.3	16.9	13.0	27.1	21.0	15.3	37.8	20.1	14.4	12.0	17.9	11.6	11.2	12.0	10.5	16.8	10.7	12.1	22.0	15.2	13.7	15.8	13.0	15.0	15.3	21.9	15.0	12.7	9.7	33.8	16.1	10.0	21.1	22.0	13.4	22.0	14.0	14.0	17.3	19.1	12.8	13.8	16.3	15.7	12.9	3.6	21.5	16.6	15.7	12.6	16.4	13.3	16.7	5.2	7.0	18.2	9.7	3.1	9.0	3.9	7.3	1.1	1.4	2.4	7.9	16.7	4.7	8.3	15.4	8.7	5.8	1.9	8.6	7.8	4.0	27.6	4.0	2.6	2.0	7.6	8.3	3.4	2.3	5.4	3.3	1.2	4.5	13.4	9.8	7.9	9.4	8.3	37.6	4.9	9.6	4.1	3.9	3.4	17.7	2.2	9.2	3.2	0.4	4.8	2.0	10.4	9.7	3.2	5.6	1.4	1.9	1.9	9.6	6.1	3.2	2.4	1.0	6.0	15.0	9.9	5.4	9.3	6.2	6.5	1.6	4.5	6.2	6.1	4.1	5.7	5.7	7.7	4.7	6.2	5.5	5.2	5.5	4.7	7.0	4.9	8.2	5.8	18.2	3.1	9.7	2.4	9.0	3.9	16.9	27.1	37.8	20.1	15.2	13.7	21.9	15.0	21.1	21.5	6.0	5.8	8.8	7.9	31.9	24.1	18.5	7.6	4.0	2.3	8.7	104.1	5.8	1.7	3.6	2.6	9.3	9.2	23.3	7.9	13.2	7.3	12.5	15.1	11.0	8.3	30.2	26.5	8.6	27.9	2.7	7.8	17.3	13.5	2.8	10.1	9.2	7.4	8.6	12.4	5.0	59.1	6.5	11.3	3.0	7.0	44.4	6.2	13.1	5.2	10.4
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695915-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 32.4;granulocytes: 31.1;Muller glia cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.5"	"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058227: AB_2683644"	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	7.3	21.8	24.5	3.6	23.3	4.9	4.9	25.8	53.4	6.2	3.1	4.2	2.1	1.9	6.4	10.5	4.1	4.9	5.4	5.6	23.9	52.8	6.1	5.0	3.1	3.0	28.4	33.6	8.2	2.8	7.9	12.9	4.7	35.6	6.7	3.1	3.6	2.5	8.7	1.8	1.7	2.4	6.4	11.5	3.5	2.8	4.9	5.4	0.5	9.3	1.3	2.4	5.2	2.0	0.7	0.9	0.6	0.8	1.5	3.9	1.0	0.0	1.1	7.3	4.4	10.7	6.9	0.0	7.8	4.8	4.0	6.3	0.0	0.9	0.0	3.2	4.5	1.7	1.5	12.9	3.1	7.3	2.4	0.0	13.5	4.7	1.1	9.3	6.9	8.9	10.8	1.0	4.7	0.7	5.2	7.1	7.6	3.8	0.0	11.8	0.1	8.5	0.5	3.0	3.7	0.0	4.6	2.1	0.8	2.7	3.3	9.7	29.5	0.0	1.4	5.7	8.2	0.0	2.0	5.1	4.6	1.1	2.9	3.9	2.0	0.0	0.0	9.8	0.0	3.5	0.0	0.2	0.4	3.9	0.4	2.6	0.0	1.9	3.0	0.9	0.7	3.5	3.3	0.6	1.5	0.8	0.7	1.7	1.0	24.5	23.3	25.8	41.9	23.9	52.8	28.4	33.6	35.6	5.4	3.0	7.0	2.4	3.4	1.5	32.4	4.8	0.0	1.4	6.8	5.2	13.7	12.6	13.3	1.7	0.6	5.4	0.0	0.0	2.2	1.6	8.5	2.9	31.1	2.9	4.8	14.3	16.6	10.4	0.0	0.4	10.0	1.2	5.0	2.8	1.4	32.8	1.0	0.2	17.0	3.4	17.3	19.4	9.8	5.6	2.1	1.3	18.5	7.9	0.9	1.7
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 111.2;Syncytiotrophoblasts: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.6"	"Low region specificity"	"Detected in all"							"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	58.6	10.8	9.1	11.0	9.3	6.5	19.0	17.9	18.5	15.5	41.0	3.7	7.4	30.5	10.9	12.0	9.3	14.8	10.7	8.8	9.6	5.7	14.0	22.9	13.3	5.3	10.0	6.8	17.8	23.5	45.5	11.2	20.7	11.4	15.9	9.3	11.5	13.3	8.0	8.4	17.5	30.5	15.6	19.4	4.9	13.4	11.1	12.9	3.2	20.4	16.1	4.0	30.4	23.8	0.1	5.7	1.4	6.5	0.7	5.2	2.6	2.4	3.7	5.6	7.3	32.6	13.5	9.2	5.8	7.0	2.3	2.1	3.1	5.8	0.1	2.3	4.1	3.6	1.5	8.2	4.1	5.2	0.3	5.7	4.1	5.2	0.4	9.6	3.4	0.5	12.9	3.4	5.8	2.1	10.1	3.9	1.4	10.6	0.4	4.9	0.1	0.3	1.5	6.9	0.4	3.9	5.6	9.5	2.2	4.2	12.2	14.2	3.8	1.4	4.5	5.4	5.8	3.1	0.1	1.4	6.5	3.6	3.1	3.3	2.0	1.1	0.0	9.6	0.3	3.3	0.1	6.5	0.1	1.8	3.2	1.3	0.1	4.7	0.6	5.7	0.1	5.2	1.3	1.4	0.7	1.0	1.9	2.5	2.6	9.1	9.3	17.9	18.5	9.6	5.7	10.0	6.8	11.4	12.9	11.9	27.5	3.7	19.8	9.0	19.2	22.7	22.9	81.7	46.6	10.4	33.4	57.4	24.9	8.6	2.3	12.5	34.9	0.0	14.6	29.6	23.6	13.3	1.1	111.2	17.5	0.0	4.7	8.0	29.1	2.4	41.7	12.6	18.6	4.6	37.9	26.9	31.2	63.3	31.5	34.7	10.7	0.0	24.2	4.8	6.1	6.8	233.8	6.4	14.6	16.6
TIGD2		ENSG00000180346	"Tigger transposable element derived 2"	Q4W5G0	4	89111500-89114899	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.1"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 20.3;Syncytiotrophoblasts: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054844, HPA071168"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA054844: AB_2682623, HPA071168: AB_2686353"	"unprognostic (7.11e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.47e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.94e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.02e-4)"	4.0	3.7	3.3	3.5	4.0	2.5	11.2	7.2	5.3	4.8	5.7	3.5	2.3	7.4	3.4	4.8	4.7	2.9	5.4	3.2	3.2	3.6	6.3	34.1	4.2	8.5	3.9	2.7	2.6	5.8	12.9	14.1	27.2	4.0	5.0	4.7	8.1	14.4	4.3	3.3	4.1	7.9	2.8	3.4	4.9	4.8	4.6	4.0	11.3	6.3	2.1	4.9	6.0	4.3	1.8	2.2	11.1	2.6	3.2	2.8	1.2	9.8	4.6	5.0	6.1	5.6	4.3	2.3	6.0	7.3	5.7	4.9	9.3	9.6	4.8	3.2	2.4	4.1	3.1	5.6	9.2	7.9	8.1	1.8	5.6	5.0	4.4	16.7	2.6	4.0	10.7	9.2	2.3	8.4	5.4	2.1	6.4	7.0	8.4	7.1	3.7	4.8	3.0	6.1	10.6	1.5	7.4	8.9	6.4	5.1	19.0	24.4	4.9	5.7	18.9	7.4	7.0	6.6	5.3	1.7	7.5	7.0	2.4	4.5	13.3	4.1	3.7	6.5	4.5	6.3	11.1	1.8	0.2	2.8	2.6	1.4	1.8	1.5	2.2	2.2	1.6	1.4	2.2	0.0	3.2	1.4	0.3	1.5	1.2	3.3	4.0	7.2	5.3	3.2	3.6	3.9	2.7	4.0	4.0	0.0	0.3	1.7	5.1	0.2	3.3	2.5	5.1	1.4	6.8	3.5	9.8	13.6	1.7	2.2	1.2	1.6	1.3	0.0	4.9	7.0	0.5	2.3	0.0	20.3	4.1	0.0	2.4	2.5	2.1	0.5	1.4	2.6	0.0	5.4	2.9	2.3	3.8	2.0	1.1	9.8	6.3	0.0	2.0	1.8	7.9	0.4	32.6	1.9	3.1	1.4
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236386-89308010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 75.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 53.1"	"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	7.0	1.8	4.0	11.5	9.1	8.9	3.2	41.0	5.0	3.5	7.2	2.8	0.0	8.4	2.3	1.7	1.8	2.1	5.6	5.4	3.6	4.1	5.5	2.8	11.2	12.7	4.1	3.1	4.8	7.0	1.1	12.4	1.4	6.5	2.1	9.8	6.4	2.9	1.0	2.1	1.6	7.0	2.0	6.0	12.9	4.7	1.1	6.2	5.3	2.9	1.4	10.5	4.5	2.4	0.3	1.5	0.1	2.2	2.9	6.6	1.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	12.1	0.1	0.0	12.6	0.2	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	5.7	0.0	0.2	0.0	0.0	0.1	0.5	0.0	4.8	1.7	6.6	0.3	4.7	3.7	1.5	0.1	1.9	1.9	0.1	2.9	2.2	0.0	5.3	1.4	4.0	9.1	41.0	5.0	3.6	4.1	4.1	3.1	6.5	6.2	0.0	19.9	3.7	0.7	1.0	9.4	14.6	5.1	1.4	9.1	3.5	0.0	0.1	1.7	1.1	0.1	3.6	9.6	0.0	8.2	0.0	2.3	0.2	7.0	0.0	18.9	25.4	75.7	2.5	26.9	0.0	0.3	31.5	1.7	5.4	25.1	0.8	1.7	5.8	1.1	1.8	10.3	77.6	8.2	0.1	0.1	0.9	0.2	34.6	21.8	0.3
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89724099-89838315	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.2;bone marrow: 91.0;brain: 121.3"	"Group enriched"	"Detected in many"	7	"Erythroid cells: 630.8;Melanocytes: 334.0"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 25.4;plasmacytoid DC: 31.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"HEL: 43.9;HUVEC TERT2: 53.5;RT4: 28.3;SK-MEL-30: 52.4;TIME: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		23000000			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	3.9	5.4	38.9	4.7	26.1	91.0	4.3	41.7	121.3	6.2	4.7	9.0	0.0	2.3	15.5	2.5	4.5	3.2	3.2	9.0	35.2	22.5	4.2	1.9	4.5	1.8	36.2	49.6	13.6	1.6	1.2	5.4	12.1	26.3	4.6	3.9	5.3	4.9	5.3	1.1	7.6	2.9	15.1	21.4	4.0	1.7	2.2	15.1	0.0	5.2	1.2	2.9	4.1	4.4	0.9	31.2	10.1	20.5	4.8	0.6	19.5	0.1	0.1	8.3	0.0	0.1	0.0	0.1	0.0	8.7	0.3	0.6	0.0	0.0	0.0	2.4	0.0	0.0	1.8	10.8	20.0	0.3	0.0	4.8	43.9	24.8	0.0	18.0	0.0	0.3	0.4	7.7	0.0	22.6	24.8	53.5	0.4	0.3	0.1	0.0	0.0	0.3	0.0	2.1	0.0	0.9	0.0	3.2	0.0	0.0	28.3	4.7	3.1	0.0	0.0	52.4	6.3	0.0	0.0	61.2	0.2	1.6	0.0	0.1	0.0	0.0	0.0	1.7	0.0	17.6	10.1	20.5	0.0	0.0	8.1	0.0	0.9	0.6	0.1	25.4	0.5	0.3	0.2	3.7	4.8	2.3	31.2	0.0	19.5	38.9	26.1	41.7	55.1	35.2	22.5	36.2	49.6	26.3	15.1	0.0	1.1	2.7	16.7	68.1	4.0	6.2	0.0	5.3	9.1	10.4	0.0	9.1	1.7	0.0	0.3	16.5	0.0	630.8	0.2	2.7	7.8	6.3	0.0	0.0	54.2	9.5	1.7	1.8	8.8	1.3	2.0	48.8	334.0	15.4	0.0	15.1	0.3	0.0	0.0	1.2	6.1	12.9	3.3	4.2	3.0	19.7	2.9	0.0	0.0	2.7
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 46.9;Ito cells: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NK-cell: 9.3;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.4;NK-cells: 9.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 168.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		300000000	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	13.9	1.9	1.4	5.3	1.4	0.5	14.8	0.7	1.3	22.8	14.9	0.1	9.0	2.6	9.2	12.2	17.4	18.1	11.5	4.9	1.6	1.3	3.3	9.5	22.4	30.7	2.6	0.0	10.2	2.2	0.1	1.3	38.1	2.7	10.0	8.1	3.7	3.3	2.4	6.8	6.5	10.1	14.2	3.4	1.6	5.3	16.7	2.1	2.3	43.1	7.0	3.7	19.6	30.4	0.8	3.4	0.1	0.0	9.3	0.3	1.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.1	9.3	0.0	3.4	0.3	1.7	1.4	1.4	0.7	1.3	1.6	1.3	2.6	0.0	2.7	2.1	0.0	11.8	6.1	0.1	3.8	0.0	2.0	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	11.8	46.9	0.0	0.0	0.0	0.0	1.5	0.1	2.3	0.8	0.4	0.0	0.0	114.2	6.3	3.2	0.3	2.5	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.7	0.0	4.0	0.0	0.0	0.0	0.1
CCSER1	"FAM190A, KIAA1680"	ENSG00000184305	"Coiled-coil serine rich protein 1"	Q9C0I3	4	90127535-91601913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0"	"Group enriched"	"Detected in many"	8	"Cone photoreceptor cells: 166.9;Early spermatids: 257.4;Late spermatids: 243.9;Rod photoreceptor cells: 81.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.0;myeloid DC: 1.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;OE19: 6.3;RT4: 3.2;SCLC-21H: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041880, HPA054709"	Uncertain					NA	NA					"HPA041880: AB_10796461, HPA054709: AB_2682581"	"unprognostic (4.03e-4)"	"unprognostic (4.21e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.64e-4)"	"unprognostic (6.94e-2)"	2.9	6.4	2.4	1.9	5.2	3.4	4.5	17.0	7.6	2.2	3.4	0.0	6.3	2.0	2.1	2.1	2.1	4.1	1.9	4.7	7.4	1.9	5.6	1.7	2.1	2.3	1.8	7.6	1.9	3.3	1.7	10.4	1.4	2.1	3.0	1.8	2.9	5.0	7.1	1.7	3.0	6.4	1.7	2.5	2.7	2.6	11.4	0.5	0.0	4.6	0.0	2.6	4.9	5.9	1.0	1.0	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.1	0.0	0.2	0.2	0.2	0.0	0.0	4.0	0.2	1.0	0.8	0.1	0.0	1.4	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.3	0.4	0.0	0.2	0.1	0.2	0.4	6.3	0.7	0.1	0.0	0.3	0.3	3.2	3.4	1.3	0.0	1.0	0.0	0.4	0.7	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.9	0.1	0.1	0.0	0.3	0.0	0.3	0.0	0.0	2.4	5.2	17.0	7.6	7.4	1.9	1.8	7.6	2.1	0.5	6.0	2.7	5.0	12.5	3.9	22.4	10.7	2.5	0.0	3.4	3.5	166.9	2.8	8.3	1.1	257.4	1.4	10.3	0.0	2.9	3.8	0.5	6.8	4.7	0.0	0.9	4.8	3.4	3.7	0.6	243.9	2.8	2.2	1.7	1.0	4.9	2.3	4.7	3.5	1.1	1.7	81.5	6.5	0.3	3.2	2.8	1.9	1.5	0.0	3.4	13.2
GRID2	"GluD2, GluR-delta-2"	ENSG00000152208	"Glutamate ionotropic receptor delta type subunit 2"	O43424	4	92303622-93810157	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 45.1;testis: 38.2"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 94.0;Early spermatids: 359.2;Late spermatids: 508.8;Muller glia cells: 141.0"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 12.9;U-266/70: 5.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 130.6"	"HPA056253, HPA058538"	Enhanced					NA	NA					"HPA056253: AB_2683079, HPA058538: AB_2683747"	"unprognostic (2.78e-1)"			"unprognostic (1.29e-4)"	"unprognostic (7.23e-3)"			"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.38e-3)"		0.6	3.5	8.0	0.6	13.6	0.6	0.6	45.1	7.0	1.1	0.7	2.8	0.0	0.8	0.7	0.9	0.6	0.9	0.6	0.7	6.2	3.4	0.8	0.6	0.7	0.6	7.6	6.4	3.7	0.6	0.6	0.3	0.6	7.2	0.6	0.7	0.6	0.6	0.9	0.6	0.6	0.8	0.6	9.0	0.7	0.6	38.2	7.9	0.0	0.7	0.0	0.6	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	12.9	0.0	0.0	5.8	0.0	0.6	0.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	13.6	45.1	7.0	6.2	3.4	7.6	6.4	7.2	7.9	0.0	0.0	0.0	0.0	0.0	94.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	359.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	27.0	0.0	0.0	0.0	508.8	4.6	0.0	0.0	0.0	0.0	141.0	0.0	0.0	1.1	0.0	3.9	6.5	0.7	3.4	2.0	0.0	0.0	0.0	0.0	0.0
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"intestine: 29.5"	"Cell type enriched"	"Detected in some"	36	"Mucus-secreting cells: 198.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HL-60: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.1	6.4	0.1	0.0	0.1	0.1	0.1	0.1	22.5	0.0	0.0	8.8	0.1	0.0	0.1	0.1	2.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	15.0	0.0	0.1	0.0	0.0	0.1	29.5	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.2	0.5	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	12.8	15.4	15.4	22.2	14.6	8.6	20.1	26.7	25.1	15.4	13.6	9.4	14.4	12.6	19.6	17.5	17.2	16.5	13.9	12.9	13.6	14.7	16.6	14.9	21.6	22.8	17.6	11.1	20.8	15.0	17.2	33.0	18.3	14.9	15.4	16.5	10.2	14.9	20.9	11.8	26.5	13.9	15.6	17.9	17.6	13.9	15.3	16.2	42.0	20.2	11.4	17.8	16.0	15.9	5.5	4.3	3.5	3.0	7.5	6.2	2.7	7.4	9.7	30.1	19.7	8.7	14.3	15.6	13.3	12.5	11.1	10.7	8.7	12.2	19.2	9.2	11.4	10.1	6.5	21.2	11.2	16.1	14.7	9.6	13.8	10.5	13.3	12.6	20.1	14.8	14.6	9.3	13.8	17.8	13.8	17.3	16.8	22.8	8.0	16.8	5.9	34.2	10.7	20.9	9.4	4.8	19.9	17.2	9.8	13.0	9.1	17.7	26.2	10.2	17.2	14.6	19.3	8.8	13.6	16.3	14.5	15.5	8.9	10.1	11.3	16.9	23.0	13.6	10.8	17.9	3.5	2.5	0.3	4.6	3.0	4.8	5.5	5.1	4.9	4.3	4.2	5.5	6.2	0.0	7.5	2.9	3.7	4.1	2.7	15.4	14.6	26.7	25.1	13.6	14.7	17.6	11.1	14.9	16.2	11.9	9.9	6.0	5.4	10.4	19.7	12.3	5.1	37.5	34.2	8.7	15.7	11.2	1.7	10.8	1.7	14.3	5.0	0.0	8.7	9.4	10.1	5.8	22.1	11.0	9.3	17.5	8.6	11.1	14.0	1.8	13.3	12.3	3.3	7.2	12.6	9.4	12.3	8.2	17.3	12.7	18.1	6.5	7.2	26.5	34.0	8.4	8.0	16.2	10.9	3.8
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 1000.1;Hofbauer cells: 476.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Group enriched"	"Detected in some"	8	"HEL: 32.4;HMC-1: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	2.5	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1	11.9	75.3	0.0	0.8	3.7	0.0	0.0	0.0	2.7	6.8	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	4.1	4.0	1000.1	0.0	476.4	0.0	6.8	0.0	3.9	0.0	0.3	14.5	3.3	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	4.6	4.6	0.0	0.0	0.1
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 129.6;skeletal muscle: 173.0"	"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1784.7"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 51.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		2200000	"Nucleoplasm, Plasma membrane, Focal adhesion sites"		"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11.0	3.7	7.1	5.6	37.5	12.9	14.0	10.2	11.0	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173.0	5.6	15.8	22.1	4.9	7.0	5.6	5.5	3.7	1.0	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.2	24.4	9.5	3.7	21.0	14.4	3.7	20.1	16.7	11.5	9.3	22.5	18.3	3.3	20.6	20.1	5.9	8.5	12.9	18.8	19.3	5.8	5.4	12.0	15.9	8.5	30.3	3.9	10.8	19.3	16.6	27.6	21.5	51.4	25.9	3.4	5.1	3.6	24.5	8.1	4.0	1.3	3.2	18.1	10.2	1.9	7.0	2.9	12.9	26.4	4.7	6.3	11.0	25.1	5.6	8.0	2.9	1.2	32.4	30.1	4.8	13.0	12.2	2.5	3.2	3.3	16.4	2.8	7.0	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7	41.7	23.4	12.7	232.1	172.6	4.3	1784.7	58.6	30.8	37.5	47.1	29.5	9.2	11.6	82.1	14.6	128.1	146.3	23.3	81.9	91.7	90.4	234.4	50.8	159.4	34.4	1.6	105.0	135.1	57.1	6.8	38.3	60.2	59.1	29.7	89.1	79.1	115.5	83.5	62.6	63.8	35.6	77.6	141.3	13.2	30.2	137.1	19.9	15.0	51.0	185.7
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 14.7;Club cells: 22.7;Collecting duct cells: 57.6;Glandular cells: 28.8;Intestinal endocrine cells: 17.6;Melanocytes: 27.0;Muller glia cells: 44.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.7;MCF7: 9.4;SH-SY5Y: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.7	5.0	0.0	2.0	4.6	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	0.0	1.0	2.9	6.9	0.0	0.0	4.6	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.6	2.8	5.7	0.3	0.0	0.0	0.0	0.0	7.2	9.4	0.6	0.1	1.8	0.1	3.2	0.1	2.8	0.1	3.6	0.1	0.2	15.6	0.2	2.5	2.5	0.7	1.9	0.0	0.0	4.0	3.2	0.1	3.4	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2	6.0	0.0	0.0	1.3	2.4	0.2	3.6	5.1	14.7	22.7	57.6	0.0	0.0	1.7	2.9	1.1	0.3	0.0	0.0	0.3	0.2	1.4	28.8	0.0	0.0	0.1	0.0	17.6	4.9	0.0	1.6	2.8	0.3	27.0	0.0	0.0	44.8	0.7	0.0	3.5	0.0	1.2	0.0	1.4	1.6	1.3	1.9	0.0	0.0	0.0	1.0
UNC5C		ENSG00000182168	"Unc-5 netrin receptor C"	O95185	4	95162504-95549206	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3"	"Group enriched"	"Detected in some"	7	"Leydig cells: 19.5;Paneth cells: 11.5;Peritubular cells: 11.0;Rod photoreceptor cells: 10.3;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		230000				"unprognostic (1.55e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.70e-5)"	"unprognostic (1.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.62e-4)"	3.2	17.4	13.5	2.4	16.2	0.7	3.2	4.7	14.2	4.2	5.9	31.3	1.8	3.0	5.1	4.1	1.9	4.3	4.4	5.8	10.7	7.3	2.9	2.6	5.0	1.5	13.7	10.8	6.2	1.3	1.0	2.6	3.8	19.6	7.2	7.0	6.4	11.4	8.3	0.8	1.0	4.0	5.1	13.1	7.9	4.4	5.3	19.9	0.0	22.7	0.0	1.3	4.7	7.9	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	0.1	2.7	0.1	6.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.0	4.6	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	13.5	16.2	4.7	14.2	10.7	7.3	13.7	10.8	19.6	19.9	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.1	1.5	0.2	0.0	0.0	1.4	0.0	1.2	0.6	0.0	0.2	19.5	0.0	1.7	0.0	0.2	1.4	0.0	11.5	11.0	0.0	10.3	6.5	1.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 alpha 2 subunit"	P29803	4	95840019-95841474	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 60.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 311.1;Late spermatids: 202.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	311.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	45.9	1.6	0.0	0.0	0.0	0.0	0.0
STPG2	"C4orf37, MGC46496"	ENSG00000163116	"Sperm tail PG-rich repeat containing 2"	Q8N412	4	97184093-98143240	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.0;testis: 11.1"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 5.9;Distal tubular cells: 3.3;Spermatocytes: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.1;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;SuSa: 2.4;U-266/70: 2.1"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.59e-3)"	"unprognostic (8.87e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.55e-3)"	"unprognostic (5.78e-2)"	1.0	1.5	2.5	1.2	5.3	0.8	2.9	1.9	2.5	1.3	0.9	4.5	3.7	1.3	0.9	3.9	1.0	1.8	1.3	1.0	1.8	1.4	3.5	1.9	1.7	1.3	3.7	1.5	1.6	2.1	2.1	17.0	1.7	3.8	1.4	1.2	1.7	1.5	5.8	0.6	1.7	1.1	0.7	2.3	1.5	1.3	11.1	3.4	0.4	3.0	0.0	1.0	1.4	1.2	1.1	1.3	0.0	0.0	0.5	0.3	0.0	0.2	0.3	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.6	0.0	1.2	0.1	0.3	0.3	1.1	0.6	0.1	0.8	0.0	0.0	1.8	0.8	0.6	0.0	0.0	0.1	0.6	0.0	0.6	0.0	0.5	0.4	0.0	0.0	0.2	0.9	0.4	0.3	0.2	0.7	0.4	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.3	0.2	0.4	0.7	2.4	0.5	0.6	0.0	0.2	0.3	0.0	0.1	2.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	2.5	5.3	1.9	2.5	1.8	1.4	3.7	1.5	3.8	3.4	0.0	0.0	0.0	0.4	0.0	0.8	0.3	0.0	0.0	0.0	0.0	5.9	0.0	3.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.7	1.5	0.0	0.0	2.6	0.9	0.0	0.1	0.0	0.0	0.1
RAP1GDS1	SmgGDS	ENSG00000138698	"Rap1 GTPase-GDP dissociation stimulator 1"	P52306	4	98261384-98443861	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 332.5;Late spermatids: 174.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019060	Approved		Supported	Cytosol		NA	NA		120000	Cytosol		"HPA019060: AB_1856068"	"unprognostic (8.12e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.44e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.60e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (7.11e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	11.3	9.7	25.8	12.9	28.2	9.0	13.1	28.0	43.6	9.3	12.0	20.0	9.0	7.3	8.9	8.7	13.7	6.1	8.6	6.8	29.7	28.0	12.3	15.2	10.1	15.3	36.9	20.5	7.9	13.8	8.4	15.3	9.6	30.1	8.0	14.0	8.0	8.6	11.9	3.6	10.5	9.0	16.3	37.0	12.5	8.2	15.5	26.2	16.2	13.0	4.8	17.0	12.5	7.6	13.9	31.9	16.0	14.7	19.5	22.7	8.4	17.9	10.5	13.4	11.5	17.3	20.7	5.4	30.6	17.0	18.3	14.4	7.8	23.3	21.3	10.0	22.8	8.9	10.3	16.5	28.0	24.8	21.8	6.8	13.2	13.5	10.2	34.3	21.9	9.2	24.1	17.1	16.1	25.0	15.2	23.9	21.9	8.7	18.3	45.2	9.4	36.2	10.9	4.9	14.7	7.6	15.1	8.0	7.2	18.6	14.1	19.9	12.1	12.8	28.8	16.9	7.7	6.5	14.3	23.5	19.0	13.6	8.7	18.1	6.3	11.0	18.0	15.7	16.5	24.6	16.0	10.6	5.7	14.2	14.6	14.3	13.9	14.5	13.6	16.7	11.0	7.8	11.9	1.6	19.5	14.7	31.9	22.7	8.4	25.8	28.2	28.0	30.5	29.7	28.0	36.9	20.5	30.1	26.2	14.9	9.8	23.0	8.8	12.4	41.4	10.1	20.4	5.3	15.9	15.7	47.1	5.8	19.9	16.8	332.5	13.5	11.1	23.3	18.3	13.9	11.6	11.1	15.0	16.3	22.1	14.3	20.1	16.0	29.4	174.5	8.6	23.3	16.9	29.7	13.9	15.6	19.2	16.7	10.3	15.9	66.0	0.0	11.8	14.6	22.5	14.6	3.8	30.8	17.4	12.8
TSPAN5	"NET-4, TM4SF9, Tspan-5"	ENSG00000168785	"Tetraspanin 5"	P62079	4	98470367-98658629	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5;ovary: 38.2"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 104.9;Intestinal endocrine cells: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"B-cells: 2.5;NK-cells: 4.5;T-cells: 6.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.7;BJ hTERT+: 35.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.83e-5)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.23e-1)"	1.9	1.5	14.1	3.1	17.1	7.0	12.7	47.5	37.5	11.8	3.8	20.9	2.1	1.6	13.4	23.4	10.4	4.9	4.3	2.9	15.5	10.1	4.4	0.9	3.7	7.4	13.7	13.8	38.2	1.0	0.9	5.7	6.3	17.3	4.7	3.5	8.6	7.9	7.5	2.6	15.3	2.4	13.2	16.7	7.5	7.2	9.7	13.9	5.7	14.8	2.9	7.2	4.9	5.9	2.5	0.1	0.1	0.0	4.5	6.9	1.2	7.7	3.1	3.2	0.2	12.3	36.7	1.1	32.2	35.1	11.6	14.3	2.7	4.2	0.0	0.3	11.4	6.3	2.0	2.7	15.0	26.1	9.6	1.5	4.7	0.4	0.1	12.7	2.6	0.2	20.9	0.4	21.3	26.4	17.9	18.7	3.2	1.8	8.4	27.7	0.2	7.9	0.0	2.1	6.6	14.3	2.4	3.0	1.1	1.0	2.3	22.8	4.3	0.5	10.2	0.0	1.1	0.3	0.4	19.1	24.4	11.0	8.7	11.2	5.9	8.7	0.0	9.5	6.3	8.3	0.0	0.0	0.0	4.6	0.0	5.0	1.3	6.4	6.4	0.1	2.5	3.2	2.2	0.1	4.5	0.0	0.0	6.9	1.2	14.1	17.1	47.5	24.9	15.5	10.1	13.7	13.8	17.3	13.9	20.8	7.8	5.0	13.2	19.6	43.8	1.7	0.0	0.0	6.8	27.9	25.5	1.1	5.0	2.5	64.2	10.1	0.5	46.7	6.5	0.8	16.0	33.6	2.3	1.0	1.9	104.9	77.7	6.7	2.7	68.0	42.6	2.8	27.0	0.0	4.4	20.5	15.7	0.0	15.9	0.3	39.0	6.5	15.9	3.7	6.3	50.4	2.4	20.8	2.5	44.4
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98871684-98930637	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 945.1;Late spermatids: 1606.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004077, CAB016316, HPA068358"	Supported		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		580000	"Cytosol, Cytoplasmic bodies"	Nucleoplasm	"CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	22.3	26.8	25.7	20.1	35.3	25.2	23.1	40.8	38.4	21.4	27.2	23.3	19.1	19.8	21.7	21.4	39.6	19.9	18.8	23.0	26.0	29.9	29.3	26.2	18.8	24.4	27.7	28.4	18.8	16.1	24.7	25.6	21.8	35.3	19.9	33.2	15.4	23.2	21.0	29.8	19.1	19.5	24.8	31.0	19.4	20.6	39.1	23.4	22.4	33.4	27.1	34.2	22.1	24.2	31.3	25.4	36.6	32.0	32.6	32.2	30.0	25.8	22.7	38.7	25.7	22.0	23.2	23.2	49.3	30.9	40.8	30.7	30.4	32.7	52.4	15.9	30.3	25.5	13.1	53.2	37.0	49.9	34.5	15.5	35.6	15.8	27.7	19.0	51.2	27.0	16.5	23.7	31.4	24.9	23.4	31.3	26.3	59.2	24.5	36.1	22.2	47.4	19.8	30.4	50.5	21.1	30.0	26.2	23.3	35.9	23.0	32.8	21.6	22.9	48.8	15.9	27.2	23.8	20.2	23.0	29.5	31.7	26.5	39.7	18.3	46.5	47.4	26.4	26.3	33.4	23.3	22.3	36.6	26.3	25.9	30.5	31.3	29.2	27.0	25.4	26.9	32.2	31.9	16.2	32.6	32.0	21.4	28.7	30.0	25.7	35.3	40.8	38.4	26.0	29.9	27.7	28.4	35.3	23.4	29.8	42.3	104.6	137.6	321.7	85.9	22.3	43.3	40.2	38.7	57.6	33.4	94.3	217.2	77.3	945.1	55.4	92.4	93.5	59.1	125.0	82.5	155.3	50.7	67.4	112.0	81.0	62.0	39.3	59.2	1606.7	46.9	94.3	183.9	85.6	57.3	60.6	65.2	66.6	46.3	112.9	57.1	51.8	118.5	94.7	83.0	324.2	99.5	64.2	72.3	177.8
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 345.0;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.3	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.3	12.5	25.2	16.0	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.9	16.3	38.9	24.2	17.3	22.8	22.7	24.1	20.8	21.9	18.3	22.5	19.5	28.5	16.6	34.1	18.6	23.2	37.1	17.5	22.4	29.5	17.2	42.9	28.2	25.9	15.3	10.4	32.4	12.3	22.1	12.4	14.9	17.8	21.6	27.5	19.8	27.2	14.2	19.9	25.5	18.6	20.0	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1	38.7	10.5	13.7	44.1	37.7	4.6	49.8	20.4	18.7	17.0	14.0	2.0	22.0	11.6	26.9	345.0	13.5	29.0	0.0	25.4	55.9	12.3	21.8	3.5	16.4	15.6	3.2	7.5	16.5	19.6	1171.9	17.8	14.6	15.1	6.4	25.2	8.3	22.3	34.2	21.2	22.9	3.5	25.8	22.1	15.1	46.4	33.9	6.4	15.2	32.6	39.6
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
C4orf17	DKFZP434G072	ENSG00000138813	"Chromosome 4 open reading frame 17"	Q53FE4	4	99511004-99542303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	115	"testis: 31.8"	"Cell type enriched"	"Detected in some"	48	"Early spermatids: 129.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HHSteC: 2.0"					"Low region specificity"	"Detected in all"			"HPA060374, HPA060564"	Uncertain					NA	NA					"HPA060374: AB_2684268, HPA060564: AB_2684319"																"unprognostic (1.34e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 76.6;Spermatogonia: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.7	4.8	9.3	4.8	5.5	7.8	6.7	8.2	3.2	5.8	4.3	3.9	8.4	9.3	3.2	4.8	5.2	3.9	10.8	5.2	8.9	11.8	4.8	6.4	4.1	6.4	5.3	16.2	6.9	4.9	13.4	5.8	12.7	3.4	5.8	8.5	14.7	8.4	4.9	7.8	13.6	3.3	5.5	12.1	4.6	7.9	8.9	5.9	7.8	5.5	5.8	5.1	4.5	24.9	8.2	8.1	8.1	7.0	4.2	5.9	6.1	4.8	9.3	5.8	9.8	8.5	4.5	9.5	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1	3.0	9.3	6.0	5.1	7.2	4.6	5.9	12.7	20.1	4.5	10.4	3.9	14.6	36.5	11.9	34.0	6.7	10.7	0.0	16.6	14.7	5.4	5.0	8.1	24.2	7.1	4.8	6.9	9.2	7.9	11.7	6.1	4.7	5.0	5.4	9.8	7.8	14.8	11.0	7.1	17.0	5.9	12.9	7.1	76.6	51.2	8.3	14.6	4.8	9.6	5.9
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99563761-99623999	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"intestine: 211.4;liver: 60.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 201.1"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Group enriched"	"Detected in some"	6	"AF22: 12.8;Hep G2: 14.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		450000	Cytosol		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.1	0.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.0	53.2	0.2	0.1	53.4	0.0	0.0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0.0	0.4	0.1	1.1	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.2	0.3	0.1	14.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.3	0.2	1.3	0.0	0.0	0.8	1.0	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.6	0.0	0.0	1.8	0.0	0.1	0.0	0.0	25.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	201.1	0.1	0.0	0.0	5.5	3.3	7.9	0.9	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	18.6	0.0	6.5	0.0	21.9	1.5	0.0	0.0	0.0	0.0	0.0
AC083902.2		ENSG00000248713	"Homo sapiens uncharacterized LOC285556 (LOC285556), mRNA."		4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 40.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 5.5;SK-BR-3: 3.6;SK-MEL-30: 2.0;WM-115: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.2	0.0	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	40.9	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.1	0.7	6.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DAPP1	BAM32	ENSG00000070190	"Dual adaptor of phosphotyrosine and 3-phosphoinositides 1"	Q9UN19	4	99816833-99870154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.0;lymphoid tissue: 45.6"	"Cell type enhanced"	"Detected in many"	17	"monocytes: 322.0;Urothelial cells: 169.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 14.0;HDLM-2: 32.3;RPMI-8226: 35.0;SK-BR-3: 15.1;U-698: 24.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033822, HPA046074"	Approved					NA	NA		29000			"CAB033822: AB_2245677, HPA046074: AB_2679525"	"unprognostic (9.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.60e-2)"	3.1	1.0	1.3	22.0	2.8	8.8	2.1	0.6	1.7	7.1	3.0	1.8	0.0	0.8	9.7	2.9	29.3	3.4	8.7	1.0	1.0	1.0	1.6	1.1	6.4	20.3	3.1	0.5	1.5	0.9	0.0	1.0	13.4	1.9	3.6	1.9	1.0	9.5	0.3	1.2	10.0	6.4	9.7	5.6	20.3	3.7	0.7	2.4	12.9	1.1	17.4	45.6	8.9	12.0	36.4	29.0	51.0	27.0	6.3	8.7	21.6	11.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	11.8	12.4	0.1	0.0	0.0	6.6	0.0	14.0	0.0	32.3	0.0	12.1	0.0	0.0	0.0	4.7	0.5	0.0	6.0	0.0	4.6	0.0	0.0	0.6	0.6	11.7	0.0	0.1	0.0	2.8	0.0	0.0	0.2	0.1	0.0	35.0	2.3	9.7	0.0	0.0	0.0	15.1	0.0	0.1	0.2	4.7	0.0	0.0	0.2	0.0	0.0	4.2	1.7	24.8	0.0	3.1	0.0	6.8	27.0	24.8	0.9	22.4	0.9	33.9	4.4	1.5	29.0	36.4	4.9	1.7	51.0	6.3	20.2	12.6	8.7	21.6	1.3	2.8	0.6	1.7	1.0	1.0	3.1	0.5	1.9	2.4	3.0	4.8	61.4	19.8	55.0	0.0	0.4	2.5	46.8	10.3	8.7	0.0	0.8	0.0	4.3	0.1	0.1	1.3	0.0	2.7	11.9	1.4	20.7	8.1	0.2	22.3	0.0	1.2	0.6	36.9	0.4	0.0	39.3	11.8	322.0	2.2	0.0	12.0	3.1	0.0	0.0	0.1	0.0	1.6	0.0	0.4	61.5	2.9	7.5	1.4	169.6
LAMTOR3	"MAP2K1IP1, MAPBP, MAPKSP1, MP1, Ragulator3"	ENSG00000109270	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3"	Q9UHA4	4	99878336-99894490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026858	Supported					NA	NA		16000000			"HPA026858: AB_1853523"	"unprognostic (7.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.75e-9)"	"unprognostic (5.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-2)"	20.1	24.2	29.4	14.1	26.5	25.4	23.2	24.3	34.3	24.7	22.1	15.0	17.8	20.8	22.1	37.9	32.2	18.2	17.9	21.0	26.4	30.6	42.9	21.6	17.1	16.5	26.7	23.9	23.5	19.5	21.7	32.7	27.0	34.6	26.7	24.2	21.1	21.6	18.0	17.0	21.3	31.3	20.0	19.8	20.8	18.7	14.6	20.5	17.3	33.5	25.0	18.2	27.2	22.9	5.8	9.9	30.6	13.8	9.7	8.3	6.8	10.4	3.4	14.5	9.4	20.1	19.6	11.1	10.2	10.0	10.0	8.3	7.8	21.0	9.1	10.4	10.4	9.7	5.0	14.1	12.9	14.1	10.7	7.7	6.2	7.3	14.9	19.5	18.6	18.6	12.9	26.6	7.5	8.5	14.8	11.1	6.9	15.7	11.3	18.9	10.7	15.6	18.3	8.8	22.5	5.7	10.6	8.1	10.1	29.5	12.1	11.0	13.8	6.5	21.8	20.8	15.3	11.2	15.6	11.0	7.8	9.2	13.1	7.8	14.4	15.4	17.7	16.5	10.8	11.1	17.3	9.8	19.3	5.6	13.7	7.3	5.8	7.0	6.3	9.9	4.9	8.3	8.2	30.6	9.7	13.8	7.0	6.9	6.8	29.4	26.5	24.3	34.3	26.4	30.6	26.7	23.9	34.6	20.5	53.6	28.9	24.9	53.4	44.1	23.9	30.7	28.1	24.1	20.5	33.2	11.8	41.4	114.4	48.5	5.4	27.0	61.0	23.3	28.4	46.4	33.6	54.9	40.5	23.1	66.5	17.5	34.7	19.6	37.7	7.5	37.2	55.1	35.4	65.9	45.9	38.9	35.5	59.6	40.0	105.4	22.5	19.4	28.8	51.7	30.9	56.6	65.6	26.1	35.2	63.3
DNAJB14	FLJ14281	ENSG00000164031	"DnaJ heat shock protein family (Hsp40) member B14"	Q8TBM8	4	99896248-99946726	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036016	Approved					NA	NA					"HPA036016: AB_10670594"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.12e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	14.2	13.5	21.9	9.9	25.5	17.0	13.4	21.3	28.5	13.1	14.9	7.7	10.6	10.2	14.2	12.7	11.2	11.0	11.6	9.5	18.0	18.4	15.6	12.2	13.5	15.4	15.8	24.0	14.2	9.7	18.6	22.7	18.2	30.5	14.0	11.2	8.3	11.0	12.4	6.0	11.3	13.3	13.0	16.7	15.0	13.0	4.7	15.2	11.5	19.6	5.5	11.8	13.1	12.0	15.9	14.8	25.8	22.4	15.0	19.5	13.0	8.0	21.3	7.2	8.0	13.3	14.1	7.1	20.4	12.0	6.5	5.9	14.4	19.1	7.5	11.6	8.6	4.2	6.8	5.3	9.0	10.5	19.6	6.2	12.6	13.0	11.7	11.7	10.6	19.4	11.6	10.4	7.0	7.0	11.3	12.6	8.5	11.0	11.0	14.7	16.7	12.7	6.3	4.0	5.1	9.7	12.0	8.3	6.7	11.8	16.4	4.1	9.4	11.0	16.0	10.6	6.7	9.0	5.1	18.2	11.5	9.9	8.1	6.8	13.8	29.5	9.9	9.5	4.6	13.7	25.8	14.8	16.7	19.5	16.3	17.6	15.9	15.8	17.7	12.8	15.7	18.5	16.6	22.4	15.0	22.4	14.8	18.6	13.0	21.9	25.5	21.3	28.5	18.0	18.4	15.8	24.0	30.5	15.2	59.6	51.0	31.7	47.7	40.1	88.5	22.0	33.1	21.4	48.9	38.4	51.1	37.7	28.2	25.8	3.0	48.5	34.0	0.0	26.3	24.5	38.4	52.7	39.4	26.0	27.0	104.9	34.0	46.6	48.1	3.2	46.1	51.3	42.2	51.3	28.1	59.0	26.9	22.9	50.2	35.3	90.6	25.8	44.0	16.7	10.5	32.2	40.3	66.0	23.4	46.6
H2AFZ	"H2A.Z, H2AZ"	ENSG00000164032	"H2A histone family member Z"	P0C0S5	4	99948086-99950388	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 1666.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB022549: , HPA057236: AB_2683377"	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	23.5	22.5	28.9	40.7	40.4	113.9	31.1	39.5	38.0	26.3	45.0	13.9	26.9	33.2	40.4	23.1	53.5	24.0	27.9	32.1	28.6	28.1	37.1	26.9	32.4	70.6	32.9	26.2	32.6	19.8	14.5	30.3	32.0	26.1	30.2	43.2	29.5	29.4	27.2	28.3	30.1	34.0	46.2	26.7	46.1	37.4	32.2	31.3	139.8	29.7	47.9	81.0	51.6	29.9	46.7	54.1	139.3	87.0	41.3	80.9	120.4	86.8	61.2	127.7	65.7	26.4	22.3	42.0	92.3	66.6	95.4	89.9	62.8	101.6	154.7	33.6	46.9	63.9	31.7	111.5	90.0	103.5	67.9	77.6	79.3	72.4	71.2	15.9	141.2	66.9	17.5	39.4	73.4	41.2	27.5	94.0	94.3	78.0	94.3	108.8	120.7	116.9	117.5	73.7	98.6	58.7	100.9	93.5	64.7	53.0	52.9	83.3	64.3	57.0	108.9	106.4	45.4	55.6	109.4	49.1	61.6	117.5	42.1	117.8	54.5	80.5	184.7	69.0	94.5	96.4	61.8	63.2	120.2	38.1	68.7	42.2	46.7	60.5	49.8	54.1	39.3	56.9	47.2	139.3	41.3	87.0	36.1	80.9	120.4	28.9	40.4	39.5	38.0	28.6	28.1	32.9	26.2	26.1	31.3	59.6	72.1	223.6	636.0	1666.4	166.9	102.6	150.3	116.4	97.8	188.5	51.1	382.0	321.7	310.6	14.8	301.1	184.6	210.2	358.1	1168.3	589.6	472.9	172.9	101.8	614.7	60.4	273.0	216.0	285.6	36.7	187.6	455.0	843.5	1029.8	227.7	128.4	329.3	211.3	212.2	354.3	185.1	187.5	662.3	476.9	167.0	1432.4	337.2	318.1	419.3	624.2
DDIT4L	"REDD2, Rtp801L"	ENSG00000145358	"DNA damage inducible transcript 4 like"	Q96D03	4	100185870-100190782	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 106.4"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 21.0;Distal tubular cells: 18.3;Extravillous trophoblasts: 14.7;Sertoli cells: 19.4;Smooth muscle cells: 16.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.9;BJ: 18.8;fHDF/TERT166: 10.2;HSkMC: 9.8;hTERT-RPE1: 21.5;RPTEC TERT1: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050903			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA050903: "	"unprognostic (2.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.66e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.53e-5)"	"unprognostic (4.99e-3)"	1.4	0.5	1.5	0.3	6.3	0.3	0.6	2.0	1.6	7.9	0.6	1.7	0.0	0.2	0.9	3.0	2.6	0.9	0.3	3.5	2.1	0.7	6.2	0.2	0.4	0.3	1.5	1.6	2.8	0.2	0.3	1.2	1.3	2.7	3.8	0.5	5.2	6.3	2.6	106.4	0.4	0.3	0.8	2.4	0.5	0.2	1.1	1.7	0.0	0.6	18.6	1.2	0.5	0.9	0.2	0.0	0.0	0.2	0.0	2.0	0.2	0.0	1.4	5.5	0.0	2.5	12.9	0.8	18.8	1.6	0.3	0.1	0.1	0.5	0.0	0.4	10.2	0.4	0.0	3.9	0.3	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	9.8	0.1	0.2	1.0	21.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.0	0.0	13.4	0.0	0.0	0.0	0.3	0.7	2.5	1.4	0.0	0.0	0.1	0.0	0.0	0.0	1.4	2.5	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	1.0	0.2	1.5	6.3	2.0	1.6	2.1	0.7	1.5	1.6	2.7	1.7	0.0	0.0	0.0	0.1	2.4	0.0	4.7	0.0	0.0	0.0	21.0	0.0	1.7	18.3	0.1	0.6	1.5	0.0	0.0	0.0	14.7	5.0	0.8	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	6.8	0.0	0.0	8.3	0.5	0.0	2.1	1.3	0.0	19.4	16.0	0.7	0.1	1.3	3.3	0.0	0.0	0.1
EMCN	MUC14	ENSG00000164035	Endomucin	Q9ULC0	4	100395341-100880126	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Endothelial cells: 203.6;Ito cells: 143.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005928	Approved				"Intracellular and membrane"	NA	NA					"HPA005928: AB_1078735"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (3.65e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.75e-2)"	26.3	10.8	3.1	6.2	7.5	0.1	24.0	3.8	6.8	26.4	9.7	1.4	13.1	3.5	28.2	19.7	16.3	10.4	16.4	31.5	4.2	3.9	45.5	4.6	25.1	5.3	5.4	3.5	12.9	3.3	8.3	10.5	0.4	6.7	17.1	4.3	19.8	5.8	16.5	16.8	6.1	5.5	20.4	9.1	1.9	5.5	7.3	3.5	1.0	28.1	20.9	2.5	23.5	21.7	0.2	0.1	1.6	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	26.5	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.6	0.2	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.7	1.2	0.4	0.1	0.0	0.0	3.1	7.5	3.8	6.8	4.2	3.9	5.4	3.5	6.7	3.5	6.0	8.9	0.9	0.4	14.7	0.0	9.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	203.6	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.6	0.2	0.0	0.0	143.6	8.2	0.9	1.1	1.7	15.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	13.2	0.2	0.2	12.8	0.2	0.0	0.0	0.6
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.5	21.6	16.4	7.4	21.5	19.8	8.7	9.2	8.0	24.4	9.3	9.0	19.4	10.8	9.8	13.9	28.6	14.8	22.7	6.4	14.7	19.8	10.2	15.9	23.6	7.5	17.0	15.0	19.0	21.8	16.6	16.3	6.0	5.7	25.6	13.9	23.4	4.9	17.7	6.4	22.5	9.0	9.0	35.0	10.7	8.4	15.4	30.4	11.5	17.7	15.2	10.3	5.5	13.6	13.5	19.0	20.6	23.5	18.8	14.2	12.0	12.2	16.4	11.4	13.4	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0	71.5	48.8	59.1	33.3	149.9	74.7	24.1	33.1	32.1	20.5	29.6	37.3	28.9	28.2	18.2	1.8	105.6	33.9	0.0	27.3	76.5	53.9	157.6	33.6	37.0	32.1	17.5	122.2	43.6	52.2	4.7	60.1	49.5	87.7	44.1	39.6	19.3	41.1	107.8	57.3	31.7	81.9	12.9	39.4	7.2	22.1	150.4	23.0	55.4	39.9	32.0
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0"	"Cell type enriched"	"Detected in many"	6	"B-cells: 268.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	15	"memory B-cell: 61.4;naive B-cell: 46.2"	"Lineage enriched"	"Detected in many"	17	"B-cells: 61.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.4;HEL: 8.1;HL-60: 7.3;U-266/70: 25.0"	"Low region specificity"	"Detected in many"							HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	3.3	2.9	0.7	45.4	0.9	2.0	1.9	2.1	0.7	0.7	1.3	0.7	1.4	0.7	0.4	1.2	6.0	1.0	1.6	0.9	0.8	0.7	2.0	0.5	4.9	30.3	0.7	0.2	0.9	0.6	0.0	3.7	0.5	0.6	2.2	1.1	0.5	7.7	1.8	0.4	0.6	18.0	0.3	0.8	67.0	2.5	1.3	0.7	4.8	5.5	0.4	42.3	6.5	1.1	61.4	2.0	3.6	0.3	0.2	0.0	2.1	0.0	2.3	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.3	0.5	0.0	3.6	10.4	1.0	0.0	0.0	0.1	0.1	1.1	0.3	0.0	0.0	8.1	2.1	0.0	0.1	7.3	0.0	0.5	0.3	0.0	0.0	0.9	0.1	0.0	0.0	3.1	0.5	0.4	0.0	0.4	0.0	0.3	4.4	0.1	0.5	0.0	0.3	4.8	2.1	0.0	0.2	0.1	0.0	0.0	0.4	1.9	1.0	0.0	0.5	0.0	0.0	25.0	0.0	1.7	0.1	4.1	0.0	1.5	0.3	3.6	0.0	0.1	0.0	61.4	0.0	0.0	2.0	46.2	0.0	0.0	0.1	0.2	0.0	1.0	0.0	2.1	0.7	0.9	2.1	0.7	0.8	0.7	0.7	0.2	0.6	0.7	41.7	21.9	268.2	2.1	0.1	0.2	0.4	0.0	2.7	17.0	3.5	0.0	1.8	0.0	0.2	1.9	0.4	0.0	0.0	0.2	0.6	1.0	5.2	1.1	0.0	1.2	0.0	0.0	0.0	2.7	1.8	0.0	7.7	5.0	0.0	0.0	1.1	2.5	0.2	0.4	2.4	0.0	0.0	0.0	1.4	3.2	1.0	0.2	2.5	0.4	4.0
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 67.3;salivary gland: 54.6"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038832, HPA038833"	Approved					NA	NA					"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	22.0	2.0	3.7	11.4	5.5	10.3	6.1	2.8	4.3	31.4	18.1	2.2	1.1	2.1	3.9	7.3	1.7	7.2	2.6	17.8	4.3	3.5	6.2	18.4	67.3	8.6	5.1	1.6	5.4	42.1	25.7	6.7	44.8	5.9	5.7	14.9	4.3	54.6	2.3	1.8	5.1	3.4	3.0	8.8	6.5	2.5	2.3	3.2	7.5	4.9	2.3	5.6	5.8	6.0	3.1	2.7	1.0	1.5	11.5	10.5	3.4	5.5	5.5	1.2	0.0	4.6	10.6	2.9	0.6	45.5	1.7	2.7	0.2	20.6	5.4	6.0	0.1	5.7	0.4	3.8	1.2	1.0	9.3	11.3	14.1	11.6	0.1	1.8	33.1	4.8	5.6	1.4	0.8	2.6	4.5	0.6	13.4	14.1	49.4	8.8	3.7	11.9	15.5	3.7	7.5	5.4	3.0	0.0	17.6	9.6	2.1	1.6	4.0	15.5	0.2	1.5	1.1	3.8	12.4	3.1	5.5	2.1	11.2	8.7	22.1	9.2	25.6	9.1	21.7	5.0	0.0	1.5	1.0	5.6	1.0	9.8	1.3	10.5	9.0	2.7	3.1	7.9	5.4	0.1	11.5	0.3	1.0	3.9	3.4	3.7	5.5	2.8	4.3	4.3	3.5	5.1	1.6	5.9	3.2	723.6	227.4	10.4	9.5	10.4	0.8	22.6	7.6	1.4	27.3	5.2	3.9	12.1	10.0	1.9	0.3	8.0	3.3	23.3	28.2	184.5	25.7	10.8	3.5	22.1	43.3	3.2	23.1	6.7	29.8	0.4	1.1	25.3	27.0	16.2	72.2	4.5	16.3	7.0	1.1	8.1	1.2	6.5	14.6	2.7	5.9	6.0	50.7	13.8	56.9	6.8
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501329-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 303.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	19.8	14.7	8.2	37.7	12.0	44.5	26.6	12.4	10.3	18.2	17.1	10.4	10.4	10.7	17.5	11.2	20.5	16.4	20.3	14.5	7.5	5.1	13.2	15.8	26.9	46.0	11.4	4.8	17.5	14.3	10.2	8.7	13.7	10.0	18.8	14.6	10.8	17.7	13.5	17.1	19.6	16.7	16.0	10.1	30.0	14.6	9.3	12.5	37.5	14.7	16.3	26.7	18.4	22.7	5.8	10.4	5.5	7.1	14.3	10.6	3.5	17.1	9.7	5.2	7.9	16.2	14.6	6.4	9.9	29.1	12.3	12.5	10.7	24.6	28.1	8.9	15.5	17.8	13.7	10.3	17.2	16.9	25.3	6.1	11.9	7.8	11.5	15.1	21.2	25.4	12.0	12.1	11.9	16.6	8.9	15.4	9.4	11.6	20.6	8.8	12.1	1.8	11.7	3.1	12.7	8.9	15.0	12.4	12.7	11.5	24.2	3.6	5.9	18.1	25.3	9.9	5.2	5.1	15.9	19.7	16.7	8.7	9.0	13.8	9.1	6.3	27.3	10.7	10.9	23.6	5.2	5.4	4.9	3.4	7.1	6.0	5.6	8.4	5.6	10.4	5.8	10.6	8.9	5.5	14.3	5.9	7.4	4.5	3.5	8.2	12.0	12.4	10.3	7.5	5.1	11.4	4.8	10.0	12.5	38.7	46.7	27.4	82.1	147.0	6.7	16.5	12.7	24.1	36.4	19.2	5.9	12.5	3.3	25.5	3.8	30.8	32.3	0.0	31.9	14.4	46.3	57.3	111.6	20.3	23.2	19.1	32.2	22.7	57.1	0.9	22.2	56.9	52.3	303.0	36.5	10.3	40.0	26.9	32.5	21.4	6.5	0.0	61.7	2.1	6.6	131.4	11.9	22.4	32.1	74.8
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		12000000	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.0	3.9	1.9	1.9	37.5	17.4	4.9	4.9	9.7	2.1	4.2	5.1	8.2	7.6	6.6	6.8	6.8	3.3	5.0	10.8	1.7	5.3	2.1	4.3	4.5	7.8	11.4	8.0	19.6	14.8	18.5	9.1	7.6	27.8	3.9	3.3	7.2	7.8	7.7	3.2	1.9	7.7	2.7	8.7	3.2	3.9	4.5	2.1	6.1	8.3	1.2	0.9	5.8	10.1	7.6	20.0	14.4	5.5	3.0	5.8	2.8	13.0	2.6	4.2	8.7	0.7	10.5	3.6	4.2	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5	29.8	35.2	25.3	8.3	5.3	5.4	10.4	12.7	4.0	12.5	8.7	5.9	32.0	1.7	5.7	1.9	7.2	4.6	0.0	2.4	6.3	10.6	7.4	33.5	15.8	38.4	6.4	1.7	9.2	46.4	1.1	8.3	42.8	0.0	29.7	10.9	4.3	5.7	21.0	18.7	7.6	7.1	0.0	8.3	0.2	1.1	4.0	18.9	10.9	10.5	8.3
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	53.5	30.7	51.2	41.3	54.7	79.0	44.0	54.5	72.7	48.7	46.0	46.0	76.5	57.4	35.7	55.3	63.2	30.7	54.6	73.2	67.1	53.2	27.5	52.2	31.6	37.5	57.4	73.4	45.0	59.9	46.4	53.7	75.3	63.0	63.1	47.3	65.6	58.7	64.8	43.2	107.7	41.8	37.1	61.3	30.7	56.8	50.3	41.4	49.1	51.2	51.8	43.6	33.5	86.1	61.5	63.1	35.7	43.4	57.9	51.0	43.6	33.3	49.5	52.0	67.0	87.8	54.3	40.9	54.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2	154.9	181.2	227.9	605.7	749.7	127.0	210.7	150.3	190.1	129.7	132.6	117.8	279.1	464.2	286.3	668.3	228.0	265.9	93.5	333.2	474.9	260.0	477.5	219.4	203.4	354.6	116.0	231.0	159.0	357.1	423.2	152.5	359.3	339.1	356.1	198.5	111.8	351.4	245.4	140.0	328.0	157.1	103.5	376.3	128.5	151.0	711.0	533.9	297.5	192.3	680.6
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA		80000	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	8.1	13.8	14.8	13.5	11.3	13.7	11.2	14.5	16.1	13.5	8.3	9.3	9.3	5.0	9.4	14.4	8.5	8.2	11.5	10.6	14.5	17.7	19.8	40.5	8.0	12.8	17.9	8.2	8.2	29.7	13.3	10.7	9.5	15.6	7.8	10.7	9.4	16.3	10.5	4.9	7.7	12.5	8.0	16.7	13.0	7.0	7.6	8.4	11.2	21.2	5.6	8.9	6.8	9.3	5.1	6.9	11.0	5.7	7.9	6.6	4.2	10.6	3.6	3.8	4.8	9.6	10.5	2.4	8.4	3.1	3.6	5.5	4.1	18.0	7.8	7.4	7.8	8.6	5.3	18.3	6.6	16.5	6.8	2.8	6.6	2.5	4.2	7.0	11.9	10.7	3.9	10.1	15.1	11.9	3.4	6.4	4.3	14.5	14.0	9.6	2.9	10.3	3.5	7.5	3.6	2.7	4.3	3.9	14.1	8.7	3.4	8.9	5.3	4.9	8.5	7.8	4.6	5.6	2.5	2.8	10.6	11.8	14.3	5.0	10.8	14.6	15.8	7.6	3.7	8.1	7.2	5.6	11.0	5.4	5.1	5.8	5.1	5.5	5.6	5.3	4.0	3.8	4.9	4.1	7.9	5.7	6.9	6.6	4.2	14.8	11.3	14.5	16.1	14.5	17.7	17.9	8.2	15.6	8.4	23.8	25.0	53.7	38.3	76.1	29.8	24.8	48.4	17.4	23.9	73.3	19.6	67.4	61.3	82.9	9.3	26.3	58.3	210.2	67.5	102.3	44.1	55.3	57.6	142.1	102.4	28.6	41.2	19.0	73.8	4.2	22.2	68.4	65.8	85.6	58.6	24.6	77.7	83.4	31.8	182.4	24.3	32.3	31.1	25.1	30.9	78.7	47.5	45.7	58.6	44.3
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 43.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"		NA	NA			Mitochondria	"Centriolar satellite"	"HPA058971: AB_2683865, HPA065520: AB_2685502"	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.1	1.1	1.1	1.1	3.1	0.9	0.9	1.4	2.0	0.9	0.8	3.7	0.0	0.8	2.6	2.3	0.7	0.9	1.6	0.9	1.6	1.0	0.8	0.7	1.1	2.4	2.4	1.1	1.5	1.3	1.2	2.4	0.9	3.1	1.1	0.8	2.8	0.7	0.9	0.7	1.9	0.8	0.7	4.4	1.0	0.8	43.1	2.3	4.2	1.1	0.0	1.7	1.2	0.9	2.0	1.9	0.6	0.6	0.4	4.9	0.6	0.4	0.0	2.2	3.3	4.4	3.3	0.7	0.8	1.1	0.0	0.2	0.0	0.2	1.7	0.6	1.7	0.7	0.0	1.7	0.9	1.5	3.2	2.3	2.5	2.0	0.0	0.0	0.7	0.5	0.5	1.0	0.0	1.8	0.9	1.3	4.5	1.2	1.7	1.7	1.3	1.0	2.2	0.8	0.5	0.0	2.7	1.8	0.5	0.9	0.5	2.1	5.0	0.6	0.8	2.5	1.5	0.4	1.7	0.7	0.9	0.3	1.0	1.1	5.5	4.0	1.4	1.2	1.0	2.4	0.6	0.6	0.1	1.5	0.4	1.7	1.8	1.2	1.8	0.7	2.0	4.9	2.8	0.3	0.4	0.3	1.9	1.7	0.6	1.1	3.1	1.4	2.0	1.6	1.0	2.4	1.1	3.1	2.3	3.0	1.0	1.9	0.5	1.1	1.9	0.8	0.0	0.0	0.0	0.0	15.7	0.4	1.7	0.3	118.1	0.7	0.0	0.0	0.4	0.2	1.5	0.8	0.0	0.0	1.1	3.2	0.0	0.6	4.1	86.8	4.9	0.8	1.7	1.8	0.0	2.7	0.7	0.0	2.8	0.6	5.0	0.0	1.4	121.2	8.1	0.5	0.5	1.0	0.0	0.5
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.3	7.9	8.8	6.3	13.3	5.3	5.5	16.5	24.5	5.6	5.0	5.2	0.4	2.0	8.5	4.2	4.7	5.9	9.8	5.5	8.9	12.5	1.9	45.6	3.3	7.2	10.3	13.4	8.0	2.4	1.2	8.8	5.2	20.8	5.6	3.9	8.3	2.1	6.7	4.5	3.7	3.0	9.8	9.8	4.6	5.7	4.8	4.7	2.5	2.6	1.8	6.9	5.5	8.5	5.6	1.7	0.0	0.1	12.2	6.3	1.8	2.6	1.3	3.1	6.5	15.7	13.1	0.0	12.0	4.8	2.0	1.9	1.3	1.7	16.9	2.1	13.9	2.7	0.8	7.1	5.0	2.8	14.8	4.9	16.9	4.2	12.2	8.4	11.8	5.3	11.5	6.8	4.2	14.7	6.7	8.6	4.8	5.7	12.4	6.2	1.0	9.5	7.3	2.4	0.0	3.8	0.0	3.4	7.4	5.8	1.0	10.8	9.7	5.4	1.4	3.5	0.9	1.5	7.9	10.5	4.5	2.7	7.0	4.1	10.6	7.6	12.3	5.3	10.4	1.7	0.0	0.1	0.0	5.1	0.0	6.3	5.6	5.6	4.5	0.9	3.6	3.4	4.2	0.0	12.2	0.1	1.7	2.4	1.8	8.8	13.3	16.5	21.2	8.9	12.5	10.3	13.4	20.8	4.7	0.0	0.3	6.5	2.6	4.2	8.9	2.4	7.6	0.0	1.2	0.0	25.5	0.3	0.0	5.5	10.6	8.7	0.0	0.0	60.7	2.0	8.8	2.0	1.1	33.1	1.3	7.9	2.9	4.3	1.5	5.0	5.2	2.3	10.1	6.4	0.6	0.6	60.5	0.0	4.9	1.0	2.0	6.5	10.5	1.8	4.3	3.3	0.2	4.6	0.0	0.9
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell type enhanced"	"Detected in many"	16	"Distal tubular cells: 179.1;Proximal tubular cells: 617.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.3	10.7	10.9	9.5	2.4	1.2	13.4	10.0	6.8	6.3	8.1	2.0	6.6	11.8	17.4	6.2	3.1	24.0	9.4	10.1	2.3	27.0	19.9	17.7	6.5	3.4	22.7	1.4	27.8	6.1	7.8	2.4	2.1	20.1	25.0	6.3	41.3	5.0	3.5	12.5	11.0	5.8	7.0	11.4	5.2	5.1	12.2	7.0	3.7	4.4	2.4	6.5	6.5	11.0	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4	29.8	52.6	3.4	39.4	27.0	1.3	8.5	38.2	22.7	33.0	102.9	0.0	6.7	179.1	38.9	1.1	24.3	37.4	0.0	19.3	13.9	51.4	21.0	18.5	63.8	17.7	3.2	22.0	28.3	13.2	2.1	64.7	10.3	21.9	19.8	19.9	45.8	21.4	14.1	73.2	617.5	2.2	12.9	24.2	0.7	1.7	23.3	2.9	17.3	23.0	33.1
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105806-103198409	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.3;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 93.5;Spermatocytes: 69.2;Spermatogonia: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042294	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol		NA	Yes			"Microtubules, Cytosol"	Nucleoplasm	"HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	2.7	0.9	0.6	9.4	1.5	11.3	0.7	0.2	1.3	1.0	2.1	0.5	0.0	1.9	0.7	1.9	5.9	0.5	0.8	2.5	2.0	0.8	1.3	0.6	1.4	7.3	1.9	0.6	0.7	0.5	0.1	0.4	3.1	1.4	0.7	2.7	0.2	2.2	0.8	0.4	2.2	2.4	1.4	1.3	3.3	1.6	6.6	0.6	25.1	0.6	5.9	6.4	1.5	1.9	0.6	0.5	5.7	3.0	0.8	1.4	0.2	20.9	6.0	21.9	10.6	1.5	3.4	4.3	19.1	9.6	14.3	9.5	9.5	11.4	14.2	4.9	7.0	10.0	9.4	15.7	7.7	22.6	17.7	5.8	16.7	12.6	6.9	0.2	19.8	9.7	1.0	0.6	11.4	9.6	3.2	12.0	13.0	17.3	17.0	18.3	7.6	15.6	8.9	7.0	8.5	9.4	10.5	20.5	4.7	4.0	4.2	10.1	6.0	16.9	11.8	4.6	8.8	6.7	7.0	13.0	13.8	14.5	14.3	19.5	8.3	14.2	14.8	7.7	11.1	14.6	5.7	0.1	0.7	0.2	0.6	0.0	0.6	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.8	3.0	0.5	1.4	0.2	0.6	1.5	0.2	1.3	2.0	0.8	1.9	0.6	1.4	0.6	3.0	2.1	0.0	1.0	3.2	7.1	1.4	0.0	0.0	1.2	0.0	7.9	2.4	0.0	0.4	3.4	2.8	0.5	93.5	0.0	22.1	1.5	1.3	6.9	0.8	11.2	0.0	1.2	4.3	7.3	0.7	0.9	5.5	0.0	8.2	1.4	1.4	1.3	0.6	2.5	0.0	2.5	0.0	2.5	69.2	47.7	2.5	3.0	2.5	4.7	0.6
TACR3	NK3R	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719816	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 14.4;urinary bladder: 5.5"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 1.1;Extravillous trophoblasts: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 14.4;hypothalamus: 4.1;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"BEWO: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain					NA	NA					"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.1	0.1	14.4	0.1	1.4	0.1	0.4	0.0	2.6	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.3	0.1	1.1	4.1	2.0	0.1	0.9	0.1	1.4	1.0	0.1	0.1	0.1	0.1	0.6	6.3	0.2	0.5	3.2	0.1	0.1	0.7	0.3	0.1	0.1	2.5	0.1	0.5	0.6	0.0	0.0	0.5	0.9	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	1.4	0.0	1.5	1.1	4.1	1.4	1.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468312-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 19.4;pituitary gland: 17.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.9;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	2.2	4.3	10.3	0.9	12.0	0.6	4.3	17.5	19.4	2.4	2.5	7.4	0.8	5.4	1.9	5.3	1.0	6.7	1.5	5.3	9.9	14.4	1.7	2.7	2.3	0.7	7.9	9.9	5.6	5.8	3.2	17.2	1.4	10.2	2.1	2.9	7.9	7.5	2.1	1.3	0.8	5.5	1.8	5.3	1.4	4.3	4.9	13.3	0.0	7.1	0.1	0.7	1.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	7.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	9.3	0.0	0.0	2.7	0.0	2.6	0.1	0.1	0.0	0.0	5.4	0.0	0.1	12.5	2.3	0.0	0.6	0.0	3.1	0.3	0.0	0.0	0.0	1.7	0.0	0.1	10.2	2.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.1	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.0	17.5	19.4	9.9	14.4	7.9	9.9	10.2	13.3	0.0	5.4	0.0	0.8	0.2	41.0	12.8	0.0	14.7	2.3	0.0	29.5	0.1	0.0	0.1	0.2	1.6	0.9	0.0	2.9	0.0	0.4	0.5	0.0	2.4	0.1	42.9	98.1	1.3	0.3	0.4	0.3	0.0	1.7	0.0	4.3	13.3	2.1	0.0	10.3	0.7	25.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.4
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	9.9	6.1	8.7	11.9	11.4	26.3	8.0	4.1	10.0	9.6	7.4	10.1	5.8	8.2	10.1	7.4	16.2	9.2	6.6	6.8	9.0	4.2	6.7	5.5	9.9	9.8	13.7	5.7	8.5	7.0	7.4	29.0	12.4	9.1	6.5	8.0	4.7	13.5	8.2	9.8	16.0	10.2	7.8	15.5	12.9	6.8	3.2	14.6	9.3	7.2	6.9	8.7	9.8	12.3	2.8	5.1	29.0	7.0	2.6	2.1	1.4	4.8	3.1	10.6	10.8	1.9	4.3	4.3	3.5	4.7	5.0	4.9	3.1	6.5	0.5	4.0	4.3	2.4	4.6	10.2	6.1	5.7	6.2	2.7	6.8	6.0	1.1	5.4	15.4	11.3	3.7	8.3	4.8	6.2	8.1	6.6	3.7	7.2	12.7	4.3	3.6	2.5	4.2	2.3	6.4	1.9	7.9	5.3	1.0	4.6	10.2	7.6	6.2	3.8	9.9	0.6	6.0	4.5	11.1	8.5	7.6	6.9	2.2	5.9	8.5	6.1	6.4	4.6	3.8	7.4	10.8	7.0	7.2	2.1	5.5	0.8	2.6	1.2	1.2	5.1	2.8	1.0	1.6	29.0	2.6	6.4	4.5	1.5	1.4	8.7	11.4	4.1	10.0	9.0	4.2	13.7	5.7	9.1	14.6	23.8	26.1	5.6	9.4	12.8	21.1	21.6	7.6	21.4	20.5	8.7	15.7	16.9	6.6	5.6	0.2	12.9	15.8	0.0	6.6	4.8	7.5	10.8	26.6	6.6	13.0	33.4	22.3	9.2	49.2	0.4	7.5	43.4	5.0	11.8	15.9	5.6	6.6	17.3	6.7	2.4	23.8	12.9	8.2	0.2	0.6	31.5	28.6	17.5	12.7	22.5
PPA2	FLJ20459	ENSG00000138777	"Pyrophosphatase (inorganic) 2"	Q9H2U2	4	105369077-105474081	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		8300	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	9.2	18.0	18.4	17.2	15.4	24.0	20.6	12.3	17.6	10.2	19.8	9.3	20.3	18.1	13.3	20.7	14.8	10.7	18.7	42.5	15.6	15.3	23.7	21.2	23.1	34.8	17.2	12.1	9.5	25.0	10.4	15.0	9.3	15.4	16.1	16.7	12.6	21.4	26.8	29.6	15.0	16.8	22.8	12.4	12.1	15.0	9.7	10.7	9.4	14.3	28.2	10.6	12.2	9.5	20.0	35.3	14.7	20.8	22.0	17.0	14.6	11.4	5.4	10.6	18.0	6.8	5.4	7.7	6.5	8.5	8.0	5.7	12.1	16.8	9.4	8.6	5.2	6.4	5.7	21.2	10.3	9.4	13.3	7.6	8.4	8.8	11.0	5.3	19.9	8.2	5.2	10.6	5.5	4.3	9.1	7.6	16.5	14.0	13.0	7.2	14.5	17.0	14.4	7.7	22.3	18.5	15.1	6.5	9.3	26.3	8.8	11.0	6.5	4.4	26.6	9.4	6.5	13.9	16.3	4.0	5.7	11.2	6.2	11.2	11.5	14.5	9.8	10.1	10.8	7.7	14.7	15.0	9.7	15.3	20.8	13.3	20.0	16.0	16.2	35.3	16.6	15.5	17.0	6.4	22.0	16.2	17.7	15.9	14.6	18.4	15.4	12.3	17.6	15.6	15.3	17.2	12.1	15.4	10.7	8.9	50.5	30.0	71.8	44.4	30.3	55.7	53.5	57.6	43.3	31.4	15.7	106.7	223.8	100.3	91.0	35.1	73.1	23.3	104.8	78.8	31.9	70.3	43.9	59.7	73.9	20.6	63.1	23.4	36.7	95.8	25.6	65.5	72.6	46.9	86.9	28.4	66.2	97.6	30.4	222.1	16.9	38.8	49.5	16.1	9.4	50.4	70.8	45.8	109.9	75.5
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3"					"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	16.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	6.0	33.6	0.0	0.9	0.0	0.0	1.4	2.5	45.5	18.2	12.2	0.0	0.1	8.3	4.2	1.2	0.0	4.1	0.0	5.0	0.1	0.0	13.9	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	7.7	0.0	3.3	5.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.4
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: AB_2677687"	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	16.7	13.5	18.7	12.5	20.7	25.3	20.0	17.3	18.1	14.5	17.0	13.4	11.6	17.0	16.1	17.9	13.6	14.4	12.3	19.3	18.3	15.3	18.2	21.4	15.4	12.1	16.5	11.5	15.0	16.0	17.3	20.7	11.2	17.4	18.1	15.4	10.4	14.8	13.7	28.2	14.1	21.0	16.6	19.3	15.9	14.9	12.6	13.8	22.1	31.1	15.9	15.4	13.8	12.6	20.6	27.6	33.3	17.0	27.1	21.9	14.0	12.7	6.8	15.7	16.2	15.5	18.5	11.4	15.2	15.8	19.2	20.0	9.6	14.6	18.5	8.5	17.1	14.9	7.5	17.2	21.9	23.8	19.3	10.4	13.9	11.1	13.5	25.0	24.4	12.7	17.4	28.5	19.0	28.6	12.5	17.6	15.7	20.6	14.5	20.5	13.5	28.6	15.2	6.8	18.7	10.5	14.7	17.1	14.1	17.8	8.7	17.0	13.6	10.7	17.8	16.7	12.9	14.4	14.4	11.4	12.6	13.0	13.6	16.2	22.5	20.8	27.5	14.0	16.7	24.9	33.3	15.9	24.1	17.9	16.8	20.0	20.6	20.6	20.2	18.0	19.3	21.6	20.2	12.1	27.1	17.0	27.6	21.9	14.0	18.7	20.7	17.3	18.1	18.3	15.3	16.5	11.5	17.4	13.8	11.9	7.3	22.4	10.3	9.7	9.6	17.3	17.8	5.3	5.7	3.5	9.8	14.1	36.5	19.4	33.3	13.5	8.0	0.0	17.7	15.1	9.7	14.5	24.3	8.9	15.5	9.5	5.8	12.9	6.7	20.9	11.2	9.1	6.8	19.0	5.5	11.2	16.6	8.2	7.8	12.9	9.0	0.0	10.3	13.0	12.6	9.2	15.3	10.7	8.3	10.0
GSTCD	FLJ13273	ENSG00000138780	"Glutathione S-transferase C-terminal domain containing"	Q8NEC7	4	105708778-105847728	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 93.7;Late spermatids: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 11.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046160, HPA061782"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046160: AB_10961048, HPA061782: AB_2797265"	"unprognostic (4.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.44e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.02e-2)"	6.5	6.1	7.6	7.2	10.1	9.3	11.2	11.0	9.7	8.2	7.3	8.4	5.7	5.2	9.3	10.0	10.0	8.8	7.7	5.6	7.4	7.8	10.3	5.7	6.3	9.4	7.5	6.5	7.2	6.3	7.6	13.1	7.2	10.0	8.2	8.3	14.4	7.4	7.6	5.6	6.9	5.9	8.4	10.5	6.9	6.6	20.5	6.4	15.1	10.7	5.4	9.8	7.1	7.1	2.0	1.9	11.4	1.9	1.9	2.2	0.9	7.7	7.0	16.1	14.0	4.1	5.5	12.1	10.9	5.6	13.6	12.4	6.5	14.9	9.3	5.7	4.6	7.9	6.4	18.3	11.5	19.2	13.8	5.5	7.8	6.8	8.8	1.9	14.3	5.4	2.9	5.8	12.4	9.6	5.1	8.3	9.5	14.9	8.5	11.4	6.3	14.9	5.3	8.8	11.4	8.9	10.3	9.5	5.3	14.8	5.7	13.1	5.8	8.5	12.1	4.7	14.8	10.9	5.8	6.2	10.1	10.6	6.2	8.5	3.2	6.7	5.2	6.3	7.4	13.8	0.9	1.4	0.6	1.3	1.7	1.5	1.5	1.2	0.4	1.4	2.0	1.4	2.2	11.4	1.9	1.9	1.9	0.2	0.9	7.6	10.1	11.0	9.7	7.4	7.8	7.5	6.5	10.0	6.4	6.0	3.8	1.5	3.4	2.3	19.6	2.2	10.2	1.4	1.2	8.7	25.5	4.9	3.3	4.6	93.7	3.6	2.9	0.0	4.3	6.8	3.5	4.0	2.3	5.3	6.3	20.6	4.1	3.1	4.7	41.2	7.8	3.0	5.0	4.6	3.5	7.2	5.2	0.0	4.2	3.7	22.0	0.0	4.2	7.2	4.7	3.8	2.7	2.5	4.4	1.7
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.3"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	5.4	1.6	3.4	2.4	4.4	0.0	8.3	0.7	2.5	13.3	11.0	1.9	4.2	16.4	8.7	11.4	5.7	5.9	19.0	2.5	2.5	2.7	22.7	1.3	34.9	0.9	7.5	2.4	4.1	11.6	0.0	14.6	3.0	2.2	26.3	7.6	16.9	2.8	5.7	2.6	2.1	37.7	4.0	0.9	4.4	4.0	3.0	2.8	3.4	125.3	3.7	2.3	3.7	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	15.2	0.1	0.0	0.0	0.0	7.6	9.9	0.1	0.4	0.1	0.0	0.9	3.8	0.0	0.0	0.0	3.9	0.4	17.2	13.7	0.0	0.0	0.1	1.7	1.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	12.2	0.2	0.7	0.1	0.0	6.2	0.0	0.0	0.1	20.0	0.8	0.9	0.3	0.9	7.4	0.0	2.3	26.8	0.6	0.0	0.3	0.2	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	0.7	2.5	2.5	2.7	7.5	2.4	2.2	2.8	172.7	69.4	0.0	4.6	1.6	0.2	2.0	33.1	10.7	97.8	31.4	0.0	2.2	1.7	19.0	11.6	8.0	8.0	0.0	2.1	0.1	0.9	29.6	0.0	0.0	0.3	0.0	15.0	3.1	0.0	11.8	2.3	1.3	5.0	0.0	9.2	0.0	6.3	3.1	0.0	3.0	0.1	0.0	33.5	0.5	1.5	1.0	1.3	0.0	6.9	2.8
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106321495	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 25.3;BJ hTERT+ SV40 Large T+ RasG12V: 44.5;HBF TERT88: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	12.8	19.0	14.2	7.6	15.2	3.4	10.0	16.3	15.2	13.5	8.3	10.0	11.0	4.4	10.9	14.9	10.6	13.0	13.2	9.3	12.1	11.1	17.8	10.5	9.6	6.9	15.0	8.5	17.5	8.2	12.6	24.2	13.7	12.1	11.9	9.1	9.0	9.1	14.6	4.2	8.5	7.2	13.3	10.3	8.5	8.1	12.0	13.8	18.5	13.9	4.6	8.9	14.5	10.7	10.7	6.3	11.9	6.8	5.9	8.4	4.2	0.9	2.5	5.2	1.9	19.6	12.3	0.9	3.9	6.3	25.3	44.5	4.5	3.9	1.7	5.9	13.2	3.7	2.3	3.5	4.8	30.4	2.4	1.0	5.4	2.1	4.7	5.1	2.2	3.2	11.4	4.0	2.3	4.0	11.1	6.6	3.2	4.2	2.1	7.7	3.4	2.8	2.1	1.2	6.6	1.8	2.1	3.2	3.6	6.6	4.5	2.8	2.2	3.4	2.4	3.4	7.3	3.4	4.9	3.7	4.5	2.2	1.0	1.9	1.0	2.8	3.7	6.2	3.3	2.3	11.9	6.4	6.3	6.2	6.8	7.2	6.2	6.8	8.4	6.3	10.7	7.4	6.7	0.5	5.9	4.6	6.1	6.7	4.2	14.2	15.2	16.3	15.2	12.1	11.1	15.0	8.5	12.1	13.8	17.9	28.0	8.9	5.8	2.1	19.0	6.7	5.1	14.7	20.5	14.0	19.6	9.6	3.3	3.8	35.4	8.2	3.8	0.0	0.8	5.5	7.0	4.2	10.5	4.4	5.8	11.1	5.2	9.8	4.7	28.9	10.3	4.3	5.0	2.8	6.4	10.1	2.1	5.8	12.0	6.9	15.8	0.0	3.8	10.4	8.2	2.0	6.2	6.9	5.5	4.2
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349226	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	NA	NA	6500000		Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	30.7	26.6	20.2	25.7	24.5	42.2	30.3	22.5	22.9	29.9	33.7	17.0	33.6	27.7	29.3	28.4	35.0	25.6	23.7	23.6	21.2	18.4	40.4	35.3	23.4	24.6	29.8	21.8	35.9	27.2	24.1	44.0	27.3	26.5	29.8	28.4	14.1	25.6	32.1	67.8	22.6	39.1	32.8	30.1	26.9	25.2	15.9	29.4	31.3	35.9	40.6	25.8	41.2	25.9	28.2	35.9	24.6	32.7	23.7	33.4	16.6	22.9	14.7	15.5	21.9	18.6	27.9	26.0	30.7	23.6	24.0	28.8	25.3	33.9	40.7	23.2	25.5	18.9	23.0	23.6	29.1	34.4	22.6	14.8	24.0	19.0	40.2	35.7	47.5	27.8	21.5	33.6	25.5	41.4	17.9	20.8	22.4	41.0	22.0	26.5	16.6	32.0	22.6	17.6	31.7	14.7	26.3	31.4	36.6	29.7	20.0	24.9	18.5	19.6	54.2	27.6	22.8	25.9	33.4	17.7	31.7	29.0	23.5	35.7	25.0	35.0	41.6	26.4	37.2	34.0	22.4	26.9	24.6	21.8	29.0	26.0	27.7	27.3	21.8	27.6	28.2	28.5	25.9	3.7	23.7	32.7	35.9	33.4	16.6	20.2	24.5	22.5	22.9	21.2	18.4	29.8	21.8	26.5	29.4	65.5	48.1	80.4	112.4	44.6	44.9	91.2	84.1	77.6	91.0	62.8	33.4	105.8	132.6	104.1	59.3	50.6	74.9	23.3	110.5	122.1	61.9	108.3	78.4	110.0	97.3	23.8	70.9	63.3	84.2	9.9	91.7	82.1	30.4	91.0	106.7	52.5	101.3	87.7	80.2	119.0	35.9	58.2	70.0	117.4	69.1	43.8	126.2	64.5	109.4	153.1
GIMD1		ENSG00000250298	"GIMAP family P-loop NTPase domain containing 1"	P0DJR0	4	106357485-106368825	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"intestine: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HBF TERT88: 1.0;HEL: 1.0;NB-4: 1.2;U-138 MG: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	23.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 21.7"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 6.8;Fibroblasts: 6.3;Hofbauer cells: 12.7;Ito cells: 4.9;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 3.0"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"CAB009727: AB_2091492, HPA052611: AB_2732576"	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	6.6	1.2	3.0	1.5	2.5	0.0	4.8	1.8	3.6	21.7	3.6	0.2	0.0	0.1	1.4	2.4	2.0	0.9	1.6	3.1	2.9	2.2	0.4	0.3	7.9	0.9	2.0	1.5	6.3	0.3	0.9	3.4	3.4	2.5	2.9	0.7	6.8	2.7	2.4	2.4	6.1	0.5	0.9	2.3	1.7	0.4	0.5	0.2	0.1	1.3	4.4	3.7	1.1	2.6	0.0	0.2	0.0	0.1	0.0	3.0	0.0	0.0	0.0	3.7	0.0	0.7	0.4	0.0	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.5	1.8	3.6	2.9	2.2	2.0	1.5	2.5	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	6.3	0.0	0.0	0.0	12.7	0.0	0.0	4.9	0.3	0.0	3.7	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	6.5	0.0	0.0	0.0	0.0
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720452	"Enzymes, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.3;eosinophil: 62.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 62.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	13.5	7.4	24.3	14.4	28.5	11.1	25.2	16.4	32.2	26.6	10.0	45.0	9.4	7.9	25.1	22.8	18.3	24.9	13.3	7.7	31.3	23.9	16.7	5.1	22.0	14.7	29.7	21.9	15.6	24.6	15.6	15.5	8.5	38.2	21.7	12.7	9.5	32.2	14.0	3.3	24.5	8.5	17.0	59.9	9.6	30.4	8.1	25.5	14.7	10.3	11.0	24.6	16.5	13.7	8.5	9.2	62.2	10.2	4.6	6.8	5.8	10.5	9.7	16.4	20.4	20.2	25.5	13.1	13.5	25.4	13.2	17.8	14.8	15.3	16.5	8.6	24.7	10.2	13.3	15.5	26.7	17.1	38.8	11.7	19.3	21.0	33.0	11.1	29.2	33.4	21.1	13.8	15.2	12.5	32.2	29.3	21.1	4.2	32.2	37.0	16.2	23.5	9.0	17.5	11.4	10.8	19.8	25.9	4.7	19.9	14.7	18.6	26.9	14.0	21.1	16.5	21.8	12.5	4.5	17.3	16.6	17.1	11.1	11.3	25.9	17.2	15.4	20.1	22.4	26.0	50.3	8.9	62.2	3.0	9.6	3.5	8.5	4.0	3.4	9.2	4.1	2.5	2.9	9.4	4.6	10.2	1.8	6.8	5.8	24.3	28.5	16.4	32.2	31.3	23.9	29.7	21.9	38.2	25.5	89.3	19.8	21.5	31.5	28.4	13.4	6.5	30.6	113.8	69.4	54.1	9.8	17.1	14.9	29.3	5.2	17.4	7.0	0.0	40.0	37.0	49.8	27.9	41.5	8.1	53.6	28.6	22.5	20.3	50.0	3.7	16.7	46.3	57.3	35.1	18.0	37.3	29.6	7.0	24.1	21.2	13.7	25.8	22.7	16.5	14.3	35.8	7.4	11.8	15.1	20.1
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 144.6;Ciliated cells: 116.4;Club cells: 131.9;Urothelial cells: 179.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"pons and medulla: 17.0"	"Group enriched"	"Detected in some"	8	"classical monocyte: 5.7;eosinophil: 3.9;intermediate monocyte: 2.4;myeloid DC: 6.6;non-classical monocyte: 2.0"	"Group enriched"	"Detected in many"	32	"dendritic cells: 6.6;granulocytes: 3.9;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA					"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	7.5	3.3	1.9	8.6	2.9	2.1	8.0	1.7	1.9	8.3	22.2	3.4	5.6	11.4	12.5	9.7	14.9	7.5	24.9	7.8	2.5	2.6	13.2	12.6	20.7	6.4	2.7	1.4	5.4	8.4	4.6	48.5	30.7	17.0	8.0	6.4	11.8	14.2	3.2	5.0	4.5	38.1	18.5	4.6	1.5	9.8	8.6	1.0	0.2	22.0	12.2	5.3	10.7	11.2	0.1	6.6	3.9	5.7	0.0	0.1	1.4	10.0	3.8	0.6	2.9	6.7	15.6	0.2	12.4	9.4	5.9	6.2	1.7	21.0	0.7	4.9	19.7	5.1	3.8	7.2	10.9	10.6	2.8	2.8	0.4	8.5	0.6	7.7	6.8	0.0	5.4	7.7	11.5	14.0	12.4	13.0	0.1	0.1	0.2	9.3	3.4	0.2	0.0	0.3	5.9	4.3	0.2	5.0	1.4	15.7	4.9	1.0	0.0	9.5	13.6	1.6	1.6	7.3	0.1	22.1	7.1	11.2	10.1	5.7	0.7	0.2	0.4	9.5	1.6	2.9	0.0	5.7	3.9	0.0	2.4	0.0	0.1	0.0	0.0	6.6	0.1	0.1	0.0	0.5	0.0	2.0	0.0	0.0	1.4	1.9	2.9	1.7	1.9	2.5	2.6	2.7	1.4	17.0	1.0	80.4	97.5	2.7	144.6	49.7	0.4	17.1	28.1	116.4	131.9	15.7	0.0	0.8	3.3	16.4	47.7	9.0	30.7	0.0	16.7	0.6	20.1	102.6	9.3	20.2	5.9	1.6	8.5	4.9	31.9	5.9	2.3	23.7	8.5	1.0	19.0	0.0	26.8	38.6	0.4	9.1	0.0	0.0	30.9	0.5	2.8	63.7	11.6	1.3	9.3	179.5
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 18.6;Peritubular cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	5.2	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	13.5	2.5	7.8	0.1	3.3	5.5	1.8	7.4	0.0	3.5	0.2	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	3.0	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4	3.0	3.8	3.2	3.2	1.0	4.3	3.4	2.5	13.4	3.4	8.7	3.9	0.4	0.0	0.9	9.6	5.8	2.6	0.0	1.7	0.3	5.1	1.7	4.6	6.8	1.9	1.6	2.9	6.7	6.1	6.1	16.4	4.6	18.6	3.6	1.1	9.9	0.4	0.0	16.6	2.4	3.3	0.0	5.2	0.9	4.3	1.3	0.2	1.3	1.6	0.7
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria		No	No		8700000	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.7	8.2	17.7	12.9	42.7	13.8	8.6	12.9	19.2	14.0	13.8	5.9	16.5	49.8	6.9	10.5	9.1	11.8	23.6	17.8	15.5	15.2	12.3	11.6	15.6	13.0	6.8	24.4	5.4	14.3	9.5	9.9	9.1	11.5	9.4	35.0	14.3	26.5	15.8	15.9	41.4	9.7	8.4	38.7	10.9	31.6	24.9	24.9	15.1	35.6	21.5	12.3	12.4	44.5	12.7	10.8	21.2	19.3	5.2	9.9	5.6	13.9	7.0	15.0	17.3	21.6	13.5	16.6	7.6	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2	26.8	26.0	29.0	45.8	13.9	7.3	194.2	61.1	81.7	36.4	33.2	3.9	27.5	135.9	37.9	159.1	14.3	244.0	46.7	28.1	33.2	15.5	29.6	10.4	229.1	96.2	6.4	31.2	19.0	32.4	78.4	42.8	17.2	20.3	6.4	71.1	24.6	30.7	84.2	33.2	241.4	5.7	38.8	30.8	25.1	20.1	15.8	14.2	16.2	172.2	38.7
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 231.5"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 11.6;Melanocytes: 32.1;Spermatocytes: 21.3;T-cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 42.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 42.2"	"Group enriched"	"Detected in many"	5	"JURKAT: 98.3;MOLT-4: 93.3;REH: 72.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	0.9	13.5	3.5	9.3	5.4	7.6	2.0	1.6	3.4	3.6	1.0	2.9	0.8	0.4	6.0	3.5	3.4	5.0	2.8	0.5	4.7	5.2	2.7	0.3	2.4	25.3	4.9	1.9	1.8	0.8	0.0	1.1	7.8	3.1	2.8	1.0	1.6	3.1	0.7	0.5	2.4	3.9	2.9	4.4	7.0	0.9	8.2	2.3	231.5	2.7	1.3	20.6	4.8	3.2	0.3	0.1	0.5	0.0	8.9	42.2	9.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.7	4.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.5	0.0	2.9	1.0	0.0	0.0	0.0	3.6	0.5	0.0	0.1	0.0	0.1	0.6	0.0	98.3	2.1	0.0	0.4	0.1	93.3	0.0	0.2	1.0	0.2	72.0	1.4	0.0	0.3	0.2	0.4	0.8	0.0	0.0	13.8	1.1	0.3	0.0	0.0	1.9	1.6	0.0	2.4	6.0	2.5	16.5	1.2	0.0	7.9	0.0	0.0	0.0	2.6	0.0	0.5	0.1	19.7	8.8	0.0	0.3	42.2	29.2	0.5	8.9	0.0	0.1	25.7	9.5	3.5	5.4	1.6	3.4	4.7	5.2	4.9	1.9	3.1	2.3	3.0	3.4	0.0	1.1	3.0	0.0	1.2	0.0	4.0	1.2	0.0	0.0	0.1	11.6	0.0	3.1	3.6	0.0	0.0	0.0	0.1	1.8	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.9	0.6	0.8	32.1	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.0	5.9	21.3	9.6	1.1	0.3	13.1	0.1	0.3
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620566-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 400.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	68.5	52.6	65.9	77.6	63.7	118.0	165.2	43.7	52.9	82.0	70.1	25.5	57.5	47.3	106.0	111.1	76.4	75.2	61.9	59.2	53.7	41.4	60.2	98.4	56.1	110.1	54.6	49.7	157.4	305.1	17.8	68.3	63.8	59.0	74.3	61.0	35.2	129.9	60.2	87.1	77.6	57.6	87.5	57.5	70.8	60.3	43.2	32.2	63.3	82.2	109.5	95.4	67.6	102.3	300.5	153.8	56.2	116.4	134.2	331.0	400.6	59.2	43.3	78.7	111.9	170.9	270.5	77.5	91.6	116.4	75.6	63.3	109.7	105.5	180.4	55.2	89.0	37.8	42.3	84.6	142.9	99.3	66.5	135.5	75.3	91.0	167.9	143.9	188.8	84.4	240.5	204.2	61.7	140.4	146.0	135.9	100.8	131.9	103.6	124.5	115.1	115.6	230.6	90.3	132.9	87.7	106.2	84.6	109.2	157.8	100.0	84.5	108.2	37.4	218.5	128.3	65.5	72.6	172.7	100.3	51.9	70.4	54.2	80.9	77.4	100.9	145.4	70.7	118.0	63.4	56.2	116.4	35.6	122.0	86.8	207.8	300.5	247.8	165.5	121.2	257.1	331.0	244.9	24.9	134.2	74.9	153.8	176.2	400.6	65.9	63.7	43.7	52.9	53.7	41.4	54.6	49.7	59.0	32.2	1313.2	2435.5	8127.2	9688.6	11162.7	321.1	1043.1	4914.6	1694.4	3137.0	2053.6	70.7	5336.7	5859.0	3087.8	1166.8	4211.1	1851.3	2850.1	7573.3	5633.2	3960.7	4740.0	3107.4	4896.8	3604.2	146.2	2618.2	5127.8	6804.9	1575.7	6923.4	6371.5	5538.7	4548.4	5463.9	625.8	5524.0	4699.4	3790.7	6994.4	382.0	1882.0	3701.7	706.0	481.2	13381.8	5336.0	5116.7	7038.7	7765.2
OSTC	DC2	ENSG00000198856	"Oligosaccharyltransferase complex non-catalytic subunit"	Q9NRP0	4	108650584-108667820	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 444.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (6.46e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.16e-3)"	"prognostic unfavorable (2.31e-8)"	"unprognostic (2.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-2)"	21.3	25.4	9.4	17.6	12.3	18.6	22.5	6.8	10.5	28.9	23.0	9.3	22.1	21.2	23.7	43.0	25.8	20.1	18.5	18.0	9.9	10.3	29.6	62.8	21.9	27.8	13.2	7.3	24.4	61.1	7.4	31.5	33.5	15.5	20.2	22.6	15.2	32.1	18.5	9.8	15.0	33.5	18.4	12.3	25.0	21.2	16.2	11.8	35.1	39.6	24.7	21.3	21.4	19.9	26.2	79.4	25.3	29.8	30.3	45.4	41.6	19.7	12.4	33.6	23.1	72.2	96.6	26.6	54.2	52.6	28.1	34.5	26.3	45.5	42.0	40.0	63.6	17.1	13.5	26.5	22.0	32.8	17.5	19.5	21.5	18.1	57.5	58.2	48.5	21.0	62.3	42.8	23.1	47.6	59.4	62.9	26.4	40.4	49.3	54.7	24.4	33.7	42.5	23.0	53.9	15.9	34.8	36.6	45.5	48.7	14.0	16.9	20.9	18.4	44.4	41.4	43.4	20.4	40.1	49.1	29.9	31.5	22.2	22.0	28.4	28.6	40.8	38.3	29.8	32.5	25.3	29.5	15.5	29.6	29.8	45.4	26.2	31.7	32.0	42.9	19.4	29.9	32.1	4.0	30.3	24.8	79.4	21.8	41.6	9.4	12.3	6.8	10.5	9.9	10.3	13.2	7.3	15.5	11.8	35.7	37.4	113.9	97.2	86.4	14.4	28.2	107.0	80.3	67.1	80.3	15.7	237.0	74.6	194.0	6.1	91.3	59.7	0.0	139.2	444.7	245.3	126.1	121.1	179.6	234.0	11.1	55.7	105.0	126.6	8.4	151.8	168.9	153.5	106.4	158.3	42.3	168.8	84.2	102.6	141.0	18.1	71.1	99.3	40.3	76.8	103.1	305.6	120.4	156.8	112.1
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742040-108763054	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.5;liver: 111.0"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Approved		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	1.2	1.9	50.8	1.3	51.3	1.2	1.3	7.9	53.5	1.3	1.2	13.4	0.0	1.3	1.4	1.2	1.3	1.2	1.4	3.2	37.5	20.1	6.2	111.0	1.2	1.2	26.0	28.7	1.3	1.2	1.4	0.1	1.2	15.7	1.2	1.2	0.5	19.9	1.3	1.6	1.2	1.2	1.2	7.3	1.6	10.4	1.5	18.7	0.0	1.9	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.1	11.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	2.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	51.3	7.9	24.9	37.5	20.1	26.0	28.7	15.7	18.7	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.6	1.0	1.3	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.4;retina: 22.1;testis: 23.6"	"Group enriched"	"Detected in some"	16	"Early spermatids: 89.3;Late spermatids: 22.6;Rod photoreceptor cells: 75.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HeLa: 31.5"	"Low region specificity"	"Detected in many"							HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Endoplasmic reticulum"	"HPA029107: AB_10600802"	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	9.0	0.8	6.7	0.2	4.4	0.0	5.1	0.8	3.4	1.6	0.9	0.4	0.9	4.0	2.1	3.5	0.8	1.4	3.1	2.0	4.7	2.1	2.9	3.2	0.9	0.1	0.8	0.0	1.6	0.9	3.9	17.4	0.4	2.5	0.9	0.4	22.1	6.7	1.4	1.4	1.1	3.1	1.5	0.9	1.0	0.9	23.6	1.5	0.0	3.7	0.1	0.0	1.6	3.4	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.9	0.0	0.1	0.0	2.3	4.2	31.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.2	4.0	0.0	0.5	0.0	1.2	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.4	0.8	3.4	4.7	2.1	0.8	0.0	2.5	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.8	0.0	0.0	1.2	1.8	3.9	0.0	0.0	0.0	89.3	0.7	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	1.3	0.0	22.6	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	75.2	0.0	3.4	3.2	1.5	0.1	0.0	0.0	0.0	0.0
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	25.5	20.2	15.8	18.3	16.5	26.6	34.5	26.9	18.9	21.4	20.0	16.8	19.9	15.5	26.2	19.2	22.6	18.9	18.7	20.5	14.2	12.1	18.9	49.5	20.4	17.8	15.7	11.8	24.9	20.4	30.7	27.7	22.3	15.1	19.1	18.3	22.5	20.2	28.3	37.0	25.8	17.4	25.5	14.8	17.4	18.0	12.1	16.7	31.7	20.8	18.3	21.9	24.9	31.1	13.9	15.7	14.6	13.7	15.7	16.1	10.6	12.1	11.1	17.7	13.2	21.5	21.6	10.1	15.9	19.5	13.6	12.1	10.1	14.1	11.3	8.4	24.1	11.7	10.3	19.7	15.9	20.1	13.8	9.8	11.7	10.2	11.1	14.5	15.4	13.8	21.2	20.4	15.5	18.8	19.3	20.0	11.7	17.8	10.3	20.0	9.9	22.3	7.2	6.7	15.1	9.0	14.5	15.6	6.5	16.5	15.2	12.5	10.0	12.3	26.2	9.4	19.0	7.7	6.0	18.4	16.0	10.7	13.9	11.3	10.0	12.5	10.8	14.2	6.2	12.8	8.2	12.3	14.6	12.3	13.7	13.7	13.9	13.7	12.8	15.7	11.6	16.1	13.2	12.3	15.7	13.2	6.2	11.9	10.6	15.8	16.5	26.9	18.9	14.2	12.1	15.7	11.8	15.1	16.7	23.8	12.5	8.6	17.6	31.5	21.9	25.7	17.8	13.4	17.0	5.2	5.9	10.9	5.0	8.9	3.3	20.2	15.4	23.3	11.2	7.7	14.2	18.4	10.5	24.5	10.7	15.9	15.0	17.8	22.5	5.9	19.0	12.9	16.9	3.6	15.3	19.7	10.8	15.6	20.5	8.4	20.7	12.9	15.0	13.0	13.6	32.0	13.5	12.5	13.2	27.8
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative beta subunit"	Q9NWR8	4	109560205-109688726	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 39.3;lymphoid tissue: 45.3"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	11.6	2.2	4.1	21.0	3.2	8.3	16.6	0.4	3.7	8.2	4.9	4.6	1.4	3.5	12.3	5.5	9.2	6.3	7.3	14.9	4.5	4.7	3.9	2.1	7.8	44.2	3.5	2.6	7.5	2.1	2.3	5.1	9.9	6.5	5.4	6.1	4.1	6.5	2.2	4.3	7.6	8.8	8.4	8.5	13.8	4.2	3.6	1.9	45.3	4.7	9.5	24.8	7.3	9.0	14.0	15.7	1.1	16.0	20.0	39.3	25.7	10.4	4.5	2.5	12.8	2.8	7.4	9.7	9.0	5.5	9.9	8.9	0.2	8.5	36.7	1.9	7.7	5.5	3.0	9.4	5.5	8.8	23.3	7.4	4.4	5.0	0.6	4.9	8.9	0.1	4.7	1.5	6.0	5.1	7.0	13.2	13.6	1.3	23.4	7.5	12.8	20.4	0.1	11.6	1.8	6.5	7.8	19.4	4.1	11.6	4.6	10.3	4.5	9.7	28.9	3.0	2.1	3.6	0.4	9.4	3.9	5.1	20.6	15.6	9.1	6.3	8.9	12.0	1.9	2.7	0.0	16.0	0.2	6.3	9.7	9.0	13.5	26.7	19.0	15.7	14.0	39.3	22.2	1.1	20.0	7.2	11.0	22.4	25.7	4.1	3.2	0.4	3.7	4.5	4.7	3.5	2.6	6.5	1.9	8.9	6.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	5.2	0.0	107.3	0.0	22.4	0.0	0.0	0.0	0.0	99.3	82.0	0.0	0.0	1.1	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	25.2	0.0	0.0	50.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	8.1	6.1	3.6	6.7	4.3	5.3	14.3	2.8	3.8	6.9	25.5	2.8	4.5	23.4	5.9	4.3	8.7	5.3	11.7	4.9	4.0	2.0	11.0	14.3	5.6	8.5	5.0	1.6	7.0	13.0	2.3	6.4	4.3	4.5	8.1	19.5	3.4	8.0	10.3	3.4	6.5	42.8	14.0	6.6	9.1	9.2	2.7	4.3	14.5	11.2	3.3	8.4	8.2	12.7	4.4	8.0	8.5	7.0	5.6	21.3	8.0	12.6	4.1	8.5	7.7	6.2	6.1	12.6	7.1	4.9	6.4	6.9	6.8	26.1	1.3	8.3	7.3	8.9	5.9	10.1	11.2	5.1	20.1	6.6	11.1	3.7	6.0	5.0	11.1	7.9	6.7	8.4	6.1	1.5	8.6	12.1	15.1	14.4	39.6	10.3	7.1	28.7	7.0	6.5	8.7	7.5	10.0	5.4	6.9	21.0	12.0	9.0	6.7	7.5	13.6	4.2	10.7	5.8	4.1	10.2	7.1	7.5	3.4	8.0	5.8	10.5	1.4	9.2	13.4	3.6	8.5	5.3	6.3	4.9	4.8	5.3	4.1	17.8	9.3	6.0	4.4	21.3	11.8	1.1	5.6	7.0	8.0	16.4	8.0	3.6	4.3	2.8	3.8	4.0	2.0	5.0	1.6	4.5	4.3	14.9	13.4	8.5	9.5	9.6	5.2	3.3	30.6	25.4	20.5	19.2	5.9	16.7	8.3	35.9	2.0	9.2	52.0	0.0	40.5	34.0	12.1	6.6	9.3	17.8	17.1	0.0	56.7	6.2	8.6	1.6	11.8	8.5	1.7	25.2	48.2	12.8	42.5	56.1	9.2	26.3	1.3	6.5	6.9	1.7	8.3	10.2	4.8	12.8	64.3	7.8
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730077	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA					"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	9.8	9.9	13.1	4.4	16.2	5.6	12.9	14.5	14.3	9.6	12.2	13.4	7.3	11.9	8.9	8.2	12.6	9.2	9.2	21.0	13.0	11.4	15.3	20.6	7.8	4.9	16.8	11.7	11.9	38.8	22.8	19.0	10.4	12.7	16.4	12.0	10.7	12.1	8.3	21.1	9.8	16.3	8.1	20.3	5.5	10.0	5.7	12.4	4.9	19.0	9.2	6.2	7.5	7.7	4.9	8.7	3.6	4.6	4.9	10.2	13.8	9.6	3.6	2.8	4.2	9.0	9.0	5.5	8.9	7.1	5.0	5.3	8.9	17.0	13.8	6.7	6.5	8.4	5.4	8.6	11.5	7.7	5.1	13.4	4.9	10.4	5.3	8.9	10.6	3.5	9.1	13.4	5.1	12.6	9.1	5.0	13.0	27.0	6.4	8.5	17.0	8.6	4.8	5.0	22.0	14.0	5.2	8.5	10.9	9.4	14.3	18.1	6.0	7.8	20.7	6.7	7.6	12.4	2.3	5.9	7.3	6.1	7.5	6.1	10.9	19.6	10.2	8.2	6.2	9.1	3.6	4.6	2.7	7.2	2.9	6.6	4.2	9.0	6.9	8.7	4.9	10.2	9.2	2.2	4.9	4.4	7.6	8.7	13.8	13.1	16.2	14.5	14.3	13.0	11.4	16.8	11.7	12.7	12.4	23.8	17.9	15.2	28.9	32.5	46.8	53.4	30.6	10.7	13.6	21.0	47.1	33.9	23.2	12.4	18.0	12.7	27.4	23.3	22.2	44.9	23.9	62.2	13.9	86.9	17.1	25.4	103.4	18.4	19.4	7.1	30.8	8.9	28.7	1.8	52.7	39.7	13.5	35.1	32.5	14.6	39.5	19.4	19.1	55.2	41.1	37.3	28.8	13.8	59.3	35.7
AC126283.2		ENSG00000285330			4	109713916-109801999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	13	"kidney: 61.8;liver: 135.8"	"Group enriched"	"Detected in some"	60	"Alveolar cells type 2: 2.9;Club cells: 9.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.6;EFO-21: 5.2;Hep G2: 9.6;RPTEC TERT1: 9.8"									"HPA001143, HPA024061, HPA035909"	Uncertain					NA	NA					"HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074"																		2.4	2.3	0.4	2.0	0.4	0.0	1.6	0.0	1.3	2.6	2.2	0.1	1.3	3.8	2.2	7.6	2.4	1.8	2.5	2.6	0.5		61.8	135.8	4.3	1.5	0.6	0.0	6.6	6.5	0.7	2.0	2.2	1.1	2.0	0.7	4.0	0.5	0.7	1.4	0.0	3.9	0.8	1.4	4.7	1.3	1.8	0.4	0.0	3.0	0.9	0.4	2.6	1.8	0.2	0.8	0.2	0.3	0.2	0.7	1.2	0.0	0.5	0.0	0.3	0.2	0.1	0.0	0.4	1.0	0.0	0.1	0.1	27.6	0.1	5.2	0.2	0.2	0.0	0.1	0.0	0.0	4.2	0.1	0.0	0.4	9.6	3.3	0.3	0.0	3.5	0.0	0.0	0.1	0.5	1.8	0.0	0.3	1.6	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.1	9.8	0.8	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	4.2	0.1	1.2	0.2	0.3	0.0	0.3	0.0	0.4	0.1	0.5	0.3	0.7	0.2	0.7	0.5	0.0	0.2	0.2	0.8	0.5	1.2											0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell type enhanced"	"Detected in many"	18	"Hepatocytes: 510.3;Muller glia cells: 130.7;Proximal tubular cells: 205.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 29.5;Hep G2: 46.8;HSkMC: 19.5;RPTEC TERT1: 52.4"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	29.5	0.0	9.4	0.1	0.2	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.1	46.8	2.0	0.0	0.0	19.5	0.0	0.0	0.0	1.3	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.4	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6	11.9	34.5	6.7	10.2	0.9	2.4	1.9	107.0	2.7	36.4	61.1	2.0	0.1	26.6	36.3	0.2	49.6	1.1	0.0	27.7	0.1	3.8	1.7	3.5	510.3	0.6	1.6	0.0	54.6	14.3	0.2	15.5	1.7	0.0	2.8	0.7	130.7	34.8	2.9	0.0	205.0	5.6	0.0	3.2	0.7	0.5	1.0	0.2	4.4	0.6	10.3
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	16.6	18.9	15.2	19.5	19.9	34.7	22.4	11.0	16.5	14.6	20.9	12.4	15.5	17.0	24.3	14.8	26.6	17.2	17.8	11.6	14.2	13.3	15.6	20.0	13.7	17.2	15.5	17.1	20.2	24.1	15.7	19.1	24.8	13.8	17.3	21.0	14.5	23.3	17.5	13.8	25.4	16.3	19.0	18.1	18.8	15.1	27.7	16.3	29.5	17.3	27.6	22.4	15.5	15.5	11.3	9.3	7.4	9.3	9.5	10.7	4.3	15.9	18.5	12.7	17.2	6.8	9.7	11.0	16.6	9.0	13.7	11.1	28.8	20.2	38.8	10.9	12.5	14.6	7.6	23.3	16.5	22.8	11.5	22.9	23.2	16.7	31.5	16.5	49.5	12.2	8.8	17.3	16.9	12.1	9.6	16.6	17.9	55.2	11.9	16.8	34.0	30.6	34.2	20.7	25.2	22.4	20.7	20.8	14.4	18.0	22.4	18.7	19.2	10.4	27.2	14.7	10.1	9.6	14.8	14.4	13.7	19.2	10.1	21.1	15.1	24.5	48.0	9.8	24.3	14.8	7.4	5.9	3.3	9.7	9.3	10.3	11.3	9.2	9.8	9.3	10.0	10.7	9.9	1.0	9.5	8.0	9.2	9.6	4.3	15.2	19.9	11.0	16.5	14.2	13.3	15.5	17.1	13.8	16.3	3.0	13.4	29.0	25.3	51.4	11.1	12.3	15.3	34.8	30.7	15.7	13.7	56.9	21.6	40.4	1.1	23.2	12.3	46.7	46.3	54.6	20.3	18.3	18.5	18.7	31.5	4.8	17.9	17.8	12.3	3.6	20.4	16.5	16.9	10.8	34.7	25.7	41.7	24.6	17.7	33.6	8.6	6.5	18.6	42.1	37.3	52.4	73.5	17.0	40.4	30.3
RRH	peropsin	ENSG00000180245	"Retinal pigment epithelium-derived rhodopsin homolog"	O14718	4	109827994-109844604	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"retina: 66.3"	"Cell type enriched"	"Detected in single"	53	"Muller glia cells: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.1;U-266/84: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.18e-2)"	0.4	1.4	1.3	0.5	1.2	0.3	2.1	3.7	1.8	0.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.4	0.4	1.2	1.2	1.9	1.0	0.4	0.5	1.2	0.6	0.6	0.5	0.7	0.5	0.4	0.4	0.9	0.8	66.3	0.5	0.7	0.7	2.3	0.4	0.4	0.8	0.5	0.4	0.7	0.4	0.4	0.9	0.4	0.4	0.4	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.9	0.7	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.2	0.3	0.9	0.8	0.3	0.0	0.0	2.2	0.1	0.2	1.0	0.9	0.1	0.0	0.3	0.1	1.5	0.0	0.0	4.1	0.0	0.3	0.4	0.2	0.7	1.0	0.3	0.7	0.1	1.2	1.6	0.5	0.7	0.2	1.0	0.2	0.6	2.1	0.2	1.1	0.3	0.0	0.4	0.1	0.5	0.8	0.5	0.4	0.0	0.3	0.5	0.1	0.6	4.7	0.0	0.3	0.5	1.1	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	1.3	1.2	3.7	1.4	1.2	1.2	1.2	0.6	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848202-109872315	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 17.1"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.6	0.6	0.7	0.6	1.2	0.4	1.7	2.0	1.3	1.2	0.6	0.6	0.6	0.3	0.7	1.8	0.6	1.0	0.6	0.6	0.8	0.7	4.4	0.7	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.6	0.6	0.6	0.9	0.5	17.1	0.8	0.6	1.6	3.2	0.6	0.6	0.6	0.8	0.2	1.3	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.1	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.0	0.6	0.6	0.0	0.0	0.1	1.3	0.1	0.2	0.3	1.6	0.3	0.4	0.2	0.1	1.3	0.0	0.0	2.0	0.1	0.3	0.2	0.1	1.3	0.3	0.6	0.0	0.0	0.9	1.0	0.2	0.8	0.2	0.6	0.0	0.2	1.0	0.3	0.5	0.0	0.0	0.4	0.0	0.3	0.1	1.2	0.0	0.3	0.3	0.6	0.3	0.6	1.0	0.0	0.3	0.9	0.3	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.7	1.2	2.0	1.3	0.8	0.7	0.6	0.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	31.4	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912884-110012266	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 38.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;SK-BR-3: 14.9;U-251 MG: 4.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA	209000	25000				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.8	0.1	0.4	0.0	0.4	0.0	5.9	0.1	0.9	0.2	0.2	0.3	0.3	0.0	0.3	2.6	0.9	0.2	0.3	2.3	0.8	0.3	48.4	0.0	0.6	0.0	1.2	0.7	0.0	41.2	0.0	0.4	0.0	1.4	0.6	0.4	3.9	8.4	0.1	19.8	0.5	0.2	1.9	0.6	0.2	0.0	0.2	0.2	0.0	1.2	4.5	0.4	0.4	0.5	0.0	0.4	1.7	0.0	0.0	0.0	2.6	0.2	0.3	2.4	0.1	0.0	0.1	0.0	0.6	1.5	0.8	0.5	0.1	0.1	0.0	8.2	0.8	2.1	0.0	0.3	0.0	0.6	0.1	0.4	0.1	0.9	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	1.6	0.2	0.8	0.1	0.0	0.0	2.9	0.0	0.6	0.2	0.1	0.7	0.7	0.2	0.0	0.0	0.0	14.9	0.5	1.8	3.5	0.0	0.0	1.3	2.0	0.0	4.7	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	2.6	0.4	0.4	0.1	0.9	0.8	0.3	1.2	0.7	1.4	0.2	0.0	0.0	0.0	0.1	0.9	0.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	2.2	0.0	0.4	0.0	4.9	0.0	0.0	1.5	0.0	0.0	0.1	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	38.3	1.6	0.0	0.0	1.2	1.1	0.0	0.0	0.5	0.3	1.3	0.0	0.0	1.6	0.1
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.9"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 35.3;Hepatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 5.6;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA					"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	7.6	9.8	7.7	7.9	9.4	3.7	7.9	10.9	12.3	4.0	14.5	8.6	0.9	11.8	3.4	2.7	16.6	2.9	11.1	8.1	6.6	5.9	6.4	43.9	3.3	2.2	7.5	9.4	2.0	2.5	10.6	7.1	2.6	15.7	3.0	14.1	4.3	6.9	3.2	1.4	12.3	10.2	5.7	20.0	1.9	16.9	1.3	7.3	1.1	2.3	7.9	4.0	6.0	5.0	0.1	0.0	0.2	0.1	5.6	4.9	0.8	13.4	8.0	29.3	7.3	19.7	20.7	15.0	9.4	4.6	3.3	7.4	3.9	23.7	1.1	0.8	7.2	11.3	12.6	22.2	27.5	7.7	4.6	6.4	15.2	8.7	10.2	12.2	14.8	9.9	18.0	6.4	16.8	8.0	10.9	6.5	1.6	18.1	31.5	7.3	7.1	3.4	1.5	13.4	8.2	4.8	2.3	11.5	3.9	21.4	10.1	5.2	11.2	4.8	32.0	4.1	13.9	5.4	0.1	2.4	6.7	7.9	11.2	11.4	1.5	4.9	24.9	10.2	0.0	1.7	0.2	0.1	0.1	4.8	0.0	4.9	0.1	2.1	3.2	0.0	0.1	0.7	2.3	0.2	5.6	0.0	0.0	0.2	0.8	7.7	9.4	10.9	12.3	6.6	5.9	7.5	9.4	15.7	7.3	0.0	5.6	0.0	2.3	1.5	22.3	2.4	7.6	1.4	6.8	10.4	35.3	1.2	5.0	6.1	3.7	1.1	16.0	0.0	7.3	21.6	3.9	2.4	5.8	43.3	1.6	25.4	2.9	4.3	2.7	2.7	1.1	0.7	0.0	0.0	12.4	4.4	12.1	24.6	1.1	5.6	15.9	6.5	3.8	0.2	1.2	6.0	1.7	12.8	12.4	4.4
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.1;kidney: 63.8"	"Cell type enhanced"	"Detected in many"	14	"Proximal tubular cells: 153.4;Sertoli cells: 155.2;Smooth muscle cells: 60.8;Syncytiotrophoblasts: 49.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HEK 293: 11.4;MOLT-4: 2.7;SuSa: 8.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005128	Enhanced					NA	NA		37000000			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	5.8	1.0	0.4	0.4	0.6	0.0	2.8	0.3	1.0	1.1	54.4	0.4	0.7	11.1	5.3	2.4	0.8	1.4	1.1	2.3	0.5	0.3	63.8	14.5	2.7	0.5	0.4	0.3	1.0	1.0	33.3	0.8	4.4	0.5	1.4	0.0	0.8	0.6	0.5	2.3	0.4	165.1	3.1	0.5	4.7	0.7	0.4	0.4	1.4	2.4	2.0	0.4	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.1	0.2	4.2	0.6	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.5	2.7	0.5	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.1	0.2	0.0	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	1.0	0.5	0.3	0.4	0.3	0.5	0.4	0.0	1.3	0.0	0.1	1.4	0.0	3.3	0.0	0.0	0.0	10.4	0.0	33.0	14.9	0.0	0.4	1.4	2.6	0.0	0.0	2.7	19.7	0.1	0.0	24.1	2.4	0.0	1.7	1.8	0.3	0.0	0.6	0.6	0.0	0.0	0.8	0.0	0.0	0.8	0.4	153.4	0.0	155.2	60.8	0.0	0.2	0.9	49.0	1.3	1.1	0.1
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.4;retina: 53.5;skeletal muscle: 28.8"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"hypothalamus: 2.1;midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7"	"Region enhanced"	"Detected in single"		"hypothalamus: 9.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 5.1"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.6	0.1	0.0	18.6	0.0	0.1	0.3	0.0	0.1	1.1	3.0	0.0	0.3	0.1	0.1	1.3	2.7	0.2	1.1	3.5	0.0	2.1	0.3	0.1	0.1	0.1	1.1	0.0	0.1	0.5	0.1	12.5	30.4	0.0	8.3	0.3	53.5	9.3	0.2	28.8	0.9	3.4	15.9	0.0	0.1	0.5	0.3	0.0	0.0	0.1	16.8	0.4	19.4	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	1.9	0.0	0.7	1.9	1.6	3.0	0.6	0.3	2.0	1.5	18.1	0.0	0.0	3.9	3.7	2.4	0.3	0.1	0.0	1.1	0.0	8.0	0.0	1.4	0.0	6.7	0.0	3.8	2.1	0.1	0.3	0.0	0.6	0.0	2.0	0.5	0.0	18.6	0.5	2.0	0.0	0.3	0.0	0.3	0.0	15.7	0.0	0.3	2.5	0.0	0.0	1.4	2.5	0.2	0.3	0.1	0.0	0.0	2.5	5.9	0.0	2.9	0.0	0.1	0.8	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	12.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	6.5	0.0	0.3	5.4	4.5	0.2	0.0	0.0	6.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	1.7	1.2	5.6	0.1	8.8	0.0	1.2	0.0
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145397-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 49.5"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 56.6;Alveolar cells type 2: 52.1;Ciliated cells: 77.6;Club cells: 67.1;Collecting duct cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.5;HUVEC TERT2: 18.3"	"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	43.2	4.8	3.3	11.9	3.0	7.0	49.5	3.6	3.1	6.9	9.5	4.6	10.7	3.1	8.9	6.0	7.6	5.2	6.2	18.5	4.3	3.0	6.4	6.9	10.2	7.2	5.6	1.8	5.2	3.8	7.1	6.3	12.6	3.4	9.7	3.2	2.8	22.3	17.2	11.6	7.2	4.7	9.0	4.3	9.7	8.3	7.7	3.6	6.3	8.5	7.3	6.0	9.3	24.7	2.7	2.8	5.7	1.7	1.7	1.7	0.7	4.0	1.6	1.6	1.3	8.6	4.9	2.5	3.4	0.8	0.6	1.1	1.2	5.1	26.5	3.2	1.8	2.3	1.9	2.6	3.6	1.2	12.4	4.3	2.9	3.9	2.1	5.1	6.5	1.7	5.3	5.8	1.0	6.2	1.3	18.3	3.8	5.3	12.8	2.1	4.1	2.4	4.7	2.1	6.6	3.8	5.4	2.7	5.4	2.7	3.9	3.0	2.5	3.2	5.9	1.6	2.5	4.2	2.8	11.5	2.1	6.3	1.4	1.2	5.4	7.0	12.2	4.9	3.2	2.7	5.7	1.7	1.6	1.5	1.3	1.3	1.5	1.6	1.1	0.9	2.7	1.5	1.7	4.2	1.7	1.6	2.8	1.7	0.7	3.3	3.0	3.6	2.4	4.3	3.0	5.6	1.8	3.4	3.6	56.6	52.1	0.0	0.0	0.0	0.0	0.0	0.0	77.6	67.1	31.4	0.0	1.4	6.6	11.8	0.0	0.0	0.0	0.0	14.9	2.2	0.0	0.0	30.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	8.2	0.0	0.0	21.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
AP1AR	"2C18, C4orf16, gamma-BAR, PRO0971"	ENSG00000138660	"Adaptor related protein complex 1 associated regulatory protein"	Q63HQ0	4	112231737-112270047	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035863, HPA058115"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035863: AB_10672098, HPA058115: AB_2683610"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.15e-2)"	"prognostic favorable (4.05e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-3)"	"prognostic favorable (7.79e-4)"	11.6	17.8	16.3	12.7	24.0	3.7	18.6	22.1	23.6	10.1	18.9	8.3	16.8	23.4	13.4	9.3	16.5	8.7	13.9	9.2	22.1	16.3	24.4	21.8	11.5	12.2	16.5	16.1	15.3	11.7	37.6	9.6	12.8	18.1	10.3	18.0	6.8	16.5	14.8	9.4	15.7	25.9	14.1	11.9	13.8	13.6	15.4	15.2	10.2	12.5	11.5	12.9	13.3	14.9	9.0	11.2	5.9	12.0	10.5	11.8	6.2	10.1	5.5	11.8	11.9	10.7	7.9	12.0	9.3	22.4	6.7	8.1	5.3	19.8	23.4	8.0	5.9	8.0	4.7	11.8	7.2	11.6	26.8	7.4	7.7	6.2	16.6	16.5	18.8	12.4	8.6	16.5	6.1	17.1	5.5	10.5	12.0	8.6	19.5	7.1	9.7	17.0	12.4	9.3	21.9	5.9	14.9	13.6	12.0	13.0	7.2	13.0	16.9	6.4	23.1	16.8	6.2	7.6	6.5	9.7	9.5	11.8	14.3	7.7	17.9	31.7	27.0	9.9	7.2	8.2	5.9	8.9	3.0	5.4	12.0	7.2	9.0	8.4	8.2	11.2	8.0	11.8	11.6	1.4	10.5	9.5	5.5	8.7	6.2	16.3	24.0	22.1	23.6	22.1	16.3	16.5	16.1	18.1	15.2	8.9	15.0	7.5	6.8	18.7	7.3	17.1	20.4	20.1	20.5	15.7	2.0	4.8	10.0	7.3	86.3	14.3	28.4	0.0	8.7	3.6	12.7	10.6	5.8	23.6	13.1	9.5	30.4	9.8	19.2	42.7	4.4	13.9	21.9	8.2	16.1	9.5	10.7	14.2	9.6	19.5	7.0	0.0	18.4	9.1	5.5	27.4	2.6	7.0	13.5	12.6
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274542-112285903	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	5.7	6.4	3.3	16.7	3.8	19.2	7.4	6.1	4.5	7.0	3.9	2.0	8.4	3.4	3.6	2.3	14.3	4.0	4.2	7.9	4.7	2.1	4.1	14.6	6.7	22.9	5.4	1.6	9.2	32.2	4.1	3.3	7.4	3.9	6.6	3.7	5.4	21.3	4.5	4.0	9.0	8.7	4.7	4.0	20.3	7.1	3.0	4.8	12.5	14.8	7.8	23.2	7.2	7.3	23.2	7.0	11.3	3.8	9.1	17.7	6.1	7.0	1.8	2.6	4.4	3.2	2.6	5.3	5.6	10.6	3.6	6.1	0.9	6.3	21.5	4.6	2.2	5.3	2.1	3.6	4.3	7.5	17.4	2.1	2.1	4.3	2.0	2.2	6.7	2.9	3.5	2.4	3.8	4.2	6.1	5.6	6.0	2.1	46.1	4.7	3.5	11.8	3.7	0.5	4.3	2.3	20.6	6.7	14.3	7.9	4.8	6.1	6.3	4.5	9.5	2.2	1.2	4.0	9.7	4.2	5.7	6.7	4.7	4.4	28.9	26.5	39.8	5.3	4.5	4.1	2.9	3.8	2.0	6.3	2.7	10.3	21.2	11.7	11.0	7.0	23.2	5.4	6.6	11.3	9.1	3.2	6.5	17.7	6.1	3.3	3.8	6.1	4.5	4.7	2.1	5.4	1.6	3.9	4.8	17.9	20.6	34.4	9.9	18.9	1.0	14.1	10.2	6.7	11.4	12.2	0.0	42.8	16.6	12.7	0.0	14.5	5.8	0.0	21.2	17.8	22.6	27.2	3.5	8.5	16.0	0.0	8.6	4.9	10.7	0.0	8.3	11.2	32.1	6.4	7.0	11.3	12.9	3.6	10.3	6.3	0.6	6.5	13.4	0.9	3.0	22.7	66.4	27.3	6.5	10.7
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA027435, HPA027443"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.17e-4)"	15.1	10.6	5.3	8.3	7.7	17.3	9.3	1.3	5.9	10.8	9.5	5.8	3.0	4.5	9.8	9.2	8.8	9.2	7.5	6.1	6.1	2.3	10.8	13.4	13.2	11.4	9.7	1.0	17.4	9.7	11.0	14.0	11.5	6.6	14.0	7.8	9.6	10.4	6.8	5.0	11.8	12.1	11.3	16.6	16.2	7.4	4.2	8.5	13.7	12.4	4.7	13.7	13.6	11.6	0.9	3.2	16.3	4.3	0.4	0.8	1.2	1.6	5.0	1.6	0.3	6.6	10.6	2.0	1.9	3.5	2.6	3.3	0.5	7.7	5.1	3.3	3.3	5.3	1.1	1.7	3.0	3.9	6.5	1.7	3.6	2.0	0.4	10.6	2.2	2.2	13.1	8.6	3.8	7.9	5.9	1.0	2.7	0.9	8.9	5.0	3.1	1.3	2.0	0.4	3.7	1.3	0.6	1.1	1.6	3.9	1.9	0.5	0.8	1.8	6.6	2.9	0.3	3.0	4.1	1.9	2.4	2.1	3.7	1.3	2.3	0.7	4.4	5.7	4.6	2.1	1.3	3.2	1.4	0.2	4.3	0.6	0.8	0.6	0.1	3.2	0.9	0.8	0.6	16.3	0.4	1.9	0.5	0.0	1.2	5.3	7.7	1.3	5.9	6.1	2.3	9.7	1.0	6.6	8.5	11.9	20.3	0.9	9.4	2.6	0.2	3.1	0.0	20.1	13.6	5.2	0.0	4.0	0.0	5.6	7.5	5.5	7.0	0.0	5.8	2.6	4.1	7.1	5.8	5.8	8.7	0.0	1.2	5.5	14.8	1.6	3.4	14.0	6.8	10.0	8.5	11.3	6.3	8.6	7.1	4.0	0.2	6.5	5.1	0.7	0.5	4.0	6.1	2.2	5.7	10.3
NEUROG2	"Atoh4, bHLHa8, Math4A, ngn-2, NGN2"	ENSG00000178403	"Neurogenin 2"	Q9H2A3	4	112513516-112516172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.1;testis: 5.1"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 8.2"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 68.9"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"hippocampal formation: 17.3"	CAB012342	Uncertain					NA	NA					"CAB012342: "	"unprognostic (1.09e-1)"	"unprognostic (2.52e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.75e-2)"		"unprognostic (1.04e-1)"	"unprognostic (1.13e-3)"						"unprognostic (1.02e-1)"	"unprognostic (3.30e-1)"		0.4	0.1	3.0	0.0	3.6	0.1	1.2	4.1	1.6	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.9	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.6	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	68.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.6	4.1	0.8	3.9	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 19.0;Spermatocytes: 17.1;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030704: AB_2673577, HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	2.5	1.8	3.3	4.9	4.8	13.8	2.8	13.8	6.5	2.5	2.4	0.5	0.1	2.6	2.6	1.5	3.0	2.1	1.3	1.5	3.1	1.0	1.6	1.6	2.7	5.0	2.5	3.3	3.2	2.2	0.9	4.5	3.5	3.5	2.1	3.1	1.1	2.7	2.3	2.9	3.0	3.2	2.1	4.2	3.8	2.6	7.3	4.1	17.0	2.7	2.2	5.8	2.1	2.5	2.5	2.8	1.3	2.9	1.1	1.6	0.4	3.7	2.7	9.4	6.6	0.7	1.3	3.6	6.7	2.8	6.8	6.1	5.2	5.6	9.8	2.0	2.0	2.8	3.0	9.7	3.5	7.8	5.3	2.5	6.1	4.3	1.6	0.3	13.7	4.1	0.6	0.4	8.5	2.3	0.9	2.7	10.5	8.7	11.1	4.6	6.1	18.3	5.0	4.9	3.9	3.3	10.3	14.0	3.3	1.2	3.3	4.4	7.4	3.0	4.1	1.2	7.2	1.9	4.0	3.2	8.6	8.4	4.5	5.3	4.2	7.3	13.1	3.9	4.7	4.8	0.0	0.6	1.3	1.0	2.9	0.6	1.3	0.5	0.2	0.1	2.5	1.6	1.6	0.9	1.1	0.7	2.8	1.0	0.4	3.3	4.8	13.8	6.5	3.1	1.0	2.5	3.3	3.5	4.1	0.0	2.2	6.4	1.2	0.0	9.0	2.0	0.0	1.4	6.8	1.8	7.9	1.9	0.0	0.8	2.3	0.7	0.7	0.0	0.4	2.7	1.4	1.0	2.3	0.4	1.5	4.8	1.2	0.0	1.0	1.4	0.6	2.6	0.0	0.0	1.1	2.0	0.5	0.9	2.1	0.3	19.0	0.0	0.8	17.1	11.5	0.0	0.7	2.2	1.2	0.4
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein domain family member 7"	Q4G0J3	4	112636964-112657592	"Disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	22.9	20.2	26.5	24.2	37.0	23.9	23.9	32.5	33.2	26.8	24.7	15.0	24.5	20.7	26.8	23.3	26.4	21.9	20.0	38.3	34.3	21.3	38.8	26.9	18.1	25.6	33.3	26.5	26.3	14.4	21.4	42.6	23.1	34.7	27.3	23.9	11.5	19.2	19.9	35.5	19.1	35.2	31.1	46.9	32.4	20.0	16.0	41.2	27.5	26.4	21.2	25.2	30.1	20.9	23.8	34.6	30.7	27.8	17.8	19.2	10.4	11.2	11.2	23.6	11.9	16.2	18.9	11.9	14.3	12.0	13.3	12.7	7.7	17.9	27.6	12.7	13.7	12.6	7.6	22.2	12.9	18.0	23.1	15.7	15.8	9.4	12.1	12.0	37.4	23.5	15.1	15.3	11.9	7.0	18.6	12.5	13.4	19.2	14.2	17.2	9.7	30.0	13.9	60.8	19.2	8.4	16.9	18.9	12.0	20.6	12.3	13.0	17.9	9.2	22.8	14.1	41.2	10.0	14.7	12.0	12.6	12.7	12.7	15.2	9.5	15.9	28.0	16.2	14.0	13.3	30.7	15.0	25.3	18.5	20.7	16.5	23.8	18.8	19.2	12.3	22.8	18.4	17.8	18.3	17.8	27.8	34.6	18.1	10.4	26.5	37.0	32.5	33.2	34.3	21.3	33.3	26.5	34.7	41.2	89.3	68.1	68.6	56.9	22.0	61.3	101.6	96.8	136.5	94.4	45.4	27.5	68.0	94.5	57.3	9.9	57.6	66.6	0.0	56.1	62.9	53.2	37.8	100.6	146.5	61.4	55.6	37.3	81.6	89.8	8.5	87.5	66.9	23.6	73.1	66.9	107.4	53.1	75.9	94.0	93.8	47.4	116.4	44.3	77.9	66.8	18.2	84.0	66.0	67.8	40.9
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell type enhanced"	"Detected in many"	21	"Bipolar cells: 313.8;Cone photoreceptor cells: 451.6;Horizontal cells: 1352.3;Rod photoreceptor cells: 483.8"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.5;ASC TERT1: 22.9;RH-30: 31.5;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.4	4.2	16.5	22.9	0.0	1.1	1.9	0.7	2.1	4.1	0.0	4.3	1.4	3.7	2.5	0.0	7.6	0.4	0.6	1.9	6.3	2.5	0.0	1.7	1.0	1.0	0.7	9.8	1.7	0.9	4.0	2.7	0.0	0.2	0.0	7.0	3.5	0.1	0.2	0.0	5.4	0.0	1.8	0.5	31.5	0.0	0.1	0.0	8.4	15.8	0.1	0.3	5.4	7.4	0.1	0.6	0.0	3.2	1.8	0.2	1.9	4.2	1.2	0.6	12.9	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2	0.0	3.8	0.0	0.0	9.3	313.8	152.3	0.0	1.4	2.3	19.2	451.6	0.1	13.3	0.0	92.0	11.6	0.0	0.0	1.5	0.1	44.2	0.4	1.1	0.4	0.8	1352.3	63.4	0.0	0.0	26.4	33.6	1.0	16.9	1.0	0.0	40.0	0.1	0.0	28.3	129.2	483.8	6.5	20.5	1.1	1.5	8.3	0.0	0.0	0.1	0.1
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.5	16.1	5.4	35.2	67.4	5.7	34.1	22.8	13.4	11.6	9.8	4.1	20.9	5.0	23.7	17.0	0.5	10.0	5.3	13.7	8.0	2.5	0.0	5.3	11.2	17.9	0.0	0.0	43.0	7.3	10.4	25.8	21.3	11.9	2.6	0.8	9.3	25.3	3.9	2.1	0.8	2.3	13.9	5.4	4.0	18.9	0.1	13.7	9.9	4.3	4.4	4.6	6.9	4.6	14.0	0.1	5.6	7.1	35.5	8.4	15.1	6.7	7.3	3.6	17.9	18.3	1.3	16.7	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5	38.7	29.9	22.6	16.0	16.4	72.0	243.3	58.6	20.1	28.4	27.9	82.5	0.4	5.0	6.4	2.9	29.8	57.0	0.0	17.5	0.4	34.7	31.3	9.3	49.4	15.8	68.3	99.5	19.6	16.8	4.5	18.7	21.0	5.0	2.8	82.1	41.3	11.4	45.6	18.7	17.7	71.5	6.5	33.3	2.9	4.4	27.9	0.9	17.5	41.1	16.3
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 32.8;Basal glandular cells: 42.2;Glandular cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 20.4;HUVEC TERT2: 18.4;LHCN-M2: 18.6;TIME: 23.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 15.4"	"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA			"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	3.5	2.2	2.6	2.0	2.7	0.0	2.6	10.3	3.4	7.9	4.7	0.9	4.1	1.0	4.8	2.2	9.1	4.6	6.0	5.2	1.5	1.2	9.4	3.4	6.9	3.5	1.8	3.6	4.7	2.6	13.3	1.8	6.7	4.2	7.2	5.4	1.8	9.1	3.9	0.8	1.7	1.7	10.5	2.9	0.5	5.8	0.9	2.0	0.6	1.9	3.6	1.7	7.5	18.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	2.5	0.2	0.0	4.5	9.3	0.0	20.4	15.5	12.8	5.0	0.5	1.4	0.0	2.6	9.6	4.5	2.2	0.1	5.0	16.1	0.0	0.9	0.0	2.0	0.0	13.9	0.0	0.0	5.7	5.1	8.6	17.8	9.0	18.4	0.0	0.0	0.0	18.6	0.1	0.0	0.0	0.6	0.0	3.7	0.0	2.2	0.0	16.8	0.0	0.0	0.7	1.3	0.2	0.9	3.4	0.1	0.0	23.4	14.8	4.0	2.2	9.6	0.0	0.0	0.0	7.2	0.0	4.5	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	10.3	3.4	1.5	1.2	1.8	3.6	4.2	2.0	32.8	9.8	0.0	42.2	2.6	0.1	0.9	10.2	4.0	12.5	24.4	0.0	0.3	0.0	7.3	0.0	4.0	0.9	0.0	0.7	0.1	13.6	38.6	0.0	1.3	0.4	1.6	22.5	3.7	0.0	0.0	2.3	0.7	3.3	0.0	16.4	5.2	3.6	2.9	1.4	2.9	0.1	0.0	15.1	0.0	0.2	1.0	0.3	0.5	4.3	22.3
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598455-114678224	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.6"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 7.3;naive B-cell: 10.6"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.9	0.8	13.2	2.8	30.0	1.0	3.1	2.7	44.8	4.9	15.5	66.6	0.0	18.4	2.7	0.6	1.2	3.0	7.1	0.9	24.2	12.4	20.1	0.8	1.0	3.2	53.9	15.9	0.8	4.8	0.3	0.9	0.5	38.3	0.9	17.3	0.0	4.5	0.8	0.8	1.8	16.1	1.5	96.6	1.3	10.0	3.3	42.6	0.0	8.5	0.0	3.4	0.8	1.0	10.6	0.0	0.9	0.0	0.0	0.6	0.3	0.2	0.1	1.7	0.3	0.1	0.0	0.3	0.1	0.0	0.0	1.2	5.8	21.5	6.4	0.5	0.1	5.1	9.1	0.0	0.0	0.0	0.1	4.5	0.1	9.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.1	5.4	1.3	0.0	0.1	0.1	0.7	2.5	41.1	3.2	0.6	10.3	0.1	21.3	0.2	12.1	1.8	0.0	1.9	0.3	0.4	0.3	2.1	0.4	0.5	7.3	0.3	6.8	2.1	0.3	0.2	10.6	0.3	6.6	0.2	0.0	0.9	0.0	0.0	0.6	7.3	0.1	0.0	0.0	10.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	13.2	30.0	2.7	24.4	24.2	12.4	53.9	15.9	38.3	42.6	6.0	1.0	8.1	1.2	0.0	0.0	0.4	7.6	2.7	6.8	24.4	0.0	0.0	8.3	1.8	5.5	0.1	20.6	0.0	11.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	46.4	0.0	0.0	1.7	1.1	0.7	1.7	0.0	25.7	0.0	9.1	17.5	0.0	1.3	0.0	0.0	0.2	10.6	36.2	0.1	0.0	0.0	21.1	0.9
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	17	"pons and medulla: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011129	Uncertain					NA	NA					"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.1	0.0	1.3	0.0	1.7	0.0	0.1	0.2	3.4	1.4	0.3	0.3	0.3	0.1	1.5	0.0	0.1	0.1	0.3	0.1	0.7	1.9	0.1	0.0	0.1	0.0	1.3	1.4	5.7	0.1	0.0	0.6	0.0	34.6	1.5	0.1	0.0	0.5	0.6	0.1	0.2	0.1	1.6	1.0	2.5	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.2	1.7	0.7	1.9	1.3	1.4	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
MTRNR2L13		ENSG00000270394	"MT-RNR2-like 13"	S4R3P1	4	116298876-116300320	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 11.5"	"Cell type enriched"	"Detected in some"	39	"Cardiomyocytes: 161.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.9"	"Group enriched"	"Detected in some"	5	"HeLa: 8.3;Hep G2: 4.4"														"Secreted - unknown location"	NA	NA										"unprognostic (6.40e-2)"					"unprognostic (2.88e-1)"			"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"				1.7	2.5	0.6	0.2	1.1	0.4	0.6	0.6	1.8	0.6	1.2	0.0	2.9	0.5	0.6	1.0	0.6	0.6	0.4	3.3	0.6	0.6	2.3	1.4	0.9	1.7	0.6	0.5	0.6	0.6	0.0	0.6	0.4	2.7	0.6	1.1	0.2	1.2	0.4	11.5	0.6	1.0	1.1	2.6	0.6	0.6	2.0	1.2	0.0	0.6	1.4	0.2	1.0	0.6	0.4	0.2	4.9	0.4	0.3	0.2	0.3	0.3	1.1	0.1	1.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.1	0.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.1	8.3	4.4	0.1	0.1	0.4	0.4	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.4	0.3	1.2	0.1	0.4	0.2	0.1	0.5	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.4	1.0	0.1	0.3	0.1	0.3	0.2	0.1	0.2	0.4	0.2	0.2	4.9	0.3	0.2	0.2	0.0	0.3	0.6	1.1	0.6	1.8	0.6	0.6	0.6	0.5	2.7	1.2	0.0	0.0	0.0	4.2	0.1	0.0	161.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.5
TRAM1L1	MGC26568	ENSG00000174599	"Translocation associated membrane protein 1 like 1"	Q8N609	4	117083554-117085576	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 6.9;Horizontal cells: 4.8;Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.6;U-138 MG: 11.8;U-266/70: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044560	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA044560: AB_10796097"	"unprognostic (9.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	2.1	4.3	7.8	1.1	10.0	0.3	7.3	5.6	14.9	4.6	1.8	9.4	0.0	0.9	3.4	10.5	1.6	6.8	3.1	2.2	8.8	8.6	11.9	0.5	2.9	1.0	8.5	5.9	4.1	5.0	0.6	8.5	1.2	10.3	7.5	2.2	4.5	2.5	4.7	0.7	4.1	1.1	3.6	10.3	1.2	3.2	5.9	7.4	0.0	8.4	0.3	0.9	3.2	1.2	0.1	0.2	0.0	0.0	0.1	0.2	0.0	1.4	1.0	4.5	2.2	0.0	0.0	0.0	0.6	0.5	0.9	2.7	0.1	5.2	0.0	0.5	1.2	5.8	0.1	2.1	2.4	3.7	0.0	0.1	1.2	1.2	0.6	1.3	1.3	0.0	4.9	2.1	1.1	0.0	3.8	0.0	0.0	0.0	2.7	7.3	0.3	2.3	0.0	0.3	0.0	1.1	0.0	5.8	0.0	0.8	0.3	2.6	9.6	0.0	3.8	4.4	2.5	6.5	1.4	3.1	11.8	5.2	0.1	1.8	9.6	2.1	0.0	4.5	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	7.8	10.0	5.6	13.9	8.8	8.6	8.5	5.9	10.3	7.4	0.0	1.0	0.0	0.2	0.8	6.9	0.6	0.0	4.0	2.3	1.8	3.9	1.7	1.7	2.1	0.1	1.0	0.0	0.0	0.6	0.2	2.2	0.2	0.0	0.0	0.3	4.8	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	0.1	3.1	0.3	0.0	1.8	1.8	2.9	0.0	0.9	1.7	5.1	1.3	0.2	0.0	0.0	0.0
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258648	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 20.2;Horizontal cells: 6.4;Kupffer cells: 27.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA					"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.3	2.0	3.2	0.3	17.0	0.6	0.3	22.2	6.9	2.1	0.4	0.0	0.0	0.3	0.4	0.2	0.3	1.3	0.4	0.3	2.3	2.0	0.9	4.6	0.4	0.6	0.9	1.7	0.6	0.2	0.2	7.6	0.4	1.7	0.5	0.4	1.3	0.2	1.2	0.3	0.4	0.4	0.4	0.6	6.8	1.0	0.5	2.4	6.8	0.6	0.0	0.4	0.3	0.3	0.3	0.4	1.3	0.2	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.9	1.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.3	0.4	0.1	0.4	0.0	0.0	3.2	17.0	22.2	5.7	2.3	2.0	0.9	1.7	1.7	2.4	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.4	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5"	"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.5	0.0	0.5	0.0	0.0	4.2	0.0	13.7	12.5	2.9	4.9	0.0	5.6	0.0	0.0	20.8	1.5	0.2	9.3	2.8	3.9	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.3	5.3	1.0	3.0	9.6	0.0	0.1	0.0	0.0	2.4	0.0	0.1	2.8	0.6	10.7	0.9	0.0	11.8	0.0	0.0	2.0	1.5	66.0	0.0	0.0	0.8	9.9	0.0	29.5	0.0	5.9	0.8	3.7	2.7	0.3	0.0	0.0	0.3	0.9	3.4	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2	6.0	2.9	0.0	0.8	7.4	0.4	1.2	12.7	84.3	46.6	1.8	0.0	36.7	0.0	0.4	7.1	0.7	9.7	0.0	8.8	2.7	5.6	0.3	6.9	0.0	3.2	0.0	5.1	0.0	0.0	11.8	0.0	1.1	5.0	0.0	2.2	0.0	6.5	8.0	0.0	0.3	0.2	0.0	2.1	8.0	13.8	3.8	10.0	0.0	4.2	4.2
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685368-118715433	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	17.3	16.4	15.5	12.4	19.2	25.8	18.0	25.9	19.4	21.8	16.1	12.8	11.7	13.4	19.1	17.2	16.4	15.9	12.0	12.3	13.3	11.3	17.4	22.0	13.9	15.9	16.4	16.0	22.6	14.6	17.1	34.5	13.6	16.0	20.0	13.0	12.3	13.7	14.9	13.5	16.4	15.4	14.5	17.3	17.3	14.2	26.6	18.4	24.1	18.7	10.6	16.2	23.0	16.1	18.9	12.3	24.1	17.5	17.1	18.4	10.7	14.7	6.8	14.9	14.0	9.4	11.9	10.9	13.2	10.1	10.0	11.5	9.8	17.7	16.8	7.9	9.2	10.0	7.3	12.6	10.9	12.8	13.2	7.7	14.0	8.6	10.9	10.8	22.6	16.8	10.5	12.6	11.5	7.7	13.1	9.0	13.5	14.9	14.3	13.6	9.9	22.1	19.0	12.8	12.7	6.0	12.7	18.7	8.4	10.8	9.8	12.3	13.8	9.3	17.3	12.5	14.3	7.8	21.6	12.1	14.5	13.3	12.9	10.4	12.0	12.5	19.1	10.3	12.7	11.7	24.1	10.6	22.3	14.7	15.6	16.6	18.9	15.4	15.1	12.3	18.1	18.4	16.6	8.5	17.1	17.5	9.8	16.2	10.7	15.5	19.2	25.9	19.4	13.3	11.3	16.4	16.0	16.0	18.4	23.8	23.4	4.8	15.3	9.6	15.8	13.7	15.3	13.4	27.3	22.7	21.6	15.0	10.0	9.5	64.5	14.8	10.9	0.0	13.6	8.9	10.1	14.5	20.9	29.7	10.5	7.9	11.6	14.7	15.5	9.0	17.3	12.0	6.8	7.2	14.1	12.0	12.0	15.0	13.1	18.2	24.7	12.9	11.7	18.9	16.8	10.5	12.8	17.5	13.0	13.2
SEC24D	KIAA0755	ENSG00000150961	"SEC24 homolog D, COPII coat complex component"	O94855	4	118722823-118838683	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041626, HPA053486"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041626: AB_10796348, HPA053486: AB_2682166"	"unprognostic (9.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (3.42e-6)"	"unprognostic (1.09e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	14.7	10.6	3.1	12.5	4.0	7.3	13.9	6.4	6.1	26.8	25.2	2.9	27.9	18.0	25.4	24.6	11.5	16.6	18.6	16.7	4.0	4.0	11.1	65.5	17.9	11.4	3.8	4.7	21.9	32.4	6.1	37.0	33.8	3.8	16.9	16.2	10.1	23.0	38.0	6.5	8.1	41.8	20.2	4.0	19.3	14.3	9.3	2.4	7.6	21.1	8.6	17.0	24.0	15.9	1.8	5.9	15.7	7.0	5.2	6.8	2.4	7.6	4.1	9.5	7.6	27.2	36.4	6.7	32.8	36.6	16.9	20.2	4.3	5.7	6.0	4.7	52.4	8.7	2.6	5.2	10.4	18.3	5.0	2.8	6.7	6.4	18.3	27.7	17.3	12.5	21.6	5.9	14.8	24.4	30.1	27.8	4.2	1.7	18.6	26.4	5.3	8.4	5.2	8.9	17.3	6.6	5.2	6.9	10.5	15.0	3.8	5.6	11.3	4.6	23.9	3.9	14.5	3.3	14.1	30.1	13.2	4.2	18.8	7.4	14.4	5.2	10.1	28.6	11.1	18.2	5.9	5.5	15.7	3.4	6.2	6.8	1.8	3.5	4.8	5.9	1.4	2.3	2.9	5.1	5.2	7.0	3.1	4.5	2.4	3.1	4.0	6.4	6.1	4.0	4.0	3.8	4.7	3.8	2.4	3.0	11.7	11.9	13.0	18.7	3.8	3.4	20.4	10.7	18.2	14.0	0.0	20.2	0.0	8.9	73.3	15.7	24.8	0.0	22.1	49.1	54.0	27.5	8.1	60.6	24.7	1.6	39.6	27.6	37.6	64.8	42.3	20.7	16.9	8.2	58.7	1.2	15.6	14.0	36.0	3.1	2.9	25.8	43.4	10.9	6.6	15.4	37.6	10.0	13.6	16.6
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 185.8"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 123.7;Peritubular cells: 95.5;Sertoli cells: 129.4;Smooth muscle cells: 291.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.4;LHCN-M2: 9.4;SH-SY5Y: 40.3"	"Region enriched"	"Detected in many"	5	"thalamus: 64.1"	"Low region specificity"	"Detected in many"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	11.4	2.3	1.8	9.6	3.9	0.0	7.3	1.0	5.6	26.5	56.0	4.4	20.5	6.5	37.5	23.9	37.0	14.2	19.4	29.0	2.6	1.5	2.4	1.7	3.7	5.7	1.9	5.2	27.9	1.4	0.9	2.6	3.8	3.8	35.9	11.1	21.2	4.1	58.8	185.8	3.7	14.5	88.7	4.0	6.1	29.5	9.6	3.1	3.0	3.7	12.8	2.1	50.7	15.5	1.8	0.2	2.0	0.4	1.2	2.3	0.4	0.1	1.9	0.1	0.0	5.6	1.9	0.3	5.9	6.4	0.2	0.2	0.0	0.3	0.6	0.0	26.4	0.4	0.1	0.2	0.1	0.3	2.5	0.0	0.3	0.4	0.0	1.3	0.0	0.1	6.8	0.1	1.8	0.1	2.0	0.0	0.1	0.0	0.3	9.4	0.1	0.3	3.6	0.6	0.0	0.0	0.2	0.7	0.2	0.1	0.1	0.2	40.3	0.2	0.1	0.0	1.7	0.0	3.4	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	1.9	0.3	2.0	1.2	0.1	1.9	1.3	2.0	1.2	0.1	1.8	2.1	1.3	0.9	1.2	0.4	0.2	2.3	0.4	1.8	3.9	1.0	5.6	2.6	1.5	1.9	5.2	3.8	3.1	3.0	1.4	0.8	19.5	11.9	0.3	123.7	0.0	4.0	0.0	1.8	0.0	1.0	0.0	0.0	1.5	7.7	0.0	0.0	1.7	0.7	19.8	3.2	0.0	0.5	1.3	0.0	0.0	15.4	0.8	3.9	25.0	1.9	5.0	22.6	0.0	0.0	0.2	0.0	95.5	0.3	0.3	129.4	291.5	0.5	0.4	7.0	0.7	0.0	0.0	2.7
MYOZ2	"C4orf5, CS-1"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135784-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 219.1;skeletal muscle: 188.6"	"Cell type enriched"	"Detected in some"	343	"Cardiomyocytes: 2214.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	3.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.9	0.1	188.6	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.0	13.9	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.5	1.7	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	10.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.7	0.7	0.0	6.5	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 84.0;SK-MEL-30: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	26.7	11.9	4.6	11.2	7.9	0.7	20.7	10.9	6.2	16.5	15.0	2.9	27.4	4.5	11.6	16.1	17.9	24.7	8.2	18.6	6.4	5.3	20.2	6.6	26.1	8.7	8.8	4.0	11.4	19.3	6.2	33.9	10.4	13.4	10.7	13.1	17.2	17.7	25.8	33.7	11.3	11.2	9.0	15.5	14.1	13.6	10.2	4.9	4.8	10.7	15.6	8.0	20.5	27.0	1.9	0.8	3.1	0.0	2.2	5.1	0.9	2.8	1.7	0.6	0.0	16.1	16.2	3.5	18.0	84.0	1.6	2.1	1.8	2.6	11.5	0.6	5.3	3.1	1.4	1.4	1.3	4.2	1.5	1.1	0.7	1.3	0.6	12.6	0.9	0.1	5.4	3.9	5.7	8.2	3.1	7.6	0.7	1.7	0.4	2.1	0.6	0.7	1.3	1.7	1.7	0.9	0.2	2.9	2.2	4.2	1.8	0.9	0.7	1.0	7.1	26.0	3.6	1.8	0.6	8.2	0.5	1.8	6.8	1.6	0.8	1.2	1.9	8.2	0.4	2.0	3.1	0.0	0.2	1.3	0.0	1.4	1.7	2.6	2.0	0.4	1.9	5.1	2.7	0.6	2.2	0.0	0.8	2.2	0.9	4.6	7.9	10.9	6.2	6.4	5.3	8.8	4.0	13.4	4.9	32.8	45.2	11.8	55.8	55.0	22.5	82.3	28.1	24.1	35.2	113.4	27.5	41.0	38.1	22.7	3.3	36.0	117.1	0.0	53.9	14.3	44.2	81.1	67.2	21.7	7.6	23.8	33.3	24.5	17.1	2.6	17.5	32.4	13.5	78.5	63.2	26.1	75.8	58.3	10.3	14.2	29.1	6.5	33.5	14.1	3.0	36.9	41.6	17.0	43.2	107.0
C4orf3	HCVFTP1	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Proximal tubular cells: 865.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	51.6	41.9	46.2	39.1	47.2	19.0	31.7	18.2	41.1	46.1	33.5	41.1	25.6	41.3	39.4	49.0	101.3	33.8	37.0	43.4	46.5	45.4	55.8	63.4	33.6	32.2	61.2	31.6	45.1	32.7	19.6	34.7	36.6	47.3	38.7	20.3	33.4	42.6	34.1	70.5	37.7	45.0	41.5	68.7	38.0	26.9	19.4	35.8	30.3	44.2	42.3	39.3	50.0	59.8	60.4	66.8	112.7	53.3	38.0	48.6	65.5	69.1	8.0	23.3	19.3	32.7	24.9	19.0	30.6	8.3	9.0	16.7	8.5	23.1	47.6	23.7	29.2	16.8	13.6	10.3	25.3	14.1	31.9	10.2	19.7	18.5	29.9	9.8	32.3	21.6	26.0	21.2	12.9	5.6	42.0	15.0	13.7	17.5	19.9	33.0	19.9	20.9	30.2	11.8	26.9	8.2	15.0	31.2	12.1	17.0	15.8	14.7	23.8	23.2	30.8	15.9	23.9	16.5	16.9	29.5	33.3	19.8	20.1	12.4	33.6	34.4	22.1	62.6	13.4	18.8	69.3	50.7	60.4	40.1	53.3	38.7	60.4	47.8	45.0	42.7	46.4	48.4	46.9	112.7	38.0	49.0	66.8	48.6	65.5	46.2	47.2	18.2	41.1	46.5	45.4	61.2	31.6	47.3	35.8	145.9	143.1	236.2	239.8	280.2	80.9	421.0	165.6	215.5	144.5	211.1	23.6	289.6	325.0	242.8	18.7	229.5	160.4	23.3	156.7	297.9	248.2	254.6	179.3	378.8	279.6	144.6	65.7	200.7	283.9	15.8	155.1	255.4	189.0	413.8	155.2	139.4	215.9	181.4	202.6	865.1	58.0	194.1	282.9	205.3	54.1	303.0	372.8	183.3	101.9	339.6
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Group enriched"	"Detected in some"	5	"Enterocytes: 422.5;Mucus-secreting cells: 344.1;Paneth cells: 175.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.5;NB-4: 3.9;RPMI-8226: 3.3;SH-SY5Y: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		46000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.4	0.4	0.4	0.1	0.0	0.3	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.5	2.5	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.3	0.5	0.0	0.1	0.4	3.9	0.2	0.2	0.5	0.3	0.3	3.3	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.2	0.3	0.1	0.9	0.4	0.4	1.5	0.2	0.7	0.3	0.6	0.3	0.3	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	422.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	344.1	0.0	0.0	175.6	0.0	18.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	64.7	0.0
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494395-119628991	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Peritubular cells: 98.6;Smooth muscle cells: 79.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.6;HHSteC: 35.4;hTERT-RPE1: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		3100000	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	12.3	4.9	2.0	28.2	2.3	0.4	8.1	3.0	2.3	21.3	28.0	1.7	20.1	6.5	17.3	21.4	30.7	10.7	13.3	5.3	2.0	2.8	3.8	1.2	11.4	4.1	2.4	3.4	10.0	7.8	5.1	3.4	8.9	4.4	31.8	11.7	20.2	8.5	23.7	6.8	4.2	15.6	45.6	2.0	2.1	9.1	7.6	1.2	0.9	9.1	8.1	2.2	25.9	15.9	1.5	0.5	1.4	0.4	0.6	2.1	4.2	8.1	0.4	5.7	0.6	2.0	3.0	1.0	5.5	24.6	0.2	0.5	0.5	0.7	0.8	0.2	6.8	1.5	3.0	1.8	0.8	0.7	0.2	3.7	9.1	1.4	0.4	35.4	1.9	0.9	3.3	1.7	0.6	0.0	12.9	0.7	1.9	1.0	1.5	0.8	0.4	2.4	0.3	1.2	0.9	1.4	0.3	2.9	2.1	2.1	2.5	2.2	4.6	6.3	8.0	0.6	4.4	1.4	1.0	1.2	3.2	2.8	1.7	0.7	2.1	1.0	0.7	3.1	0.5	0.4	0.0	0.3	0.0	0.6	0.1	2.1	1.5	1.3	0.4	0.2	1.0	0.6	0.9	1.4	0.6	0.4	0.5	0.4	4.2	2.0	2.3	3.0	2.3	2.0	2.8	2.4	3.4	4.4	1.2	6.0	4.6	0.0	2.3	3.1	8.1	3.5	12.7	1.4	5.7	1.8	13.7	0.2	0.0	12.0	25.6	3.3	6.3	0.0	2.5	0.2	3.8	2.4	1.1	1.0	0.2	4.8	2.4	1.3	0.0	9.4	19.2	0.7	5.0	0.0	10.1	28.4	4.2	9.1	98.6	0.5	5.9	19.4	79.9	2.9	5.5	2.0	0.2	0.0	8.6	1.6
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055608-120067074	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.3"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 100.5;Spermatocytes: 142.5;Spermatogonia: 91.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (5.15e-5)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	1.4	1.8	2.4	4.2	5.7	10.3	2.4	4.4	4.1	1.9	4.4	1.2	0.3	3.8	1.7	1.4	6.5	2.9	1.1	1.7	2.7	2.7	1.2	1.2	1.5	7.6	2.3	3.6	1.7	1.2	0.7	1.0	3.5	2.4	1.6	5.5	0.7	2.4	1.2	1.2	2.3	4.2	1.8	2.8	3.8	1.9	13.7	1.2	27.3	1.2	8.2	7.3	2.1	2.4	1.8	2.2	2.0	0.8	2.5	3.9	1.7	14.7	6.4	15.2	9.9	1.6	2.0	6.5	11.7	6.6	12.2	9.5	8.6	9.1	21.7	3.9	4.2	5.4	4.0	15.1	8.9	17.2	10.2	10.6	12.0	6.3	8.1	0.5	19.5	6.9	1.1	1.3	8.3	5.2	3.1	7.0	9.3	14.3	12.4	6.4	6.5	18.7	8.5	10.4	7.7	7.4	9.7	20.4	8.9	5.0	5.7	16.2	11.5	5.8	7.2	3.6	7.8	4.8	7.2	4.4	8.3	9.4	8.3	14.7	11.6	12.4	14.2	7.7	10.1	10.8	2.0	0.5	0.4	1.6	0.5	2.1	1.8	3.8	3.0	0.4	1.4	3.5	3.5	1.3	2.5	0.8	2.2	3.9	1.7	2.4	5.7	4.4	4.1	2.7	2.7	2.3	3.6	2.4	1.2	0.0	2.2	6.0	6.3	15.3	8.5	3.0	2.5	6.7	2.3	7.0	2.0	18.3	0.0	2.9	1.8	3.1	2.9	23.3	1.4	100.5	6.1	4.5	15.0	1.6	23.3	19.1	1.7	2.5	6.3	3.6	4.4	6.2	8.5	4.6	8.1	10.6	1.7	2.9	1.4	4.3	3.6	12.9	6.6	142.5	91.0	7.9	9.0	17.9	16.2	4.5
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 57.4;Late spermatids: 22.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"eosinophil: 9.1;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	5.0	5.9	3.5	3.6	3.9	4.6	5.4	1.9	5.4	9.3	5.2	2.7	6.3	1.9	8.6	7.0	3.3	7.7	6.1	5.0	3.2	3.1	3.1	0.8	7.4	2.7	3.4	4.2	15.2	10.3	19.3	12.5	5.0	6.1	7.7	4.4	9.4	3.3	6.8	2.2	2.7	3.2	9.5	6.2	3.3	4.1	5.0	3.3	0.5	8.4	5.1	2.3	5.8	14.1	0.0	0.0	9.1	0.0	0.0	0.3	0.0	1.8	2.9	6.6	0.1	4.0	8.3	7.8	3.9	8.6	4.0	3.5	3.7	1.1	0.4	1.1	5.2	3.8	0.0	0.0	0.8	5.3	0.0	1.1	2.4	2.6	0.2	4.3	8.1	0.1	5.8	2.6	2.8	3.6	3.7	2.9	1.0	0.0	12.1	4.9	0.3	1.2	0.0	4.9	0.6	2.2	0.0	7.7	5.0	1.4	0.0	1.2	5.3	0.0	0.1	0.8	3.6	5.5	3.4	1.1	0.2	2.4	4.1	3.8	11.2	15.6	0.0	3.0	0.0	3.0	0.1	0.0	9.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	6.7	0.0	0.0	0.0	0.0	0.0	3.5	3.9	1.9	5.4	3.2	3.1	3.4	4.2	6.1	3.3	11.9	3.5	0.5	2.5	1.4	9.5	7.3	0.0	2.7	5.7	1.8	7.9	0.8	1.7	1.8	57.4	4.9	0.0	0.0	2.1	2.1	4.4	2.0	2.3	0.0	0.7	0.0	3.5	3.7	0.3	22.0	8.1	0.8	1.7	0.0	2.7	8.2	1.9	0.0	8.9	0.0	8.0	6.5	3.6	5.0	3.3	1.5	0.5	0.0	2.4	0.6
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 229.3;Early spermatids: 225.6;Late spermatids: 164.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 23.2;U-266/70: 10.3;U-266/84: 39.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.2	0.0	7.0	5.7	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	23.2	0.4	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.4	3.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.3	0.1	0.0	0.0	5.7	0.0	0.1	0.2	10.3	39.6	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8	229.3	38.7	0.0	0.0	1.0	69.0	1.6	15.3	22.7	52.4	12.2	17.7	0.2	0.0	0.0	225.6	11.7	0.0	0.0	0.2	0.0	3.1	0.0	2.3	0.0	0.1	1.6	1.7	4.3	0.0	164.5	3.1	0.4	5.0	0.0	0.2	15.1	0.1	0.0	0.7	0.0	18.7	0.0	3.3	7.5	4.7	0.6	0.5	0.0	1.2	0.0
TNIP3	"ABIN-3, FLJ21162, LIND"	ENSG00000050730	"TNFAIP3 interacting protein 3"	Q96KP6	4	121131408-121227466	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.2;lung: 8.5;lymphoid tissue: 15.4"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 2: 23.7;Early spermatids: 11.2;Late spermatids: 32.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 9.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.7;hTEC/SVTERT24-B: 6.6;U-138 MG: 25.4;U-266/70: 7.2;U-266/84: 7.1;U-87 MG: 5.2"					"Low region specificity"	"Detected in many"			HPA043063	Uncertain					NA	NA					"HPA043063: AB_10793989"	"unprognostic (2.89e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.23e-3)"	"unprognostic (8.75e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.84e-7)"	"unprognostic (3.35e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.78e-2)"	2.2	0.3	1.0	9.8	0.2	1.3	0.3	0.3	0.7	2.0	1.3	0.2	0.2	0.6	0.2	0.2	1.8	0.4	1.5	0.4	0.4	0.6	0.3	0.7	8.5	3.5	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.5	0.9	0.4	0.2	0.8	0.2	0.4	0.3	1.2	0.5	0.3	2.8	0.8	1.4	0.2	15.4	0.4	3.6	6.3	1.3	0.4	0.2	0.1	0.7	0.2	0.1	9.2	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.9	0.1	0.1	0.1	2.2	3.7	0.0	0.0	0.5	0.8	5.7	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	6.6	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.1	25.4	0.5	2.0	0.1	7.2	7.1	0.2	5.2	0.2	0.8	0.7	0.2	0.0	4.0	0.0	2.7	0.1	1.8	9.2	0.0	0.2	0.8	4.4	0.6	0.1	0.2	0.1	1.1	0.8	1.0	0.2	0.3	0.7	0.4	0.6	0.7	0.2	0.5	0.2	3.0	23.7	0.5	0.0	0.1	0.0	0.4	0.0	0.0	2.3	0.0	5.9	0.0	0.0	0.1	11.2	0.7	0.0	0.0	1.0	0.0	0.2	0.1	6.9	0.0	0.4	0.0	0.0	0.0	1.2	32.4	0.3	5.2	0.0	0.0	0.0	0.1	0.4	1.1	0.0	0.0	1.1	0.0	0.0	0.5	0.4	0.4	0.0	6.7	0.0	0.1
QRFPR	GPR103	ENSG00000186867	"Pyroglutamylated RFamide peptide receptor"	Q96P65	4	121329312-121381059	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;heart muscle: 4.6"	"Cell type enhanced"	"Detected in some"	29	"Cardiomyocytes: 3.2;Early spermatids: 1.6"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 5.3;hTERT-HME1: 7.2;JURKAT: 2.3;RPTEC TERT1: 4.6;SCLC-21H: 2.9;U-2 OS: 7.8;WM-115: 4.4"					"Low region specificity"	"Detected in many"			HPA050236	Approved					NA	NA					"HPA050236: "	"unprognostic (1.24e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.93e-2)"		"unprognostic (3.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"		1.6	1.2	0.7	0.3	1.9	0.0	0.5	0.1	2.0	0.3	0.2	0.3	0.0	0.0	0.2	1.1	0.8	0.1	1.1	4.6	1.3	6.9	3.2	0.2	0.1	0.0	0.8	0.8	0.4	0.0	1.0	0.8	0.2	4.9	0.6	0.1	3.3	0.0	2.3	0.1	0.0	0.4	0.2	2.6	0.0	1.3	0.7	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	7.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	4.6	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	7.8	0.0	0.0	0.1	1.8	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.1	2.0	1.3	6.9	0.8	0.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667955-121697113	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 989.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		6100000	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	130.1	65.6	24.6	43.2	26.1	15.3	151.3	10.0	17.9	85.9	35.6	33.8	45.1	17.5	64.4	45.9	42.8	42.4	54.7	46.8	22.5	25.1	62.2	73.1	68.0	49.3	37.8	16.4	62.6	52.1	25.7	55.3	135.8	40.8	57.1	29.8	56.1	83.7	49.8	23.1	28.0	30.1	68.3	51.5	67.9	39.4	33.3	27.8	15.9	61.8	32.5	31.2	57.3	69.8	13.9	80.0	37.2	87.3	4.8	29.9	64.7	30.9	23.0	31.3	17.3	151.1	115.4	34.2	110.1	98.2	57.1	51.2	16.7	13.5	2.3	19.9	151.0	40.0	11.0	19.9	48.7	53.7	22.1	11.4	6.9	21.7	45.4	86.6	14.9	12.0	66.5	23.7	48.6	48.0	65.3	75.3	1.6	6.8	18.7	144.2	20.5	15.1	5.1	16.1	28.0	48.2	0.5	71.7	4.7	95.9	4.6	8.0	9.7	39.7	15.5	100.2	64.9	13.6	17.9	55.6	91.0	44.5	65.0	32.7	16.8	20.3	5.2	58.2	8.1	106.9	9.2	74.0	37.2	11.9	87.3	15.5	13.9	18.2	14.8	80.0	8.8	6.1	8.8	17.1	4.8	79.7	9.7	29.9	64.7	24.6	26.1	10.0	17.9	22.5	25.1	37.8	16.4	40.8	27.8	226.3	227.0	73.7	202.4	177.1	4.9	75.9	209.0	279.7	232.0	125.6	23.6	989.9	252.0	588.9	12.3	263.9	14.2	0.0	297.2	883.6	492.7	311.2	142.3	46.9	681.5	12.7	46.7	191.5	406.3	27.8	351.8	564.0	334.0	369.7	81.0	152.9	380.8	32.0	344.4	128.7	28.3	291.1	342.1	9.5	14.1	123.1	954.0	91.3	35.2	131.9
AC079341.3		ENSG00000284849			4	121758930-121765185	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	14	"brain: 16.4"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 6.8"									HPA077585	Approved					NA	NA					"HPA077585: AB_2732353"																		0.3	0.3	1.1	0.3	7.1	0.3	0.3	0.0	16.4	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	6.8		0.3	0.3	0.3	0.4	0.0	7.6	0.3	0.3	0.3	0.0	1.1	0.4	0.3	0.3	0.5	0.3	0.4	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM155	FLJ30834	ENSG00000164112	"Transmembrane protein 155"	Q4W5P6	4	121758933-121765427	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.6"	"Cell type enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.1"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.6"	"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.3;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 7.4;HAP1: 3.4;LHCN-M2: 10.5;MOLT-4: 6.3"									HPA077585	Approved				"Secreted in brain"	NA	NA					"HPA077585: AB_2732353"	"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.6	0.3	5.9	0.5	8.3	0.3	0.3	0.3	25.6	0.4	1.3	0.0	0.0	0.4	0.3	0.3	0.5	0.3	0.4	0.4	7.9	1.6	0.3	0.3	0.6	4.0	0.9	8.9	0.3	0.3	0.2	0.2	6.1	0.7	0.5	0.7	0.9	0.5	0.6	0.3	0.3	0.6	0.9	0.3	0.8	0.5	0.7	0.0	0.0	0.3	0.0	0.6	0.5	0.3	0.0	0.0	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.1	0.0	1.4	0.3	1.0	0.7	0.2	0.3	0.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	3.4	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	10.5	0.0	6.3	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	5.9	8.3	0.3	25.6	7.9	1.6	0.9	8.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	3.8	0.0	0.0	0.0
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801317-121817021	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 108.4;Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	12.5	12.7	10.1	18.9	14.7	29.7	13.9	16.8	18.6	11.2	9.7	8.1	12.5	7.5	12.5	12.4	13.3	11.8	7.8	13.1	13.5	11.3	11.3	14.0	11.9	19.8	11.3	12.2	12.6	10.4	14.2	15.5	12.1	12.9	10.3	12.0	9.6	10.9	8.9	17.6	12.1	10.3	10.6	11.7	14.2	10.4	36.7	10.0	33.7	9.2	15.4	18.9	12.2	10.5	19.9	15.9	20.1	17.7	11.6	23.6	14.0	19.5	9.2	24.9	14.8	3.9	8.0	12.1	25.4	14.7	36.4	28.2	9.9	16.4	34.3	6.3	15.8	11.0	7.0	26.9	11.8	32.5	15.2	12.3	17.2	14.2	12.8	8.2	29.1	16.0	6.0	6.1	25.4	7.3	7.5	17.9	22.1	29.4	13.6	34.0	11.4	44.6	22.5	13.1	7.6	10.8	24.9	41.7	15.4	12.4	6.4	15.9	16.7	9.3	13.9	15.4	13.2	11.8	18.8	10.8	16.3	24.1	13.7	24.4	19.8	15.0	41.2	16.9	20.3	10.7	12.0	13.3	20.1	18.7	17.7	18.4	19.9	20.5	23.6	15.9	19.9	23.3	20.7	3.3	11.6	17.0	15.7	21.6	14.0	10.1	14.7	16.8	18.6	13.5	11.3	11.3	12.2	12.9	10.0	41.7	15.5	16.4	12.6	11.3	10.7	11.1	7.6	18.7	26.1	3.5	9.8	24.1	1.7	17.1	108.4	14.2	4.5	0.0	26.6	25.0	13.6	7.6	30.1	4.9	21.1	15.9	5.8	12.3	10.3	9.2	12.0	18.0	8.5	20.8	7.9	13.8	16.5	8.7	10.3	7.1	16.3	6.5	11.3	107.2	58.5	12.9	9.2	19.2	10.5	12.9
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 70.0;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.7	10.1	27.7	11.8	1.5	3.8	22.7	27.1	11.9	36.0	26.8	22.0	24.1	35.7	7.3	14.2	12.7	13.1	34.8	15.9	29.7	17.1	16.1	28.6	13.4	21.3	0.3	43.1	20.3	1.0	1.2	14.9	8.9	5.7	21.5	19.0	40.7	35.9	28.5	13.9	54.9	25.0	21.8	24.3	11.3	25.2	53.7	17.4	10.2	7.7	11.8	12.5	14.2	17.4	7.5	21.7	14.5	18.3	12.7	16.9	25.7	17.8	25.8	22.8	24.1	40.9	9.7	43.9	18.7	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8	0.0	0.6	0.0	0.7	2.5	1.1	0.7	0.0	2.7	1.2	0.0	11.8	5.7	0.0	0.3	4.8	0.7	1.5	70.0	0.2	72.3	3.3	1.1	0.0	1.5	21.0	0.0	1.2	2.5	7.5	1.5	0.9	2.9	1.7	0.0	3.1	1.3	0.4	1.5	1.1	0.0	14.2	0.0	0.9	6.1	7.9	1.1	7.1	3.2	6.4	1.3
BBS7	"BBS2L1, FLJ10715"	ENSG00000138686	"Bardet-Biedl syndrome 7"	Q8IWZ6	4	121824440-121870497	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044592	Approved					NA	NA					"HPA044592: AB_10795882"	"unprognostic (6.36e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.15e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.33e-1)"	9.2	9.6	10.4	7.2	15.7	2.8	10.7	19.6	27.4	11.6	8.6	7.0	5.7	7.2	15.1	7.5	9.2	11.8	8.6	6.9	11.9	13.8	9.9	3.6	7.7	6.5	10.7	14.5	18.5	5.3	16.6	21.9	6.8	22.3	10.3	9.3	8.4	6.9	10.2	5.0	9.6	7.3	14.8	9.4	6.3	6.8	12.2	9.0	7.0	8.1	6.9	6.7	8.4	10.3	2.8	3.3	4.2	3.0	4.7	5.6	2.8	9.6	4.7	10.9	8.0	14.2	20.7	4.0	13.3	10.6	11.5	10.6	3.7	5.4	10.7	3.8	15.5	8.5	5.1	11.2	10.7	13.2	10.0	9.0	6.3	7.5	4.4	12.6	8.8	5.9	10.6	7.9	13.1	9.8	15.0	12.2	7.2	4.2	10.8	16.1	3.0	14.8	4.3	5.8	5.9	6.0	6.8	14.1	3.2	11.5	3.5	12.1	5.2	12.6	5.6	9.7	15.3	4.7	3.4	12.1	8.7	9.4	11.9	8.4	10.2	7.0	9.4	10.0	7.1	8.3	1.7	2.8	4.2	5.6	2.9	4.4	2.7	4.3	5.1	3.2	2.8	3.7	4.7	0.7	4.7	3.0	3.3	4.1	2.8	10.4	15.7	19.6	27.4	11.9	13.8	10.7	14.5	22.3	9.0	6.0	9.6	3.7	9.5	7.7	14.8	6.9	2.5	17.4	15.9	10.4	45.2	7.5	11.6	12.5	18.8	10.1	5.1	0.0	8.7	15.1	10.4	6.4	15.0	5.0	9.8	15.9	5.8	9.2	7.6	8.4	12.0	5.6	8.5	4.6	6.9	11.7	13.7	3.5	10.6	9.6	67.3	19.4	10.0	16.3	12.4	7.4	4.8	8.7	7.8	7.2
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121879027-121951754	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;HEL: 5.6;Karpas-707: 5.9;U-2 OS: 3.7;U-251 MG: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	1.4	0.4	1.8	0.7	9.3	0.3	0.5	5.8	7.4	3.3	0.8	1.7	0.8	0.8	1.6	1.2	0.6	1.1	7.3	0.5	1.8	2.3	0.7	0.5	2.9	0.5	2.3	1.9	0.8	0.2	0.6	12.0	4.2	7.3	1.1	0.8	0.3	0.8	2.5	0.6	0.5	1.2	9.4	1.1	1.0	0.9	1.6	3.6	0.0	0.6	0.0	0.4	3.6	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.6	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.9	0.0	0.1	0.0	3.7	5.6	0.1	0.0	0.2	1.5	0.5	0.6	0.0	0.1	0.0	2.5	0.0	0.2	0.0	5.9	1.3	0.0	1.6	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	3.7	0.0	3.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	9.3	5.8	7.4	1.8	2.3	2.3	1.9	7.3	3.6	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	28.1	0.0	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152333-122362758	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	18.4	17.1	25.6	18.0	34.1	42.9	26.1	33.4	34.2	22.9	18.7	24.1	17.9	15.6	20.9	25.4	12.3	16.8	16.4	15.3	25.5	22.0	24.0	17.4	19.5	14.8	26.4	26.2	34.3	16.6	68.2	33.1	14.3	33.6	19.1	18.8	22.6	16.6	21.5	40.1	23.1	20.8	18.6	29.3	20.0	15.2	20.4	24.2	15.3	25.4	12.6	13.6	18.0	18.5	3.1	2.3	7.7	3.6	1.7	3.5	0.7	16.4	5.4	12.5	8.3	21.0	27.3	6.5	7.5	14.1	7.7	8.5	4.0	8.7	8.7	4.4	17.6	10.4	6.2	7.7	9.2	12.6	6.5	4.9	9.5	9.8	7.4	10.9	8.9	5.3	15.7	11.1	9.2	12.8	21.1	16.4	9.4	6.2	10.5	15.8	5.5	7.7	7.0	4.2	7.9	5.9	4.4	17.5	2.2	13.6	12.4	7.4	6.6	4.7	5.4	10.5	21.2	5.9	7.3	21.9	9.6	9.6	7.9	7.6	10.2	6.5	6.3	10.2	7.9	7.0	3.3	1.4	7.7	3.3	3.6	3.5	2.5	2.3	2.3	1.4	3.1	2.0	2.3	6.6	1.7	1.7	2.3	2.9	0.7	25.6	34.1	33.4	34.2	25.5	22.0	26.4	26.2	33.6	24.2	80.4	33.9	13.7	17.7	18.5	114.9	62.7	7.6	37.5	44.3	40.1	117.8	8.9	1.7	11.4	26.6	33.8	40.9	23.3	15.1	5.7	21.1	21.2	20.8	21.5	11.1	87.4	20.7	36.2	31.0	20.3	47.5	20.1	15.1	17.2	25.2	59.6	17.8	25.9	47.7	10.5	143.8	32.3	29.9	49.5	31.9	21.3	10.9	32.4	23.9	23.0
ADAD1	Tenr	ENSG00000164113	"Adenosine deaminase domain containing 1"	Q96M93	4	122378966-122429802	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	331	"testis: 65.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 815.1;Late spermatids: 770.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (1.37e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	815.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	770.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	69.4	16.8	0.0	0.0	0.0	0.0	0.0
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.4;lymphoid tissue: 1.9"	"Group enriched"	"Detected in some"	6	"Melanocytes: 3.3;T-cells: 3.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Group enriched"	"Detected in some"	19	"JURKAT: 1.7;MOLT-4: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB010310	Uncertain				"Secreted to blood"	NA	NA	20300				"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.6	0.0	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.9	0.3			0.5	0.1	0.0	0.8	0.6	0.5	0.0	0.0	0.0	0.2	0.3	0.7	1.1	0.0		0.1	0.0	0.0	0.0	0.0		0.4	1.9		0.1	0.0	0.0	0.4	2.4	0.0	0.2	0.8	0.3	0.0			0.4		1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.0
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 11.9"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Group enriched"	"Detected in some"	4	"HeLa: 4.3;Karpas-707: 1.1;SiHa: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	55700												"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BBS12	"C4orf24, FLJ35630, FLJ41559"	ENSG00000181004	"Bardet-Biedl syndrome 12"	Q6ZW61	4	122732702-122744943	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 24.3;Rod photoreceptor cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061856	Approved					NA	NA					"HPA061856: AB_2684626"	"unprognostic (9.59e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (5.69e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.89e-6)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	5.0	6.0	5.5	3.1	12.2	0.8	5.8	3.8	7.6	5.9	4.7	2.0	3.6	4.4	5.6	8.5	3.8	8.9	3.6	7.3	6.0	5.5	15.9	1.8	4.1	2.6	3.3	6.2	5.0	3.3	15.4	14.5	3.7	5.6	3.5	3.8	5.6	3.5	5.5	1.5	2.9	5.9	4.7	3.6	4.2	3.3	12.4	3.9	4.6	23.8	1.0	3.0	4.2	6.0	5.3	3.0	4.5	4.5	2.8	5.5	2.8	1.9	1.9	3.0	3.7	9.2	11.3	1.2	2.7	4.9	3.6	3.7	1.3	3.3	1.2	2.1	3.9	3.9	1.5	2.4	3.6	3.6	4.1	2.0	0.4	3.0	1.3	6.2	1.2	1.9	7.9	9.0	4.6	6.7	12.5	3.9	2.1	4.3	1.4	4.8	1.2	2.4	0.8	1.8	1.3	1.6	1.4	8.4	0.7	8.3	0.5	1.8	3.7	4.0	0.9	3.0	6.6	1.2	1.1	3.6	3.0	1.8	2.8	1.4	2.4	1.3	0.8	5.2	1.0	5.1	2.4	2.9	4.5	3.8	4.1	4.5	5.3	4.8	5.5	2.9	2.7	5.2	4.8	0.1	2.8	4.5	3.0	4.7	2.8	5.5	12.2	3.8	7.6	6.0	5.5	3.3	6.2	5.6	3.9	6.0	0.6	0.0	1.1	0.9	6.1	3.4	0.0	13.4	2.3	0.0	2.0	6.1	3.3	4.7	24.3	1.1	3.2	0.0	2.4	1.5	1.9	0.9	1.1	0.5	1.7	3.2	2.9	2.5	2.6	7.1	3.7	1.1	5.0	1.8	2.1	7.3	3.2	5.8	6.3	14.4	30.2	6.5	2.0	10.1	4.4	0.9	3.7	1.3	2.1	0.7
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 12.4;Smooth muscle cells: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 57.4;BJ hTERT+: 33.7;fHDF/TERT166: 62.3;hTERT-HME1: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500		"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	28.1	3.8	19.4	6.9	21.3	0.7	12.1	6.5	15.3	10.2	14.2	10.3	1.9	2.6	17.9	6.3	6.4	10.1	9.4	5.6	17.1	11.0	5.5	2.9	8.3	2.5	9.9	10.7	16.8	2.4	10.1	4.0	8.1	18.6	10.3	5.6	7.5	4.6	11.9	2.0	2.3	4.1	16.2	17.3	1.9	7.6	3.0	12.3	0.0	3.1	3.8	2.7	7.5	14.5	0.8	0.8	0.5	0.5	0.3	1.0	0.0	1.2	3.1	1.8	6.9	4.4	7.4	0.0	57.4	33.7	24.1	14.0	0.0	0.1	0.0	6.7	62.3	19.0	0.2	1.8	0.1	24.3	4.5	0.8	0.0	6.5	0.0	13.0	0.3	0.0	3.9	0.4	23.8	34.4	12.1	2.6	0.0	1.7	1.9	6.2	0.0	0.0	0.0	5.2	0.0	1.4	0.0	0.9	0.0	7.6	0.0	1.0	0.9	11.1	0.0	0.4	10.8	0.0	0.1	2.4	20.0	3.9	7.4	4.9	3.4	3.6	0.0	5.7	0.0	2.1	0.5	0.5	0.4	0.3	0.4	0.2	0.4	0.5	0.4	0.2	0.8	0.7	1.0	0.4	0.3	0.4	0.8	0.7	0.0	19.4	21.3	6.5	15.3	17.1	11.0	9.9	10.7	18.6	12.3	6.0	0.0	0.0	1.5	1.4	3.5	3.9	0.0	0.0	2.3	7.0	0.0	1.8	3.3	6.9	8.7	5.8	0.0	0.0	0.8	0.0	12.4	5.2	0.0	0.4	0.4	0.0	1.7	7.4	0.0	2.5	9.2	0.9	5.0	1.0	0.0	8.4	6.7	0.0	7.8	0.4	1.8	0.0	15.5	3.1	0.2	1.1	4.0	0.0	0.0	0.3
NUDT6	"FGF-AS, FGF2AS, gfg, gfg-1"	ENSG00000170917	"Nudix hydrolase 6"	P53370	4	122888697-122922968	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 31.5;Proximal tubular cells: 33.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039202, HPA066115"	Uncertain					NA	NA					"HPA039202: AB_10795032, HPA066115: AB_2685620"	"unprognostic (7.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.91e-6)"	"unprognostic (1.13e-5)"	"unprognostic (2.32e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-1)"	5.9	12.5	5.7	3.8	9.8	2.3	6.0	7.7	8.8	5.1	8.1	6.5	5.6	4.9	4.7	8.2	4.7	7.6	5.0	11.2	6.5	5.6	20.5	28.4	3.6	3.9	6.8	5.2	5.0	4.5	8.8	10.2	3.6	6.2	4.2	6.9	10.6	5.4	5.2	9.8	4.6	3.9	4.1	6.3	4.8	3.4	7.2	6.2	6.3	9.3	6.7	2.6	5.1	3.4	6.1	7.8	0.5	4.8	2.0	4.7	3.2	4.4	6.6	9.7	8.7	9.0	9.4	3.6	5.1	6.8	4.5	6.3	2.8	10.2	4.6	4.1	2.7	10.0	2.3	4.3	4.1	4.7	11.4	2.9	4.2	6.1	7.5	3.4	8.5	2.6	5.7	1.8	3.9	3.5	8.4	5.9	8.2	10.3	11.6	7.7	5.3	11.7	9.2	3.6	17.0	8.6	4.0	12.4	5.2	10.8	2.7	5.2	6.5	5.2	7.2	10.3	11.9	4.8	6.8	3.6	11.0	5.9	9.4	4.6	13.8	10.6	8.8	6.6	12.8	4.9	0.0	3.8	0.0	3.0	4.8	3.5	6.1	3.9	4.7	7.8	2.3	2.9	3.4	0.5	2.0	4.2	3.0	3.7	3.2	5.7	9.8	7.7	8.8	6.5	5.6	6.8	5.2	6.2	6.2	14.9	8.5	3.0	3.4	0.8	10.5	4.6	2.5	12.0	3.4	5.2	0.0	14.2	31.5	5.2	24.4	4.5	2.1	0.0	5.0	2.6	3.5	1.1	1.1	15.5	7.5	14.3	6.9	4.3	3.3	2.8	5.8	2.3	5.0	0.0	6.1	10.9	3.5	7.0	8.5	33.1	10.9	0.0	2.8	20.9	3.4	1.6	3.3	6.9	11.8	0.9
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923074-123319450	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"Early spermatids: 147.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	8.2	4.7	5.8	8.5	9.3	6.0	7.8	20.7	8.0	8.3	6.1	6.4	5.6	3.8	12.8	5.5	5.7	6.0	4.4	5.3	5.5	4.6	5.9	5.2	5.3	8.0	7.1	5.2	6.4	5.1	11.2	13.5	5.9	6.9	6.0	6.1	7.4	6.1	5.3	6.4	7.4	4.8	9.1	7.4	7.3	11.6	11.3	9.0	13.6	6.7	5.0	9.3	6.2	7.0	2.9	2.8	2.3	1.9	2.5	2.8	0.7	2.9	3.2	4.0	8.0	3.1	2.1	2.6	4.2	1.8	3.2	3.1	2.1	4.3	4.4	2.8	2.6	2.3	2.7	5.2	2.8	6.3	6.2	1.3	3.8	5.9	3.4	1.4	6.5	4.8	1.5	1.5	4.5	4.2	2.0	3.1	3.0	7.4	7.8	5.5	3.2	10.9	4.5	2.3	4.8	1.6	3.8	8.4	2.4	2.6	2.1	5.9	4.2	3.9	3.4	2.4	5.5	2.4	2.5	3.8	8.5	5.6	5.4	5.0	5.1	5.2	3.1	4.4	5.9	7.3	2.3	1.2	1.1	2.7	1.9	1.6	2.0	2.2	2.3	0.9	2.9	2.4	2.8	1.8	2.5	1.1	2.8	1.1	0.7	5.8	9.3	20.7	8.0	5.5	4.6	7.1	5.2	6.9	9.0	14.9	5.3	4.4	5.1	4.5	5.1	3.4	17.8	9.4	11.4	1.8	13.7	3.9	0.0	2.3	147.3	8.0	2.0	0.0	3.1	3.5	3.7	3.0	4.7	2.1	3.0	3.2	2.4	5.5	3.7	13.2	6.6	4.8	0.0	1.0	1.6	4.9	3.4	2.6	4.2	2.7	11.6	0.0	3.6	13.3	10.0	4.6	1.8	5.3	3.7	2.6
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.1"	"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 160.4;Leydig cells: 414.8;Muller glia cells: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 29.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 30.2;AN3-CA: 61.1;ASC diff: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	139.1	12.6	3.3	14.7	4.3	5.8	69.0	4.9	3.5	28.5	24.8	1.9	18.0	4.5	18.6	28.0	38.1	19.1	27.1	34.1	2.6	1.7	10.2	6.4	23.1	9.1	3.3	2.8	32.2	9.8	17.0	9.5	15.6	2.9	25.0	8.8	11.8	14.6	16.5	48.1	25.5	8.1	20.7	2.8	7.1	11.6	28.4	1.5	13.0	29.6	16.3	8.6	60.8	39.9	29.9	0.7	2.8	0.1	6.1	15.5	0.9	1.9	0.5	30.2	61.1	24.8	16.9	2.0	0.1	1.5	0.1	0.6	1.8	3.2	0.0	13.6	0.9	0.1	0.3	0.8	1.4	0.2	0.0	3.1	0.6	0.0	9.4	7.0	4.2	0.0	6.8	0.8	0.2	0.6	3.3	2.5	0.7	0.5	0.5	1.4	0.2	4.9	10.5	7.2	6.9	10.0	2.1	3.2	0.0	4.1	4.4	4.6	3.9	0.0	6.1	5.8	3.3	0.6	0.0	6.2	0.4	0.0	0.1	0.9	0.3	0.0	0.0	0.4	0.8	1.0	0.0	0.1	2.8	0.5	0.0	15.5	9.6	1.8	4.2	0.0	29.9	2.7	2.9	0.1	6.1	0.0	0.7	0.0	0.9	3.3	4.3	4.9	3.5	2.6	1.7	3.3	2.8	2.9	1.5	26.8	27.0	15.2	13.8	44.1	75.2	10.9	35.7	13.4	27.3	26.2	31.4	10.0	68.0	3.5	1.7	160.4	6.3	0.0	9.4	1.5	42.7	12.9	9.2	4.4	8.2	6.4	25.4	120.9	11.6	4.0	414.8	9.7	43.9	1.0	13.1	173.3	8.4	3.5	54.5	12.6	80.4	148.8	86.8	1.9	1.5	37.9	2.6	25.5	14.1	12.5
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664052-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.4;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;HUVEC TERT2: 22.1;TIME: 55.6"					"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	10.1	4.8	6.6	8.2	6.8	4.7	7.6	4.0	8.3	17.1	10.0	4.3	8.7	3.7	17.5	7.4	11.4	5.9	10.2	7.3	6.2	6.5	9.8	6.9	13.4	5.4	5.5	6.5	9.0	5.2	12.5	3.9	17.1	6.2	19.1	6.9	6.7	7.7	7.9	3.2	12.9	7.9	14.2	4.8	7.1	8.2	16.8	4.8	15.4	9.2	5.8	4.4	16.5	10.9	0.1	2.4	0.5	3.8	0.4	0.1	0.4	2.3	4.3	12.3	5.7	9.8	6.3	1.2	6.0	5.1	3.1	2.0	1.9	3.0	0.0	1.9	8.5	2.8	2.1	8.1	4.6	5.5	0.0	1.7	1.9	5.6	1.8	7.0	3.2	2.5	6.3	6.3	4.9	22.2	5.9	22.1	2.2	3.5	4.2	5.9	5.3	4.0	1.1	2.5	3.4	6.4	3.3	3.8	0.5	3.9	9.6	3.5	4.4	4.1	2.6	4.8	5.3	2.8	2.7	55.6	6.7	5.2	3.2	5.1	3.1	0.0	0.8	3.0	1.4	7.6	0.0	1.5	0.5	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.4	2.3	0.9	0.0	0.4	6.6	6.8	4.0	8.3	6.2	6.5	5.5	6.5	6.2	4.8	29.8	18.2	0.5	15.0	35.8	2.8	8.4	15.3	8.1	6.8	5.2	0.0	1.9	0.0	8.8	35.0	14.5	3.8	0.0	17.2	23.7	15.5	12.9	4.7	6.8	4.8	20.6	8.1	31.9	10.0	45.7	6.4	8.7	10.1	2.8	3.1	2.9	13.7	2.9	11.3	3.3	1.0	0.0	18.6	16.8	9.7	26.8	3.4	0.0	4.5	15.8
FAT4	"CDHF14, CDHR11, FAT-J"	ENSG00000196159	"FAT atypical cadherin 4"	Q6V0I7	4	125316399-125492932	"Cancer-related genes, Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Endothelial cells: 11.1;Fibroblasts: 9.3;Ito cells: 30.7"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.3;ASC TERT1: 9.1;fHDF/TERT166: 8.9;HSkMC: 10.5;HUVEC TERT2: 11.1;TIME: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052819	Approved		Approved	Cytosol		NA	NA		7900000	Cytosol		"HPA052819: AB_2681963"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.81e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-3)"	3.8	0.5	0.9	0.8	0.7	0.0	3.2	0.0	0.5	4.4	7.1			0.3	2.7	0.6	1.9	2.1	4.1	5.0	1.0	0.4	2.6	2.0	5.3	0.1	0.9		5.3	0.5	6.7	0.4	2.5		3.6	1.9		1.0	2.3	1.1	1.4	2.4	3.3	0.6	2.1	2.4	0.1			3.9		0.2	3.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	6.0	0.6	12.3	9.1	0.0	2.0	2.4	1.0	1.0	0.0	0.3	0.0	2.5	8.9	1.2	0.0	2.2	2.5	0.6	0.0	1.0	1.3	2.5	0.0	4.0	0.8	0.0	10.5	1.4	0.5	5.5	7.2	11.1	0.0	0.0	1.6	5.0	0.1	0.4	0.0	0.4	0.0	0.2	0.7	1.2	0.0	0.1	0.0	0.1	1.2	0.3	0.0	0.0	0.3	0.0	0.0	17.3	6.1	1.7	2.1	0.9	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0											6.0	0.0	0.0	0.1	1.4	1.3	5.3	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.7	0.8	11.1	0.0	0.0	0.2	0.0	9.3	0.1	0.0	6.8	0.2	0.0	0.0	30.7	2.4	0.0	5.5	0.0	3.3	0.0	0.0	1.2	0.2	0.0	4.6	0.6	0.1	0.0	3.9	0.0	0.6	0.5	0.0	0.0	0.0	0.0
INTU	"KIAA1284, PDZD6, PDZK6"	ENSG00000164066	"Inturned planar cell polarity protein"	Q9ULD6	4	127623271-127726737	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 112.4;Cone photoreceptor cells: 129.6;Rod photoreceptor cells: 185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036714, HPA036715, HPA061467"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: "	"unprognostic (1.09e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.33e-2)"	4.4	4.8	8.3	3.7	23.0	7.3	8.1	5.6	12.6	7.7	4.0	11.9	5.6	5.9	10.2	14.6	4.0	8.1	4.7	3.2	12.0	8.0	5.7	2.4	4.9	3.4	7.2	8.1	9.9	4.1	4.7	25.8	3.3	12.3	5.2	4.8	9.1	5.2	4.2	3.3	10.6	3.1	4.4	9.1	3.8	6.1	6.9	8.0	0.5	7.9	2.8	2.3	4.6	5.0	1.4	1.5	4.7	0.9	1.0	0.9	0.1	3.3	2.3	12.6	4.7	1.8	4.4	1.0	2.0	1.0	1.3	2.6	1.7	3.1	2.8	3.3	2.0	3.9	2.0	10.0	1.9	3.9	1.2	3.0	3.5	4.0	4.2	1.7	3.1	1.8	1.8	2.1	4.2	1.0	3.9	3.8	1.3	4.2	2.9	1.9	1.6	1.1	1.8	5.9	1.2	2.3	1.2	3.1	0.8	2.6	2.6	5.9	4.2	4.3	2.3	1.5	6.7	2.7	1.9	3.2	3.6	2.9	3.5	2.8	1.9	2.8	0.9	3.0	1.6	2.2	2.8	0.8	0.5	0.9	0.6	0.8	0.7	0.7	0.6	0.4	1.4	0.7	0.8	4.7	1.0	0.9	1.5	0.4	0.1	8.3	23.0	5.6	12.6	12.0	8.0	7.2	8.1	12.3	8.0	20.8	12.5	0.5	9.8	5.4	58.4	12.7	7.6	112.4	25.0	3.5	129.6	6.8	6.6	6.2	9.1	5.6	0.9	0.0	4.4	5.1	5.9	7.3	4.7	2.4	2.6	35.0	11.1	7.4	1.5	8.4	13.0	7.4	6.8	0.0	5.5	15.8	2.9	0.0	11.0	6.2	185.9	0.0	7.6	7.7	20.9	5.4	1.6	2.2	6.3	6.2
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730378-127774299	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	687	"testis: 68.6"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 113.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	113.2	11.9	0.0	0.0	0.0	0.0	0.0
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 393.1;Late spermatids: 711.4;Spermatocytes: 194.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	9.1	12.0	6.5	10.3	4.5	4.6	7.6	4.2	1.7	4.0	4.5	8.8	4.2	0.0	7.7	1.2	3.3	2.1	38.0	15.0	5.6	17.0	11.3	4.9	16.5	10.7	1.7	18.8	8.4	4.2	14.0	2.6	9.6	4.2	5.2	4.3	8.7	5.6	5.0	6.6	6.0	1.6	1.5	9.7	10.0	0.0	0.7	0.9	13.8	4.2	12.0	4.4	7.5	13.1	0.7	4.1	10.0	3.2	1.4	1.4	0.0	1.7	10.0	11.0	12.6	2.9	5.5	12.9	4.3	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2	3.0	9.4	0.8	68.9	25.2	54.9	12.6	12.7	56.2	31.8	8.7	98.2	9.5	16.6	6.7	393.1	5.4	0.4	0.0	2.5	1.7	7.0	17.8	15.1	8.3	1.0	38.1	17.6	2.5	1.6	711.4	9.5	7.3	8.5	4.6	2.0	15.2	3.2	0.0	9.2	19.6	62.8	0.0	15.5	194.6	9.3	37.1	14.0	2.9	2.9	72.9
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.8	5.6	21.1	10.8	0.7	2.1	9.6	11.6	8.2	15.5	16.0	7.8	12.2	16.0	4.3	6.4	12.6	7.8	14.8	9.3	23.9	12.4	6.1	14.5	9.0	7.3	0.2	20.4	17.1	0.6	0.9	14.1	6.5	2.8	11.9	12.3	16.8	21.4	13.0	8.2	31.4	9.1	9.8	12.1	6.4	16.4	14.7	5.5	5.1	7.6	11.6	9.6	7.3	6.7	3.5	9.3	5.4	8.8	5.1	12.2	11.8	8.3	14.4	11.0	12.1	22.8	6.2	15.5	13.5	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0	0.0	1.1	0.8	0.6	1.4	2.1	0.5	0.0	2.7	0.0	1.8	0.0	3.6	0.0	0.6	48.9	0.4	0.0	23.3	0.3	10.4	0.7	0.4	1.1	0.2	3.1	0.0	2.4	0.6	1.0	60.1	2.6	1.6	0.0	1.8	1.9	1.1	0.1	0.0	0.4	0.3	0.7	0.0	0.3	27.0	12.1	0.6	3.2	1.8	2.1	0.9
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917732-127966034	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	8.9	9.6	9.1	11.7	15.4	5.3	13.0	19.6	15.4	12.2	12.1	14.6	9.4	17.1	19.0	11.9	10.3	9.8	9.2	7.5	8.9	10.1	12.6	19.1	9.1	9.7	9.3	11.8	13.2	14.5	16.7	21.5	18.0	15.8	10.2	15.6	14.8	10.9	9.7	7.2	11.0	15.0	12.4	11.8	13.5	12.0	9.4	10.2	12.9	13.6	7.1	15.0	9.9	10.5	7.0	5.8	7.1	8.2	5.4	8.3	4.1	8.3	6.9	7.2	4.0	6.4	5.7	6.2	6.2	8.1	8.2	8.2	4.3	11.9	3.9	12.2	11.2	13.2	6.9	8.4	6.3	11.8	9.1	6.7	4.8	7.8	6.6	7.2	5.0	5.9	6.2	2.1	7.7	5.8	4.1	8.7	6.1	8.1	5.3	11.6	7.7	4.3	1.7	1.4	8.6	4.6	4.6	0.5	4.5	5.8	11.9	7.3	2.6	7.8	8.0	3.3	5.7	4.7	3.4	4.5	2.7	2.8	10.1	5.9	11.5	18.9	8.8	8.7	4.3	7.3	4.6	5.6	7.1	7.1	6.2	6.2	7.0	7.9	6.6	4.5	3.6	8.3	8.3	6.3	5.4	8.2	5.8	8.0	4.1	9.1	15.4	19.6	15.4	8.9	10.1	9.3	11.8	15.8	10.2	11.9	13.1	8.1	4.7	2.9	16.3	2.8	2.5	10.7	13.6	15.7	19.6	9.8	1.7	7.4	9.5	5.6	7.0	0.0	6.1	6.5	5.6	4.3	12.7	9.4	6.6	11.1	4.1	8.0	7.5	10.7	8.6	6.0	3.3	6.4	6.8	11.0	6.3	9.7	8.9	5.7	21.2	6.5	3.8	11.4	4.3	5.0	18.4	14.4	6.8	3.5
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	7.6	8.2	7.4	13.2	10.5	9.9	8.4	14.1	7.9	7.1	13.6	8.6	8.3	13.7	9.2	9.8	7.2	7.8	9.6	25.1	7.0	7.5	9.1	15.7	9.2	12.0	7.2	5.2	10.8	24.5	8.0	16.3	7.0	8.4	6.8	10.2	7.5	8.9	11.1	18.7	10.6	19.0	9.8	9.7	10.0	8.2	4.0	8.1	18.2	9.2	10.9	10.5	8.4	7.5	10.2	8.8	14.2	7.1	5.2	8.8	3.5	3.5	2.9	3.7	4.5	2.9	4.1	5.5	3.6	2.9	3.2	4.2	6.8	6.3	9.7	5.9	1.4	2.9	3.5	7.7	4.2	3.5	8.0	2.5	7.1	4.7	5.4	4.1	12.0	9.0	3.4	2.9	3.4	2.2	3.8	5.6	7.4	11.7	7.1	2.9	6.4	15.7	5.7	3.8	7.6	2.9	8.8	1.3	6.2	4.7	3.7	8.5	3.1	3.4	6.1	3.7	5.5	5.2	5.0	4.8	2.0	2.7	5.2	3.4	12.7	12.6	11.5	3.5	13.0	3.3	11.1	7.1	9.5	6.3	5.9	4.6	6.8	8.0	7.3	5.7	10.2	8.7	8.8	14.2	5.2	4.2	8.8	8.2	3.5	7.4	10.5	14.1	7.9	7.0	7.5	7.2	5.2	8.4	8.1	6.0	12.5	5.3	8.0	0.0	13.0	0.0	5.1	6.7	10.3	7.0	19.6	4.5	0.0	4.0	2.8	3.0	8.5	0.0	6.4	3.9	2.1	10.7	1.1	20.2	6.7	17.5	5.8	9.2	17.0	0.9	5.8	10.9	0.0	3.6	11.7	6.5	6.5	3.5	5.3	6.2	17.4	12.9	0.0	5.5	3.6	0.0	7.7	5.0	10.1	7.8
LARP1B	"DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2"	ENSG00000138709	"La ribonucleoprotein domain family member 1B"	Q659C4	4	128061268-128222931	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 378.6;Late spermatids: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036280	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA036280: AB_10673126"	"unprognostic (1.84e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.39e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.13e-5)"	"unprognostic (8.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.50e-2)"	9.3	7.1	8.1	6.5	9.8	10.1	9.8	11.7	11.4	11.2	12.6	6.2	21.4	11.7	8.9	20.3	10.3	8.1	8.2	8.7	7.8	9.0	14.8	39.9	9.1	5.1	8.5	10.3	10.1	37.9	12.3	21.4	17.2	9.4	9.3	13.5	4.8	17.0	17.2	26.2	9.7	13.9	9.6	8.4	6.4	12.1	41.9	7.1	5.3	11.3	8.8	7.4	13.2	9.2	3.1	8.5	2.3	3.9	4.6	6.2	1.5	10.7	3.8	6.9	8.9	7.3	8.4	14.4	9.3	10.3	9.0	5.7	8.6	8.6	13.4	13.0	9.1	6.7	4.3	17.3	10.5	10.7	12.6	10.9	10.6	6.5	21.1	16.0	20.2	4.3	4.4	15.2	7.2	26.3	8.5	10.3	10.0	18.6	22.4	5.0	12.6	17.6	11.7	8.0	16.7	6.3	9.7	10.7	15.1	10.1	8.4	20.9	8.2	8.1	18.9	8.4	9.7	5.5	8.9	8.3	5.7	6.3	9.2	9.2	29.5	11.2	15.5	7.4	15.9	6.0	0.3	3.9	2.3	3.4	2.8	6.2	3.1	3.8	4.3	4.4	3.0	3.1	3.3	1.0	4.6	3.0	8.5	3.0	1.5	8.1	9.8	11.7	11.4	7.8	9.0	8.5	10.3	9.4	7.1	32.8	25.7	18.2	21.4	24.6	34.4	27.1	35.7	42.8	48.9	19.2	49.1	27.6	11.6	20.2	378.6	17.5	36.5	46.7	25.7	20.4	16.4	36.2	19.7	143.6	10.9	22.3	32.6	16.5	12.9	340.9	33.6	15.7	16.9	10.8	61.0	15.5	27.3	34.5	18.7	37.6	67.1	19.4	26.9	140.5	12.9	30.4	43.0	12.8	44.7	23.4
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 87.8"	"Low region specificity"	"Detected in all"							"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		64000	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	47.9	29.5	18.3	13.3	20.4	12.8	38.3	17.7	19.3	27.3	46.6	14.8	42.5	46.8	26.1	20.2	32.8	21.1	31.2	27.2	18.4	18.4	36.5	64.7	22.4	13.6	17.4	18.5	24.1	41.6	25.6	34.4	95.6	18.0	29.4	24.8	22.0	29.8	33.4	17.9	46.0	69.1	29.5	16.3	16.7	35.1	19.3	19.2	15.3	33.1	15.7	16.2	35.1	33.8	3.2	6.0	4.7	2.5	2.6	4.8	1.4	23.4	8.6	16.0	12.8	69.4	36.5	16.1	32.2	36.0	23.9	32.0	8.9	24.2	16.5	37.8	41.4	27.8	13.7	14.6	15.9	30.1	9.4	8.4	11.1	22.8	16.9	87.8	16.0	8.3	28.7	32.3	20.0	24.8	55.8	21.4	10.8	18.4	20.9	34.3	7.2	14.8	7.4	12.5	28.5	7.8	11.9	12.8	11.3	35.3	8.3	12.6	12.0	18.0	20.5	18.3	27.5	15.7	7.3	39.6	20.2	16.5	20.7	14.9	24.2	19.6	17.7	22.1	14.4	13.8	4.7	2.5	4.6	3.9	2.1	1.9	3.2	4.8	3.9	1.4	2.7	4.4	4.0	2.2	2.6	1.8	6.0	4.7	1.4	18.3	20.4	17.7	19.3	18.4	18.4	17.4	18.5	18.0	19.2	50.6	34.2	23.8	45.7	89.0	20.4	51.2	48.4	24.1	39.8	41.8	9.8	66.3	24.9	50.1	71.9	50.2	83.0	70.0	64.9	109.7	60.6	46.0	11.5	114.3	31.8	11.1	34.1	27.6	12.7	27.3	42.8	25.2	64.1	18.0	64.6	72.5	60.7	56.1	35.3	99.8	34.3	12.9	59.7	27.7	25.9	97.7	229.9	23.5	49.5	29.8
JADE1	"JADE-1, PHF17"	ENSG00000077684	"Jade family PHD finger 1"	Q6IE81	4	128809623-128875224	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020016	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA020016: AB_1855292"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.93e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (8.22e-6)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.68e-1)"	20.5	14.6	5.7	12.7	7.9	25.9	27.9	16.3	9.7	10.8	9.8	4.6	18.9	5.6	8.4	9.0	8.1	11.8	14.3	14.2	5.7	7.1	22.1	7.4	12.6	13.2	6.9	4.9	18.6	55.7	17.4	10.8	7.2	7.3	12.0	4.3	8.5	25.6	16.8	10.5	8.6	10.6	16.3	5.4	10.2	12.5	6.1	8.5	13.3	28.7	7.2	7.9	12.1	31.1	12.6	6.9	23.0	14.3	20.1	18.4	10.4	6.1	12.3	12.2	9.0	16.8	11.9	16.1	10.0	6.0	10.9	10.0	10.7	11.0	19.1	11.9	5.7	4.8	2.2	14.3	3.5	12.3	14.8	6.3	10.6	16.9	9.7	29.0	17.3	8.6	13.2	5.7	13.3	9.9	9.1	11.8	12.5	16.9	26.4	8.5	7.5	21.8	13.0	32.8	6.3	6.2	15.6	8.4	10.3	17.4	3.0	15.9	11.6	9.6	7.8	7.7	17.9	6.3	9.8	8.1	10.8	17.8	8.2	11.7	17.5	13.9	21.7	11.8	17.4	8.8	17.2	7.2	23.0	12.3	11.6	15.3	9.5	13.4	13.5	6.9	12.6	18.4	14.5	9.1	20.1	14.3	3.3	9.4	10.4	5.7	7.9	16.3	9.7	5.7	7.1	6.9	4.9	7.3	8.5	35.7	20.1	17.2	15.1	13.3	37.9	30.3	33.1	32.1	19.4	47.1	47.1	22.1	16.6	28.2	2.8	23.2	6.3	0.0	42.1	12.0	18.5	12.6	17.3	35.0	9.1	27.0	9.8	16.5	28.2	3.2	33.4	11.9	20.3	4.6	7.2	27.1	37.2	7.6	45.3	28.6	26.8	84.1	34.0	4.8	22.2	11.7	3.3	31.9	7.3	5.2
SCLT1	"FLJ30655, hCAP-1A"	ENSG00000151466	"Sodium channel and clathrin linker 1"	Q96NL6	4	128864921-129093607	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.0"	"Group enriched"	"Detected in all"	4	"granulocytes: 31.0;monocytes: 13.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036560, HPA036561"	Approved					NA	Yes					"HPA036560: AB_2675190, HPA036561: AB_10673658"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.05e-2)"	"unprognostic (8.92e-2)"	7.4	6.5	8.5	16.5	10.5	25.0	7.1	11.8	10.6	6.9	7.1	9.7	9.8	7.8	9.5	7.2	8.3	6.8	9.1	8.1	8.9	8.0	5.5	6.7	11.6	14.9	7.8	5.2	10.8	7.5	7.6	10.3	8.9	9.3	5.5	8.6	9.7	6.0	8.8	3.6	6.5	8.3	8.4	8.9	14.5	6.8	8.9	7.9	24.3	6.8	6.0	11.9	9.2	7.6	2.0	4.5	31.0	13.3	5.0	2.2	3.1	11.7	3.4	11.9	8.4	4.1	6.7	6.6	10.2	9.0	11.1	10.1	3.5	11.0	10.4	6.6	5.7	7.8	4.7	7.7	7.4	11.6	23.2	6.2	13.7	7.0	3.9	5.7	16.0	11.0	4.2	2.8	8.8	8.9	5.5	8.6	5.7	15.1	26.1	9.5	5.5	13.0	8.0	5.4	8.7	6.4	7.5	11.9	6.5	7.0	3.4	17.8	5.3	8.0	7.2	6.7	5.6	4.2	6.7	7.9	9.4	11.5	12.2	13.5	12.5	9.3	17.8	5.1	18.0	14.3	6.5	8.1	16.1	2.2	11.2	1.4	2.0	1.4	1.7	4.5	2.0	1.5	1.8	31.0	5.0	13.3	2.3	2.1	3.1	8.5	10.5	11.8	10.6	8.9	8.0	7.8	5.2	9.3	7.9	11.9	9.8	11.7	7.9	9.8	14.3	18.9	15.3	21.4	12.5	1.8	27.5	10.1	3.3	4.8	43.1	9.5	6.4	0.0	5.5	17.2	10.6	3.1	11.5	1.5	11.6	15.9	5.2	7.4	14.9	34.6	10.0	14.5	8.5	8.2	6.2	7.7	6.6	7.2	8.5	2.7	22.2	12.9	13.1	16.6	11.1	12.2	7.8	21.5	8.3	4.8
C4orf33	FLJ33703	ENSG00000151470	"Chromosome 4 open reading frame 33"	Q8N1A6	4	129093317-129116640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA061199	Uncertain		Approved	"Nuclear bodies,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nuclear bodies"	"HPA061199: AB_2684450"	"unprognostic (7.27e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.49e-5)"	7.5	12.2	12.7	7.4	15.9	17.7	9.4	24.2	27.9	5.8	18.1	8.2	4.7	17.7	5.8	12.0	10.7	8.9	10.8	6.7	15.8	14.8	14.5	10.7	11.4	8.3	17.0	16.5	12.8	10.8	13.1	25.8	9.9	26.7	5.5	17.4	5.8	7.2	5.2	3.0	9.0	23.9	5.9	32.4	9.4	17.7	5.6	10.7	8.8	14.0	6.7	6.5	9.7	6.7	3.5	7.5	23.5	8.1	5.2	3.3	3.4	5.5	2.6	7.8	8.6	4.7	6.1	9.8	5.3	6.2	6.7	8.0	2.4	21.8	5.3	10.2	6.0	7.7	4.0	8.6	7.3	6.2	26.4	6.3	8.9	8.4	2.1	7.3	6.2	10.5	5.1	6.5	5.9	2.4	9.5	4.6	16.7	12.4	23.6	5.8	2.1	9.7	6.1	0.4	10.6	3.5	4.0	6.5	5.3	18.1	4.7	11.2	2.2	3.4	9.4	6.3	2.0	8.2	5.5	3.2	6.0	1.9	3.9	4.4	11.6	4.5	9.1	10.3	14.6	4.7	9.5	8.1	23.5	2.3	7.8	1.9	3.5	2.0	2.7	7.5	2.0	2.0	3.3	3.8	5.2	8.1	4.2	3.2	3.4	12.7	15.9	24.2	27.9	15.8	14.8	17.0	16.5	26.7	10.7	6.0	10.2	5.6	6.8	9.3	13.7	2.8	15.3	33.5	6.8	12.2	7.9	16.4	43.1	7.2	2.6	5.8	22.5	0.0	8.3	16.0	7.8	4.3	13.9	4.7	12.5	1.6	4.7	9.8	20.0	2.8	2.0	14.7	11.8	7.2	13.9	10.5	7.8	16.4	2.1	23.7	11.4	0.0	13.1	2.8	5.1	8.2	15.8	13.1	14.3	9.0
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149315-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0;placenta: 31.1;seminal vesicle: 23.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	1.9	7.6	17.9	1.5	35.5	1.2	1.3	1.7	48.0	3.3	1.5	23.2	4.5	1.3	3.1	1.9	1.6	2.6	1.9	1.8	17.5	12.6	3.7	1.3	2.0	1.2	13.2	16.3	4.1	1.4	1.2	1.7	31.1	13.6	14.7	1.5	1.3	1.8	23.6	1.2	1.3	1.7	2.0	6.8	1.2	1.3	2.9	19.2	0.9	1.5	0.0	1.2	3.6	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	5.2	0.0	0.1	0.0	0.0	5.0	2.7	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	16.1	0.0	0.2	0.0	2.4	0.0	13.4	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	32.0	8.6	0.0	0.0	7.3	0.0	0.0	0.0	0.6	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.9	35.5	1.7	27.7	17.5	12.6	13.2	16.3	13.6	19.2	0.0	1.1	0.0	0.2	0.1	16.2	2.0	0.0	0.0	1.2	0.0	0.0	0.7	1.7	0.0	3.3	1.0	0.0	0.0	0.0	0.7	1.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.4	0.0	2.3	0.0	4.7	1.8	0.7	0.3	2.4	0.0	0.0	0.4
PABPC4L		ENSG00000254535	"Poly(A) binding protein cytoplasmic 4 like"	P0CB38	4	134196333-134201748	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Early spermatids: 2.6;Endothelial cells: 2.4;Leydig cells: 5.2;Peritubular cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 11.3;HeLa: 15.0;REH: 7.7;RH-30: 8.5;U-2 OS: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (1.11e-5)"	"unprognostic (4.41e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-3)"	3.8	0.9	0.7	0.5	0.8	0.0	5.4	0.6	0.7	8.8	1.5	0.0	3.5	0.3	10.3	2.6	3.3	2.7	1.4	4.7	0.8	0.8	2.5	0.6	1.1	0.5	0.9	0.4	3.2	1.1	11.0	2.1	13.2	0.6	6.5	0.3	2.7	2.7	5.9	1.7	0.8	1.4	5.0	0.8	0.6	1.3	2.3	0.2	6.0	4.7	1.5	1.1	2.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	3.3	2.3	1.6	1.9	0.0	0.0	0.0	3.6	0.0	0.0	0.3	11.3	0.1	2.4	0.0	2.6	4.3	15.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.6	0.0	2.1	0.0	1.3	0.0	0.1	0.0	0.0	0.0	1.4	7.7	8.5	0.0	0.5	0.0	3.4	0.9	0.0	0.7	0.2	3.1	0.0	1.5	0.2	2.9	8.8	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.6	0.7	0.8	0.8	0.9	0.4	0.6	0.2	3.0	0.6	0.0	0.5	0.2	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	2.6	2.4	0.0	0.0	0.0	0.3	1.8	0.4	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.9	0.5	0.4	0.1	0.7	0.0	0.0	0.0
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 43.4;Leydig cells: 35.1;Peritubular cells: 55.2;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"AF22: 35.8;ASC diff: 43.2;ASC TERT1: 48.1;BJ hTERT+: 21.1;fHDF/TERT166: 34.1;HHSteC: 31.9;HSkMC: 48.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		1200000	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	28.4	3.5	4.2	7.2	4.0	0.0	16.2	2.0	2.7	30.4	13.3	2.1	9.8	6.0	34.0	8.7	11.2	8.6	14.9	8.9	2.7	3.6	5.4	3.0	5.9	2.6	5.2	1.4	14.9	2.4	1.8	3.5	29.0	5.4	23.3	9.5	21.8	6.3	9.5	10.3	5.1	9.0	25.4	5.4	4.0	5.5	9.7	4.0	1.0	8.2	7.7	1.9	17.5	16.3	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	35.8	0.0	43.2	48.1	0.0	6.4	21.1	1.2	1.9	0.0	0.0	0.0	0.0	34.1	0.1	0.0	8.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	31.9	0.0	0.0	48.9	0.0	2.3	0.9	1.2	0.2	0.1	0.0	0.1	0.6	0.0	0.9	0.0	0.0	0.0	0.6	2.7	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	9.8	0.2	0.0	0.0	16.7	1.0	3.3	0.1	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.2	4.0	2.0	2.7	2.7	3.6	5.2	1.4	5.4	4.0	0.0	0.3	0.0	0.2	3.7	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	43.4	0.0	0.0	0.0	2.6	0.0	0.0	4.3	0.0	0.2	35.1	0.0	1.7	0.0	0.0	6.5	0.0	0.0	55.2	0.0	0.1	19.4	8.6	0.7	0.1	2.3	0.7	0.0	0.0	0.0
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	1.1	0.9	16.3	4.7	15.8	2.2	1.5	8.2	26.0	2.4	2.0	17.9	0.0	1.5	1.3	13.4	3.3	8.9	3.8	2.5	17.4	6.9	0.9	0.9	2.3	1.5	12.6	16.8	1.7	5.4	1.0	1.2	2.1	17.2	2.0	2.8	0.3	1.6	1.0	0.8	1.9	1.4	1.0	27.2	1.4	9.2	2.2	14.0	0.0	8.9	6.0	2.2	4.0	0.8	0.1	3.8	0.4	0.0	0.1	0.0	0.0	1.6	13.8	6.2	4.8	1.3	1.7	1.7	7.6	5.3	1.7	4.0	1.5	5.8	3.1	10.0	26.5	9.4	2.2	3.3	6.5	7.4	5.9	0.7	2.2	13.1	3.4	20.6	5.8	2.1	4.1	28.6	4.9	22.1	2.6	21.6	3.2	3.0	8.2	9.1	1.2	0.8	0.5	1.2	8.1	3.9	0.9	2.0	3.6	1.0	6.6	2.5	0.5	3.3	0.9	11.7	1.4	1.5	12.4	31.4	2.3	6.5	3.4	6.0	6.9	3.1	3.2	3.9	3.2	46.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	3.8	0.0	0.0	16.3	15.8	8.2	15.9	17.4	6.9	12.6	16.8	17.2	14.0	0.0	5.9	3.7	7.0	4.0	4.0	3.6	2.5	1.4	3.4	0.0	2.0	2.2	0.0	3.6	2.1	1.6	1.1	0.0	21.4	0.5	1.0	37.7	4.6	0.4	0.5	1.6	25.9	3.7	0.0	0.4	2.3	9.0	5.0	90.2	5.4	48.4	27.4	1.1	2.1	0.0	1.9	0.0	1.0	0.7	0.7	2.8	0.9	0.0	1.3	11.1
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015789-139045939	"Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	17.5	3.9	3.3	4.9	8.0	38.7	7.4	3.2	7.3	2.7	3.1	2.7	0.0	2.2	2.8	1.5	4.0	2.5	7.9	5.4	4.9	3.7	6.9	25.8	5.1	3.1	3.0	3.1	1.7	4.4	4.0	4.7	9.3	3.7	2.0	2.8	1.8	10.8	1.4	12.0	3.9	10.5	4.5	2.3	3.2	3.0	4.9	2.6	3.7	2.9	11.8	3.9	3.7	4.6	1.9	1.5	6.3	3.1	1.4	2.4	0.2	4.7	5.5	2.2	4.1	5.0	2.1	13.5	7.1	5.1	10.1	7.3	7.3	2.0	15.8	5.7	5.3	14.3	3.4	11.4	6.2	9.6	7.0	4.6	7.3	3.3	6.4	4.5	10.7	4.3	2.4	3.1	11.2	7.6	2.0	4.4	3.2	13.1	5.2	4.5	5.4	7.3	5.6	7.0	2.1	5.9	6.0	6.4	5.6	6.8	3.1	8.2	5.5	4.5	5.1	4.0	8.9	3.7	8.3	6.6	5.5	7.1	5.2	8.4	4.3	4.0	10.0	5.1	21.2	6.9	1.5	1.4	0.8	2.4	1.5	1.4	1.1	1.1	1.3	0.6	1.9	0.8	1.6	6.3	1.4	3.1	1.5	0.7	0.2	3.3	8.0	3.2	7.3	4.9	3.7	3.0	3.1	3.7	2.6	8.9	0.6	0.0	2.6	0.0	4.7	0.0	2.5	1.4	1.2	0.0	13.7	4.3	1.7	1.9	0.6	0.0	0.3	0.0	0.2	7.7	0.5	2.0	2.3	1.5	1.4	1.6	0.0	0.6	2.2	0.0	0.9	0.7	0.0	0.0	0.1	0.3	1.8	0.0	0.0	3.1	4.6	0.0	0.0	0.9	3.2	0.0	10.1	0.0	0.0	1.7
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	35.3	12.6	13.2	17.4	24.9	34.3	24.2	29.7	21.6	23.4	22.4	15.2	25.7	12.7	22.9	17.5	18.8	19.0	15.7	20.3	16.1	11.6	15.6	17.4	18.6	19.8	29.3	10.2	25.5	19.5	19.5	23.6	22.8	17.7	23.4	16.9	14.2	21.0	22.4	27.6	19.1	17.9	30.0	23.4	22.8	16.2	30.1	25.1	31.1	21.6	22.4	17.6	25.2	35.0	19.3	19.1	12.5	8.0	10.6	14.8	4.8	9.1	6.8	17.0	12.3	17.2	20.8	16.1	11.1	19.2	11.9	13.7	12.7	18.2	18.6	11.2	14.8	6.3	9.5	25.3	14.8	12.5	11.6	10.9	16.9	15.7	10.9	13.2	18.6	13.4	18.4	15.1	11.3	13.9	16.4	17.7	11.1	27.1	10.7	10.0	15.4	20.8	15.6	10.6	21.6	7.5	20.5	22.1	16.9	14.4	16.1	17.2	19.2	13.5	16.7	9.9	20.0	11.4	21.3	14.8	11.0	9.6	10.0	7.1	24.2	27.0	16.4	8.2	19.0	9.9	8.6	8.0	12.5	12.4	6.4	12.9	15.3	11.8	10.5	8.8	19.3	14.8	13.4	8.0	10.6	6.4	19.1	9.3	4.8	13.2	24.9	29.7	21.6	16.1	11.6	29.3	10.2	17.7	25.1	44.7	22.7	30.8	38.3	47.3	40.0	35.1	38.2	49.5	42.1	38.4	70.7	26.9	36.5	22.2	16.6	56.3	26.2	0.0	21.2	26.4	42.7	41.9	33.5	40.9	19.4	63.5	45.4	47.9	43.9	18.1	48.6	35.4	28.7	25.2	31.6	41.7	20.8	29.6	35.7	13.2	51.7	38.8	55.6	47.2	42.1	41.7	19.8	42.8	26.7	32.4
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266163-139280338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 88.9;retina: 30.7"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;cerebellum: 8.0"	"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4"					"Low region specificity"	"Detected in some"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	3.2	88.9	1.0	0.5	4.5	0.4	1.2	8.0	1.2	3.6	1.0	2.1	1.1	0.4	2.6	3.0	0.5	0.8	1.3	6.1	0.8	1.4	1.0	0.4	0.5	0.6	1.0	0.0	20.1	0.5	0.4	15.3	0.5	1.5	2.0	0.5	30.7	0.4	2.0	0.6	0.5	0.4	2.3	0.7	0.6	0.4	5.9	0.5	0.0	0.5	0.0	0.5	2.1	1.0	0.5	0.0	0.0	0.3	0.5	1.7	0.3	0.0	0.5	0.3	0.2	0.8	0.4	0.0	10.7	0.0	1.6	0.0	0.0	0.1	0.0	0.1	15.9	4.6	0.2	2.3	0.0	0.9	0.0	1.0	0.0	0.0	0.1	12.9	0.1	0.1	3.9	0.3	1.7	0.1	3.8	32.4	0.1	0.2	0.2	2.6	0.0	0.4	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	4.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.7	0.4	0.0	0.3	1.6	0.7	0.0	0.5	0.2	0.0	0.3	0.3	1.0	4.5	8.0	1.2	0.8	1.4	1.0	0.0	1.5	0.5	0.0	0.0	0.0	0.7	1.4	140.5	2.5	0.0	0.0	0.0	0.0	7.9	0.2	1.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	2.4	0.3	0.0	0.0	0.5	197.0	0.0	0.6	0.0	0.0	15.8	0.0	0.0	0.0	0.0	424.1	0.1	0.0	23.3	7.6	28.7	0.0	0.4	0.7	0.3	0.6	0.2	0.0	0.0	0.3
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.1"	"Cell type enhanced"	"Detected in all"	8	"Cardiomyocytes: 1810.7;Distal tubular cells: 963.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	7.4	17.0	15.2	6.4	15.8	5.6	8.3	12.2	15.7	8.5	13.1	11.8	7.0	15.2	6.6	12.0	11.7	8.3	7.7	55.5	12.4	14.6	20.3	17.1	8.4	6.7	13.0	12.1	9.7	13.1	11.4	14.3	8.9	10.0	8.1	12.6	11.3	10.9	10.5	164.1	9.1	16.4	7.2	10.4	10.5	11.9	27.1	8.5	6.1	11.6	57.6	9.4	7.0	7.3	32.7	40.0	40.8	24.4	12.8	31.4	26.1	8.7	3.7	10.7	13.3	7.7	8.4	8.6	10.8	7.2	8.0	6.1	6.5	11.0	3.8	3.9	7.6	7.9	5.2	20.9	7.1	6.3	5.5	6.7	6.1	7.1	10.4	9.7	5.0	3.3	12.1	10.7	7.6	11.2	10.3	7.9	8.8	14.0	16.4	5.5	6.2	7.4	12.4	8.2	16.4	5.0	6.3	6.6	29.1	12.8	5.7	9.1	6.9	7.7	9.5	4.9	9.0	10.4	9.9	3.9	7.9	3.7	5.5	6.1	13.2	23.2	9.6	8.5	13.3	6.3	16.0	24.4	40.8	21.7	17.3	17.3	28.3	24.4	23.2	24.0	32.7	31.4	23.1	15.4	12.8	18.8	40.0	28.3	26.1	15.2	15.8	12.2	15.7	12.4	14.6	13.0	12.1	10.0	8.5	83.4	126.2	85.5	146.6	124.6	118.7	1810.7	239.5	211.5	137.6	417.0	31.4	127.4	963.3	232.9	260.2	150.4	371.3	93.5	293.9	141.6	109.0	170.1	69.5	334.5	190.8	112.8	212.7	108.1	87.2	30.8	156.8	98.4	253.1	220.0	288.1	223.0	228.9	313.4	194.1	826.9	103.1	97.0	148.0	386.4	224.2	156.7	98.7	62.3	275.8	158.3
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N(alpha)-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301455-139420033	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA023589: AB_1854311, HPA050661: AB_2681208"	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	13.7	12.9	13.7	17.8	14.2	18.6	15.2	21.0	18.9	10.8	12.3	7.8	9.0	10.1	13.4	9.8	20.5	11.4	9.7	14.8	16.6	10.1	10.3	14.5	13.3	17.7	15.6	10.7	13.1	11.4	16.8	20.3	14.0	13.8	11.6	12.6	6.7	13.8	10.4	54.4	13.8	10.3	19.3	22.2	12.2	11.4	17.6	15.9	18.0	12.2	22.3	19.9	15.3	15.1	8.7	7.1	4.1	5.6	6.8	9.4	3.1	16.8	12.4	12.0	19.3	8.8	10.8	14.8	16.4	10.8	15.9	12.3	17.4	14.9	34.8	10.1	13.5	13.8	11.0	31.4	20.1	22.9	16.2	11.6	18.7	12.0	11.3	9.3	34.0	12.1	7.6	12.3	20.0	15.7	8.4	15.8	13.7	34.5	15.2	16.8	13.5	32.4	10.1	20.0	31.9	9.8	20.2	16.2	17.9	12.6	14.3	15.7	12.3	10.9	18.0	10.9	12.7	10.9	13.4	13.5	15.4	10.8	14.5	18.6	18.5	33.0	34.6	13.2	24.9	14.6	4.1	5.4	1.7	8.0	5.6	9.3	7.4	8.4	9.4	7.1	8.7	8.3	9.3	4.1	6.8	5.3	6.0	8.0	3.1	13.7	14.2	21.0	18.9	16.6	10.1	15.6	10.7	13.8	15.9	44.7	29.8	38.0	57.7	83.0	32.8	40.0	33.1	40.2	39.8	19.2	19.6	34.9	13.3	24.8	5.1	26.3	10.0	23.3	16.8	38.0	39.1	29.9	33.5	22.9	28.5	38.1	15.0	11.1	25.3	8.2	23.6	28.7	27.0	26.2	18.1	25.1	20.6	17.5	27.3	13.6	35.4	32.3	30.9	81.6	51.1	86.8	34.9	28.8	24.7	61.8
RAB33B	DKFZP434G099	ENSG00000172007	"RAB33B, member RAS oncogene family"	Q9H082	4	139453232-139476609	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 32.3;Late spermatids: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048367	Uncertain					NA	NA					"HPA048367: AB_2680372"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.06e-3)"	"prognostic favorable (9.19e-4)"	11.5	7.1	8.5	7.0	8.6	14.4	12.1	17.4	9.5	13.9	9.6	9.7	8.2	5.2	12.5	8.0	9.8	8.2	8.0	8.8	9.0	10.6	6.7	24.5	8.9	9.6	13.2	6.7	19.1	13.1	6.7	13.4	11.6	11.1	11.8	5.5	7.5	6.8	8.0	7.1	6.6	7.1	11.5	15.9	9.2	7.4	6.8	9.9	6.5	8.4	4.3	7.4	15.3	8.9	3.8	2.5	17.8	2.8	3.8	5.1	2.9	4.2	1.6	4.8	6.5	10.9	10.6	8.2	5.2	7.2	4.4	5.5	4.6	6.8	9.1	2.6	5.9	2.2	4.0	5.0	4.5	5.2	8.8	3.6	3.2	4.0	5.4	11.2	5.6	7.3	8.4	5.1	5.5	5.2	7.9	13.0	5.7	3.6	17.4	3.2	3.0	4.7	5.1	3.4	7.0	3.0	6.1	7.3	3.8	6.2	2.9	6.4	6.8	3.7	7.1	8.2	5.5	3.3	3.8	8.9	5.3	4.0	9.1	2.9	9.5	10.8	5.9	5.5	6.1	4.7	3.0	2.8	6.8	3.2	2.8	5.1	3.8	4.0	3.5	1.9	3.4	5.1	4.4	17.8	3.8	2.6	2.5	4.2	2.9	8.5	8.6	17.4	9.5	9.0	10.6	13.2	6.7	11.1	9.9	6.0	7.7	10.9	6.4	8.9	5.1	9.4	2.5	8.1	4.5	3.5	0.0	5.8	1.7	4.9	32.3	10.8	4.9	0.0	4.0	5.3	8.2	6.6	5.8	16.2	5.5	3.2	8.1	7.4	7.1	44.5	9.8	6.7	1.7	6.4	6.9	5.3	5.9	4.8	12.0	3.3	8.5	6.5	8.1	4.2	4.3	10.2	14.1	8.7	5.8	4.2
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	9.0	11.7	4.5	2.6	26.5	22.9	9.9	21.5	22.4	11.0	9.3	6.9	12.4	21.1	8.5	36.2	7.6	4.6	14.9	17.0	17.9	10.4	10.5	2.9	15.3	0.2	13.1	10.1	4.5	19.8	19.9	17.5	18.7	14.0	13.9	9.0	1.7	32.9	14.0	15.1	6.6	1.5	2.2	13.3	7.7	6.2	15.5	12.1	10.7	8.3	17.4	5.8	14.3	21.3	5.1	4.5	8.4	9.2	22.5	19.5	13.9	23.2	17.8	28.4	27.2	13.4	22.5	10.2	9.3	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5	6.0	13.1	3.4	10.9	15.2	6.6	35.4	17.8	4.0	6.8	8.7	11.8	21.9	0.0	20.5	0.9	24.7	1.8	23.3	18.1	14.4	19.2	35.1	2.3	64.4	18.3	7.9	1.2	36.8	29.7	3.5	21.3	18.3	10.1	7.2	11.2	13.3	21.5	0.0	26.5	3.9	12.6	19.4	21.0	3.2	1.9	19.3	38.6	5.0	9.9	14.2
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.9;monocytes: 25.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;OE19: 91.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA010707	Approved					NA	NA					"HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	26.9	30.2	6.9	9.7	10.8	7.4	29.0	12.6	9.3	16.4	27.3	7.3	31.3	27.3	12.2	19.4	54.9	14.7	42.0	26.9	7.4	9.0	25.3	79.1	20.6	21.6	10.1	5.9	10.6	27.8	16.4	18.2	19.2	10.2	23.3	25.4	14.7	30.4	36.7	20.4	24.2	60.3	13.3	10.7	19.6	15.2	29.0	8.8	8.3	23.7	40.9	26.8	19.1	22.6	0.5	46.9	8.1	25.9	5.8	8.8	8.8	6.6	9.7	5.0	0.0	0.8	2.7	3.0	1.2	11.0	0.5	1.8	10.1	47.4	0.0	27.7	2.9	2.4	12.6	8.9	13.7	0.8	3.7	8.0	29.3	10.7	40.0	2.3	25.2	22.6	9.2	33.7	0.3	2.1	11.1	27.7	0.0	12.1	4.4	4.0	5.5	0.0	4.1	1.1	91.7	9.9	2.1	5.9	8.9	25.8	14.3	12.7	3.8	9.0	14.1	10.7	0.3	9.0	33.5	17.6	0.9	4.8	1.3	1.0	5.2	3.6	1.6	0.6	42.7	2.2	8.1	25.9	7.0	1.1	15.4	0.7	0.3	1.9	0.9	35.7	0.5	0.6	0.6	4.4	5.8	4.8	46.9	8.8	8.8	6.9	10.8	12.6	9.3	7.4	9.0	10.1	5.9	10.2	8.8	23.8	29.3	18.2	223.2	54.3	8.1	90.8	229.3	57.6	47.8	90.7	23.6	70.4	76.3	102.7	5.6	212.7	268.6	23.3	122.5	52.4	30.4	143.0	43.7	322.9	310.1	6.4	117.0	164.5	94.6	9.0	41.1	102.8	37.1	19.0	165.9	13.7	108.9	204.6	31.5	203.6	2.7	12.9	48.4	3.7	15.1	109.2	56.2	27.1	227.8	357.7
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 29.1"	"Cell type enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 11.5;SCLC-21H: 12.1;SH-SY5Y: 18.5;WM-115: 15.4"	"Low region specificity"	"Detected in many"							HPA037717	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	5.9	5.5	6.0	10.3	4.2	3.9	6.4	29.1	4.1	10.0	6.3	5.4	8.3	6.8	19.4	11.5	10.5	8.4	11.2	3.7	3.2	3.6	4.2	4.8	6.8	6.0	4.9	2.8	13.3	11.3	7.4	16.7	7.2	5.8	8.4	5.7	5.5	15.3	16.2	2.5	12.9	6.2	9.2	7.8	4.9	6.0	6.5	5.1	13.5	6.2	5.9	6.8	8.9	8.9	0.6	1.8	11.0	1.9	3.9	0.6	1.3	0.4	6.1	4.2	2.1	1.7	3.5	3.8	0.7	3.4	0.3	0.2	2.4	1.7	1.3	0.4	0.6	0.2	0.1	1.6	1.4	0.2	0.0	0.9	4.3	1.4	0.2	0.3	2.0	6.8	3.4	1.2	0.1	0.7	2.6	11.5	0.1	1.1	0.0	0.2	0.6	0.4	0.9	1.0	2.7	2.7	2.6	0.4	2.6	1.9	8.4	12.1	18.5	0.0	3.2	4.1	3.4	1.8	0.6	9.8	0.5	1.1	0.0	1.4	2.3	2.5	0.0	0.6	6.9	15.4	11.0	1.9	3.5	0.0	1.3	0.2	0.0	0.0	0.0	1.8	0.6	0.6	0.5	4.5	3.9	1.2	1.5	0.0	1.3	6.0	4.2	29.1	4.1	3.2	3.6	4.9	2.8	5.8	5.1	3.0	8.6	1.7	7.0	7.1	5.7	2.8	15.3	9.4	12.5	5.2	17.7	4.4	5.0	4.4	3.5	8.8	9.2	0.0	4.5	6.2	4.2	9.2	18.5	16.3	6.9	11.1	14.3	8.6	21.2	7.2	3.7	15.8	3.3	2.8	12.8	2.8	2.5	11.8	3.5	4.3	3.3	0.0	6.2	0.5	1.7	11.8	6.9	1.3	11.0	5.8
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 356.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	16.2	26.6	49.3	9.7	45.0	4.5	27.7	36.3	57.1	17.7	16.1	25.0	15.0	16.5	18.8	32.2	20.4	17.3	15.3	38.3	47.1	66.9	38.6	27.9	13.7	9.7	59.7	32.5	16.6	19.0	29.6	30.5	18.5	74.5	24.2	19.2	15.0	17.9	20.1	13.5	11.0	16.0	19.9	61.8	9.9	19.6	11.1	25.0	6.0	26.0	13.0	11.8	14.8	11.8	18.8	14.3	18.5	12.4	19.2	27.9	19.2	14.8	10.1	27.9	14.5	25.0	34.7	20.0	24.4	23.8	19.7	22.2	6.7	22.2	6.1	21.8	25.0	18.2	6.4	16.9	34.7	30.1	21.0	12.1	9.6	5.2	15.9	22.1	19.3	12.2	23.1	47.0	17.5	19.8	38.3	26.3	18.0	14.8	18.2	34.4	9.8	23.9	11.7	8.7	13.1	17.5	14.7	11.7	9.0	57.9	13.7	19.6	20.5	16.5	24.9	26.8	25.9	18.1	11.9	20.0	30.2	17.6	24.8	23.7	27.9	47.7	16.3	35.1	8.8	29.5	18.5	9.0	11.7	15.7	12.4	20.1	18.8	19.0	15.5	11.2	15.2	27.9	21.4	5.2	19.2	12.0	14.3	16.6	19.2	49.3	45.0	36.3	57.1	47.1	66.9	59.7	32.5	74.5	25.0	44.7	38.0	35.7	59.8	54.3	131.0	122.4	43.3	54.9	37.5	120.4	21.6	120.6	271.9	89.4	356.8	55.2	50.3	0.0	99.5	67.4	61.2	77.2	35.8	56.1	42.7	162.1	36.2	44.2	22.2	56.1	55.5	40.5	131.6	45.9	40.9	160.2	87.9	28.8	62.2	179.9	63.0	45.3	62.8	39.4	51.3	49.4	74.4	27.3	40.9	46.3
CLGN		ENSG00000153132	Calmegin	O14967	4	140388455-140427968	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 243.4;Early spermatids: 78.2;Muller glia cells: 200.1;Spermatocytes: 280.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 21.7;U-251 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	3.6	2.1	0.7	3.7	1.2	1.6	5.9	3.5	0.8	1.4	0.5	0.0	0.4	1.0	1.6	0.9	7.0	0.4	40.3	0.9	3.4	0.4	3.7	0.5	0.5	1.4	1.6	1.8	1.6	0.2	23.6	0.3	8.6	11.9	0.8	2.4	0.6	0.6	0.4	0.3	0.8	0.9	0.8	0.3	1.6	52.6	0.3	3.1	1.5	0.0	0.8	0.6	0.4	0.5	1.0	3.4	1.1	0.0	0.0	0.1	0.0	4.0	4.2	2.7	1.7	8.8	1.0	0.0	3.7	4.0	7.5	0.1	0.3	0.0	11.5	0.4	3.5	0.1	2.9	0.0	6.6	0.2	3.4	1.1	4.0	2.9	17.5	14.6	0.2	1.0	16.1	0.4	0.4	21.7	0.1	3.9	0.7	0.0	0.0	0.2	18.3	0.2	4.8	0.1	11.4	12.2	0.0	0.1	0.0	0.1	6.8	12.3	2.5	1.6	0.7	1.6	0.8	2.2	0.0	11.0	2.0	4.0	28.9	5.8	12.6	7.9	17.7	0.6	1.2	3.4	1.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	5.9	3.5	0.9	3.4	1.4	1.6	8.6	0.3	0.0	2.1	0.0	1.0	0.0	8.5	243.4	0.0	28.1	4.5	0.0	3.9	0.3	0.0	0.9	78.2	1.1	0.0	23.3	3.7	0.1	0.5	35.3	0.0	2.6	0.1	23.8	5.1	0.0	0.0	42.6	4.6	0.0	1.7	0.0	0.0	200.1	1.4	0.0	4.2	0.0	11.8	0.0	0.3	280.7	9.8	0.1	0.2	0.0	0.4	0.9
MGAT4D	GnT1IP	ENSG00000205301	"MGAT4 family member D"	A6NG13	4	140442262-140498377	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	56	"testis: 33.8"	"Cell type enhanced"	"Detected in some"	33	"Early spermatids: 12.4;Late spermatids: 20.4;Spermatocytes: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036523	Enhanced					NA	NA					"HPA036523: AB_10670110"										"unprognostic (2.70e-1)"		"unprognostic (3.16e-2)"						0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	70.7	1.0	0.0	0.0	0.0	0.0	0.0
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524158-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: AB_2680098"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.82e-2)"	11.6	20.8	9.2	11.9	14.0	8.5	16.7	14.0	10.6	13.8	17.9	10.4	24.7	14.4	15.4	15.8	13.9	13.9	10.9	18.0	10.4	11.2	20.6	19.3	14.5	13.9	13.6	9.2	13.0	17.2	20.2	24.1	17.3	13.6	15.5	15.2	12.1	13.5	21.2	8.4	10.5	31.0	12.4	14.4	11.6	12.1	9.1	12.3	18.2	19.6	10.5	11.2	12.1	11.6	6.0	10.6	17.0	7.8	7.8	8.6	4.8	6.6	7.4	15.2	11.6	15.9	18.4	9.8	15.8	15.0	8.8	10.6	7.3	14.2	10.9	7.0	9.8	10.7	6.1	14.4	10.0	10.9	10.5	8.5	8.9	5.8	9.4	14.5	13.6	8.0	12.6	16.7	7.4	7.7	13.9	9.6	13.3	11.4	18.0	15.0	4.8	14.8	4.7	8.0	9.7	6.1	17.4	11.7	7.0	12.7	10.6	7.2	26.8	10.3	10.6	11.3	17.8	10.4	5.7	9.6	20.3	7.3	9.4	16.2	18.9	26.8	13.8	14.8	10.8	15.2	2.6	7.2	8.7	7.5	7.8	8.6	3.8	6.9	8.3	6.1	6.0	7.1	7.0	17.0	7.8	5.9	10.6	8.0	4.8	9.2	14.0	14.0	10.6	10.4	11.2	13.6	9.2	13.6	12.3	26.8	15.3	5.2	9.6	8.1	19.0	12.3	5.1	25.4	5.7	17.4	17.7	19.0	1.7	20.2	2.0	11.7	15.3	0.0	22.7	7.3	13.3	8.8	19.6	24.6	17.2	14.3	8.7	11.1	17.4	1.0	12.0	13.4	16.9	11.8	12.5	18.5	21.7	12.2	10.3	15.1	22.8	6.5	6.1	25.6	19.4	10.2	16.8	10.7	10.8	4.8
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559434-140568805	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1"	"Cell type enhanced"	"Detected in single"	24	"Syncytiotrophoblasts: 1.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 9.8;HAP1: 7.1;JURKAT: 2.5"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	2.4	8.4	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	7.1	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.8	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.8	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620765-140756120	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 52.4"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.0"	"Group enriched"	"Detected in many"	38	"B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	15.9	6.2	8.1	9.2	10.0	1.0	33.6	37.6	13.7	9.2	6.7	3.8	32.1	5.2	5.5	6.4	5.9	6.7	9.4	5.7	7.5	13.9	10.7	8.0	10.4	9.6	9.6	8.2	10.9	6.0	9.9	5.7	13.1	11.0	9.8	4.3	10.6	7.3	27.4	1.7	2.8	9.9	5.0	5.3	20.4	10.0	2.9	3.8	1.6	4.3	3.0	12.2	11.1	8.9	9.0	4.6	0.1	2.4	0.1	0.0	0.9	0.4	6.4	6.0	5.1	14.6	13.8	12.2	8.1	8.8	5.9	7.6	1.3	5.6	0.0	5.2	10.6	7.4	1.2	7.4	5.8	5.6	0.0	4.1	3.6	4.6	5.5	5.3	0.5	0.5	11.3	9.7	5.1	20.6	17.3	16.4	2.0	0.0	0.0	5.5	6.3	0.8	0.0	0.9	6.7	5.6	3.9	9.8	9.3	6.8	11.8	8.8	6.2	8.5	15.0	5.5	10.6	3.5	0.2	25.4	15.7	4.7	10.2	7.0	0.0	0.0	0.0	9.5	0.7	8.5	0.0	2.4	0.0	0.0	1.9	0.0	9.0	0.0	0.0	4.0	4.0	0.0	0.0	0.1	0.1	0.7	4.6	0.0	0.9	8.1	10.0	37.6	13.7	7.5	13.9	9.6	8.2	11.0	3.8	50.6	9.4	15.7	8.9	4.0	33.1	6.5	17.8	5.3	6.8	52.4	3.9	10.8	6.6	13.3	0.4	24.1	4.1	0.0	15.0	3.9	11.5	19.8	0.0	14.5	15.9	9.5	7.5	17.8	30.7	0.0	12.0	30.7	8.5	25.2	4.5	40.9	13.2	5.9	25.1	3.8	7.0	0.0	9.5	0.7	1.5	3.3	36.2	0.5	1.7	8.4
RNF150	KIAA1214	ENSG00000170153	"Ring finger protein 150"	Q9ULK6	4	140859807-141212877	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 45.5;Cardiomyocytes: 62.2;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 67.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;fHDF/TERT166: 17.7;SH-SY5Y: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037987	Uncertain				"Intracellular and membrane"	NA	NA					"HPA037987: AB_10669512"	"prognostic favorable (1.41e-4)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.88e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.41e-2)"	12.3	14.4	9.2	4.1	26.2	0.9	7.6	13.2	9.6	12.2	18.9	2.5	5.1	1.5	14.1	13.0	8.3	14.5	4.4	18.6	8.0	5.1	10.3	1.5	2.0	3.6	3.2	6.7	12.8	2.8	0.9	18.1	2.6	4.7	10.2	4.8	17.2	30.3	13.6	18.9	1.6	5.0	19.2	4.4	7.7	6.3	2.3	3.8	0.6	7.3	5.9	3.7	12.4	5.8	0.1	0.9	0.4	1.1	0.1	0.1	0.1	0.2	0.3	3.2	2.9	13.8	1.0	0.1	5.6	2.3	1.8	0.8	0.0	0.1	0.0	0.7	17.7	0.1	0.0	7.1	0.1	1.0	0.0	3.4	0.0	7.9	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.2	1.1	0.0	3.5	0.0	0.1	0.6	0.1	3.6	0.1	1.8	0.0	1.3	2.1	8.3	0.1	1.9	0.0	1.5	25.7	0.4	0.2	1.2	1.7	0.1	0.0	0.0	9.1	3.8	5.9	2.5	0.2	0.0	0.0	0.1	0.0	6.7	0.4	1.1	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.9	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.0	0.1	9.2	26.2	13.2	9.6	8.0	5.1	3.2	6.7	4.7	3.8	0.0	0.3	0.0	0.6	1.0	45.5	62.2	2.5	0.0	3.4	10.4	106.0	0.5	1.7	0.3	3.0	1.9	0.0	0.0	0.5	0.1	2.7	0.9	0.0	0.0	0.5	25.4	1.7	2.5	0.6	1.1	26.4	0.5	0.0	0.0	0.0	11.5	0.1	0.0	17.0	1.1	67.8	12.9	18.4	0.0	1.5	0.5	0.3	0.0	0.0	0.0
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 80.7"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015705, HPA056325"	Uncertain		Supported	Nucleoli		NA	NA			Nucleoli		"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	21.7	15.9	8.9	12.2	13.7	16.2	13.8	17.5	11.2	14.9	17.4	9.8	14.2	9.5	19.0	15.6	13.6	14.0	10.5	80.7	9.0	9.5	14.9	26.7	15.2	13.4	13.7	8.6	14.9	16.5	13.2	15.1	10.4	12.7	12.2	12.3	22.3	44.9	11.4	34.7	10.9	12.6	18.9	14.1	16.0	14.2	14.2	13.3	14.3	23.5	15.4	13.5	18.7	16.0	16.3	21.9	12.2	20.8	14.6	19.3	11.8	7.7	9.6	11.6	9.2	20.9	18.9	16.4	21.0	12.1	13.5	12.8	12.9	15.0	33.4	12.9	13.2	7.6	6.3	20.5	13.6	20.8	15.4	13.4	15.5	14.8	18.1	22.4	38.9	12.5	18.9	16.0	12.7	18.6	16.5	14.1	20.7	31.4	22.8	17.2	17.6	30.1	18.3	10.3	24.1	18.3	24.6	16.7	21.1	14.5	8.7	20.3	9.4	7.3	16.9	20.6	13.7	8.4	10.7	15.0	17.3	11.7	10.4	14.9	38.2	27.4	31.7	14.5	24.4	12.3	9.7	20.8	12.2	12.9	17.5	17.8	16.3	16.4	16.6	21.9	13.4	18.0	16.2	3.2	14.6	13.5	15.0	19.3	11.8	8.9	13.7	17.5	11.2	9.0	9.5	13.7	8.6	12.7	13.3	50.6	29.6	27.4	41.1	43.7	64.5	140.4	22.9	20.1	23.9	8.7	13.7	30.9	49.7	27.5	163.4	28.7	21.1	23.3	44.0	30.7	29.8	28.9	23.0	63.5	61.1	15.9	16.1	33.7	48.2	40.5	36.2	41.2	43.9	17.2	22.7	29.8	35.0	24.6	26.9	67.2	23.1	12.9	36.8	47.3	16.1	45.0	28.7	24.9	26.0	54.1
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636599-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"monocytes: 96.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.5;Karpas-707: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	NA	NA	182000		"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: AB_2675640"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.7	1.1	21.3	1.5	2.9	9.2	1.8	2.2	6.0	8.8	0.8	2.2	6.3	11.3	7.4	5.6	4.6	9.9	9.3	1.1	1.5	6.9	3.7	14.4	18.8	2.3	1.6	3.2	3.1	0.5	4.5	9.9	2.1	7.7	5.7	5.9	6.9	3.6	9.1	3.2	14.2	7.1	2.6	17.0	5.3	2.6	2.0	9.8	18.1	5.9	11.0	9.8	16.9	3.7	4.6	8.1	14.0	2.6	4.5	4.4	2.4	5.2	0.2	0.5	0.8	4.7	1.3	5.6	5.2	5.8	4.7	2.8	6.8	2.3	7.3	4.8	5.0	3.6	0.1	3.0	3.2	15.5	1.4	0.4	13.7	0.4	3.9	1.6	1.1	1.7	1.2	3.8	0.4	11.9	3.7	1.8	3.8	15.2	3.7	0.8	3.4	0.3	2.6	1.8	1.6	0.9	13.4	0.3	7.6	0.6	0.5	1.3	2.4	3.7	2.7	0.6	0.9	0.2	5.5	5.9	3.8	1.7	3.4	10.7	1.3	0.7	6.3	0.6	2.1	8.1	14.0	0.8	2.5	12.4	4.5	3.7	2.9	2.2	4.6	3.4	1.2	1.3	1.0	2.6	12.5	0.1	1.5	4.4	1.1	1.5	1.8	2.2	1.1	1.5	2.3	1.6	2.1	2.0	0.0	3.2	10.4	2.8	5.5	0.3	2.4	0.0	4.0	7.9	5.2	0.0	1.0	0.0	8.1	4.0	11.3	3.9	0.0	12.2	1.8	7.2	4.3	0.0	1.7	4.9	0.0	0.0	11.6	18.3	1.5	2.6	19.3	8.5	96.4	4.7	15.1	14.3	3.5	1.1	8.4	0.5	6.5	3.1	0.5	0.7	3.0	0.2	6.4	2.3	2.1
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 19.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 9.1;T-cells: 19.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 52.6;SK-MEL-30: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	15.4	4.7	8.4	8.5	12.5	2.2	21.2	5.1	10.3	28.1	7.1	1.8	5.6	5.0	19.7	18.4	9.1	9.2	8.7	18.4	5.9	6.1	6.1	2.0	9.9	10.8	5.5	8.9	15.4	4.0	2.3	3.8	6.2	4.6	8.3	5.8	1.7	4.9	6.8	10.8	4.7	7.3	10.2	3.1	7.0	7.0	19.6	2.4	8.2	6.5	4.9	7.4	15.8	14.6	0.0	0.0	2.2	0.1	9.1	19.2	3.7	9.3	3.9	2.6	1.2	2.0	1.2	0.5	11.3	13.3	2.9	5.5	1.0	52.6	0.2	3.2	10.1	4.5	14.3	0.0	13.2	6.9	0.0	0.4	2.2	1.5	0.0	0.6	0.4	1.8	2.1	1.8	2.0	7.0	8.8	1.6	0.0	0.0	0.5	6.3	16.7	0.3	0.0	0.1	5.7	2.8	0.1	8.7	0.4	4.0	17.4	0.2	0.2	1.3	4.0	23.4	1.6	12.0	1.6	1.0	6.7	8.2	9.9	0.1	0.1	0.0	0.0	1.5	10.3	17.4	2.2	0.1	0.0	3.3	0.0	6.5	0.0	19.2	8.5	0.0	0.0	13.2	5.7	0.2	9.1	0.0	0.0	9.8	3.7	8.4	12.5	5.1	10.3	5.9	6.1	5.5	8.9	4.6	2.4	0.0	1.1	0.0	9.8	6.0	7.3	36.2	7.6	17.4	9.1	8.7	0.0	1.4	5.0	12.2	163.6	10.8	8.4	0.0	26.9	3.9	4.1	13.4	5.8	0.0	6.2	6.4	8.5	3.7	4.4	196.7	12.7	1.9	69.2	0.0	3.4	0.8	47.4	0.0	6.0	0.8	0.6	84.1	43.7	3.1	2.0	2.3	1.6	16.6	3.4	41.0
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.8	4.5	4.0	6.9	5.3	5.3	3.0	7.7	7.5	7.2	6.1	13.1	7.2	6.0	5.5	6.5	4.6	3.8	9.5	7.7	5.9	14.6	6.1	5.5	5.4	2.8	7.3	11.1	5.5	6.4	7.1	7.3	5.9	5.1	7.1	6.9	11.9	18.9	4.7	7.7	14.5	2.1	3.6	9.8	8.9	9.5	6.0	5.7	4.6	5.6	8.2	7.4	6.0	10.5	6.7	3.1	6.4	4.2	8.4	6.6	5.4	5.7	8.0	21.1	35.7	10.9	6.7	8.5	5.5	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2	20.8	13.7	10.5	16.5	47.6	7.5	15.1	7.6	13.4	14.8	0.0	11.8	10.9	1.7	7.5	27.8	12.0	18.4	0.0	6.6	5.8	9.7	16.1	3.5	32.7	9.2	7.9	29.4	17.8	14.5	15.4	6.4	12.2	11.8	1.8	19.9	13.6	8.5	11.5	8.9	14.2	8.2	12.9	15.1	9.5	5.1	51.7	22.3	13.4	14.5	38.1
GAB1		ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 38.0;U-266/70: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli fibrillar center"	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	9.2	8.4	15.0	7.3	33.3	8.8	9.7	5.8	22.0	10.1	17.0	64.0	10.2	10.4	17.7	13.1	18.2	8.6	11.1	26.2	19.5	11.4	12.9	7.9	15.6	5.0	35.7	19.0	18.1	7.0	17.2	6.3	18.0	30.5	7.8	20.3	15.4	11.7	13.9	11.2	11.1	10.4	15.9	32.3	6.2	11.0	7.9	41.7	1.0	7.8	6.0	7.3	9.9	11.9	3.1	3.4	5.9	2.3	7.4	0.4	0.4	3.4	0.7	8.9	6.4	4.5	4.3	11.6	2.4	8.0	2.9	5.1	6.6	5.9	0.1	0.7	3.3	2.0	1.9	8.5	2.8	3.3	0.5	2.0	6.2	1.9	3.1	3.1	0.8	1.2	5.3	5.0	3.5	2.3	6.2	3.8	0.1	2.0	11.5	2.0	4.9	0.5	0.0	2.5	1.8	2.8	38.0	4.3	4.4	4.5	4.2	2.1	6.3	1.6	7.0	3.0	6.2	4.5	0.8	2.8	3.7	2.9	1.7	1.8	18.5	9.0	13.7	2.5	2.5	3.0	5.9	0.6	0.7	0.0	0.8	0.4	1.3	0.1	0.0	0.8	3.1	0.0	0.0	4.0	7.4	2.3	3.4	0.0	0.4	15.0	33.3	5.8	22.0	19.5	11.4	35.7	19.0	30.5	41.7	26.8	14.7	6.7	7.6	18.0	1.9	27.8	7.6	2.7	5.7	12.2	0.0	18.0	0.0	5.0	0.9	16.5	11.2	0.0	2.2	8.5	11.5	6.2	2.3	5.8	5.3	3.2	21.4	11.6	9.7	2.1	19.2	5.7	15.1	2.8	25.0	14.1	4.1	8.6	17.7	5.0	0.7	12.9	16.5	1.8	5.2	21.8	8.7	1.3	13.5	11.1
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513463-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751, HPA074181"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"CAB005227: AB_2191863, HPA008751: AB_1857268, HPA074181: "	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	21.0	39.5	24.7	24.8	32.6	34.5	21.9	26.9	29.2	24.0	23.8	27.7	24.6	17.9	27.3	26.3	19.8	23.0	23.8	29.8	25.0	25.1	21.1	21.0	33.3	29.5	30.2	26.5	29.4	24.6	33.1	33.3	27.7	29.6	23.1	22.5	16.3	22.0	25.7	24.6	14.7	22.6	22.9	34.6	28.6	22.8	37.8	32.8	44.3	28.5	15.1	29.7	25.6	23.7	11.7	13.2	15.4	19.4	15.6	16.3	10.6	11.9	9.4	34.6	21.7	20.3	14.7	20.7	15.2	18.1	22.1	18.8	16.0	16.8	32.4	10.5	12.9	8.9	9.5	31.6	14.2	21.5	21.5	11.2	24.2	13.9	13.1	15.0	29.9	14.3	12.9	10.3	15.7	13.5	13.0	17.1	16.6	21.8	20.5	14.4	10.7	34.8	10.4	28.1	20.0	13.5	38.7	22.2	10.5	17.3	14.6	27.7	23.5	19.8	14.0	17.5	27.1	10.1	14.0	18.2	14.7	11.3	15.3	14.9	22.6	27.0	39.4	11.5	25.1	14.9	5.0	10.7	15.4	13.9	12.7	16.3	11.7	14.2	15.0	13.2	11.5	14.9	14.7	9.7	15.6	19.4	10.1	16.1	10.6	24.7	32.6	26.9	29.2	25.0	25.1	30.2	26.5	29.6	32.8	285.9	217.7	44.0	61.8	41.2	94.8	89.1	28.1	137.9	128.5	41.8	60.9	60.5	33.2	66.8	37.7	52.0	32.2	0.0	53.1	58.4	45.4	47.0	98.4	21.7	39.5	81.0	76.6	36.2	50.0	18.9	55.8	51.0	28.7	101.0	33.6	83.9	56.1	32.8	58.4	29.3	110.5	51.8	54.2	117.2	123.0	35.8	85.4	55.4	37.9	62.6
FREM3		ENSG00000183090	"FRAS1 related extracellular matrix 3"	P0C091	4	143577302-143700675	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"brain: 5.0;lung: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"TIME: 3.2"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.3;hypothalamus: 3.2;thalamus: 4.8"	"Low region specificity"	"Detected in some"			HPA041641	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA041641: AB_2677592"	"unprognostic (1.19e-2)"			"unprognostic (4.09e-9)"	"unprognostic (3.09e-3)"	"unprognostic (2.74e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.24e-1)"	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	1.8	0.0	0.2		0.0	0.0	0.1	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GYPE	"GPE, MNS"	ENSG00000197465	"Glycophorin E (MNS blood group)"	P15421	4	143870867-143905563	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 14.5;lymphoid tissue: 6.9"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 70.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5"	"Group enriched"	"Detected in many"	12	"B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3"	"Group enriched"	"Detected in some"	11	"HEL: 50.9;K-562: 16.4"															NA	NA						"unprognostic (2.17e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.10e-4)"	"unprognostic (7.81e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.49e-2)"	2.7	0.2	1.2	1.5	0.5	14.5	1.2	0.5	1.2	0.9	0.5	0.5	0.5	0.0	0.5	0.8	0.5	0.1	0.7	2.6	1.1	0.3	0.7	0.5	3.7	1.0	0.5	0.5	1.5	0.5	0.0	0.5	5.7	1.1	0.5	0.4	0.5	0.5	0.6	0.5	0.5	1.7	0.5	0.7	6.9	0.4	0.8	0.5	1.5	1.4	0.5	3.1	0.9	0.5	3.5	0.1	0.0	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	3.0	3.0	0.0	1.2	2.7	0.6	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	50.9	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.5	0.0	0.0	0.0	1.1	0.8	0.6	0.0	2.1	0.0	0.1	0.0	0.0	1.2	0.5	0.5	1.2	1.1	0.3	0.5	0.5	1.1	0.5	14.9	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	70.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.1	0.0	0.0	0.0
GYPB	"CD235b, GPB, MNS, SS"	ENSG00000250361	"Glycophorin B (MNS blood group)"	P06028	4	143996104-144019345	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"bone marrow: 37.1"	"Cell type enriched"	"Detected in some"	591	"Erythroid cells: 981.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 61.4"														"Intracellular and membrane"	NA	NA																							0.2	0.0	0.2	0.1	0.1	37.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.2	3.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.2	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	981.2	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140786	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 56.9"	"Cell type enriched"	"Detected in some"	311	"Erythroid cells: 1331.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"HEL: 57.0"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.0	0.2	0.1	0.4	56.9	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	1.7	1.3	3.2	0.1	0.3	0.1	0.1	0.1	0.0	0.3	4.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.3	0.4	0.2	0.2	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.2	0.9	0.1	0.2	0.2	1.5	0.2	0.6	0.2	0.2	0.2	0.3	0.0	0.8	0.2	0.4	0.1	0.5	0.2	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.3	0.0	0.0	1331.6	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646021-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.5;lung: 29.7"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 69.8;TIME: 80.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	4.0	5.2	9.9	1.7	22.2	2.3	1.1	2.3	16.0	3.4	6.5	31.5	0.0	5.5	4.1	8.1	1.0	1.2	3.0	1.1	16.0	6.3	2.4	12.7	29.7	1.0	21.6	9.9	2.2	4.8	1.0	1.1	1.0	17.5	9.8	6.8	4.4	1.3	6.2	1.3	1.1	8.2	1.3	12.3	1.0	11.2	3.7	26.5	2.3	1.6	0.0	1.0	7.1	1.0	0.1	2.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	3.8	69.8	6.2	0.0	0.0	1.0	0.0	9.8	0.0	0.9	0.0	0.6	0.1	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	0.0	0.8	0.0	0.5	0.4	0.0	2.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.6	0.0	0.0	9.9	22.2	2.3	16.0	16.0	6.3	21.6	9.9	17.5	26.5	11.9	177.0	0.0	0.0	0.0	1.4	1.1	0.0	8.1	6.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.0	0.4	0.0	16.1	0.0	0.1	0.0	0.0	16.0	0.0	1.8	126.0	1.0	1.7	0.0	0.0	0.2	0.1	0.0	41.4	0.0	3.5	0.0	0.4	0.2	0.2	0.5	0.0	0.0	0.0	0.0
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	19.0	15.6	16.4	11.9	22.1	14.0	23.4	29.8	24.6	19.3	14.4	16.6	10.6	7.1	19.3	21.3	13.8	17.5	12.5	21.4	17.2	17.6	21.2	21.0	15.8	15.0	18.1	16.2	19.9	14.2	15.1	28.6	19.6	25.9	15.4	16.7	15.9	14.5	15.5	23.8	13.7	11.7	19.4	20.2	14.8	13.1	27.3	20.5	20.4	19.2	13.3	16.7	15.4	15.5	13.5	13.9	18.2	8.4	14.1	15.1	6.7	9.1	5.2	14.0	5.2	13.3	14.3	9.1	11.1	11.8	15.0	10.8	11.6	12.7	14.4	7.3	8.4	10.6	5.7	11.7	15.8	15.3	12.2	9.2	7.7	4.0	9.5	16.9	15.8	9.0	11.8	10.9	12.0	19.1	11.9	12.0	15.9	21.2	18.9	15.0	6.8	27.1	19.0	9.2	11.0	11.7	12.8	11.7	8.3	16.2	6.0	9.5	7.8	8.0	6.5	14.3	13.3	6.1	13.2	9.6	9.4	6.2	9.1	14.9	15.7	17.2	21.8	13.1	20.1	12.6	18.2	6.8	8.6	11.9	8.4	12.0	13.5	12.8	12.2	9.4	10.9	13.0	12.9	2.0	14.1	8.2	13.9	15.1	6.7	16.4	22.1	29.8	24.6	17.2	17.6	18.1	16.2	25.9	20.5	11.9	13.4	18.6	19.9	14.4	8.3	14.1	5.1	22.7	19.4	14.0	0.0	32.6	39.7	20.4	45.0	20.2	7.7	0.0	22.8	30.5	14.3	19.9	25.4	15.3	31.0	4.8	2.9	19.0	11.1	14.9	31.4	20.5	10.1	33.3	12.0	15.4	22.4	12.4	25.5	37.2	8.8	32.3	20.6	111.9	38.5	17.3	24.7	20.8	12.1	22.2
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145097932-145129179	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No			Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	27.5	19.4	17.5	23.3	23.7	17.5	25.3	21.0	23.2	20.8	16.5	17.7	14.7	14.4	19.5	15.8	28.5	19.4	16.4	19.5	19.5	18.0	23.1	40.1	17.3	27.3	22.1	15.5	28.2	34.2	23.0	31.7	21.2	26.0	18.4	21.1	11.0	19.0	15.1	33.1	19.9	14.1	20.7	22.1	29.0	16.7	21.2	20.7	36.5	20.1	29.7	29.5	26.0	19.0	9.9	13.2	1.0	8.8	10.4	18.2	9.9	26.7	14.0	21.7	15.0	18.9	27.4	21.2	29.3	21.1	35.7	25.3	21.1	25.4	43.9	9.5	26.1	18.8	18.0	32.3	38.2	48.4	24.4	19.0	24.7	10.5	18.6	24.9	56.9	20.0	20.2	26.7	37.8	53.4	18.4	38.3	33.5	49.6	32.9	38.1	16.1	54.5	19.0	17.9	41.4	32.5	29.0	26.1	31.3	26.8	17.8	27.1	13.3	17.8	30.3	20.9	17.2	18.1	22.3	25.2	35.4	21.8	24.6	35.3	29.5	47.0	47.0	21.7	49.7	39.1	1.0	6.7	0.7	9.2	8.8	18.2	9.9	11.1	11.1	13.2	9.2	15.6	12.9	0.6	10.4	8.1	7.4	12.4	9.9	17.5	23.7	21.0	23.2	19.5	18.0	22.1	15.5	26.0	20.7	23.8	16.0	38.8	65.1	53.1	33.8	21.0	15.3	32.1	52.4	24.4	19.6	32.6	33.2	31.5	22.0	37.2	6.4	23.3	24.2	35.3	34.5	51.8	31.3	28.0	37.4	39.7	19.7	22.1	22.2	9.3	43.4	34.8	18.6	27.9	22.3	17.5	33.7	3.5	32.5	29.3	34.2	32.3	31.6	76.0	70.9	51.9	22.2	27.7	30.4	68.4
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180161	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.3	11.8	16.6	11.6	16.7	24.7	12.0	22.7	15.9	14.0	15.3	16.0	10.1	10.0	13.9	13.3	14.8	14.9	11.2	15.6	12.0	9.2	11.1	17.7	15.5	13.1	14.1	8.4	14.3	13.4	22.4	12.2	17.9	12.7	10.6	11.2	10.6	12.7	11.0	36.2	13.6	16.2	12.4	10.1	13.5	10.8	26.8	18.8	13.1	13.4	13.6	12.3	11.5	12.8	3.3	2.8	2.8	2.8	1.6	3.5	1.0	15.2	8.7	10.5	9.6	12.4	15.1	14.0	13.3	15.1	17.3	13.8	9.4	18.9	28.1	6.1	18.7	10.6	9.3	18.0	18.7	22.7	12.0	8.6	13.4	10.6	8.5	14.5	28.2	10.2	11.8	19.1	21.1	27.7	14.6	15.2	12.4	22.2	21.1	16.9	9.1	17.4	12.3	11.6	14.8	10.0	14.4	11.5	6.6	16.7	11.2	10.1	8.3	12.3	18.7	13.3	14.4	6.2	11.6	18.3	19.5	12.4	10.0	17.7	15.6	15.3	18.6	13.5	20.1	18.8	0.0	1.7	2.8	3.5	2.1	2.6	3.3	2.7	2.8	1.6	2.4	2.7	2.4	0.5	1.6	2.8	2.8	2.0	1.0	16.6	16.7	22.7	15.9	12.0	9.2	14.1	8.4	12.7	18.8	59.6	19.7	15.9	40.5	56.1	15.3	18.5	28.1	42.8	23.9	26.2	23.6	17.2	8.3	11.1	130.8	21.8	10.5	0.0	12.7	17.3	25.9	44.8	19.7	20.2	11.8	6.4	14.6	22.1	18.0	63.1	18.7	17.9	30.4	5.4	12.1	7.5	18.4	14.0	28.3	6.6	19.1	0.0	29.9	28.8	41.0	47.6	13.4	14.6	14.3	50.2
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145558079	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 132.8;Endothelial cells: 56.4;Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 22.2;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.2;monocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	20.4	7.8	19.9	7.9	21.3	3.8	21.1	17.9	17.8	18.5	15.5	14.3	13.6	11.9	33.2	22.7	16.2	20.3	13.7	10.3	13.5	10.3	12.7	37.4	11.0	11.9	9.3	10.0	12.3	13.1	33.7	14.7	8.7	12.2	13.6	16.9	7.8	17.5	16.0	22.6	20.2	15.3	24.6	12.6	10.1	11.4	10.5	14.3	15.3	15.2	14.9	10.3	16.5	21.9	0.0	4.0	22.2	11.9	1.2	0.7	0.8	3.9	5.2	9.7	11.7	3.8	5.5	4.8	5.6	13.6	9.2	7.1	2.5	14.5	3.4	3.4	12.9	4.1	5.8	11.0	12.6	5.5	0.0	5.5	0.0	4.3	5.1	10.1	6.5	1.0	7.5	15.0	4.9	9.7	7.5	46.6	8.5	4.4	0.1	11.7	3.8	9.8	0.1	9.0	6.3	6.3	18.9	9.0	11.7	10.0	6.9	15.2	7.3	8.0	17.5	3.5	6.2	5.9	0.0	14.0	4.5	6.2	4.6	3.4	12.9	0.0	22.8	7.2	0.1	4.6	22.2	2.1	0.8	0.0	5.3	0.0	0.0	0.4	0.0	4.0	0.0	0.2	0.0	0.0	1.2	11.9	0.0	0.7	0.8	19.9	21.3	17.9	14.9	13.5	10.3	9.3	10.0	12.2	14.3	8.9	10.4	0.0	14.6	10.2	5.7	3.9	12.7	10.7	12.5	14.0	13.7	4.1	6.6	10.1	132.8	56.4	8.0	0.0	16.1	2.7	6.2	12.3	0.0	10.5	2.1	9.5	8.7	9.8	6.3	63.2	4.0	2.3	1.7	1.0	8.6	4.8	11.9	5.8	5.3	9.8	6.1	0.0	4.6	5.6	11.9	11.0	1.8	0.0	7.5	15.4
MMAA	cblA	ENSG00000151611	"Methylmalonic aciduria (cobalamin deficiency) cblA type"	Q8IVH4	4	145618263-145660035	"Disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.7"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 28.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Approved	Cytosol		No	No			Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	1.7	3.3	1.4	1.4	1.7	0.5	2.6	2.3	1.5	1.5	3.1			4.2	1.4	2.6	2.3	1.5	2.0	1.8	1.2	1.5	4.3	14.7	1.7	1.3	1.4		1.3	2.5	1.4	0.9	1.1		1.3	3.5		2.0	1.3	5.2	2.3	3.4	1.2	1.2	1.6	1.9	2.0			2.2		1.7	1.6	1.6	4.2	4.2	4.1	10.0	5.8	7.8	2.9	2.3	1.3	4.3	2.2	10.4	10.4	0.9	5.9	4.7	2.4	1.4	1.8	4.7	7.9	2.0	3.9	1.2	1.9	2.1	4.5	1.6	5.5	1.0	3.5	0.9	1.4	7.5	4.2	3.2	6.5	6.4	2.5	6.6	4.1	7.4	9.5	1.0	5.4	5.1	2.9	7.6	1.6	1.6	6.1	2.2	3.6	1.5	1.5	14.1	1.8	2.1	1.7	3.4	7.2	3.2	2.2	3.7	2.0	6.1	3.8	1.6	4.6	1.5	3.0	1.9	3.6	4.0	4.2	3.4	4.1	3.8	3.2	6.3	8.4	5.8	4.2	7.8	6.4	3.6	3.3	5.9	7.8	0.0	5.8	10.0	4.2	6.1	2.9											11.9	3.5	2.2	7.3	2.6	2.9	7.0	12.7	4.0	15.9	10.4	2.0	6.9	13.3	8.5	7.0	3.3	8.8	0.0	10.8	2.8	3.8	5.2	8.1	28.6	4.5	0.0	2.4	7.4	2.7	4.7	4.4	2.6	1.7	3.6	4.9	2.2	7.8	7.0	2.8	15.3	1.5	0.0	3.1	6.7	4.9	1.0	6.4	1.7	5.9	9.5
C4orf51		ENSG00000237136	"Chromosome 4 open reading frame 51"	C9J302	4	145680115-145771032	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	12	"testis: 10.8"	"Cell type enriched"	"Detected in some"	14	"Early spermatids: 60.4"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.0;CAPAN-2: 1.3"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"		"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.37e-1)"		"unprognostic (1.32e-1)"		"unprognostic (2.19e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	4.4	1.2	0.0	0.0	0.0	0.0	0.0
ZNF827		ENSG00000151612	"Zinc finger protein 827"	Q17R98	4	145757627-145938635	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 12.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 23.5;WM-115: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021166	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021166: AB_2670608"	"unprognostic (2.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.88e-2)"	3.8	9.5	8.2	9.6	15.6	3.9	6.5	37.3	12.3	6.0	7.1	8.1	7.7	8.1	10.7	6.5	3.8	8.3	6.3	7.0	5.9	5.8	6.3	1.1	4.7	6.4	5.8	8.2	11.0	4.3	14.9	28.3	2.2	7.4	26.3	6.4	4.3	28.1	9.3	24.9	3.4	10.0	11.4	13.0	5.5	6.3	4.5	9.5	14.0	10.9	3.3	7.7	10.2	5.0	1.9	2.6	5.4	0.0	12.3	3.4	1.2	2.7	4.4	8.0	5.2	3.5	3.9	0.0	4.6	4.4	3.6	2.8	2.2	7.2	0.7	1.6	8.4	3.2	1.7	4.6	3.5	3.8	5.6	2.2	2.2	4.3	2.5	3.7	1.6	0.0	5.3	3.2	2.8	7.9	7.8	6.4	1.2	0.4	4.4	3.0	0.0	2.4	0.1	3.9	0.0	5.8	7.2	4.2	1.4	3.8	4.1	7.3	6.7	4.0	6.9	10.4	4.4	3.1	0.1	23.5	9.6	7.8	0.6	5.3	3.1	0.2	3.0	3.1	9.0	36.4	5.4	0.0	0.0	3.3	0.0	0.9	1.5	1.2	3.1	0.0	1.9	2.1	3.4	0.0	12.3	0.0	2.6	0.1	1.2	8.2	15.6	37.3	12.3	5.9	5.8	5.8	8.2	7.4	9.5	11.9	13.7	4.2	7.6	5.7	12.7	18.9	2.5	10.7	11.4	22.7	9.8	2.1	3.3	8.9	11.8	4.3	10.3	0.0	6.3	0.4	6.6	19.8	2.3	1.3	1.1	17.5	24.8	7.4	1.2	5.8	8.3	1.0	1.7	1.0	19.5	4.8	10.4	3.5	15.9	9.8	1.1	6.5	4.7	1.6	1.7	4.3	1.1	6.4	18.6	9.5
LSM6	YDR378C	ENSG00000164167	"LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62312	4	146175685-146200000	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing, tRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045079	Approved		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA045079: AB_10961320"	"unprognostic (5.04e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.36e-1)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.08e-3)"	17.8	14.0	14.7	16.1	14.6	14.6	18.5	14.2	14.8	11.1	12.8	10.8	4.8	11.4	12.4	13.7	13.7	11.2	12.8	15.0	14.1	18.0	14.5	16.6	16.8	28.0	16.1	11.6	15.8	20.6	6.2	11.6	16.6	12.8	15.0	12.3	11.0	14.4	10.2	14.2	10.6	15.3	13.8	11.8	21.6	12.4	14.1	10.0	25.0	11.7	15.5	25.4	12.8	12.5	11.8	8.7	7.7	20.7	8.6	13.0	9.9	6.6	2.1	8.2	4.3	6.2	7.2	8.3	5.4	6.2	8.2	7.7	5.3	10.1	13.8	2.8	3.8	6.3	3.8	9.1	6.4	11.4	14.1	5.8	6.7	4.3	11.5	6.2	14.3	5.8	4.1	5.6	5.5	5.3	4.0	5.8	6.7	10.5	13.4	7.5	5.8	17.3	17.8	10.4	6.1	5.8	11.8	5.2	6.4	5.6	8.7	9.9	4.4	2.8	5.1	6.8	7.5	3.6	13.8	3.9	7.2	6.9	5.5	10.4	9.6	8.4	8.7	7.3	7.2	8.1	2.8	11.3	7.7	7.4	14.9	10.7	11.8	11.1	9.7	8.7	9.9	13.0	11.4	5.4	8.6	20.7	7.8	11.0	9.9	14.7	14.6	14.2	14.8	14.1	18.0	16.1	11.6	12.8	10.0	20.8	25.6	91.0	75.1	61.6	19.1	21.9	53.5	33.5	29.6	26.2	2.0	123.1	58.0	54.6	2.3	61.8	39.3	23.3	58.0	156.0	62.1	96.1	55.4	57.0	111.9	17.5	22.5	47.3	104.5	10.0	70.5	97.4	49.0	119.0	56.5	20.5	48.8	75.3	54.5	80.2	21.2	32.3	50.8	104.8	189.9	62.7	61.7	49.8	74.7	81.4
REELD1		ENSG00000250673	"Reeler domain containing 1"		4	146214515-146230878	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"breast: 1.3;epididymis: 1.5;skin 1: 1.7"	"Cell type enriched"	"Detected in single"	17	"Ciliated cells: 2.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	87	"HDLM-2: 14.6"															NA	NA						"unprognostic (6.26e-3)"	"unprognostic (1.40e-1)"		"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.55e-6)"	"unprognostic (2.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.13e-2)"	0.1	0.0		0.9		0.4	1.3		0.2	0.4	0.0			0.0	0.0	1.5	0.0	0.2	0.0	0.0			0.1	0.7	0.2	0.2			0.0	0.4	0.0		0.0		0.3	0.0		0.0	0.0	0.5	1.7	0.0	0.0		1.0	0.0	0.1			0.0		0.7	0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC10A7	"C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043"	ENSG00000120519	"Solute carrier family 10 member 7"	Q0GE19	4	146253975-146521964	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3;granulocytes: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039996	Uncertain					NA	NA					"HPA039996: AB_10673266"	"unprognostic (9.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.69e-2)"	"unprognostic (9.57e-2)"	12.0	10.7	8.0	8.1	14.3	8.8	11.3	17.0	10.5	13.5	11.8	10.0	17.4	7.8	13.2	21.4	14.9	9.2	9.7	8.3	8.6	6.4	8.6	17.2	16.0	13.9	10.9	6.9	12.0	14.5	7.9	22.2	15.0	11.2	11.1	16.2	7.8	15.5	16.0	8.8	9.4	10.3	10.3	19.3	11.0	16.3	6.6	11.7	16.8	12.3	9.2	12.8	10.2	12.7	6.7	6.4	11.5	7.7	7.5	7.8	3.7	3.8	1.3	9.5	4.0	7.1	8.5	4.7	4.9	6.4	4.5	4.6	3.6	16.7	7.4	3.4	5.3	2.8	4.0	5.5	6.7	5.4	8.4	2.6	8.9	3.2	6.4	4.5	15.5	14.2	4.1	5.6	5.3	6.8	2.7	8.0	7.7	9.9	19.5	3.2	2.7	11.6	3.7	1.8	8.8	6.4	6.4	6.9	10.1	3.2	2.9	2.9	2.6	3.3	10.0	4.0	5.3	5.9	6.2	4.4	4.0	4.2	6.1	3.3	16.4	17.9	10.1	5.5	6.5	5.7	11.5	5.1	6.8	6.4	7.7	6.6	6.7	6.5	5.8	6.4	4.5	6.0	5.9	0.5	7.5	5.9	4.4	7.8	3.7	8.0	14.3	17.0	10.5	8.6	6.4	10.9	6.9	11.2	11.7	3.0	3.8	3.7	2.8	3.0	5.6	1.6	12.7	9.4	2.3	1.8	3.9	5.7	1.7	3.3	1.4	3.6	4.9	23.3	4.4	11.7	4.9	5.4	23.0	9.0	5.2	7.9	4.6	8.6	6.3	0.7	6.9	3.6	0.0	2.8	11.3	4.3	3.0	2.9	4.6	1.7	11.3	0.0	5.1	5.4	4.1	4.3	5.1	4.8	5.6	3.5
POU4F2	"Brn-3b, BRN3B"	ENSG00000151615	"POU class 4 homeobox 2"	Q12837	4	146638893-146642474	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"brain: 5.7;testis: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"midbrain: 1.8;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;SCLC-21H: 6.4;THP-1: 1.0"	"Region enriched"	"Detected in single"	6	"midbrain: 5.2"	"Group enriched"	"Detected in some"	15	"midbrain: 4.7;pons and medulla: 1.3;thalamus: 1.8"							NA	NA										"unprognostic (4.18e-2)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTC29	NYD-SP14	ENSG00000137473	"Tetratricopeptide repeat domain 29"	Q8NA56	4	146706638-146945882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 55.9"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 136.5;Early spermatids: 509.6;Late spermatids: 355.5"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;pons and medulla: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.1;hTERT-HME1: 3.2;Karpas-707: 2.3;U-266/70: 4.2;U-87 MG: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA037006, HPA061473"	Uncertain					NA	NA					"HPA037006: AB_10670379, HPA061473: AB_2684534"	"unprognostic (1.28e-3)"			"unprognostic (1.52e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.70e-1)"		"unprognostic (6.70e-2)"		"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.67e-4)"	"unprognostic (9.81e-4)"	"unprognostic (7.30e-2)"	"unprognostic (6.88e-4)"		0.2	0.1	0.9	0.1	4.3	0.1	0.1	0.1	1.2	0.8	0.1	1.7	0.5	0.1	0.3	10.7	0.1	13.3	0.1	0.1	1.5	1.3	0.2	0.1	7.0	0.1	0.3	0.7	2.6	0.1	0.8	0.2	0.1	12.7	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.1	55.9	0.6	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	10.1	0.0	0.0	0.8	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.9	3.2	0.3	0.3	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.2	0.0	0.0	4.2	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.1	1.2	1.5	1.3	0.3	0.7	12.7	0.6	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	136.5	15.9	0.0	0.0	0.0	0.0	0.0	509.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	85.1	7.3	0.0	0.0	0.0	0.0	0.0
EDNRA		ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 62.6;seminal vesicle: 52.3"	"Cell type enhanced"	"Detected in some"	14	"Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	7.6	2.6	1.3	1.4	1.8	0.0	7.2	0.6	2.4	62.6	2.6	1.0	21.7	1.5	37.3	14.2	4.7	13.3	7.3	15.1	1.3	1.3	3.1	1.4	12.7	2.0	1.8	1.0	23.5	0.9	1.9	2.2	5.9	2.7	21.5	1.5	10.3	4.1	52.3	4.8	3.2	1.8	19.4	1.6	11.5	4.4	9.1	1.4	2.9	5.0	6.0	2.6	14.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.2	0.0	7.3	14.5	0.0	2.2	2.9	0.4	0.1	0.2	0.0	0.0	0.0	0.7	0.5	0.0	0.3	0.6	0.2	0.0	1.5	0.0	2.5	0.0	7.4	0.0	0.0	5.6	0.5	0.4	0.0	2.7	0.0	0.0	0.0	1.1	17.2	0.2	0.0	0.1	1.2	0.0	0.9	0.0	0.7	0.1	1.1	0.8	0.0	13.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.9	0.6	0.0	0.0	1.1	0.3	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.6	2.4	1.3	1.3	1.8	1.0	2.7	1.4	3.0	4.0	0.0	0.6	2.7	0.0	17.1	0.0	0.0	7.9	0.0	0.0	0.2	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.1	11.8	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	40.6	0.3	3.3	0.0	0.0	0.0	0.2	0.0	64.0	0.0	0.0	51.8	84.6	0.6	0.6	2.4	0.1	0.0	0.0	0.2
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617383-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	10.4	18.4	11.3	9.6	13.1	5.5	10.0	12.3	15.9	11.8	13.0	12.3	14.3	11.8	12.4	9.8	10.7	10.0	9.6	14.3	11.8	11.3	18.0	18.7	9.2	7.7	16.1	11.8	15.7	11.6	107.2	10.5	14.0	12.7	12.0	11.6	9.3	12.1	12.8	16.2	9.5	14.8	10.1	14.0	10.0	10.6	8.3	14.1	11.7	32.9	10.3	9.4	11.8	11.2	12.8	17.3	17.7	18.1	14.7	22.8	11.6	9.2	14.5	18.4	14.0	25.2	24.6	12.1	17.3	20.3	12.9	15.0	11.9	17.7	8.6	8.7	13.5	12.8	11.1	14.9	13.3	14.3	19.1	8.7	11.1	11.2	8.6	19.4	14.8	16.6	18.3	18.0	14.2	14.9	18.8	16.6	9.8	14.2	24.3	18.0	13.8	12.8	5.4	11.8	21.1	8.5	12.8	6.3	14.8	14.3	17.3	14.3	18.5	9.4	14.7	15.1	14.9	14.7	9.3	16.2	16.4	8.9	13.3	11.0	26.6	34.8	11.5	19.2	8.9	17.7	17.7	14.1	15.5	18.0	18.0	22.8	12.3	16.7	16.4	17.3	12.8	15.9	14.8	11.0	14.7	18.1	11.9	15.3	11.6	11.3	13.1	12.3	15.9	11.8	11.3	16.1	11.8	12.7	14.1	8.9	5.7	6.4	6.6	4.0	7.7	16.5	10.2	5.3	14.8	5.2	11.8	12.5	1.7	10.6	19.6	9.8	8.5	0.0	11.1	10.6	8.4	7.2	20.8	8.5	9.0	11.1	5.2	6.7	10.4	10.3	10.0	8.8	5.0	4.6	8.3	7.8	7.5	3.5	13.8	5.3	6.2	6.5	7.3	5.4	4.9	3.0	7.2	6.4	9.9	6.4
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684230	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 79.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	6.0	17.2	6.0	5.2	8.6	12.4	6.9	8.0	8.9	5.6	4.5	4.2	7.9	2.5	8.6	7.6	5.0	7.5	8.4	6.5	5.6	5.0	7.5	5.8	7.6	5.3	5.8	5.3	22.6	7.2	16.3	10.0	5.0	7.1	6.0	4.5	9.8	5.8	11.3	6.7	5.6	4.3	6.1	4.6	4.5	5.9	11.2	3.9	11.6	15.8	2.8	5.4	5.5	5.2	9.6	6.0	10.8	6.1	5.1	10.4	2.7	3.5	2.3	5.7	4.3	4.4	7.6	5.0	3.9	6.3	6.0	6.4	1.8	4.0	12.3	1.8	3.4	3.1	2.5	6.7	3.4	8.3	4.4	3.9	6.8	4.5	3.0	3.3	9.8	3.8	5.2	3.5	3.7	3.3	4.9	5.0	6.2	6.7	7.2	5.1	2.0	8.3	3.9	2.9	3.4	4.3	5.6	4.8	4.5	4.9	2.8	3.5	5.4	6.3	5.0	3.2	3.9	2.1	2.2	4.2	3.9	3.1	4.3	4.3	8.2	6.5	8.1	4.3	6.1	2.8	7.4	6.0	10.8	6.7	6.1	6.5	9.5	8.1	8.2	4.0	9.6	10.4	9.0	4.2	5.1	4.4	6.0	6.8	2.7	6.0	8.6	8.0	8.9	5.6	5.0	5.8	5.3	7.1	3.9	0.0	7.7	61.1	2.9	0.0	54.5	5.5	7.6	2.7	1.2	33.2	106.0	12.1	5.0	5.9	58.8	4.3	5.9	0.0	5.8	8.6	8.5	4.1	34.5	5.7	15.3	47.7	16.7	12.3	31.0	9.5	16.7	14.9	0.0	9.0	4.8	26.9	5.9	3.6	15.9	3.3	79.2	12.9	4.6	29.1	14.0	0.0	12.7	30.5	4.7	1.4
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072780	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 127.4;monocytes: 96.4;Peritubular cells: 113.8;Rod photoreceptor cells: 129.8;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 154.3"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (8.15e-5)"	"prognostic unfavorable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	31.2	7.9	2.3	11.3	3.2	2.0	27.8	1.8	3.7	20.1	23.9	1.9	13.2	3.4	15.4	17.6	25.2	17.6	20.3	20.0	2.8	1.6	9.6	4.8	11.8	8.3	3.8	1.9	19.9	7.8	20.8	4.7	7.5	9.9	19.8	6.0	16.0	6.7	17.0	37.5	12.3	8.9	58.0	5.2	9.7	15.9	11.2	2.5	8.7	9.9	12.4	7.9	28.7	24.9	0.0	2.6	14.0	1.5	4.1	9.7	2.1	9.8	4.0	2.2	4.5	16.7	22.8	22.7	13.7	11.4	8.8	6.9	10.3	5.7	0.0	2.3	11.6	7.4	4.9	7.9	11.2	10.7	5.4	5.3	3.3	3.1	0.3	25.8	3.3	4.0	11.8	8.8	11.0	9.4	11.2	10.6	2.9	0.5	18.7	15.7	12.0	2.0	0.0	2.0	6.6	2.0	3.8	6.2	11.5	6.1	9.1	5.3	2.5	3.6	14.4	3.8	9.8	1.8	0.3	10.6	8.3	6.4	5.0	6.5	7.0	0.8	0.0	12.7	0.4	7.3	0.0	1.5	14.0	5.2	0.0	9.7	0.0	3.9	5.7	2.6	0.0	1.1	5.7	0.2	4.1	0.0	0.0	4.6	2.1	2.3	3.2	1.8	3.7	2.8	1.6	3.8	1.9	9.9	2.5	3.0	2.6	0.0	6.9	12.8	3.8	58.3	5.1	0.0	2.3	1.8	41.2	24.2	0.0	4.2	7.8	9.0	0.0	0.0	13.5	41.5	17.5	3.3	1.1	11.3	20.5	3.2	0.0	6.2	3.9	6.2	127.4	12.8	5.0	96.4	0.0	7.7	14.2	0.0	113.8	11.7	129.8	142.3	59.0	3.9	16.1	8.9	10.6	12.5	1.1	2.4
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 47.2;Mucus-secreting cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.1;HUVEC TERT2: 6.8;Karpas-707: 7.3;PC-3: 6.8;RPTEC TERT1: 9.1;TIME: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	7.0	5.6	9.0	12.9	9.5	1.5	7.2	16.8	14.5	8.2	23.4	8.2	6.5	9.7	7.2	4.8	3.8	7.1	10.2	9.7	12.7	6.5	13.8	9.6	8.2	4.2	7.5	7.7	17.0	8.6	22.5	16.7	2.4	5.7	5.9	28.4	12.1	16.9	9.6	12.1	4.6	26.5	8.6	6.5	5.7	9.0	4.8	6.5	2.2	21.7	7.6	5.0	10.7	5.6	0.8	0.0	0.0	0.4	0.1	4.8	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.0	0.1	0.0	0.5	0.0	0.1	1.5	2.9	1.1	0.2	0.0	1.6	0.8	0.1	0.3	2.8	0.3	0.7	0.0	0.0	1.8	0.4	0.1	0.0	0.1	0.0	11.1	6.8	1.1	0.0	7.3	2.3	0.0	0.0	0.0	0.1	1.3	6.8	0.6	0.0	0.1	9.1	0.1	0.1	0.1	0.0	1.6	0.7	0.1	0.8	0.0	8.9	4.8	2.8	0.2	0.9	0.0	0.0	0.1	1.6	0.6	1.2	0.0	0.0	0.0	1.5	0.0	4.8	0.4	1.8	1.2	0.0	0.8	2.9	2.9	0.0	0.1	0.4	0.0	0.5	0.4	9.0	9.5	16.8	14.5	12.7	6.5	7.5	7.7	5.7	6.5	26.8	11.5	3.5	1.7	1.8	8.9	17.5	10.2	5.3	10.3	10.4	17.7	0.7	8.3	3.1	47.2	4.9	35.4	0.0	5.1	0.2	3.1	1.8	5.7	4.0	0.5	12.7	17.3	6.2	3.7	30.6	4.0	0.9	6.8	1.0	43.5	7.3	3.7	23.4	3.5	1.7	9.3	0.0	3.1	1.2	4.9	1.5	0.1	0.0	20.3	1.8
IQCM		ENSG00000234828	"IQ motif containing M"	A0A1B0GVH7	4	149351903-149896233	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	20	"testis: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"fHDF/TERT166: 2.3"															NA	NA								"unprognostic (3.22e-1)"			"unprognostic (1.17e-3)"		"unprognostic (2.18e-1)"						"unprognostic (2.85e-2)"	"unprognostic (1.91e-1)"		"unprognostic (8.47e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078274-150257457	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 60.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 18.2;Cone photoreceptor cells: 15.7;Horizontal cells: 33.4;Muller glia cells: 39.2"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.6;BJ: 8.4;BJ hTERT+: 19.4;fHDF/TERT166: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA					"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	2.9	3.9	23.3	2.1	23.5	1.6	2.0	9.3	60.5	3.1	2.8	16.5	0.8	2.8	4.3	3.5	3.0	2.8	4.0	14.4	23.5	17.5	2.9	1.8	2.7	1.6	14.9	14.5	4.3	3.5	1.4	4.7	2.9	20.2	3.9	3.5	2.1	2.0	3.6	2.3	2.1	2.7	6.4	23.4	2.1	2.2	4.2	15.9	0.0	4.1	0.0	1.5	3.3	2.0	2.5	1.5	0.0	0.5	0.0	0.0	0.0	0.8	3.2	18.6	2.9	0.0	0.9	0.3	8.4	19.4	2.8	0.6	0.1	0.0	0.0	0.3	8.5	2.8	0.0	2.7	0.0	3.5	3.8	1.6	0.0	4.9	0.0	4.0	0.5	0.5	0.5	0.0	1.7	0.2	1.7	0.9	0.5	0.0	0.0	1.9	0.1	0.3	0.0	0.4	0.2	1.0	0.0	2.1	0.7	0.0	0.8	7.1	6.8	3.5	2.6	0.8	1.6	0.0	0.0	1.6	2.6	1.0	1.7	0.9	0.8	0.0	0.0	2.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	23.3	23.5	9.3	19.3	23.5	17.5	14.9	14.5	20.2	15.9	0.0	0.0	0.0	0.1	0.5	18.2	9.1	2.5	0.0	1.2	3.5	15.7	0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.6	0.0	2.2	0.9	4.6	0.0	1.3	33.4	2.9	8.6	0.0	0.0	1.7	1.0	5.0	0.0	0.2	39.2	0.2	0.0	3.5	0.3	8.9	12.9	4.1	0.1	0.2	0.5	0.2	0.0	1.3	0.1
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264531-151015727	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cone photoreceptor cells: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		190000	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.6	15.8	7.1	14.7	10.9	7.2	16.5	14.4	8.3	11.3	12.2	7.3	17.9	9.8	12.9	11.8	21.4	11.9	12.7	10.5	6.4	4.3	18.4	10.2	10.1	14.2	7.4	5.6	10.1	13.8	33.0	32.1	8.8	7.7	14.3	13.0	8.3	18.2	15.1	10.5	20.5	14.7	7.9	8.3	11.3	12.8	10.1	7.8	26.5	15.2	11.0	17.9	14.0	12.4	5.7	2.6	5.9	0.8	3.8	7.9	2.3	15.5	8.0	7.3	6.3	7.8	10.8	9.1	3.3	8.9	6.3	6.2	17.3	19.8	18.0	4.1	5.0	4.6	8.0	12.2	19.5	9.6	13.5	8.8	12.7	12.4	9.3	4.6	17.0	10.2	8.4	11.7	9.3	14.5	14.2	19.0	8.5	13.2	12.8	7.4	10.4	12.4	2.2	6.2	11.6	6.0	10.2	7.6	6.6	20.4	20.6	18.9	7.7	8.9	18.1	4.4	11.3	17.9	3.3	10.0	9.1	6.7	5.0	6.4	12.0	11.6	12.3	14.2	7.0	4.6	5.9	0.7	1.6	7.9	0.3	4.7	5.7	5.3	6.9	1.5	3.5	3.7	5.6	0.2	3.8	0.8	2.6	5.9	2.3	7.1	10.9	14.4	8.3	6.4	4.3	7.4	5.6	7.7	7.8	14.9	9.3	40.2	13.9	15.5	29.4	50.2	20.4	22.7	15.9	48.8	139.4	19.8	8.3	13.5	14.3	11.7	19.3	23.3	11.7	9.5	8.8	23.4	5.8	18.7	5.4	28.6	40.4	11.6	8.5	3.1	8.9	9.2	15.1	5.4	25.0	21.7	13.7	21.8	9.6	13.6	68.2	6.5	6.6	8.1	21.3	20.7	20.3	34.9	29.8	21.2
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150581922-150584693	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.2;intestine: 59.8;smooth muscle: 15.2"	"Cell type enhanced"	"Detected in some"	24	"Cholangiocytes: 12.7;Horizontal cells: 23.8;Muller glia cells: 5.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Region enriched"	"Detected in some"	18	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTERT-RPE1: 46.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.6	3.1	0.2	8.6	0.4	0.0	0.1	0.2	0.2	0.2	59.8	0.1	0.0	6.8	0.1	0.9	0.9	0.2	0.5	0.7	0.2	0.6	0.1	0.5	0.1	0.6	1.0	0.0	0.1	0.2	0.0	0.3	0.0	19.2	0.2	8.1	9.0	2.2	0.0	0.3	0.2	14.7	15.2	4.5	0.1	0.3	0.1	0.0	0.2	1.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.6	1.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.8	12.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	80.5	59.3	113.1	111.1	145.6	285.0	115.5	85.9	132.7	121.8	75.4	114.6	117.8	365.6	43.0	93.6	43.0	53.5	114.6	143.5	115.8	80.5	110.9	78.9	73.3	132.3	168.6	187.3	81.9	211.3	296.1	74.9	199.3	172.0	144.4	137.0	126.9	191.5	144.6	120.4	202.3	222.6	106.1	129.0	45.9	148.2	110.4	122.3	141.0	97.9	108.8	107.7	38.6	141.4	189.2	83.4	94.6	227.8	87.6	59.6	78.9	65.7	94.5	148.9	239.5	223.9	76.5	136.8	70.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7	902.2	1351.4	4981.2	6887.5	5470.3	389.5	334.4	1689.1	1088.1	1918.8	783.4	113.9	3954.4	3630.9	1946.8	1331.3	2405.0	1231.3	1425.0	3246.4	6519.9	2822.1	4092.8	1400.9	1318.9	2985.4	154.1	2072.9	2006.5	3842.5	3230.8	4100.5	4536.3	3092.4	3236.3	3439.0	634.6	3016.2	2304.0	2436.9	3691.6	432.9	1739.7	3595.7	655.4	688.2	5905.5	3840.1	4239.4	5672.4	6561.2
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5;ASC TERT1: 47.4;HSkMC: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: AB_2683758"	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	56.0	9.5	6.8	11.2	14.2	0.0	24.2	4.4	9.2	19.2	28.5	20.1	10.7	20.3	22.8	13.9	23.6	17.3	29.6	31.7	7.8	5.1	12.8	23.1	26.1	3.7	13.6	5.5	27.2	7.8	15.4	6.0	16.8	12.7	18.8	23.0	12.4	14.1	19.8	12.8	17.4	35.9	26.6	7.7	3.1	14.6	12.3	15.1	0.3	15.6	12.8	6.7	27.7	23.8	0.0	2.3	0.0	0.0	0.0	0.2	0.0	7.1	5.3	3.4	2.6	55.5	47.4	7.4	8.9	9.5	3.9	4.1	6.8	8.9	0.0	3.6	8.3	6.5	5.3	3.6	10.2	3.9	0.0	2.8	0.0	6.5	7.3	13.4	0.0	0.0	37.6	7.9	5.9	9.2	6.8	23.0	0.0	0.0	0.0	10.4	2.9	0.0	0.1	6.9	11.1	7.7	0.0	0.2	0.1	4.9	5.0	0.2	4.7	6.3	6.5	5.2	7.4	2.1	0.0	16.6	12.5	4.5	5.5	3.5	0.0	0.0	0.0	6.5	0.0	15.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	6.8	14.2	4.4	9.2	7.8	5.1	13.6	5.5	12.7	15.1	20.8	30.4	2.9	11.9	25.3	5.6	85.4	28.1	40.2	40.9	15.7	13.7	21.5	5.0	10.4	3.7	29.2	75.0	0.0	13.3	16.3	37.6	28.4	19.8	40.8	6.5	6.4	17.9	27.6	5.7	4.7	57.5	5.6	25.3	0.0	33.2	19.1	18.2	54.7	45.3	23.1	11.4	12.9	20.6	2.1	6.6	33.6	22.8	5.0	42.0	28.8
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;skin 1: 1.9;testis: 4.1"	"Cell type enriched"	"Detected in some"	6	"Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted in male reproductive system"	NA	NA					"HPA053801: AB_2682267"			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.2		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.3	0.0	1.9	0.0	0.0	0.5	0.0	0.0	4.1			0.0		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	6.5	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409216-151663632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 10.5;Horizontal cells: 7.9;Suprabasal keratinocytes: 12.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 5.8"	"Cell line enhanced"	"Detected in many"		"A-431: 8.3;HeLa: 10.1;hTERT-HME1: 9.5;SiHa: 9.0;SK-BR-3: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046348	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	1.4	1.2	3.0	3.4	0.8	1.5	3.8	7.5	0.9	6.3	5.2	0.6	10.4	1.7	6.1	5.9	13.1	2.8	4.9	6.5	0.7	0.7	7.0	1.6	5.4	0.1	0.6	0.0	3.7	23.7	11.1	9.4	1.8	4.8	4.5	3.3	10.0	11.1	12.5	33.6	12.6	9.0	1.8	0.7	0.7	2.3	3.5	0.0	0.9	11.4	22.0	10.0	6.2	5.0	0.0	5.8	0.4	0.0	0.1	0.1	0.0	8.3	0.7	0.0	0.2	0.0	0.0	3.1	0.4	2.0	0.8	0.2	3.6	3.1	0.0	0.9	0.1	2.8	7.6	2.2	6.3	1.3	0.0	3.6	0.0	10.1	0.8	0.0	0.0	0.1	0.1	6.3	0.0	9.5	1.9	0.1	0.7	0.0	0.0	0.5	1.2	0.0	0.0	2.9	2.6	0.8	0.0	2.1	0.3	4.4	5.7	1.4	0.4	9.0	7.9	0.0	2.5	3.4	0.0	0.0	0.6	3.7	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	3.0	0.8	7.5	0.9	0.7	0.7	0.6	0.0	4.8	0.0	3.0	1.3	0.0	6.2	10.5	0.0	1.6	0.0	0.0	6.8	0.0	0.0	0.3	0.0	1.3	1.8	0.3	3.4	0.0	1.5	0.5	0.3	5.9	1.1	0.5	0.2	7.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.0	3.7	1.2	0.0	0.0	0.3	4.5	0.0	0.3	2.1	4.1	12.7	1.4	0.0	1.4	6.8
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761023	"Predicted intracellular proteins"	"Protein biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 317.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favorable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.2	17.0	12.3	10.5	13.6	8.2	9.2	10.7	19.8	7.3	9.7	11.2	6.4	5.8	5.9	8.9	10.1	9.1	7.0	31.3	10.7	10.8	21.4	21.8	5.3	6.8	15.8	11.1	12.1	6.8	14.6	8.4	9.9	10.6	5.9	9.9	7.8	7.7	7.1	22.7	8.5	6.3	8.1	22.6	6.9	7.4	7.8	10.4	10.5	7.7	18.9	9.3	8.0	5.8	9.1	17.0	1.5	13.2	6.8	6.8	8.3	8.8	6.9	9.9	9.5	14.5	14.0	8.6	11.7	15.3	20.8	16.3	11.6	14.5	12.0	3.1	12.1	12.7	8.3	21.2	22.4	22.3	6.7	13.0	5.5	9.6	23.9	14.2	11.3	5.5	14.4	14.4	20.0	7.0	12.0	15.4	17.1	21.4	10.5	15.9	9.7	14.1	12.2	10.1	7.4	13.0	12.0	9.5	9.5	18.8	7.4	10.3	11.4	9.4	13.0	13.7	10.0	11.0	8.2	8.4	10.5	5.7	7.2	8.0	12.6	16.3	10.0	14.7	10.0	7.6	0.7	9.4	1.5	4.0	13.2	6.3	9.1	5.3	5.6	17.0	8.2	6.8	6.4	0.9	6.8	9.4	6.7	5.4	8.3	12.3	13.6	10.7	19.8	10.7	10.8	15.8	11.1	10.6	10.4	8.9	3.7	2.2	5.5	0.0	8.7	58.8	0.0	2.7	6.8	10.4	7.9	19.7	23.2	8.8	5.7	2.9	2.6	0.0	6.4	13.2	7.4	2.9	1.1	13.6	15.4	9.5	2.4	2.5	6.5	6.0	4.9	5.8	0.0	13.6	5.9	317.1	6.9	6.5	4.2	14.9	13.6	6.5	3.6	12.2	12.0	0.0	11.2	1.5	8.8	2.6
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536063	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 60.1;skin 1: 45.0"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 179.3;Suprabasal keratinocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	9.2	6.8	27.0	8.9	27.9	11.1	9.8	27.2	60.1	5.5	6.1	3.6	3.8	4.9	6.0	18.3	9.8	10.6	6.3	10.9	21.4	10.1	4.1	7.3	6.9	9.8	9.1	40.5	6.4	8.0	6.4	7.3	6.2	37.2	5.1	6.9	2.8	7.6	5.3	15.8	45.0	6.5	6.1	6.4	10.1	8.0	13.7	5.7	6.5	6.8	10.6	12.3	7.9	6.5	2.9	2.2	16.6	3.4	7.8	5.0	1.3	4.9	4.0	10.3	7.5	7.2	5.2	8.6	7.2	6.6	4.5	4.2	8.0	6.4	12.9	2.0	6.9	3.4	3.0	8.9	16.2	6.3	7.3	4.2	6.0	4.9	5.7	7.3	14.6	5.5	8.2	25.8	7.7	13.1	4.7	7.8	10.5	9.4	13.8	5.6	7.0	16.8	5.8	5.0	4.2	3.2	16.9	4.4	2.5	5.5	8.6	6.6	5.7	4.6	6.3	3.9	12.2	3.4	6.9	8.2	6.1	6.9	3.1	4.0	38.0	21.7	12.6	4.9	4.8	4.3	16.6	3.1	1.7	5.0	3.4	3.3	2.9	3.7	3.2	1.8	2.4	3.9	3.2	5.5	7.8	2.5	2.2	3.3	1.3	27.0	27.9	27.2	60.1	21.4	10.1	9.1	40.5	37.2	5.7	8.9	18.5	27.6	32.1	179.3	67.8	54.1	7.6	8.1	13.6	8.7	29.5	9.7	3.3	11.6	13.1	26.4	13.5	0.0	11.7	33.1	24.6	28.4	15.1	15.6	9.4	11.1	13.9	17.8	16.2	7.4	14.1	20.2	27.0	16.2	11.7	30.1	15.8	15.8	10.6	6.0	40.5	12.9	25.6	57.9	80.3	152.9	26.1	34.6	11.3	48.9
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618632-152680165	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 75.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	1.4	0.7	0.8	12.5	0.8	8.3	2.0	0.7	0.7	5.0	1.4	1.3	0.9	1.0	1.1	1.2	36.1	1.1	2.4	1.7	0.8	0.8	1.0	4.8	7.9	20.4	1.3	0.1	0.7	0.8	0.1	3.5	3.5	0.8	3.9	1.1	0.5	16.1	2.5	1.3	28.7	3.0	2.2	1.2	16.2	2.7	0.6	0.1	8.2	1.5	26.0	38.0	7.1	6.3	8.3	2.9	75.4	6.0	0.1	3.4	2.2	12.2	0.0	0.1	0.0	0.2	3.5	5.6	3.1	11.5	3.4	6.5	0.1	1.6	12.6	1.3	2.8	3.7	9.0	0.0	24.7	6.3	0.0	0.0	0.7	0.1	0.0	3.7	9.7	28.5	3.4	11.9	10.9	9.5	0.0	8.4	7.8	0.0	22.2	0.2	0.8	3.8	3.0	0.6	0.0	2.9	0.4	0.0	0.0	19.5	7.5	0.0	0.5	0.7	2.4	0.4	3.5	0.3	6.9	3.4	0.5	2.0	0.3	4.3	27.8	9.4	6.9	4.7	22.1	2.6	49.8	5.8	44.8	0.8	5.9	1.5	8.3	1.8	1.3	2.9	7.2	1.8	1.2	75.4	0.1	6.0	0.3	3.4	2.2	0.8	0.8	0.7	0.7	0.8	0.8	1.3	0.1	0.8	0.1	11.9	22.9	42.2	7.7	65.9	0.0	1.4	0.0	60.2	19.4	21.0	2.0	21.8	0.0	6.1	0.0	5.7	0.0	0.0	3.3	12.7	5.5	5.3	97.2	3.9	4.2	3.2	1.2	0.6	8.7	0.0	0.6	15.0	5.0	0.0	0.6	0.0	12.8	9.1	0.0	0.3	0.4	0.0	1.9	0.0	0.2	169.9	21.6	15.8	3.1	23.5
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779764	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.1;testis: 11.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 76.3;Rod photoreceptor cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.7	1.0	2.2	0.7	8.6	0.2	2.1	3.5	3.6	2.5	0.8	2.1	3.9	1.1	2.0	4.2	0.6	5.5	0.8	1.0	4.8	2.1	2.0	0.6	3.5	0.5	1.6	3.2	1.7	0.9	5.4	14.1	0.5	5.8	1.3	0.9	5.4	2.0	1.1	1.2	1.3	0.8	0.9	2.7	0.8	1.0	11.8	1.3	0.3	2.1	0.6	0.5	1.0	0.8	0.4	0.0	1.6	1.1	2.1	1.3	0.0	0.6	0.5	3.0	1.2	0.2	0.4	0.3	0.1	0.7	0.3	0.6	0.6	1.3	1.0	0.1	0.1	1.4	0.5	1.1	0.5	0.5	1.0	0.2	1.5	0.7	0.3	0.2	0.6	0.3	0.1	0.5	0.5	0.3	0.6	0.1	2.2	0.4	4.6	0.3	0.3	2.9	0.4	1.4	0.4	0.4	0.5	0.6	0.0	2.0	0.1	1.4	1.6	0.2	0.3	2.9	1.4	0.7	0.2	0.0	0.4	0.6	0.5	0.6	6.8	13.2	0.6	1.0	1.6	2.2	0.0	0.3	0.8	0.0	1.1	0.2	0.0	0.3	1.3	0.0	0.4	0.1	0.4	1.6	2.1	0.2	0.0	0.0	0.0	2.2	8.6	3.5	3.6	4.8	2.1	1.6	3.2	5.8	1.3	0.0	1.0	0.0	0.4	0.0	6.7	0.0	0.0	12.0	0.0	1.8	11.8	0.1	0.0	0.5	76.3	0.1	0.0	0.0	1.0	0.1	0.1	0.3	0.0	0.0	0.5	1.6	1.2	0.0	0.0	8.5	0.3	0.0	0.0	0.0	0.1	12.1	0.4	0.0	0.4	1.5	29.0	0.0	0.0	5.1	1.7	0.0	0.2	0.0	0.4	0.3
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	17.8	15.6	12.2	22.6	13.2	2.8	22.3	15.7	12.3	22.8	25.3	17.5	25.6	20.9	21.1	23.8	23.4	17.6	20.8	11.9	12.6	13.2	23.6	15.3	20.3	14.9	16.1	9.5	22.9	18.8	20.4	22.5	29.0	13.5	23.8	26.4	19.1	19.6	23.9	12.7	19.1	29.9	18.5	18.3	18.5	20.2	12.7	13.9	14.7	23.9	10.2	17.9	24.3	20.4	8.4	10.9	35.7	13.8	12.3	7.6	7.7	13.2	9.9	13.8	13.5	21.8	22.3	17.1	15.9	22.5	16.1	15.4	11.5	27.8	10.6	5.3	22.1	12.4	9.5	14.3	16.1	20.1	8.9	8.9	10.5	10.1	11.4	15.4	19.7	22.2	15.7	17.9	13.7	13.6	17.5	14.8	6.2	12.3	23.0	22.5	15.4	11.0	11.0	11.6	16.6	10.1	6.4	7.8	9.8	29.1	17.8	17.5	14.4	12.0	22.7	15.8	14.1	20.3	10.6	9.1	15.6	11.1	15.1	11.2	25.3	20.8	14.5	19.8	19.8	21.5	12.1	12.0	17.9	6.7	13.8	6.7	8.4	5.3	5.5	10.9	7.7	4.1	5.5	35.7	12.3	12.6	1.3	7.6	7.7	12.2	13.2	15.7	12.3	12.6	13.2	16.1	9.5	13.5	13.9	6.0	25.6	10.4	15.8	26.3	17.3	8.1	28.1	25.4	21.6	36.6	0.0	24.5	23.2	23.7	30.8	19.9	26.4	0.0	15.9	21.2	22.4	21.3	22.0	17.8	19.1	17.5	37.3	19.0	22.2	19.7	20.8	18.5	20.3	5.4	34.5	32.0	19.3	24.6	20.5	24.5	23.6	32.3	18.9	25.5	31.9	29.6	36.7	11.4	29.7	29.4
FHDC1	KIAA1727	ENSG00000137460	"FH2 domain containing 1"	Q9C0D6	4	152936352-152979696	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 86.7"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 65.7;Erythroid cells: 70.0;Syncytiotrophoblasts: 66.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.5;RT4: 8.1;SK-BR-3: 11.4;WM-115: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008527	Uncertain					NA	NA					"HPA008527: AB_2104099"	"unprognostic (5.42e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.95e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.30e-1)"	0.7	0.2	0.5	2.0	4.3	11.3	1.9	2.8	4.4	2.4	4.0	0.5	1.4	3.0	1.8	1.6	8.0	1.1	4.9	0.6	0.9	0.8	1.5	0.4	7.7	0.8	0.9	0.8	1.0	1.8	7.4	3.4	86.7	1.5	6.8	4.3	6.9	4.4	1.4	0.4	11.0	6.7	1.0	0.9	4.4	4.2	1.5	0.7	0.8	15.0	4.6	8.7	1.3	3.8	0.5	0.4	2.8	0.3	1.0	0.3	0.0	4.3	0.4	0.8	0.6	0.4	0.2	24.5	0.3	0.9	1.0	0.1	0.3	2.7	0.2	0.1	0.4	0.8	0.9	0.2	1.8	0.3	0.5	0.3	0.5	2.5	0.3	0.1	0.1	0.7	0.1	2.2	0.0	0.5	1.0	0.0	0.4	1.1	0.5	0.3	2.7	0.1	0.1	5.0	0.4	0.3	0.0	0.2	0.1	4.5	8.1	4.4	0.2	1.5	11.4	1.6	5.8	1.7	0.3	0.1	0.3	0.8	2.0	1.0	0.6	0.4	0.1	0.2	0.1	8.4	0.6	0.3	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.2	0.3	2.8	1.0	0.2	0.4	0.1	0.0	0.5	4.3	2.8	1.6	0.9	0.8	0.9	0.8	1.5	0.7	14.9	65.7	0.0	2.3	5.3	0.0	0.6	5.1	5.3	21.6	3.5	2.0	10.4	0.0	0.8	1.7	0.9	7.4	70.0	2.7	11.1	1.4	6.4	3.5	0.0	1.8	0.0	13.3	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.8	0.0	5.2	7.8	0.7	0.0	0.0	0.0	0.0	0.4	0.2	6.1	66.9	0.0	6.4	2.5
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152342-153339320	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 5.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 28.6;NTERA-2: 23.5;RPTEC TERT1: 26.7;SK-MEL-30: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035853, HPA035854"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	4.2	9.9	28.4	4.4	35.7	0.6	12.2	28.9	56.9	19.6	17.8	67.0	5.9	13.5	9.7	15.1	8.5	12.9	10.3	6.2	38.9	25.3	22.1	6.4	5.9	2.3	39.4	34.6	10.9	8.2	1.0	10.9	2.5	45.3	11.5	19.2	4.6	30.1	11.8	1.8	3.8	14.4	6.6	44.2	8.8	23.5	1.9	44.7	0.0	38.9	0.6	4.3	7.6	5.5	1.9	0.8	0.3	0.6	0.3	5.4	0.7	4.8	0.2	28.6	12.5	10.8	12.4	0.5	6.4	8.7	1.8	2.7	2.8	0.3	0.2	4.1	11.1	5.5	4.3	13.3	2.4	1.9	0.1	5.0	0.2	2.9	0.6	12.6	0.2	0.1	8.0	1.4	3.6	2.3	7.0	1.7	0.3	0.2	0.1	2.2	0.4	1.4	0.0	23.5	14.3	5.7	0.8	5.2	0.0	26.7	6.3	9.2	18.1	3.0	11.6	25.6	4.3	1.2	0.2	2.4	8.0	2.3	6.2	3.0	0.1	0.0	0.1	11.9	0.1	9.8	0.3	0.6	0.1	0.1	0.0	0.0	1.6	5.4	0.1	0.8	1.9	1.6	1.0	0.2	0.3	0.0	0.1	2.6	0.7	28.4	35.7	28.9	41.1	38.9	25.3	39.4	34.6	45.3	44.7	6.0	22.3	3.2	14.9	6.3	65.3	26.2	12.7	81.7	61.4	55.8	27.5	1.4	86.2	8.4	2.7	14.0	51.1	0.0	23.1	0.4	18.1	22.3	1.1	10.9	1.1	104.9	59.8	18.4	1.5	2.1	27.3	2.6	60.8	4.6	59.2	78.7	19.0	31.6	30.8	12.2	20.8	25.8	9.9	0.4	0.9	3.4	0.6	1.0	74.3	26.7
MND1	GAJ	ENSG00000121211	"Meiotic nuclear divisions 1"	Q9BWT6	4	153344649-153415118	"Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.5;testis: 15.7"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Spermatocytes: 52.9;Spermatogonia: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5;T-reg: 4.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.5;NK-cells: 1.2;T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA043499	Enhanced					NA	NA					"HPA043499: AB_2732506"	"unprognostic (2.21e-2)"	"unprognostic (6.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.71e-8)"	"unprognostic (7.65e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.84e-2)"	"unprognostic (7.64e-2)"	0.8	0.9	1.5	10.5	1.4	9.4	3.0	0.9	1.3	1.0	3.6	0.4	0.3	2.5	1.2	1.0	5.3	0.3	0.9	1.1	1.8	1.7	1.0	0.9	1.2	9.5	1.8	0.6	1.0	2.0	0.0	0.7	3.7	0.8	0.9	4.4	0.3	1.4	0.6	1.5	1.5	2.3	1.3	1.9	4.0	1.7	15.7	0.3	28.5	0.7	4.2	11.1	1.4	1.7	0.6	3.5	0.0	0.0	1.2	4.4	0.6	11.6	5.4	17.8	10.1	0.2	2.4	6.5	11.1	4.7	9.9	8.1	10.4	8.6	22.7	2.2	2.8	9.4	4.8	18.0	5.0	12.8	14.6	6.7	12.2	5.3	12.7	0.4	26.8	6.1	0.7	1.1	7.7	6.7	2.5	3.3	26.8	21.2	29.8	8.2	6.4	37.7	34.8	12.3	5.7	5.6	23.7	6.1	10.9	6.6	2.9	8.6	7.8	5.0	5.7	9.1	9.1	4.5	21.9	0.8	7.8	11.4	8.8	10.5	25.1	29.0	18.8	7.8	21.4	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.6	1.6	0.1	3.5	0.1	1.4	0.1	0.0	1.2	0.0	0.3	4.4	0.6	1.5	1.4	0.9	1.3	1.8	1.7	1.8	0.6	0.8	0.3	0.0	0.3	0.0	0.8	2.5	0.0	0.6	5.1	1.4	0.0	0.0	0.0	3.4	1.7	0.4	16.4	0.2	0.5	46.7	0.5	16.2	1.6	0.5	0.0	0.8	10.0	0.0	0.0	1.8	2.2	13.3	0.9	1.1	3.3	0.0	1.7	0.0	0.5	0.9	2.1	0.0	0.0	6.5	0.7	52.9	77.3	1.3	2.1	1.3	6.8	1.8
TMEM131L	"DKFZp586H1322, KIAA0922"	ENSG00000121210	"Transmembrane 131 like"	A2VDJ0	4	153466346-153636711	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.4"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 11.1;Ciliated cells: 10.7;Exocrine glandular cells: 8.0;monocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;MOLT-4: 34.7;U-698: 44.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043472, HPA048443"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			Vesicles	"Nucleoli fibrillar center"	"HPA043472: AB_2678496, HPA048443: AB_2680395"	"unprognostic (1.12e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-2)"	7.5	1.9	2.1	37.9	6.0	27.3	6.6	0.5	3.0	6.5	5.6	2.3	3.5	1.5	11.9	7.9	6.6	5.0	4.3	5.6	2.5	1.6	3.4	13.0	6.1	27.6	2.2	1.6	4.9	23.0	0.8	6.4	2.5	2.1	5.3	3.1	5.3	10.3	3.2	17.5	5.2	10.0	8.1	3.0	26.5	6.0	3.2	3.9	69.4	4.1	5.5	36.8	7.1	5.8	18.5	13.3	13.6	23.7	14.9	17.9	10.3	2.0	1.3	5.7	6.0	3.4	3.0	0.1	2.9	1.4	2.1	2.6	9.2	1.3	37.3	0.7	3.9	2.3	2.0	4.4	5.1	3.1	3.4	3.2	7.3	2.5	2.3	2.2	8.0	0.4	2.7	3.2	2.7	2.5	2.3	5.2	6.9	6.8	0.1	2.0	3.7	34.7	5.8	5.1	0.0	1.9	12.1	5.6	2.4	1.4	0.8	4.3	3.3	2.3	5.2	3.0	3.1	2.0	5.9	4.1	2.8	5.0	3.3	2.4	4.1	4.1	44.2	0.8	4.8	2.2	6.1	12.4	13.1	8.5	23.7	11.2	18.5	10.7	7.9	13.3	17.3	17.9	12.0	13.6	14.9	18.6	1.3	12.9	10.3	2.1	6.0	0.5	3.0	2.5	1.6	2.2	1.6	2.1	3.9	6.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.4	0.0	0.0	0.5	1.7	1.9	0.0	0.0	0.0	0.0	8.0	0.2	0.0	0.0	4.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	5.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153705702	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	16.3	6.9	6.9	30.0	11.1	34.6	7.3	1.4	5.3	4.7	4.7	3.0	9.3	2.2	3.1	8.0	3.2	7.2	10.0	7.2	6.7	3.3	9.8	7.3	31.1	37.8	12.4	1.4	4.2	5.1	1.1	4.4	6.4	9.9	5.5	1.9	3.3	15.0	9.9	2.5	3.1	4.0	6.6	21.9	29.3	3.9	4.8	9.5	0.9	3.3	1.0	8.5	7.3	3.5	0.2	19.1	72.9	29.5	0.8	0.2	9.3	4.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.3	0.3	0.5	1.9	0.2	0.0	0.4	0.0	0.0	3.6	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.4	0.0	6.9	0.5	7.5	7.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.4	0.0	1.6	0.1	0.0	0.0	7.7	9.5	0.0	0.2	0.4	0.0	1.8	0.2	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.9	6.2	29.5	0.2	0.0	28.1	0.0	0.0	0.1	0.0	19.1	0.2	0.2	0.0	72.9	0.8	18.4	0.1	0.0	9.3	6.9	11.1	1.4	5.3	6.7	3.3	12.4	1.4	9.9	9.5	6.0	64.7	0.8	1.1	1.0	0.0	1.2	5.1	2.7	12.5	3.5	0.0	0.1	0.0	4.8	0.3	0.6	0.0	0.0	3.2	0.1	0.9	2.0	3.5	0.9	16.3	0.0	0.0	2.5	106.5	0.0	0.6	52.5	1.7	0.0	0.1	0.0	3.1	0.0	0.4	1.0	0.3	12.9	0.4	0.2	0.4	1.0	0.1	0.7	0.0	1.4
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710125-153760235	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 52.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	26	"classical monocyte: 2.4;intermediate monocyte: 1.7;myeloid DC: 1.7;naive CD4 T-cell: 4.0;neutrophil: 4.5;non-classical monocyte: 3.6;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;HSkMC: 5.2;REH: 6.7;SH-SY5Y: 6.7;THP-1: 16.1;U-87 MG: 3.9"									HPA035837	Uncertain					NA	NA					"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	2.7	4.8	8.6	5.4	14.3	9.5	1.3	9.3	17.3	5.4	0.8	1.4	0.8	0.8	0.8	2.0	1.5	0.6	2.2	4.4	9.0	12.1	0.6	0.5	2.2	2.2	6.4	9.8	0.5	1.1	0.4	3.0	0.6	13.0	4.7	0.6	0.6	3.4	6.7	0.5	1.6	0.9	0.6	2.5	3.4	0.8	2.8	1.8	0.0	0.6	0.3	1.3	1.8	1.5	0.0	1.7	4.5	3.6	0.0	4.0	1.2	0.1	0.0	7.9	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	0.0	0.0	6.7	0.0	0.3	0.0	0.1	0.0	6.7	0.0	0.0	0.2	0.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.9	0.0	0.0	2.4	0.0	0.0	1.7	0.0	0.0	0.1	0.0	1.7	0.0	4.0	0.1	4.5	0.0	3.6	0.0	1.1	1.2	8.6	14.3	9.3	17.3	9.0	12.1	6.4	9.8	13.0	1.8	0.0	0.3	0.0	0.0	0.3	0.2	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	52.2	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.1	10.2	0.0	1.4	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.3	1.4	1.4	0.3	0.0	0.0	0.0	0.1
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	15	"Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA			"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	53.5	0.0	20.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0	3.0	1.1	0.0	0.6	102.6	0.0	0.3	0.0	5.3	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	163.9	0.3	1.1	0.0	3.3	0.0	0.0	0.0	0.0	0.2	3.7	2.2	113.1	1.0	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	47.4	0.0	0.2	92.6	0.1	0.0	0.0	1.0
DCHS2	"CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ"	ENSG00000197410	"Dachsous cadherin-related 2"		4	154231742-154495570	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"endometrium 1: 8.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 20.6;Horizontal cells: 23.8;Intestinal endocrine cells: 6.4;Late spermatids: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-2 OS: 8.0"					"Low region specificity"	"Detected in many"			HPA064159	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA064159: AB_2685201"	"unprognostic (1.38e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-3)"	0.9	1.6	3.4	1.3	7.0	1.1	1.0	0.6	4.8	2.6	4.0	1.9	1.1	1.3	8.6	1.5	1.0	2.0	1.6	0.8	3.5	2.6	0.9	0.7	1.1	0.8	3.0	2.3	1.9	0.6	1.1	1.7	0.8	4.6	1.6	1.5	2.7	0.8	3.6	1.0	2.1	1.0	3.0	7.0	0.8	4.9	2.6	2.9	0.0	1.0	0.0	0.9	2.3	1.2	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.4	7.0	0.6	4.8	3.5	2.6	3.0	2.3	4.6	2.9	0.0	0.0	0.0	0.2	0.3	0.0	1.7	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	23.8	6.4	0.0	0.0	14.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.3	0.0	0.0	0.0	0.0
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535006-154550435	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	20.2	18.1	23.3	14.9	30.9	17.5	25.2	29.3	28.6	22.7	19.5	24.7	16.7	15.6	24.4	19.3	24.4	22.8	16.0	16.2	22.9	22.2	26.0	34.9	17.1	20.4	28.9	24.3	23.9	14.2	28.2	21.9	17.8	29.4	18.4	22.7	13.3	19.4	23.3	23.0	16.5	22.1	29.2	32.5	19.1	16.8	13.3	25.9	22.0	24.8	22.3	31.5	18.3	16.5	25.2	25.2	23.2	30.9	34.0	28.8	23.7	23.9	19.6	25.4	27.1	30.1	26.1	21.4	30.8	37.8	42.2	34.5	23.1	21.2	26.1	15.8	36.6	27.8	17.7	33.1	41.2	46.9	26.3	16.5	31.4	15.6	22.3	30.8	31.2	26.4	28.0	38.3	49.8	39.2	25.4	36.1	28.9	32.0	33.6	36.6	17.1	23.9	14.9	19.2	19.1	21.4	23.8	13.2	15.8	29.2	15.4	14.8	16.7	18.8	20.3	29.4	25.1	19.5	21.9	23.2	25.2	28.6	22.2	27.4	17.6	22.8	32.9	23.7	15.1	33.5	23.2	19.4	15.2	23.7	22.5	28.2	25.2	24.8	25.6	25.2	19.2	26.6	24.8	5.2	34.0	30.9	24.8	28.8	23.7	23.3	30.9	29.3	28.6	22.9	22.2	28.9	24.3	29.4	25.9	23.8	14.9	29.0	28.9	14.4	27.4	22.1	12.7	37.5	14.8	21.0	11.8	43.2	13.3	39.6	14.7	21.9	18.7	0.0	30.4	31.8	28.3	15.4	45.0	25.5	30.6	58.8	26.0	17.2	20.6	1.3	25.9	20.4	13.5	38.7	14.1	29.8	28.6	20.9	32.9	29.0	19.5	19.4	21.7	22.8	29.6	15.2	37.1	28.8	19.1	20.2
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell type enriched"	"Detected in some"	33	"Hepatocytes: 15347.2"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 77.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		120000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	77.7	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	153.8	0.0	0.0	0.0	0.4	257.4	0.0	0.0	3.5	0.0	0.0	1.7	3.0	0.4	0.0	0.0	467.2	3.2	0.1	0.0	0.0	0.0	15347.2	0.3	0.0	1.7	349.9	342.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell type enriched"	"Detected in many"	40	"Hepatocytes: 16694.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 96.9"	"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	96.9	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	83.9	0.0	0.0	0.0	0.4	420.4	17.4	5.7	0.0	0.0	0.0	1.7	5.5	23.9	0.0	0.0	256.9	1.5	0.0	0.0	0.0	0.0	16694.6	0.1	0.0	0.0	255.3	257.1	29.3	0.6	0.0	0.0	0.0	0.0	0.0	31.5	0.0	1.1	1.0	0.0	0.0	0.0	14.4	0.6	0.0	0.1	4.3	0.0	0.0
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	495	"liver: 2225.7"	"Cell type enriched"	"Detected in many"	15	"Hepatocytes: 7797.1"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"Hep G2: 128.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	68000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2225.7	4.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	128.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	17.9	218.6	146.9	0.0	0.0	0.0	0.2	507.0	2.7	4.5	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	327.1	40.0	0.1	0.0	0.0	10.5	7797.1	0.2	0.0	0.0	232.7	240.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	266.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.3	20.1	0.0	0.0
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753118	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 82.4"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 7.6;Early spermatids: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"NTERA-2: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.9	0.8	2.2	0.8	3.2	1.8	1.4	0.7	1.1	0.9	4.2	3.0	0.8	3.7	0.5	1.2	0.5	0.9	2.3	0.6	3.1	4.2	0.6	3.3	1.0	0.5	2.9	2.4	1.0	2.9	0.3	1.0	0.3	8.9	1.6	0.4	82.4	0.5	1.6	2.3	1.4	11.1	0.3	7.0	0.7	0.9	2.9	3.1	0.0	4.9	0.2	0.6	0.5	0.7	0.9	3.7	2.0	4.5	0.6	0.3	3.9	0.7	0.5	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.1	0.2	0.5	0.4	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.3	16.5	0.0	0.0	0.1	0.0	0.1	2.0	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	1.0	4.5	0.4	0.3	1.6	0.3	0.5	0.3	0.3	3.7	0.9	0.3	0.3	2.0	0.6	0.5	0.5	0.2	3.9	2.2	3.2	0.7	1.1	3.1	4.2	2.9	2.4	8.9	3.1	0.0	4.1	0.0	4.2	1.0	0.8	0.2	7.6	0.0	1.2	0.0	0.0	0.1	3.3	0.8	7.2	0.2	2.0	0.0	0.7	0.1	0.3	2.4	0.0	2.0	0.1	0.0	0.0	1.8	0.0	1.6	0.0	0.0	5.0	0.0	0.7	3.7	1.4	0.0	0.0	0.3	0.9	0.0	0.1	4.8	4.5	1.0	0.2	0.7	0.3	0.6
RBM46	"CT68, MGC27016"	ENSG00000151962	"RNA binding motif protein 46"	Q8TBY0	4	154781213-154828813	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"testis: 34.5"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 74.4;Spermatogonia: 75.5"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 2.7;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079488			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA079488: "	"unprognostic (4.79e-1)"				"unprognostic (1.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.99e-7)"	"unprognostic (4.86e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.27e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	74.4	75.5	0.0	0.0	0.0	0.0	0.0
NPY2R		ENSG00000185149	"Neuropeptide Y receptor Y2"	P49146	4	155208629-155217078	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;breast: 4.1"	"Cell type enriched"	"Detected in some"	11	"Leydig cells: 19.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;ASC diff: 3.6;HSkMC: 1.7;SH-SY5Y: 12.9"	"Group enriched"	"Detected in many"	5	"amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7"	"Region enriched"	"Detected in all"	5	"hippocampal formation: 19.7"							NA	NA						"unprognostic (7.14e-2)"				"unprognostic (4.36e-3)"					"unprognostic (7.08e-2)"		"unprognostic (5.50e-2)"			"unprognostic (9.35e-2)"			0.8	1.1	3.4	1.3	6.9	0.1	4.1	0.1	8.6	0.4	2.7	1.8	0.0	1.1	0.2	0.4	0.2	0.5	0.2	0.7	7.3	5.5	0.3	0.1	0.2	0.2	0.8	0.0	0.4	0.1	0.1	0.2	0.2	7.8	0.5	2.8	0.2	2.0	0.2	0.1	0.5	1.5	0.6	10.2	0.6	0.3	2.5	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	6.9	0.1	8.6	7.3	5.5	0.8	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0
MAP9	"ASAP, FLJ21159"	ENSG00000164114	"Microtubule associated protein 9"	Q49MG5	4	155342658-155376970	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3;parathyroid gland: 43.5"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 153.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 25.3"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (8.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.54e-2)"	3.5	5.1	8.9	3.3	16.3	1.6	3.9	7.5	19.0	5.4	3.8	2.2	7.2	1.1	6.5	6.7	2.8	8.3	6.8	5.7	8.9	13.3	8.4	0.9	4.3	2.7	11.2	10.3	5.5	4.8	43.5	25.7	4.4	31.3	10.9	1.8	3.3	2.5	8.0	0.6	0.8	1.9	5.1	7.6	2.1	5.2	10.2	4.8	1.6	12.9	0.4	2.2	3.7	2.4	6.7	4.1	0.2	0.6	1.3	4.6	0.9	0.0	5.9	6.5	5.6	7.0	8.4	1.3	6.5	5.9	3.9	3.4	0.0	0.0	4.2	8.8	4.8	14.8	0.0	6.7	7.0	6.4	0.0	5.6	2.7	0.0	0.0	5.2	0.0	0.0	7.0	3.9	5.4	3.4	11.9	0.0	1.7	0.0	0.0	4.4	2.6	4.9	0.0	5.0	2.1	7.7	0.0	0.0	0.1	13.1	5.1	9.0	25.3	0.0	11.3	0.3	4.4	9.2	0.0	0.9	5.3	9.7	0.1	4.8	5.3	0.0	4.7	15.3	0.0	8.4	0.0	0.0	0.0	4.6	0.6	3.7	5.1	2.6	4.1	0.1	6.7	2.4	3.1	0.2	1.3	0.0	4.1	1.5	0.9	8.9	16.3	7.5	19.0	8.9	13.3	11.2	10.3	31.3	4.8	14.9	34.9	7.3	12.6	1.1	63.8	29.9	12.7	153.9	33.0	24.4	74.6	6.3	28.2	28.3	18.9	1.8	0.0	0.0	14.0	3.1	16.6	12.2	2.3	0.4	0.9	68.3	20.3	3.1	0.0	9.8	42.3	1.5	5.0	1.8	0.5	56.8	16.1	0.0	46.3	28.0	88.8	12.9	21.6	66.1	49.5	1.0	1.9	11.4	0.6	2.2
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666711-155732349	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 55.2"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 2: 41.4;Club cells: 12.5;Collecting duct cells: 10.4;Distal tubular cells: 16.6;Ductal cells: 15.1;Proximal tubular cells: 10.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.1;HEK 293: 5.0;Karpas-707: 8.7;MOLT-4: 15.9;RPTEC TERT1: 10.9;RT4: 12.7;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		6100	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	10.9	5.3	12.4	10.2	19.9	0.9	11.1	3.4	11.6	13.7	31.2	7.3	2.8	5.6	14.7	6.0	7.0	6.8	8.3	21.0	9.0	7.2	11.6	5.1	13.2	7.3	4.7	12.5	5.4	8.5	55.2	5.8	16.3	6.3	17.2	6.9	39.7	7.0	9.8	4.5	3.6	10.1	18.8	6.6	8.5	12.9	2.1	8.5	4.5	8.1	7.3	5.9	6.4	10.6	0.1	11.6	0.3	9.2	7.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	6.1	0.0	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	3.3	0.0	8.7	0.0	0.0	15.9	0.0	0.0	0.0	0.2	3.5	0.0	2.6	10.9	12.7	2.2	8.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	7.6	9.2	11.6	0.0	1.0	12.4	19.9	3.4	11.6	9.0	7.2	4.7	12.5	6.3	8.5	8.9	41.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	12.5	10.4	0.0	0.4	16.6	15.1	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	3.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807591	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.6"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 6.0;Collecting duct cells: 8.7;Ductal cells: 14.1;Proximal tubular cells: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 5.6;non-classical monocyte: 17.8"	"Lineage enriched"	"Detected in many"	12	"monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HEL: 25.3;Karpas-707: 13.4;MOLT-4: 16.0;RPTEC TERT1: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA		5200	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	8.8	5.4	18.7	9.8	42.0	1.8	5.5	12.2	36.8	8.1	14.9	5.7	0.4	4.2	11.3	4.7	5.9	9.5	9.2	12.2	16.1	25.0	9.2	5.4	9.4	6.6	14.5	23.2	3.7	7.4	71.6	3.8	28.0	20.6	9.8	6.2	5.8	3.2	8.7	3.8	2.2	5.9	16.3	6.7	7.2	8.9	2.1	5.5	2.6	4.6	2.4	5.1	8.0	6.8	0.2	1.4	1.1	17.8	0.9	0.0	4.8	0.0	0.2	3.6	0.0	1.2	6.8	0.0	1.1	2.0	0.1	0.0	0.0	0.0	0.0	1.7	0.6	2.9	0.0	7.4	0.1	0.4	0.0	2.7	25.3	0.0	0.0	0.7	0.0	0.0	3.0	0.2	0.0	0.1	2.5	0.0	5.7	0.0	13.4	1.8	1.1	16.0	0.0	0.2	0.0	1.9	1.8	0.5	0.4	25.7	2.4	0.4	4.5	0.0	0.1	0.0	3.7	0.0	0.0	0.0	4.2	0.9	7.2	5.3	0.1	0.0	0.0	9.2	0.0	0.0	1.1	0.4	0.3	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.0	0.4	0.9	17.8	1.2	0.0	4.8	18.7	42.0	12.2	36.8	16.1	25.0	14.5	23.2	20.6	5.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.5	5.0	14.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.1	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
ASIC5	"ACCN5, HINAC, INAC"	ENSG00000256394	"Acid sensing ion channel subunit family member 5"	Q9NY37	4	155829729-155866273	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	13	"intestine: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014903, HPA029444"	Approved					NA	NA					"HPA014903: AB_1844498, HPA029444: AB_10611671"					"unprognostic (8.52e-5)"		"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"									"unprognostic (4.05e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	7.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.3	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 187.9"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1048.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8"	"Group enriched"	"Detected in some"	9	"cerebellum: 7.0;hippocampal formation: 5.9"	"Not detected"	"Not detected"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	0.5	0.2	2.5	0.5	0.0	0.1	0.1	2.0	0.1	0.2	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0.0	5.8	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0.0	0.0	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.2	0.0	0.1	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.9	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.4	0.4	0.0	2.7	0.0	0.0	9.8	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.0	1.5	0.2	0.2	0.7	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.4	132.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	23.3	0.0	0.0	0.1	0.3	0.0	1048.1	0.9	0.0	0.0	25.2	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0
CTSO	CTSO1	ENSG00000256043	"Cathepsin O"	P43234	4	155924118-155953917	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.5;HSkMC: 14.8;Karpas-707: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002041	Approved				"Intracellular and membrane"	NA	NA		24000			"HPA002041: AB_1078408"	"unprognostic (3.96e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	13.7	16.4	11.9	12.6	12.0	1.8	14.9	3.7	12.4	16.0	18.5	11.6	10.2	13.3	19.3	27.3	10.8	15.6	16.9	19.7	9.7	8.6	21.2	41.6	26.4	19.4	10.2	6.7	16.3	10.7	13.6	9.4	18.7	9.7	16.1	9.8	24.0	13.8	16.8	5.9	6.2	27.5	14.4	11.4	19.3	10.8	9.0	7.7	5.5	17.1	10.2	10.3	12.4	12.5	7.0	8.9	5.3	14.8	12.0	10.9	8.9	0.3	0.2	1.5	1.6	5.7	12.5	0.0	3.6	7.2	1.3	1.8	0.0	4.6	0.0	0.7	2.4	0.4	0.0	0.0	0.3	0.9	5.3	0.1	0.4	0.0	0.0	5.9	0.7	0.1	14.8	1.3	0.8	0.6	8.4	1.2	0.2	0.0	27.8	4.1	0.3	0.3	0.1	0.3	0.2	0.2	1.7	0.3	1.7	5.4	2.3	0.2	1.7	0.9	3.0	1.1	0.8	1.5	1.0	2.1	4.4	0.2	0.4	1.2	3.2	0.0	0.0	7.9	0.0	5.9	5.3	12.0	0.8	7.9	14.8	10.9	5.8	6.1	7.3	8.9	7.0	6.7	6.8	0.5	12.0	10.7	8.3	6.8	8.9	11.9	12.0	3.7	12.4	9.7	8.6	10.2	6.7	9.7	7.7	35.7	17.3	20.1	9.8	9.3	6.6	4.8	35.7	12.0	14.8	24.4	2.0	16.9	11.6	16.2	0.4	26.9	14.2	0.0	17.8	5.0	32.5	16.5	8.1	50.0	15.1	4.8	6.4	36.8	29.9	0.4	28.1	17.9	28.7	13.6	10.0	15.8	12.5	7.0	23.7	8.4	1.3	19.4	16.4	0.2	1.1	8.0	8.8	13.1	5.6	7.8
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971394	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 44.1;Cholangiocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;hTERT-RPE1: 26.6;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	11.5	9.1	3.2	6.5	3.4	0.7	7.9	1.3	3.5	21.8	6.1	1.9	8.4	2.2	21.3	9.4	6.1	9.0	12.7	3.6	2.4	2.0	9.7	10.3	6.9	4.3	2.2	3.8	10.4	9.8	28.0	2.2	4.9	1.9	17.7	2.4	5.5	26.6	9.3	6.5	4.1	5.4	11.9	2.0	4.1	5.6	4.3	1.7	2.2	10.4	4.4	1.5	8.3	4.7	0.0	0.2	0.0	2.1	0.0	0.0	0.7	1.0	1.6	17.8	11.7	3.3	6.5	0.4	9.3	9.9	5.6	7.5	1.0	4.2	0.0	1.6	27.1	4.3	1.1	4.9	6.1	7.7	0.0	2.2	10.8	1.6	1.0	8.7	1.6	0.1	6.7	3.0	14.2	10.2	26.6	2.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	3.7	0.0	10.6	0.4	0.0	0.0	0.0	0.0	0.1	2.9	1.4	0.5	12.0	19.4	0.2	4.9	7.5	0.0	0.0	0.0	7.4	0.0	0.7	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.7	3.2	3.4	1.3	3.5	2.4	2.0	2.2	3.8	1.9	1.7	6.0	13.9	0.0	18.3	44.1	0.3	13.7	45.9	0.0	7.9	12.2	0.0	0.4	0.0	13.8	31.1	4.9	0.4	0.0	6.2	0.2	15.8	6.7	1.1	13.0	10.6	0.0	0.0	11.6	21.7	18.1	4.9	14.8	10.1	16.2	2.0	6.7	12.6	0.0	21.5	14.9	0.3	6.5	17.3	0.2	2.2	11.8	0.5	0.5	1.3	4.3
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076057-157172090	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 43.1;parathyroid gland: 37.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 12.6;Cholangiocytes: 7.6;Ciliated cells: 8.1;Muller glia cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.5;hTERT-RPE1: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA					"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.5	7.2	12.6	1.5	20.9	0.7	10.3	15.9	43.1	9.4	2.3	2.8	0.1	1.1	3.3	5.4	1.5	7.4	3.5	9.9	18.3	17.3	4.1	1.6	3.4	0.8	11.1	21.3	1.8	14.2	37.0	6.7	2.9	16.5	6.5	1.4	0.7	16.7	5.2	3.3	1.5	1.2	4.0	6.1	0.6	2.2	1.9	4.5	0.0	1.5	0.5	0.7	1.9	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.8	2.0	5.8	17.5	11.3	4.6	0.0	9.6	6.2	4.7	8.9	0.0	14.8	0.0	2.3	9.7	5.8	0.0	4.4	1.5	8.9	0.0	5.8	2.9	2.2	0.2	5.2	3.7	0.0	4.1	1.3	8.2	1.2	23.3	4.2	3.1	0.0	0.0	8.5	0.0	0.4	0.0	0.3	0.0	1.3	0.0	7.9	0.0	12.7	0.8	6.3	3.8	0.0	4.5	0.7	0.9	4.1	0.9	6.2	2.8	8.3	4.7	9.3	0.0	0.0	0.0	6.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	12.6	20.9	15.9	43.1	18.3	17.3	11.1	21.3	16.5	4.5	0.0	0.6	0.0	0.7	1.0	6.9	12.6	7.6	8.1	3.4	0.0	2.0	0.3	0.0	6.9	0.2	1.0	0.0	0.0	1.5	0.0	2.6	0.6	1.1	0.0	0.1	1.6	0.0	1.8	0.0	0.0	0.3	0.0	3.3	1.0	0.0	11.6	1.9	0.0	3.2	0.4	1.6	0.0	1.1	1.1	3.0	0.3	0.1	0.0	0.0	0.1
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 242.0;Horizontal cells: 130.3"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA					"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	1.2	6.5	36.9	1.3	39.1	1.1	2.0	22.1	95.9	8.2	1.3	5.6	0.0	1.2	13.5	9.8	1.2	9.6	1.2	1.2	30.1	15.7	1.5	1.1	1.4	1.2	10.0	30.6	1.7	2.2	1.2	10.5	1.2	7.1	1.8	1.2	0.1	2.1	3.0	1.2	1.1	1.2	6.1	6.9	1.3	1.5	2.1	8.8	0.0	1.2	0.0	1.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.9	2.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.2	0.0	0.0	0.6	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	39.1	22.1	41.2	30.1	15.7	10.0	30.6	7.1	8.8	0.0	0.0	0.0	0.0	0.0	242.0	2.2	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	130.3	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	3.1	0.0	0.0	0.4	0.0	14.0	0.0	0.7	3.9	1.5	0.0	0.0	0.0	0.0	0.0
FAM198B	"C4orf18, DKFZp434L142, ENED, FLJ38155"	ENSG00000164125	"Family with sequence similarity 198 member B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 83.8"	"Cell type enhanced"	"Detected in many"	13	"Endothelial cells: 51.3;Hofbauer cells: 56.1;Ito cells: 49.7;Kupffer cells: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8"	"Group enriched"	"Detected in many"	37	"dendritic cells: 7.6;monocytes: 23.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.5;ASC TERT1: 40.6;HSkMC: 46.6;HUVEC TERT2: 52.0;WM-115: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	24.1	83.8	13.9	12.9	12.6	0.9	15.9	22.9	16.0	16.7	8.9	12.1	6.2	4.5	27.5	13.2	6.0	10.6	12.6	25.8	24.2	9.0	4.2	2.9	6.9	7.1	18.6	20.2	50.1	4.8	4.4	2.7	9.5	12.4	8.3	8.1	4.2	7.9	10.8	3.8	3.5	6.3	23.9	25.9	15.7	7.5	7.0	17.5	0.0	8.2	3.1	2.3	14.2	7.3	0.0	7.6	0.4	23.8	0.0	0.0	7.3	3.2	2.6	1.6	0.3	21.5	40.6	3.1	0.8	0.6	0.1	1.0	3.5	1.3	0.0	0.1	1.3	1.4	0.0	19.0	5.0	0.5	0.0	0.0	0.2	0.0	9.7	14.4	0.1	0.0	46.6	1.2	6.6	0.7	2.2	52.0	0.0	3.3	0.0	9.6	0.2	0.0	0.0	0.1	11.3	0.0	0.0	0.1	0.0	0.0	7.3	0.1	0.0	0.0	7.5	2.1	9.6	1.4	0.0	2.5	4.4	4.8	2.6	1.6	0.0	0.0	11.8	0.6	0.0	20.0	0.0	23.8	0.0	0.0	14.8	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.4	0.0	6.8	0.3	0.0	7.3	13.9	12.6	22.9	16.0	24.2	9.0	18.6	20.2	12.4	17.5	8.9	3.8	1.7	1.7	8.1	0.0	30.3	0.0	2.7	2.3	3.5	0.0	3.6	0.0	0.5	2.4	51.3	2.6	0.0	5.0	0.9	14.8	2.4	1.1	0.8	56.1	6.4	1.7	49.7	140.4	4.3	32.5	27.2	8.5	0.0	6.5	0.0	3.2	1.9	39.6	0.0	0.0	6.5	10.3	4.4	0.5	6.5	4.9	2.2	2.9	1.0
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255411	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 88.7"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 195.0;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.3;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.7;hTCEpi: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063554: AB_2685039"	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	4.7	6.7	20.7	2.0	60.9	1.5	9.2	4.7	37.7	4.7	7.4	88.7	0.2	14.3	3.7	8.3	3.1	3.9	6.8	8.2	31.5	18.3	1.9	1.7	3.5	0.9	80.4	26.6	8.6	3.8	3.0	1.4	3.5	48.9	5.4	8.6	0.0	3.1	7.2	1.4	1.9	9.6	4.2	79.2	2.2	5.4	15.8	67.4	0.0	9.2	0.0	0.8	5.1	1.9	0.0	4.3	0.1	3.3	0.4	0.1	0.7	2.6	7.1	0.1	1.4	5.2	7.8	23.7	1.2	1.9	1.1	1.7	8.9	9.8	0.0	1.4	0.3	5.1	1.2	3.3	11.0	1.5	0.0	3.2	4.4	2.2	7.9	1.8	5.5	1.4	5.6	13.6	4.6	1.6	0.3	5.9	1.1	2.9	0.1	8.2	3.0	0.0	0.0	1.8	7.3	1.7	0.0	0.0	0.3	2.0	7.5	1.1	0.0	0.2	9.6	2.7	4.3	6.8	1.5	1.2	2.2	1.8	0.4	1.3	0.0	0.6	0.6	3.0	0.8	1.5	0.0	3.3	0.0	0.0	1.4	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.4	0.7	4.3	0.0	0.7	20.7	60.9	4.7	35.1	31.5	18.3	80.4	26.6	48.9	67.4	8.9	7.8	0.0	6.7	2.7	0.0	10.6	17.8	5.3	4.5	0.0	0.0	11.5	0.0	9.5	195.0	3.6	34.8	0.0	11.4	5.8	2.0	5.7	4.6	1.0	24.1	0.0	4.7	3.1	19.9	77.6	9.8	10.7	3.3	3.6	17.2	1.3	10.6	14.7	8.5	5.6	0.0	0.0	2.2	1.2	1.7	4.4	7.3	0.0	14.5	4.2
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin/insulin like family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;placenta: 12.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Group enriched"	"Detected in many"	6	"basal ganglia: 10.4;cerebral cortex: 18.5;olfactory region: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 24.2;HEL: 8.0;RPTEC TERT1: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA027067	Approved					NA	NA					"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.5	6.5	2.1	0.5	10.4	0.2	0.4	0.4	19.7	4.0	0.5	0.0	1.1	0.3	9.0	1.6	0.5	1.3	1.2	0.4	2.0	1.7	2.9	2.1	5.1	0.7	0.8	12.4	0.8	0.6	0.2	0.6	12.2	0.0	1.0	0.3	0.6	0.4	4.2	0.4	0.4	0.9	1.3	0.4	0.6	0.6	0.6	0.0	0.0	2.4	0.0	0.6	0.5	2.2	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.1	10.4	0.4	18.5	2.0	1.7	0.8	12.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.1	0.0	0.0	0.0
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666679-158672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	4.5	4.6	4.2	5.4	5.6	16.7	4.3	6.4	5.5	5.4	4.5	10.7	2.4	4.2	7.2	5.1	5.5	4.2	4.0	5.1	4.5	3.7	3.9	2.7	4.8	7.7	7.3	3.5	6.4	5.8	2.2	3.1	6.3	5.3	4.1	6.1	7.2	4.1	3.4	2.8	4.1	4.4	5.7	6.6	5.4	4.3	25.5	7.3	26.3	6.1	5.8	7.2	5.3	5.0	4.0	5.1	4.9	4.9	8.6	5.8	3.4	6.9	4.2	10.4	15.3	4.6	4.8	5.2	11.9	8.2	13.8	12.1	3.7	6.3	12.5	1.9	6.0	5.1	3.9	9.0	6.1	18.1	17.0	4.6	18.8	4.8	5.0	1.6	14.3	10.4	2.8	2.2	11.2	4.9	4.6	10.0	12.6	8.2	31.5	18.9	3.7	27.2	12.9	7.1	4.5	5.6	19.8	5.9	5.5	4.2	3.5	5.7	17.3	5.2	4.8	4.3	5.4	4.0	11.5	5.3	21.5	9.8	11.9	9.8	7.2	9.1	15.7	5.4	12.8	8.2	4.9	4.7	4.5	4.9	3.9	3.7	4.0	4.0	4.8	5.1	3.9	5.5	5.8	1.6	8.6	4.9	4.4	4.1	3.4	4.2	5.6	6.4	5.5	4.5	3.7	7.3	3.5	5.3	7.3	3.0	2.6	10.0	5.2	21.4	5.6	3.6	0.0	1.4	0.0	1.8	3.9	7.4	6.6	3.2	0.9	4.5	2.6	0.0	2.6	9.4	12.3	4.9	6.9	2.1	8.0	9.5	7.5	4.3	10.8	1.5	4.4	4.4	18.6	27.1	4.0	4.2	4.0	2.9	5.6	2.1	25.5	6.5	8.2	32.0	14.2	13.7	2.7	7.7	3.6	4.1
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.8"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 138.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced					NA	NA					"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favorable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	11.3	20.1	7.0	3.9	8.6	2.8	12.9	10.3	8.2	5.1	12.5	6.5	6.1	23.0	5.7	6.4	10.9	4.3	5.2	47.8	7.2	5.0	17.3	72.8	4.3	2.9	8.0	5.3	5.0	8.9	11.4	8.8	9.0	8.5	5.2	10.5	7.4	7.2	5.6	33.7	7.7	20.4	8.5	4.8	4.8	9.2	4.1	8.4	4.9	6.0	17.5	5.4	5.8	6.1	5.8	11.0	24.5	13.5	6.2	9.2	5.4	5.7	3.6	6.0	10.8	25.9	15.5	2.9	10.1	10.2	7.5	7.3	2.0	12.7	14.0	2.2	12.2	7.8	6.7	11.5	10.1	10.6	22.2	8.4	12.8	8.2	3.4	11.3	11.0	12.3	14.3	12.7	8.1	6.9	11.5	14.6	9.5	7.1	26.5	12.0	5.9	10.7	5.5	2.3	16.9	8.8	8.6	2.0	9.8	11.2	5.0	9.1	3.5	10.1	20.2	9.6	5.7	13.7	8.5	6.5	6.1	3.1	8.9	5.2	14.9	18.5	9.5	12.6	9.3	6.5	2.5	13.5	24.5	6.7	13.3	8.1	5.8	6.3	6.8	11.0	5.4	7.8	6.6	4.6	6.2	11.7	8.4	9.2	5.4	7.0	8.6	10.3	8.2	7.2	5.0	8.0	5.3	8.5	8.4	11.9	9.3	20.1	42.9	29.3	26.0	138.5	12.7	10.7	12.5	17.4	60.9	18.8	24.9	11.1	2.6	18.0	45.5	46.7	10.2	7.3	20.8	16.4	4.7	70.6	11.7	23.8	17.2	12.3	7.8	3.6	21.3	13.7	8.5	7.2	18.2	11.7	10.7	23.7	22.3	23.7	43.8	32.3	23.1	37.2	33.4	32.2	35.9	18.3	21.5	33.8
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.5	14.5	14.6	20.0	21.7	16.3	22.1	15.4	8.4	14.2	10.8	18.8	10.7	16.5	6.9	14.3	22.3	12.0	44.2	17.7	17.3	54.5	15.4	29.5	13.1	25.8	16.8	18.4	22.2	10.3	14.4	12.1	18.2	18.4	15.4	28.2	36.7	29.4	15.8	14.9	26.4	16.7	20.1	25.5	19.4	12.0	7.2	14.1	15.6	7.8	24.7	16.6	11.5	24.0	21.9	22.1	11.0	17.7	14.9	14.2	16.0	15.6	20.3	16.9	35.0	21.0	18.1	20.0	14.2	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4	6.0	12.0	18.8	25.3	9.0	24.6	50.0	28.1	76.3	33.0	26.2	21.6	33.4	31.5	34.8	23.6	25.6	19.0	0.0	20.1	39.2	21.3	25.8	31.2	16.1	36.7	71.5	18.8	18.4	11.0	15.7	19.0	21.8	13.5	63.1	22.9	21.7	26.7	21.6	21.2	24.9	25.3	6.5	30.2	78.8	76.3	10.3	39.8	27.4	24.2	17.2
FNIP2	"FNIPL, KIAA1450, MAPO1"	ENSG00000052795	"Folliculin interacting protein 2"	Q9P278	4	158769138-158908049	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.8;myeloid DC: 3.1;non-classical monocyte: 9.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.1;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.4;U-266/70: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042779, HPA052758, HPA072420"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA042779: AB_10794386, HPA052758: , HPA072420: AB_2732200"	"unprognostic (3.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.96e-11)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.10e-2)"	23.6	8.6	12.5	7.4	15.5	5.8	11.3	10.9	16.0	10.4	15.7	17.5	11.4	5.6	9.3	9.8	11.0	7.6	15.3	20.9	15.1	9.1	35.5	44.0	21.8	12.0	14.1	14.4	8.5	14.2	13.0	5.2	21.7	11.1	8.5	16.8	8.0	10.0	14.7	15.3	11.4	8.1	13.3	12.9	9.6	16.3	7.2	15.0	5.5	13.9	8.3	4.1	9.3	9.5	0.0	3.1	0.6	9.4	0.9	1.0	0.5	1.4	1.6	6.9	3.6	5.2	3.3	7.7	3.0	3.2	3.1	3.5	1.8	1.4	0.0	0.7	11.0	3.9	1.3	6.6	3.1	3.8	62.4	2.4	6.6	0.9	2.5	3.3	2.7	13.2	2.4	2.7	2.1	2.8	4.7	3.5	3.5	3.9	0.3	5.3	0.4	6.3	0.3	2.2	4.5	1.6	3.7	3.4	1.8	2.5	3.6	4.5	4.0	1.7	1.1	7.0	2.3	1.4	1.5	4.4	5.2	3.2	3.5	2.2	21.1	8.8	1.3	5.1	3.3	3.6	0.6	1.1	0.3	0.7	4.8	0.4	0.0	0.4	0.3	3.1	0.0	0.4	1.0	0.2	0.9	9.4	0.6	0.1	0.5	12.5	15.5	10.9	16.0	15.1	9.1	14.1	14.4	11.1	15.0	17.9	99.9	7.6	29.3	31.6	17.1	51.3	45.9	20.1	29.6	38.4	51.1	11.5	19.9	30.8	10.5	63.3	49.6	0.0	67.9	5.1	26.6	43.7	27.6	77.0	56.9	9.5	60.0	78.5	68.8	8.2	12.4	58.9	38.8	20.8	43.1	3.8	80.3	63.3	9.2	56.1	27.2	51.8	34.1	16.6	25.4	32.1	6.9	11.5	37.2	27.8
C4orf45	FLJ25371	ENSG00000164123	"Chromosome 4 open reading frame 45"	Q96LM5	4	158893134-159038760	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 16.1"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 290.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;U-2197: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.64e-1)"				"unprognostic (1.14e-1)"			"unprognostic (2.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.45e-2)"		0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.2	0.3	0.2	0.3	0.0	0.3	0.0	0.4	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	290.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	2.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.4	0.0	0.0	6.5	0.0	2.4	2.1	0.0	0.0	0.0	0.0	0.0
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.4;NK-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068798			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA068798: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	16.7	8.0	28.4	8.8	23.8	51.0	16.3	21.5	34.1	12.6	14.5	11.3	10.4	10.9	12.7	7.3	9.9	10.2	14.1	14.9	23.4	15.3	16.4	20.9	18.1	8.5	14.1	29.6	10.2	13.4	20.7	13.8	26.1	16.9	9.3	14.8	10.0	18.7	9.4	15.7	12.7	11.9	14.0	13.9	19.2	13.7	6.7	14.3	9.3	27.5	8.9	7.8	11.9	13.8	0.4	1.4	9.4	1.4	5.2	1.5	0.3	3.3	4.5	21.5	6.6	8.5	9.6	33.1	6.5	8.2	5.9	4.3	13.9	7.4	19.0	2.4	6.4	8.6	3.0	7.3	8.3	7.1	3.2	5.1	29.5	9.5	8.0	6.2	3.5	40.9	5.6	4.7	14.2	5.0	12.6	16.9	7.9	6.5	17.8	7.3	5.9	8.8	0.5	9.1	3.9	4.5	7.3	5.4	0.7	5.3	7.6	6.1	8.2	9.5	4.6	7.9	10.8	2.3	2.4	17.8	9.4	9.9	11.9	5.3	19.9	11.7	0.3	11.1	1.5	5.7	2.7	1.4	1.0	0.8	0.8	1.0	0.4	0.7	0.5	0.8	0.3	0.9	0.4	9.4	5.2	0.9	1.4	1.5	0.3	28.4	23.8	21.5	34.1	23.4	15.3	14.1	29.6	16.9	14.3	53.6	26.7	7.5	10.9	18.1	16.3	32.9	12.7	16.0	17.0	7.0	39.3	9.4	0.0	8.1	4.0	30.0	12.3	46.7	10.8	8.1	15.0	16.7	48.7	25.6	10.1	31.8	13.8	31.9	25.1	3.8	7.2	14.1	32.1	7.2	10.8	29.8	16.9	17.5	8.1	6.4	23.4	51.8	17.8	3.6	6.5	17.6	4.9	7.5	6.4	12.8
FSTL5	"DKFZp566D234, KIAA1263"	ENSG00000168843	"Follistatin like 5"	Q8N475	4	161383897-162164035	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 106.9"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 248.5;Cone photoreceptor cells: 435.9;Rod photoreceptor cells: 131.6"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA							"unprognostic (4.90e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-10)"	"unprognostic (8.45e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-3)"	0.5	12.1	3.5	0.6	6.9	0.5	0.5	106.9	19.9	0.5	0.6	0.6	0.0	0.5	0.5	1.7	0.5	0.6	0.5	0.5	3.2	5.9	0.6	0.5	0.5	0.5	3.0	3.0	0.5	1.0	0.5	1.1	0.7	18.2	0.5	0.8	7.1	0.5	0.6	0.5	0.8	0.6	0.6	3.1	0.5	0.5	1.5	2.9	0.0	0.6	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	5.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.9	106.9	6.9	3.2	5.9	3.0	3.0	18.2	2.9	0.0	0.0	0.0	0.0	0.2	248.5	0.1	0.0	0.0	0.0	0.0	435.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	27.0	0.0	0.0	0.0	1.7	0.6	0.0	1.7	0.0	0.0	18.6	0.1	0.0	0.4	0.0	131.6	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166921	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	13.3	12.3	8.6	9.6	19.8	8.7	11.9	10.7	18.9	12.9	10.6	14.7	6.4	6.2	18.8	8.6	11.0	17.3	10.9	11.7	10.5	7.8	9.5	10.5	10.9	10.7	7.2	9.1	20.1	11.1	15.7	18.7	8.8	10.1	12.0	11.4	13.4	10.4	12.5	36.4	14.3	8.3	12.7	7.4	10.0	11.3	17.2	7.5	12.3	14.0	12.2	12.2	12.5	10.4	2.5	2.4	0.1	1.6	1.2	3.5	1.4	9.1	7.7	10.0	10.2	5.9	9.4	11.7	10.8	7.2	9.5	9.5	8.7	10.9	23.7	3.1	6.6	7.6	7.7	20.2	11.6	12.5	10.4	12.5	25.1	6.9	7.4	10.3	16.2	9.0	8.9	10.4	11.5	9.4	9.9	8.4	7.7	28.1	12.6	12.6	8.9	18.7	9.2	13.0	6.9	7.7	15.6	7.4	12.4	9.4	4.2	10.9	8.2	7.1	13.0	7.7	9.2	7.0	7.1	8.8	11.4	9.8	8.8	12.1	7.9	11.0	18.3	10.8	9.4	11.2	0.0	1.5	0.1	2.2	1.6	0.9	1.9	2.5	3.3	2.4	2.5	3.5	2.3	0.0	1.2	1.5	2.4	0.7	1.4	8.6	19.8	10.7	18.9	10.5	7.8	7.2	9.1	10.1	7.5	6.0	14.7	11.5	15.4	28.7	11.4	3.1	10.2	36.1	7.9	8.7	17.7	12.3	3.3	7.0	37.3	8.5	2.7	0.0	5.9	13.9	10.6	10.3	10.4	4.4	10.8	7.9	18.4	14.1	15.7	16.6	6.4	9.3	8.5	6.4	5.3	9.3	6.7	3.5	4.9	6.9	13.7	32.3	14.4	17.6	14.3	35.9	17.8	10.0	8.4	10.5
NPY1R	NPYR	ENSG00000164128	"Neuropeptide Y receptor Y1"	P25929	4	163323961-163344832	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.2"	"Cell type enhanced"	"Detected in many"	25	"Intestinal endocrine cells: 31.4;Ito cells: 157.8;Sertoli cells: 45.3"	"Cancer enriched"	"Detected in many"	13	"breast cancer: 65.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	18	"HEL: 51.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (7.68e-5)"	"unprognostic (9.14e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	18.0	15.9	5.2	1.5	17.1	0.2	17.5	0.9	11.4	6.2	3.1	0.7	3.9	0.7	5.0	5.4	2.3	4.3	2.4	2.6	7.1	4.2	16.6	8.3	1.2	7.2	1.5	5.8	1.8	14.5	1.1	3.9	2.7	3.5	1.9	2.4	2.0	11.0	4.5	1.5	5.0	0.9	3.1	3.7	55.2	1.2	2.7	6.0	0.0	4.4	1.4	0.6	3.4	3.3	0.5	0.3	1.2	0.4	0.3	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	0.0	2.0	0.7	0.4	1.2	0.5	0.1	0.6	0.4	0.7	0.9	0.0	0.5	0.7	1.2	1.1	0.3	0.2	0.3	0.3	0.0	5.2	17.1	0.9	11.4	7.1	4.2	1.5	5.8	3.5	6.0	0.0	0.3	0.0	0.7	2.5	4.4	0.8	0.0	0.0	0.0	0.0	2.0	0.0	11.6	7.6	3.7	2.4	2.0	0.0	0.0	0.0	1.2	0.4	0.0	0.8	0.1	0.0	31.4	157.8	11.8	2.0	10.6	0.0	5.0	0.0	0.9	0.5	0.2	10.4	0.4	0.0	1.8	45.3	5.1	0.5	0.2	1.5	0.0	0.0	1.3	0.3
NPY5R	NPYR5	ENSG00000164129	"Neuropeptide Y receptor Y5"	Q15761	4	163343939-163351934	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.2;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in single"	21	"Spermatocytes: 1.6"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.5;RPTEC TERT1: 3.5;T-47d: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.63e-6)"		"unprognostic (3.00e-1)"		"unprognostic (2.79e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"			"unprognostic (3.74e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-1)"	10.6	5.7	3.6	1.6	12.2	0.1	3.2	0.3	6.2	1.5	0.7	0.1	0.3	0.2	2.2	1.9	0.6	1.4	1.0	1.3	4.5	3.1	7.8	1.8	0.7	6.6	1.3	4.6	0.5	1.8	0.8	0.6	4.9	2.3	0.5	0.6	1.1	6.1	1.7	0.4	1.4	0.3	1.5	4.2	13.6	0.5	9.1	2.2	0.0	1.3	0.4	0.3	0.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	12.2	0.3	6.2	4.5	3.1	1.3	4.6	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0
TKTL2	"DKFZP434L1717, FLJ32975"	ENSG00000151005	"Transketolase like 2"	Q9H0I9	4	163471093-163473746	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 66.8"	"Group enriched"	"Detected in some"	19	"Early spermatids: 47.2;Late spermatids: 27.7;Spermatocytes: 100.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"			"unprognostic (8.62e-2)"			"unprognostic (2.05e-2)"		"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"		"unprognostic (7.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	100.1	1.6	0.0	0.0	0.0	0.0	0.0
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.1	13.1	7.1	25.3	9.6	10.2	16.0	8.9	11.5	17.5	11.5	8.9	11.8	9.4	18.5	17.7	16.1	12.8	13.5	12.0	8.7	7.4	13.5	16.8	10.2	22.1	7.6	8.8	16.0	19.3	7.2	12.4	12.6	9.9	11.6	11.0	8.8	16.9	12.2	17.2	15.1	9.8	13.1	11.1	21.1	13.0	30.0	8.5	28.2	10.6	15.0	18.3	15.6	13.5	21.4	28.2	3.3	21.9	13.5	14.0	7.4	15.7	8.3	13.4	12.2	5.6	9.6	13.8	18.5	9.3	10.1	8.6	8.0	21.6	35.0	7.7	9.8	8.3	8.0	15.6	13.2	12.8	18.0	13.4	48.8	7.9	12.7	12.4	38.5	15.2	6.2	12.0	8.5	10.7	8.4	11.0	11.3	17.1	25.7	11.0	14.2	23.1	20.0	14.9	8.6	12.2	22.1	12.7	22.1	8.0	7.8	7.8	11.5	11.7	15.7	13.8	8.9	9.4	15.0	19.3	8.1	15.3	7.7	19.5	18.7	24.0	40.7	16.0	20.5	24.2	3.3	14.5	1.3	7.7	21.9	11.4	21.4	14.0	9.9	16.5	19.9	13.2	11.1	0.5	13.5	17.7	28.2	11.5	7.4	7.1	9.6	8.9	11.5	8.7	7.4	7.6	8.8	9.9	8.5	20.8	28.2	49.6	29.7	29.2	13.2	32.7	50.9	14.7	27.3	31.4	3.9	47.8	54.7	39.8	141.5	25.9	10.6	23.3	60.9	76.4	30.6	17.5	27.8	47.0	32.6	14.3	29.3	38.6	33.4	132.5	51.5	37.8	25.3	35.1	34.4	14.7	45.8	28.1	30.1	37.2	13.4	38.8	30.6	59.7	38.5	34.6	25.5	21.7	37.6	23.0
MARCH1	"FLJ20668, MARCH-I, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 128.6;Cone photoreceptor cells: 184.6;Kupffer cells: 192.5;Macrophages: 105.3;Rod photoreceptor cells: 172.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	95	"classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.6;U-266/70: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014600	Uncertain					NA	NA					"HPA014600: AB_1853573"	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	7.7	4.2	11.6	20.5	19.7	3.9	4.0	3.1	14.5	3.7	3.9	8.5	0.1	4.4	3.9	4.6	3.6	4.2	5.9	2.6	12.6	10.1	3.0	4.5	8.3	28.5	17.3	6.3	4.2	4.1	1.5	4.1	10.2	13.5	3.5	5.1	2.4	4.6	1.8	1.6	4.9	9.0	6.5	24.4	32.4	4.1	2.3	17.9	2.6	3.2	1.4	24.6	9.0	4.2	18.5	18.1	9.9	17.2	0.1	0.0	6.6	0.8	0.7	2.9	1.7	0.0	0.0	1.9	1.2	0.1	0.0	0.0	1.6	3.3	9.6	3.6	0.0	0.4	1.4	0.0	0.0	0.0	1.0	1.0	6.8	3.7	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.2	4.0	0.0	1.9	2.5	5.0	3.3	1.0	2.3	2.6	3.6	0.3	1.3	2.7	0.5	0.7	0.1	1.6	1.5	1.3	0.9	1.5	0.5	2.2	4.0	0.7	3.1	1.1	2.0	0.7	2.3	9.8	3.3	2.7	1.4	2.1	1.5	0.0	16.8	9.9	0.0	17.0	0.0	18.5	0.0	0.0	18.1	15.7	0.0	0.0	0.1	0.1	17.2	6.8	0.0	6.6	11.6	19.7	3.1	12.5	12.6	10.1	17.3	6.3	13.5	17.9	0.0	2.7	128.6	0.0	1.5	24.7	2.4	0.0	1.4	4.5	3.5	184.6	0.3	0.0	0.0	4.6	1.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.9	43.0	11.1	0.0	3.1	192.5	1.7	0.0	105.3	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	172.3	12.9	0.0	0.6	1.5	0.9	0.7	0.8	0.0	0.0
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"		4	164754064-164803795	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	4	"intestine: 42.7"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 81.2;Pancreatic endocrine cells: 87.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 3.3;RPTEC TERT1: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"	NA	NA						"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.0	0.0	0.1	4.0	0.0	0.2	0.6	0.0	0.0	3.1	25.4	0.0	0.0	13.7	0.7	0.2	0.1	0.0	6.9	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	9.8	9.8	0.0	2.1	0.0	0.0	0.0	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.1	1.4	3.1	0.5	1.3	0.5	0.0	0.4	3.3	0.2	0.8	0.2	0.4	0.9	0.3	0.1	0.3	0.3	1.2	0.4	0.6	0.3	0.2	0.2	0.8	0.1	0.4	0.1	0.3	0.4	0.1	0.4	0.3	0.4	0.6	0.9	0.3	0.3	0.2	0.2	0.1	0.0	0.5	0.5	1.5	0.0	0.6	0.4	1.4	0.4	1.7	0.1	0.6	0.2	1.4	4.5	0.6	0.5	0.2	0.4	0.5	0.6	0.5	0.4	0.7	0.4	0.5	0.2	0.8	0.5	1.8	0.4	0.7	0.8	0.7	1.2	3.1	0.5	0.6	0.4	0.3	0.4	0.4	0.4	0.4	0.2	1.1	0.5	0.5	2.8	1.3	0.4	1.4	0.3	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.7	17.0	3.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	81.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877004-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.8;prostate: 8.2"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 22.2;Syncytiotrophoblasts: 34.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NTERA-2: 27.8;SuSa: 17.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.1	0.0	0.2	2.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0		3.9	0.0	1.5	0.1	0.0	2.2	0.7	0.0	0.0	0.0	7.8	0.0	8.2	0.0	0.0	1.9	0.0	0.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.6	0.6	2.5	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	2.5	0.3	0.0	0.6	0.2	0.0											0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	22.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 16.1;thyroid gland: 15.5"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 14.4;Late spermatids: 9.0;Spermatocytes: 18.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HHSteC: 9.7;HSkMC: 6.5;hTERT-RPE1: 5.2;SuSa: 6.9;U-266/70: 12.9;U-266/84: 6.5"									HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.4	5.4	1.8	3.0	2.5	3.3	1.6	1.3	2.1	2.6	1.4	1.1	7.2	2.2	2.8	1.9	0.8	3.5	3.1	5.9	2.4	3.0	1.0	1.1	2.1	2.9	2.7	1.3	5.8	0.9	1.5	6.8	1.8	3.8	2.1	1.1	2.9	0.9	1.9	1.2	1.1	1.7	2.1	4.2	4.7	1.5	16.1	1.6	2.7	15.5	0.7	2.8	3.0	5.2	5.5	5.1	3.6	1.3	7.8	4.1	1.5	0.2	0.4	0.9	0.8	0.6	0.6	0.6	2.4	0.8	0.0	0.0	0.3	0.3	0.7	0.2	3.5	0.2	0.3	0.6	0.6	0.4	0.4	0.5	0.2	0.5	0.7	9.7	0.5	0.6	6.5	0.5	2.1	0.2	5.2	0.2	0.3	0.5	1.4	0.3	0.4	0.3	0.7	3.8	0.0	0.0	0.5	0.2	1.0	0.3	0.9	0.8	0.5	0.1	0.3	0.4	6.9	0.3	0.3	0.7	1.2	0.4	0.1	0.2	12.9	6.5	0.4	0.3	0.2	0.3	3.6	1.3	0.1	3.3	1.1	3.4	3.6	1.6	3.3	1.5	5.5	4.1	4.0	0.5	7.8	0.8	5.1	0.4	1.5	1.8	2.5	1.3	2.1	2.4	3.0	2.7	1.3	3.8	1.6	0.0	3.5	2.2	0.6	0.2	0.7	1.7	0.0	0.0	0.0	3.5	3.9	0.1	0.0	0.3	14.4	0.3	0.0	0.0	0.6	0.0	0.7	0.3	0.0	0.4	1.0	1.6	0.0	0.0	0.6	9.0	1.1	0.3	0.0	2.8	0.0	2.8	0.1	0.0	1.4	2.5	0.3	0.0	0.3	18.1	3.4	0.0	0.2	2.9	0.0	0.5
FAM218A	"C4orf39, FLJ31659"	ENSG00000250486	"Family with sequence similarity 218 member A"	Q96MZ4	4	164956948-164959122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Muller glia cells: 6.3;Rod photoreceptor cells: 9.0;Spermatocytes: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.3;SCLC-21H: 8.4"															NA	NA						"unprognostic (1.94e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.28e-4)"	"unprognostic (8.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.16e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (7.25e-2)"	1.2	3.2	5.9	1.5	12.1	0.5	4.5	7.2	6.5	2.4	1.7	8.6	2.0	1.2	2.6	7.3	1.5	3.5	1.2	1.9	6.2	5.7	3.2	0.5	2.5	2.2	9.0	7.3	5.8	2.3	3.7	6.6	2.3	7.3	6.7	2.0	2.7	1.7	2.6	1.5	2.6	1.4	2.0	5.6	1.7	1.3	8.8	9.4	0.9	7.6	0.0	2.3	1.6	1.3	3.1	1.1	0.0	0.7	1.2	2.5	0.6	0.0	0.1	2.1	0.0	0.0	0.0	0.2	0.9	0.0	0.5	0.2	0.0	0.0	1.4	0.3	0.6	3.0	0.5	0.0	2.3	0.2	0.0	1.4	0.0	0.0	0.0	1.5	0.0	0.0	2.1	0.0	0.3	1.4	2.4	0.1	0.0	0.0	2.4	4.3	3.4	0.0	0.0	1.9	0.0	1.0	0.0	0.0	0.1	0.3	0.0	8.4	0.0	0.0	0.7	0.2	2.1	0.0	0.0	0.0	0.0	2.6	0.4	0.2	2.9	3.4	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.5	0.0	1.8	1.9	1.2	1.9	0.3	3.1	2.5	1.9	0.0	1.2	0.7	1.1	2.3	0.6	5.9	12.1	7.2	6.3	6.2	5.7	9.0	7.3	7.3	9.4	0.0	0.6	0.0	1.7	0.3	6.4	2.3	0.0	1.4	4.5	3.5	5.9	0.9	0.0	0.6	1.3	0.0	0.0	0.0	0.6	0.7	1.1	0.2	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.4	6.3	0.1	0.0	1.4	1.0	9.0	0.0	1.2	10.6	3.4	0.4	0.6	0.0	0.5	0.1
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165031953-165041744	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"placenta: 5.0;testis: 6.6"	"Cell type enhanced"	"Detected in some"	11	"Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"BEWO: 18.0"	"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540"															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	1.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.1	0.2	1.1	0.2	0.3	0.0	0.5	0.3	0.2	1.1	0.1	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.5	0.0	1.4	0.0	0.0	0.0	4.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	8.2	0.2	0.2	0.0	0.8	0.4	0.0	0.0	0.0	2.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.3	0.0	0.0	3.8	6.4	0.3	4.7	0.5	0.0	0.0
TRIM75P	TRIM75	ENSG00000250374	"Tripartite motif containing 75, pseudogene"	A6NK02	4	165059148-165060554	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"placenta: 1.8;testis: 1.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	8	"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"BEWO: 7.0"															NA	NA										"unprognostic (8.51e-2)"					"unprognostic (2.81e-2)"			"unprognostic (1.94e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.78e-2)"			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2			0.4	0.0	0.0		1.8		0.0	0.0		0.0	0.0	0.2	0.2	0.0	0.0		0.0	0.0	1.2			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.6	14.4	11.3	7.4	13.6	5.3	12.1	12.0	11.9	11.6	9.7	10.5	6.2	8.3	9.7	10.0	7.8	10.1	8.9	10.4	9.9	9.4	40.7	37.7	9.1	8.5	13.0	10.6	21.8	21.3	20.3	14.2	9.3	13.1	19.4	11.7	24.7	11.3	7.8	19.0	7.4	8.2	8.6	13.3	10.8	10.5	8.6	11.3	3.1	22.9	5.2	6.6	12.1	7.3	18.2	12.0	3.4	12.5	13.4	12.8	7.7	6.3	9.6	3.5	8.8	9.1	3.2	8.1	9.7	14.3	10.1	11.3	5.6	10.5	14.0	5.8	6.2	16.5	5.7	13.0	9.9	11.7	9.0	6.7	7.8	7.2	6.3	23.3	19.1	10.5	11.7	21.2	9.1	18.6	8.8	8.2	7.6	13.2	23.6	12.4	13.8	3.3	5.6	7.3	13.3	8.3	7.5	3.0	12.7	8.2	9.4	7.5	7.8	15.1	24.1	15.3	5.4	11.7	8.8	6.1	4.5	5.5	14.0	10.9	23.2	30.6	19.5	10.7	10.6	17.8	2.0	12.5	3.4	9.7	10.9	12.8	18.2	7.5	9.9	11.6	15.2	8.3	10.0	1.4	13.4	5.8	12.0	6.0	7.7	11.3	13.6	12.0	11.9	9.9	9.4	13.0	10.6	13.1	11.3	29.8	33.4	17.1	16.9	8.7	34.9	28.7	48.4	12.0	22.7	52.4	15.7	23.8	10.0	18.4	13.5	19.6	13.2	0.0	22.3	16.3	19.5	28.7	38.3	68.1	32.6	35.0	20.8	27.0	24.1	7.5	36.8	24.0	27.0	9.0	15.9	31.7	12.7	14.0	31.5	49.7	25.3	6.5	13.2	13.1	11.9	11.3	28.1	19.8	22.9	12.3
KLHL2	MAV	ENSG00000109466	"Kelch like family member 2"	O95198	4	165207618-165323156	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.6"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 10.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051637			Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA051637: "	"unprognostic (1.14e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.67e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.81e-1)"	10.5	11.2	25.1	10.4	36.0	16.4	12.1	9.7	41.6	6.1	5.8	19.6	4.0	5.0	7.0	13.4	15.8	8.9	9.5	5.0	37.2	17.7	13.3	23.8	10.6	9.4	25.7	14.7	3.8	6.6	5.3	18.4	6.9	15.1	7.8	6.5	4.0	16.3	9.7	3.2	4.7	5.6	9.6	25.7	11.1	7.4	5.4	25.0	1.6	11.3	3.4	8.4	10.9	7.2	1.3	1.2	10.8	1.9	0.3	1.6	0.6	8.7	8.1	5.6	5.8	8.7	7.8	6.0	11.9	9.4	6.2	6.7	4.8	6.6	9.1	3.0	6.0	11.0	6.1	9.1	6.3	8.0	14.8	3.5	7.6	7.2	7.5	7.6	7.8	11.1	6.5	18.0	5.6	21.2	10.9	14.8	3.4	3.4	19.2	9.5	3.3	0.2	2.5	3.4	5.0	3.6	3.1	4.2	2.8	11.3	8.5	28.8	4.8	7.5	2.7	7.2	10.9	1.8	8.9	20.4	4.9	10.1	5.6	8.0	12.5	8.7	7.3	6.0	5.6	9.6	1.9	1.4	1.9	0.8	1.4	0.5	0.4	0.6	0.5	1.2	1.3	1.4	1.6	10.8	0.3	1.9	0.7	0.7	0.6	25.1	36.0	9.7	24.7	37.2	17.7	25.7	14.7	15.1	25.0	6.0	14.1	5.6	11.1	5.4	8.3	4.0	7.6	5.3	7.9	21.0	13.7	3.5	23.2	6.7	1.1	13.4	4.1	0.0	11.3	8.3	5.4	10.1	9.2	30.8	7.4	30.2	14.9	17.2	40.5	1.3	3.7	20.7	5.0	4.6	4.7	3.2	8.8	4.8	4.2	14.7	6.4	0.0	6.8	2.1	7.1	6.6	3.1	7.0	3.1	16.1
GK3P	"GKP3, GKTB"	ENSG00000229894	"Glycerol kinase 3 pseudogene"	Q14409	4	165277812-165279679	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.0"	"Cell type enriched"	"Detected in single"	17	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in single"		"TIME: 1.1"									HPA060687	Uncertain					NA	NA					"HPA060687: AB_2684343"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.19e-2)"			"unprognostic (6.99e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.56e-1)"	"unprognostic (3.34e-4)"	0.0	0.0		0.0		0.4	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	17.0			0.0		0.0	0.0		0.0	0.1	2.9	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327623-165343160	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 171.6"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 234.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 69.5;Karpas-707: 68.2;RPTEC TERT1: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056127	Enhanced					NA	NA					"HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	5.0	26.5	17.1	6.7	23.7	3.5	21.5	7.7	29.6	15.6	12.6	22.8	4.0	22.6	6.1	31.5	44.9	7.1	7.4	5.8	18.8	20.8	16.3	171.6	30.0	6.4	13.1	18.6	18.0	7.5	10.9	7.0	7.4	41.1	19.1	10.8	12.1	10.6	4.7	2.2	22.5	20.7	5.7	33.5	4.3	10.3	15.8	12.5	4.3	7.5	17.6	12.9	8.6	17.7	21.2	10.1	6.2	9.8	12.1	20.8	15.8	14.0	3.4	33.1	6.0	16.4	52.8	6.2	5.7	25.9	7.4	20.5	6.6	60.4	7.0	3.4	6.9	69.5	11.6	16.6	59.9	8.2	5.9	10.2	3.1	3.6	20.3	33.1	5.6	4.4	32.6	39.4	27.1	16.8	10.1	9.5	9.1	5.5	68.2	12.1	7.2	5.0	9.2	19.0	7.4	3.4	2.6	3.6	21.0	65.8	16.5	6.6	4.9	8.9	12.7	5.3	21.2	5.9	7.1	10.9	3.4	6.1	3.0	3.9	12.6	13.2	9.2	7.3	5.7	4.6	6.2	4.6	4.5	19.0	5.9	14.2	21.2	18.3	17.6	7.8	18.9	20.0	20.8	3.4	12.1	9.8	10.1	15.8	15.8	17.1	23.7	7.7	29.6	18.8	20.8	13.1	18.6	41.1	12.5	47.6	144.4	35.8	51.9	32.1	27.2	5.8	45.9	68.3	60.3	66.3	25.5	47.4	29.9	52.5	2.8	17.5	70.9	0.0	62.6	72.4	27.9	84.9	48.3	234.0	24.0	33.4	58.1	29.4	29.7	4.5	23.0	15.0	30.4	36.1	42.1	22.3	58.7	24.6	17.7	36.0	46.7	19.4	20.2	7.4	14.4	100.6	102.9	22.4	21.1	123.4
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498320	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 203.7"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		470000	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	27.7	33.8	123.1	4.4	135.5	0.9	21.5	82.9	203.7	10.7	9.6	31.6	5.3	5.0	13.3	94.3	16.4	15.7	14.0	19.6	116.9	56.3	12.0	6.3	11.0	7.6	56.9	70.7	23.4	35.5	33.9	40.0	2.2	53.0	66.5	8.8	13.2	12.0	20.1	11.0	5.5	6.2	18.5	40.5	2.8	19.2	30.4	53.3	0.9	40.7	4.3	7.7	6.3	9.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	8.9	1.7	7.1	0.7	0.4	0.0	3.6	1.3	2.9	0.0	0.0	0.0	2.6	0.0	0.3	0.2	3.4	0.7	0.7	0.0	13.0	0.0	3.6	49.0	0.5	0.0	0.0	17.3	3.6	0.0	0.0	17.2	0.0	0.0	0.0	0.3	1.8	2.4	0.0	0.4	5.6	0.0	2.0	0.0	0.0	0.1	0.1	0.5	69.0	22.8	101.3	12.7	0.0	59.1	7.6	0.3	0.0	2.7	7.0	0.2	0.2	3.9	0.0	0.3	2.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	123.1	135.5	82.9	82.2	116.9	56.3	56.9	70.7	53.0	53.3	0.0	9.3	0.0	67.8	23.2	533.2	32.3	40.8	0.0	3.4	21.0	585.1	0.4	0.0	15.1	5.5	57.1	1.6	0.0	1.5	0.1	129.4	402.2	0.0	7.9	0.8	66.7	564.2	115.4	9.2	11.5	463.7	12.5	82.7	1.8	12.7	511.1	19.3	2.9	583.8	9.6	443.0	840.8	614.9	17.7	9.6	18.2	0.7	1.9	3.7	11.3
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.6	1.5	0.0	1.8	0.0	1.4	0.0	0.0	13.6	0.0	0.0	0.0	0.2	1.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1	0.0	1.1	0.0	0.2	1.5	15.1	4.1	0.0	1.4	1.2	0.0	0.0	3.9	0.0	1.5	0.0	11.3	0.0	0.0	1.9	0.9	1.6	0.8	0.0	0.0	0.2	7.9	0.0	1.8	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	4.2	0.8	0.5	0.0	0.3	0.1	0.0	1.5	1.6	0.0	0.0	0.1
SPOCK3	testican-3	ENSG00000196104	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3"	Q9BQ16	4	166733384-167234796	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.8;parathyroid gland: 184.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 45.8;Ciliated cells: 12.0;Club cells: 18.2;Early spermatids: 12.6;Horizontal cells: 14.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.3;intermediate monocyte: 1.8;myeloid DC: 4.5;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.5;monocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;hTERT-RPE1: 9.9;PC-3: 3.9;RH-30: 10.4;SCLC-21H: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (3.54e-2)"	"unprognostic (8.69e-2)"		"unprognostic (2.90e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.09e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-4)"	"unprognostic (8.92e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.64e-1)"	1.2	10.0	21.7	1.3	30.4	1.1	1.1	5.8	23.2	1.4	1.4	32.2	2.2	1.4	2.2	8.0	1.2	1.5	1.2	1.2	31.3	21.4	1.2	1.2	1.2	1.2	45.4	15.9	7.8	1.3	184.6	0.3	1.1	27.4	28.1	1.3	0.0	1.2	14.1	1.2	1.1	1.6	2.1	46.8	1.2	1.4	1.3	42.9	0.0	1.1	0.9	1.2	1.9	0.3	0.0	4.5	0.0	3.3	0.3	0.0	1.1	0.0	2.4	0.3	0.0	0.0	0.0	0.4	0.0	3.2	0.1	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.1	0.6	0.2	0.3	0.0	1.6	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	9.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	0.0	3.9	0.0	10.4	0.6	0.0	1.5	4.5	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	3.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	1.1	21.7	30.4	5.8	22.8	31.3	21.4	45.4	15.9	27.4	42.9	0.0	0.0	0.0	1.1	0.0	45.8	0.9	0.0	12.0	18.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.1	0.0	4.0	1.1	0.0	0.1	14.3	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.4	0.0	5.1	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.6
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092515-168187690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 33.5;stomach 1: 105.3"	"Group enriched"	"Detected in some"	14	"Exocrine glandular cells: 153.7;Hepatocytes: 62.3;Pancreatic endocrine cells: 198.3"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 72.5;PC-3: 32.8;RT4: 44.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005469, HPA074650"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849, HPA074650: "	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favorable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.4	0.1	4.2	0.1	0.1	0.5	0.0	33.5	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	105.3	0.1	0.1	0.1	0.1	0.1	0.1	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	32.8	0.0	0.1	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	10.2	0.0	2.3	0.0	2.0	0.0	0.0	3.5	7.3	0.0	0.0	0.0	153.7	0.0	0.0	0.6	0.0	62.3	0.0	0.0	0.0	1.3	2.7	0.0	0.0	0.0	0.0	1.0	0.4	0.0	198.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216293-168318807	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 22.8;BJ hTERT+ SV40 Large T+ RasG12V: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	18.0	8.3	4.1	18.5	5.0	4.4	9.0	1.3	3.8	11.4	14.8	4.3	5.1	8.8	10.8	15.2	10.7	8.1	11.5	8.5	3.7	3.5	10.0	8.8	21.6	18.7	4.2	3.2	20.3	5.5	8.8	6.7	25.5	5.6	11.6	14.3	9.0	15.6	6.2	5.6	7.9	16.7	11.2	6.1	18.9	29.2	5.7	3.9	23.2	14.5	6.0	9.3	8.2	7.2	4.1	2.5	3.2	6.3	7.6	10.0	3.5	5.6	1.2	2.8	1.1	2.1	7.8	3.2	1.9	13.7	22.8	22.1	0.0	12.4	0.0	1.1	3.0	10.5	4.7	0.3	4.5	6.6	4.3	0.6	8.8	4.8	0.0	10.3	3.3	2.2	7.0	2.0	5.8	1.3	5.5	8.5	4.2	0.0	1.7	2.8	0.3	5.0	2.4	0.5	0.8	1.6	3.4	1.5	0.1	6.7	3.4	0.6	0.6	3.6	1.0	13.7	0.2	0.9	4.2	5.6	1.4	1.5	0.5	1.4	1.0	0.2	0.0	4.3	3.8	4.0	3.2	2.8	2.6	8.5	5.1	10.0	4.1	6.7	8.0	2.5	3.3	6.8	8.5	2.8	7.6	6.3	0.2	5.5	3.5	4.1	5.0	1.3	3.8	3.7	3.5	4.2	3.2	5.6	3.9	32.8	6.2	5.0	4.0	3.8	0.7	7.1	10.2	14.7	12.5	12.2	0.0	6.4	5.0	7.0	1.7	10.3	10.7	0.0	5.9	8.5	5.0	3.8	26.5	3.8	5.8	0.0	2.9	15.4	4.1	1.4	7.5	8.8	3.3	0.0	13.6	8.0	8.7	7.2	8.9	3.3	3.0	6.5	3.8	0.9	0.7	2.4	2.4	10.1	5.8	3.1
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 22.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 23.3"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	12.7	5.0	2.8	13.1	3.1	33.0	9.9	1.4	3.2	7.2	8.4	3.2	2.7	6.0	9.2	7.9	3.8	6.9	6.7	6.0	2.4	2.4	4.5	6.0	25.8	17.7	3.8	1.4	7.3	5.1	4.4	5.2	32.6	3.4	5.0	6.5	6.8	7.0	5.7	3.3	4.3	14.0	5.3	4.2	11.9	9.5	2.7	3.1	25.3	5.8	3.5	8.1	4.9	6.8	1.6	2.4	22.5	7.8	1.7	3.7	1.6	6.1	3.6	1.4	0.6	3.7	10.8	7.0	6.2	13.1	23.3	16.2	0.0	14.5	0.1	0.3	6.3	12.7	2.4	0.6	3.7	6.8	3.5	0.5	13.6	4.0	0.3	4.5	5.5	3.4	3.0	1.1	8.4	0.7	4.9	16.4	3.1	0.2	0.1	14.9	0.1	4.9	3.5	0.3	0.6	3.1	2.7	3.2	0.0	2.2	3.6	0.2	1.9	11.0	1.3	6.2	0.2	1.0	7.8	17.5	1.2	8.2	2.9	2.1	5.9	0.9	0.0	4.1	16.5	1.8	1.6	4.0	3.5	2.7	6.3	3.7	0.9	2.7	2.7	2.4	1.6	2.2	2.3	22.5	1.7	7.8	0.0	3.6	1.6	2.8	3.1	1.4	3.2	2.4	2.4	3.8	1.4	3.4	3.1	8.9	7.9	0.0	2.1	0.9	1.3	8.1	5.1	12.0	3.4	3.5	21.6	4.5	0.0	6.8	10.7	13.1	11.6	0.0	8.7	29.4	7.0	2.6	8.1	5.4	22.5	0.0	0.0	9.2	23.2	3.6	3.1	29.7	0.0	26.2	13.2	3.2	17.0	14.0	3.9	3.3	16.8	6.5	3.3	0.5	1.3	2.0	5.9	8.7	3.8	1.4
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497066-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 203.3"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 352.0;Cardiomyocytes: 495.5;Peritubular cells: 375.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		No	No			"Plasma membrane, Actin filaments"	Cytosol	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.28e-4)"	17.3	8.9	8.5	19.6	7.5	0.1	28.1	2.1	6.7	58.4	71.9	5.7	46.4	6.7	82.2	25.6	84.3	31.3	30.8	95.0	9.2	3.2	12.7	3.6	24.9	17.0	4.6	4.7	28.0	3.0	25.6	3.9	14.0	6.0	71.4	17.9	9.2	11.4	50.9	30.5	8.9	16.8	203.3	6.7	25.8	31.4	14.1	6.9	2.2	12.7	17.2	5.8	140.3	82.7	0.2	2.2	13.6	3.2	0.6	5.1	1.5	17.7	8.7	19.5	12.0	17.9	19.6	27.3	12.1	30.5	10.7	15.2	0.2	1.0	7.7	3.1	5.2	6.5	3.7	11.8	30.8	13.7	16.0	3.6	0.1	25.2	2.2	31.4	0.0	0.2	29.7	19.3	19.1	28.7	25.8	4.5	4.4	0.0	0.1	64.5	0.8	5.1	0.3	5.6	4.5	5.2	1.7	18.0	0.1	1.2	3.5	2.0	10.5	22.8	1.7	1.6	35.4	10.8	0.1	14.5	11.2	42.5	4.7	19.7	10.9	0.1	0.3	9.4	0.2	3.1	13.6	3.2	0.0	5.1	1.9	0.2	0.1	0.6	2.7	2.2	0.2	0.6	2.0	0.8	0.6	1.2	0.2	0.5	1.5	8.5	7.5	2.1	6.7	9.2	3.2	4.6	4.7	6.0	6.9	29.8	10.3	2.4	352.0	83.1	5.7	495.5	28.1	104.4	76.2	41.8	17.7	42.5	1.7	24.0	99.1	28.5	10.3	0.0	44.7	98.6	137.0	124.3	50.8	12.3	21.9	25.4	42.9	68.7	21.6	111.6	120.6	22.6	21.9	88.4	27.7	54.5	57.6	17.3	375.5	14.4	3.4	174.6	188.1	18.6	3.9	43.2	18.7	4.5	24.8	88.9
CBR4	"FLJ14431, SDR45C1"	ENSG00000145439	"Carbonyl reductase 4"	Q8N4T8	4	168863770-169010275	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037499	Supported					NA	NA		33000			"HPA037499: AB_10672386"	"unprognostic (1.60e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.64e-14)"	"unprognostic (1.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.38e-3)"	9.9	15.0	13.8	8.8	13.7	6.2	14.7	18.1	18.7	10.5	12.3	14.0	14.2	12.8	10.8	21.4	11.9	10.0	8.6	17.3	13.8	14.7	27.6	48.1	7.7	10.3	15.9	18.0	13.9	13.4	12.7	27.1	8.5	16.6	12.6	14.6	13.6	13.3	17.1	15.8	15.7	11.8	12.4	16.7	10.6	10.9	14.4	13.6	9.7	16.1	10.6	11.5	12.0	10.1	11.6	7.0	9.0	7.3	8.3	10.3	3.1	6.0	4.6	14.2	8.9	12.4	14.8	2.9	4.4	6.0	5.3	4.9	5.4	6.5	12.5	2.4	3.3	5.0	6.6	13.1	13.9	5.8	4.7	6.5	21.9	10.8	7.2	7.5	8.6	7.8	9.6	12.1	3.8	6.5	12.7	15.6	10.6	11.8	10.1	8.4	3.1	8.9	14.1	5.1	4.2	7.0	7.8	5.0	5.3	18.7	6.4	12.6	9.5	5.3	7.6	11.3	12.4	8.2	5.6	9.2	5.6	3.0	6.2	4.4	10.1	6.7	6.0	9.7	10.6	3.4	8.6	6.1	9.0	10.3	5.3	6.2	8.5	7.1	10.0	5.2	11.6	8.0	10.2	4.6	8.3	7.3	7.0	5.9	3.1	13.8	13.7	18.1	18.7	13.8	14.7	15.9	18.0	16.6	13.6	0.0	6.5	22.4	28.5	20.5	34.4	26.0	28.1	10.7	9.1	47.1	37.3	35.3	43.1	51.8	12.8	15.2	25.9	46.7	36.9	21.5	17.7	26.4	2.3	66.8	22.0	58.8	28.2	18.4	25.1	19.4	41.1	19.0	33.7	21.6	21.3	37.5	33.5	28.5	29.4	68.1	45.4	58.2	15.1	50.2	34.3	17.7	16.9	25.5	23.4	19.4
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.1	5.6	16.1	6.0	7.6	7.2	20.5	9.9	15.2	7.1	6.1	8.9	0.0	1.0	21.2	4.1	4.9	4.5	8.0	16.9	0.0	2.6	4.3	14.0	3.2	13.7	1.5	0.1	4.5	4.4	13.0	10.4	19.4	9.4	1.6	0.0	0.0	14.1	3.0	1.5	1.4	2.8	9.5	5.3	2.2	1.8	0.3	7.0	5.8	4.2	5.1	5.1	8.0	2.0	2.5	2.6	0.6	8.4	7.2	5.6	12.0	7.2	0.5	0.0	0.0	8.2	1.5	8.6	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3	59.6	33.6	6.2	32.4	30.5	2.1	5.2	45.9	34.8	45.5	26.2	0.0	9.8	10.0	35.2	4.4	11.2	52.9	0.0	55.1	19.0	14.9	71.6	10.3	7.6	6.5	0.0	30.1	8.6	6.5	3.1	11.2	7.5	3.3	1.8	26.8	11.3	54.5	27.9	11.3	13.3	0.9	64.7	42.1	2.3	7.5	11.0	11.0	0.0	28.8	55.9
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 85.6;Early spermatids: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	9.6	10.5	13.5	9.2	15.8	6.0	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8.0	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16.0	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8.0	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10.0	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.8	7.8	8.4	12.1	13.5	2.5	8.9	8.0	7.2	6.8	2.4	5.0	11.3	1.7	7.8	6.9	1.4	7.3	7.6	8.2	12.4	5.0	7.6	7.7	2.9	7.1	7.6	6.1	10.8	4.3	7.3	12.8	14.7	7.0	10.9	13.4	21.5	9.2	2.7	9.8	3.4	2.5	2.7	4.5	6.1	5.1	3.6	7.6	5.0	8.5	9.7	6.5	3.2	6.0	6.2	4.0	3.4	8.4	4.6	4.2	4.7	6.0	8.7	13.3	8.6	7.6	3.8	8.0	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16.0	14.8	11.9	13.1	13.3	12.5	8.5	20.5	31.9	0.0	85.6	22.7	17.4	27.5	17.5	14.9	8.5	83.6	9.0	5.4	23.3	5.5	6.7	16.2	7.0	17.4	6.6	9.1	17.5	6.9	8.6	6.9	39.7	21.9	8.9	5.0	2.8	5.0	23.4	6.9	4.2	29.7	8.1	24.4	12.9	18.6	59.1	27.4	5.5	24.7	8.6	6.8	9.5
CLCN3	"ClC-3, CLC3"	ENSG00000109572	"Chloride voltage-gated channel 3"	P51790	4	169612633-169723673	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044723	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA044723: AB_10959733"	"unprognostic (1.92e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.49e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.38e-3)"	11.6	21.1	27.6	10.9	29.9	5.9	18.4	24.9	37.7	15.0	26.7	32.4	15.5	17.1	11.1	17.7	26.6	15.6	22.0	19.6	29.3	29.7	22.2	14.7	11.9	9.0	32.7	22.7	14.0	23.4	29.4	38.7	14.5	36.1	19.5	30.8	20.6	48.5	13.5	14.6	18.0	16.5	10.4	46.1	9.0	23.2	18.4	25.4	10.8	21.7	18.4	13.5	20.5	16.7	8.6	11.9	6.2	8.1	6.9	11.5	7.9	11.4	11.9	17.8	22.6	36.3	30.5	8.7	15.4	19.3	10.4	12.7	8.4	26.0	14.1	9.6	12.8	12.0	9.8	22.1	9.5	17.5	12.5	8.6	11.9	19.3	9.6	24.7	14.2	19.9	21.2	21.9	18.5	18.3	43.3	18.7	19.7	29.3	32.5	18.4	4.1	19.4	3.3	7.3	19.8	8.1	8.7	7.9	11.0	21.7	23.7	19.3	19.0	13.7	15.0	24.1	15.3	10.2	6.7	15.8	8.4	9.4	13.4	11.9	14.4	21.7	12.6	25.1	5.4	22.0	6.2	6.5	4.7	9.0	8.1	11.5	8.6	6.7	8.2	9.5	7.4	10.4	9.2	5.3	6.9	6.5	11.9	8.1	7.9	27.6	29.9	24.9	36.8	29.3	29.7	32.7	22.7	36.1	25.4	29.8	22.1	14.3	22.7	10.1	84.1	61.8	45.9	71.0	13.6	59.3	123.7	19.6	6.6	32.1	76.3	24.8	82.7	23.3	38.3	14.8	13.8	65.9	112.9	33.3	15.9	57.2	64.2	33.7	32.6	56.4	22.7	13.3	30.4	7.2	61.7	156.2	31.4	48.2	19.8	15.9	109.5	6.5	19.6	16.9	16.4	22.8	59.5	16.0	47.2	30.6
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729465-169757953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 58.5;Distal tubular cells: 77.9;Extravillous trophoblasts: 50.1;Hofbauer cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	16.5	18.6	27.3	14.9	26.3	13.7	20.9	22.9	31.7	17.6	17.5	17.6	10.0	11.5	23.2	25.2	17.2	16.9	12.7	20.9	27.3	24.0	17.5	20.8	13.5	18.0	24.9	22.6	23.1	13.1	13.9	22.9	16.0	33.4	17.4	17.6	15.1	12.2	16.0	17.4	18.6	11.3	24.2	23.8	16.4	14.0	12.9	19.8	20.8	18.5	14.9	19.3	19.0	14.8	13.6	15.6	12.8	14.1	14.9	22.2	13.3	12.6	8.0	28.0	14.7	17.1	21.3	11.9	23.1	22.9	28.8	30.6	5.4	13.7	6.6	6.2	15.0	21.1	5.7	19.2	16.8	30.6	20.7	13.1	21.6	11.8	7.7	12.1	18.2	7.9	13.7	17.1	18.5	5.7	17.5	24.9	22.9	16.2	26.0	25.0	10.2	38.1	15.9	11.4	12.2	10.5	16.8	13.3	7.9	16.4	8.4	6.7	25.0	15.3	6.7	20.8	20.3	13.3	16.4	12.0	9.8	15.6	23.0	20.5	12.4	18.4	19.7	27.2	17.8	15.6	8.9	12.3	12.8	18.5	14.1	21.9	13.6	21.5	22.2	15.6	11.1	21.2	21.7	3.3	14.9	13.1	10.7	22.0	13.3	27.3	26.3	22.9	31.7	27.3	24.0	24.9	22.6	33.4	19.8	41.7	23.7	0.0	0.0	0.0	0.0	0.0	0.0	28.1	31.8	26.2	0.0	58.5	77.9	38.2	0.0	0.0	0.0	0.0	40.0	50.1	0.0	0.0	16.3	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	6.4	0.0	0.0	27.9	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 409.5;Late spermatids: 1347.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.4;RT4: 23.5;SK-BR-3: 21.6;SuSa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	15.0	1.3	19.6	2.7	10.2	4.9	19.4	11.4	2.1	21.1	4.2	1.0	4.9	32.9	1.2	4.0	2.6	1.9	15.4	11.1	25.6	29.5	2.7	1.2	21.8	10.0	1.1	1.6	5.7	3.3	5.5	21.1	2.9	2.2	17.5	2.0	11.7	4.2	19.7	1.1	3.9	16.4	1.7	1.3	30.6	20.8	0.0	2.8	0.2	1.0	11.9	1.5	0.0	0.7	7.9	0.8	0.0	0.8	6.9	0.2	3.5	1.9	2.0	1.6	0.8	0.7	3.8	0.5	1.8	1.6	1.2	0.2	0.0	0.1	5.9	3.4	1.8	6.9	0.8	0.8	0.0	2.6	0.0	3.7	1.4	0.9	0.0	14.4	1.2	2.1	0.2	0.6	1.0	0.2	2.2	0.5	0.7	3.6	2.0	0.6	0.5	2.0	0.4	3.0	0.0	1.1	0.0	5.2	23.5	1.6	3.5	3.2	21.6	6.9	12.8	1.2	0.0	0.1	1.9	7.1	3.5	7.3	0.3	0.0	0.0	4.8	0.7	7.1	7.9	0.2	2.1	0.8	0.8	0.4	0.0	0.7	0.2	0.3	0.0	0.3	0.1	4.9	0.0	0.0	0.7	0.1	6.9	15.0	19.6	4.9	15.4	15.4	11.1	21.8	10.0	21.1	20.8	0.0	6.4	0.0	0.2	2.3	9.2	2.5	0.0	0.0	0.0	34.9	19.6	2.9	5.0	0.4	409.5	2.3	0.4	23.3	1.0	0.9	0.5	0.5	4.6	43.3	0.9	3.2	2.4	4.9	1.0	1347.3	4.9	0.6	6.8	0.0	0.1	2.3	1.3	0.0	8.5	17.3	14.7	19.4	3.4	18.0	13.6	7.3	7.9	0.0	0.4	2.1
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 56.5"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 60.6;Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.0	3.1	9.2	2.2	9.0	0.9	4.7	0.8	10.8	8.3	4.7	10.3	2.9	1.9	9.7	5.8	2.8	5.7	3.9	2.8	7.2	6.4	6.3	56.5	4.7	1.1	8.2	8.0	4.7	4.6	7.6	8.9	2.2	6.0	13.3	5.0	6.6	1.7	5.4	3.6	1.8	2.0	7.0	7.0	2.0	3.2	7.2	9.2	0.9	7.0	1.2	1.3	5.5	4.9	0.4	0.4	0.0	0.7	0.0	0.7	0.0	2.2	5.5	16.7	0.0	3.3	13.0	6.0	5.7	2.8	3.3	3.3	5.3	0.6	0.0	0.9	6.3	4.3	1.9	7.4	2.7	2.3	0.0	6.4	0.0	6.2	8.9	2.7	0.0	2.4	5.3	1.6	2.7	3.5	9.1	3.1	7.5	0.9	0.1	12.6	5.6	2.7	0.1	12.6	6.2	5.0	0.0	5.2	0.0	2.9	10.0	13.5	15.7	4.5	1.1	5.4	5.6	0.0	1.1	2.1	8.4	9.0	9.5	8.8	0.0	0.0	0.0	8.4	0.0	9.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.4	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	9.2	9.0	0.8	10.8	7.2	6.4	8.2	8.0	6.0	9.2	0.0	5.1	0.0	2.6	0.8	5.1	1.1	2.5	14.7	3.4	0.0	2.0	1.4	0.0	1.3	0.4	0.5	0.0	0.0	1.9	60.6	2.4	3.6	0.0	22.9	1.4	0.0	6.4	0.0	0.3	0.6	1.1	0.6	1.7	0.0	1.3	3.2	0.9	0.0	2.1	6.5	8.2	6.5	2.2	2.4	12.5	0.4	4.7	0.0	2.3	1.4
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 7.3;testis: 6.4"	"Group enriched"	"Detected in some"	5	"Club cells: 3.4;Early spermatids: 11.9;Exocrine glandular cells: 3.7;Late spermatids: 13.6;Melanocytes: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 3.2;Karpas-707: 2.2;SCLC-21H: 2.3;SK-MEL-30: 1.8;U-266/70: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031019	Uncertain				"Intracellular and membrane"	NA	NA					"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.2	0.7	3.9	1.2	8.3	1.1	0.7	1.0	9.5	3.3	1.0	0.6	0.0	0.7	0.3	0.3	0.2	0.3	0.5	0.5	3.6	4.1	0.3	0.5	0.5	1.3	7.6	2.4	0.1	0.5	0.1	0.0	0.1	1.8	2.2	0.7	1.3	0.3	0.2	0.5	0.6	1.2	0.3	0.5	7.3	2.9	6.4	1.2	0.0	0.5	1.1	0.4	0.5	0.6	4.5	0.5	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.7	1.1	0.0	1.2	0.0	0.3	0.6	0.0	0.0	0.0	3.2	0.0	0.3	0.7	2.2	0.2	1.0	0.3	0.5	1.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.9	0.0	0.5	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	2.6	0.0	0.0	0.3	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.3	1.0	5.9	3.6	4.1	7.6	2.4	1.8	1.2	0.0	1.0	0.0	0.0	0.2	0.6	1.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.6	0.3	0.0	5.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.9	0.3	0.0	0.0	0.1	0.1
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168753-173323967	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		5000000	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	3.7	4.4	8.4	7.4	8.4	5.0	12.0	27.6	8.0	13.4	23.3	9.4	2.8	14.1	9.3	5.5	12.0	4.9	9.5	3.5	6.5	5.2	4.9	1.2	4.5	5.2	10.8	7.0	7.2	14.9	5.3	5.6	6.3	11.2	20.3	26.7	6.2	20.1	4.2	1.4	3.1	16.2	8.4	16.3	5.7	32.8	6.4	8.8	67.4	6.6	4.4	9.6	9.4	4.8	5.0	9.8	16.8	11.4	5.5	6.8	4.7	20.4	10.7	10.6	3.3	5.7	8.4	15.2	5.4	6.1	5.1	7.0	3.3	32.5	11.4	4.0	4.8	13.7	17.5	4.4	9.5	6.9	44.2	8.7	13.9	22.3	0.1	3.8	20.4	9.9	5.4	8.6	11.3	5.7	19.3	33.5	8.3	9.2	17.8	25.7	6.7	15.0	11.3	10.4	20.4	7.1	15.0	9.8	2.9	37.2	9.6	8.5	6.5	2.5	15.0	7.4	14.4	6.0	6.1	40.0	3.6	16.2	0.1	11.6	5.2	0.0	6.1	14.8	12.3	13.0	9.6	11.4	14.6	4.3	6.0	6.2	5.0	4.9	4.6	9.8	3.1	3.9	3.0	16.8	5.5	6.1	4.1	6.8	4.7	8.4	8.4	27.6	8.0	6.5	5.2	10.8	7.0	11.2	8.8	6.0	29.4	4.7	7.8	1.5	36.4	5.9	12.7	14.7	30.7	19.2	2.0	0.9	0.0	12.2	1.8	6.9	70.2	0.0	43.4	2.9	6.6	85.7	23.1	0.0	9.6	9.5	21.9	8.0	21.3	3.1	8.6	8.8	8.5	8.2	125.7	7.5	33.8	50.7	4.9	8.6	23.6	12.9	6.8	2.3	4.4	1.0	0.7	4.4	37.4	15.7
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell type enhanced"	"Detected in all"	15	"Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 166.6;MOLT-4: 171.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	Yes		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109"	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.9	8.4	72.2	32.2	9.0	9.0	27.7	26.1	19.9	28.8	25.8	23.7	48.8	118.3	5.9	14.5	15.4	13.7	47.3	14.2	45.0	72.4	22.1	130.0	21.2	34.7	8.8	115.0	50.2	8.7	4.3	14.4	32.8	15.7	29.5	62.9	49.0	166.6	26.3	29.2	171.4	106.6	26.3	20.9	14.6	86.7	37.1	43.9	16.5	15.0	62.5	56.4	26.3	15.3	11.7	26.4	21.2	83.9	16.9	12.9	38.3	15.9	39.1	53.9	30.1	135.4	11.0	84.1	33.6	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6	26.8	58.1	117.6	176.4	141.0	43.0	211.0	35.7	147.2	66.0	52.4	33.4	154.7	121.0	20.6	24.5	124.1	53.3	2616.4	14.4	751.8	109.8	81.7	104.4	22.2	176.6	42.9	71.7	149.1	275.5	29.5	97.5	149.6	64.1	109.2	104.0	79.8	10.0	83.9	54.1	36.3	129.5	77.6	96.6	461.9	435.2	117.1	107.7	264.5	185.0	64.8
SAP30		ENSG00000164105	"Sin3A associated protein 30"	O75446	4	173369969-173377532	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022627, HPA059012"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB022627: , HPA059012: AB_2683880"	"unprognostic (1.53e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.83e-2)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (4.95e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (3.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	16.9	19.8	15.6	19.2	18.3	29.6	13.7	19.4	21.6	13.5	21.9	22.5	11.1	14.3	13.6	15.2	13.0	15.4	13.4	20.1	18.0	14.7	7.6	10.3	13.5	10.5	23.4	13.9	17.3	10.5	6.6	9.2	10.7	15.8	16.3	11.2	15.3	11.8	15.7	10.0	8.0	13.8	19.0	24.2	15.7	28.6	26.8	23.3	10.7	12.1	7.2	9.7	24.9	17.6	0.7	2.9	1.9	4.1	0.0	1.9	0.8	15.5	5.3	15.4	14.9	9.9	6.2	3.4	7.3	6.3	8.2	10.3	2.2	6.3	14.1	3.4	8.5	10.4	3.9	12.4	6.2	6.4	15.8	11.8	18.8	12.8	6.3	9.4	10.8	12.0	10.2	3.0	7.0	7.1	11.7	9.7	10.3	9.7	60.2	10.6	6.6	15.2	12.1	6.8	7.0	10.3	12.4	5.5	10.0	5.0	2.5	12.6	26.6	10.4	10.5	4.7	4.1	4.4	6.4	9.4	5.9	8.0	13.8	16.9	34.0	12.1	13.4	19.2	26.4	16.8	1.3	4.1	0.0	1.9	2.4	0.7	0.4	1.0	1.2	2.9	0.7	0.2	0.6	1.9	0.0	1.3	0.1	1.4	0.8	15.6	18.3	19.4	21.6	18.0	14.7	23.4	13.9	15.8	23.3	0.0	2.9	4.5	6.1	45.9	23.7	25.0	2.5	4.0	3.4	7.0	21.6	2.3	0.0	2.4	12.6	13.1	3.6	23.3	3.1	8.4	19.9	7.4	6.9	7.9	8.2	23.8	18.9	10.4	63.3	2.3	9.5	10.8	32.1	2.8	7.4	48.7	2.5	3.5	6.0	4.5	43.5	51.8	19.5	53.9	9.8	46.3	1.0	5.0	9.7	2.6
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 148.4"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"HSkMC: 6.8;WM-115: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA					"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	5.8	3.1	19.2	2.6	18.6	2.2	2.3	6.0	30.6	2.1	2.9	15.9	4.0	2.5	2.5	7.7	2.3	2.1	5.1	3.6	19.9	12.0	1.5	1.4	1.5	1.5	24.9	12.9	1.6	1.8	1.2	1.1	1.6	20.5	6.4	2.7	0.0	3.4	11.6	1.9	2.0	2.0	15.6	33.4	2.4	2.8	16.3	22.5	0.0	1.5	0.3	1.3	4.1	1.0	1.4	1.3	4.4	1.8	1.6	1.0	0.4	0.1	0.0	0.9	0.3	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.8	0.2	0.2	6.8	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.1	19.8	3.9	1.8	1.2	0.8	1.2	0.6	0.8	0.6	0.7	0.7	1.4	0.8	1.0	4.4	1.6	1.3	1.3	0.5	0.4	19.2	18.6	6.0	16.7	19.9	12.0	24.9	12.9	20.5	22.5	0.0	4.0	0.5	1.0	3.2	11.8	0.8	0.0	1.4	1.2	0.0	35.3	0.2	0.0	0.2	14.9	2.0	0.0	0.0	0.0	0.2	5.2	1.4	9.2	0.0	0.5	15.9	1.2	6.2	3.1	21.8	24.2	1.6	21.9	0.0	0.0	148.4	0.1	0.0	19.4	0.0	30.2	12.9	10.9	1.9	2.2	2.3	0.6	3.9	0.2	0.7
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 61.4;placenta: 62.9"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 81.1;Leydig cells: 36.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB025576: , HPA019591: AB_2670199"	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.2	24.2	0.2	10.9	0.2	0.0	4.7	0.4	0.2	34.3	42.7	0.2	7.5	1.9	42.7	7.9	16.6	9.7	61.4	54.1	0.2	0.2	0.2	8.2	0.2	0.1	0.2	0.0	13.4	3.8	0.0	0.3	62.9	0.0	13.1	3.6	5.2	1.1	4.2	0.6	1.7	13.5	37.5	0.2	1.8	19.9	5.4	0.0	0.0	1.5	2.7	2.2	25.7	12.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.9	3.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	81.1	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.0	0.4	1.1	13.7	0.0	0.0	0.0	2.3	0.0	0.0	11.1	0.0	0.8	36.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	2.2	0.1	0.1	0.3	1.9	0.0	0.0	0.0
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174284264	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	16.8	18.5	13.5	9.2	14.1	7.3	16.4	19.4	14.0	15.6	17.3	14.0	10.7	13.4	13.1	19.5	16.4	15.1	13.1	19.1	13.3	12.0	20.2	43.5	11.8	9.5	14.6	10.1	15.7	22.6	16.5	26.9	27.1	14.3	16.8	15.3	14.7	13.3	13.1	7.4	16.0	18.9	18.8	14.7	13.9	14.7	10.0	14.0	18.2	19.9	6.5	12.4	20.6	18.2	12.6	8.6	19.2	8.9	9.8	15.5	7.8	4.8	3.2	6.6	2.2	14.9	16.3	5.2	9.9	9.1	6.6	6.7	2.5	8.6	3.7	9.4	6.4	5.6	3.1	4.4	5.7	7.0	11.1	10.0	3.2	5.5	4.0	11.4	4.4	3.6	9.3	14.2	6.0	8.0	11.8	6.5	4.1	6.8	19.1	8.6	4.8	4.5	4.6	1.8	7.8	3.4	2.7	4.3	5.8	10.2	2.0	6.2	40.1	4.4	7.8	11.0	6.7	4.4	4.8	7.4	3.8	3.7	11.0	5.5	9.9	4.7	3.1	13.0	3.2	5.3	19.2	6.2	12.7	12.3	7.8	15.5	12.6	14.2	12.1	8.5	10.7	13.5	11.8	6.2	9.8	8.9	8.6	15.0	7.8	13.5	14.1	19.4	14.0	13.3	12.0	14.6	10.1	14.3	14.0	3.0	11.4	16.0	15.8	18.3	11.9	9.0	12.7	18.7	13.6	21.0	5.9	29.9	43.1	14.8	14.7	16.8	18.2	23.3	9.7	44.8	19.0	18.2	2.3	50.0	18.5	17.5	11.6	19.0	16.9	4.1	16.1	8.5	10.1	19.8	20.1	20.7	11.1	19.3	24.8	32.6	16.1	12.9	14.7	33.3	17.4	27.5	74.9	17.5	13.4	20.6
CEP44	KIAA1712	ENSG00000164118	"Centrosomal protein 44"	Q9C0F1	4	174283677-174333380	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 27.5;SH-SY5Y: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041515, HPA041835"	Approved					NA	NA					"HPA041515: AB_10795638, HPA041835: AB_10794637"	"unprognostic (2.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (8.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.72e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	10.7	13.1	9.6	12.4	13.8	11.6	15.2	21.1	14.9	15.2	14.6	15.6	14.6	10.6	18.1	14.5	11.9	12.0	10.7	13.1	11.8	9.8	9.1	10.5	10.4	13.6	16.8	9.3	18.5	12.6	14.8	30.0	15.2	15.3	13.0	12.6	15.9	12.9	12.3	11.3	19.3	10.8	16.9	16.5	11.9	11.7	24.0	15.8	20.2	14.0	8.7	13.5	16.5	13.6	7.8	4.6	7.4	6.7	4.4	9.4	4.3	4.7	3.7	7.3	3.5	5.0	7.8	4.3	6.5	3.0	5.2	5.2	2.4	10.0	7.4	6.2	1.8	4.0	4.2	8.3	3.8	6.7	11.3	8.5	8.3	11.0	3.1	3.6	6.1	6.2	4.0	6.4	3.9	4.6	4.9	4.5	6.0	10.8	27.5	6.0	1.7	7.5	5.2	3.8	3.1	2.6	5.9	5.9	5.7	4.5	1.9	12.4	47.5	4.6	4.2	5.7	7.7	5.2	4.2	4.1	3.3	4.1	8.5	4.0	7.9	5.0	8.2	7.1	6.5	7.3	7.4	4.3	3.0	6.0	5.1	6.4	7.8	5.9	5.8	4.6	7.2	8.5	7.3	4.1	4.4	6.7	3.5	9.4	4.3	9.6	13.8	21.1	14.9	11.8	9.8	16.8	9.3	15.3	15.8	8.9	13.1	10.9	7.8	8.9	20.4	13.7	10.2	36.1	12.5	1.8	31.4	5.4	5.0	6.6	3.4	7.1	7.4	0.0	7.1	8.6	9.4	7.1	11.5	5.3	5.6	14.3	7.5	6.2	7.2	5.9	15.3	6.2	8.5	5.4	7.4	10.5	7.5	3.5	9.6	3.7	27.6	12.9	13.2	40.8	15.4	9.7	5.6	10.4	7.9	7.4
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.7	0.0	0.0	17.2	1.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	60.6	2.1	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	15.8	1.4	2.8	0.0	0.2	5.7	94.3	0.1	0.1	0.0	0.2	0.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5	14.9	46.1	5.2	57.7	15.3	3.1	0.4	43.3	5.3	20.5	21.0	0.0	25.6	18.3	2.4	1.1	0.5	273.6	0.0	86.5	488.8	12.1	51.1	816.1	165.7	20.7	0.0	8.1	18.4	16.1	0.2	18.4	10.6	72.6	1.0	48.2	0.0	26.0	217.5	0.0	68.8	0.6	0.0	6.6	0.4	0.4	19.6	47.4	50.3	31.0	266.0
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636914-174829314	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 6.1;pituitary gland: 12.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 18.4;Late spermatids: 13.2"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 2.7;Karpas-707: 6.3;U-698: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.5	2.6	13.3	0.6	7.3	0.6	6.1	0.7	15.2	0.5	0.5	0.3	0.0	0.5	0.7	0.5	0.5	0.4	0.6	0.4	2.7	7.4	0.5	0.4	0.5	0.9	4.6	8.7	0.4	1.4	0.5	12.5	0.5	4.4	0.5	0.5	0.0	0.5	0.5	0.4	0.7	0.5	0.8	2.1	0.6	0.5	1.7	0.0	0.0	0.5	0.0	0.9	0.4	0.2	2.7	0.1	1.1	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.0	0.7	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	2.3	0.1	0.1	0.1	0.6	0.0	0.4	0.1	0.0	0.5	2.7	0.2	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.1	0.1	0.0	13.3	7.3	0.7	14.5	2.7	7.4	4.6	8.7	4.4	0.0	0.0	1.1	0.0	1.0	0.0	0.7	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.6	0.0	0.4	0.2	1.5	0.1	0.0	0.0	0.0	0.3
ADAM29	"CT73, svph1"	ENSG00000168594	"ADAM metallopeptidase domain 29"	Q9UKF5	4	174829668-174978180	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 38.2"	"Group enriched"	"Detected in some"	68	"Early spermatids: 330.7;Late spermatids: 253.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 1.0;naive CD8 T-cell: 1.3;T-reg: 2.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.3;RH-30: 2.2;U-266/70: 1.7;U-698: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.40e-3)"				"unprognostic (2.03e-2)"			"unprognostic (4.72e-3)"			"unprognostic (4.93e-2)"		"unprognostic (1.16e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	330.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.3	1.6	0.0	0.0	0.0	0.0	0.0
GPM6A	GPM6	ENSG00000150625	"Glycoprotein M6A"	P51674	4	175632934-176002664	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 249.7"	"Cell type enhanced"	"Detected in many"	21	"Alveolar cells type 1: 89.3;Bipolar cells: 197.8;Horizontal cells: 117.6;Muller glia cells: 415.5"	"Cancer enriched"	"Detected in many"	107	"glioma: 110.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 22.2;naive B-cell: 9.1"	"Lineage enriched"	"Detected in many"	12	"B-cells: 22.2"	"Group enriched"	"Detected in some"	10	"AF22: 26.8;Daudi: 22.3;HAP1: 9.2;U-251 MG: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017338	Supported					NA	NA					"HPA017338: AB_1849933"	"unprognostic (1.36e-4)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.82e-5)"	"unprognostic (2.24e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.60e-3)"	2.4	3.1	81.8	2.0	51.1	1.8	2.5	83.3	249.7	4.1	4.1	15.9	0.0	2.2	4.3	2.7	2.3	4.4	3.1	2.3	54.4	31.2	4.3	6.2	8.8	2.4	23.5	39.4	6.5	2.2	2.0	1.0	1.7	13.1	3.7	3.8	6.3	1.9	4.2	1.8	1.9	2.3	5.5	9.6	6.9	2.0	2.1	17.0	0.0	5.9	0.0	2.0	2.4	0.5	22.2	1.7	0.3	0.1	0.0	0.0	0.4	0.1	0.4	26.8	0.2	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.5	0.4	22.3	0.1	0.1	0.9	0.4	9.2	0.7	0.0	0.1	2.1	0.2	1.8	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.9	0.0	0.6	0.8	0.3	0.6	0.0	0.3	0.1	0.1	0.1	0.0	1.1	0.2	0.2	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.5	0.3	0.3	26.5	0.8	0.0	1.3	0.9	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.1	9.1	0.0	0.0	0.1	0.0	0.1	1.7	0.0	0.4	81.8	51.1	83.3	79.7	54.4	31.2	23.5	39.4	13.1	17.0	89.3	8.3	7.5	4.6	1.5	197.8	0.6	0.0	0.0	1.2	0.0	13.7	0.0	1.7	0.0	6.9	10.3	0.0	0.0	0.2	0.1	0.2	6.5	0.0	0.8	0.3	117.6	0.0	71.2	4.1	2.5	3.1	0.6	0.0	0.0	0.0	415.5	0.0	0.0	1.4	0.9	24.7	0.0	0.7	0.2	0.0	0.6	0.1	0.0	0.0	4.2
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065834-176182818	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 15.7;Cone photoreceptor cells: 60.9;Horizontal cells: 20.6;Rod photoreceptor cells: 35.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.9;SCLC-21H: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA042766: AB_10806372, HPA054501: AB_2732586"	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	2.1	5.8	12.4	2.2	22.1	1.5	3.3	12.2	23.9	2.0	2.9	3.4	0.0	1.6	4.5	6.2	1.9	3.5	3.0	1.3	9.7	7.1	6.2	1.0	3.6	1.8	4.4	16.3	4.0	3.0	19.0	22.5	0.7	7.9	2.3	3.1	6.0	1.7	2.2	0.7	1.2	1.8	2.8	4.0	2.9	3.1	4.1	6.9	0.1	10.2	0.0	1.6	1.9	1.5	1.1	0.7	2.6	1.6	1.3	0.8	0.2	0.0	3.7	8.9	0.1	0.2	0.6	0.3	0.2	0.0	0.8	3.1	0.2	0.1	6.1	0.0	0.1	4.8	0.1	3.9	2.0	0.8	0.0	3.1	0.0	0.7	0.0	0.3	3.3	4.8	1.4	1.2	0.1	0.5	1.3	0.0	7.1	0.0	0.3	0.6	1.6	3.4	0.1	2.0	0.0	1.9	0.0	3.8	0.0	0.5	0.0	10.2	7.4	0.0	2.4	6.2	1.4	0.4	0.0	0.0	1.2	1.7	0.1	5.7	4.4	2.9	3.5	7.0	0.0	2.4	2.6	0.6	0.3	0.6	1.6	0.3	1.1	0.6	0.4	0.2	0.8	0.7	0.8	1.7	1.3	0.3	0.7	0.3	0.2	12.4	22.1	12.2	21.8	9.7	7.1	4.4	16.3	7.9	6.9	0.0	4.3	0.0	0.4	0.1	15.7	0.8	2.5	12.0	2.3	0.0	60.9	0.0	1.7	0.3	1.2	0.5	0.0	0.0	0.5	0.0	0.5	0.2	3.5	0.0	0.2	20.6	4.6	1.8	0.3	0.8	0.9	0.2	1.7	0.0	0.0	9.5	0.3	0.0	1.4	4.4	35.8	0.0	1.0	2.6	4.5	0.0	0.0	0.0	0.0	0.3
SPATA4	"SPEF1B, TSARG2"	ENSG00000150628	"Spermatogenesis associated 4"	Q8NEY3	4	176184638-176195671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 84.3"	"Group enriched"	"Detected in some"	8	"Early spermatids: 888.4;Late spermatids: 383.1;Spermatocytes: 280.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.9;U-87 MG: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019220	Enhanced					NA	NA					"HPA019220: AB_1857420"	"unprognostic (1.97e-3)"	"unprognostic (6.08e-2)"		"unprognostic (2.83e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-2)"		"unprognostic (1.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-3)"	"unprognostic (9.77e-2)"	"unprognostic (4.38e-6)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.59e-1)"	0.0	0.2	0.4	0.0	2.3	0.0	0.3	0.1	0.7	0.2	0.2	0.7	0.1	0.0	0.1	2.2	0.2	3.9	0.1	0.2	0.5	0.6	1.0	0.0	0.9	0.0	0.4	1.5	0.7	0.2	0.1	1.3	0.0	0.8	0.1	0.0	0.2	0.1	0.2	0.5	0.0	0.1	0.1	0.4	0.0	0.1	84.3	0.2	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.9	5.2	1.3	1.5	1.0	0.6	0.2	1.0	0.1	0.0	0.4	1.2	0.0	0.5	0.8	0.2	1.0	0.5	0.5	0.2	0.0	0.5	3.9	0.0	0.0	1.6	0.4	0.1	0.0	0.0	0.4	0.3	0.7	0.0	0.2	0.2	2.3	0.9	0.9	1.2	0.0	0.5	0.1	0.6	0.7	0.1	0.2	0.3	0.2	0.1	0.7	0.1	1.2	0.1	0.8	0.0	0.8	0.4	1.4	0.1	0.1	0.4	0.2	0.0	0.0	0.5	0.4	0.2	0.8	0.1	0.1	0.0	7.1	0.0	0.2	5.2	0.5	0.9	0.5	0.8	1.0	0.8	0.7	0.6	0.6	0.8	0.8	0.8	1.5	1.5	1.3	0.9	0.8	0.6	0.4	2.3	0.1	0.7	0.5	0.6	0.4	1.5	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.6	0.2	0.0	64.3	3.4	0.0	0.0	0.0	5.0	0.3	888.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	383.1	10.6	0.0	0.0	0.0	0.0	1.0	1.0	0.0	7.8	5.1	3.3	0.0	0.1	280.2	8.8	0.0	0.0	0.0	0.0	0.1
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 133.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 229.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 165.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028870: AB_10611679"					"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	2.3	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.3	3.5	0.0	0.0	0.1	0.2	6.3	7.9	0.0	0.4	1.3	0.2	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.6	1.3	0.0	8.0	0.1	133.4	0.0	0.5	23.5	1.0	0.0	2.0	2.2	0.0	0.0	2.3	31.4	2.2	15.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	3.6	7.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	229.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0
SPCS3	"FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W"	ENSG00000129128	"Signal peptidase complex subunit 3"	P61009	4	176319964-176332245	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 88.1"					"Low region specificity"	"Detected in all"			HPA053180	Approved					NA	NA					"HPA053180: AB_2682071"	"unprognostic (4.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.20e-3)"	"prognostic favorable (8.89e-6)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.44e-1)"	20.3	14.2	15.5	24.5	15.8	29.3	30.0	18.3	24.9	26.2	25.3	12.6	40.9	17.3	23.5	27.4	18.2	19.2	20.0	24.4	14.1	14.5	18.1	41.3	25.4	38.2	18.9	17.5	15.8	85.0	21.2	24.9	26.3	14.6	17.6	19.8	11.0	52.4	37.4	17.4	16.2	18.6	26.4	21.2	29.5	24.5	8.3	12.9	19.1	32.5	16.1	23.8	22.4	19.5	8.0	17.1	26.2	14.6	13.0	16.3	12.8	14.6	4.9	13.7	11.2	19.6	34.8	14.5	29.0	27.9	17.0	14.7	5.3	32.4	28.3	6.0	16.7	8.9	10.2	12.9	21.4	25.9	19.0	5.7	24.4	8.0	12.1	20.0	36.5	21.6	21.0	23.6	15.0	14.6	19.1	25.0	13.8	15.7	88.1	23.3	8.9	22.2	13.9	9.3	10.4	4.9	11.0	21.3	24.6	20.9	10.7	10.9	10.0	30.3	22.7	13.3	12.4	7.3	17.1	23.2	12.6	12.6	11.2	13.2	40.9	12.1	35.6	26.8	18.5	17.3	26.2	12.2	10.3	12.3	14.6	16.3	8.0	11.5	11.1	9.2	5.3	9.7	12.0	12.2	13.0	11.6	17.1	8.9	12.8	15.5	15.8	18.3	24.9	14.1	14.5	18.9	17.5	14.6	12.9	50.6	81.3	47.6	49.0	50.8	32.2	67.8	40.8	42.8	54.6	27.9	25.5	58.7	18.3	68.9	48.1	87.5	44.5	116.8	117.4	151.8	62.7	93.0	89.0	104.2	140.2	22.3	43.0	92.1	105.2	14.2	20.8	125.0	104.6	64.9	66.2	31.5	141.6	34.5	15.9	52.2	28.5	12.9	51.2	75.3	39.6	57.0	154.2	63.7	42.2	96.6
VEGFC	VRP	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792727	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 20.1"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 10.5;Fibroblasts: 7.4;Ito cells: 5.5;Leydig cells: 12.7"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"BJ: 41.6;HBF TERT88: 33.9;hTEC/SVTERT24-B: 34.0;LHCN-M2: 37.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	383000	50000				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	8.9	2.0	0.5	1.9	2.0	0.0	20.1	1.5	1.9	4.8	4.5	0.7	2.9	0.8	6.2	1.5	5.5	5.1	7.7	5.9	0.8		1.5	1.7	16.0	3.5	0.0	0.1	3.9	0.5	0.6	0.0	11.6	1.6	4.8	1.6	3.4	4.3	2.7	6.2	0.2	1.6	3.8	1.7	2.6	0.4	2.4	0.4	0.3	17.7	3.4	2.3	6.8	9.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.8	0.5	0.0	7.6	7.6	0.0	41.6	25.1	23.2	18.5	0.0	0.2	0.0	0.0	23.5	9.7	1.2	0.3	15.7	33.9	0.0	0.8	0.0	1.1	0.0	4.1	0.0	0.0	8.0	0.7	34.0	23.8	23.3	14.3	0.0	0.0	0.0	37.6	0.6	0.0	0.0	0.3	0.0	13.6	0.0	2.4	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.2	0.2	0.0	6.9	24.7	2.6	6.0	11.7	0.0	0.0	0.0	10.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1											3.0	0.0	0.0	1.2	2.2	0.6	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	2.6	10.5	0.0	0.0	0.0	0.0	7.4	1.9	0.0	0.0	0.3	1.6	0.0	5.5	0.0	1.0	12.7	0.9	3.3	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	1.7	0.0	1.7	1.8	0.0	0.0	0.0	2.2
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309836-177362943	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 70.8"	"Cell type enhanced"	"Detected in some"	8	"Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065761			Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.5	0.4	0.2	7.4	0.2	9.3	0.7	0.1	0.2	0.8	1.5	0.1	0.1	1.5	0.5	0.1	5.6	0.2	0.3	0.5	0.2	0.2	0.4	0.4	0.9	5.1	0.2	0.1	0.3	0.2	0.0	0.2	1.6	0.2	0.2	2.1	0.2	0.8	0.1	0.2	3.4	1.7	0.5	0.7	1.5	0.8	3.5	0.3	70.8	0.2	1.1	5.0	0.7	1.3	0.2	0.3	0.8	0.0	1.6	1.6	0.2	7.1	5.9	6.3	3.1	0.7	1.3	3.1	8.8	3.3	9.8	5.8	2.1	6.3	7.9	1.3	2.3	9.7	3.3	6.6	3.5	14.3	26.6	4.3	5.4	4.7	5.6	0.2	29.0	3.7	0.1	0.2	10.1	2.2	2.0	3.7	20.5	5.6	38.1	6.3	3.1	29.3	11.1	2.9	2.1	4.4	6.0	4.3	2.5	2.5	0.9	5.0	3.4	4.4	5.1	2.4	2.9	4.2	7.6	1.7	5.9	4.6	3.0	8.9	2.6	1.7	12.5	3.9	10.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.2	0.0	1.1	0.8	1.6	0.0	0.3	1.6	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.6	2.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.9	3.0	1.1	0.2	0.5	0.4	0.1
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430770-177442503	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 32.2;Karpas-707: 45.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		28000000			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	12.8	15.1	11.2	11.2	11.9	10.9	18.5	4.4	13.7	13.5	12.1	24.2	8.0	8.0	9.8	26.4	18.8	7.1	15.1	8.4	13.0	9.4	20.5	26.5	12.4	12.3	14.0	11.0	10.2	14.7	19.2	9.0	9.3	15.0	10.1	11.1	24.0	27.1	10.8	6.7	16.9	14.4	8.1	22.3	14.9	13.0	13.3	10.0	13.4	14.0	14.3	18.3	9.0	10.2	10.0	11.1	16.3	23.8	8.9	16.3	10.3	2.1	4.7	5.4	7.7	6.4	5.7	3.7	15.8	32.2	8.2	10.4	2.5	10.6	10.5	2.9	12.2	4.0	2.6	4.6	5.2	16.7	6.8	3.0	4.4	5.2	6.9	4.2	7.6	3.0	4.0	9.1	6.0	2.7	7.4	7.7	4.7	3.9	45.6	3.3	5.8	6.1	4.8	2.1	4.2	4.9	1.9	2.2	1.6	8.7	5.3	3.0	6.9	4.7	4.1	12.5	4.3	9.3	15.7	2.4	5.7	5.1	2.7	6.1	8.8	6.7	5.6	9.2	8.7	6.4	15.0	10.7	16.3	11.7	18.9	13.4	10.0	12.8	14.0	10.5	8.1	11.4	16.3	2.4	8.9	23.8	11.1	12.0	10.3	11.2	11.9	4.4	13.7	13.0	9.4	14.0	11.0	15.0	10.0	11.9	9.1	12.3	14.9	21.3	3.3	5.7	17.8	5.3	11.4	14.0	2.0	21.6	5.0	21.9	11.4	11.1	9.1	0.0	27.5	25.3	15.5	15.7	13.9	15.1	21.7	6.4	5.2	6.2	9.1	6.8	10.3	22.8	37.1	25.2	16.6	17.6	20.6	5.8	9.2	16.3	3.7	0.0	12.4	34.8	31.5	23.8	19.0	22.3	13.4	15.2
TENM3	"KIAA1455, ODZ3, Ten-M3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Bipolar cells: 28.4;Cytotrophoblasts: 88.5;Extravillous trophoblasts: 46.4;Syncytiotrophoblasts: 111.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 24.4;BEWO: 23.3;HDLM-2: 31.7;T-47d: 31.4"	"Low region specificity"	"Detected in many"							HPA047043	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	9.5	10.8	11.3	3.7	12.5	1.0	9.3	8.5	17.8	3.9	8.5	1.5	5.7	2.4	6.4	2.6	2.4	2.9	5.3	3.5	11.8	9.4	2.7	1.4	2.4	2.3	3.5	15.4	8.4	3.2	17.0	15.0	24.5	5.4	8.3	2.5	6.4	2.0	8.0	4.3	1.4	2.5	5.2	6.1	4.8	2.2	4.7	2.3	0.8	12.3	1.8	3.0	3.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	24.4	0.1	5.0	8.9	23.3	2.8	1.0	2.5	2.2	12.1	6.3	0.0	0.3	18.8	10.6	1.2	5.8	1.2	2.5	31.7	9.7	0.0	0.0	0.0	0.5	0.0	0.0	11.7	0.4	7.9	5.5	5.7	3.5	0.0	0.0	0.1	3.8	0.8	0.0	0.0	7.8	0.0	1.0	0.0	6.3	0.0	0.0	0.0	10.0	9.3	1.4	0.1	0.0	13.8	31.4	1.2	7.6	20.0	14.4	0.0	14.1	0.0	0.0	0.0	10.5	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.5	8.5	17.8	11.8	9.4	3.5	15.4	5.4	2.3	0.0	0.0	0.0	0.2	0.3	28.4	3.3	0.0	0.0	0.0	3.5	3.9	88.5	1.7	0.0	8.3	0.3	0.0	0.0	1.5	46.4	3.1	0.2	0.0	0.6	9.0	4.8	5.1	0.6	0.0	1.8	7.8	0.0	1.7	0.0	0.0	11.8	0.6	0.0	2.5	0.1	2.8	0.0	1.0	3.7	7.1	0.0	111.6	0.0	0.0	0.0
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		13000	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	24.8	46.2	24.7	19.9	23.8	12.9	27.3	11.6	28.3	27.1	20.4	17.3	22.6	16.4	26.0	20.1	30.9	25.9	40.9	25.8	22.5	22.2	25.7	47.6	25.8	29.4	21.1	20.3	35.9	51.7	28.3	25.3	18.9	21.3	23.7	21.5	30.0	26.4	22.8	24.8	19.4	19.1	27.4	25.6	24.9	27.2	11.8	16.7	15.0	52.9	21.3	26.0	24.5	25.1	31.9	24.8	23.7	25.7	30.8	36.8	22.7	22.7	21.0	21.4	19.8	32.4	44.3	28.1	43.9	39.2	31.5	19.5	21.3	44.2	7.9	10.9	42.7	21.5	11.3	15.6	27.4	29.0	38.3	11.8	36.5	12.2	25.3	34.8	35.5	22.9	36.8	29.2	27.6	28.8	31.9	26.9	17.5	36.2	79.2	41.8	16.6	23.0	21.7	17.0	9.2	18.3	25.1	15.3	15.3	25.4	27.3	21.2	13.1	20.7	17.9	20.5	20.8	13.7	18.6	31.3	26.2	20.2	12.6	33.4	30.4	16.4	10.1	28.9	23.3	30.8	23.7	22.0	19.7	29.2	25.7	36.8	31.9	25.6	29.7	24.8	21.7	25.5	26.7	1.6	30.8	24.9	19.1	21.9	22.7	24.7	23.8	11.6	28.3	22.5	22.2	21.1	20.3	21.3	16.7	11.9	15.0	31.7	28.8	22.6	4.3	20.6	38.2	18.7	11.4	31.4	3.9	16.6	31.5	61.9	6.3	32.1	15.5	23.3	47.4	19.9	41.7	29.4	22.0	38.0	48.4	3.2	13.9	25.2	29.6	13.2	40.9	29.6	25.3	38.7	28.6	31.5	60.2	10.5	33.2	34.1	6.3	32.3	28.2	9.3	15.4	20.1	6.1	27.4	29.9	34.5
WWC2	"BOMB, FLJ22029"	ENSG00000151718	"WW and C2 domain containing 2"	Q6AWC2	4	183099293-183320777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 244.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"monocytes: 1.9;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044005	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA044005: AB_10960552"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (7.16e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (3.27e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.52e-2)"	10.8	6.7	8.2	4.8	9.1	0.9	12.3	3.5	7.4	11.6	8.5	8.6	9.8	2.4	17.6	7.1	6.7	8.6	9.7	12.3	9.6	4.8	20.3	19.9	28.8	3.3	10.0	7.2	12.8	13.1	15.5	5.9	14.9	9.1	8.9	3.4	16.5	11.3	9.9	5.5	5.4	4.0	11.2	9.9	6.4	8.9	15.4	8.5	0.0	16.8	4.5	3.1	9.8	17.0	0.0	0.4	0.0	1.9	0.4	2.1	0.3	10.1	4.3	9.4	8.4	7.1	7.9	10.9	13.8	11.0	15.3	11.0	19.1	9.9	0.0	7.0	22.2	5.3	3.7	14.5	5.7	19.5	0.0	4.4	10.3	10.0	9.8	7.3	4.8	11.4	6.0	4.4	10.1	9.5	12.7	10.1	1.5	7.3	0.5	11.6	2.9	0.0	3.2	9.0	0.3	3.7	0.0	8.6	5.5	21.8	2.7	0.6	4.8	33.8	29.7	4.4	15.7	7.2	1.6	15.1	5.7	16.0	3.3	9.9	0.0	0.0	0.1	5.6	2.2	10.0	0.0	1.4	0.0	0.6	1.1	1.0	0.0	0.6	0.2	0.4	0.0	2.1	0.6	0.0	0.4	1.9	0.0	0.0	0.3	8.2	9.1	3.5	7.4	9.6	4.8	10.0	7.2	9.1	8.5	244.2	50.8	0.0	6.7	21.3	3.2	25.8	43.3	14.7	37.5	7.0	60.9	11.9	23.2	13.2	30.2	20.4	0.0	0.0	12.4	7.5	16.9	19.6	18.5	33.7	8.5	0.0	1.2	16.5	13.1	16.8	16.4	7.1	11.8	7.2	0.1	11.8	23.0	0.0	19.8	19.0	60.1	25.8	18.0	29.8	16.8	13.4	5.5	1.0	0.1	7.6
CLDN22	CLDN21	ENSG00000177300	"Claudin 22"	Q8N7P3	4	183318194-183320774	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"fallopian tube: 4.2;salivary gland: 7.2"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0;Club cells: 3.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;MCF7: 1.0;RT4: 1.3;SCLC-21H: 1.5;THP-1: 1.1"															NA	NA																							0.0	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.5	0.1	0.1			0.0	1.0	0.0	0.9	4.2	0.0	0.0	0.5	0.2	1.1	1.3	0.1	0.0	0.1		0.0	0.2	0.1	0.4	0.0		0.4	0.0		7.2	0.1	0.5	0.4	0.0	0.1	0.2	0.2	0.0	0.1			0.5		0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0											3.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN24	CLDN21	ENSG00000185758	"Claudin 24"	A6NM45	4	183321764-183322426	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"kidney: 4.6;salivary gland: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.9;fHDF/TERT166: 3.6;HSkMC: 1.5;SCLC-21H: 1.5;SK-BR-3: 3.1"															NA	NA							"unprognostic (1.49e-1)"				"unprognostic (9.27e-2)"		"unprognostic (1.89e-1)"					"unprognostic (4.93e-3)"					0.1	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.1	0.1			0.0	0.1	0.0	1.0	0.1	0.0	0.2	0.0	0.0	4.6	0.4	0.6	0.0	0.0		0.2	0.3	0.5	0.1	0.0		0.1	0.0		2.1	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.2			0.2		0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.3	1.9	0.7	0.0	0.3	0.0	0.4	3.6	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444591-183448198	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 103.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041397: AB_10794297, HPA062142: AB_2684696"	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	14.2	14.3	13.9	13.6	15.6	32.3	15.9	20.8	13.8	18.1	18.1	15.0	10.1	18.7	17.1	13.2	27.7	13.0	13.3	15.0	13.0	12.9	18.1	17.2	17.8	17.8	15.4	10.7	24.0	18.4	15.9	21.9	16.4	14.0	21.5	14.2	13.0	15.9	15.2	11.1	14.2	18.0	14.8	13.7	16.0	17.2	20.1	12.2	24.7	23.4	20.6	27.3	16.6	24.1	8.3	4.6	28.5	5.9	8.1	14.7	8.4	5.1	2.9	8.7	6.2	7.3	5.3	6.5	8.7	7.3	9.0	6.0	4.3	5.0	17.3	1.8	5.9	3.7	4.1	7.9	6.4	9.5	7.0	4.7	17.9	14.0	5.5	5.8	13.1	7.2	6.3	6.0	5.3	7.0	4.8	7.1	6.6	8.9	18.7	6.2	2.7	14.8	10.7	6.3	1.9	6.0	12.8	4.2	6.9	60.3	4.9	8.9	7.6	6.3	26.6	10.4	5.9	3.9	11.4	4.0	3.2	4.5	2.9	7.0	9.1	3.7	8.9	5.0	11.3	5.1	28.5	4.8	10.4	9.0	5.6	9.4	7.4	11.1	9.7	4.6	8.3	14.7	13.3	5.7	8.1	5.9	3.1	10.9	8.4	13.9	15.6	20.8	13.8	13.0	12.9	15.4	10.7	14.0	12.2	14.9	30.7	18.2	22.6	31.9	21.9	15.7	22.9	33.5	27.3	15.7	9.8	20.1	14.9	11.0	103.2	21.8	25.7	0.0	13.7	12.2	23.7	35.9	61.1	12.8	13.7	20.6	29.1	17.8	8.8	51.4	19.5	18.9	20.3	11.8	19.1	18.8	13.2	20.1	16.3	10.5	19.8	12.9	21.1	32.3	36.3	34.8	15.7	34.1	17.5	48.5
ING2	"ING1L, p33ING2"	ENSG00000168556	"Inhibitor of growth family member 2"	Q9H160	4	183504994-183511096	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019486, HPA021517"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019486: AB_1851780, HPA021517: AB_10601914"	"prognostic favorable (5.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (7.47e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.30e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.82e-2)"	6.1	28.5	7.8	4.4	12.2	20.0	7.6	8.3	10.3	6.2	13.0	6.0	5.9	10.1	4.2	11.6	15.7	8.0	8.1	5.0	8.0	8.9	10.4	9.4	6.1	6.0	9.9	6.0	34.4	17.3	6.3	18.8	11.5	9.5	6.0	6.3	6.5	6.8	6.7	16.2	7.4	23.1	6.8	11.0	7.2	7.5	16.9	7.2	11.5	9.1	10.9	6.8	10.3	9.4	11.4	7.4	21.8	7.9	3.5	10.7	3.9	14.8	7.8	12.8	10.4	20.3	13.3	11.1	16.6	14.1	13.0	11.9	7.6	15.0	11.5	3.7	12.1	9.5	6.3	7.6	14.1	18.7	8.0	6.9	17.0	9.1	9.1	5.9	13.2	19.3	10.1	11.3	13.6	5.3	9.5	6.7	9.6	10.4	40.8	10.4	14.5	18.4	15.8	9.2	4.8	10.5	8.6	6.4	17.8	15.0	7.3	12.1	8.3	9.7	13.6	4.0	8.3	6.4	9.9	4.6	8.7	14.8	6.8	9.6	8.7	5.7	7.2	16.9	12.0	6.1	13.1	6.2	21.8	3.6	6.3	5.5	11.4	7.6	6.5	7.4	8.1	10.7	9.0	7.4	3.5	7.9	7.0	5.6	3.9	7.8	12.2	8.3	10.3	8.0	8.9	9.9	6.0	9.5	7.2	6.0	16.0	25.2	16.6	43.8	23.5	7.6	25.5	54.9	15.9	15.7	11.8	20.8	63.0	17.7	41.4	15.0	33.7	46.7	30.8	78.8	23.6	23.6	39.3	19.2	26.7	23.8	17.9	10.4	16.1	27.5	76.5	29.3	25.3	8.2	19.6	27.5	27.8	28.1	50.5	28.3	21.0	19.4	21.1	80.2	75.2	40.4	17.7	18.3	20.5	27.7
RWDD4	"FAM28A, MGC10198, RWDD4A"	ENSG00000182552	"RWD domain containing 4"	Q6NW29	4	183639635-183659225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036501, HPA036502"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA036501: AB_2675159, HPA036502: AB_10670800"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (1.01e-6)"	"unprognostic (6.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.65e-2)"	11.0	37.4	8.3	9.3	8.2	8.5	14.8	10.0	7.5	10.0	11.6	8.1	10.6	7.6	9.7	12.1	16.0	9.7	11.6	15.7	7.8	9.1	17.6	13.3	10.3	9.9	8.4	6.1	28.6	17.9	7.1	28.4	10.3	8.1	12.2	8.5	8.9	25.6	13.6	30.7	8.2	11.2	10.4	8.4	11.4	9.5	12.3	7.7	10.6	17.1	17.7	10.5	13.2	13.7	7.4	8.5	11.8	9.7	11.4	9.9	6.4	13.3	7.8	12.0	14.7	19.3	20.5	9.1	16.9	13.5	21.4	13.6	5.0	17.6	20.2	4.0	13.8	10.3	6.3	16.6	15.8	22.6	13.4	7.4	14.6	9.2	12.8	13.7	22.4	11.1	13.3	16.5	11.7	13.1	16.6	16.0	15.9	13.9	26.4	22.3	5.6	22.9	18.9	8.0	5.1	10.2	16.0	9.3	12.8	20.9	6.5	11.5	16.2	15.9	18.7	14.6	9.6	9.4	13.6	11.6	9.0	4.4	9.6	13.0	8.9	6.6	6.9	16.9	16.6	12.7	6.0	6.1	11.8	8.6	8.2	8.4	7.4	7.8	8.1	8.0	5.2	7.4	7.7	5.3	11.4	9.7	8.5	9.9	6.4	8.3	8.2	10.0	7.5	7.8	9.1	8.4	6.1	8.1	7.7	20.8	15.0	21.6	28.9	29.9	17.0	9.4	28.1	29.4	20.5	17.4	5.9	22.5	63.0	27.5	5.6	26.2	14.0	0.0	67.9	34.3	27.8	53.7	35.7	29.7	32.4	9.5	20.8	19.0	31.4	7.3	68.4	22.4	54.0	30.7	25.4	27.0	45.6	10.5	66.4	98.2	21.6	19.4	33.3	39.5	54.4	31.0	22.7	26.1	24.3	39.9
TRAPPC11	"C4orf41, FLJ12716, foigr, gry"	ENSG00000168538	"Trafficking protein particle complex 11"	Q7Z392	4	183659267-183713594	"Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038173			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA038173: "	"unprognostic (2.24e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.14e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.92e-2)"	18.3	28.1	14.0	14.2	24.5	11.5	17.8	21.8	24.7	17.0	16.1	19.3	10.9	12.2	19.8	16.1	18.3	17.4	12.9	15.6	15.5	12.6	17.5	18.9	15.2	16.7	14.4	15.1	24.9	16.7	27.9	31.3	21.2	17.1	16.9	17.5	17.0	19.7	14.8	26.0	18.0	16.5	18.2	12.8	15.2	17.4	17.3	14.8	26.2	17.2	10.7	19.3	22.1	16.8	4.2	10.5	6.4	18.8	8.0	6.6	5.7	9.3	9.1	15.0	14.8	18.9	20.9	11.4	13.7	13.9	11.6	10.7	5.6	12.1	12.9	3.9	13.8	9.0	6.8	13.6	13.0	13.4	14.2	5.9	16.2	7.8	7.9	17.4	17.4	16.1	16.0	14.0	11.5	13.5	15.2	16.9	15.2	12.9	27.0	14.4	6.7	20.8	8.4	5.6	6.4	6.8	14.5	8.9	9.7	14.8	9.6	10.2	13.5	13.4	13.9	13.4	14.0	10.7	19.3	16.9	6.6	7.8	6.3	7.7	14.1	7.6	7.8	13.5	11.7	11.5	3.1	10.3	6.4	5.0	12.2	6.6	4.2	5.4	5.2	10.5	3.1	5.1	5.2	2.9	8.0	18.8	2.7	4.3	5.7	14.0	24.5	21.8	24.7	15.5	12.6	14.4	15.1	17.1	14.8	3.0	12.6	5.2	2.5	3.9	10.7	12.6	10.2	14.7	10.3	7.0	7.9	6.4	3.3	6.8	38.8	6.7	8.4	0.0	8.0	7.3	5.8	5.3	7.0	7.8	10.3	7.9	12.6	10.4	14.6	2.0	12.4	10.0	3.3	10.0	7.9	8.0	7.6	5.8	10.6	4.3	12.5	0.0	4.8	6.0	14.7	5.4	5.8	7.9	8.5	4.8
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 30.6;Horizontal cells: 31.8;Ito cells: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.6;HeLa: 9.9;NTERA-2: 14.7;SH-SY5Y: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	3.0	2.8	12.0	1.2	12.6	8.4	3.1	20.3	17.5	3.9	2.1	18.2	1.6	1.6	3.2	5.9	8.2	4.7	4.5	4.9	9.6	8.3	3.4	4.0	3.5	1.1	16.2	18.0	5.8	10.6	12.0	8.1	2.4	11.8	4.1	1.7	2.5	11.0	4.2	3.2	6.2	1.8	3.2	9.2	6.2	3.7	1.6	16.4	0.8	9.6	0.8	1.9	4.3	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.7	3.7	11.6	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	1.5	0.0	2.3	0.0	2.4	0.2	6.4	1.0	0.0	0.0	5.1	0.0	9.9	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.4	0.0	1.5	0.0	0.5	0.0	0.1	14.7	0.0	0.5	0.1	4.3	0.0	2.8	3.5	6.0	14.0	2.7	0.0	0.0	4.4	0.2	0.3	0.0	0.0	2.5	0.0	0.1	0.1	3.2	1.8	0.6	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.0	12.6	20.3	16.6	9.6	8.3	16.2	18.0	11.8	16.4	11.9	16.6	0.0	5.8	3.8	30.6	19.3	5.1	20.1	12.5	7.0	0.0	2.3	3.3	3.9	0.8	18.3	0.0	0.0	2.7	1.7	1.5	4.2	0.0	4.9	0.9	31.8	1.7	22.1	2.6	2.2	0.6	0.2	1.7	0.0	0.0	15.1	2.4	0.0	4.2	1.9	3.4	0.0	1.0	0.5	2.4	2.9	0.6	0.0	0.0	2.6
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;kidney: 30.8"	"Group enriched"	"Detected in some"	5	"Peritubular cells: 33.2;Proximal tubular cells: 21.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 1.9;Karpas-707: 6.4;SH-SY5Y: 7.3;U-266/70: 6.0;U-266/84: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		68000	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.5	0.6	2.0	1.1	8.0	1.1	1.0	1.7	6.7	0.5	1.3	35.2	0.4	2.0	0.5	6.9	1.3	0.5	0.8	0.5	5.4	3.5	30.8	0.4	0.6	1.1	26.1	3.3	13.7	0.3	0.3	4.1	0.4	19.5	2.7	1.3	7.7	0.9	6.9	0.4	0.5	2.5	0.4	28.2	1.2	1.5	2.7	14.0	0.0	0.5	0.0	3.1	0.9	0.7	0.9	0.8	2.2	0.9	1.5	0.6	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	0.7	0.3	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.2	7.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.1	0.0	0.1	6.0	3.2	0.1	0.1	0.1	0.0	2.2	0.9	0.6	0.5	0.5	0.6	0.7	0.4	0.3	0.1	0.9	0.4	0.5	1.7	1.5	0.3	0.8	0.5	0.1	2.0	8.0	1.7	6.7	5.4	3.5	26.1	3.3	19.5	14.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.9	0.8	0.2	0.0	0.0	0.2	0.0	0.2	0.1	5.7	0.0	0.2	0.0	0.0	0.0	0.6	0.0	3.7	0.0	1.7	1.8	0.0	0.0	0.0	0.0	33.2	21.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387713-184474580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 173.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 50.9;Karpas-707: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	27.5	30.6	15.2	31.0	19.3	11.3	21.0	21.5	16.4	21.5	23.7	28.8	16.6	21.2	19.8	16.5	20.5	18.1	17.3	16.1	15.3	12.1	15.3	26.1	24.0	38.7	22.8	9.7	28.0	14.9	12.4	24.5	19.7	17.8	20.5	20.4	16.8	22.1	16.1	21.9	18.1	27.7	21.2	22.4	39.4	21.3	8.4	22.0	36.1	24.0	12.6	34.5	28.8	26.4	22.2	16.2	83.9	27.5	18.1	21.9	17.2	6.1	4.5	5.6	3.7	12.3	12.7	3.3	4.5	14.2	11.1	11.7	1.3	11.9	3.8	2.4	6.7	9.1	5.7	3.8	8.6	7.2	50.9	2.1	10.5	2.5	8.2	12.2	6.4	8.9	13.6	7.9	6.3	16.5	9.6	8.4	4.6	2.0	53.1	4.6	4.3	12.3	7.8	1.2	5.6	3.3	16.2	2.1	16.9	8.5	9.5	2.4	3.7	6.4	5.3	9.3	2.4	4.1	5.8	6.9	3.2	3.5	3.6	3.9	15.2	12.1	3.3	6.7	6.3	5.6	17.7	19.4	34.5	16.4	25.3	16.9	21.2	16.3	17.6	16.2	22.2	17.5	17.3	83.9	18.1	27.5	4.1	21.9	17.2	15.2	19.3	21.5	16.4	15.3	12.1	22.8	9.7	17.8	22.0	35.7	23.2	51.9	43.4	43.6	11.8	19.6	28.1	64.3	26.1	24.4	5.9	27.6	31.5	24.5	0.1	35.9	32.5	23.3	26.4	13.4	30.4	57.1	26.5	32.6	42.8	19.1	29.4	37.4	73.6	1.3	34.5	47.6	18.6	173.1	25.9	25.5	27.3	37.4	49.8	23.7	7.8	38.8	24.7	0.2	1.1	38.9	22.3	58.6	20.9	59.3
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		310000	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.3	4.7	18.7	8.9	11.6	15.5	10.8	25.3	19.2	17.8	10.3	8.5	7.1	11.7	4.0	12.3	8.4	7.2	14.8	9.0	20.3	30.0	8.1	18.7	3.7	19.7	13.9	15.2	17.8	21.1	11.0	11.3	9.1	12.8	22.0	12.1	15.4	74.2	18.3	3.6	24.0	14.2	18.5	9.3	5.9	17.4	8.8	11.3	15.3	13.8	10.7	11.7	10.9	10.0	14.2	19.4	5.4	9.9	14.9	8.1	7.5	6.0	11.7	34.5	32.3	8.0	9.9	10.6	11.5	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9	17.9	12.0	18.6	18.8	43.3	17.6	14.1	5.1	25.4	20.5	12.2	0.0	41.4	11.6	16.0	7.6	23.3	28.6	0.0	20.9	27.1	16.9	14.4	17.3	12.9	20.5	12.7	17.3	20.9	25.1	3.2	6.9	17.5	28.7	55.9	34.1	13.8	20.4	19.9	7.1	6.5	10.2	12.9	14.4	7.5	14.2	25.0	43.0	36.2	21.5	31.5
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649613-184694963	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 18.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	12.3	12.6	8.3	17.0	11.5	9.1	13.5	14.6	11.0	17.7	14.3	15.4	18.1	6.9	25.4	13.1	12.0	15.1	14.6	12.0	8.0	8.3	8.6	9.9	11.3	10.8	8.4	11.5	18.7	9.0	9.8	14.0	10.8	10.2	14.8	13.2	12.0	11.0	17.9	10.3	10.0	11.2	14.8	14.7	11.9	11.0	8.0	10.2	15.0	12.1	6.4	10.8	16.3	15.9	3.3	2.5	18.6	4.1	3.6	4.9	2.6	9.4	3.8	9.6	11.0	12.8	16.7	6.5	9.2	15.2	16.2	14.3	3.0	9.2	5.4	3.5	7.1	9.3	5.6	7.8	9.8	17.2	10.9	4.0	5.7	5.5	3.6	8.3	4.9	8.5	10.5	8.1	14.8	9.8	9.5	8.5	14.7	11.3	18.7	11.5	3.1	9.4	4.2	3.2	4.3	3.4	8.6	7.0	6.1	8.1	5.7	7.3	9.1	5.7	1.6	10.4	8.0	4.9	8.6	4.5	5.4	7.3	4.4	6.2	9.5	6.8	2.7	8.0	6.3	13.5	7.8	2.0	18.6	3.5	1.9	4.9	3.1	3.2	3.4	2.5	3.3	2.7	2.7	1.0	3.6	4.1	2.2	3.7	2.6	8.3	11.5	14.6	11.0	8.0	8.3	8.4	11.5	10.2	10.2	6.0	7.5	3.7	10.1	8.5	5.8	2.0	10.2	17.4	9.1	5.2	0.0	11.3	5.0	6.4	4.0	4.2	6.1	0.0	4.5	8.4	8.3	4.1	15.0	5.4	8.3	7.9	6.4	8.0	11.8	4.1	11.5	6.1	8.5	6.4	61.4	10.1	3.6	7.0	8.5	4.7	8.2	12.9	7.0	18.0	9.4	8.5	4.1	8.6	8.1	3.3
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694618-184734133	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 353.4;Late spermatids: 668.4;Spermatocytes: 448.9;Spermatogonia: 166.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 14.1;eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 58.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	2.7	1.7	1.4	7.8	1.0	30.7	3.1	1.2	1.3	2.8	4.4	1.2	2.9	2.8	1.4	3.2	11.2	0.9	1.7	1.0	1.2	0.6	1.4	2.3	2.0	9.5	1.3	0.2	1.1	1.3	0.7	0.6	7.0	1.0	2.0	5.1	0.9	3.5	0.5	1.2	7.1	5.2	1.5	1.0	5.8	2.3	50.2	0.6	30.0	0.9	7.3	9.1	1.6	4.5	0.8	1.7	14.3	2.8	3.0	2.5	0.7	23.3	6.6	28.4	14.3	1.5	2.5	15.1	14.1	6.3	11.6	8.0	7.9	13.5	19.5	1.3	6.6	8.9	9.4	23.4	14.4	11.8	9.4	9.3	16.8	6.0	4.0	0.2	29.6	11.7	1.2	0.7	14.2	2.7	3.9	12.0	20.2	18.4	58.6	21.6	15.5	38.0	18.9	15.0	5.6	8.9	30.1	9.2	5.7	6.4	9.0	20.1	21.4	10.2	13.1	10.7	12.1	18.0	16.2	7.2	10.4	13.5	10.6	16.2	8.7	8.7	16.0	14.5	23.0	33.9	14.1	0.7	14.3	0.6	1.9	0.4	0.8	1.0	1.0	0.5	0.8	0.6	0.8	0.1	3.0	2.8	1.7	2.5	0.7	1.4	1.0	1.2	1.3	1.2	0.6	1.3	0.2	1.0	0.6	8.9	2.7	6.0	3.6	12.4	0.9	2.4	2.5	6.7	10.3	1.8	0.0	13.0	3.3	4.4	353.4	0.7	1.1	23.3	2.2	45.0	5.2	2.9	9.2	0.8	18.2	0.0	0.0	1.3	5.4	668.4	8.3	9.9	0.0	7.2	5.6	0.3	2.7	0.0	6.3	0.6	1.3	19.4	1.0	448.9	166.7	18.7	6.3	4.4	8.5	5.4
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 2.9;lung: 2.2;skin 1: 2.0"	"Cell type enriched"	"Detected in single"	9	"Distal tubular cells: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 5.2;HEK 293: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain					NA	NA					"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.5	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"		"Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 4236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.3	2.7	5.5	3.0	0.3	5.0	2.7	0.9	3.3	3.3	7.1	1.8	2.4	2.0	3.3	2.6	2.6	10.4	2.9	2.2	4.0	8.9	1.6	4.9	8.3	6.1	1.4	1.6	2.2	7.1	5.1	1.4	7.8	2.4	4.2	3.8	1.9	2.0	5.1	1.6	3.2	4.4	2.3	7.1	2.6	1.4	3.3	7.5	5.1	8.8	6.7	3.2	1.4	12.6	5.1	2.6	1.2	1.8	0.2	1.5	1.7	3.5	7.9	3.6	3.1	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3	80.4	55.4	33.5	125.8	39.2	174.4	4236.1	140.1	112.4	42.1	68.0	98.2	59.7	837.3	68.4	15.8	25.9	41.2	0.0	65.1	47.9	24.6	55.0	11.5	83.9	50.1	151.0	51.6	24.5	7.6	7.7	43.1	7.9	180.5	15.4	35.7	473.2	51.1	24.6	106.1	140.9	178.4	103.5	194.8	24.0	35.3	15.8	33.9	10.7	48.8	46.9
CFAP97	"DKFZp434F1728, hmw, KIAA1430"	ENSG00000164323	"Cilia and flagella associated protein 97"	Q9P2B7	4	185159665-185209504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 196.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049446, HPA053335"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049446: AB_2680770, HPA053335: AB_2682117"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.29e-1)"	23.2	12.5	11.2	17.2	13.7	4.4	19.5	11.6	15.1	18.7	15.9	8.8	17.1	7.0	19.2	13.3	18.2	15.2	14.2	13.2	11.3	10.3	18.4	24.8	15.0	19.4	12.7	12.5	25.4	13.7	23.2	20.7	12.7	13.5	19.2	10.8	10.7	15.0	23.6	11.6	13.0	9.9	21.8	17.4	19.2	12.5	32.2	14.5	14.7	25.8	11.9	14.5	27.9	14.7	17.0	16.0	3.5	9.4	10.2	19.3	5.3	12.2	7.7	10.3	17.7	12.2	21.2	6.2	16.0	14.6	12.3	9.6	4.7	15.6	31.0	5.6	18.9	9.3	6.8	11.4	14.4	16.6	27.4	7.5	12.5	4.7	11.1	15.1	16.2	9.9	14.0	20.2	13.5	29.7	15.5	10.7	14.6	21.9	29.2	17.3	5.9	8.5	8.4	5.9	3.9	6.3	13.4	5.0	19.1	15.2	6.7	7.0	18.7	12.1	11.9	22.9	6.3	7.9	10.4	15.3	11.5	7.3	4.5	12.9	11.6	5.1	9.6	14.7	14.7	23.4	3.5	3.7	1.4	16.0	6.3	19.3	17.0	16.0	15.5	4.5	16.3	16.1	11.2	0.7	10.2	9.4	16.0	10.7	5.3	11.2	13.7	11.6	15.1	11.3	10.3	12.7	12.5	13.5	14.5	59.6	32.9	20.5	43.4	0.0	54.9	23.8	40.8	66.9	42.1	43.6	49.1	23.9	59.7	46.0	196.2	42.5	3.4	23.3	44.3	27.8	20.0	39.8	25.6	55.1	17.9	65.2	11.7	37.4	23.9	108.2	75.6	16.4	0.0	50.5	14.6	57.4	41.0	3.5	82.4	68.8	62.4	71.1	35.6	177.3	98.2	0.0	13.2	20.0	17.9	32.1
SNX25	SBBI31	ENSG00000109762	"Sorting nexin 25"	Q9H3E2	4	185204237-185370185	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 113.6"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6"	"Group enriched"	"Detected in many"	4	"B-cells: 3.6;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036928			Supported	Vesicles		NA	NA			Vesicles		"HPA036928: AB_10669720"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.89e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.55e-3)"	3.0	3.7	2.6	2.9	5.3	0.1	4.6	11.9	4.2	2.7	5.6			1.1	3.3	2.8	3.1	4.7	3.9	4.4	3.3	5.6	5.6	4.1	15.1	4.9	4.6		3.4	4.6	7.2	5.7	5.6		7.9	3.0		2.8	4.3	4.8	2.5	3.5	3.1	2.1	4.2	2.6	5.9			8.5		6.0	3.8	2.2	3.6	0.2	0.0	0.2	0.6	1.5	0.2	5.8	3.1	3.9	5.6	10.6	7.9	5.9	18.0	8.6	9.1	7.6	2.6	4.1	16.8	2.0	12.8	6.3	2.3	4.5	3.9	10.3	27.8	7.5	2.8	3.8	6.1	6.2	1.9	4.1	5.4	4.3	7.9	4.4	18.4	7.9	3.1	5.9	16.9	12.0	1.7	0.7	3.3	3.2	0.8	3.0	2.4	4.5	4.2	22.1	2.2	8.5	6.2	3.7	1.0	14.7	5.9	2.1	2.4	15.2	5.2	3.4	5.0	7.8	15.3	6.2	3.6	8.6	1.4	6.5	0.0	0.0	0.0	0.6	0.2	1.0	2.5	1.3	1.5	0.0	3.6	0.4	0.9	0.0	0.6	0.0	0.2	0.8	0.2											23.8	113.6	3.7	3.4	4.2	14.7	6.0	0.0	6.7	10.3	5.2	29.5	3.4	0.0	5.2	5.6	8.9	4.5	0.0	2.2	4.0	3.3	8.0	1.1	7.3	1.6	6.4	0.0	9.2	3.5	3.4	8.9	2.2	20.3	1.0	4.7	5.8	3.5	0.0	9.2	2.1	15.9	0.0	5.1	3.7	17.6	5.4	4.7	5.0	2.4	3.8
LRP2BP	DKFZp761O0113	ENSG00000109771	"LRP2 binding protein"	Q9P2M1	4	185363879-185395899	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 19.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 28.6;Cone photoreceptor cells: 31.4;Early spermatids: 52.8;Horizontal cells: 25.4;Late spermatids: 29.3;Rod photoreceptor cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036664, HPA036665"	Approved					NA	NA					"HPA036664: AB_10672361, HPA036665: AB_10673660"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.15e-5)"	"unprognostic (2.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-4)"	"unprognostic (2.17e-2)"	"unprognostic (9.76e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-4)"	2.8	3.9	7.0	1.9	6.9	1.4	2.7	10.7	8.8	2.1	2.3	8.7	0.9	1.1	3.2	6.5	1.8	15.1	2.5	3.3	6.9	7.3	2.6	1.4	5.1	1.8	8.8	4.0	6.5	3.3	1.1	15.5	1.7	5.5	2.6	1.4	3.4	2.7	2.0	4.6	3.1	1.7	1.9	9.5	2.3	2.1	19.9	10.7	0.4	4.8	1.4	1.0	3.4	2.4	2.4	2.3	1.0	0.6	0.8	2.6	0.4	1.1	0.8	1.0	2.2	0.5	0.4	2.0	2.8	0.9	0.3	0.7	1.0	1.1	3.3	0.3	0.3	1.1	0.7	0.7	0.5	0.6	3.3	1.8	0.9	2.6	2.9	0.5	0.6	1.1	0.6	0.7	1.5	0.6	2.9	1.1	3.0	1.5	2.8	1.0	0.2	1.2	2.5	1.2	0.2	0.4	0.5	0.6	0.8	0.9	0.6	2.5	2.0	0.8	0.8	1.8	1.5	0.8	0.2	2.7	1.6	1.2	0.6	1.5	11.5	1.2	0.6	3.0	0.7	1.1	0.3	0.4	0.4	1.2	0.2	1.2	2.1	1.7	1.3	0.1	2.4	2.6	1.4	1.0	0.8	0.6	2.3	1.6	0.4	7.0	6.9	10.7	8.8	6.9	7.3	8.8	4.0	5.5	10.7	8.9	1.6	0.8	3.4	2.2	28.6	3.9	0.0	18.7	2.3	0.0	31.4	0.9	0.0	1.3	52.8	3.1	1.4	0.0	0.8	1.9	1.8	3.6	0.0	0.0	0.4	25.4	7.5	1.8	0.0	29.3	2.6	1.2	5.0	1.0	1.7	10.3	0.9	0.0	3.5	1.3	36.6	0.0	3.4	3.5	1.4	2.8	1.4	1.7	1.1	1.7
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	7.7	8.9	11.0	3.9	15.2	3.3	10.9	9.9	20.9	17.2	7.5	6.0	5.4	4.8	4.9	4.1	35.8	8.0	4.8	13.6	12.0	9.6	6.4	14.2	12.4	3.0	12.3	5.8	14.8	13.5	1.7	11.7	10.7	16.8	24.1	7.0	8.4	35.4	21.9	22.1	7.3	4.9	5.0	16.1	4.6	5.2	8.7	14.2	1.5	14.2	18.6	12.2	14.3	22.8	7.7	4.2	10.2	3.9	3.2	8.1	3.0	6.2	0.9	0.7	3.6	4.9	3.1	3.4	2.9	2.2	2.1	4.7	1.5	1.8	3.0	1.2	5.3	4.4	2.4	3.4	3.7	2.7	8.5	0.9	2.0	3.2	4.5	2.1	1.9	4.7	0.6	4.0	2.0	2.8	15.7	2.7	2.0	3.1	5.1	5.9	1.6	1.6	7.5	1.0	0.6	5.0	0.5	1.0	8.2	2.6	0.5	5.0	8.9	2.0	2.0	8.6	2.7	1.8	1.2	3.5	4.6	3.7	2.6	3.3	9.6	2.8	1.3	13.1	1.4	5.3	0.4	3.8	10.2	5.5	3.5	4.7	7.6	4.3	8.1	2.6	7.7	3.3	4.7	2.0	3.2	3.9	4.2	5.1	3.0	11.0	15.2	9.9	20.9	12.0	9.6	12.3	5.8	16.8	14.2	20.8	23.7	16.6	23.8	52.8	24.8	1.2	0.0	101.7	22.7	8.7	27.5	15.7	21.6	17.9	3.7	11.7	61.7	23.3	20.0	36.6	28.6	40.4	63.2	20.4	13.8	9.5	115.1	10.4	6.7	2.0	8.6	24.5	135.0	28.9	93.8	89.4	40.5	35.1	11.0	15.7	103.2	6.5	35.0	13.3	15.1	42.0	70.6	11.7	31.3	16.2
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399540-185425985	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	15.8	20.3	12.5	10.3	14.9	4.1	18.7	11.3	20.3	17.3	17.4	16.3	17.0	11.0	19.4	17.4	20.1	17.3	13.5	24.2	11.4	11.7	28.1	19.2	13.2	11.6	14.6	11.3	30.5	20.1	18.3	22.8	12.3	17.0	18.4	12.6	13.7	14.4	20.3	40.8	16.6	13.6	16.9	20.2	14.2	17.3	23.7	14.6	15.8	23.5	19.2	12.2	20.8	13.3	15.6	13.0	5.5	7.9	13.9	17.9	8.2	12.2	7.5	21.1	15.2	19.1	19.8	11.7	12.7	12.9	15.2	14.4	12.5	15.7	12.3	5.9	15.3	11.4	9.7	16.4	20.6	15.8	13.2	9.5	6.5	7.3	11.3	21.1	9.9	8.1	11.6	16.1	13.3	13.7	19.6	24.3	16.0	16.5	24.9	19.6	7.4	13.2	7.4	5.4	8.9	10.8	13.0	8.3	14.8	14.6	7.1	12.6	11.8	7.9	12.9	15.4	13.1	9.9	7.0	14.1	6.3	11.2	4.4	9.8	22.7	8.7	5.9	20.5	6.2	16.1	5.5	7.9	5.4	16.3	6.8	17.1	15.6	16.5	17.6	9.8	11.0	17.8	17.9	0.4	13.9	6.6	13.0	14.0	8.2	12.5	14.9	11.3	20.3	11.4	11.7	14.6	11.3	17.0	14.6	6.0	19.2	16.7	28.0	19.6	46.6	23.8	10.2	28.1	29.6	19.2	62.8	22.2	94.5	25.2	125.0	22.7	9.1	23.3	28.8	24.6	26.8	16.4	27.8	14.9	23.8	17.5	18.6	14.1	16.7	32.5	32.8	19.1	33.7	14.4	16.8	50.3	19.5	19.3	39.6	62.7	79.4	64.7	30.1	53.7	53.4	16.6	35.0	21.5	15.3	15.4
C4orf47	LOC441054	ENSG00000205129	"Chromosome 4 open reading frame 47"	A7E2U8	4	185426249-185449826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8;fallopian tube: 20.3;testis: 20.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 125.8;Early spermatids: 125.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;hTERT-RPE1: 8.3;U-87 MG: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043662, HPA063485"	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"HPA043662: AB_10964715, HPA063485: "	"unprognostic (3.38e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.82e-5)"	"unprognostic (3.72e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.50e-1)"	0.9	0.5	4.4	0.7	13.3	0.8	3.7	1.7	4.0	1.8	0.7	3.6	0.8	0.6	2.2	12.3	0.7	20.3	1.8	1.2	3.8	3.8	2.4	1.0	3.3	0.5	2.4	2.9	3.0	1.3	1.0	7.1	0.7	20.8	1.2	0.7	2.1	1.0	1.4	0.6	1.9	0.7	1.0	4.7	0.8	0.5	20.6	5.5	0.0	7.3	0.0	0.6	1.0	0.6	0.1	0.7	4.1	0.6	0.9	0.6	0.2	3.9	0.0	0.4	2.1	0.8	4.1	1.2	0.1	0.3	0.3	0.5	0.6	2.4	0.1	0.8	0.1	0.4	0.3	0.5	0.6	0.9	0.8	0.7	0.0	0.1	0.6	1.0	0.0	0.3	0.9	0.9	1.0	0.4	8.3	0.0	0.9	0.5	0.2	3.0	0.5	0.0	0.0	0.5	0.0	1.5	0.1	0.0	0.3	1.1	0.1	2.2	1.0	0.7	0.1	2.4	0.8	0.2	0.6	1.2	0.6	0.3	0.0	0.1	1.7	0.0	0.0	10.0	0.0	0.2	0.0	0.6	0.6	0.2	0.1	0.4	0.0	0.6	0.6	0.2	0.1	0.1	0.2	4.1	0.9	0.2	0.7	0.0	0.2	4.4	13.3	1.7	4.0	3.8	3.8	2.4	2.9	20.8	5.5	3.0	1.0	0.0	0.5	0.6	0.6	0.5	0.0	125.8	17.0	3.5	9.8	0.1	1.7	1.2	125.8	0.6	0.0	0.0	0.5	1.2	0.8	1.2	0.0	0.0	0.2	1.6	0.0	1.3	0.3	7.5	0.6	0.4	1.7	0.0	0.0	1.6	1.4	0.0	0.7	3.2	14.2	0.0	1.0	3.5	4.3	0.5	0.2	0.0	0.0	0.3
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.9;testis: 49.2"	"Cell type enhanced"	"Detected in many"	31	"Early spermatids: 458.9;Late spermatids: 84.6;Spermatocytes: 151.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 11.0;U-266/70: 9.1;U-266/84: 10.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.7	0.8	0.8	1.1	5.0	0.0	1.8	3.4	1.6	1.9	1.5	0.2	2.2	0.4	0.7	2.7	1.3	1.5	0.6	0.8	1.0	1.0	1.6	0.6	0.5	0.5	0.8	1.0	2.5	15.9	0.4	8.5	0.3	3.0	2.4	0.9	0.9	4.6	1.7	2.9	0.6	0.6	0.7	0.7	0.6	1.5	49.2	1.2	0.0	6.2	0.0	0.5	2.8	1.6	0.8	0.0	0.0	0.0	0.0	2.8	0.2	0.5	0.0	0.3	0.2	2.8	3.1	0.1	0.0	0.0	0.0	0.2	0.0	2.0	3.3	0.5	0.0	2.9	0.4	2.1	0.0	0.2	1.9	2.6	0.0	0.1	0.0	1.4	0.0	0.0	0.8	0.0	1.2	0.0	1.7	1.0	0.9	0.2	0.3	3.5	0.8	0.0	0.0	0.3	0.3	1.6	0.2	0.0	0.5	0.7	0.0	11.0	2.3	0.0	1.1	1.0	0.5	4.9	0.0	0.6	0.4	0.9	0.2	0.1	9.1	10.7	0.0	5.1	0.0	0.7	0.0	0.0	0.0	0.4	0.0	1.1	0.8	0.1	0.4	0.0	0.2	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	5.0	3.4	1.6	1.0	1.0	0.8	1.0	3.0	1.2	0.0	0.0	0.0	0.4	0.2	0.5	3.9	0.0	8.1	0.0	1.8	0.0	0.0	1.7	1.7	458.9	1.0	0.0	0.0	2.9	0.1	1.1	0.4	0.0	0.4	0.1	0.0	0.0	2.5	0.0	84.6	6.6	0.0	3.3	0.0	0.7	2.4	3.4	0.0	5.6	0.8	5.0	0.0	1.4	151.8	4.1	0.4	0.0	0.0	0.7	0.0
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535612	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 447.7"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 159.2;Ductal cells: 168.1;Melanocytes: 118.1;Peritubular cells: 184.2;Smooth muscle cells: 182.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 51.1;RH-30: 12.6;U-266/70: 41.1;U-266/84: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		NA	NA		270000	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.78e-3)"	7.8	1.2	1.6	5.2	1.9	0.1	3.7	2.2	1.0	6.6	16.5	1.4	7.9	2.3	22.2	17.0	27.2	9.3	9.9	29.5	1.5	1.6	0.8	0.8	5.6	1.4	1.6	1.0	11.1	2.1	0.1	1.9	2.2	1.6	15.2	3.6	4.8	5.3	18.7	447.7	1.0	6.1	49.5	1.4	3.4	10.2	3.9	0.7	0.1	6.2	87.3	9.1	28.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.4	1.9	5.6	0.0	0.0	4.0	0.0	1.2	0.0	5.1	4.2	0.0	0.0	0.0	51.1	0.0	0.0	0.0	0.9	0.0	0.4	0.0	12.6	0.1	0.0	0.0	7.6	5.7	0.0	0.0	3.0	1.5	0.3	0.0	2.8	0.0	3.0	0.0	2.6	41.1	11.6	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	2.2	1.0	1.5	1.6	1.6	1.0	1.6	0.7	8.9	5.9	0.0	9.4	7.9	7.2	159.2	7.6	5.3	3.4	0.0	11.8	1.4	0.0	168.1	0.3	50.8	0.0	0.0	14.6	2.1	51.6	14.4	0.0	0.6	1.3	4.8	3.4	65.1	2.7	1.5	18.1	4.4	118.1	5.4	0.0	30.9	51.1	0.0	184.2	0.0	39.4	103.5	182.4	2.8	12.4	6.1	10.2	0.0	0.0	4.1
SORBS2	"ARGBP2, KIAA0777"	ENSG00000154556	"Sorbin and SH3 domain containing 2"	O94875	4	185585444-185956652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 141.4;urinary bladder: 126.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 512.4;Cone photoreceptor cells: 726.5;Muller glia cells: 377.2;Rod photoreceptor cells: 785.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 68.1;TIME: 36.7;WM-115: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.30e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (1.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.51e-2)"	10.3	45.6	6.3	13.7	11.3	0.4	10.0	4.3	9.9	16.5	27.4	2.7	16.7	2.9	11.1	13.7	44.5	9.9	26.6	141.4	5.6	4.7	8.7	31.8	5.1	1.5	4.4	5.4	8.2	28.9	46.9	12.8	17.0	7.9	52.7	6.9	43.3	17.9	21.9	6.5	3.1	6.1	111.0	3.6	6.5	15.3	4.4	2.8	2.4	71.2	9.0	4.5	126.4	29.0	1.3	0.0	0.5	0.0	0.0	0.2	1.3	0.1	0.1	68.1	0.0	9.7	17.1	3.4	0.1	0.0	0.0	0.1	1.8	5.3	0.0	7.3	0.6	0.4	0.0	0.0	2.4	0.0	0.0	1.0	0.9	5.3	4.3	0.0	0.0	0.0	6.3	0.7	10.2	0.7	9.0	12.6	1.8	0.0	0.0	0.7	0.0	0.0	0.1	6.4	0.0	0.0	6.3	0.0	0.0	9.3	1.6	8.5	2.5	0.0	0.0	3.8	6.9	2.0	0.0	36.7	5.1	0.6	0.0	2.5	0.0	0.0	0.0	11.3	0.0	20.4	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	6.3	11.3	4.3	9.9	5.6	4.7	4.4	5.4	7.9	2.8	20.8	33.8	0.0	14.9	5.8	53.0	512.4	206.4	61.6	31.8	61.1	726.5	10.0	5.0	115.9	2.7	68.1	8.5	46.7	96.6	2.9	9.5	34.8	2.3	158.4	1.4	4.8	40.2	19.6	2.7	4.6	5.2	3.4	18.6	5.4	11.7	377.2	65.8	21.0	3.5	15.4	785.5	116.4	294.8	0.2	0.9	4.8	9.2	0.0	27.3	12.4
TLR3	CD283	ENSG00000164342	"Toll like receptor 3"	O15455	4	186069152-186088069	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Receptor, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 48.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 46.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 7.6;memory CD8 T-cell: 8.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.5;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.6;ASC TERT1: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;CAPAN-2: 28.0;HSkMC: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025658	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025658: "	"unprognostic (2.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.83e-1)"	11.9	10.7	3.1	6.8	5.0	0.0	11.1	1.7	3.5	9.9	20.1	3.0	6.8	13.4	5.6	7.3	12.9	7.8	8.6	7.7	3.5	2.6	12.4	11.2	12.2	1.0	3.3	1.9	8.9	8.2	4.8	2.7	48.1	3.0	11.3	9.5	5.0	8.5	10.2	2.3	3.8	34.9	6.5	8.0	7.0	8.2	5.8	4.2	1.2	11.8	7.6	3.0	10.3	14.6	0.0	2.5	0.5	0.0	0.7	8.0	1.1	1.9	0.5	0.3	0.0	11.6	12.1	0.9	0.1	8.4	5.1	18.0	0.0	28.0	0.0	1.1	1.2	10.2	2.9	0.0	5.8	0.9	10.7	0.1	1.7	0.5	0.0	5.1	1.8	0.7	11.9	2.2	6.8	0.3	3.1	2.4	1.8	0.0	0.0	2.9	0.0	2.0	0.0	0.9	0.0	1.0	2.6	0.0	0.1	4.9	2.7	0.0	0.1	1.5	1.2	2.3	0.1	0.3	0.0	1.7	0.9	0.6	0.0	1.2	0.0	0.0	0.0	2.4	1.2	2.0	0.5	0.0	0.0	7.6	0.0	4.3	0.0	1.8	8.0	2.5	0.0	1.2	3.9	0.3	0.7	0.0	0.0	0.2	1.1	3.1	5.0	1.7	3.5	3.5	2.6	3.3	1.9	3.0	4.2	17.9	5.6	1.3	3.2	3.4	0.0	0.8	17.8	2.7	11.4	14.0	0.0	16.9	0.0	6.4	46.2	3.2	14.4	0.0	8.7	4.6	4.0	2.6	2.3	6.4	2.3	0.0	1.2	6.7	0.3	3.8	7.8	2.5	0.0	0.0	6.7	3.8	6.2	8.6	3.5	5.4	0.4	0.0	1.4	0.0	0.4	0.9	16.4	0.0	4.5	5.0
FAM149A	"DKFZP564J102, MST119, MSTP119"	ENSG00000109794	"Family with sequence similarity 149 member A"	A5PLN7	4	186104419-186172667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.7"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 34.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 11.3;JURKAT: 8.1;MOLT-4: 8.0;RT4: 9.3;SCLC-21H: 14.2"					"Low region specificity"	"Detected in all"			"HPA044019, HPA055004"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044019: AB_2732513, HPA055004: AB_2682667"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.64e-2)"	"prognostic favorable (2.67e-6)"	"unprognostic (7.08e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.36e-1)"	8.7	4.3	17.6	3.7	22.7	0.3	8.6	5.1	12.4	6.1	7.3	8.2	4.7	4.6	6.0	9.8	9.1	11.1	12.8	7.3	15.4	10.0	27.3	37.7	4.3	1.1	8.9	5.8	6.2	19.6	8.8	3.7	1.9	7.4	7.5	6.2	12.2	12.2	13.3	7.0	1.7	3.9	13.8	12.4	1.9	8.4	3.6	5.7	1.0	2.7	3.2	1.5	8.4	4.9	1.0	0.7	0.2	0.0	0.0	4.0	0.0	0.0	3.2	2.9	0.1	11.3	4.6	0.1	0.0	0.0	0.3	0.3	0.0	1.9	0.0	1.6	1.5	2.9	0.0	5.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.7	0.1	0.2	2.1	0.3	0.2	0.0	1.1	0.0	8.1	0.0	2.5	1.3	1.6	8.0	0.3	5.1	0.0	0.0	0.3	0.0	2.0	1.7	9.3	14.2	3.9	0.1	0.0	4.4	0.9	1.0	0.0	0.8	0.2	1.7	0.0	1.6	0.0	0.0	0.0	0.8	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.1	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.7	4.0	0.0	17.6	22.7	5.1	12.4	15.4	10.0	8.9	5.8	7.4	5.7	0.0	1.0	0.0	2.3	0.5	11.0	6.9	17.8	10.7	6.8	5.2	43.2	0.6	5.0	8.6	10.0	0.3	0.8	0.0	4.8	0.7	2.0	2.4	0.0	11.4	0.2	1.6	9.1	1.3	1.5	3.2	3.1	1.6	3.3	0.0	2.7	20.8	4.0	3.5	3.9	7.7	34.6	6.5	2.2	1.0	2.8	0.3	0.7	0.0	3.0	1.8
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191520-186213456	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 92.7;Muller glia cells: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.1;SK-MEL-30: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	6.6	16.6	7.8	5.0	12.4	1.6	5.5	8.9	7.5	6.7	8.0	8.9	4.9	11.4	5.7	4.2	5.2	6.2	13.7	7.4	7.7	4.6	21.6	64.7	7.3	4.1	7.7	9.0	6.3	12.1	30.8	16.1	3.0	6.7	5.6	8.2	19.1	6.2	9.1	3.3	2.8	14.7	6.4	7.0	7.5	5.2	3.2	7.4	4.4	11.9	2.1	3.8	8.0	5.1	2.3	2.5	0.0	6.2	1.3	4.0	1.5	2.6	1.8	0.6	0.0	11.3	4.6	0.1	3.8	8.1	1.4	2.0	0.0	10.9	1.0	0.5	2.5	5.7	1.3	1.3	1.2	0.4	6.5	1.3	4.1	0.4	0.5	3.4	2.2	2.0	4.2	0.5	1.4	0.7	4.7	0.1	4.2	1.6	13.1	4.7	2.3	2.5	0.6	1.4	1.1	0.0	2.1	0.5	1.1	4.6	5.2	2.8	4.1	0.9	0.0	19.4	0.2	1.9	3.5	4.2	3.0	0.7	3.3	1.6	0.0	0.0	0.5	9.0	8.3	3.6	0.0	1.2	0.0	4.0	4.1	2.5	1.0	2.5	3.4	1.5	2.3	2.7	2.3	0.0	1.3	6.2	2.5	2.1	1.5	7.8	12.4	8.9	7.5	7.7	4.6	7.7	9.0	6.7	7.4	6.0	7.8	8.3	3.1	2.3	31.1	15.3	45.9	12.0	10.3	14.0	29.5	1.8	8.3	16.1	2.4	5.5	19.2	0.0	19.5	1.7	8.4	5.5	6.9	92.7	11.5	4.8	16.3	9.2	11.2	1.7	4.6	7.1	3.3	0.0	19.1	64.2	11.0	10.5	6.0	31.8	27.1	0.0	10.2	8.1	5.4	2.8	0.8	10.7	8.9	5.0
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 102.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 203.0"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.3;SCLC-21H: 5.0;SK-MEL-30: 2.2;U-937: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	28900000000	4900000000				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.3	0.3	0.8	0.3	1.2	0.0	0.3	0.7	0.5	0.3	0.4	0.3	0.3	0.7	0.4	0.4	0.3	0.2	0.7	0.5	0.6	0.5	1.3	102.9	0.3	0.3	0.5	0.5	0.3	1.3	0.5	1.0	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.5	0.1	0.6	0.3	0.3	0.5	0.0	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	7.3	0.1	0.0	0.1	0.0	0.2	1.3	0.0	5.0	0.4	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.2	0.7	0.5	0.6	0.5	0.5	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	17.8	1.4	0.0	1.8	15.7	0.0	0.0	1.1	2.2	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	203.0	0.2	0.0	2.9	5.5	3.2	0.8	0.6	0.0	0.0	0.0	0.3	14.6	0.7	0.3	0.0	0.9	3.6	0.0	0.2	1.4	0.9	0.0	0.0	0.0	0.4	0.0
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186265945-186288806	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 88.9"	"Cell type enhanced"	"Detected in some"	27	"Alveolar cells type 2: 19.3;Distal tubular cells: 10.0;Hepatocytes: 59.9"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 14.0"	"Not detected"	"Not detected"							HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	2.7	0.1	0.1	5.5	0.2	0.3	0.1	0.1	4.8	0.1	0.1	0.1	10.2	88.9	2.8	0.1	0.1	0.1	0.1	19.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.1	6.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.3	2.5	0.0	4.5	1.8	0.0	0.0	10.0	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC018709.1		ENSG00000272297			4	186426546-186555328	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	14	"testis: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 6.8;OE19: 3.6;T-47d: 3.5"															NA	NA																							0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0			0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.6	0.2	0.3	0.0	0.0	0.0	0.0		0.0	0.5	0.0	0.0	0.0		1.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.8;EFO-21: 2.0;HEK 293: 2.1;NTERA-2: 1.8;SCLC-21H: 1.6;SH-SY5Y: 3.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA								"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.1	1.2	0.1	0.0	0.0	3.8	0.2	0.0	3.1			0.3	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	5.7	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.0	2.4		0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5			0.0		0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAT1	"CDHF7, CDHR8, FAT"	ENSG00000083857	"FAT atypical cadherin 1"	Q14517	4	186587783-186726722	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.4"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 64.9;LHCN-M2: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001869, HPA023882"	Enhanced				"Intracellular and membrane"	NA	NA		120000			"HPA001869: AB_1078818, HPA023882: AB_1848429"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.80e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.25e-3)"	"unprognostic (4.27e-2)"	15.5	1.3	7.9	12.3	9.8	0.4	15.4	11.9	8.4	15.9	40.4	11.8	8.1	17.9	20.6	14.0	9.7	9.6	28.2	21.1	10.0	6.0	29.1	13.3	10.9	1.4	11.4	6.2	9.7	13.8	7.5	10.5	14.6	24.7	15.9	22.9	5.0	13.9	18.2	3.0	13.1	76.4	18.3	12.8	1.7	11.5	7.0	11.2	1.3	10.5	10.2	6.7	17.5	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	19.0	18.9	0.0	18.9	22.8	4.6	25.4	41.9	12.4	7.9	11.3	11.2	0.0	6.1	64.9	8.0	9.2	7.4	31.3	16.9	0.0	3.0	0.0	6.7	11.4	9.4	8.2	6.8	8.2	11.3	23.0	15.0	17.0	0.2	10.3	0.1	0.0	47.7	6.0	14.6	0.0	4.2	9.5	3.2	0.0	5.2	0.4	18.6	17.9	2.0	7.6	4.4	7.5	3.0	13.5	0.0	3.0	5.4	35.4	13.7	0.4	15.7	0.1	0.0	0.1	8.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	9.8	11.9	8.4	10.0	6.0	11.4	6.2	24.7	11.2	14.9	4.1	0.0	25.5	75.6	5.2	20.3	35.7	16.0	25.0	50.6	0.0	1.1	5.0	21.9	0.6	5.1	58.5	0.0	23.2	3.5	24.9	37.8	16.1	22.9	0.3	0.0	13.9	1.8	1.0	0.4	13.6	3.1	11.8	0.0	54.8	4.2	24.0	23.0	35.0	21.4	0.3	38.8	54.6	1.8	7.7	40.9	1.4	0.0	38.7	20.0
ZFP42	"REX1, ZNF754"	ENSG00000179059	"ZFP42 zinc finger protein"	Q96MM3	4	187995771-188005050	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.7;placenta: 6.6;testis: 7.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 41.4;Extravillous trophoblasts: 49.9"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 40.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"BEWO: 47.2;SuSa: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025557	Uncertain					NA	NA					"CAB025557: "	"unprognostic (2.30e-1)"					"unprognostic (1.07e-4)"		"unprognostic (4.88e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.77e-1)"				"unprognostic (3.86e-1)"	"unprognostic (2.27e-1)"		"unprognostic (4.66e-3)"	0.5	0.2	0.2	0.3	0.2	1.3	0.2	0.2	0.3	0.3	0.9	0.2	0.2	0.6	0.2	0.5	0.2	0.5	0.2	0.2	0.2	0.3	0.4	0.2	1.1	0.8	0.3	0.2	0.2	0.2	0.0	0.2	6.6	1.3	0.2	0.3	0.2	0.4	0.2	1.9	1.8	0.2	0.2	0.2	1.1	0.5	7.1	0.2	0.2	0.2	0.2	0.4	0.2	0.2	1.9	1.2	4.7	1.0	2.3	2.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	47.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	33.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	4.3	1.0	1.2	2.0	0.8	1.5	1.7	1.6	1.3	0.4	1.9	1.7	1.7	4.7	2.3	0.9	1.2	1.5	0.4	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	41.4	0.0	0.0	0.0	0.0	49.9	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	7.9	0.0	0.0	0.1
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell type enhanced"	"Detected in some"	17	"Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 58.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.6	0.0	0.0	0.0	0.0	7.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.3	2.4	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	58.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	5.5	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	0.0	7.4	0.0	0.0	0.3
TRIML1	"FLJ36180, RNF209"	ENSG00000184108	"Tripartite motif family like 1"	Q8N9V2	4	188139419-188147743	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 94.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA											"unprognostic (6.99e-2)"									"unprognostic (5.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	94.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.9	0.0	0.0	0.0
FRG1	"FRG1A, FSG1"	ENSG00000109536	"FSHD region gene 1"	Q14331	4	189940788-189963204	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Myogenesis, Ribosome biogenesis, rRNA processing"	"Actin-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA075683	Approved					NA	NA					"HPA075683: "	"unprognostic (1.67e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.84e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.01e-1)"	25.1	19.1	20.2	17.6	24.4	37.9	30.0	23.4	25.5	22.5	22.5	13.9	20.1	17.3	25.5	26.1	22.9	18.5	16.0	21.2	23.9	18.3	30.1	28.5	17.5	26.9	19.2	13.8	24.4	22.2	23.3	17.4	24.3	19.9	19.8	18.8	12.1	18.0	22.3	36.6	19.5	22.4	21.8	34.5	24.2	21.0	15.3	16.9	40.3	19.2	18.2	25.6	25.5	19.8	21.9	19.7	23.9	21.8	19.0	21.3	13.4	7.5	4.4	11.8	8.9	8.0	10.1	9.3	9.3	8.3	12.0	8.9	5.5	10.7	12.3	6.4	7.0	6.4	4.8	11.4	8.7	12.5	9.6	7.3	20.0	5.5	4.5	8.2	16.3	8.7	6.7	8.7	8.8	5.1	8.2	9.3	11.7	18.2	24.0	10.6	3.9	20.3	21.8	3.7	3.4	6.8	14.6	2.8	7.2	9.5	4.4	8.5	9.0	5.9	6.6	10.7	7.1	5.4	12.4	7.1	4.8	7.7	4.5	8.4	8.3	6.7	10.2	9.0	11.4	7.5	23.9	17.7	19.5	15.3	20.6	16.0	21.9	18.4	17.1	15.4	20.1	17.0	16.8	16.1	19.0	21.8	19.7	21.3	13.4	20.2	24.4	23.4	25.5	23.9	18.3	19.2	13.8	19.9	16.9	74.5	51.1	64.7	33.8	29.8	38.6	59.2	68.8	62.9	52.4	31.4	15.7	63.8	111.0	92.4	37.4	56.2	43.4	70.0	105.8	57.2	44.3	19.9	81.0	100.8	60.5	30.2	43.1	77.3	80.4	12.2	70.5	79.2	20.3	80.2	45.2	56.5	75.2	49.1	68.2	80.4	43.9	51.8	48.4	75.6	63.2	24.6	44.7	83.5	48.8	30.6
FRG2	FRG2A	ENSG00000205097	"FSHD region gene 2"	Q64ET8	4	190024351-190027257	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.0;brain: 2.8;skin 1: 3.8"	"Cell type enriched"	"Detected in single"	8	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.1;HMC-1: 2.1;Karpas-707: 1.1"									"HPA039264, HPA047769"	Uncertain					NA	NA					"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.8	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.4			0.2		0.0	0.1	0.0	0.2	0.1	2.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	1.1	0.4	0.8	0.4	0.3	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	0.3	0.3	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.7	0.2	0.3	0.2	0.2	0.0	0.2	0.3	0.2	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Group enriched"	"Detected in some"	21	"Early spermatids: 4.1;Late spermatids: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4"									HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.7	0.0	8.0	10.4	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
